data_1mut_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1mut _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 49.5 tp . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.449 ' O ' ' CG2' ' A' ' 40' ' ' ILE . 12.4 mt-30 -137.86 119.51 15.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.035 . . . . 0.0 109.809 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.585 ' O ' ' CD1' ' A' ' 83' ' ' TRP . 12.9 mm -102.46 179.66 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.431 -0.793 . . . . 0.0 109.665 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.468 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -142.38 108.21 5.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.197 -0.939 . . . . 0.0 108.849 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.497 HG21 ' CB ' ' A' ' 36' ' ' PRO . 7.8 p -113.07 164.15 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.024 . . . . 0.0 110.221 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.479 ' N ' ' CG2' ' A' ' 8' ' ' VAL . . . -149.73 120.63 1.17 Allowed Glycine 0 N--CA 1.482 1.719 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.614 ' CD1' ' CD2' ' A' ' 86' ' ' LEU . 1.2 mt -98.99 152.91 4.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 121.181 -1.188 . . . . 0.0 108.793 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.583 HG21 ' CZ3' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -120.62 153.44 23.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 118.902 -1.119 . . . . 0.0 109.138 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.506 ' O ' ' O ' ' A' ' 88' ' ' GLU . 38.2 ttp180 -155.76 114.13 3.43 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.565 -0.709 . . . . 0.0 109.823 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.603 ' HB3' ' CZ3' ' A' ' 90' ' ' TRP . 43.4 p-10 -158.76 -159.59 0.8 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.975 . . . . 0.0 109.883 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER 77.89 -72.52 0.09 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.991 0.9 . . . . 0.0 108.759 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 0.5 OUTLIER -147.41 -47.3 0.17 Allowed 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 122.286 1.041 . . . . 0.0 108.236 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 108' ' ' VAL . 6.1 t-20 179.15 35.44 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 3.0 mt-10 -107.29 148.93 28.37 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.637 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.54 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -116.8 156.1 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 109.857 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.575 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 11.5 t80 -92.5 69.48 4.94 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 176.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.518 HG22 ' N ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -82.05 -161.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 122.126 0.965 . . . . 0.0 112.093 -176.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.561 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.1 OUTLIER -141.01 132.21 26.46 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.454 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 9.9 ttp180 . . . . . 0 C--N 1.302 -1.49 0 O-C-N 121.373 -0.829 . . . . 0.0 109.929 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.8 m120 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.47 141.51 43.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.09 -1.006 . . . . 0.0 109.781 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.573 HD13 ' CD1' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -136.79 -178.02 5.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -0.8 . . . . 0.0 109.679 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.512 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -161.66 -155.86 0.41 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.716 0.769 . . . . 0.0 109.771 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.683 ' CZ ' ' CZ ' ' A' ' 115' ' ' PHE . 95.0 m-85 -117.3 150.3 46.11 Favored Pre-proline 0 C--N 1.296 -1.721 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.497 ' CB ' HG21 ' A' ' 8' ' ' VAL . 6.2 Cg_exo -58.01 -152.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 121.884 1.723 . . . . 0.0 109.671 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 134.96 170.02 12.06 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.119 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -164.8 -61.3 0.02 OUTLIER Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 1.3 tttt 178.15 153.46 0.32 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.507 -0.996 . . . . 0.0 109.369 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.63 ' CD1' ' CZ2' ' A' ' 83' ' ' TRP . 7.6 tt -129.78 50.97 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.869 . . . . 0.0 109.623 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -118.63 7.2 11.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 109.654 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.2 tpp -108.57 -3.01 18.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.174 -0.954 . . . . 0.0 109.729 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.18 172.68 14.6 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.81 -13.5 13.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.166 -1.197 . . . . 0.0 109.808 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.58 ' CB ' ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -144.38 179.53 1.15 Allowed Pre-proline 0 C--N 1.305 -1.335 0 O-C-N 121.044 -1.035 . . . . 0.0 109.496 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 45' ' ' THR . 4.9 Cg_endo -72.94 1.61 6.32 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.347 2.031 . . . . 0.0 110.843 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.512 ' O ' HG11 ' A' ' 51' ' ' VAL . 1.9 mt-10 -124.02 -51.88 1.78 Allowed 'General case' 0 C--O 1.198 -1.654 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.508 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -49.62 -34.81 19.09 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 122.388 1.09 . . . . 0.0 108.378 178.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.486 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -67.63 -60.74 2.31 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.323 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.557 HG23 ' CE2' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -75.95 -48.01 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.123 -0.986 . . . . 0.0 109.162 -179.059 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.581 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 3.1 p -39.48 -48.92 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 121.533 0.682 . . . . 0.0 109.163 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.581 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -75.73 -33.15 60.26 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 3.1 mm-40 -67.07 -10.64 52.07 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.456 ' CD2' ' OE1' ' A' ' 63' ' ' GLN . 0.3 OUTLIER -60.4 -64.6 0.89 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.429 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -81.79 -25.77 34.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.556 -0.715 . . . . 0.0 109.37 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.486 ' HG3' ' HG3' ' A' ' 52' ' ' ARG . 29.3 mm-40 -81.57 32.14 0.35 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.168 -0.958 . . . . 0.0 110.479 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.561 ' HB3' ' CB ' ' A' ' 95' ' ' TRP . 5.3 mm-40 -147.03 -67.78 0.26 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.965 -1.085 . . . . 0.0 109.27 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.672 ' HB ' ' HB3' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -114.27 -46.59 4.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.647 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.469 ' N ' ' CG1' ' A' ' 58' ' ' VAL . . . 100.48 53.49 1.06 Allowed Glycine 0 N--CA 1.482 1.713 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.458 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.53 HG12 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -90.33 167.73 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.593 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.2 m -119.02 -65.13 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.587 -1.32 . . . . 0.0 111.299 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 18.8 Cg_endo -77.5 33.66 0.45 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.628 1.552 . . . . 0.0 110.905 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.613 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 55.8 tt0 -82.27 65.74 7.54 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.584 0.707 . . . . 0.0 109.636 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -51.28 144.85 8.98 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.503 ' CG ' ' CZ3' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -153.93 170.94 19.85 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.596 -1.315 . . . . 0.0 111.21 -179.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.0 -177.51 6.16 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.0 tp -105.71 127.04 52.84 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.732 -1.23 . . . . 0.0 109.728 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.666 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -86.18 -70.48 0.6 Allowed 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.666 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -173.96 117.19 0.24 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.112 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -87.4 138.36 31.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.33 -0.856 . . . . 0.0 109.137 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.568 ' CD2' HG21 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -96.9 -170.93 2.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.244 -0.91 . . . . 0.0 110.63 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -154.4 137.24 15.35 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -131.11 175.39 9.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.934 -1.103 . . . . 0.0 110.407 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -158.55 126.29 5.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.473 -0.767 . . . . 0.0 109.175 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.603 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -88.5 177.9 2.36 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.846 . . . . 0.0 109.258 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.603 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 2.6 Cg_exo -56.24 -16.82 18.52 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.864 1.709 . . . . 0.0 110.408 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -165.99 15.09 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.345 -0.847 . . . . 0.0 110.623 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.501 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 6.4 mmm180 -124.49 178.94 5.15 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 120.818 -1.176 . . . . 0.0 109.097 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -129.41 110.76 12.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.0 109.26 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 24.3 mm -106.16 109.27 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 109.695 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.9 m -116.69 142.35 47.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.336 -0.852 . . . . 0.0 109.139 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.483 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -149.87 167.0 27.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.68 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.64 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 1.1 m95 -124.48 155.63 38.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.375 -0.828 . . . . 0.0 109.402 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.499 ' CZ ' ' CD2' ' A' ' 35' ' ' PHE . 3.0 m-85 -133.43 88.38 2.48 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.438 -0.789 . . . . 0.0 109.046 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.583 ' O ' ' CG ' ' A' ' 85' ' ' TRP . 1.2 p-90 -111.39 104.43 12.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.474 -1.391 . . . . 0.0 109.55 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.614 ' CD2' ' CD1' ' A' ' 10' ' ' ILE . 1.9 mm? -80.97 141.43 34.46 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.282 0.563 . . . . 0.0 111.178 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.544 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 5.0 m -99.53 -174.33 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 O-C-N 121.217 -0.927 . . . . 0.0 108.906 178.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.506 ' O ' ' O ' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -120.8 -46.87 2.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.986 -1.071 . . . . 0.0 111.444 -179.039 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.35 150.5 14.49 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.366 -1.459 . . . . 0.0 110.75 -179.222 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.603 ' CZ3' ' HB3' ' A' ' 13' ' ' ASN . 11.6 p90 -151.41 178.4 9.33 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 122.066 0.936 . . . . 0.0 109.896 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.537 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 22.6 tt0 -128.66 86.74 2.48 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.484 ' O ' ' CD1' ' A' ' 90' ' ' TRP . . . 148.99 175.07 21.12 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.585 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 1.2 mt-10 -80.26 118.55 72.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.141 -1.211 . . . . 0.0 108.21 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.573 ' CB ' ' CD1' ' A' ' 11' ' ' ILE . 3.4 Cg_endo -70.3 167.44 25.14 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.516 2.144 . . . . 0.0 112.064 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.672 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 29.2 p-90 -113.64 -167.86 1.26 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 162.01 -78.86 0.16 Allowed Glycine 0 N--CA 1.481 1.669 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.477 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -101.88 -174.86 2.68 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.726 -0.867 . . . . 0.0 108.701 179.149 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -125.24 -53.8 1.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.937 -1.102 . . . . 0.0 109.575 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.48 -0.09 89.61 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.469 ' OE1' HG23 ' A' ' 21' ' ' THR . 0.0 OUTLIER -113.07 128.92 25.05 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.178 -1.19 . . . . 0.0 109.452 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.69 -71.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.116 1.877 . . . . 0.0 110.503 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . 95.74 166.18 34.64 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -159.27 159.49 34.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.566 -1.549 . . . . 0.0 111.08 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.553 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -84.37 94.74 8.55 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.483 ' HE1' HG23 ' A' ' 20' ' ' ILE . 1.1 ttm -86.77 132.11 33.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.225 -0.922 . . . . 0.0 109.662 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.436 ' HB3' ' CD ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -111.26 99.3 8.15 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.419 -0.8 . . . . 0.0 109.43 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.543 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 2.0 mt -122.75 -85.97 0.65 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 109.575 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 107' ' ' LEU . 1.5 t -177.82 -55.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -159.68 88.2 0.11 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 109' ' ' GLY . 1.0 OUTLIER -40.39 143.74 0.29 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.518 -0.989 . . . . 0.0 110.015 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.457 ' OD1' ' HG2' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -128.64 -171.02 2.36 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.451 -0.781 . . . . 0.0 109.184 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.472 ' HA ' HG23 ' A' ' 123' ' ' ILE . . . -75.98 -9.34 58.53 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.197 -0.939 . . . . 0.0 109.431 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -62.81 -56.66 15.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.871 . . . . 0.0 109.687 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.475 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -81.3 -13.63 58.22 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.683 ' CZ ' ' CZ ' ' A' ' 35' ' ' PHE . 3.1 m-85 -90.58 110.6 42.39 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.514 ' CG ' ' O ' ' A' ' 33' ' ' LEU . 6.6 Cg_exo -50.96 141.19 37.51 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.953 1.769 . . . . 0.0 110.094 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 4.4 Cg_exo -59.35 126.52 21.03 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.195 1.93 . . . . 0.0 110.804 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 152.97 -18.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.53 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 0.9 OUTLIER -123.33 48.52 1.82 Allowed 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.655 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.2 mm-40 -65.99 -35.88 12.07 Favored Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.655 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 6.2 Cg_exo -60.59 -35.11 91.32 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 121.678 1.585 . . . . 0.0 112.094 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.568 HG21 ' CD2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -102.67 -46.66 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 120.588 -1.32 . . . . 0.0 108.672 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.602 HD11 ' CD2' ' A' ' 115' ' ' PHE . 24.8 mm -50.15 -38.35 14.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 127' ' ' LYS . . . -52.06 -44.35 64.25 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -71.08 -42.63 69.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.41 -0.806 . . . . 0.0 109.782 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.594 HD23 ' CE2' ' A' ' 68' ' ' PHE . 1.4 mt -63.01 -9.73 11.21 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.276 -0.89 . . . . 0.0 109.732 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.457 ' HG2' ' OD1' ' A' ' 111' ' ' ASN . 55.6 mttt -56.81 -48.7 77.35 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.14 -0.975 . . . . 0.0 108.69 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 129' ' ' LEU . 1.8 ptt180 -89.33 0.95 56.42 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.407 -0.808 . . . . 0.0 109.27 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 126' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.851 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 122.112 0.958 . . . . 0.0 110.546 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.447 ' O ' ' O ' ' A' ' 4' ' ' LEU . 8.8 mt-30 58.36 126.53 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.568 0.699 . . . . 0.0 110.485 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.496 ' CG2' ' N ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -129.89 176.05 9.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.496 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . -117.79 80.26 1.48 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.841 -1.162 . . . . 0.0 110.283 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.57 ' CG1' ' O ' ' A' ' 83' ' ' TRP . 3.2 p -100.18 145.27 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 118.896 -1.122 . . . . 0.0 108.485 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -129.37 110.36 1.06 Allowed Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.614 ' CD1' ' CD1' ' A' ' 86' ' ' LEU . 1.3 mt -92.49 166.19 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.685 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -154.48 146.42 13.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.271 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.492 ' HD2' ' CD1' ' A' ' 107' ' ' LEU . 38.2 ttp180 -161.5 77.27 0.54 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.532 -0.73 . . . . 0.0 110.039 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.514 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 20.2 m-80 -160.1 -162.04 0.95 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -0.893 . . . . 0.0 109.543 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.37 -85.98 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.619 0.723 . . . . 0.0 109.528 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 13' ' ' ASN . 28.9 t-20 -94.75 28.68 2.59 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.529 -0.732 . . . . 0.0 109.335 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 15' ' ' ASN . 30.1 t30 42.31 43.73 3.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.475 -0.766 . . . . 0.0 109.318 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 105' ' ' MET . 2.5 mt-10 -129.41 149.33 51.24 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.685 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 3.0 mt -101.12 156.99 4.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 118.326 -1.35 . . . . 0.0 110.672 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.483 ' HB3' HG13 ' A' ' 11' ' ' ILE . 60.3 t80 -97.03 78.25 2.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.545 ' O ' ' CA ' ' A' ' 102' ' ' GLY . 11.3 mm -78.09 167.14 2.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.404 -0.81 . . . . 0.0 110.084 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.539 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -128.01 139.88 52.3 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.848 178.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 32' ' ' LYS . 1.2 ttp180 . . . . . 0 C--N 1.307 -1.277 0 O-C-N 121.055 -1.028 . . . . 0.0 109.433 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.425 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 1.5 m120 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.458 ' O ' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -108.13 135.0 50.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.317 -0.864 . . . . 0.0 109.375 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.538 ' O ' ' CG ' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -104.63 -176.94 3.22 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.351 -0.843 . . . . 0.0 109.073 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -162.17 -155.91 0.39 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 110.073 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.447 ' O ' ' O ' ' A' ' 36' ' ' PRO . 21.8 m-85 -142.31 141.41 21.06 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.555 ' CG ' HG21 ' A' ' 8' ' ' VAL . 5.9 Cg_exo -57.54 -150.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.87 1.714 . . . . 0.0 110.074 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.562 ' HA2' ' CA ' ' A' ' 8' ' ' VAL . . . 148.78 -149.08 21.04 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.086 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . 144.93 -79.93 0.23 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 178.07 133.87 0.07 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.395 -1.061 . . . . 0.0 109.652 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.434 ' CG2' ' O ' ' A' ' 40' ' ' ILE . 9.0 tt -121.84 74.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.253 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.444 ' CG ' ' HG2' ' A' ' 39' ' ' LYS . 1.9 mm-40 -113.04 -179.71 3.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.611 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.2 ttm 44.09 83.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.31 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 168.85 124.31 0.72 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.21 -11.17 39.09 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.19 -1.183 . . . . 0.0 110.192 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.56 HG21 ' HD2' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -125.18 149.03 62.53 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 120.927 -1.108 . . . . 0.0 108.715 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.608 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 9.3 Cg_endo -71.12 14.98 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.753 2.302 . . . . 0.0 112.343 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.485 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -124.01 -60.92 1.4 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.508 -1.37 . . . . 0.0 109.766 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.553 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -48.12 -28.5 2.95 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.823 1.296 . . . . 0.0 109.379 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . -67.54 -67.17 0.48 Allowed 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.374 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.606 HG12 ' CE3' ' A' ' 85' ' ' TRP . 10.0 p -83.29 3.55 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.259 -0.901 . . . . 0.0 111.463 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.582 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 4.9 p -81.92 -43.67 19.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.582 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -69.34 -29.08 66.82 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 113.745 -1.571 . . . . 0.0 108.101 177.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 49' ' ' ALA . 69.9 mt-10 -70.36 -22.78 62.74 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.128 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.594 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 3.4 mt -63.43 -48.09 79.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -0.908 . . . . 0.0 109.467 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.505 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 2.1 pt20 -81.37 -30.64 33.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.937 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 9.1 mm-40 -81.88 32.56 0.37 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.219 -0.926 . . . . 0.0 111.014 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.655 ' CB ' ' CD1' ' A' ' 95' ' ' TRP . 25.6 mm-40 -155.3 -57.63 0.1 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.629 -1.294 . . . . 0.0 109.985 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.645 ' CG2' ' CD1' ' A' ' 95' ' ' TRP . 10.6 m -113.92 -49.8 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 92.4 37.69 5.82 Favored Glycine 0 C--N 1.299 -1.482 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.611 HG12 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -79.83 174.67 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -1.092 . . . . 0.0 108.255 178.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.546 ' HB ' ' CB ' ' A' ' 91' ' ' GLU . 8.1 m -115.3 90.13 23.59 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.542 ' HG3' ' CD1' ' A' ' 54' ' ' LEU . 4.3 Cg_endo -61.0 122.75 11.66 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 121.809 1.672 . . . . 0.0 110.11 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.518 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 1.8 mt-30 -86.89 -34.18 19.5 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.834 -0.541 . . . . 0.0 109.773 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.466 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 45.5 t60 -176.42 97.48 0.06 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.179 -0.951 . . . . 0.0 110.315 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.403 ' CE2' ' HB2' ' A' ' 62' ' ' PRO . 13.7 p90 -111.7 175.5 5.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.908 -1.12 . . . . 0.0 109.307 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.1 m -161.97 173.18 14.81 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.624 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.572 HD23 ' CZ3' ' A' ' 83' ' ' TRP . 4.6 tp -116.09 114.16 24.15 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.215 -0.928 . . . . 0.0 109.153 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.641 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 2.6 p90 -73.78 -53.76 9.57 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.294 -0.879 . . . . 0.0 109.876 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.641 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 0.5 OUTLIER 176.45 149.59 0.13 Allowed 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.039 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.503 ' HB3' ' HA ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -111.66 163.46 14.09 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.312 -0.868 . . . . 0.0 109.895 -179.466 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.54 ' CD2' HG22 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -113.93 -164.6 0.94 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 109.145 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -136.03 156.28 48.96 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.133 -0.979 . . . . 0.0 109.557 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.57 82.85 1.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.59 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 1.0 OUTLIER -103.12 114.2 28.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 110.327 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.512 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -81.69 177.04 3.25 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 1.9 Cg_endo -63.95 2.67 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.926 1.751 . . . . 0.0 111.42 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -125.52 -55.05 1.55 Allowed 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.623 -1.298 . . . . 0.0 111.162 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.524 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -118.49 -179.42 3.78 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.253 -0.904 . . . . 0.0 110.387 -178.114 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.59 ' CD2' ' HG3' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -128.51 96.44 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 12.6 mt -97.74 128.68 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.506 -0.746 . . . . 0.0 110.815 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' A' ' 71' ' ' LEU . 3.7 m -115.85 118.43 32.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 108.769 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.467 ' HB2' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -81.93 132.15 35.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.154 -0.966 . . . . 0.0 109.81 -179.502 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.689 ' CD1' ' O ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -122.9 113.64 19.39 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.31 -0.869 . . . . 0.0 109.575 -178.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.554 ' CA ' HG11 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -122.37 113.54 19.52 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 120.358 -1.464 . . . . 0.0 109.955 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.63 ' CD1' ' O ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -83.34 87.05 6.97 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.363 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.614 ' CD1' ' CD1' ' A' ' 10' ' ' ILE . 0.6 OUTLIER -44.39 107.87 0.1 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.038 -1.039 . . . . 0.0 109.21 -179.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.55 ' CG2' ' CG2' ' A' ' 11' ' ' ILE . 19.8 m -81.0 174.66 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.531 -0.73 . . . . 0.0 110.308 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.501 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 1.0 OUTLIER -129.22 -18.48 3.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 110.422 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.501 ' HD3' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -162.16 174.08 13.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.89 -1.131 . . . . 0.0 110.252 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.527 ' CZ3' ' CG2' ' A' ' 11' ' ' ILE . 35.1 p90 174.65 -179.71 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.093 0.949 . . . . 0.0 109.883 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.546 ' CB ' ' HB ' ' A' ' 61' ' ' THR . 1.4 tt0 -134.7 109.17 8.43 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.727 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 94' ' ' PRO . . . 114.37 -156.97 15.28 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.333 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.476 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 1.9 mt-10 -107.29 102.22 42.65 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.344 -1.092 . . . . 0.0 109.067 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.669 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 3.4 Cg_endo -66.46 -169.82 0.19 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.118 1.879 . . . . 0.0 111.972 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.655 ' CD1' ' CB ' ' A' ' 57' ' ' GLU . 4.8 p-90 -136.01 -168.27 2.19 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.69 0.757 . . . . 0.0 108.986 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.496 ' C ' ' CB ' ' A' ' 36' ' ' PRO . . . -159.98 -77.86 0.03 OUTLIER Glycine 0 C--N 1.295 -1.742 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.524 ' CB ' ' HB3' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -87.06 -179.27 6.44 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.524 -0.986 . . . . 0.0 109.494 179.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -92.59 -36.04 13.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.346 -0.846 . . . . 0.0 109.819 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -139.76 9.61 3.12 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.524 ' HB3' ' CB ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -99.04 109.59 54.64 Favored Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 121.189 -1.183 . . . . 0.0 109.694 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.97 122.2 11.03 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.949 1.766 . . . . 0.0 109.679 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 20' ' ' ILE . . . -98.22 168.58 23.29 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.467 ' HG3' ' HE1' ' A' ' 105' ' ' MET . 14.4 pt-20 -125.81 154.61 42.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.857 -1.378 . . . . 0.0 110.086 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.442 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -94.65 104.01 15.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.543 -0.723 . . . . 0.0 109.351 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 1.2 ttm -92.51 168.73 11.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.178 -0.951 . . . . 0.0 109.257 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.4 t -116.21 65.63 0.71 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.176 -0.953 . . . . 0.0 109.567 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.493 HD13 ' CD2' ' A' ' 110' ' ' LEU . 3.1 tp 48.03 59.52 4.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.274 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.34 -72.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 109.555 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.48 ' HA3' ' CB ' ' A' ' 114' ' ' ASP . . . -100.75 30.92 9.27 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.545 ' CD1' ' O ' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -67.24 -20.6 65.69 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.311 -1.111 . . . . 0.0 109.33 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -78.93 -177.89 5.77 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.427 -0.795 . . . . 0.0 109.731 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.532 ' CB ' HG23 ' A' ' 123' ' ' ILE . . . -68.76 -6.81 28.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.378 -0.826 . . . . 0.0 109.656 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -62.91 -54.77 33.53 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.257 -0.902 . . . . 0.0 109.944 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.48 ' CB ' ' HA3' ' A' ' 109' ' ' GLY . 19.8 t0 -90.56 -6.7 54.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.872 . . . . 0.0 109.811 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.554 ' CG ' HD13 ' A' ' 123' ' ' ILE . 1.8 m-85 -89.32 142.13 29.57 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.026 -1.046 . . . . 0.0 109.388 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.538 ' CG ' ' O ' ' A' ' 33' ' ' LEU . 2.1 Cg_endo -71.65 158.13 54.19 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.303 2.002 . . . . 0.0 110.584 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.448 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 2.8 Cg_endo -60.62 -177.04 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.484 2.123 . . . . 0.0 110.563 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 74.43 -1.85 2.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.458 -0.776 . . . . 0.0 109.902 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.566 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 0.9 OUTLIER -127.15 41.7 3.47 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.032 -1.042 . . . . 0.0 109.511 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.675 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 26.6 mt-10 -74.94 -39.12 3.24 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.299 -0.875 . . . . 0.0 112.065 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.6 Cg_exo -62.37 -32.36 81.26 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.954 1.769 . . . . 0.0 112.089 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.567 HG13 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -101.4 -50.4 10.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 120.508 -1.37 . . . . 0.0 109.288 -179.592 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.566 ' CG1' ' HB3' ' A' ' 119' ' ' ASN . 14.1 mm -50.95 -36.88 16.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' A' ' 120' ' ' GLU . . . -58.73 -43.85 90.3 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -63.01 -41.46 99.57 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.293 -0.88 . . . . 0.0 109.465 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.495 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 5.3 mp -58.06 -17.21 16.29 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.233 -0.917 . . . . 0.0 109.678 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 124' ' ' ALA . 13.8 mmtt -57.07 -53.46 57.87 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -91.25 9.77 29.96 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.009 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.549 ' CD1' HD22 ' A' ' 86' ' ' LEU . 3.4 tp . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.748 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.445 ' C ' HG12 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -164.26 119.66 1.52 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.695 -1.253 . . . . 0.0 110.713 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.538 ' N ' HG12 ' A' ' 40' ' ' ILE . 6.0 mm -152.02 157.49 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.483 ' O ' ' CA ' ' A' ' 37' ' ' GLY . . . -146.42 119.31 8.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.762 -1.211 . . . . 0.0 110.465 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.561 ' CG2' ' O ' ' A' ' 36' ' ' PRO . 7.5 p -122.2 147.17 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.565 ' HA3' ' CZ3' ' A' ' 95' ' ' TRP . . . -129.1 119.55 2.99 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.605 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 1.2 mt -92.2 166.15 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.699 HG23 ' CD2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -149.19 153.38 10.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 118.584 -1.246 . . . . 0.0 110.492 -178.3 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 88' ' ' GLU . 11.0 ttp180 -129.39 122.23 29.01 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.39 -169.46 1.8 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.098 -1.001 . . . . 0.0 110.632 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -78.36 -6.93 56.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.558 -0.714 . . . . 0.0 110.302 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.467 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 24.3 t30 -88.43 21.35 2.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.443 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 20.2 t30 48.46 42.92 19.35 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.413 -0.804 . . . . 0.0 109.339 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.467 ' CG ' ' O ' ' A' ' 15' ' ' ASN . 2.9 mt-10 -140.45 147.65 39.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 108.835 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.556 ' N ' ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -103.09 153.92 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.111 -0.993 . . . . 0.0 109.415 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 56.6 t80 -88.84 73.15 8.46 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.544 ' CG2' HD22 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -80.06 -161.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.344 -0.848 . . . . 0.0 109.354 -178.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.575 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.2 OUTLIER -159.96 152.66 21.31 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.823 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.517 ' CD ' ' O ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.246 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.337 0.589 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.517 ' O ' ' CD ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -151.55 125.88 9.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.424 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.544 HD22 ' CG2' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -121.17 -165.38 1.22 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.349 -0.844 . . . . 0.0 109.36 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.2 -160.89 0.82 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.337 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.69 ' CE2' ' CZ ' ' A' ' 84' ' ' PHE . 5.8 m-85 -156.12 70.47 5.09 Favored Pre-proline 0 C--N 1.294 -1.833 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.561 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 4.3 Cg_exo -55.19 164.69 3.5 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.046 1.831 . . . . 0.0 109.588 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.483 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . -161.57 -147.71 5.07 Favored Glycine 0 N--CA 1.486 1.969 0 C-N-CA 119.325 -1.417 . . . . 0.0 109.814 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -134.51 -76.03 0.09 OUTLIER Glycine 0 N--CA 1.484 1.887 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 13.1 tttt 176.38 155.7 0.23 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.628 -0.924 . . . . 0.0 109.822 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.538 HG12 ' N ' ' A' ' 6' ' ' ILE . 15.2 mm -78.92 107.5 11.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.464 ' OE1' ' HD3' ' A' ' 52' ' ' ARG . 5.6 mt-10 -116.63 177.78 4.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.963 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.437 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 54.3 mmm 71.38 -164.99 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.863 . . . . 0.0 109.732 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.8 -26.53 3.29 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.539 ' HB2' ' NE2' ' A' ' 48' ' ' GLN . 0.9 OUTLIER -79.61 -154.91 0.09 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.399 -1.059 . . . . 0.0 109.19 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.567 ' CG2' ' HD3' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -160.82 -58.09 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.032 -1.043 . . . . 0.0 111.374 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.567 ' HD3' ' CG2' ' A' ' 45' ' ' THR . 1.3 Cg_endo -67.62 3.88 1.62 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 121.492 1.461 . . . . 0.0 112.765 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.509 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -148.91 -69.28 0.21 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.331 -1.48 . . . . 0.0 109.157 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.568 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 13.3 mt-30 -51.37 -27.57 10.2 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 122.54 1.162 . . . . 0.0 110.116 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 45' ' ' THR . . . -65.65 -66.18 0.58 Allowed 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.671 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.486 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 9.9 p -81.9 -6.59 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 111.25 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.58 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 3.1 p -72.38 -48.3 48.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.58 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -75.09 -22.5 58.23 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -52.98 -21.45 4.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.89 -1.131 . . . . 0.0 108.808 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.6 OUTLIER -66.08 -59.44 3.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.419 -0.801 . . . . 0.0 110.401 -179.435 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.531 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 7.2 pt20 -79.97 -30.22 39.73 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.177 -0.952 . . . . 0.0 111.891 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.531 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 1.1 pp20? -79.64 -29.17 40.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.869 -1.144 . . . . 0.0 111.377 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.538 ' OE2' ' CD1' ' A' ' 95' ' ' TRP . 4.4 pt-20 -91.59 -46.63 7.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.684 -1.26 . . . . 0.0 110.428 -178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.525 ' CG1' ' HG3' ' A' ' 57' ' ' GLU . 0.5 OUTLIER -147.96 -67.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.353 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 54' ' ' LEU . . . 119.99 71.36 0.33 Allowed Glycine 0 N--CA 1.48 1.589 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.643 HG22 ' HD2' ' A' ' 94' ' ' PRO . 0.1 OUTLIER -107.52 -156.49 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.114 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 91' ' ' GLU . 2.3 m -146.51 91.87 5.27 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.507 ' HA ' ' CB ' ' A' ' 90' ' ' TRP . 1.8 Cg_endo -66.05 150.55 85.23 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.34 2.027 . . . . 0.0 110.729 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -121.28 -40.07 2.62 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.592 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -128.69 -179.56 5.13 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.592 ' CD1' ' O ' ' A' ' 64' ' ' HIS . 22.9 m-85 -148.7 170.65 17.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.144 -0.972 . . . . 0.0 110.053 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.547 ' HB3' ' O ' ' A' ' 86' ' ' LEU . 3.8 t -159.24 0.84 0.09 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.296 -0.877 . . . . 0.0 111.96 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.639 ' CD2' ' CZ3' ' A' ' 85' ' ' TRP . 9.6 tp -29.0 148.52 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 CA-C-O 121.911 0.863 . . . . 0.0 110.991 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 84' ' ' PHE . 14.3 p90 -116.46 -51.19 2.61 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.811 0.815 . . . . 0.0 109.431 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.528 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.3 pt-20 -179.18 161.84 1.15 Allowed 'General case' 0 C--N 1.291 -1.946 0 O-C-N 121.743 -0.598 . . . . 0.0 110.135 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.59 ' HD3' ' CE3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -105.59 -175.8 2.9 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.311 -0.868 . . . . 0.0 110.221 -179.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.518 HD13 ' N ' ' A' ' 72' ' ' GLU . 3.8 pp -147.51 -161.52 1.35 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.262 -0.899 . . . . 0.0 109.564 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.518 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -143.45 162.16 36.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.461 -0.775 . . . . 0.0 109.425 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -141.09 164.07 31.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.709 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -158.5 108.69 2.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.427 -0.796 . . . . 0.0 109.097 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.521 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 2.1 m-85 -79.31 170.6 15.36 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.2 Cg_exo -57.84 -10.52 7.69 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.905 1.737 . . . . 0.0 111.204 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -153.54 -5.69 0.18 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.87 -1.144 . . . . 0.0 112.204 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.521 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 3.7 ptt180 -133.34 -176.91 4.3 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.406 -1.434 . . . . 0.0 109.548 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.426 ' C ' HG12 ' A' ' 80' ' ' ILE . 5.9 m80 -134.99 156.11 49.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.157 -0.965 . . . . 0.0 109.381 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.426 HG12 ' C ' ' A' ' 79' ' ' HIS . 33.1 mm -148.87 92.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.084 -1.01 . . . . 0.0 109.897 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.417 HG23 ' CH2' ' A' ' 83' ' ' TRP . 4.0 m -79.33 90.52 4.99 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.513 ' CD1' HG23 ' A' ' 6' ' ' ILE . 11.0 tp -108.24 141.57 39.82 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.315 -0.866 . . . . 0.0 109.614 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.59 ' CE3' ' HD3' ' A' ' 70' ' ' LYS . 8.7 m95 -89.56 -174.54 4.38 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.521 -0.737 . . . . 0.0 109.388 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.69 ' CZ ' ' CE2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -144.05 76.13 1.49 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.639 ' CZ3' ' CD2' ' A' ' 67' ' ' LEU . 55.7 m95 -81.46 157.89 24.74 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 122.218 1.008 . . . . 0.0 110.628 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.605 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 6.2 tp -150.24 98.12 2.64 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.608 ' CG2' ' CG2' ' A' ' 11' ' ' ILE . 15.8 m -93.64 178.46 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.8 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -110.59 -28.15 8.62 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.23 -0.919 . . . . 0.0 112.32 -178.094 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -161.68 153.77 19.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.547 -1.346 . . . . 0.0 110.788 -178.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.7 ' NE1' ' O ' ' A' ' 92' ' ' GLY . 0.9 OUTLIER -161.96 -167.43 1.66 Allowed 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.582 -0.699 . . . . 0.0 109.564 178.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.535 ' O ' ' O ' ' A' ' 92' ' ' GLY . 22.7 tt0 -90.89 -105.82 0.1 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.274 -0.891 . . . . 0.0 110.062 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.7 ' O ' ' NE1' ' A' ' 90' ' ' TRP . . . -45.18 173.25 0.01 OUTLIER Glycine 0 N--CA 1.495 2.598 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.814 ' N ' ' HD3' ' A' ' 94' ' ' PRO . 1.5 pt-20 -115.26 28.53 0.11 Allowed Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 119.354 1.577 . . . . 0.0 113.29 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.814 ' HD3' ' N ' ' A' ' 93' ' ' GLU . 60.6 Cg_endo -90.41 -123.54 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 122.508 2.139 . . . . 0.0 108.447 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.638 ' CD1' ' CD1' ' A' ' 60' ' ' ILE . 0.0 OUTLIER 85.76 75.53 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.042 -1.036 . . . . 0.0 111.707 177.661 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 161.26 -121.77 1.05 Allowed Glycine 0 C--N 1.297 -1.634 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.494 ' CD ' ' HB2' ' A' ' 100' ' ' GLN . 7.3 tttt -94.5 145.86 24.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.109 -1.23 . . . . 0.0 109.995 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 11.6 pt-20 -89.72 -33.81 16.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.168 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.439 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . -88.11 -10.83 68.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HB2' ' CD ' ' A' ' 97' ' ' LYS . 7.1 tt0 -102.65 113.2 66.02 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 121.374 -1.074 . . . . 0.0 109.381 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.29 102.62 0.33 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.041 1.827 . . . . 0.0 110.726 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -65.38 172.31 22.83 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.476 ' O ' HG21 ' A' ' 20' ' ' ILE . 4.2 pt-20 -147.0 134.22 20.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.543 -1.563 . . . . 0.0 110.14 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.599 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -81.81 94.72 7.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.448 -0.783 . . . . 0.0 109.08 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.457 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -85.04 169.51 13.88 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.082 -1.011 . . . . 0.0 109.471 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.43 145.51 25.59 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.199 -0.938 . . . . 0.0 109.596 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.474 ' HG ' HD13 ' A' ' 110' ' ' LEU . 1.8 tt -101.39 61.41 0.92 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.59 -25.95 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.565 -0.709 . . . . 0.0 109.505 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -162.58 38.04 0.35 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.474 HD13 ' HG ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -43.13 145.82 0.48 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.397 -1.061 . . . . 0.0 109.632 -179.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.454 ' ND2' ' HE2' ' A' ' 127' ' ' LYS . 2.6 t30 -156.87 163.12 39.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.082 -1.011 . . . . 0.0 110.028 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.483 ' HA ' ' CG2' ' A' ' 123' ' ' ILE . . . -61.29 -15.64 37.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 109.184 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -68.44 -33.15 73.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.425 -0.797 . . . . 0.0 109.4 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -79.13 2.09 22.07 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.041 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.605 ' CE1' ' CE2' ' A' ' 35' ' ' PHE . 10.2 m-85 -130.97 104.72 15.28 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.443 -0.786 . . . . 0.0 109.179 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.436 ' HG3' ' HB2' ' A' ' 32' ' ' LYS . 21.6 Cg_exo -43.18 160.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.513 2.142 . . . . 0.0 110.831 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.525 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 5.0 Cg_exo -58.03 130.25 37.2 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.518 2.145 . . . . 0.0 111.365 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 160.31 -56.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.549 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 16.1 m-20 -107.84 42.41 1.35 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.641 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -61.51 -38.68 54.33 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.433 -0.792 . . . . 0.0 113.004 -179.131 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 1.9 Cg_endo -65.06 -37.46 32.8 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 122.0 1.8 . . . . 0.0 111.977 -177.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.586 HG12 ' CG ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -90.23 -39.34 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.523 -1.361 . . . . 0.0 108.186 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.549 ' CG1' ' O ' ' A' ' 119' ' ' ASN . 6.6 mm -56.35 -34.31 40.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.43 -36.78 74.15 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.871 -0.731 . . . . 0.0 109.271 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -55.1 8.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.91 . . . . 0.0 109.967 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.428 ' HG ' ' HA ' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -50.65 -17.66 0.56 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.199 -0.938 . . . . 0.0 110.126 -179.475 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.454 ' HE2' ' ND2' ' A' ' 111' ' ' ASN . 15.2 mttt -47.59 -46.37 28.2 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.825 -1.172 . . . . 0.0 108.923 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -95.98 47.71 1.1 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.459 -0.775 . . . . 0.0 109.319 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.464 ' CD2' HD22 ' A' ' 86' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.305 -1.345 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.658 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.4 tp . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.351 0.595 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.558 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . 2.0 mt-30 -118.12 159.25 23.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 0.0 109.177 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.475 ' CG2' ' HG ' ' A' ' 82' ' ' LEU . 2.1 tt -134.4 -173.94 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.132 -0.98 . . . . 0.0 109.365 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.466 ' N ' HG22 ' A' ' 6' ' ' ILE . . . -138.31 104.92 5.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.198 -0.939 . . . . 0.0 109.311 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 7.6 p -113.08 139.96 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.428 -0.795 . . . . 0.0 109.567 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.609 ' CA ' ' NE1' ' A' ' 85' ' ' TRP . . . -121.77 126.32 6.44 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.639 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.581 HD12 ' CE2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -107.17 144.27 16.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.085 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.604 HG21 ' CE3' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -123.69 156.04 30.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.866 -1.146 . . . . 0.0 109.253 179.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -157.44 125.25 5.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.474 -0.766 . . . . 0.0 109.451 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.577 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 26.9 p-10 -156.63 -168.48 2.7 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.879 -1.138 . . . . 0.0 111.169 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 13' ' ' ASN . 3.8 mt-10 66.16 -83.44 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.863 0.84 . . . . 0.0 110.048 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -132.68 -59.21 0.91 Allowed 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 122.004 0.907 . . . . 0.0 109.593 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -164.72 32.55 0.07 Allowed 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 3.7 mt-10 -89.39 148.95 23.21 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.535 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 0.9 OUTLIER -131.21 154.91 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.06 -1.025 . . . . 0.0 109.582 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.586 ' CZ ' ' OE1' ' A' ' 100' ' ' GLN . 9.6 t80 -116.63 84.87 2.21 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.455 ' CD1' ' HE2' ' A' ' 105' ' ' MET . 0.6 OUTLIER -107.3 -152.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 108.619 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.546 ' CG2' ' HD3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -131.23 151.32 51.59 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.015 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.306 -1.305 0 O-C-N 121.43 -0.794 . . . . 0.0 109.818 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.499 ' HB2' ' HG3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -148.81 132.31 16.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.206 -0.934 . . . . 0.0 109.339 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.59 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -93.6 -176.86 4.21 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 120.93 -1.106 . . . . 0.0 108.389 179.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.482 ' O ' ' CG ' ' A' ' 35' ' ' PHE . 4.8 tt0 -163.44 -158.9 0.49 Allowed 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 118.804 -1.159 . . . . 0.0 111.067 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.656 ' CZ ' ' CZ ' ' A' ' 115' ' ' PHE . 57.8 m-85 -161.64 64.75 1.85 Allowed Pre-proline 0 C--N 1.299 -1.601 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 34' ' ' GLU . 2.3 Cg_endo -60.62 -84.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.235 1.957 . . . . 0.0 110.706 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 97' ' ' LYS . . . 105.6 -120.64 6.51 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -156.46 -77.85 0.02 OUTLIER Glycine 0 N--CA 1.488 2.1 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 6.0 tttp 177.41 132.31 0.06 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.483 -1.01 . . . . 0.0 109.318 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.558 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 14.2 tt -118.93 120.04 62.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.378 -0.826 . . . . 0.0 108.978 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -85.55 144.73 27.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.033 -1.042 . . . . 0.0 109.826 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.17 165.15 23.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.372 -0.83 . . . . 0.0 109.406 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.67 -17.23 57.08 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.24 -153.95 0.44 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.588 -0.948 . . . . 0.0 108.816 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.572 ' CG2' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -122.1 176.96 1.74 Allowed Pre-proline 0 C--N 1.307 -1.277 0 O-C-N 120.791 -1.193 . . . . 0.0 108.526 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.572 ' CD ' ' CG2' ' A' ' 45' ' ' THR . 10.2 Cg_endo -76.96 -7.57 17.42 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.052 1.835 . . . . 0.0 110.986 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.505 ' O ' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -113.59 -62.34 1.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.934 -1.104 . . . . 0.0 110.609 -178.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.518 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 2.5 tt0 -39.29 -36.22 0.32 Allowed 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.658 1.218 . . . . 0.0 109.502 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 47' ' ' GLU . . . -60.42 -67.08 0.43 Allowed 'General case' 0 C--N 1.271 -2.824 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.313 -178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -81.55 -44.0 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.271 -0.893 . . . . 0.0 110.447 -178.468 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.548 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 7.4 p -39.95 -45.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.548 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -73.94 -37.36 64.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.114 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 50' ' ' VAL . 5.1 mm-40 -67.4 -7.06 22.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.197 -0.939 . . . . 0.0 109.446 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.598 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -76.45 -54.76 6.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.957 -1.089 . . . . 0.0 109.62 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -80.02 -29.77 39.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.009 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.457 ' HG3' ' HG3' ' A' ' 52' ' ' ARG . 11.9 mm-40 -81.55 35.37 0.4 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.136 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.491 ' HB2' ' CD1' ' A' ' 95' ' ' TRP . 12.3 mt-10 -150.53 -66.52 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.901 -1.124 . . . . 0.0 109.613 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.59 ' CG2' ' O ' ' A' ' 93' ' ' GLU . 1.4 p -122.56 -27.21 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 O-C-N 121.043 -1.035 . . . . 0.0 109.788 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.51 ' N ' HG11 ' A' ' 58' ' ' VAL . . . 69.02 70.23 1.21 Allowed Glycine 0 N--CA 1.489 2.177 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.26 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.478 HG12 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -90.12 172.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.671 ' CB ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -123.36 -70.02 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 120.201 -1.562 . . . . 0.0 111.221 -178.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.671 ' HD3' ' CB ' ' A' ' 61' ' ' THR . 12.3 Cg_endo -75.35 49.04 2.24 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 122.057 1.838 . . . . 0.0 111.251 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.641 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 11.7 tt0 -101.52 72.3 1.39 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.672 -1.267 . . . . 0.0 109.276 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -65.59 105.13 1.14 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.541 ' HB3' ' CG1' ' A' ' 87' ' ' VAL . 30.5 p90 -125.41 179.58 5.05 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.758 1.266 . . . . 0.0 111.97 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 68' ' ' PHE . 4.9 m -162.19 131.82 4.54 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.556 ' CD1' ' O ' ' A' ' 84' ' ' PHE . 43.5 tp -49.04 94.76 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.726 -1.234 . . . . 0.0 109.578 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.586 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 1.0 OUTLIER -42.93 -77.15 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.586 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 3.3 mm-40 -156.67 -173.5 4.51 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.486 ' CE ' HD23 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -140.43 147.81 40.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.065 -1.022 . . . . 0.0 109.845 -179.542 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.538 ' CG ' ' HB ' ' A' ' 122' ' ' VAL . 0.5 OUTLIER -124.32 -178.45 4.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.15 -0.969 . . . . 0.0 109.671 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -160.88 146.77 14.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.478 -0.764 . . . . 0.0 109.398 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -129.3 -163.53 1.3 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.957 . . . . 0.0 109.29 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -157.44 117.6 3.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 0.0 109.187 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.586 ' CD2' HD12 ' A' ' 80' ' ' ILE . 1.4 m-85 -79.62 170.37 16.24 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.511 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.0 Cg_exo -56.89 -6.34 1.7 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.063 1.842 . . . . 0.0 111.983 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.63 -17.04 0.32 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.566 -1.334 . . . . 0.0 112.113 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -131.44 -177.76 4.55 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.446 -1.409 . . . . 0.0 110.507 -178.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -121.67 121.69 37.91 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.586 HD12 ' CD2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -101.92 161.38 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.083 -1.011 . . . . 0.0 109.734 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.4 m -152.42 105.28 3.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.417 -0.802 . . . . 0.0 109.354 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.528 ' CB ' HD12 ' A' ' 71' ' ' LEU . 1.2 mp -85.94 149.93 24.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 109.821 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.592 ' CE2' ' HB3' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -110.35 115.97 30.62 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.584 ' CD2' HG12 ' A' ' 122' ' ' VAL . 2.2 m-85 -97.55 100.72 12.14 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.327 -0.858 . . . . 0.0 111.695 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.612 ' O ' ' CG ' ' A' ' 85' ' ' TRP . 29.1 p-90 -105.72 82.8 1.84 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.8 -1.188 . . . . 0.0 108.263 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.471 HD11 ' HB ' ' A' ' 10' ' ' ILE . 24.7 tp -78.06 146.01 35.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.434 -0.791 . . . . 0.0 110.673 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.564 ' CG2' ' CG2' ' A' ' 11' ' ' ILE . 17.7 m -113.13 -163.01 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.548 -0.72 . . . . 0.0 109.642 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 7.3 mt-10 -141.35 -29.72 0.63 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -0.981 . . . . 0.0 111.041 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.672 ' O ' ' HB3' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -143.78 -172.85 3.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.745 -1.222 . . . . 0.0 109.432 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.672 ' HB3' ' O ' ' A' ' 89' ' ' ARG . 17.2 p90 154.47 162.59 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 122.72 1.248 . . . . 0.0 110.968 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.574 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 46.8 tt0 -126.11 90.11 3.13 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.186 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 157.66 -158.1 28.74 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.59 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -121.37 78.68 35.98 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.57 ' CD ' ' NE1' ' A' ' 90' ' ' TRP . 16.7 Cg_exo -40.02 156.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.064 2.509 . . . . 0.0 112.906 -177.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.598 ' CZ2' ' HA ' ' A' ' 54' ' ' LEU . 45.4 p-90 -98.91 -163.4 1.03 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.476 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . 161.1 -21.99 0.22 Allowed Glycine 0 C--N 1.295 -1.708 0 C-N-CA 119.233 -1.46 . . . . 0.0 109.738 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.546 ' HD3' ' CG2' ' A' ' 21' ' ' THR . 29.6 tttt -146.44 160.03 42.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.418 -1.048 . . . . 0.0 109.312 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -44.24 104.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 108.587 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.98 -133.09 11.61 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.586 ' OE1' ' CZ ' ' A' ' 19' ' ' PHE . 0.1 OUTLIER -150.09 53.58 1.31 Allowed Pre-proline 0 C--N 1.306 -1.322 0 O-C-N 120.926 -1.338 . . . . 0.0 110.24 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.583 ' HD3' ' N ' ' A' ' 100' ' ' GLN . 9.4 Cg_endo -71.16 -15.95 31.87 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.0 1.8 . . . . 0.0 110.236 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -64.04 -173.64 3.06 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.408 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 2.0 pm0 -156.96 169.62 24.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -1.148 . . . . 0.0 109.753 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -99.48 105.27 17.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -0.838 . . . . 0.0 109.228 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.455 ' HE2' ' CD1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -83.44 163.26 20.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 109.506 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.89 91.48 3.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.315 -0.866 . . . . 0.0 109.302 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 mt 49.55 51.59 16.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 109.735 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.403 ' O ' ' CG1' ' A' ' 108' ' ' VAL . 44.6 t -104.33 26.74 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 108.955 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 114' ' ' ASP . . . 104.22 60.03 0.68 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.541 ' CD1' ' O ' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -64.25 -13.99 52.82 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.201 -1.176 . . . . 0.0 108.663 179.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.27 -177.35 5.12 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.363 -0.836 . . . . 0.0 109.462 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.53 ' CB ' HG23 ' A' ' 123' ' ' ILE . . . -62.32 -12.15 19.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 109.712 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -60.04 -52.63 64.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.845 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 13.6 t0 -79.17 -2.87 42.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.351 -0.843 . . . . 0.0 108.908 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.656 ' CZ ' ' CZ ' ' A' ' 35' ' ' PHE . 18.1 m-85 -109.27 108.19 60.08 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.288 -0.882 . . . . 0.0 108.816 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.499 ' HG3' ' HB2' ' A' ' 32' ' ' LYS . 10.0 Cg_exo -49.83 160.35 1.26 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.516 2.144 . . . . 0.0 111.152 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.537 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 4.8 Cg_exo -59.17 118.08 4.91 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.397 2.065 . . . . 0.0 110.232 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 161.28 -36.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.559 ' OD1' ' CZ ' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -118.49 39.53 3.44 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.348 -0.845 . . . . 0.0 109.193 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.688 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.9 mt-10 -69.92 -34.65 4.51 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.411 -0.806 . . . . 0.0 112.575 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.3 Cg_exo -59.56 -37.2 90.1 Favored 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 121.644 1.563 . . . . 0.0 112.012 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.584 HG12 ' CD2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -102.18 -42.75 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.441 -1.412 . . . . 0.0 108.128 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.588 HD13 ' CD2' ' A' ' 115' ' ' PHE . 14.7 mm -54.05 -28.66 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.55 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -73.1 -36.35 66.76 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.518 -0.739 . . . . 0.0 109.571 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -70.49 -48.3 56.37 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.209 -0.932 . . . . 0.0 110.51 -179.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.559 ' HB2' ' CD1' ' A' ' 129' ' ' LEU . 0.9 OUTLIER -80.59 20.59 0.71 Allowed 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.842 -1.161 . . . . 0.0 110.741 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.55 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 17.2 mttt -63.63 -40.6 97.31 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.9 -1.125 . . . . 0.0 108.394 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.493 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -79.11 7.43 7.49 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.903 -0.498 . . . . 0.0 110.125 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.559 ' CD1' ' HB2' ' A' ' 126' ' ' LEU . 4.7 tp . . . . . 0 N--CA 1.499 2.011 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.447 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.519 ' N ' ' HB2' ' A' ' 79' ' ' HIS . 2.5 pp . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.24 0.543 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.491 ' CG ' ' C ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER 169.84 99.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 109.81 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.533 HD12 ' CG2' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -122.02 167.1 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.485 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . -134.15 81.8 1.94 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.341 -0.849 . . . . 0.0 109.133 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.615 HG11 ' HA ' ' A' ' 84' ' ' PHE . 12.1 p -88.84 139.28 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.359 -0.838 . . . . 0.0 108.751 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.27 117.22 2.23 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.567 ' CD1' ' CD1' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -100.28 170.06 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.246 -1.15 . . . . 0.0 108.692 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.59 HG21 ' CZ3' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -147.58 154.71 11.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.981 -1.075 . . . . 0.0 110.479 -179.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.459 ' HD2' ' HG ' ' A' ' 107' ' ' LEU . 1.4 ttp180 -161.32 117.76 2.2 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.531 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 1.9 t-20 -105.54 -153.32 0.49 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.873 -1.142 . . . . 0.0 110.831 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -80.45 -5.4 56.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.748 -0.595 . . . . 0.0 109.536 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -79.71 5.57 13.05 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.233 -0.917 . . . . 0.0 108.952 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 21.9 t-20 52.86 42.91 32.06 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.467 -0.77 . . . . 0.0 109.338 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -134.82 150.1 50.45 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.529 HD12 ' CD1' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -110.48 155.09 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.025 -1.047 . . . . 0.0 109.459 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.559 ' HB3' ' CG1' ' A' ' 11' ' ' ILE . 45.0 t80 -103.36 71.68 1.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 0.0 109.29 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.471 HG13 HD13 ' A' ' 33' ' ' LEU . 2.5 mm -81.16 -177.73 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.542 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.543 ' CB ' ' HG3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -155.89 144.14 19.99 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.144 -0.972 . . . . 0.0 109.15 179.127 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.438 ' HG2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.994 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.439 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 1.8 m-20 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.432 0.634 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.538 ' HD3' ' CG ' ' A' ' 116' ' ' PRO . 12.1 mttp -92.09 170.19 10.03 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.363 -0.836 . . . . 0.0 108.754 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.635 ' N ' ' CD2' ' A' ' 33' ' ' LEU . 3.0 mm? -105.5 176.66 5.09 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 109.58 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.438 ' HB2' ' HG2' ' A' ' 22' ' ' ARG . 2.8 tt0 -160.97 -160.9 0.78 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 122.246 1.022 . . . . 0.0 110.577 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.595 ' CD1' ' HG3' ' A' ' 117' ' ' PRO . 29.3 m-85 -144.59 84.72 8.95 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.543 ' HG3' ' CB ' ' A' ' 21' ' ' THR . 3.1 Cg_exo -60.13 -150.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.405 2.07 . . . . 0.0 110.208 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 151.08 -168.71 30.75 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -147.46 18.05 1.49 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER 69.34 149.11 0.07 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.35 -1.088 . . . . 0.0 109.919 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.09 131.71 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 42' ' ' MET . 4.8 mt-10 -134.81 -147.82 0.29 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.09 -1.006 . . . . 0.0 110.052 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 41' ' ' GLU . 1.9 ptm -39.7 162.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.559 -0.713 . . . . 0.0 110.137 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.51 -157.08 27.1 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.404 ' HG3' ' OE1' ' A' ' 48' ' ' GLN . 3.7 mt-10 -125.34 -34.86 2.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -1.165 . . . . 0.0 109.426 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.511 ' OG1' ' HD2' ' A' ' 46' ' ' PRO . 0.5 OUTLIER -160.32 171.55 7.02 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.511 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 5.0 Cg_exo -59.02 -1.96 1.0 Allowed 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.536 2.157 . . . . 0.0 112.971 -178.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.475 ' O ' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -102.5 -54.24 2.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.479 -1.388 . . . . 0.0 109.056 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.499 ' O ' HG13 ' A' ' 51' ' ' VAL . 2.3 tt0 -63.79 -46.7 84.01 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 122.55 1.167 . . . . 0.0 108.738 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -45.36 -49.63 12.82 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.042 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.511 HG11 ' N ' ' A' ' 51' ' ' VAL . 3.5 p -79.94 -20.32 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.343 -0.848 . . . . 0.0 110.003 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.615 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -61.04 -50.98 78.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.615 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -57.62 -35.86 71.03 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 113.114 -1.857 . . . . 0.0 109.847 178.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.461 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 2.4 mt-10 -64.87 -24.75 67.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.816 -1.178 . . . . 0.0 109.153 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.612 ' HA ' ' CE2' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -73.53 -70.98 0.34 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.525 -0.735 . . . . 0.0 109.909 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.575 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -59.19 -21.15 58.99 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.974 -0.454 . . . . 0.0 111.504 -178.414 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 52' ' ' ARG . 8.8 pt-20 -80.74 1.52 29.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.578 -1.326 . . . . 0.0 110.549 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -135.72 -59.38 0.76 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.927 -1.108 . . . . 0.0 110.982 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.651 ' CG1' ' HB3' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -114.18 -42.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.228 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.575 ' CA ' ' HA ' ' A' ' 55' ' ' GLN . . . 59.42 72.25 0.64 Allowed Glycine 0 C--N 1.293 -1.835 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.577 HG22 ' CD1' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -79.78 163.4 3.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.81 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.606 ' CB ' ' HD3' ' A' ' 62' ' ' PRO . 1.3 m -100.91 -68.93 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 120.219 -1.55 . . . . 0.0 110.471 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.606 ' HD3' ' CB ' ' A' ' 61' ' ' THR . 5.6 Cg_endo -70.36 49.31 0.83 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.152 1.901 . . . . 0.0 111.766 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.596 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 1.3 pt20 -83.81 55.73 3.37 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.953 -1.092 . . . . 0.0 109.231 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -62.22 118.02 6.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.185 -0.947 . . . . 0.0 109.278 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.418 ' CB ' ' HA ' ' A' ' 87' ' ' VAL . 48.0 p90 -133.18 -173.52 3.23 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.171 0.986 . . . . 0.0 110.764 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 67' ' ' LEU . 8.0 t -157.51 -4.02 0.1 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.12 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.586 HD21 ' CH2' ' A' ' 83' ' ' TRP . 21.9 tp 55.18 110.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.889 -1.132 . . . . 0.0 110.164 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.58 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.9 OUTLIER -55.92 -75.07 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.58 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.3 mt-10 -155.25 -169.15 3.07 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.309 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -145.86 126.66 14.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.261 -0.9 . . . . 0.0 109.55 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.529 HD23 ' ND2' ' A' ' 119' ' ' ASN . 0.7 OUTLIER -112.48 -169.29 1.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.131 -0.981 . . . . 0.0 109.49 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -146.64 140.82 26.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.917 . . . . 0.0 109.216 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.48 ' OH ' ' O ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -129.74 169.93 14.49 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.246 -0.909 . . . . 0.0 109.923 -179.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -161.05 113.6 1.92 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.583 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -79.23 175.2 4.99 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.086 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.583 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 1.4 Cg_endo -63.87 2.69 0.94 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.149 1.899 . . . . 0.0 111.88 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.82 -24.96 0.46 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.507 -1.371 . . . . 0.0 111.899 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -131.65 179.72 5.88 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.611 -1.305 . . . . 0.0 110.974 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.519 ' HB2' ' N ' ' A' ' 4' ' ' LEU . 1.1 m170 -119.11 135.41 54.66 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.533 ' CG2' HD12 ' A' ' 6' ' ' ILE . 22.8 mm -146.27 107.99 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.032 -1.043 . . . . 0.0 110.716 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.447 ' OG1' HD12 ' A' ' 4' ' ' LEU . 3.1 m -101.67 105.26 16.15 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.435 ' CD2' ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -79.89 131.66 35.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.962 -1.086 . . . . 0.0 110.41 -178.55 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.606 ' CD1' ' O ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -121.76 124.03 43.24 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -124.1 119.99 31.07 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.444 -1.41 . . . . 0.0 110.036 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.636 ' CZ3' ' CG1' ' A' ' 87' ' ' VAL . 18.5 p-90 -100.41 87.97 3.54 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.567 ' CD1' ' CD1' ' A' ' 10' ' ' ILE . 2.8 mm? -56.35 130.29 44.03 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.571 0.701 . . . . 0.0 110.474 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.636 ' CG1' ' CZ3' ' A' ' 85' ' ' TRP . 3.7 m -103.53 -170.85 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.475 -0.766 . . . . 0.0 109.322 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 1.0 OUTLIER -138.93 -36.09 0.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.914 -1.116 . . . . 0.0 110.643 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.596 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -142.72 178.88 7.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.051 -1.031 . . . . 0.0 109.906 -179.52 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.623 ' CE2' ' HG3' ' A' ' 94' ' ' PRO . 41.3 p90 168.68 168.47 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.628 1.204 . . . . 0.0 110.74 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.551 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 9.9 tt0 -125.9 99.17 5.82 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.905 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.472 ' O ' ' HD3' ' A' ' 94' ' ' PRO . . . 135.12 -169.25 23.4 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.558 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 0.7 OUTLIER -99.23 104.98 29.7 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.623 ' HG3' ' CE2' ' A' ' 90' ' ' TRP . 4.5 Cg_exo -55.73 178.5 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.257 1.971 . . . . 0.0 112.256 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.651 ' HB3' ' CG1' ' A' ' 58' ' ' VAL . 3.7 p-90 -125.58 -167.32 1.67 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.797 0.808 . . . . 0.0 109.468 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.35 -32.12 0.08 OUTLIER Glycine 0 N--CA 1.482 1.759 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.523 ' HG3' ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -126.0 -145.27 0.32 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -115.09 38.56 3.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.133 -0.979 . . . . 0.0 108.834 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.31 55.53 0.76 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.483 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -119.85 151.99 53.17 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.275 -1.132 . . . . 0.0 109.8 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -67.08 98.61 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.355 2.037 . . . . 0.0 110.339 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.52 ' HA2' ' CG2' ' A' ' 21' ' ' THR . . . -82.35 -171.35 46.44 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -147.46 123.44 10.71 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.957 -1.319 . . . . 0.0 109.471 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.483 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 26.8 m95 -77.99 84.2 4.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.039 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.528 ' CE ' HD13 ' A' ' 33' ' ' LEU . 12.6 ttp -80.46 148.55 30.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 0.0 109.224 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.52 160.7 6.68 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.119 -0.988 . . . . 0.0 109.976 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.549 ' O ' ' CD1' ' A' ' 107' ' ' LEU . 1.6 tm? -130.63 70.91 1.45 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.2 t -103.14 -43.7 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 109.78 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -139.95 50.91 0.75 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.529 ' CD1' HD12 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -42.79 141.61 1.05 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.424 -1.045 . . . . 0.0 109.732 -179.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.467 ' HB3' ' OD2' ' A' ' 113' ' ' ASP . 4.4 t30 -157.41 -173.88 4.62 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.466 -0.771 . . . . 0.0 108.995 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.529 ' CB ' HG23 ' A' ' 123' ' ' ILE . . . -80.77 -10.34 59.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.731 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -66.57 -37.58 85.25 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.067 -1.021 . . . . 0.0 110.637 -179.167 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.562 ' O ' ' CG ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER -96.85 27.7 3.84 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.968 -1.083 . . . . 0.0 109.483 -179.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.625 ' C ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER -146.26 89.81 5.85 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.939 . . . . 0.0 109.207 179.593 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.558 ' N ' ' HD3' ' A' ' 117' ' ' PRO . 36.9 Cg_endo -98.93 36.18 0.09 OUTLIER 'Trans proline' 0 CA--C 1.556 1.6 0 C-N-CA 123.58 2.854 . . . . 0.0 115.941 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.625 ' CD ' ' C ' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -73.55 -1.05 10.14 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 121.686 1.591 . . . . 0.0 110.06 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 80.35 24.98 0.34 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.568 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 10.4 m120 -107.22 42.0 1.39 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.593 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.2 mt-10 -47.09 -44.12 47.22 Favored Pre-proline 0 C--N 1.296 -1.735 0 O-C-N 121.164 -0.96 . . . . 0.0 112.083 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 5.3 Cg_exo -61.88 -39.18 53.39 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.881 1.721 . . . . 0.0 112.562 -178.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 71' ' ' LEU . 1.6 t -90.23 -54.95 6.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 O-C-N 120.291 -1.506 . . . . 0.0 107.842 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.529 HG23 ' CB ' ' A' ' 112' ' ' ALA . 11.4 mm -43.84 -33.96 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.474 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -52.33 -52.94 50.38 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -42.86 98.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.51 -0.744 . . . . 0.0 109.787 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.574 HD23 ' CD2' ' A' ' 68' ' ' PHE . 1.9 mt -66.42 -5.32 10.51 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.104 -0.997 . . . . 0.0 110.328 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.482 ' CE ' ' HB1' ' A' ' 112' ' ' ALA . 22.3 mttt -56.41 -49.65 73.88 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.051 -1.031 . . . . 0.0 108.351 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 129' ' ' LEU . 11.6 mtp180 -90.3 34.89 0.86 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.451 -0.781 . . . . 0.0 108.984 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 126' ' ' LEU . 1.2 mt . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.893 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.456 HD13 HG22 ' A' ' 80' ' ' ILE . 2.6 pp . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.513 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . 26.1 mt-30 -133.01 150.61 52.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.201 -0.937 . . . . 0.0 109.853 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.577 ' O ' ' CD1' ' A' ' 83' ' ' TRP . 9.9 mt -121.76 167.15 15.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.357 -0.839 . . . . 0.0 109.495 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.548 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . -132.82 106.02 7.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -0.952 . . . . 0.0 109.543 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 36' ' ' PRO . 8.5 p -122.08 83.88 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.216 -0.927 . . . . 0.0 109.778 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.471 ' HA2' ' HB2' ' A' ' 85' ' ' TRP . . . -68.97 117.22 7.86 Favored Glycine 0 C--N 1.294 -1.786 0 N-CA-C 107.496 -2.242 . . . . 0.0 107.496 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.549 ' HB ' HD11 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -76.42 -172.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.071 -1.253 . . . . 0.0 107.688 -179.104 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.65 ' CD1' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -144.97 149.53 16.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 117.864 -1.534 . . . . 0.0 111.371 -176.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 17' ' ' GLU . 10.4 ttp180 -148.53 128.27 13.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.634 ' ND2' ' CH2' ' A' ' 90' ' ' TRP . 1.2 m-20 -98.07 -160.68 0.82 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.817 -1.177 . . . . 0.0 110.74 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -91.56 -6.05 53.04 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.393 0.616 . . . . 0.0 109.367 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.495 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 3.2 t-20 -85.21 14.5 5.13 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.48 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 13.6 t30 58.41 48.24 12.56 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.571 -0.706 . . . . 0.0 109.908 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 105' ' ' MET . 1.4 pt-20 -136.73 171.84 13.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.251 -0.906 . . . . 0.0 109.235 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.487 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 1.3 mt -125.35 157.67 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.932 . . . . 0.0 109.427 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.65 ' CD2' ' CD1' ' A' ' 11' ' ' ILE . 46.0 t80 -106.87 83.13 1.79 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.492 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -79.81 -173.68 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 120.988 -1.07 . . . . 0.0 110.163 -178.292 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.554 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -130.75 142.85 50.43 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.199 -0.601 . . . . 0.0 109.815 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.563 ' HG3' ' CD2' ' A' ' 33' ' ' LEU . 6.1 ttm180 . . . . . 0 C--N 1.305 -1.331 0 O-C-N 121.247 -0.908 . . . . 0.0 109.91 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.56 139.28 34.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 109.881 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.574 ' HB2' ' CD1' ' A' ' 115' ' ' PHE . 25.3 mt -105.77 -174.3 2.5 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.379 -0.825 . . . . 0.0 108.943 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.492 ' O ' ' CD1' ' A' ' 20' ' ' ILE . 3.1 tt0 -161.39 -157.5 0.51 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.564 -1.335 . . . . 0.0 110.732 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.687 ' CZ ' ' CZ ' ' A' ' 115' ' ' PHE . 81.1 m-85 -152.65 152.51 28.85 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.522 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 2.0 Cg_endo -63.08 -151.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.17 1.913 . . . . 0.0 109.861 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 91.79 179.21 41.95 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.45 -40.59 0.05 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -167.19 169.85 12.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.18 -1.188 . . . . 0.0 109.765 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.513 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 14.1 tt -133.69 123.94 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.379 -0.825 . . . . 0.0 109.1 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -80.26 130.92 35.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 110.027 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 42' ' ' MET . 31.1 ttp -117.32 72.22 0.83 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 109.105 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.67 1.53 5.18 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -151.59 -71.1 0.16 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.114 -1.227 . . . . 0.0 110.026 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.484 ' OG1' ' HD2' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -154.62 168.19 12.44 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 120.904 -1.122 . . . . 0.0 109.776 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.484 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 2.1 Cg_endo -67.88 -27.93 36.62 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.786 2.324 . . . . 0.0 112.103 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.533 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 0.4 OUTLIER -78.56 -69.75 0.54 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.832 -1.167 . . . . 0.0 109.197 -179.208 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.671 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 12.7 tt0 -37.63 -34.66 0.11 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 122.938 1.352 . . . . 0.0 109.078 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.517 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -52.64 -67.72 0.23 Allowed 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.254 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.493 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 9.0 p -80.99 -43.87 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.096 -1.003 . . . . 0.0 111.274 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.671 ' CG1' ' HA ' ' A' ' 48' ' ' GLN . 2.3 p -43.6 -48.88 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.449 -0.782 . . . . 0.0 109.168 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 48' ' ' GLN . 1.2 ttt180 -81.39 -26.12 35.71 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.308 -0.87 . . . . 0.0 110.506 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.517 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 3.4 mm-40 -72.88 -67.23 0.58 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.748 -1.22 . . . . 0.0 110.674 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.651 ' CB ' ' CE2' ' A' ' 95' ' ' TRP . 14.1 mt -54.06 -38.18 64.99 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.303 -0.873 . . . . 0.0 110.726 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.488 ' O ' ' HA2' ' A' ' 59' ' ' GLY . 3.7 pt20 -67.89 -32.12 72.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.971 -1.08 . . . . 0.0 110.075 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.493 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 1.3 pt-20 -78.59 -4.7 50.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.878 -1.139 . . . . 0.0 109.596 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.34 -49.19 5.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.174 -0.954 . . . . 0.0 109.538 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.538 HG12 ' CA ' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -114.04 -30.07 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.182 -0.949 . . . . 0.0 108.49 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 55' ' ' GLN . . . 74.25 90.2 0.17 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.445 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.678 ' CG2' ' O ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -114.54 170.53 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.367 -1.078 . . . . 0.0 108.48 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.685 ' CB ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -118.17 -70.4 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.807 -1.183 . . . . 0.0 109.596 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.685 ' HD3' ' CB ' ' A' ' 61' ' ' THR . 10.0 Cg_endo -74.73 40.69 0.65 Allowed 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 122.006 1.804 . . . . 0.0 111.325 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 0.9 OUTLIER -81.68 59.07 4.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 109.783 -179.219 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -65.62 126.54 28.7 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.559 ' CB ' ' HA ' ' A' ' 87' ' ' VAL . 4.0 p90 -146.63 -177.42 5.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.738 -1.226 . . . . 0.0 111.755 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.4 m -161.77 143.53 11.33 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 36.8 tp -71.49 97.13 1.6 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.604 -1.31 . . . . 0.0 109.792 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.666 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -44.79 -77.96 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.666 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -158.94 125.19 4.53 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -90.57 151.96 21.1 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.141 -0.974 . . . . 0.0 110.112 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.54 ' CD2' ' HB ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -116.43 -167.25 1.25 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -160.04 161.9 34.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.896 -1.128 . . . . 0.0 110.275 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -154.46 127.22 8.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.493 -0.754 . . . . 0.0 109.205 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -99.88 122.26 42.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 109.735 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.547 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -84.01 177.97 2.68 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 3.9 Cg_exo -56.71 -10.4 5.28 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.828 1.686 . . . . 0.0 111.736 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -161.7 -3.3 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.728 -1.232 . . . . 0.0 112.484 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.488 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -128.1 -172.38 2.67 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.212 -1.555 . . . . 0.0 110.041 -179.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -132.03 91.94 3.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.395 -0.816 . . . . 0.0 109.613 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.456 HG22 HD13 ' A' ' 4' ' ' LEU . 11.4 mt -81.84 102.5 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 109.462 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.23 126.05 52.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.738 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.458 HD23 HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -120.31 150.04 41.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.29 -0.881 . . . . 0.0 109.073 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.577 ' CD1' ' O ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -120.06 149.04 42.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.054 -1.029 . . . . 0.0 109.574 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.566 ' CG ' HG12 ' A' ' 122' ' ' VAL . 6.5 m-85 -113.35 94.41 4.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.222 -0.924 . . . . 0.0 109.221 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.471 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 77.7 m95 -88.51 90.37 8.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.043 -1.036 . . . . 0.0 108.948 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.549 HD11 ' HB ' ' A' ' 10' ' ' ILE . 10.7 tp -79.28 117.45 20.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.478 -0.763 . . . . 0.0 109.442 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.561 HG23 ' CG2' ' A' ' 11' ' ' ILE . 3.1 m -88.46 -161.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 O-C-N 121.213 -0.93 . . . . 0.0 110.33 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 20.7 mt-10 -147.67 -33.97 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.987 . . . . 0.0 111.231 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -147.21 164.39 33.32 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.658 -1.276 . . . . 0.0 110.479 -179.134 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.634 ' CH2' ' ND2' ' A' ' 13' ' ' ASN . 13.6 p90 179.19 171.44 0.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 122.029 0.918 . . . . 0.0 109.644 178.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.539 ' O ' ' C ' ' A' ' 92' ' ' GLY . 77.2 tt0 -116.34 -92.86 0.51 Allowed 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.509 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . -23.76 -91.47 0.01 OUTLIER Glycine 0 N--CA 1.499 2.866 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.678 ' O ' ' CG2' ' A' ' 60' ' ' ILE . 1.6 mt-10 -131.19 166.09 30.34 Favored Pre-proline 0 C--O 1.188 -2.138 0 O-C-N 121.647 -0.913 . . . . 0.0 108.862 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.616 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 6.1 Cg_exo -36.7 -93.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.281 -3.023 0 C-N-CA 123.106 2.537 . . . . 0.0 112.091 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.651 ' CE2' ' CB ' ' A' ' 54' ' ' LEU . 4.0 t90 171.03 -21.6 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.132 -0.98 . . . . 0.0 111.265 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.481 ' HA3' ' CB ' ' A' ' 36' ' ' PRO . . . -107.21 -101.21 2.7 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.469 -1.348 . . . . 0.0 109.821 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.477 ' N ' ' HB3' ' A' ' 36' ' ' PRO . 3.0 tttt 41.07 94.12 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.493 -1.004 . . . . 0.0 110.215 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -116.52 52.56 0.92 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.88 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.57 2.35 53.2 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -124.61 123.34 25.73 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.205 -1.173 . . . . 0.0 109.701 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -60.85 111.4 1.05 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.939 1.759 . . . . 0.0 109.899 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -93.41 -179.81 39.34 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -138.07 161.18 37.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.073 -1.251 . . . . 0.0 111.137 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.464 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 34.7 m0 -94.73 93.37 7.48 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.526 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -82.45 -173.89 4.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.016 -1.052 . . . . 0.0 109.674 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.05 160.77 15.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.891 . . . . 0.0 109.153 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 1.8 tp -108.9 45.84 1.01 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.145 -0.972 . . . . 0.0 109.795 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 108' ' ' VAL . 18.2 t -103.39 19.06 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.082 -1.011 . . . . 0.0 108.83 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 132.82 74.05 0.1 OUTLIER Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.466 ' HG ' HD13 ' A' ' 18' ' ' ILE . 2.7 mt -43.49 138.77 2.33 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.372 -1.075 . . . . 0.0 109.626 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.44 98.79 11.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.439 -0.788 . . . . 0.0 109.777 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.525 ' CB ' HG21 ' A' ' 123' ' ' ILE . . . -64.59 -21.76 66.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 108.971 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -68.6 -27.79 66.36 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.488 -0.758 . . . . 0.0 109.506 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.498 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 2.8 t0 -78.43 -9.99 59.52 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.687 ' CZ ' ' CZ ' ' A' ' 35' ' ' PHE . 11.0 m-85 -94.03 154.98 40.59 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 108.83 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.53 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 1.2 Cg_endo -71.42 144.7 46.06 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.994 1.796 . . . . 0.0 110.211 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.522 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 1.2 Cg_endo -64.71 112.71 2.06 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.341 2.028 . . . . 0.0 110.41 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 162.35 -22.56 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 109.84 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.551 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 0.7 OUTLIER -119.76 45.25 2.2 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.092 -1.005 . . . . 0.0 109.314 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.68 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 7.1 mt-10 -68.87 -32.77 3.7 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.5 Cg_exo -58.83 -38.78 86.8 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.409 1.406 . . . . 0.0 111.992 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.566 HG12 ' CG ' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -104.37 -38.06 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 120.434 -1.416 . . . . 0.0 108.784 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.551 ' CG1' ' O ' ' A' ' 119' ' ' ASN . 7.4 mm -55.25 -38.81 48.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.471 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -55.32 -46.27 76.32 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.522 -0.736 . . . . 0.0 109.292 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -66.85 -33.92 76.67 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.424 -0.798 . . . . 0.0 109.563 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.499 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 4.2 mp -54.32 -25.78 25.84 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.192 -0.942 . . . . 0.0 109.551 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.476 ' HE2' ' HB2' ' A' ' 112' ' ' ALA . 33.7 mttt -58.2 -49.45 77.0 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.454 ' O ' ' C ' ' A' ' 129' ' ' LEU . 6.5 mtp180 -84.62 -1.47 56.05 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.699 -0.625 . . . . 0.0 109.532 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.523 HD23 ' CD2' ' A' ' 86' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.824 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.479 ' O ' ' HG3' ' A' ' 5' ' ' GLN . 14.8 tp . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.541 ' HG2' ' CZ2' ' A' ' 83' ' ' TRP . 0.9 OUTLIER -145.35 128.38 16.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.041 -1.037 . . . . 0.0 110.834 -179.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.588 ' O ' ' CD1' ' A' ' 83' ' ' TRP . 5.3 mm -102.93 -163.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.319 -0.863 . . . . 0.0 108.807 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.461 ' HB3' HG13 ' A' ' 40' ' ' ILE . . . -144.86 117.29 8.52 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.739 -1.225 . . . . 0.0 110.605 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.611 ' CG2' ' O ' ' A' ' 35' ' ' PHE . 3.2 p -133.45 129.74 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.108 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.578 ' CA ' ' NE1' ' A' ' 85' ' ' TRP . . . -117.04 119.32 4.43 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.62 ' CD1' ' CD1' ' A' ' 86' ' ' LEU . 1.2 mt -96.98 159.16 3.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.265 -1.138 . . . . 0.0 108.781 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.613 ' CD1' ' CB ' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -154.24 146.62 13.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 108.822 -178.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.519 ' HB2' HG22 ' A' ' 18' ' ' ILE . 20.9 ttp180 -157.96 84.26 0.87 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.406 -0.809 . . . . 0.0 110.626 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.566 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 10.9 m-80 -160.59 179.46 8.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.924 -1.11 . . . . 0.0 109.662 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 2.9 mm-40 81.44 -68.94 0.09 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.888 0.851 . . . . 0.0 109.219 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.474 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 38.4 t-20 -111.15 22.94 14.67 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.431 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 23.4 t-20 49.71 47.52 22.78 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 15' ' ' ASN . 3.7 mt-10 -140.69 147.61 39.52 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.5 mt -96.97 151.94 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.904 -1.123 . . . . 0.0 110.56 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -100.07 76.96 1.96 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.574 HD12 ' CE1' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -79.7 -178.02 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.952 0.882 . . . . 0.0 110.611 -177.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.527 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -114.3 137.17 52.13 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.034 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.428 ' HG3' ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.597 0 O-C-N 120.963 -1.086 . . . . 0.0 109.683 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.432 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 36.1 m120 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -146.6 126.85 13.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.172 -0.955 . . . . 0.0 109.488 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.515 ' O ' ' CG ' ' A' ' 116' ' ' PRO . 7.2 mt -93.45 -165.17 1.28 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.436 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -149.53 -163.86 1.89 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.68 -1.263 . . . . 0.0 110.194 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.615 ' CZ ' ' CZ ' ' A' ' 115' ' ' PHE . 6.5 m-85 -162.25 -66.62 0.01 OUTLIER Pre-proline 0 C--N 1.292 -1.909 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.769 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 35' ' ' PHE . 15.3 Cg_exo -40.26 153.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.775 1.65 . . . . 0.0 110.467 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.98 -86.59 1.69 Allowed Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -117.18 -61.07 0.31 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 170.93 175.84 0.06 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.179 -1.189 . . . . 0.0 110.069 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.544 ' O ' ' CG2' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -144.25 102.4 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.53 -3.43 5.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.971 -1.081 . . . . 0.0 109.725 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.429 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 1.2 mpt? -53.06 -27.36 19.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.0 108.976 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.48 15.97 26.92 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 42' ' ' MET . 45.3 mm-40 -86.32 -80.68 0.23 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.539 -0.977 . . . . 0.0 109.782 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.583 ' CB ' ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -148.51 177.5 1.77 Allowed Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 120.949 -1.094 . . . . 0.0 109.968 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 45' ' ' THR . 6.3 Cg_endo -73.77 -40.24 1.51 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.694 2.263 . . . . 0.0 111.063 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.01 -52.85 5.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.324 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.535 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 2.1 tt0 -45.01 -29.1 0.78 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 122.441 1.115 . . . . 0.0 110.026 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . -72.86 -59.84 2.52 Favored 'General case' 0 C--N 1.271 -2.834 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.576 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.56 HG23 ' CE2' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -81.82 -3.08 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.016 -1.052 . . . . 0.0 111.029 -178.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 4.5 p -81.8 -45.3 20.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.571 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -70.64 -28.57 64.91 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.168 177.515 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.56 ' O ' ' NE1' ' A' ' 95' ' ' TRP . 3.0 mt-10 -76.6 -17.81 58.99 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.594 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.585 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 5.7 mt -71.1 -54.96 9.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.482 -0.761 . . . . 0.0 110.432 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.485 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -82.64 -37.11 25.37 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.705 -1.247 . . . . 0.0 111.355 -178.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -80.66 35.03 0.34 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.722 -1.236 . . . . 0.0 111.52 -178.36 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 1.1 mm-40 -149.8 -58.23 0.19 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.581 -1.324 . . . . 0.0 110.098 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.637 ' CG1' ' CD1' ' A' ' 95' ' ' TRP . 5.2 p -123.07 -10.75 7.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.287 -0.883 . . . . 0.0 108.677 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 60.84 73.09 0.53 Allowed Glycine 0 N--CA 1.486 1.98 0 O-C-N 121.775 -0.578 . . . . 0.0 112.901 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.552 HD13 ' CD2' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -112.26 179.97 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.289 -1.124 . . . . 0.0 108.428 177.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 47.2 m -131.34 86.88 48.95 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.461 ' HG3' ' CD1' ' A' ' 54' ' ' LEU . 1.0 OUTLIER -59.72 129.04 29.07 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.107 1.871 . . . . 0.0 110.572 -177.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.456 ' HG3' ' HB3' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -83.69 -37.58 22.57 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.499 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 65' ' ' PHE . 0.8 OUTLIER -168.47 51.6 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.779 -1.2 . . . . 0.0 111.49 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.575 ' CB ' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -46.75 173.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.601 -1.312 . . . . 0.0 109.475 179.19 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -161.26 157.14 25.1 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.565 -0.709 . . . . 0.0 109.651 179.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 50.0 tp -112.01 92.85 4.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.186 -0.946 . . . . 0.0 109.19 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.7 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -53.76 -59.52 4.51 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.605 0.717 . . . . 0.0 109.635 -179.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.7 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.8 tp10 -168.28 141.41 3.1 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.643 -0.66 . . . . 0.0 110.032 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.425 ' HG3' ' HA ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -121.14 138.94 53.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.426 -0.796 . . . . 0.0 109.008 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.503 ' CD1' ' C ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -109.88 -171.49 1.85 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.078 -1.014 . . . . 0.0 109.941 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -143.83 175.04 10.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.472 -0.767 . . . . 0.0 108.971 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 80' ' ' ILE . 1.6 t80 -150.13 163.44 38.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.934 -1.103 . . . . 0.0 110.155 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.0 tt0 -142.45 109.14 5.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.409 -0.807 . . . . 0.0 109.19 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.603 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -78.83 173.52 7.57 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.066 -1.021 . . . . 0.0 108.901 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.603 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 5.7 Cg_exo -51.4 -26.07 20.24 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.723 1.615 . . . . 0.0 109.543 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -148.16 2.22 0.66 Allowed 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.888 -0.508 . . . . 0.0 110.071 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.473 ' HG3' ' HB3' ' A' ' 75' ' ' PHE . 4.8 mtp180 -122.68 -161.58 0.96 Allowed 'General case' 0 C--N 1.31 -1.142 0 O-C-N 120.9 -1.125 . . . . 0.0 109.547 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.625 ' N ' ' CD2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -162.01 109.46 1.37 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.005 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 73' ' ' TYR . 25.2 mm -99.3 124.85 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.031 -1.043 . . . . 0.0 110.038 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.476 ' HB ' ' HG3' ' A' ' 5' ' ' GLN . 67.6 m -130.08 116.51 18.61 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.544 ' CD1' ' CG1' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -107.98 153.52 22.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.068 -1.02 . . . . 0.0 110.229 -179.135 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.596 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 3.2 m95 -110.54 118.17 35.51 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.587 ' CD2' HG12 ' A' ' 122' ' ' VAL . 4.1 m-85 -99.97 70.71 1.61 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.123 -0.986 . . . . 0.0 109.362 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.578 ' NE1' ' CA ' ' A' ' 9' ' ' GLY . 46.5 p-90 -80.28 84.18 5.99 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.138 -1.425 . . . . 0.0 108.889 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.62 ' CD1' ' CD1' ' A' ' 10' ' ' ILE . 1.6 tp -64.1 121.51 14.35 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.152 0.501 . . . . 0.0 109.918 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.575 ' HB ' ' CB ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -102.96 161.59 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 119.095 -1.042 . . . . 0.0 108.986 179.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.46 ' N ' ' CG2' ' A' ' 87' ' ' VAL . 9.0 pm0 -118.35 -24.0 7.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.919 . . . . 0.0 110.768 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.456 ' HB3' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -146.81 152.88 39.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.807 -1.183 . . . . 0.0 110.56 -179.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.566 ' CZ3' ' HB2' ' A' ' 13' ' ' ASN . 28.2 p90 -168.64 -173.41 1.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.842 0.829 . . . . 0.0 109.367 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.496 ' HB3' ' HB ' ' A' ' 61' ' ' THR . 9.4 tt0 -137.18 113.63 10.13 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.357 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' ' 94' ' ' PRO . . . 106.65 169.45 22.64 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.6 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -79.13 115.0 49.41 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.296 -1.12 . . . . 0.0 108.935 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.613 ' CB ' ' CD1' ' A' ' 11' ' ' ILE . 5.5 Cg_endo -73.77 177.03 8.59 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.672 2.248 . . . . 0.0 112.571 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.637 ' CD1' ' CG1' ' A' ' 58' ' ' VAL . 3.1 p-90 -115.1 -163.01 0.85 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.407 ' N ' ' HE3' ' A' ' 95' ' ' TRP . . . 179.61 -32.7 0.06 OUTLIER Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HG3' HG23 ' A' ' 21' ' ' THR . 0.3 OUTLIER -129.2 -163.96 1.35 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 9.9 pt-20 -55.15 -46.13 75.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.956 -1.09 . . . . 0.0 108.554 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.41 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . -124.84 -129.73 3.42 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.64 ' N ' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -125.24 42.78 0.79 Allowed Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.01 -1.288 . . . . 0.0 110.971 179.191 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.64 ' HD3' ' N ' ' A' ' 100' ' ' GLN . 6.2 Cg_endo -67.56 -12.9 37.25 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 C-N-CA 121.471 1.448 . . . . 0.0 110.011 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -61.09 179.84 3.05 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -141.99 160.93 39.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.076 -1.249 . . . . 0.0 110.3 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -89.03 103.49 16.1 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.394 -0.817 . . . . 0.0 109.576 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 13.9 ttm -87.44 129.51 35.02 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.306 -0.871 . . . . 0.0 109.515 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.475 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -92.96 72.67 4.76 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.314 -0.867 . . . . 0.0 109.452 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.0 tp 49.85 50.92 17.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.134 -0.979 . . . . 0.0 109.565 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 106' ' ' SER . 29.3 t -139.2 101.3 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.261 -0.9 . . . . 0.0 109.473 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.478 ' HA3' ' HB2' ' A' ' 114' ' ' ASP . . . 92.99 17.24 44.5 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.516 ' CD1' ' O ' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -62.64 -18.03 61.49 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.296 -1.12 . . . . 0.0 108.987 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.504 ' ND2' ' HD3' ' A' ' 127' ' ' LYS . 10.2 m-20 -78.3 178.33 7.74 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.738 -0.601 . . . . 0.0 109.461 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.566 ' CB ' HG23 ' A' ' 123' ' ' ILE . . . -67.51 -6.85 21.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.47 -53.03 60.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.249 -0.907 . . . . 0.0 110.11 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.478 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -79.33 -12.78 59.93 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.1 -1.0 . . . . 0.0 108.817 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.615 ' CZ ' ' CZ ' ' A' ' 35' ' ' PHE . 12.8 m-85 -94.59 140.41 22.63 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.515 ' CG ' ' O ' ' A' ' 33' ' ' LEU . 5.7 Cg_exo -63.31 148.4 92.93 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.99 1.794 . . . . 0.0 110.037 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.53 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 3.9 Cg_exo -58.87 118.61 5.52 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.13 1.886 . . . . 0.0 110.33 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 162.37 -24.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.491 -0.756 . . . . 0.0 109.132 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.533 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 0.9 OUTLIER -123.14 43.97 2.8 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.307 -0.871 . . . . 0.0 109.732 -179.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.678 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 7.0 mt-10 -66.34 -39.14 24.74 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 112.161 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 2.9 Cg_endo -64.51 -34.55 52.63 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 122.117 1.878 . . . . 0.0 112.371 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.587 HG12 ' CD2' ' A' ' 84' ' ' PHE . 1.1 t -93.76 -50.04 12.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.585 HD13 ' CD2' ' A' ' 115' ' ' PHE . 8.8 mm -49.53 -33.73 7.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.486 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -53.24 -47.11 69.32 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -66.73 -28.76 68.67 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.322 -0.861 . . . . 0.0 109.524 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.518 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 11.4 mt -70.74 -10.69 60.01 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.143 -0.973 . . . . 0.0 109.646 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.504 ' HD3' ' ND2' ' A' ' 111' ' ' ASN . 1.3 mmtp -56.76 -52.92 63.14 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.251 -0.906 . . . . 0.0 109.195 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -98.42 26.76 5.21 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.406 -0.809 . . . . 0.0 109.049 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.518 ' CD1' ' HA ' ' A' ' 126' ' ' LEU . 2.4 tp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.558 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 4' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.481 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 7.0 mt-30 -96.42 114.03 25.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.229 -0.92 . . . . 0.0 109.509 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.477 ' O ' HD11 ' A' ' 40' ' ' ILE . 3.1 mm -99.42 -175.99 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.248 -0.908 . . . . 0.0 109.231 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.543 ' HA ' ' CD1' ' A' ' 83' ' ' TRP . . . -149.39 101.83 3.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.719 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.513 ' O ' HG11 ' A' ' 8' ' ' VAL . 10.2 p -108.51 135.06 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.154 -0.966 . . . . 0.0 108.538 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.28 106.56 1.43 Allowed Glycine 0 N--CA 1.484 1.87 0 C-N-CA 119.372 -1.394 . . . . 0.0 109.696 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.582 ' CD1' ' CD1' ' A' ' 86' ' ' LEU . 1.7 mt -82.89 143.99 10.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.598 HG21 ' CZ3' ' A' ' 90' ' ' TRP . 1.8 mt -131.51 128.97 61.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.819 -177.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 88' ' ' GLU . 5.9 ttp180 -139.75 125.99 20.04 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.464 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 6.0 p30 -118.72 -167.16 1.33 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.983 . . . . 0.0 109.985 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -71.64 -2.39 17.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 109.944 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.459 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 1.5 t30 -79.78 5.66 12.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.176 -0.952 . . . . 0.0 109.136 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.467 ' OD1' ' HB ' ' A' ' 108' ' ' VAL . 22.6 t30 54.95 46.57 24.07 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.264 -0.898 . . . . 0.0 109.619 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 4.5 mt-10 -146.5 133.63 20.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 108.892 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -102.16 160.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.221 -0.924 . . . . 0.0 108.801 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 25.8 t80 -118.55 82.03 1.78 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.922 -1.111 . . . . 0.0 108.565 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.44 ' C ' ' HE3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -121.04 -160.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.556 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -117.31 138.48 51.73 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.39 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.49 ' CG ' ' OD1' ' A' ' 31' ' ' ASN . 4.9 ttp180 . . . . . 0 C--N 1.306 -1.326 0 O-C-N 121.288 -0.882 . . . . 0.0 109.465 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.49 ' OD1' ' CG ' ' A' ' 22' ' ' ARG . 3.0 t-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.325 0.583 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HB3' ' HG3' ' A' ' 116' ' ' PRO . 6.8 mmmt -95.29 125.03 39.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.641 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.581 HD11 ' CE2' ' A' ' 115' ' ' PHE . 56.5 mt -107.8 -174.59 2.56 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -160.69 -162.11 0.91 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.027 -1.045 . . . . 0.0 110.878 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.694 ' CZ ' ' CE1' ' A' ' 115' ' ' PHE . 65.5 m-85 -155.18 69.27 5.51 Favored Pre-proline 0 C--N 1.295 -1.788 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.522 ' CD ' ' OG1' ' A' ' 21' ' ' THR . 2.4 Cg_endo -61.74 -81.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.173 1.915 . . . . 0.0 110.409 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 100.49 -150.02 18.74 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -139.8 24.15 2.75 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 2.5 mptt 70.25 148.2 0.07 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -1.143 . . . . 0.0 110.034 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.654 ' CD1' ' CZ2' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -101.57 119.27 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.459 ' O ' ' C ' ' A' ' 42' ' ' MET . 0.6 OUTLIER -79.06 -159.58 0.19 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.008 -1.058 . . . . 0.0 108.845 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.459 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -42.04 -52.78 4.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.372 -0.83 . . . . 0.0 108.997 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 42' ' ' MET . . . 58.38 122.77 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.236 -1.145 . . . . 0.0 110.236 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -106.53 -9.72 16.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -1.106 . . . . 0.0 108.785 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.506 ' OG1' ' HD2' ' A' ' 46' ' ' PRO . 0.5 OUTLIER -160.55 171.54 6.98 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.506 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 3.7 Cg_exo -61.36 -37.2 74.16 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.294 1.996 . . . . 0.0 111.706 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.494 ' O ' HG11 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -86.45 -56.98 3.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.809 -1.182 . . . . 0.0 109.583 -179.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.547 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 1.7 tt0 -38.13 -32.28 0.06 Allowed 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.252 1.025 . . . . 0.0 110.049 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 47' ' ' GLU . . . -64.82 -65.29 0.69 Allowed 'General case' 0 C--N 1.272 -2.797 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.66 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.523 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 1.2 p -81.21 -45.45 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.898 -1.126 . . . . 0.0 110.301 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 6.1 p -40.62 -47.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.653 -0.654 . . . . 0.0 109.332 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.558 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -74.61 -34.57 62.85 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.498 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 2.4 mt-10 -60.07 -19.95 55.65 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.903 -1.123 . . . . 0.0 108.363 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.631 ' CD2' ' CH2' ' A' ' 95' ' ' TRP . 13.8 mt -75.31 -68.61 0.54 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.197 0.522 . . . . 0.0 110.381 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 2.4 pt20 -61.3 -28.62 69.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.775 -1.203 . . . . 0.0 111.637 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.498 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 1.2 pp20? -72.88 1.02 9.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.701 -1.249 . . . . 0.0 109.56 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.416 ' HB3' ' HD1' ' A' ' 95' ' ' TRP . 3.5 mm-40 -143.78 -68.74 0.33 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.415 -0.803 . . . . 0.0 109.96 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.667 ' CG1' ' CG ' ' A' ' 95' ' ' TRP . 2.4 p -111.55 -54.59 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.691 -1.255 . . . . 0.0 107.62 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.585 ' N ' ' CG1' ' A' ' 58' ' ' VAL . . . 81.84 47.2 6.36 Favored Glycine 0 N--CA 1.479 1.567 0 O-C-N 121.438 -0.789 . . . . 0.0 113.86 175.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.558 ' O ' ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -79.68 124.53 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 120.12 1.96 . . . . 0.0 106.403 176.362 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.645 ' N ' ' CD ' ' A' ' 62' ' ' PRO . 8.4 t -149.26 23.77 0.04 OUTLIER Pre-proline 0 C--N 1.279 -2.5 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 61' ' ' THR . 2.2 Cg_endo -62.35 -47.15 10.37 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 CA-C-N 120.072 1.061 . . . . 0.0 109.725 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 89' ' ' ARG . 1.2 pt20 -162.88 -31.24 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.962 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.612 ' CG ' ' O ' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -42.76 113.73 0.5 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 122.214 1.007 . . . . 0.0 112.962 -177.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.409 ' CB ' ' O ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER 171.74 130.58 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.159 -0.963 . . . . 0.0 110.044 177.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -163.67 -35.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 110.574 179.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.583 HD11 ' CG ' ' A' ' 85' ' ' TRP . 37.7 tp 39.35 96.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.765 0.793 . . . . 0.0 109.273 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.61 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 30.2 p90 -66.62 -54.03 27.74 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.446 -0.784 . . . . 0.0 110.705 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.61 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER 178.35 134.11 0.08 Allowed 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.247 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.545 ' CB ' ' HB3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -94.69 168.55 10.76 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.498 -0.751 . . . . 0.0 109.79 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.516 ' CD2' ' HB ' ' A' ' 122' ' ' VAL . 1.2 pp -126.41 -166.53 1.59 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.096 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -160.0 142.62 13.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 109.625 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.407 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -130.03 96.12 4.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.343 -0.848 . . . . 0.0 109.41 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.434 ' HG2' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -84.15 109.39 17.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.4 -0.813 . . . . 0.0 109.297 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.571 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -79.63 179.63 1.76 Allowed Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.571 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 6.0 Cg_endo -75.81 40.76 0.75 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.329 2.019 . . . . 0.0 111.198 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 76' ' ' PRO . 0.1 OUTLIER 172.3 -25.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.712 -1.243 . . . . 0.0 110.214 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.5 ' HG2' ' NH1' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -124.44 170.45 10.84 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 109.977 -178.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.434 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 6.1 m80 -126.01 92.11 3.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.438 -0.789 . . . . 0.0 108.969 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.417 ' CD1' HD13 ' A' ' 4' ' ' LEU . 27.1 mm -79.4 137.19 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.29 -0.881 . . . . 0.0 109.503 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.54 84.52 1.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.299 -0.876 . . . . 0.0 109.454 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.476 ' O ' HD11 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -108.09 158.58 17.28 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.348 -0.845 . . . . 0.0 109.407 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.654 ' CZ2' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -131.03 151.91 50.9 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.964 -1.085 . . . . 0.0 110.75 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.618 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -119.71 120.98 38.18 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.583 ' CG ' HD11 ' A' ' 67' ' ' LEU . 10.9 m95 -96.4 98.09 9.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.002 -1.061 . . . . 0.0 110.202 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.582 ' CD1' ' CD1' ' A' ' 10' ' ' ILE . 1.0 OUTLIER -68.61 89.5 0.37 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.539 HG22 ' CG2' ' A' ' 11' ' ' ILE . 0.9 OUTLIER -60.52 174.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.633 0.73 . . . . 0.0 110.533 -178.106 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' A' ' 12' ' ' ARG . 11.0 mm-40 -97.05 -72.29 0.65 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.049 -0.661 . . . . 0.0 109.371 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -159.2 148.85 18.77 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.614 ' HA ' ' HG2' ' A' ' 62' ' ' PRO . 3.7 p90 -136.95 -171.41 2.93 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.833 -1.167 . . . . 0.0 111.243 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.507 ' H ' ' CG ' ' A' ' 62' ' ' PRO . 15.6 tt0 -128.88 -33.69 2.0 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.68 -134.82 0.11 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.539 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 1.0 OUTLIER -121.66 132.51 24.21 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.197 -1.178 . . . . 0.0 110.156 -179.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.537 ' CB ' HD13 ' A' ' 11' ' ' ILE . 2.4 Cg_endo -71.82 119.53 6.27 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.581 2.187 . . . . 0.0 109.814 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.667 ' CG ' ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -126.31 38.64 4.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.02 -1.05 . . . . 0.0 112.923 -177.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -49.71 -20.42 2.79 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.464 ' HD2' ' HG2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.73 -171.9 1.94 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.422 -1.046 . . . . 0.0 109.912 -179.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -141.5 -41.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.441 -0.787 . . . . 0.0 109.045 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.28 23.87 1.1 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.426 ' CB ' ' CD ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -102.61 172.05 4.67 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.417 -1.049 . . . . 0.0 109.639 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' A' ' 102' ' ' GLY . 4.9 Cg_endo -70.88 5.54 2.08 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.538 2.159 . . . . 0.0 111.443 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -39.77 146.91 0.23 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 9.8 pt-20 -161.33 -171.51 3.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.614 -0.933 . . . . 0.0 110.434 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.563 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 20.6 m0 -94.53 100.56 12.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.569 -0.707 . . . . 0.0 109.772 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -84.42 -163.17 0.76 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.142 -0.974 . . . . 0.0 108.908 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.58 103.21 4.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.315 -0.865 . . . . 0.0 109.369 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.515 ' O ' HG11 ' A' ' 108' ' ' VAL . 18.4 mt -139.57 -78.28 0.32 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.527 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 0.4 OUTLIER 67.53 25.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.002 0.906 . . . . 0.0 108.814 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 178.39 44.74 0.07 OUTLIER Glycine 0 N--CA 1.485 1.902 0 N-CA-C 107.187 -2.365 . . . . 0.0 107.187 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.52 ' CD2' ' OD1' ' A' ' 114' ' ' ASP . 1.1 mt -36.42 153.69 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 O-C-N 122.103 -0.645 . . . . 0.0 109.886 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.508 ' O ' ' HE2' ' A' ' 127' ' ' LYS . 0.7 OUTLIER -134.81 9.01 3.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.139 -0.976 . . . . 0.0 109.667 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 111' ' ' ASN . . . 73.91 -9.94 1.17 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.062 -1.024 . . . . 0.0 110.47 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -74.71 -42.1 58.97 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.833 -1.167 . . . . 0.0 109.101 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' CD2' ' A' ' 110' ' ' LEU . 3.4 p30 -78.62 0.61 25.73 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.694 ' CE1' ' CZ ' ' A' ' 35' ' ' PHE . 10.1 m-85 -120.0 106.29 41.44 Favored Pre-proline 0 N--CA 1.485 1.323 0 O-C-N 121.441 -0.787 . . . . 0.0 109.073 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 115' ' ' PHE . 35.4 Cg_exo -40.17 152.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.281 1.988 . . . . 0.0 110.71 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.558 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 5.9 Cg_exo -56.19 -160.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.622 2.215 . . . . 0.0 111.357 -178.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 82.97 -42.67 0.11 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.73 -0.606 . . . . 0.0 109.674 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.544 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 2.9 m120 -98.0 33.66 2.09 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.087 -1.008 . . . . 0.0 109.357 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.645 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 4.2 mt-10 -62.49 -38.85 49.84 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.374 -0.829 . . . . 0.0 112.688 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.3 Cg_exo -58.89 -41.97 57.12 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.776 1.651 . . . . 0.0 112.314 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.538 HG12 ' CE2' ' A' ' 84' ' ' PHE . 1.1 t -97.43 -47.98 12.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 120.44 -1.412 . . . . 0.0 108.295 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.544 ' CG1' ' O ' ' A' ' 119' ' ' ASN . 7.5 mm -47.61 -34.35 3.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.364 -0.835 . . . . 0.0 108.802 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.492 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -54.34 -45.15 72.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.494 -0.754 . . . . 0.0 109.598 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.65 -52.36 65.48 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.228 -0.92 . . . . 0.0 109.849 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.577 HD22 ' CE2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -53.98 -15.83 1.6 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.182 -0.949 . . . . 0.0 110.347 -179.234 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.508 ' HE2' ' O ' ' A' ' 111' ' ' ASN . 12.6 mttt -51.41 -51.42 54.91 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.815 -1.178 . . . . 0.0 108.715 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -94.89 46.45 1.13 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.511 ' CD1' ' HB2' ' A' ' 110' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.777 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.493 ' C ' ' HB ' ' A' ' 40' ' ' ILE . 72.1 mt-30 -133.59 142.51 48.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.188 -0.945 . . . . 0.0 110.0 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.536 HG23 ' CD1' ' A' ' 82' ' ' LEU . 4.5 mt -149.26 157.7 6.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.462 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -111.84 126.63 55.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.123 -0.986 . . . . 0.0 108.973 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.534 HG21 ' CB ' ' A' ' 36' ' ' PRO . 1.4 p -125.46 83.89 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.918 . . . . 0.0 110.202 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.471 ' HA2' ' CD1' ' A' ' 85' ' ' TRP . . . -74.21 117.42 5.59 Favored Glycine 0 C--N 1.291 -1.952 0 N-CA-C 107.732 -2.147 . . . . 0.0 107.732 178.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.564 ' HB ' HD12 ' A' ' 86' ' ' LEU . 0.6 OUTLIER -97.21 172.19 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 120.973 -1.31 . . . . 0.0 109.755 -178.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.616 ' CD1' ' CB ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -140.49 154.82 22.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.438 -0.788 . . . . 0.0 109.211 -179.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.484 ' HD3' ' CD2' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -160.34 68.19 0.36 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.343 -0.848 . . . . 0.0 110.281 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.599 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 52.1 m-80 -163.83 -171.58 2.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.185 -0.947 . . . . 0.0 109.628 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 6.1 tt0 83.95 -46.15 0.11 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.86 0.838 . . . . 0.0 109.542 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.444 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 47.7 t30 -142.13 25.2 1.93 Allowed 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.474 ' OD1' HG22 ' A' ' 108' ' ' VAL . 12.4 t30 55.64 45.85 23.9 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 105' ' ' MET . 4.0 mt-10 -140.41 149.85 43.14 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.099 -1.0 . . . . 0.0 109.386 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.555 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 0.4 OUTLIER -97.95 151.67 4.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.305 -0.872 . . . . 0.0 109.22 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.511 ' HB3' HG12 ' A' ' 11' ' ' ILE . 50.3 t80 -88.54 82.5 6.91 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 21' ' ' THR . 42.2 mm -78.28 167.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.295 -0.878 . . . . 0.0 110.122 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.516 ' CG2' ' HB2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -121.73 128.36 51.7 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.525 ' N ' ' OE1' ' A' ' 100' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.677 0 O-C-N 121.512 -0.743 . . . . 0.0 109.193 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.327 0.584 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -134.63 137.74 43.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 109.264 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.537 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 3.1 mt -99.13 -169.68 1.8 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.259 -0.901 . . . . 0.0 108.722 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.49 -156.52 0.48 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.12 -0.987 . . . . 0.0 109.837 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -144.57 158.27 54.08 Favored Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.534 ' CB ' HG21 ' A' ' 8' ' ' VAL . 3.1 Cg_exo -55.71 -153.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.186 1.924 . . . . 0.0 109.816 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 163.24 -166.98 37.33 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.564 -1.303 . . . . 0.0 110.009 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . 173.95 -80.12 0.08 OUTLIER Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 9.0 tttt 166.72 136.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.494 -1.004 . . . . 0.0 109.198 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.523 HD13 ' NE1' ' A' ' 83' ' ' TRP . 3.8 mt -115.2 105.77 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 109.158 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.543 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -108.23 17.2 22.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.086 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.543 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 78.85 -137.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.47 -112.27 1.66 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.476 ' HB3' ' OE1' ' A' ' 48' ' ' GLN . 9.7 tt0 -127.99 -38.99 1.79 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.315 -1.109 . . . . 0.0 109.467 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.502 ' OG1' ' HD2' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -156.97 167.76 13.88 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.072 -1.017 . . . . 0.0 108.957 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.502 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 3.3 Cg_exo -60.25 -18.1 50.27 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.879 2.386 . . . . 0.0 112.851 -177.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.534 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -79.74 -63.12 1.49 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.795 -1.191 . . . . 0.0 109.251 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.597 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 3.2 tt0 -38.02 -32.71 0.07 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.578 1.18 . . . . 0.0 109.626 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 47' ' ' GLU . . . -61.79 -65.51 0.68 Allowed 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.537 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.54 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 4.3 p -80.86 -43.97 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.927 -1.108 . . . . 0.0 110.79 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.597 ' CG1' ' HA ' ' A' ' 48' ' ' GLN . 7.5 p -42.6 -33.52 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.502 ' NH1' ' HG2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -75.82 -43.74 44.57 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.566 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.54 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 2.7 pt-20 -70.84 -7.3 44.46 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 118.74 -1.184 . . . . 0.0 108.5 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.567 ' HA ' ' CE2' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -64.99 -62.56 1.48 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.477 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 25.5 mt-30 -81.56 -24.19 36.7 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.569 -0.707 . . . . 0.0 109.458 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 52' ' ' ARG . 4.1 mm-40 -81.66 31.04 0.35 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.28 -0.887 . . . . 0.0 110.813 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.544 ' HB3' ' CB ' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -148.67 -64.01 0.24 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.696 -1.253 . . . . 0.0 109.863 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.659 HG11 ' HB3' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -118.78 -36.79 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.061 -1.025 . . . . 0.0 108.263 178.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 89.93 55.08 2.06 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.656 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -82.08 -179.28 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.183 -1.186 . . . . 0.0 109.834 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.546 ' N ' ' HD3' ' A' ' 62' ' ' PRO . 8.6 t -135.41 58.31 25.03 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.656 ' HD3' ' HB ' ' A' ' 60' ' ' ILE . 4.6 Cg_exo -53.8 129.17 32.72 Favored 'Trans proline' 0 C--N 1.29 -2.541 0 C-N-CA 122.35 2.033 . . . . 0.0 111.08 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.52 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 0.7 OUTLIER -81.21 -42.91 20.04 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.463 -179.198 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -160.85 114.96 2.08 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.676 -1.21 . . . . 0.0 111.018 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.473 ' CB ' ' HA ' ' A' ' 87' ' ' VAL . 1.8 p90 -121.98 177.89 5.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -0.846 . . . . 0.0 109.088 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 m -161.31 158.68 27.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 47.5 tp -84.76 96.25 9.2 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.876 -1.14 . . . . 0.0 109.536 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.64 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -41.76 -76.09 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.837 0.827 . . . . 0.0 108.904 179.267 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.64 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 4.0 tp10 -171.09 126.95 0.69 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 83' ' ' TRP . 8.9 ptpt -89.41 153.49 20.8 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.339 -0.85 . . . . 0.0 110.051 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.554 HD23 ' CG2' ' A' ' 122' ' ' VAL . 0.5 OUTLIER -127.41 -157.36 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.333 -0.854 . . . . 0.0 109.114 178.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -161.02 165.09 30.39 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.359 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.452 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . 1.1 t80 -152.82 175.39 12.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.543 -0.723 . . . . 0.0 109.174 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -160.43 109.33 1.69 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.665 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.573 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -79.71 177.16 3.09 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.184 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.573 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 6.3 Cg_endo -74.34 31.31 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.496 2.13 . . . . 0.0 111.335 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.29 -39.1 0.05 Allowed 'General case' 0 N--CA 1.482 1.157 0 O-C-N 120.509 -1.369 . . . . 0.0 110.112 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -135.99 -177.22 4.59 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.363 -0.835 . . . . 0.0 110.299 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.475 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 3.5 m170 -113.55 126.72 55.6 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 80' ' ' ILE . 1.6 mm -94.6 149.22 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.168 -0.958 . . . . 0.0 109.652 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.1 m -157.21 107.51 2.26 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.536 ' CD1' HG23 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -136.34 129.02 30.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.149 -0.969 . . . . 0.0 110.1 -178.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.523 ' NE1' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -119.05 149.21 42.05 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.237 -0.914 . . . . 0.0 110.108 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -127.67 123.03 34.53 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.667 ' CD1' ' O ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -91.13 80.9 5.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.616 -1.303 . . . . 0.0 109.209 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.564 HD12 ' HB ' ' A' ' 10' ' ' ILE . 0.5 OUTLIER -42.43 121.15 1.85 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.249 -0.907 . . . . 0.0 110.306 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.546 ' CG2' HG21 ' A' ' 11' ' ' ILE . 18.9 m -87.61 170.19 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.494 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 5.2 mt-10 -122.54 -19.79 6.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.854 -1.153 . . . . 0.0 111.078 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.52 ' HG3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.93 156.64 20.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.597 -1.314 . . . . 0.0 110.238 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.643 ' CD1' ' N ' ' A' ' 91' ' ' GLU . 6.2 p90 177.27 -169.38 0.07 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.096 0.951 . . . . 0.0 110.445 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.643 ' N ' ' CD1' ' A' ' 90' ' ' TRP . 7.2 tt0 -147.53 128.28 14.31 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.839 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 119.85 -165.92 13.48 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.848 -1.167 . . . . 0.0 110.279 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 58' ' ' VAL . 0.5 OUTLIER -111.01 105.07 56.98 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.166 -1.196 . . . . 0.0 109.05 179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.616 ' CB ' ' CD1' ' A' ' 11' ' ' ILE . 4.8 Cg_exo -58.96 176.38 0.47 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.782 2.321 . . . . 0.0 113.066 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.659 ' HB3' HG11 ' A' ' 58' ' ' VAL . 3.8 p-90 -122.57 -161.28 0.93 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.764 0.793 . . . . 0.0 109.834 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.519 ' HA3' ' HB3' ' A' ' 36' ' ' PRO . . . 165.79 -107.31 0.29 Allowed Glycine 0 N--CA 1.481 1.696 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.521 ' HD3' ' CB ' ' A' ' 100' ' ' GLN . 11.1 tttp -60.99 -178.94 0.11 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.981 -1.305 . . . . 0.0 108.568 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.58 -73.35 0.66 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.952 -1.092 . . . . 0.0 109.713 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.96 10.81 56.81 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -110.33 121.99 39.9 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 121.033 -1.275 . . . . 0.0 109.447 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.43 -53.51 0.78 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.144 1.896 . . . . 0.0 111.155 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . 90.29 172.0 44.38 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 7.4 pt-20 -140.5 144.92 36.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.715 -1.462 . . . . 0.0 110.246 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.599 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -89.94 107.25 19.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.332 -0.855 . . . . 0.0 109.208 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 7.4 ttm -96.25 152.08 18.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.128 -0.982 . . . . 0.0 109.671 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.457 ' O ' ' HG ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -108.12 105.47 15.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 109.372 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.531 ' O ' ' CG1' ' A' ' 108' ' ' VAL . 49.1 mt -147.98 -65.66 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.15 -0.969 . . . . 0.0 109.651 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER 77.15 -1.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.484 -0.76 . . . . 0.0 109.821 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -138.99 25.77 2.77 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 107.072 -2.411 . . . . 0.0 107.072 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 109' ' ' GLY . 0.9 OUTLIER -40.11 145.18 0.17 Allowed 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.935 -0.744 . . . . 0.0 110.149 -179.134 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.9 -171.71 1.95 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.371 -0.831 . . . . 0.0 108.991 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.502 ' HA ' HG22 ' A' ' 123' ' ' ILE . . . -91.12 10.26 27.64 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.238 -0.914 . . . . 0.0 109.3 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -85.99 -43.83 12.84 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.26 -0.9 . . . . 0.0 109.894 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.486 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -79.31 -14.89 58.71 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.256 -0.903 . . . . 0.0 108.744 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.537 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 1.4 m-85 -96.53 140.0 21.95 Favored Pre-proline 0 N--CA 1.489 1.516 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.854 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.482 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 1.8 Cg_endo -67.01 145.07 72.49 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.028 1.819 . . . . 0.0 110.446 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.543 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 1.8 Cg_endo -63.13 127.48 20.34 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.376 2.051 . . . . 0.0 110.574 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 156.9 -32.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.538 ' OD1' ' CD2' ' A' ' 71' ' ' LEU . 41.0 m-80 -112.81 46.85 1.16 Allowed 'General case' 0 C--O 1.201 -1.49 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.633 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 15.5 mt-10 -61.14 -41.39 80.56 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.237 -0.914 . . . . 0.0 112.901 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 1.3 Cg_endo -67.3 -29.05 39.15 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.544 2.162 . . . . 0.0 111.736 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.554 ' CG2' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -95.08 -41.25 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.021 -1.049 . . . . 0.0 108.444 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 119' ' ' ASN . 8.8 mm -58.36 -35.42 53.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.02 -39.25 63.02 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . 20.2 mmtt -80.63 -31.56 36.51 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.41 -0.806 . . . . 0.0 109.803 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 4.3 mp -56.9 -25.13 56.53 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.3 -0.875 . . . . 0.0 109.212 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -56.43 -46.5 80.23 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 129' ' ' LEU . 7.3 mtt180 -84.72 -7.02 59.37 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.721 -0.612 . . . . 0.0 109.476 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 126' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.812 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.508 ' HG ' ' CG2' ' A' ' 80' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.542 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -152.9 159.44 42.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.881 . . . . 0.0 109.387 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 7' ' ' ALA . 11.6 mm -116.89 168.44 8.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.226 -0.921 . . . . 0.0 109.353 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.545 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . -125.74 115.25 19.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.096 -1.002 . . . . 0.0 110.167 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.598 ' CG2' ' O ' ' A' ' 35' ' ' PHE . 5.8 p -129.54 146.13 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.53 112.33 1.08 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.616 ' CD1' ' CD1' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -94.25 162.12 2.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.61 ' CG2' ' CZ3' ' A' ' 90' ' ' TRP . 2.2 mt -146.03 135.95 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 118.319 -1.352 . . . . 0.0 112.037 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 35.1 ttp180 -126.98 129.57 48.36 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.536 ' OD1' ' CZ2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -98.48 -156.95 0.57 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.895 -1.128 . . . . 0.0 111.012 -178.062 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -85.67 -5.51 59.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.753 -0.592 . . . . 0.0 109.758 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.547 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 6.6 t-20 -91.34 23.12 3.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.919 . . . . 0.0 108.839 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 48.32 46.38 20.19 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.615 -0.678 . . . . 0.0 110.897 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.547 ' CG ' ' HB3' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -134.2 165.94 23.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.197 -0.94 . . . . 0.0 108.649 178.562 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.54 HG13 ' CD2' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -116.66 167.65 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.113 -0.992 . . . . 0.0 109.439 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 94' ' ' PRO . 57.3 t80 -120.13 88.21 2.89 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 121.028 -1.045 . . . . 0.0 108.963 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.522 HG22 ' CD1' ' A' ' 33' ' ' LEU . 9.4 mm -77.81 174.57 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -118.16 128.51 54.78 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.863 -1.148 . . . . 0.0 108.67 178.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.406 ' NH1' ' HD2' ' A' ' 32' ' ' LYS . 1.4 tpt180 . . . . . 0 C--N 1.298 -1.64 0 O-C-N 121.155 -0.966 . . . . 0.0 109.865 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -137.67 128.89 27.74 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.699 -179.538 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.576 HD11 ' CE1' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -96.51 -174.57 3.07 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 21' ' ' THR . 5.6 mm-40 -119.37 172.88 7.31 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.936 -1.103 . . . . 0.0 110.271 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.608 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -161.12 -66.02 0.02 OUTLIER Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 35' ' ' PHE . 11.5 Cg_exo -42.81 150.08 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.115 1.21 . . . . 0.0 109.489 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -116.17 -85.89 1.23 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.72 53.52 0.48 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.403 ' HA ' HD11 ' A' ' 6' ' ' ILE . 4.6 mptt 64.75 175.52 0.2 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.44 -1.035 . . . . 0.0 109.716 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.542 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 1.3 tt -148.44 79.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.385 -0.822 . . . . 0.0 109.78 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 42' ' ' MET . 0.6 OUTLIER -150.22 148.95 29.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.92 -1.113 . . . . 0.0 110.05 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.49 ' HB3' ' O ' ' A' ' 41' ' ' GLU . 0.5 OUTLIER 164.31 -33.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.19 37.04 0.2 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 48' ' ' GLN . 39.9 mt-10 -131.84 -148.12 0.34 Allowed 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.487 -1.007 . . . . 0.0 109.915 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.599 ' CB ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -142.66 -176.77 0.59 Allowed Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.215 -0.928 . . . . 0.0 108.695 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 45' ' ' THR . 1.1 Cg_endo -69.12 -3.17 11.05 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.808 1.672 . . . . 0.0 110.68 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.469 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -108.14 -45.5 3.93 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.001 -1.062 . . . . 0.0 109.165 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.514 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -75.67 -54.83 6.35 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.341 1.067 . . . . 0.0 109.396 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 45' ' ' THR . . . -38.02 -54.29 1.33 Allowed 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.176 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 5.3 p -76.12 -31.55 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.141 -0.975 . . . . 0.0 109.119 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.627 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -44.53 -58.05 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.627 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -67.92 -28.87 67.87 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.339 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.539 ' HA ' ' CG ' ' A' ' 56' ' ' GLU . 3.9 mt-10 -56.47 -18.79 12.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.831 -1.168 . . . . 0.0 108.301 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.52 ' CD1' ' HG3' ' A' ' 62' ' ' PRO . 14.6 mt -68.9 -42.73 76.51 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.372 -0.83 . . . . 0.0 109.056 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -81.25 -41.82 21.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 110.485 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 14.6 pt-20 -80.94 37.82 0.44 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.023 -1.048 . . . . 0.0 110.98 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.576 ' HB3' ' CG ' ' A' ' 95' ' ' TRP . 58.0 mm-40 -146.69 -55.76 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.881 -1.137 . . . . 0.0 109.204 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.62 ' CG1' ' HB3' ' A' ' 95' ' ' TRP . 1.6 m -143.83 -33.08 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.523 -0.736 . . . . 0.0 109.279 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.533 ' N ' HG21 ' A' ' 58' ' ' VAL . . . 84.46 59.77 1.98 Allowed Glycine 0 N--CA 1.479 1.558 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.61 HG12 ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -95.6 164.91 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.489 -1.006 . . . . 0.0 109.012 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 97.4 m -112.53 83.98 5.95 Favored Pre-proline 0 C--N 1.3 -1.577 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 2.4 Cg_endo -59.48 117.63 4.39 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.439 2.093 . . . . 0.0 110.246 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.52 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 1.2 mt-30 -79.55 -28.02 41.25 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.559 -0.713 . . . . 0.0 109.183 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 12.5 t-160 -171.1 117.17 0.45 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.936 -1.102 . . . . 0.0 111.037 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.509 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . 11.3 p90 -129.66 171.19 12.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.245 -0.909 . . . . 0.0 109.586 178.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.18 161.4 24.97 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.382 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.52 ' CD1' ' HA ' ' A' ' 85' ' ' TRP . 27.0 tp -109.31 108.78 19.49 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.645 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 27.1 p90 -69.62 -56.62 6.78 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.308 -0.87 . . . . 0.0 111.117 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.645 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 3.3 tp10 -172.23 144.68 1.63 Allowed 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.348 -0.845 . . . . 0.0 109.857 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.58 ' HD3' ' CE3' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -111.59 158.11 19.61 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.336 -0.853 . . . . 0.0 110.549 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.524 ' CD2' ' HB ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -113.02 -165.08 0.96 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 1.7 pt-20 -149.07 133.96 17.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.822 -1.174 . . . . 0.0 110.353 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.518 ' HB3' ' CG1' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -96.29 117.74 31.42 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.277 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -110.94 99.76 8.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.156 -0.965 . . . . 0.0 109.547 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.506 ' HB2' ' HG3' ' A' ' 78' ' ' ARG . 5.1 m-85 -79.49 170.17 17.15 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 2.2 Cg_endo -62.87 -2.39 3.54 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.01 1.807 . . . . 0.0 111.516 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -143.18 -20.62 0.63 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.692 -1.255 . . . . 0.0 111.764 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.506 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -126.63 163.18 24.02 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.663 -1.273 . . . . 0.0 110.642 -178.495 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -127.35 74.24 1.5 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.518 ' CG1' ' HB3' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -78.91 -174.85 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.352 -0.843 . . . . 0.0 110.576 -178.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 72' ' ' GLU . 3.0 m -151.01 153.62 35.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.421 -0.799 . . . . 0.0 109.209 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -129.34 143.1 50.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.083 -1.011 . . . . 0.0 109.324 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.638 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -133.11 128.91 37.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 109.837 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.612 ' CE1' HG12 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -121.83 101.16 7.4 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.702 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.594 ' CD1' ' O ' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -79.89 83.44 5.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.188 -0.945 . . . . 0.0 110.594 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.616 ' CD1' ' CD1' ' A' ' 10' ' ' ILE . 3.4 tp -52.38 114.02 1.23 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 109.574 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.586 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 8.5 m -85.11 -163.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.218 -0.926 . . . . 0.0 109.581 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 12' ' ' ARG . 76.3 mt-10 -137.57 -31.82 0.78 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.113 -0.992 . . . . 0.0 110.355 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.52 ' HG3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -161.95 175.5 11.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.82 -1.175 . . . . 0.0 110.019 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.643 ' CZ2' ' HG3' ' A' ' 94' ' ' PRO . 42.3 p90 -179.6 -168.24 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.081 0.943 . . . . 0.0 110.362 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.461 ' HB3' ' HB ' ' A' ' 61' ' ' THR . 17.4 tt0 -141.27 96.46 2.99 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.913 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.574 ' CA ' HG21 ' A' ' 60' ' ' ILE . . . 144.34 -152.12 24.05 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.273 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.555 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -106.51 112.36 63.76 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.22 -1.165 . . . . 0.0 109.601 -179.5 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.643 ' HG3' ' CZ2' ' A' ' 90' ' ' TRP . 3.6 Cg_endo -56.81 130.71 41.35 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.155 2.57 . . . . 0.0 113.661 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.62 ' HB3' ' CG1' ' A' ' 58' ' ' VAL . 33.7 p-90 -107.01 -168.96 1.47 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 165.11 -15.72 0.09 OUTLIER Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.988 -1.577 . . . . 0.0 111.242 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.525 ' CB ' HG23 ' A' ' 21' ' ' THR . 11.3 tttp -117.49 -99.15 0.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.829 -1.395 . . . . 0.0 109.765 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 97' ' ' LYS . 1.3 tt0 -134.81 28.11 3.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.22 -0.925 . . . . 0.0 109.407 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.79 22.9 19.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.453 ' HG2' ' HD2' ' A' ' 101' ' ' PRO . 2.0 mt-30 -103.15 166.88 11.06 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.136 -1.214 . . . . 0.0 109.619 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.453 ' HD2' ' HG2' ' A' ' 100' ' ' GLN . 1.1 Cg_endo -64.94 128.19 20.23 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.346 2.031 . . . . 0.0 110.513 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.557 ' HA3' ' CZ ' ' A' ' 19' ' ' PHE . . . -104.05 174.14 22.1 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.463 ' OE1' ' HA ' ' A' ' 103' ' ' GLU . 45.6 mm-40 -112.87 151.56 30.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.891 -1.358 . . . . 0.0 110.672 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.602 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -103.25 101.09 11.01 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.042 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.518 ' HE3' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -100.55 -166.81 1.36 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.974 -1.079 . . . . 0.0 110.002 -179.437 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -111.9 151.86 28.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 109.825 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 tt -61.94 -27.58 68.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.44 -0.787 . . . . 0.0 110.183 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 109' ' ' GLY . 62.6 t -65.24 112.7 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.189 -0.945 . . . . 0.0 109.433 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 108' ' ' VAL . . . 45.1 40.71 7.42 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.588 ' HG ' ' N ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -51.82 -42.69 62.72 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.476 -1.014 . . . . 0.0 110.127 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.588 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -130.28 -165.68 1.57 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.378 -0.826 . . . . 0.0 110.071 -179.436 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 111' ' ' ASN . . . 87.48 -25.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -120.43 -37.72 3.0 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.334 -0.854 . . . . 0.0 108.937 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.407 ' OD1' HD22 ' A' ' 33' ' ' LEU . 9.8 t0 -96.3 0.86 51.42 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.414 -0.804 . . . . 0.0 109.002 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.583 ' CE1' ' HB3' ' A' ' 111' ' ' ASN . 1.7 m-85 -91.46 164.57 24.01 Favored Pre-proline 0 N--CA 1.489 1.501 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.498 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.496 ' HD2' ' CD2' ' A' ' 115' ' ' PHE . 1.3 Cg_endo -67.7 142.21 57.39 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.949 1.766 . . . . 0.0 109.794 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.543 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 1.6 Cg_endo -64.53 96.78 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.26 1.973 . . . . 0.0 110.31 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 161.3 -21.42 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.387 -0.821 . . . . 0.0 109.765 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.544 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 0.8 OUTLIER -97.51 29.88 3.11 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.135 -0.978 . . . . 0.0 109.411 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.672 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 22.5 mt-10 -68.79 -34.2 5.08 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.47 -0.769 . . . . 0.0 112.891 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.0 Cg_exo -58.6 -37.38 94.69 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.545 1.497 . . . . 0.0 111.674 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.612 HG12 ' CE1' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -101.79 -47.83 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.633 -1.292 . . . . 0.0 107.863 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.573 ' CG2' ' CA ' ' A' ' 112' ' ' ALA . 12.4 mm -47.81 -31.1 2.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.507 -0.745 . . . . 0.0 109.013 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 127' ' ' LYS . . . -52.92 -49.86 65.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.388 -0.82 . . . . 0.0 108.857 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -41.31 92.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.453 -0.78 . . . . 0.0 109.263 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 10.9 mt -57.13 -13.78 3.31 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.232 -0.917 . . . . 0.0 109.768 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 124' ' ' ALA . 25.1 mttt -61.7 -46.04 91.37 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.701 -1.249 . . . . 0.0 108.816 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 129' ' ' LEU . 14.9 mtm180 -88.45 11.87 15.84 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.425 -0.797 . . . . 0.0 109.563 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.556 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.402 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.53 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.224 0.535 . . . . 0.0 109.895 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.487 ' HA ' ' HB ' ' A' ' 81' ' ' THR . 1.8 mt-30 -63.66 154.25 33.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.151 -0.968 . . . . 0.0 110.847 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.549 ' CG2' ' N ' ' A' ' 7' ' ' ALA . 5.1 mm -141.79 171.26 11.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.549 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . -132.23 89.96 2.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.797 -1.189 . . . . 0.0 109.848 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 35' ' ' PHE . 7.2 p -100.98 164.41 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.229 -0.919 . . . . 0.0 109.67 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.514 ' HA2' ' CD1' ' A' ' 85' ' ' TRP . . . -147.87 114.43 0.69 Allowed Glycine 0 N--CA 1.48 1.603 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.598 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -97.21 123.43 49.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.66 ' CD1' ' HB3' ' A' ' 94' ' ' PRO . 3.4 mt -117.8 153.21 19.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.201 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.516 ' CZ ' ' OE2' ' A' ' 88' ' ' GLU . 9.1 tpp180 -78.08 -147.41 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.912 0 O-C-N 120.965 -1.085 . . . . 0.0 108.763 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.56 ' CB ' ' HB2' ' A' ' 17' ' ' GLU . 0.9 OUTLIER -146.55 -11.46 0.46 Allowed 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.34 -0.85 . . . . 0.0 111.656 -179.174 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 13' ' ' ASN . 0.6 OUTLIER 82.97 -36.23 0.08 Allowed 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.603 -0.686 . . . . 0.0 109.274 -178.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.54 ' O ' ' HB3' ' A' ' 16' ' ' ASN . 14.9 t-20 -94.45 26.14 3.56 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.54 ' HB3' ' O ' ' A' ' 15' ' ' ASN . 18.8 t-20 71.16 37.17 1.25 Allowed 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.815 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.56 ' HB2' ' CB ' ' A' ' 13' ' ' ASN . 3.6 mt-10 -127.86 -163.5 1.27 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.639 -1.288 . . . . 0.0 109.353 178.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.588 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 1.1 mt -151.65 154.33 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.816 -1.178 . . . . 0.0 109.737 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 82.7 t80 -95.19 66.28 2.91 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.565 HG22 ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -81.73 -156.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.849 0.833 . . . . 0.0 110.736 -177.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.598 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.1 OUTLIER -145.51 147.1 31.77 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.385 0.612 . . . . 0.0 109.721 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.293 -0.879 . . . . 0.0 110.144 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.453 ' O ' ' HE3' ' A' ' 32' ' ' LYS . 1.5 m-20 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.48 ' HG3' ' HG3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -137.38 146.14 44.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.292 179.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.565 ' CD2' HG22 ' A' ' 20' ' ' ILE . 0.7 OUTLIER -105.1 -174.15 2.47 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.209 -0.932 . . . . 0.0 109.341 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.466 ' O ' HD13 ' A' ' 20' ' ' ILE . 1.6 tt0 -162.02 -155.34 0.37 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.988 0.899 . . . . 0.0 109.985 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.546 ' HB3' HG22 ' A' ' 8' ' ' VAL . 17.9 m-85 -132.26 131.32 22.33 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.543 ' HA ' ' NE2' ' A' ' 100' ' ' GLN . 5.3 Cg_exo -57.41 -157.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.071 1.847 . . . . 0.0 111.004 -178.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.537 ' CA ' ' HA ' ' A' ' 8' ' ' VAL . . . 85.2 154.55 22.63 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.99 -31.82 0.15 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -171.15 161.94 6.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.815 -1.403 . . . . 0.0 110.529 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 40' ' ' ILE . 2.9 tt -136.25 98.29 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.474 -0.766 . . . . 0.0 109.151 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 42' ' ' MET . 7.0 mt-10 -81.56 -173.51 4.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.207 -0.933 . . . . 0.0 110.122 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 12.8 mtt 63.62 -94.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.47 -0.769 . . . . 0.0 109.594 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.01 31.73 4.64 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -71.54 0.44 Allowed 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.601 -0.94 . . . . 0.0 109.463 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.591 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 24.2 m -133.84 144.01 49.97 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.054 -1.029 . . . . 0.0 109.08 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.591 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.0 Cg_endo -55.66 -8.63 2.14 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.69 2.26 . . . . 0.0 112.33 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.404 ' H ' HG21 ' A' ' 45' ' ' THR . 0.5 OUTLIER -103.06 -36.26 8.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.762 -1.211 . . . . 0.0 108.686 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.559 ' O ' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -62.0 -50.72 70.93 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.598 1.19 . . . . 0.0 108.811 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' GLN . . . -38.23 -60.61 0.76 Allowed 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.339 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.582 HG22 ' CD1' ' A' ' 85' ' ' TRP . 2.3 p -71.95 -29.84 34.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.018 -1.051 . . . . 0.0 109.923 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.626 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -42.55 -56.33 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 122.039 0.923 . . . . 0.0 108.781 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.626 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -65.87 -33.34 75.63 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.39 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 5.8 mt-10 -73.08 -5.02 36.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.113 -0.992 . . . . 0.0 109.416 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.585 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 3.7 mt -79.92 -62.88 1.55 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 0.0 109.43 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.506 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 3.0 mm100 -81.94 -23.64 36.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.205 -0.935 . . . . 0.0 110.999 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -80.58 17.79 1.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.688 -1.257 . . . . 0.0 110.816 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.57 ' HB3' ' CD1' ' A' ' 95' ' ' TRP . 1.6 mt-10 -130.59 -65.3 0.8 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.673 -1.267 . . . . 0.0 110.003 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.714 ' CG2' HG12 ' A' ' 60' ' ' ILE . 2.8 m -121.92 -26.47 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 108.907 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.512 ' N ' HG21 ' A' ' 58' ' ' VAL . . . 95.99 59.7 1.05 Allowed Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.714 HG12 ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -95.84 174.01 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -1.172 . . . . 0.0 110.7 -179.527 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.722 ' N ' ' CD ' ' A' ' 62' ' ' PRO . 10.3 t -144.99 41.22 0.3 Allowed Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.722 ' CD ' ' N ' ' A' ' 61' ' ' THR . 4.8 Cg_exo -43.29 122.39 2.94 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.711 2.274 . . . . 0.0 110.852 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -98.89 -5.85 30.07 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.352 -178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.71 39.31 2.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.165 -1.584 . . . . 0.0 111.952 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.561 ' CB ' ' HB ' ' A' ' 87' ' ' VAL . 45.0 p90 -79.9 168.07 19.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.63 -1.294 . . . . 0.0 110.52 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.5 m -164.38 145.23 8.15 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.571 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 44.7 tp -73.91 98.1 2.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.562 -1.336 . . . . 0.0 108.897 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.586 ' CE2' HG13 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -44.77 -80.14 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.748 0.785 . . . . 0.0 108.981 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.582 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 16.0 mt-10 -152.9 164.45 37.88 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.297 0.57 . . . . 0.0 109.809 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 13.4 ttpp -134.33 108.87 8.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.996 -1.065 . . . . 0.0 110.214 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.535 ' CD2' HG21 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -98.55 -167.82 1.55 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.177 -0.952 . . . . 0.0 109.32 179.284 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -149.62 146.32 27.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.92 . . . . 0.0 109.689 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 74' ' ' GLU . 47.7 t80 -136.01 152.69 51.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 108.988 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 52.6 tt0 -143.2 115.05 8.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.527 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 3.9 m-85 -78.94 172.31 10.23 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.3 Cg_exo -59.61 -7.37 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.814 1.676 . . . . 0.0 111.453 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.27 -8.51 0.14 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.819 -1.175 . . . . 0.0 112.186 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.512 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -130.93 178.52 6.61 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.282 -1.511 . . . . 0.0 109.92 -179.158 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 4' ' ' LEU . 27.6 m80 -125.4 161.99 25.81 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.355 -0.84 . . . . 0.0 108.977 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 34.7 mm -149.99 74.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 110.005 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.487 ' HB ' ' HA ' ' A' ' 5' ' ' GLN . 18.7 m -79.64 136.91 36.94 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.479 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 12.5 tp -132.98 150.26 52.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.965 -1.085 . . . . 0.0 110.676 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.637 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -123.45 109.67 14.14 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.139 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.593 ' CZ ' HG23 ' A' ' 122' ' ' VAL . 3.0 m-85 -79.73 88.41 5.2 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.14 -0.975 . . . . 0.0 109.865 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.694 ' O ' ' CG ' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -86.59 74.91 9.79 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 123.514 1.626 . . . . 0.0 107.135 178.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.598 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 8.0 tp -67.17 133.85 50.59 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.431 -177.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.561 ' HB ' ' CB ' ' A' ' 65' ' ' PHE . 7.3 p -144.28 168.61 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.476 -0.765 . . . . 0.0 109.197 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.516 ' OE2' ' CZ ' ' A' ' 12' ' ' ARG . 7.0 mt-10 -144.36 -18.95 0.55 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.916 -1.115 . . . . 0.0 111.923 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -110.85 141.88 43.63 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.313 -1.492 . . . . 0.0 109.303 -179.526 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.616 ' CD1' ' CG2' ' A' ' 60' ' ' ILE . 14.3 p90 178.62 -172.57 0.14 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.502 1.144 . . . . 0.0 111.002 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.475 ' N ' ' CD1' ' A' ' 90' ' ' TRP . 15.3 tt0 -147.14 85.98 1.62 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.798 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 168.46 -156.04 27.17 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.577 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -117.04 102.42 52.84 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.281 -1.129 . . . . 0.0 109.889 -179.296 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.66 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 31.9 Cg_exo -39.26 128.27 1.51 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 123.388 2.725 . . . . 0.0 113.289 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.667 ' HB3' ' CG1' ' A' ' 58' ' ' VAL . 2.0 p-90 -105.09 -164.83 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 154.61 92.95 0.09 OUTLIER Glycine 0 C--N 1.298 -1.537 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.525 ' HB2' ' N ' ' A' ' 37' ' ' GLY . 17.8 tttm 58.89 105.99 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.365 -1.08 . . . . 0.0 109.907 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -68.76 105.51 2.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.255 -0.903 . . . . 0.0 109.345 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 132.1 -11.75 5.32 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.543 ' NE2' ' HA ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -101.46 108.58 56.01 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 121.347 -1.09 . . . . 0.0 109.157 179.734 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.89 89.99 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.068 1.845 . . . . 0.0 110.62 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -86.99 177.56 47.92 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.414 ' OE2' ' CZ ' ' A' ' 22' ' ' ARG . 14.1 pt-20 -159.11 177.6 10.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.65 -1.5 . . . . 0.0 111.108 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.47 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 35.0 m0 -87.88 110.95 20.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.698 -0.627 . . . . 0.0 109.799 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 30.5 ttp -101.75 144.46 30.41 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.273 -0.892 . . . . 0.0 108.804 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.36 131.1 41.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.937 . . . . 0.0 109.869 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.515 HD11 ' CD1' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -107.08 57.5 0.63 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.297 -0.877 . . . . 0.0 109.247 179.653 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.407 HG11 ' O ' ' A' ' 108' ' ' VAL . 61.8 t -81.98 -19.35 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 178.29 49.01 0.07 OUTLIER Glycine 0 N--CA 1.487 2.04 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.474 HD13 HD13 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -37.31 143.31 0.1 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.954 -0.733 . . . . 0.0 110.441 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -148.67 -174.5 4.63 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.461 -0.775 . . . . 0.0 109.092 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.426 ' CB ' HG23 ' A' ' 123' ' ' ILE . . . -80.41 5.56 14.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 109.325 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -74.08 -48.54 29.07 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.305 -0.872 . . . . 0.0 110.079 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.542 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -79.66 -15.24 57.95 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.228 -0.92 . . . . 0.0 108.941 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.613 ' CG ' HD13 ' A' ' 123' ' ' ILE . 4.9 m-85 -102.86 130.77 23.13 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.624 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.534 ' CG ' ' O ' ' A' ' 33' ' ' LEU . 1.8 Cg_endo -62.93 158.97 40.33 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.035 1.824 . . . . 0.0 110.082 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.492 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 3.1 Cg_exo -59.49 -172.8 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.43 2.087 . . . . 0.0 110.937 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 77.73 -0.71 2.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.502 -0.749 . . . . 0.0 109.775 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.548 ' HB3' HG12 ' A' ' 123' ' ' ILE . 2.0 m-80 -133.66 49.03 2.31 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.103 -0.998 . . . . 0.0 109.776 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.647 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 4.6 mm-40 -75.46 -39.98 3.24 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 112.52 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 2.1 Cg_endo -64.54 -25.85 62.38 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.948 1.765 . . . . 0.0 111.837 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.593 HG23 ' CZ ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -104.01 -50.85 8.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 120.79 -1.194 . . . . 0.0 109.115 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.613 HD13 ' CG ' ' A' ' 115' ' ' PHE . 19.7 mm -55.15 -37.98 45.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 120' ' ' GLU . . . -49.57 -40.61 39.07 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.51 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -80.1 -35.23 37.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.53 -0.731 . . . . 0.0 109.776 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 9.5 mt -73.25 -4.12 31.08 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.191 -0.943 . . . . 0.0 109.825 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 110' ' ' LEU . 11.1 mttt -64.23 -49.05 73.48 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.277 -0.889 . . . . 0.0 109.185 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.27 -0.75 42.22 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.373 -0.83 . . . . 0.0 109.339 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.508 HD22 ' NH1' ' A' ' 12' ' ' ARG . 2.3 tp . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.716 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.2 tp . . . . . 0 N--CA 1.485 1.298 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.508 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . 0.3 OUTLIER -125.31 148.49 48.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.081 -1.012 . . . . 0.0 109.558 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.525 ' O ' ' CD1' ' A' ' 83' ' ' TRP . 5.5 mm -107.04 178.37 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.248 -0.908 . . . . 0.0 109.409 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.47 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -139.29 96.63 3.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 109.616 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 11.8 p -121.22 135.36 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 110.257 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.32 115.94 2.79 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.556 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 1.5 mt -84.28 157.83 3.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.6 ' CD1' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -127.29 148.72 32.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.897 -1.127 . . . . 0.0 110.137 -178.068 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 88' ' ' GLU . 32.9 ttp180 -153.26 115.87 4.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.699 -0.625 . . . . 0.0 109.319 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.74 -153.65 0.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.087 -1.008 . . . . 0.0 109.751 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.587 ' CG ' ' NH1' ' A' ' 89' ' ' ARG . 51.8 mt-10 -89.07 -5.13 58.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.749 . . . . 0.0 109.882 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.538 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 55.6 t30 -94.72 33.64 1.43 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 15' ' ' ASN . 1.8 m120 33.74 41.46 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.59 0.71 . . . . 0.0 110.814 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 15' ' ' ASN . 5.0 mt-10 -119.94 128.81 53.94 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.581 ' N ' ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -105.7 150.21 8.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.643 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 13.6 t80 -98.24 81.7 2.82 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.518 HD11 ' N ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -93.09 -157.9 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 110.177 -178.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.602 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.2 OUTLIER -125.01 169.2 12.35 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.201 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 . . . . . 0 C--N 1.306 -1.311 0 O-C-N 120.821 -1.174 . . . . 0.0 110.453 -179.566 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -131.08 136.15 48.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.361 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.566 ' CB ' ' O ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -135.59 -179.53 5.7 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.151 -0.968 . . . . 0.0 109.41 179.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.49 ' O ' HD13 ' A' ' 20' ' ' ILE . 2.0 tt0 -164.53 -154.96 0.26 Allowed 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.545 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -122.95 93.39 48.4 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.511 ' CD ' ' OG1' ' A' ' 21' ' ' THR . 5.9 Cg_exo -57.11 -153.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.501 2.134 . . . . 0.0 110.749 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 140.1 -153.84 23.58 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -148.94 23.62 1.28 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 73.58 160.58 0.23 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.134 . . . . 0.0 109.215 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.508 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 2.9 tt -102.07 129.24 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.197 -0.939 . . . . 0.0 109.347 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -126.54 -70.54 0.72 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.945 . . . . 0.0 109.554 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.48 108.61 20.13 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.405 0.622 . . . . 0.0 109.376 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.12 141.28 3.43 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.1 -10.59 15.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -1.142 . . . . 0.0 109.984 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.583 ' CB ' ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -146.24 177.23 1.84 Allowed Pre-proline 0 N--CA 1.486 1.353 0 O-C-N 120.963 -1.086 . . . . 0.0 109.87 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 45' ' ' THR . 6.3 Cg_endo -74.55 -4.93 16.18 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.466 2.111 . . . . 0.0 110.548 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.474 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 2.9 mt-10 -105.36 -37.28 6.9 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.202 -0.936 . . . . 0.0 108.884 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.435 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -73.04 -57.52 3.98 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.362 1.077 . . . . 0.0 108.868 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 53' ' ' GLU . . . -46.11 -43.12 14.57 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.52 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.609 ' CG2' ' CE3' ' A' ' 85' ' ' TRP . 14.5 p -79.79 -27.64 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.378 -0.827 . . . . 0.0 109.175 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.631 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -54.44 -57.93 5.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.631 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -81.22 -25.01 37.02 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.418 -178.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.579 ' CG ' ' HA ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -81.08 -31.58 34.31 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.003 -1.686 . . . . 0.0 111.457 -177.564 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.578 ' HG ' ' CD2' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -79.86 -42.34 24.44 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.008 -1.058 . . . . 0.0 109.995 -179.321 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.491 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 1.7 mt-30 -67.96 -34.45 76.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.013 -1.054 . . . . 0.0 109.901 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.52 -9.68 58.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.033 -1.042 . . . . 0.0 110.132 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.495 ' CA ' ' OE1' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -101.2 -64.06 1.08 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.089 -1.007 . . . . 0.0 109.675 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.597 HG22 ' HA ' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -101.85 -29.16 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.457 -0.777 . . . . 0.0 109.158 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 59.5 53.48 45.74 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.571 ' CD1' ' C ' ' A' ' 94' ' ' PRO . 0.7 OUTLIER -92.43 -165.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.535 ' HB ' ' CB ' ' A' ' 91' ' ' GLU . 98.8 m -137.51 91.04 14.38 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.595 -1.316 . . . . 0.0 109.418 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.594 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 1.8 Cg_endo -63.93 157.22 53.88 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.33 2.02 . . . . 0.0 110.809 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -120.73 -45.39 2.4 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 110.037 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.87 104.24 3.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.997 -1.064 . . . . 0.0 109.759 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.8 OUTLIER -134.84 172.29 13.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.197 -0.94 . . . . 0.0 110.317 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.59 151.99 17.5 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.535 ' CD1' ' O ' ' A' ' 84' ' ' PHE . 27.1 tp -70.27 100.64 1.74 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.906 -1.121 . . . . 0.0 109.594 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.635 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.7 OUTLIER -43.43 -77.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.635 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 2.3 tt0 -169.15 114.87 0.58 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.775 -0.578 . . . . 0.0 109.572 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.456 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -86.35 163.65 17.53 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.371 -0.831 . . . . 0.0 110.119 -179.623 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.531 ' CD2' ' HB ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -126.13 -165.69 1.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -153.42 145.92 24.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.011 -1.056 . . . . 0.0 110.278 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.59 174.44 10.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 109.06 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 13.9 tt0 -155.63 113.68 3.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.147 -0.97 . . . . 0.0 109.623 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.565 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -79.59 -178.35 1.09 Allowed Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.724 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.565 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 4.8 Cg_endo -73.2 30.51 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.109 1.873 . . . . 0.0 111.486 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.447 ' OD2' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -162.52 -44.69 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.376 -1.452 . . . . 0.0 110.51 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.447 ' HG2' ' OD2' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -133.16 -178.18 4.86 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.163 -0.961 . . . . 0.0 110.069 -178.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -108.3 121.52 45.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.355 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.412 HD13 ' CD1' ' A' ' 75' ' ' PHE . 4.9 mt -90.28 88.26 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.052 -1.03 . . . . 0.0 109.639 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 5' ' ' GLN . 1.3 m -85.28 120.63 26.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.288 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.462 ' HG ' ' HB ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -120.77 138.21 54.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.552 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.525 ' CD1' ' O ' ' A' ' 6' ' ' ILE . 1.4 m95 -96.43 165.27 12.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.371 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.535 ' O ' ' CD1' ' A' ' 67' ' ' LEU . 2.5 m-85 -130.59 74.62 1.61 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.915 . . . . 0.0 109.261 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.609 ' CE3' ' CG2' ' A' ' 50' ' ' VAL . 2.9 m0 -79.68 86.43 5.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.193 -0.942 . . . . 0.0 109.741 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.556 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 28.4 tp -88.37 106.32 18.17 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 65' ' ' PHE . 16.3 m -87.75 177.21 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.028 -1.045 . . . . 0.0 110.235 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -132.58 -23.44 2.08 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.395 -0.816 . . . . 0.0 110.118 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.587 ' NH1' ' CG ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -147.87 148.84 31.28 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 120.841 -1.162 . . . . 0.0 110.944 -179.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.634 ' NE1' ' O ' ' A' ' 92' ' ' GLY . 4.1 p90 -166.4 -172.26 2.16 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.663 0.744 . . . . 0.0 109.579 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.535 ' CB ' ' HB ' ' A' ' 61' ' ' THR . 5.3 tt0 -92.76 -84.1 0.29 Allowed 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.837 -178.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.634 ' O ' ' NE1' ' A' ' 90' ' ' TRP . . . -46.59 178.83 0.01 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.802 ' N ' ' CD ' ' A' ' 94' ' ' PRO . 1.6 tt0 -87.32 -25.5 0.33 Allowed Pre-proline 0 N--CA 1.502 2.168 0 O-C-N 121.222 -1.164 . . . . 0.0 114.078 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.802 ' CD ' ' N ' ' A' ' 93' ' ' GLU . 49.3 Cg_endo -94.51 -159.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.951 0 C-N-CA 124.333 3.355 . . . . 0.0 110.566 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.677 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 3.1 t90 150.59 35.88 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 123.551 0.741 . . . . 0.0 110.815 176.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -135.13 -105.85 0.84 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -93.92 146.1 24.15 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.358 -1.084 . . . . 0.0 108.884 179.34 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -101.54 133.44 46.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 109.369 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.25 -11.09 72.15 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.458 ' CG ' ' HD2' ' A' ' 101' ' ' PRO . 8.4 tp60 -88.64 138.94 29.6 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.433 -1.039 . . . . 0.0 108.888 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 102' ' ' GLY . 6.3 Cg_exo -57.48 -78.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.98 1.787 . . . . 0.0 110.916 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . 51.87 174.49 0.03 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.6 OUTLIER -160.27 176.57 11.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.606 -1.526 . . . . 0.0 111.437 -178.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.545 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 3.9 m0 -95.8 144.85 25.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.783 -0.573 . . . . 0.0 109.869 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.523 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.6 ttm -110.37 -176.0 2.87 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.503 ' O ' ' C ' ' A' ' 107' ' ' LEU . 29.1 t -131.57 32.79 4.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.846 -1.159 . . . . 0.0 110.342 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.503 ' C ' ' O ' ' A' ' 106' ' ' SER . 1.0 OUTLIER 33.04 59.4 0.44 Allowed 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.141 0.496 . . . . 0.0 109.988 179.419 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.9 t -108.87 -40.42 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.163 -0.961 . . . . 0.0 109.779 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -149.79 35.71 1.0 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 109' ' ' GLY . 1.0 OUTLIER -45.48 138.45 4.34 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.208 -1.172 . . . . 0.0 109.207 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -160.91 154.13 21.59 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.256 -0.902 . . . . 0.0 109.852 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.47 -14.64 20.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -0.892 . . . . 0.0 109.039 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.94 -41.85 97.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.898 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.539 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.5 t0 -77.82 -10.57 59.62 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.591 ' CD1' HD13 ' A' ' 123' ' ' ILE . 8.6 m-85 -103.79 106.53 53.02 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.494 ' HG2' ' O ' ' A' ' 33' ' ' LEU . 11.7 Cg_exo -48.37 158.47 1.01 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.804 1.67 . . . . 0.0 110.047 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 6.1 Cg_exo -56.71 -173.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.185 1.923 . . . . 0.0 110.86 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 84.39 -21.08 0.27 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.81 -0.556 . . . . 0.0 110.118 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.554 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 0.8 OUTLIER -124.27 39.89 3.86 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.932 -1.105 . . . . 0.0 109.869 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.694 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.9 mm-40 -71.76 -33.99 2.83 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 112.712 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.9 Cg_exo -61.79 -36.31 74.33 Favored 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 121.842 1.695 . . . . 0.0 112.088 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.54 ' O ' HD21 ' A' ' 126' ' ' LEU . 1.2 t -100.92 -43.53 10.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 O-C-N 120.498 -1.376 . . . . 0.0 108.399 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.591 HD13 ' CD1' ' A' ' 115' ' ' PHE . 22.5 mm -54.6 -32.92 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 O-C-N 121.494 -0.754 . . . . 0.0 109.41 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.92 -39.55 26.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.544 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.45 -33.17 36.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.361 -0.837 . . . . 0.0 110.909 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.549 ' CA ' HD13 ' A' ' 129' ' ' LEU . 4.4 mm? -47.86 -31.4 5.02 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.907 -1.121 . . . . 0.0 109.801 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -60.78 -52.28 65.77 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.53 ' O ' ' C ' ' A' ' 129' ' ' LEU . 4.7 mtt180 -82.19 10.1 7.46 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.472 -0.767 . . . . 0.0 109.275 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.549 HD13 ' CA ' ' A' ' 126' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 117.937 -1.03 . . . . 0.0 111.023 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.3 tp . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.495 ' HB3' HG22 ' A' ' 40' ' ' ILE . 3.4 tt0 -143.68 158.95 43.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.208 -0.933 . . . . 0.0 109.433 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.551 ' CG2' ' N ' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -123.04 167.43 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.097 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.551 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . -129.93 93.23 3.46 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.07 -1.019 . . . . 0.0 109.609 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.567 HG11 ' HA ' ' A' ' 84' ' ' PHE . 7.5 p -102.32 155.65 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.209 -0.932 . . . . 0.0 109.861 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.4 125.49 2.91 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.563 HD11 ' CD2' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -104.37 155.85 5.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.006 -1.291 . . . . 0.0 107.565 -179.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.629 ' CG2' ' CZ3' ' A' ' 90' ' ' TRP . 2.0 mt -147.03 138.39 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.518 -1.364 . . . . 0.0 111.504 -176.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 23.4 ttp180 -140.46 127.53 20.86 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.57 ' OD1' ' CZ2' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -108.09 -169.46 1.52 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.258 -0.901 . . . . 0.0 110.66 -178.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.68 -5.3 19.48 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.56 -0.712 . . . . 0.0 110.075 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -79.1 7.32 7.66 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.457 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 5.4 t-20 53.75 44.56 29.44 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.776 0.798 . . . . 0.0 109.759 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 4.9 mt-10 -140.85 153.41 45.74 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.9 mt -119.56 163.71 16.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.99 -1.069 . . . . 0.0 109.453 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -116.78 98.59 6.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.835 -1.166 . . . . 0.0 109.192 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.518 ' CD1' ' HE3' ' A' ' 105' ' ' MET . 0.8 OUTLIER -119.76 -159.72 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.475 ' OG1' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -121.08 132.86 55.13 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.023 -1.048 . . . . 0.0 109.521 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.445 ' HD2' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.39 0 O-C-N 121.304 -0.873 . . . . 0.0 109.682 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HB2' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -159.0 134.96 8.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.018 -1.051 . . . . 0.0 110.059 -179.425 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.541 ' CD1' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -115.11 -170.11 1.69 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.274 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.496 ' O ' HG23 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -162.97 -164.48 0.98 Allowed 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.868 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.515 ' CE2' ' CD2' ' A' ' 84' ' ' PHE . 48.7 m-85 -132.37 106.37 13.32 Favored Pre-proline 0 C--N 1.291 -1.949 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.486 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 2.8 Cg_exo -54.94 -149.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.986 1.79 . . . . 0.0 110.659 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 151.67 154.53 6.62 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -130.15 28.27 3.89 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 4.3 mptp? 74.35 160.18 0.23 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.615 -0.933 . . . . 0.0 109.238 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.516 HG23 ' N ' ' A' ' 6' ' ' ILE . 2.4 tt -155.34 58.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.322 -0.861 . . . . 0.0 109.222 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 42' ' ' MET . 3.9 mm-40 -84.32 -127.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.298 -0.877 . . . . 0.0 109.314 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.425 ' C ' ' O ' ' A' ' 41' ' ' GLU . 4.6 mtp -44.66 163.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.858 -1.151 . . . . 0.0 109.629 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.6 -131.08 3.43 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.531 ' CB ' ' OE1' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -132.3 -64.44 0.77 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.144 -1.209 . . . . 0.0 109.553 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.598 ' CB ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -146.19 -178.09 0.74 Allowed Pre-proline 0 C--N 1.305 -1.369 0 O-C-N 121.369 -0.832 . . . . 0.0 108.821 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.598 ' CD ' ' CB ' ' A' ' 45' ' ' THR . 1.8 Cg_endo -68.09 -10.76 29.89 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.945 1.763 . . . . 0.0 110.338 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -100.76 -56.15 2.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.335 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.577 ' O ' HG13 ' A' ' 51' ' ' VAL . 2.9 tt0 -58.5 -40.18 82.11 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.608 1.194 . . . . 0.0 108.741 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.462 ' HB2' HG13 ' A' ' 40' ' ' ILE . . . -43.38 -60.02 1.88 Allowed 'General case' 0 C--N 1.273 -2.719 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.446 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.58 HG12 ' CH2' ' A' ' 85' ' ' TRP . 9.8 p -81.45 -11.52 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.473 -0.767 . . . . 0.0 110.88 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.608 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -66.04 -50.44 69.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.608 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -59.55 -35.73 74.8 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.279 177.171 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HA ' ' HB2' ' A' ' 56' ' ' GLU . 25.7 mt-10 -73.02 -21.23 60.86 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.539 ' CD2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -60.84 -55.89 27.65 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.501 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 10.6 mt-30 -80.79 -22.57 39.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 109.742 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 53' ' ' GLU . 2.5 mt-10 -80.67 17.31 1.16 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.096 -1.003 . . . . 0.0 110.455 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.597 ' HB3' ' CD1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -137.75 -61.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.873 -1.142 . . . . 0.0 109.892 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.572 HG22 ' CG2' ' A' ' 60' ' ' ILE . 4.3 m -128.59 -34.03 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 109.704 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 90.94 36.2 6.83 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.596 ' O ' ' CB ' ' A' ' 61' ' ' THR . 17.1 pt -92.53 -166.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.053 -1.263 . . . . 0.0 109.521 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.759 ' N ' ' CD ' ' A' ' 62' ' ' PRO . 0.6 OUTLIER 93.05 13.77 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.292 -179.274 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.759 ' CD ' ' N ' ' A' ' 61' ' ' THR . 3.5 Cg_endo -63.75 -22.84 69.52 Favored 'Trans proline' 0 C--N 1.326 -0.615 0 CA-C-N 119.909 1.003 . . . . 0.0 110.401 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.611 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 7.1 mm100 -86.78 -68.7 0.73 Allowed 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.611 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 3.8 t-160 167.52 158.27 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.21 0.529 . . . . 0.0 110.545 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.651 ' CE2' ' CZ3' ' A' ' 85' ' ' TRP . 29.4 p90 -141.99 171.22 14.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.318 -0.864 . . . . 0.0 109.118 177.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' O ' ' A' ' 86' ' ' LEU . 73.2 m -163.77 128.76 2.91 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.036 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.598 HD12 ' CE3' ' A' ' 83' ' ' TRP . 0.6 OUTLIER -80.21 124.95 29.25 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.604 -1.31 . . . . 0.0 108.898 179.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.653 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 27.9 p90 -73.2 -52.18 15.05 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.55 -0.719 . . . . 0.0 109.701 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.653 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 2.4 tt0 176.74 138.74 0.06 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.656 -0.652 . . . . 0.0 109.808 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.41 165.6 11.15 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.07 -1.019 . . . . 0.0 109.029 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.547 ' CD2' ' HB ' ' A' ' 122' ' ' VAL . 0.4 OUTLIER -129.44 -170.1 2.23 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.352 -0.842 . . . . 0.0 109.456 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.492 ' HG2' ' N ' ' A' ' 73' ' ' TYR . 19.1 tt0 -145.6 146.6 31.42 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.423 -0.798 . . . . 0.0 109.194 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.492 ' N ' ' HG2' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -144.84 79.92 1.61 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.422 -0.799 . . . . 0.0 109.36 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.4 OUTLIER -81.69 114.58 20.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 109.34 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.53 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -79.45 176.69 3.49 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 1.7 Cg_endo -63.3 -8.77 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 121.67 1.58 . . . . 0.0 109.734 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -102.69 -66.87 0.9 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.402 -0.811 . . . . 0.0 110.881 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.04 -171.62 2.53 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.192 -0.942 . . . . 0.0 110.686 -177.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.557 ' N ' ' CD2' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -105.49 88.18 2.78 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.3 mm -81.71 118.2 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 109.474 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.459 HG21 ' HA ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -119.05 146.56 44.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.496 HD11 ' N ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -131.14 123.94 29.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 108.893 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.603 ' CD1' ' O ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -119.0 124.29 46.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.363 -0.835 . . . . 0.0 110.082 -177.759 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.682 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -129.07 103.17 6.84 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 120.489 -1.382 . . . . 0.0 109.975 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.652 ' CD1' ' O ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -82.42 98.9 9.12 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.706 0.765 . . . . 0.0 109.156 179.331 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.563 ' CD2' HD11 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -63.14 118.52 8.03 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.735 -1.228 . . . . 0.0 109.712 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.606 ' CG2' ' CG2' ' A' ' 11' ' ' ILE . 19.3 m -81.24 -167.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 120.95 -1.094 . . . . 0.0 109.686 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.508 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 8.9 mt-10 -125.14 -45.76 1.84 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.165 -0.959 . . . . 0.0 110.49 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.518 ' HB3' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -160.94 171.2 19.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.183 -0.948 . . . . 0.0 109.963 -179.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.629 ' CZ3' ' CG2' ' A' ' 11' ' ' ILE . 38.8 p90 -170.14 -175.02 1.88 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.2 1.0 . . . . 0.0 111.052 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.59 ' N ' ' HG2' ' A' ' 62' ' ' PRO . 2.6 tt0 -120.69 -34.5 3.57 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.381 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.479 ' O ' ' CD1' ' A' ' 90' ' ' TRP . . . -80.18 -155.93 11.78 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 121.092 -1.005 . . . . 0.0 110.911 -178.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.567 ' O ' ' CB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -105.31 127.97 27.54 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.437 -1.037 . . . . 0.0 109.456 -179.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.587 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 2.8 Cg_endo -58.74 133.83 56.58 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.432 2.088 . . . . 0.0 111.705 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.597 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 4.8 p-90 -110.56 -171.74 1.89 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.923 -1.111 . . . . 0.0 108.49 178.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 36' ' ' PRO . . . 146.18 -42.91 0.92 Allowed Glycine 0 C--N 1.296 -1.679 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 100' ' ' GLN . 1.1 ptmm? -66.08 126.48 28.76 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.651 -0.911 . . . . 0.0 109.781 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -93.57 -49.56 5.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.198 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.91 5.58 5.42 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 1.3 mt-30 -109.09 160.57 27.0 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.27 -1.135 . . . . 0.0 109.43 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 102' ' ' GLY . 1.9 Cg_endo -66.21 -30.43 46.05 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.156 1.904 . . . . 0.0 111.427 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 101' ' ' PRO . . . 56.66 162.55 0.03 OUTLIER Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -161.58 -168.7 2.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.66 -1.494 . . . . 0.0 110.503 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.493 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 31.9 m95 -107.47 132.34 53.32 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.556 -0.715 . . . . 0.0 109.219 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.518 ' HE3' ' CD1' ' A' ' 20' ' ' ILE . 30.2 ttp -108.29 147.63 31.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.268 -0.895 . . . . 0.0 109.217 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.436 ' OG ' HG22 ' A' ' 108' ' ' VAL . 45.6 t -83.66 138.71 33.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.891 -1.131 . . . . 0.0 109.126 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.44 ' O ' HD21 ' A' ' 107' ' ' LEU . 3.1 tt -108.29 59.73 0.61 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.211 -0.931 . . . . 0.0 109.411 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.436 HG22 ' OG ' ' A' ' 106' ' ' SER . 2.1 t -93.44 19.31 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 145.03 49.85 0.03 OUTLIER Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.495 ' CD2' ' OD2' ' A' ' 114' ' ' ASP . 1.1 mt -41.59 142.59 0.6 Allowed 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.694 -0.886 . . . . 0.0 109.317 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 2.4 t-20 -133.71 155.9 48.92 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 109.51 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.479 ' HB3' HG21 ' A' ' 123' ' ' ILE . . . -63.64 -19.02 64.53 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.271 -0.893 . . . . 0.0 108.747 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.437 ' O ' ' CG ' ' A' ' 113' ' ' ASP . 26.3 t0 -93.0 22.5 4.9 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.429 -0.795 . . . . 0.0 109.487 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.541 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -78.16 -1.61 33.5 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.551 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.68 ' N ' ' CD1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -160.5 160.32 25.89 Favored Pre-proline 0 C--N 1.3 -1.553 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.291 177.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 74.7 Cg_exo -36.69 124.6 0.39 Allowed 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.828 2.352 . . . . 0.0 110.403 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.562 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 4.6 Cg_exo -58.55 144.2 97.42 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 122.561 2.174 . . . . 0.0 111.382 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 156.67 -19.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.581 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 0.8 OUTLIER -119.88 42.15 2.99 Favored 'General case' 0 C--O 1.205 -1.286 0 O-C-N 121.316 -0.865 . . . . 0.0 109.368 -179.364 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.639 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 6.0 mt-10 -60.16 -39.12 66.05 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 120.949 -1.094 . . . . 0.0 113.243 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 5.2 Cg_exo -62.29 -46.8 11.38 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.229 1.953 . . . . 0.0 113.011 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.579 HG12 ' CE2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -90.22 -30.09 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.417 -1.427 . . . . 0.0 108.95 -178.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.626 HD13 ' CE1' ' A' ' 115' ' ' PHE . 1.6 mm -64.06 -34.38 68.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.465 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -60.95 -20.38 62.19 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.419 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.73 -61.75 1.88 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.399 -0.813 . . . . 0.0 110.985 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 123' ' ' ILE . 0.6 OUTLIER -78.82 22.69 0.36 Allowed 'General case' 0 C--N 1.31 -1.137 0 O-C-N 120.803 -1.186 . . . . 0.0 111.403 -178.672 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.465 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 5.3 mtmt -65.91 -35.57 81.0 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.652 -1.28 . . . . 0.0 107.932 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.534 ' O ' ' C ' ' A' ' 129' ' ' LEU . 9.0 mtm180 -78.77 -0.03 28.76 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.897 -0.502 . . . . 0.0 110.03 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.554 ' CD2' HD22 ' A' ' 86' ' ' LEU . 4.3 tp . . . . . 0 N--CA 1.5 2.032 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.882 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 79' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.441 ' HB2' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -133.09 147.41 52.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.735 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 7' ' ' ALA . 4.4 mt -121.98 168.61 14.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.325 -0.86 . . . . 0.0 108.895 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.559 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . -135.74 98.31 3.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.123 -0.986 . . . . 0.0 109.618 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.499 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 7.3 p -106.92 161.89 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.811 . . . . 0.0 109.366 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.581 ' HA3' ' CZ3' ' A' ' 95' ' ' TRP . . . -141.33 121.21 1.83 Allowed Glycine 0 C--N 1.297 -1.621 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.569 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -94.33 156.6 3.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.613 ' CG2' ' CE3' ' A' ' 90' ' ' TRP . 2.2 mt -143.15 124.1 10.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 118.486 -1.286 . . . . 0.0 111.308 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.536 ' HD3' ' CG1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -122.21 136.31 54.89 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.268 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -109.12 -169.37 1.47 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 0.0 110.179 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -81.12 0.21 37.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.682 -0.636 . . . . 0.0 109.327 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.446 ' OD1' ' OE2' ' A' ' 17' ' ' GLU . 6.5 t-20 -89.34 12.82 15.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.282 -0.886 . . . . 0.0 109.063 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.466 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 18.4 t30 57.41 44.07 22.1 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.768 0.795 . . . . 0.0 109.224 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 3.4 mt-10 -143.25 149.21 37.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.091 -1.006 . . . . 0.0 109.038 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.539 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -128.19 151.24 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.094 -1.004 . . . . 0.0 109.864 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.582 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 21.8 t80 -85.97 66.83 9.78 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.567 ' CG2' ' N ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -83.91 -155.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.102 -0.999 . . . . 0.0 110.303 -178.592 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.567 ' N ' ' CG2' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -132.11 142.16 49.4 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.558 ' HG2' ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 O-C-N 121.039 -1.038 . . . . 0.0 110.675 -178.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -100.79 140.78 34.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.843 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.558 ' CD2' ' HG2' ' A' ' 22' ' ' ARG . 5.3 mt -103.7 -172.72 2.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.452 -0.78 . . . . 0.0 109.026 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.467 ' O ' HD13 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -160.68 -154.68 0.38 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.626 ' CE2' ' CZ ' ' A' ' 84' ' ' PHE . 3.6 m-85 -150.65 137.49 11.43 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.436 ' HD2' HG22 ' A' ' 8' ' ' VAL . 2.6 Cg_endo -61.19 -160.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.87 1.713 . . . . 0.0 109.582 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.518 ' N ' ' HB2' ' A' ' 97' ' ' LYS . . . 152.87 158.42 8.51 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.096 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.78 20.85 2.88 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.18 158.51 0.16 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.509 -0.995 . . . . 0.0 109.516 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.441 HG22 ' HB2' ' A' ' 5' ' ' GLN . 11.2 tt -138.43 101.61 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.349 -0.844 . . . . 0.0 109.222 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -111.77 -7.45 14.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.81 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.56 -76.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.167 -0.958 . . . . 0.0 109.307 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.78 4.82 18.86 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.09 -79.4 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.046 -1.267 . . . . 0.0 109.585 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.499 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -160.8 169.07 10.61 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.846 -1.159 . . . . 0.0 109.762 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.499 ' HD2' HG22 ' A' ' 45' ' ' THR . 8.5 Cg_endo -74.59 19.21 0.47 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 123.255 2.637 . . . . 0.0 112.004 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.492 ' HB2' ' CG2' ' A' ' 45' ' ' THR . 2.0 mt-10 -111.5 -46.07 3.31 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.857 -1.152 . . . . 0.0 108.789 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.523 ' O ' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -73.28 -55.06 6.92 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.245 1.021 . . . . 0.0 109.1 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.481 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . -38.3 -59.94 0.83 Allowed 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.089 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 51' ' ' VAL . 7.1 p -66.26 -33.11 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.214 -0.929 . . . . 0.0 108.936 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.629 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -45.5 -58.2 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.428 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.629 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -66.37 -28.93 69.03 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.308 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.525 ' HA ' ' CG ' ' A' ' 56' ' ' GLU . 4.2 mm-40 -72.64 -6.79 46.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.016 -1.053 . . . . 0.0 109.058 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.601 HD13 ' CH2' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -80.5 -60.64 2.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.555 -0.716 . . . . 0.0 109.659 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.468 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 5.7 mt-30 -80.57 -23.44 39.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.294 -0.879 . . . . 0.0 110.708 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 1.4 pp20? -80.86 20.15 0.79 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.024 -1.048 . . . . 0.0 110.615 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 95' ' ' TRP . 3.0 mt-10 -142.18 -63.18 0.44 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.742 -1.224 . . . . 0.0 110.061 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.589 ' CG1' ' HB3' ' A' ' 95' ' ' TRP . 2.0 m -123.52 -31.78 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.985 -1.072 . . . . 0.0 109.154 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.57 ' N ' HG21 ' A' ' 58' ' ' VAL . . . 67.88 66.2 2.42 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.586 ' CG2' ' HB2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -83.19 155.67 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.55 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.594 ' OG1' ' HD3' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -107.46 -60.99 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.263 0 O-C-N 120.527 -1.358 . . . . 0.0 111.834 -177.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.594 ' HD3' ' OG1' ' A' ' 61' ' ' THR . 7.0 Cg_endo -73.7 52.7 2.57 Favored 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 122.031 1.821 . . . . 0.0 110.875 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.648 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -105.82 69.28 0.81 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.867 -1.146 . . . . 0.0 110.054 -178.535 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -63.68 115.08 4.41 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.554 ' CD1' ' CZ3' ' A' ' 85' ' ' TRP . 39.3 p90 -131.14 176.0 8.63 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 122.941 1.353 . . . . 0.0 112.209 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 68' ' ' PHE . 19.1 m -163.04 130.16 3.53 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 68' ' ' PHE . 26.6 tp -50.31 96.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.486 -1.384 . . . . 0.0 109.162 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.599 ' CZ ' HD21 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -43.06 -74.33 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.597 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 3.3 tt0 -162.61 161.83 26.86 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.352 0.596 . . . . 0.0 109.704 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.544 ' HG2' ' N ' ' A' ' 71' ' ' LEU . 22.3 ttmt -116.16 154.3 30.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 0.0 109.174 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.577 HD23 ' CE1' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -126.67 -174.89 3.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.078 -1.014 . . . . 0.0 109.642 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -157.29 151.22 24.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.389 -0.819 . . . . 0.0 109.2 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.46 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . 6.8 t80 -154.39 165.13 37.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.058 -1.026 . . . . 0.0 110.082 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -148.14 122.24 9.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.414 -0.803 . . . . 0.0 109.365 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.524 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -82.32 172.27 9.96 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.524 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 6.0 Cg_exo -58.38 -15.77 25.87 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.934 1.756 . . . . 0.0 110.01 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -156.81 7.28 0.18 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.513 -0.742 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.496 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 1.8 mmm180 -129.18 -169.59 2.12 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 120.659 -1.276 . . . . 0.0 109.613 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.483 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 35.5 m80 -144.48 129.74 18.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.333 -0.854 . . . . 0.0 108.969 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 2.7 mm -116.26 83.98 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.93 . . . . 0.0 110.03 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.26 86.62 6.2 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.435 ' O ' HD13 ' A' ' 71' ' ' LEU . 1.4 mp -102.31 167.52 9.92 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.181 -0.949 . . . . 0.0 110.364 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.541 ' CD1' ' O ' ' A' ' 6' ' ' ILE . 1.7 m95 -122.65 164.26 18.56 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.626 ' CZ ' ' CE2' ' A' ' 35' ' ' PHE . 1.8 m-85 -136.51 88.94 2.42 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.07 -1.019 . . . . 0.0 109.557 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.645 ' CZ2' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.04 151.53 21.61 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.388 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.569 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 14.7 tp -142.55 127.67 18.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.787 -1.195 . . . . 0.0 109.615 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.645 ' CG1' ' CZ2' ' A' ' 85' ' ' TRP . 9.1 m -99.07 -161.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.314 -0.866 . . . . 0.0 109.997 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -141.99 -23.42 0.7 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.287 -0.883 . . . . 0.0 111.484 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.648 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -159.96 -167.43 1.96 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.343 -1.473 . . . . 0.0 110.672 -179.186 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.62 ' HB3' ' O ' ' A' ' 89' ' ' ARG . 28.6 p90 158.68 171.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.517 1.151 . . . . 0.0 110.294 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.593 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 8.9 tt0 -111.93 -63.19 1.45 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.743 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.5 ' N ' HG23 ' A' ' 60' ' ' ILE . . . -56.74 -156.39 0.01 OUTLIER Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.573 ' O ' ' CB ' ' A' ' 58' ' ' VAL . 1.2 pm0 -105.8 128.09 27.14 Favored Pre-proline 0 C--N 1.307 -1.244 0 O-C-N 121.38 -1.07 . . . . 0.0 109.348 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.585 ' HG3' ' CZ2' ' A' ' 90' ' ' TRP . 13.5 Cg_exo -46.77 144.91 7.32 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.465 2.11 . . . . 0.0 112.05 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.589 ' HB3' ' CG1' ' A' ' 58' ' ' VAL . 11.1 p-90 -107.51 -167.72 1.3 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.61 -96.18 0.14 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.518 ' HB2' ' N ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -118.0 138.74 51.99 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.506 -0.996 . . . . 0.0 109.25 179.515 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 98' ' ' GLU . 12.0 tm-20 -92.66 68.88 4.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 109.202 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.436 ' O ' ' HD3' ' A' ' 101' ' ' PRO . . . 175.13 -31.89 0.09 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.413 ' HG2' HG23 ' A' ' 21' ' ' THR . 0.0 OUTLIER -92.74 111.19 49.94 Favored Pre-proline 0 C--N 1.297 -1.689 0 O-C-N 121.65 -0.912 . . . . 0.0 108.745 179.363 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 99' ' ' GLY . 1.1 Cg_endo -63.25 82.14 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.059 1.839 . . . . 0.0 110.935 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -86.12 170.61 43.41 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -161.33 172.88 15.81 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.586 -1.538 . . . . 0.0 111.504 -179.282 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.482 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 4.6 m0 -84.91 106.86 16.74 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.458 ' HE3' HG23 ' A' ' 20' ' ' ILE . 3.7 ttp -107.8 136.56 47.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.335 -0.853 . . . . 0.0 109.067 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.86 85.81 4.9 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.227 -0.921 . . . . 0.0 109.359 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.523 ' O ' ' CG1' ' A' ' 108' ' ' VAL . 1.4 mt -76.96 -52.58 9.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.916 . . . . 0.0 109.59 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 0.4 OUTLIER 72.52 27.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 122.155 0.979 . . . . 0.0 108.579 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 163.63 50.6 0.02 OUTLIER Glycine 0 N--CA 1.485 1.944 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 109' ' ' GLY . 0.7 OUTLIER -38.12 144.28 0.1 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.769 -0.842 . . . . 0.0 109.98 -178.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -156.43 151.87 26.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.122 -0.986 . . . . 0.0 109.801 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.527 ' CB ' HG23 ' A' ' 123' ' ' ILE . . . -68.36 -7.5 31.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.264 -0.898 . . . . 0.0 109.403 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -61.02 -42.73 99.01 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.256 -0.902 . . . . 0.0 109.93 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.484 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -79.12 -9.2 59.49 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.096 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.534 ' CE2' ' CE2' ' A' ' 35' ' ' PHE . 9.6 m-85 -98.43 137.43 20.71 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.005 -1.059 . . . . 0.0 109.456 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 115' ' ' PHE . 1.9 Cg_endo -68.8 164.19 34.35 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.256 1.97 . . . . 0.0 110.281 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.537 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 1.5 Cg_endo -63.29 119.07 5.99 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.404 2.07 . . . . 0.0 110.434 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 161.74 -51.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 109.831 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.562 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 28.2 m-20 -106.19 38.38 2.05 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.234 -0.916 . . . . 0.0 109.347 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.68 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 20.2 mt-10 -65.89 -36.71 14.59 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.346 -0.846 . . . . 0.0 112.704 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.8 Cg_exo -63.34 -36.2 57.42 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.099 1.866 . . . . 0.0 112.425 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.581 HG12 ' CG ' ' A' ' 84' ' ' PHE . 1.2 t -98.51 -39.3 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 120.449 -1.407 . . . . 0.0 108.003 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.562 ' CG1' ' O ' ' A' ' 119' ' ' ASN . 25.2 mm -58.66 -30.57 42.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.517 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -70.3 -26.37 63.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.468 -0.77 . . . . 0.0 110.688 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.427 ' HG2' ' OE1' ' A' ' 69' ' ' GLU . 16.9 tptt -76.19 -57.21 4.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.882 -1.136 . . . . 0.0 110.522 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.599 HD21 ' CZ ' ' A' ' 68' ' ' PHE . 2.4 pt? -74.84 11.78 0.99 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.054 -1.029 . . . . 0.0 111.219 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.517 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 37.4 mttt -49.51 -43.05 45.22 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.353 -1.467 . . . . 0.0 107.695 178.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.477 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -109.84 46.15 1.04 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.797 -0.565 . . . . 0.0 110.842 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.539 ' CD2' ' HB2' ' A' ' 126' ' ' LEU . 1.3 mp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.336 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.482 HD11 HD12 ' A' ' 80' ' ' ILE . 23.5 mt . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.251 0.548 . . . . 0.0 109.801 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.459 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . 1.1 mp0 -87.46 116.47 25.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.228 -0.92 . . . . 0.0 108.869 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 38' ' ' GLY . 1.4 mp -112.47 141.18 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.094 -1.004 . . . . 0.0 109.791 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.408 ' O ' ' CA ' ' A' ' 37' ' ' GLY . . . -103.8 110.72 22.94 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.533 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 3.0 p -127.78 100.09 5.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.131 -0.981 . . . . 0.0 110.352 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.531 ' HA2' ' CD1' ' A' ' 85' ' ' TRP . . . -84.58 118.5 4.74 Favored Glycine 0 C--N 1.296 -1.683 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.564 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 1.8 mt -81.49 173.49 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 120.867 -1.373 . . . . 0.0 107.541 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.556 ' HA ' ' CG2' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -144.56 153.54 14.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 118.039 -1.464 . . . . 0.0 110.435 -178.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 17' ' ' GLU . 37.7 ttp180 -159.3 131.52 6.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.517 -0.739 . . . . 0.0 109.24 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.31 -162.69 0.97 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.14 -0.975 . . . . 0.0 110.577 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.36 -7.32 58.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.626 -0.671 . . . . 0.0 109.713 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.536 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 5.2 t30 -84.53 12.61 6.68 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.124 -0.985 . . . . 0.0 108.667 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' A' ' 107' ' ' LEU . 11.6 t-20 60.03 43.38 14.57 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.64 -0.662 . . . . 0.0 110.522 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.536 ' CG ' ' HB3' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -127.37 154.27 45.19 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.512 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 1.6 mt -119.78 156.34 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.859 -1.15 . . . . 0.0 110.203 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 26.0 t80 -103.15 86.11 2.63 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.627 ' CG2' ' N ' ' A' ' 21' ' ' THR . 0.5 OUTLIER -78.73 176.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.187 0.994 . . . . 0.0 110.101 -178.319 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.627 ' N ' ' CG2' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -153.46 144.24 22.7 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.581 ' CG ' ' HA ' ' A' ' 33' ' ' LEU . 6.4 tpm_? . . . . . 0 C--N 1.3 -1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 110.062 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.8 m120 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 22' ' ' ARG . 5.9 mmtp -114.55 129.08 56.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.195 -0.941 . . . . 0.0 109.991 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.581 ' HA ' ' CG ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -146.21 -175.71 4.87 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.797 0.808 . . . . 0.0 109.544 179.6 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.57 ' O ' ' CD1' ' A' ' 20' ' ' ILE . 2.3 tt0 -163.06 -154.21 0.28 Allowed 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.634 ' CE2' ' CE2' ' A' ' 84' ' ' PHE . 85.4 m-85 -114.02 158.97 37.92 Favored Pre-proline 0 C--N 1.285 -2.206 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.507 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 3.3 Cg_exo -58.21 -154.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 121.854 1.703 . . . . 0.0 110.167 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.408 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 82.48 -170.65 50.7 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 6' ' ' ILE . . . 177.66 -37.61 0.09 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -168.79 143.61 3.25 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.562 -0.964 . . . . 0.0 109.076 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.524 ' CG2' ' O ' ' A' ' 40' ' ' ILE . 15.5 tt -100.35 115.32 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.103 -0.998 . . . . 0.0 109.705 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 42' ' ' MET . 4.7 mt-10 -101.85 -175.93 2.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.337 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.47 ' O ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 49.16 -178.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.913 . . . . 0.0 109.331 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.98 148.21 10.91 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.444 ' OE1' ' N ' ' A' ' 44' ' ' GLU . 39.6 mp0 -91.47 121.75 33.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.177 -1.19 . . . . 0.0 109.75 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.585 ' CB ' ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -159.96 178.61 1.61 Allowed Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.428 -0.795 . . . . 0.0 109.642 179.738 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 45' ' ' THR . 6.1 Cg_endo -73.62 -20.1 20.73 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.596 2.198 . . . . 0.0 110.903 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.504 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -124.12 -59.04 1.52 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.075 -1.016 . . . . 0.0 110.085 -179.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.563 ' O ' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -44.14 -32.99 1.36 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.285 1.04 . . . . 0.0 110.596 -179.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 45' ' ' THR . . . -81.76 -57.17 3.55 Favored 'General case' 0 C--N 1.272 -2.8 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.988 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -81.9 4.98 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.395 -0.816 . . . . 0.0 110.513 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.563 HG11 ' O ' ' A' ' 48' ' ' GLN . 13.2 p -82.75 -37.65 14.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.501 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -74.65 -31.1 61.85 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.879 -1.509 . . . . 0.0 108.659 178.575 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -72.0 -7.12 46.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.122 -0.986 . . . . 0.0 109.075 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.62 HD21 ' CZ2' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -76.55 -68.11 0.63 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.651 -0.656 . . . . 0.0 109.428 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -82.33 -17.52 45.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.493 -0.754 . . . . 0.0 111.335 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.494 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 2.3 mm-40 -80.28 18.22 0.92 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.791 -1.193 . . . . 0.0 110.461 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.536 ' CB ' ' HB2' ' A' ' 95' ' ' TRP . 7.1 mm-40 -146.76 -65.38 0.28 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.734 -1.229 . . . . 0.0 110.565 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.596 ' CG2' ' O ' ' A' ' 93' ' ' GLU . 3.7 m -124.8 -32.56 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.156 -0.965 . . . . 0.0 108.979 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.445 ' N ' HG21 ' A' ' 58' ' ' VAL . . . 72.16 67.64 1.79 Allowed Glycine 0 N--CA 1.483 1.815 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.572 HG12 ' CG2' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -95.52 171.11 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.351 -1.087 . . . . 0.0 108.17 178.439 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.527 ' HB ' ' CB ' ' A' ' 91' ' ' GLU . 2.7 m -112.99 89.36 13.57 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 1.4 Cg_endo -59.3 131.12 39.17 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.093 1.862 . . . . 0.0 110.177 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.475 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -92.71 -55.48 3.36 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.553 -0.717 . . . . 0.0 110.164 -178.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.45 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 12.0 t-160 -142.27 112.47 7.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.91 -1.119 . . . . 0.0 110.2 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.683 ' CD1' ' CH2' ' A' ' 85' ' ' TRP . 5.5 p90 -135.25 175.26 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.141 -0.974 . . . . 0.0 110.368 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.3 m -162.39 -179.71 7.19 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.54 ' CD1' ' HA ' ' A' ' 85' ' ' TRP . 34.8 tp -105.95 107.63 18.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.953 -1.092 . . . . 0.0 109.014 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.625 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 3.3 t80 -47.33 -83.53 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.625 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -147.12 175.56 10.63 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.492 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.518 ' HD3' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.33 129.02 38.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 0.0 109.61 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.476 HD21 HG22 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -120.94 -176.89 3.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 109.505 179.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.18 158.87 33.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.363 -0.836 . . . . 0.0 109.388 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.0 147.15 31.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 0.0 109.737 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.73 116.74 10.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.077 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.495 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 1.1 m-85 -83.99 172.99 7.98 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.348 -0.845 . . . . 0.0 109.379 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 4.0 Cg_exo -59.17 -12.95 17.54 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.152 1.901 . . . . 0.0 110.791 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -165.16 16.18 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 110.585 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.493 ' HG3' ' NH1' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -131.17 -172.89 2.95 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 120.632 -1.293 . . . . 0.0 109.445 -179.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -146.32 136.64 23.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.352 -0.843 . . . . 0.0 109.018 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.482 HD12 HD11 ' A' ' 4' ' ' LEU . 22.4 mm -140.04 80.31 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.093 -1.004 . . . . 0.0 110.169 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.61 130.57 34.99 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.497 ' CD1' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -136.86 113.58 10.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.955 -1.091 . . . . 0.0 110.366 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -79.86 156.04 27.54 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.634 ' CE2' ' CE2' ' A' ' 35' ' ' PHE . 2.0 m-85 -135.87 71.12 1.42 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.94 -1.1 . . . . 0.0 109.838 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.683 ' CH2' ' CD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -84.05 145.17 28.62 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.564 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 20.9 tp -134.8 127.25 30.49 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.951 -1.093 . . . . 0.0 110.139 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.643 ' CG1' ' CZ2' ' A' ' 85' ' ' TRP . 34.5 m -98.1 -174.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.73 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' ARG . 2.9 mt-10 -126.43 -29.88 2.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.845 . . . . 0.0 109.428 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.72 169.3 20.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.195 -0.941 . . . . 0.0 109.326 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.512 ' CD1' HG22 ' A' ' 60' ' ' ILE . 46.1 p90 -164.95 -169.83 1.79 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.102 -0.999 . . . . 0.0 110.015 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.527 ' CB ' ' HB ' ' A' ' 61' ' ' THR . 30.6 tt0 -131.34 99.13 4.74 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.972 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.52 ' CA ' HG23 ' A' ' 60' ' ' ILE . . . 128.88 -152.13 19.27 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.627 -1.273 . . . . 0.0 109.946 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.596 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 14.5 tp10 -99.96 127.06 34.61 Favored Pre-proline 0 N--CA 1.486 1.339 0 O-C-N 121.324 -1.103 . . . . 0.0 109.187 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.528 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 4.0 Cg_exo -52.36 144.96 37.93 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.665 2.244 . . . . 0.0 111.706 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.62 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 23.4 p-90 -113.15 -175.55 2.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.523 -0.736 . . . . 0.0 109.09 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.503 ' HA3' ' CB ' ' A' ' 36' ' ' PRO . . . 158.06 -62.36 0.32 Allowed Glycine 0 N--CA 1.484 1.843 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.296 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -105.31 171.47 7.31 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.355 -1.085 . . . . 0.0 109.631 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.46 ' HA ' ' OE2' ' A' ' 57' ' ' GLU . 2.9 tp10 -39.23 -37.41 0.41 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.65 -0.656 . . . . 0.0 109.438 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.488 ' C ' ' CD ' ' A' ' 101' ' ' PRO . . . -126.18 -160.42 10.6 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.626 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -117.85 40.15 0.32 Allowed Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.137 -1.213 . . . . 0.0 111.541 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 100' ' ' GLN . 6.9 Cg_endo -68.13 -6.81 18.16 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 C-N-CA 121.327 1.351 . . . . 0.0 110.106 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -41.83 163.53 0.02 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -119.17 131.08 55.81 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.405 -1.056 . . . . 0.0 109.175 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.46 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 10.8 m0 -78.21 95.77 5.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.199 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.31 -163.35 0.6 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.403 -0.811 . . . . 0.0 109.653 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 t -141.33 158.08 44.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.628 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.459 HD12 HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -113.4 63.0 0.64 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.347 -0.846 . . . . 0.0 108.974 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.481 HG11 ' N ' ' A' ' 109' ' ' GLY . 8.2 p -104.33 -26.55 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.367 -0.833 . . . . 0.0 109.208 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.481 ' N ' HG11 ' A' ' 108' ' ' VAL . . . -168.25 43.92 0.23 Allowed Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 109' ' ' GLY . 1.1 mt -45.46 145.79 1.16 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.217 -1.166 . . . . 0.0 108.676 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -125.24 9.98 8.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 110.182 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.518 ' CB ' HG23 ' A' ' 123' ' ' ILE . . . 52.59 19.64 1.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.902 -1.124 . . . . 0.0 108.39 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -100.82 -34.41 9.83 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.358 -0.839 . . . . 0.0 109.747 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.477 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -76.69 -3.66 39.17 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.31 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.575 ' CD2' HD11 ' A' ' 123' ' ' ILE . 22.3 m-85 -96.44 109.99 50.53 Favored Pre-proline 0 N--CA 1.485 1.281 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.539 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 7.1 Cg_exo -50.14 154.96 4.98 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.166 1.911 . . . . 0.0 110.512 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.539 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 5.4 Cg_exo -58.38 121.2 9.59 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.553 2.169 . . . . 0.0 110.995 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 158.54 -37.21 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.566 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 18.2 m120 -115.36 41.25 2.5 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.507 -0.746 . . . . 0.0 109.472 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.66 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 20.0 mt-10 -66.53 -41.48 40.43 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.95 -1.094 . . . . 0.0 112.427 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 1.1 Cg_endo -67.7 -30.89 33.79 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.581 2.187 . . . . 0.0 112.231 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.583 HG12 ' CD2' ' A' ' 84' ' ' PHE . 2.1 t -95.32 -43.77 12.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 120.593 -1.317 . . . . 0.0 107.493 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.575 HD11 ' CD2' ' A' ' 115' ' ' PHE . 12.2 mm -56.67 -29.0 28.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.22 -35.12 63.88 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.703 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -80.4 -61.73 1.89 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.916 -1.115 . . . . 0.0 110.945 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.579 ' HG ' ' CE2' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -80.87 27.38 0.38 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.918 -1.114 . . . . 0.0 110.522 -179.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.586 ' HG3' ' N ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -71.33 -31.48 67.44 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.586 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 2.2 ptt180 -119.63 44.74 2.31 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.632 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.532 ' CD1' ' O ' ' A' ' 126' ' ' LEU . 1.1 mp . . . . . 0 C--N 1.308 -1.228 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.971 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -118.27 162.31 18.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.717 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.63 119.08 31.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -0.874 . . . . 0.0 109.52 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 49.5 tp -116.43 128.57 55.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.581 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.449 ' O ' ' CG2' ' A' ' 40' ' ' ILE . 12.4 mt-30 -137.86 119.51 15.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.035 . . . . 0.0 109.809 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.585 ' O ' ' CD1' ' A' ' 83' ' ' TRP . 12.9 mm -102.46 179.66 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.431 -0.793 . . . . 0.0 109.665 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.468 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -142.38 108.21 5.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.197 -0.939 . . . . 0.0 108.849 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.497 HG21 ' CB ' ' A' ' 36' ' ' PRO . 7.8 p -113.07 164.15 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.024 . . . . 0.0 110.221 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.479 ' N ' ' CG2' ' A' ' 8' ' ' VAL . . . -149.73 120.63 1.17 Allowed Glycine 0 N--CA 1.482 1.719 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.614 ' CD1' ' CD2' ' A' ' 86' ' ' LEU . 1.2 mt -98.99 152.91 4.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 121.181 -1.188 . . . . 0.0 108.793 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.583 HG21 ' CZ3' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -120.62 153.44 23.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 118.902 -1.119 . . . . 0.0 109.138 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.506 ' O ' ' O ' ' A' ' 88' ' ' GLU . 38.2 ttp180 -155.76 114.13 3.43 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.565 -0.709 . . . . 0.0 109.823 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.603 ' HB3' ' CZ3' ' A' ' 90' ' ' TRP . 43.4 p-10 -158.76 -159.59 0.8 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.975 . . . . 0.0 109.883 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER 77.89 -72.52 0.09 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.991 0.9 . . . . 0.0 108.759 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 0.5 OUTLIER -147.41 -47.3 0.17 Allowed 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 122.286 1.041 . . . . 0.0 108.236 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 108' ' ' VAL . 6.1 t-20 179.15 35.44 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 3.0 mt-10 -107.29 148.93 28.37 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.637 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.54 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -116.8 156.1 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 109.857 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.575 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 11.5 t80 -92.5 69.48 4.94 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 176.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.518 HG22 ' N ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -82.05 -161.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 122.126 0.965 . . . . 0.0 112.093 -176.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.561 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.1 OUTLIER -141.01 132.21 26.46 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.454 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 9.9 ttp180 -136.96 -175.52 4.06 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.373 -0.829 . . . . 0.0 109.929 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.539 ' CB ' ' HB1' ' A' ' 27' ' ' ALA . 1.7 ptt180 -72.32 99.18 2.35 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.35 -0.844 . . . . 0.0 109.832 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -44.86 -85.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 108.958 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.91 52.57 2.04 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -145.67 -128.8 0.07 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.195 -0.94 . . . . 0.0 109.451 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.539 ' HB1' ' CB ' ' A' ' 23' ' ' ARG . . . 67.8 154.03 0.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.758 -1.214 . . . . 0.0 109.238 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -103.27 -70.39 0.76 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 0.0 109.605 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.31 151.85 40.71 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.297 -0.877 . . . . 0.0 109.524 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.82 174.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.63 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -104.77 145.35 30.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.396 -0.815 . . . . 0.0 109.376 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.47 141.51 43.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.09 -1.006 . . . . 0.0 109.781 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.573 HD13 ' CD1' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -136.79 -178.02 5.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -0.8 . . . . 0.0 109.679 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.512 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -161.66 -155.86 0.41 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.716 0.769 . . . . 0.0 109.771 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.683 ' CZ ' ' CZ ' ' A' ' 115' ' ' PHE . 95.0 m-85 -117.3 150.3 46.11 Favored Pre-proline 0 C--N 1.296 -1.721 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.497 ' CB ' HG21 ' A' ' 8' ' ' VAL . 6.2 Cg_exo -58.01 -152.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 121.884 1.723 . . . . 0.0 109.671 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 134.96 170.02 12.06 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.119 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -164.8 -61.3 0.02 OUTLIER Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 1.3 tttt 178.15 153.46 0.32 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.507 -0.996 . . . . 0.0 109.369 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.63 ' CD1' ' CZ2' ' A' ' 83' ' ' TRP . 7.6 tt -129.78 50.97 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.869 . . . . 0.0 109.623 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -118.63 7.2 11.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 109.654 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.2 tpp -108.57 -3.01 18.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.174 -0.954 . . . . 0.0 109.729 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.18 172.68 14.6 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.81 -13.5 13.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.166 -1.197 . . . . 0.0 109.808 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.58 ' CB ' ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -144.38 179.53 1.15 Allowed Pre-proline 0 C--N 1.305 -1.335 0 O-C-N 121.044 -1.035 . . . . 0.0 109.496 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 45' ' ' THR . 4.9 Cg_endo -72.94 1.61 6.32 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.347 2.031 . . . . 0.0 110.843 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.512 ' O ' HG11 ' A' ' 51' ' ' VAL . 1.9 mt-10 -124.02 -51.88 1.78 Allowed 'General case' 0 C--O 1.198 -1.654 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.508 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -49.62 -34.81 19.09 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 122.388 1.09 . . . . 0.0 108.378 178.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.486 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -67.63 -60.74 2.31 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.323 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.557 HG23 ' CE2' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -75.95 -48.01 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.123 -0.986 . . . . 0.0 109.162 -179.059 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.581 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 3.1 p -39.48 -48.92 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 121.533 0.682 . . . . 0.0 109.163 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.581 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -75.73 -33.15 60.26 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 3.1 mm-40 -67.07 -10.64 52.07 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.456 ' CD2' ' OE1' ' A' ' 63' ' ' GLN . 0.3 OUTLIER -60.4 -64.6 0.89 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.429 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -81.79 -25.77 34.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.556 -0.715 . . . . 0.0 109.37 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.486 ' HG3' ' HG3' ' A' ' 52' ' ' ARG . 29.3 mm-40 -81.57 32.14 0.35 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.168 -0.958 . . . . 0.0 110.479 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.561 ' HB3' ' CB ' ' A' ' 95' ' ' TRP . 5.3 mm-40 -147.03 -67.78 0.26 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.965 -1.085 . . . . 0.0 109.27 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.672 ' HB ' ' HB3' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -114.27 -46.59 4.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.647 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.469 ' N ' ' CG1' ' A' ' 58' ' ' VAL . . . 100.48 53.49 1.06 Allowed Glycine 0 N--CA 1.482 1.713 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.458 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.53 HG12 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -90.33 167.73 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.593 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.2 m -119.02 -65.13 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.587 -1.32 . . . . 0.0 111.299 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 18.8 Cg_endo -77.5 33.66 0.45 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.628 1.552 . . . . 0.0 110.905 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.613 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 55.8 tt0 -82.27 65.74 7.54 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.584 0.707 . . . . 0.0 109.636 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -51.28 144.85 8.98 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.503 ' CG ' ' CZ3' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -153.93 170.94 19.85 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.596 -1.315 . . . . 0.0 111.21 -179.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.0 -177.51 6.16 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.0 tp -105.71 127.04 52.84 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.732 -1.23 . . . . 0.0 109.728 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.666 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -86.18 -70.48 0.6 Allowed 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.666 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -173.96 117.19 0.24 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.112 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -87.4 138.36 31.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.33 -0.856 . . . . 0.0 109.137 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.568 ' CD2' HG21 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -96.9 -170.93 2.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.244 -0.91 . . . . 0.0 110.63 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -154.4 137.24 15.35 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -131.11 175.39 9.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.934 -1.103 . . . . 0.0 110.407 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -158.55 126.29 5.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.473 -0.767 . . . . 0.0 109.175 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.603 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -88.5 177.9 2.36 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.846 . . . . 0.0 109.258 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.603 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 2.6 Cg_exo -56.24 -16.82 18.52 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.864 1.709 . . . . 0.0 110.408 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -165.99 15.09 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.345 -0.847 . . . . 0.0 110.623 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.501 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 6.4 mmm180 -124.49 178.94 5.15 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 120.818 -1.176 . . . . 0.0 109.097 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -129.41 110.76 12.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.0 109.26 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 24.3 mm -106.16 109.27 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 109.695 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.9 m -116.69 142.35 47.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.336 -0.852 . . . . 0.0 109.139 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.483 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -149.87 167.0 27.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.68 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.64 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 1.1 m95 -124.48 155.63 38.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.375 -0.828 . . . . 0.0 109.402 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.499 ' CZ ' ' CD2' ' A' ' 35' ' ' PHE . 3.0 m-85 -133.43 88.38 2.48 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.438 -0.789 . . . . 0.0 109.046 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.583 ' O ' ' CG ' ' A' ' 85' ' ' TRP . 1.2 p-90 -111.39 104.43 12.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.474 -1.391 . . . . 0.0 109.55 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.614 ' CD2' ' CD1' ' A' ' 10' ' ' ILE . 1.9 mm? -80.97 141.43 34.46 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.282 0.563 . . . . 0.0 111.178 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.544 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 5.0 m -99.53 -174.33 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 O-C-N 121.217 -0.927 . . . . 0.0 108.906 178.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.506 ' O ' ' O ' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -120.8 -46.87 2.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.986 -1.071 . . . . 0.0 111.444 -179.039 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.35 150.5 14.49 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.366 -1.459 . . . . 0.0 110.75 -179.222 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.603 ' CZ3' ' HB3' ' A' ' 13' ' ' ASN . 11.6 p90 -151.41 178.4 9.33 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 122.066 0.936 . . . . 0.0 109.896 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.537 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 22.6 tt0 -128.66 86.74 2.48 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.484 ' O ' ' CD1' ' A' ' 90' ' ' TRP . . . 148.99 175.07 21.12 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.585 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 1.2 mt-10 -80.26 118.55 72.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.141 -1.211 . . . . 0.0 108.21 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.573 ' CB ' ' CD1' ' A' ' 11' ' ' ILE . 3.4 Cg_endo -70.3 167.44 25.14 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.516 2.144 . . . . 0.0 112.064 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.672 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 29.2 p-90 -113.64 -167.86 1.26 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 162.01 -78.86 0.16 Allowed Glycine 0 N--CA 1.481 1.669 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.477 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -101.88 -174.86 2.68 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.726 -0.867 . . . . 0.0 108.701 179.149 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -125.24 -53.8 1.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.937 -1.102 . . . . 0.0 109.575 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.48 -0.09 89.61 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.469 ' OE1' HG23 ' A' ' 21' ' ' THR . 0.0 OUTLIER -113.07 128.92 25.05 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.178 -1.19 . . . . 0.0 109.452 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.69 -71.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.116 1.877 . . . . 0.0 110.503 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . 95.74 166.18 34.64 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -159.27 159.49 34.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.566 -1.549 . . . . 0.0 111.08 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.553 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -84.37 94.74 8.55 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.483 ' HE1' HG23 ' A' ' 20' ' ' ILE . 1.1 ttm -86.77 132.11 33.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.225 -0.922 . . . . 0.0 109.662 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.436 ' HB3' ' CD ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -111.26 99.3 8.15 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.419 -0.8 . . . . 0.0 109.43 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.543 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 2.0 mt -122.75 -85.97 0.65 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 109.575 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 107' ' ' LEU . 1.5 t -177.82 -55.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -159.68 88.2 0.11 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 109' ' ' GLY . 1.0 OUTLIER -40.39 143.74 0.29 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.518 -0.989 . . . . 0.0 110.015 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.457 ' OD1' ' HG2' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -128.64 -171.02 2.36 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.451 -0.781 . . . . 0.0 109.184 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.472 ' HA ' HG23 ' A' ' 123' ' ' ILE . . . -75.98 -9.34 58.53 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.197 -0.939 . . . . 0.0 109.431 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -62.81 -56.66 15.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.871 . . . . 0.0 109.687 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.475 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -81.3 -13.63 58.22 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.683 ' CZ ' ' CZ ' ' A' ' 35' ' ' PHE . 3.1 m-85 -90.58 110.6 42.39 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.514 ' CG ' ' O ' ' A' ' 33' ' ' LEU . 6.6 Cg_exo -50.96 141.19 37.51 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.953 1.769 . . . . 0.0 110.094 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 4.4 Cg_exo -59.35 126.52 21.03 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.195 1.93 . . . . 0.0 110.804 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 152.97 -18.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.53 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 0.9 OUTLIER -123.33 48.52 1.82 Allowed 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.655 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.2 mm-40 -65.99 -35.88 12.07 Favored Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.655 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 6.2 Cg_exo -60.59 -35.11 91.32 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 121.678 1.585 . . . . 0.0 112.094 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.568 HG21 ' CD2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -102.67 -46.66 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 120.588 -1.32 . . . . 0.0 108.672 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.602 HD11 ' CD2' ' A' ' 115' ' ' PHE . 24.8 mm -50.15 -38.35 14.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 127' ' ' LYS . . . -52.06 -44.35 64.25 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -71.08 -42.63 69.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.41 -0.806 . . . . 0.0 109.782 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.594 HD23 ' CE2' ' A' ' 68' ' ' PHE . 1.4 mt -63.01 -9.73 11.21 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.276 -0.89 . . . . 0.0 109.732 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.457 ' HG2' ' OD1' ' A' ' 111' ' ' ASN . 55.6 mttt -56.81 -48.7 77.35 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.14 -0.975 . . . . 0.0 108.69 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 129' ' ' LEU . 1.8 ptt180 -89.33 0.95 56.42 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.407 -0.808 . . . . 0.0 109.27 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 126' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.851 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.458 ' HE2' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.431 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 6.8 ptmm? -179.34 46.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.151 -0.968 . . . . 0.0 109.653 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -110.57 89.82 3.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.977 . . . . 0.0 109.229 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -115.61 176.94 4.85 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.112 0.958 . . . . 0.0 110.546 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.447 ' O ' ' O ' ' A' ' 4' ' ' LEU . 8.8 mt-30 58.36 126.53 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.568 0.699 . . . . 0.0 110.485 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.496 ' CG2' ' N ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -129.89 176.05 9.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.496 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . -117.79 80.26 1.48 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.841 -1.162 . . . . 0.0 110.283 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.57 ' CG1' ' O ' ' A' ' 83' ' ' TRP . 3.2 p -100.18 145.27 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 118.896 -1.122 . . . . 0.0 108.485 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -129.37 110.36 1.06 Allowed Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.614 ' CD1' ' CD1' ' A' ' 86' ' ' LEU . 1.3 mt -92.49 166.19 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.685 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -154.48 146.42 13.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.271 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.492 ' HD2' ' CD1' ' A' ' 107' ' ' LEU . 38.2 ttp180 -161.5 77.27 0.54 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.532 -0.73 . . . . 0.0 110.039 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.514 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 20.2 m-80 -160.1 -162.04 0.95 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -0.893 . . . . 0.0 109.543 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.37 -85.98 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.619 0.723 . . . . 0.0 109.528 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 13' ' ' ASN . 28.9 t-20 -94.75 28.68 2.59 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.529 -0.732 . . . . 0.0 109.335 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 15' ' ' ASN . 30.1 t30 42.31 43.73 3.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.475 -0.766 . . . . 0.0 109.318 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 105' ' ' MET . 2.5 mt-10 -129.41 149.33 51.24 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.685 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 3.0 mt -101.12 156.99 4.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 118.326 -1.35 . . . . 0.0 110.672 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.483 ' HB3' HG13 ' A' ' 11' ' ' ILE . 60.3 t80 -97.03 78.25 2.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.545 ' O ' ' CA ' ' A' ' 102' ' ' GLY . 11.3 mm -78.09 167.14 2.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.404 -0.81 . . . . 0.0 110.084 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.539 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -128.01 139.88 52.3 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.848 178.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 32' ' ' LYS . 1.2 ttp180 -145.71 144.73 30.55 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.055 -1.028 . . . . 0.0 109.433 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.502 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -64.41 109.25 1.87 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.27 -0.894 . . . . 0.0 110.658 -179.499 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 23' ' ' ARG . . . 79.22 -6.03 1.91 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.727 -0.608 . . . . 0.0 110.034 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 58.71 21.27 8.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.973 . . . . 0.0 109.686 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.98 154.05 48.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.171 -0.956 . . . . 0.0 109.419 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.62 143.61 33.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 109.847 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -103.28 -31.0 10.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.573 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -133.45 137.86 45.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 109.524 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.425 ' C ' ' OD1' ' A' ' 31' ' ' ASN . . . 48.98 -172.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.306 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.425 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 1.5 m120 -134.39 114.19 12.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 109.612 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.458 ' O ' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -108.13 135.0 50.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.317 -0.864 . . . . 0.0 109.375 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.538 ' O ' ' CG ' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -104.63 -176.94 3.22 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.351 -0.843 . . . . 0.0 109.073 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -162.17 -155.91 0.39 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 110.073 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.447 ' O ' ' O ' ' A' ' 36' ' ' PRO . 21.8 m-85 -142.31 141.41 21.06 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.555 ' CG ' HG21 ' A' ' 8' ' ' VAL . 5.9 Cg_exo -57.54 -150.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.87 1.714 . . . . 0.0 110.074 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.562 ' HA2' ' CA ' ' A' ' 8' ' ' VAL . . . 148.78 -149.08 21.04 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.086 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . 144.93 -79.93 0.23 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 178.07 133.87 0.07 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.395 -1.061 . . . . 0.0 109.652 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.434 ' CG2' ' O ' ' A' ' 40' ' ' ILE . 9.0 tt -121.84 74.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.253 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.444 ' CG ' ' HG2' ' A' ' 39' ' ' LYS . 1.9 mm-40 -113.04 -179.71 3.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.611 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.2 ttm 44.09 83.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.31 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 168.85 124.31 0.72 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.21 -11.17 39.09 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.19 -1.183 . . . . 0.0 110.192 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.56 HG21 ' HD2' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -125.18 149.03 62.53 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 120.927 -1.108 . . . . 0.0 108.715 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.608 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 9.3 Cg_endo -71.12 14.98 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.753 2.302 . . . . 0.0 112.343 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.485 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -124.01 -60.92 1.4 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.508 -1.37 . . . . 0.0 109.766 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.553 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -48.12 -28.5 2.95 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.823 1.296 . . . . 0.0 109.379 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . -67.54 -67.17 0.48 Allowed 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.374 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.606 HG12 ' CE3' ' A' ' 85' ' ' TRP . 10.0 p -83.29 3.55 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.259 -0.901 . . . . 0.0 111.463 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.582 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 4.9 p -81.92 -43.67 19.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.582 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -69.34 -29.08 66.82 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 113.745 -1.571 . . . . 0.0 108.101 177.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 49' ' ' ALA . 69.9 mt-10 -70.36 -22.78 62.74 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.128 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.594 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 3.4 mt -63.43 -48.09 79.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -0.908 . . . . 0.0 109.467 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.505 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 2.1 pt20 -81.37 -30.64 33.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.937 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 9.1 mm-40 -81.88 32.56 0.37 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.219 -0.926 . . . . 0.0 111.014 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.655 ' CB ' ' CD1' ' A' ' 95' ' ' TRP . 25.6 mm-40 -155.3 -57.63 0.1 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.629 -1.294 . . . . 0.0 109.985 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.645 ' CG2' ' CD1' ' A' ' 95' ' ' TRP . 10.6 m -113.92 -49.8 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 92.4 37.69 5.82 Favored Glycine 0 C--N 1.299 -1.482 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.611 HG12 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -79.83 174.67 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -1.092 . . . . 0.0 108.255 178.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.546 ' HB ' ' CB ' ' A' ' 91' ' ' GLU . 8.1 m -115.3 90.13 23.59 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.542 ' HG3' ' CD1' ' A' ' 54' ' ' LEU . 4.3 Cg_endo -61.0 122.75 11.66 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 121.809 1.672 . . . . 0.0 110.11 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.518 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 1.8 mt-30 -86.89 -34.18 19.5 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.834 -0.541 . . . . 0.0 109.773 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.466 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 45.5 t60 -176.42 97.48 0.06 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.179 -0.951 . . . . 0.0 110.315 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.403 ' CE2' ' HB2' ' A' ' 62' ' ' PRO . 13.7 p90 -111.7 175.5 5.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.908 -1.12 . . . . 0.0 109.307 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.1 m -161.97 173.18 14.81 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.624 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.572 HD23 ' CZ3' ' A' ' 83' ' ' TRP . 4.6 tp -116.09 114.16 24.15 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.215 -0.928 . . . . 0.0 109.153 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.641 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 2.6 p90 -73.78 -53.76 9.57 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.294 -0.879 . . . . 0.0 109.876 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.641 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 0.5 OUTLIER 176.45 149.59 0.13 Allowed 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.039 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.503 ' HB3' ' HA ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -111.66 163.46 14.09 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.312 -0.868 . . . . 0.0 109.895 -179.466 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.54 ' CD2' HG22 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -113.93 -164.6 0.94 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 109.145 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -136.03 156.28 48.96 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.133 -0.979 . . . . 0.0 109.557 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.57 82.85 1.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.59 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 1.0 OUTLIER -103.12 114.2 28.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 110.327 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.512 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -81.69 177.04 3.25 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 1.9 Cg_endo -63.95 2.67 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.926 1.751 . . . . 0.0 111.42 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.458 ' O ' ' HE2' ' A' ' 1' ' ' MET . 4.9 t70 -125.52 -55.05 1.55 Allowed 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.623 -1.298 . . . . 0.0 111.162 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.524 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -118.49 -179.42 3.78 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.253 -0.904 . . . . 0.0 110.387 -178.114 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.59 ' CD2' ' HG3' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -128.51 96.44 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 12.6 mt -97.74 128.68 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.506 -0.746 . . . . 0.0 110.815 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' A' ' 71' ' ' LEU . 3.7 m -115.85 118.43 32.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 108.769 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.467 ' HB2' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -81.93 132.15 35.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.154 -0.966 . . . . 0.0 109.81 -179.502 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.689 ' CD1' ' O ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -122.9 113.64 19.39 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.31 -0.869 . . . . 0.0 109.575 -178.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.554 ' CA ' HG11 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -122.37 113.54 19.52 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 120.358 -1.464 . . . . 0.0 109.955 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.63 ' CD1' ' O ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -83.34 87.05 6.97 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.363 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.614 ' CD1' ' CD1' ' A' ' 10' ' ' ILE . 0.6 OUTLIER -44.39 107.87 0.1 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.038 -1.039 . . . . 0.0 109.21 -179.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.55 ' CG2' ' CG2' ' A' ' 11' ' ' ILE . 19.8 m -81.0 174.66 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.531 -0.73 . . . . 0.0 110.308 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.501 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 1.0 OUTLIER -129.22 -18.48 3.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 110.422 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.501 ' HD3' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -162.16 174.08 13.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.89 -1.131 . . . . 0.0 110.252 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.527 ' CZ3' ' CG2' ' A' ' 11' ' ' ILE . 35.1 p90 174.65 -179.71 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.093 0.949 . . . . 0.0 109.883 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.546 ' CB ' ' HB ' ' A' ' 61' ' ' THR . 1.4 tt0 -134.7 109.17 8.43 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.727 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 94' ' ' PRO . . . 114.37 -156.97 15.28 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.333 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.476 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 1.9 mt-10 -107.29 102.22 42.65 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.344 -1.092 . . . . 0.0 109.067 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.669 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 3.4 Cg_endo -66.46 -169.82 0.19 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.118 1.879 . . . . 0.0 111.972 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.655 ' CD1' ' CB ' ' A' ' 57' ' ' GLU . 4.8 p-90 -136.01 -168.27 2.19 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.69 0.757 . . . . 0.0 108.986 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.496 ' C ' ' CB ' ' A' ' 36' ' ' PRO . . . -159.98 -77.86 0.03 OUTLIER Glycine 0 C--N 1.295 -1.742 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.524 ' CB ' ' HB3' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -87.06 -179.27 6.44 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.524 -0.986 . . . . 0.0 109.494 179.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -92.59 -36.04 13.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.346 -0.846 . . . . 0.0 109.819 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -139.76 9.61 3.12 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.524 ' HB3' ' CB ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -99.04 109.59 54.64 Favored Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 121.189 -1.183 . . . . 0.0 109.694 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.97 122.2 11.03 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.949 1.766 . . . . 0.0 109.679 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 20' ' ' ILE . . . -98.22 168.58 23.29 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.467 ' HG3' ' HE1' ' A' ' 105' ' ' MET . 14.4 pt-20 -125.81 154.61 42.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.857 -1.378 . . . . 0.0 110.086 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.442 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -94.65 104.01 15.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.543 -0.723 . . . . 0.0 109.351 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 1.2 ttm -92.51 168.73 11.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.178 -0.951 . . . . 0.0 109.257 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.4 t -116.21 65.63 0.71 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.176 -0.953 . . . . 0.0 109.567 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.493 HD13 ' CD2' ' A' ' 110' ' ' LEU . 3.1 tp 48.03 59.52 4.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.274 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.34 -72.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 109.555 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.48 ' HA3' ' CB ' ' A' ' 114' ' ' ASP . . . -100.75 30.92 9.27 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.545 ' CD1' ' O ' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -67.24 -20.6 65.69 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.311 -1.111 . . . . 0.0 109.33 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -78.93 -177.89 5.77 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.427 -0.795 . . . . 0.0 109.731 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.532 ' CB ' HG23 ' A' ' 123' ' ' ILE . . . -68.76 -6.81 28.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.378 -0.826 . . . . 0.0 109.656 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -62.91 -54.77 33.53 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.257 -0.902 . . . . 0.0 109.944 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.48 ' CB ' ' HA3' ' A' ' 109' ' ' GLY . 19.8 t0 -90.56 -6.7 54.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.872 . . . . 0.0 109.811 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.554 ' CG ' HD13 ' A' ' 123' ' ' ILE . 1.8 m-85 -89.32 142.13 29.57 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.026 -1.046 . . . . 0.0 109.388 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.538 ' CG ' ' O ' ' A' ' 33' ' ' LEU . 2.1 Cg_endo -71.65 158.13 54.19 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.303 2.002 . . . . 0.0 110.584 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.448 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 2.8 Cg_endo -60.62 -177.04 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.484 2.123 . . . . 0.0 110.563 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 74.43 -1.85 2.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.458 -0.776 . . . . 0.0 109.902 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.566 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 0.9 OUTLIER -127.15 41.7 3.47 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.032 -1.042 . . . . 0.0 109.511 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.675 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 26.6 mt-10 -74.94 -39.12 3.24 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.299 -0.875 . . . . 0.0 112.065 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.6 Cg_exo -62.37 -32.36 81.26 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.954 1.769 . . . . 0.0 112.089 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.567 HG13 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -101.4 -50.4 10.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 120.508 -1.37 . . . . 0.0 109.288 -179.592 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.566 ' CG1' ' HB3' ' A' ' 119' ' ' ASN . 14.1 mm -50.95 -36.88 16.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' A' ' 120' ' ' GLU . . . -58.73 -43.85 90.3 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -63.01 -41.46 99.57 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.293 -0.88 . . . . 0.0 109.465 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.495 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 5.3 mp -58.06 -17.21 16.29 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.233 -0.917 . . . . 0.0 109.678 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 124' ' ' ALA . 13.8 mmtt -57.07 -53.46 57.87 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -91.25 9.77 29.96 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.009 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.549 ' CD1' HD22 ' A' ' 86' ' ' LEU . 3.4 tp . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.748 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 2.7 ttt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.3 10.51 2.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 0.0 109.16 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.5 ' O ' ' O ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -103.27 131.34 50.4 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -162.43 48.55 0.17 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.387 -0.821 . . . . 0.0 109.83 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' C ' HG12 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -164.26 119.66 1.52 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.695 -1.253 . . . . 0.0 110.713 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.538 ' N ' HG12 ' A' ' 40' ' ' ILE . 6.0 mm -152.02 157.49 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.483 ' O ' ' CA ' ' A' ' 37' ' ' GLY . . . -146.42 119.31 8.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.762 -1.211 . . . . 0.0 110.465 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.561 ' CG2' ' O ' ' A' ' 36' ' ' PRO . 7.5 p -122.2 147.17 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.565 ' HA3' ' CZ3' ' A' ' 95' ' ' TRP . . . -129.1 119.55 2.99 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.605 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 1.2 mt -92.2 166.15 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.699 HG23 ' CD2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -149.19 153.38 10.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 118.584 -1.246 . . . . 0.0 110.492 -178.3 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 88' ' ' GLU . 11.0 ttp180 -129.39 122.23 29.01 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.39 -169.46 1.8 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.098 -1.001 . . . . 0.0 110.632 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -78.36 -6.93 56.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.558 -0.714 . . . . 0.0 110.302 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.467 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 24.3 t30 -88.43 21.35 2.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.443 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 20.2 t30 48.46 42.92 19.35 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.413 -0.804 . . . . 0.0 109.339 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.467 ' CG ' ' O ' ' A' ' 15' ' ' ASN . 2.9 mt-10 -140.45 147.65 39.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 108.835 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.556 ' N ' ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -103.09 153.92 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.111 -0.993 . . . . 0.0 109.415 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 56.6 t80 -88.84 73.15 8.46 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.544 ' CG2' HD22 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -80.06 -161.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.344 -0.848 . . . . 0.0 109.354 -178.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.575 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.2 OUTLIER -159.96 152.66 21.31 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.823 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.517 ' CD ' ' O ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -136.33 161.21 36.42 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.516 ' HB2' ' NH2' ' A' ' 23' ' ' ARG . 0.2 OUTLIER -85.36 61.35 6.81 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.92 -1.113 . . . . 0.0 109.991 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 23' ' ' ARG . . . 51.21 174.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.905 . . . . 0.0 109.887 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 24' ' ' ALA . . . 71.36 86.34 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.877 . . . . 0.0 109.64 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.94 122.26 20.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.181 -0.95 . . . . 0.0 109.185 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.19 155.18 39.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 109.561 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -125.32 11.32 8.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.893 . . . . 0.0 109.45 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 19.0 mtt -155.57 -48.79 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 109.358 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.14 -153.26 0.26 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.144 -0.973 . . . . 0.0 109.534 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.39 127.2 3.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.286 -0.884 . . . . 0.0 109.536 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.517 ' O ' ' CD ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -151.55 125.88 9.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.424 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.544 HD22 ' CG2' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -121.17 -165.38 1.22 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.349 -0.844 . . . . 0.0 109.36 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.2 -160.89 0.82 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.337 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.69 ' CE2' ' CZ ' ' A' ' 84' ' ' PHE . 5.8 m-85 -156.12 70.47 5.09 Favored Pre-proline 0 C--N 1.294 -1.833 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.561 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 4.3 Cg_exo -55.19 164.69 3.5 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.046 1.831 . . . . 0.0 109.588 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . -161.57 -147.71 5.07 Favored Glycine 0 N--CA 1.486 1.969 0 C-N-CA 119.325 -1.417 . . . . 0.0 109.814 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -134.51 -76.03 0.09 OUTLIER Glycine 0 N--CA 1.484 1.887 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 13.1 tttt 176.38 155.7 0.23 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.628 -0.924 . . . . 0.0 109.822 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.538 HG12 ' N ' ' A' ' 6' ' ' ILE . 15.2 mm -78.92 107.5 11.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.464 ' OE1' ' HD3' ' A' ' 52' ' ' ARG . 5.6 mt-10 -116.63 177.78 4.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.963 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.437 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 54.3 mmm 71.38 -164.99 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.863 . . . . 0.0 109.732 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.8 -26.53 3.29 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.539 ' HB2' ' NE2' ' A' ' 48' ' ' GLN . 0.9 OUTLIER -79.61 -154.91 0.09 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.399 -1.059 . . . . 0.0 109.19 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.567 ' CG2' ' HD3' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -160.82 -58.09 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.032 -1.043 . . . . 0.0 111.374 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.567 ' HD3' ' CG2' ' A' ' 45' ' ' THR . 1.3 Cg_endo -67.62 3.88 1.62 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 121.492 1.461 . . . . 0.0 112.765 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.509 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -148.91 -69.28 0.21 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.331 -1.48 . . . . 0.0 109.157 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.568 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 13.3 mt-30 -51.37 -27.57 10.2 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 122.54 1.162 . . . . 0.0 110.116 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 45' ' ' THR . . . -65.65 -66.18 0.58 Allowed 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.671 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.486 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 9.9 p -81.9 -6.59 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 111.25 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.58 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 3.1 p -72.38 -48.3 48.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.58 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -75.09 -22.5 58.23 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -52.98 -21.45 4.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.89 -1.131 . . . . 0.0 108.808 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.6 OUTLIER -66.08 -59.44 3.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.419 -0.801 . . . . 0.0 110.401 -179.435 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.531 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 7.2 pt20 -79.97 -30.22 39.73 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.177 -0.952 . . . . 0.0 111.891 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.531 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 1.1 pp20? -79.64 -29.17 40.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.869 -1.144 . . . . 0.0 111.377 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.538 ' OE2' ' CD1' ' A' ' 95' ' ' TRP . 4.4 pt-20 -91.59 -46.63 7.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.684 -1.26 . . . . 0.0 110.428 -178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.525 ' CG1' ' HG3' ' A' ' 57' ' ' GLU . 0.5 OUTLIER -147.96 -67.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.353 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 54' ' ' LEU . . . 119.99 71.36 0.33 Allowed Glycine 0 N--CA 1.48 1.589 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.643 HG22 ' HD2' ' A' ' 94' ' ' PRO . 0.1 OUTLIER -107.52 -156.49 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.114 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 91' ' ' GLU . 2.3 m -146.51 91.87 5.27 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.507 ' HA ' ' CB ' ' A' ' 90' ' ' TRP . 1.8 Cg_endo -66.05 150.55 85.23 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.34 2.027 . . . . 0.0 110.729 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -121.28 -40.07 2.62 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.592 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -128.69 -179.56 5.13 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.592 ' CD1' ' O ' ' A' ' 64' ' ' HIS . 22.9 m-85 -148.7 170.65 17.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.144 -0.972 . . . . 0.0 110.053 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.547 ' HB3' ' O ' ' A' ' 86' ' ' LEU . 3.8 t -159.24 0.84 0.09 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.296 -0.877 . . . . 0.0 111.96 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.639 ' CD2' ' CZ3' ' A' ' 85' ' ' TRP . 9.6 tp -29.0 148.52 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 CA-C-O 121.911 0.863 . . . . 0.0 110.991 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 84' ' ' PHE . 14.3 p90 -116.46 -51.19 2.61 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.811 0.815 . . . . 0.0 109.431 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.528 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.3 pt-20 -179.18 161.84 1.15 Allowed 'General case' 0 C--N 1.291 -1.946 0 O-C-N 121.743 -0.598 . . . . 0.0 110.135 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.59 ' HD3' ' CE3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -105.59 -175.8 2.9 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.311 -0.868 . . . . 0.0 110.221 -179.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.518 HD13 ' N ' ' A' ' 72' ' ' GLU . 3.8 pp -147.51 -161.52 1.35 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.262 -0.899 . . . . 0.0 109.564 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.518 ' N ' HD13 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -143.45 162.16 36.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.461 -0.775 . . . . 0.0 109.425 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -141.09 164.07 31.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.709 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -158.5 108.69 2.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.427 -0.796 . . . . 0.0 109.097 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.521 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 2.1 m-85 -79.31 170.6 15.36 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.2 Cg_exo -57.84 -10.52 7.69 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.905 1.737 . . . . 0.0 111.204 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 1' ' ' MET . 2.1 t0 -153.54 -5.69 0.18 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.87 -1.144 . . . . 0.0 112.204 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.521 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 3.7 ptt180 -133.34 -176.91 4.3 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.406 -1.434 . . . . 0.0 109.548 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.5 ' O ' ' O ' ' A' ' 3' ' ' LYS . 5.9 m80 -134.99 156.11 49.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.157 -0.965 . . . . 0.0 109.381 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.426 HG12 ' C ' ' A' ' 79' ' ' HIS . 33.1 mm -148.87 92.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.084 -1.01 . . . . 0.0 109.897 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.417 HG23 ' CH2' ' A' ' 83' ' ' TRP . 4.0 m -79.33 90.52 4.99 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.513 ' CD1' HG23 ' A' ' 6' ' ' ILE . 11.0 tp -108.24 141.57 39.82 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.315 -0.866 . . . . 0.0 109.614 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.59 ' CE3' ' HD3' ' A' ' 70' ' ' LYS . 8.7 m95 -89.56 -174.54 4.38 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.521 -0.737 . . . . 0.0 109.388 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.69 ' CZ ' ' CE2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -144.05 76.13 1.49 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.639 ' CZ3' ' CD2' ' A' ' 67' ' ' LEU . 55.7 m95 -81.46 157.89 24.74 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 122.218 1.008 . . . . 0.0 110.628 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.605 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 6.2 tp -150.24 98.12 2.64 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.608 ' CG2' ' CG2' ' A' ' 11' ' ' ILE . 15.8 m -93.64 178.46 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.8 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -110.59 -28.15 8.62 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.23 -0.919 . . . . 0.0 112.32 -178.094 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -161.68 153.77 19.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.547 -1.346 . . . . 0.0 110.788 -178.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.7 ' NE1' ' O ' ' A' ' 92' ' ' GLY . 0.9 OUTLIER -161.96 -167.43 1.66 Allowed 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.582 -0.699 . . . . 0.0 109.564 178.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.535 ' O ' ' O ' ' A' ' 92' ' ' GLY . 22.7 tt0 -90.89 -105.82 0.1 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.274 -0.891 . . . . 0.0 110.062 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.7 ' O ' ' NE1' ' A' ' 90' ' ' TRP . . . -45.18 173.25 0.01 OUTLIER Glycine 0 N--CA 1.495 2.598 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.814 ' N ' ' HD3' ' A' ' 94' ' ' PRO . 1.5 pt-20 -115.26 28.53 0.11 Allowed Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 119.354 1.577 . . . . 0.0 113.29 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.814 ' HD3' ' N ' ' A' ' 93' ' ' GLU . 60.6 Cg_endo -90.41 -123.54 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 122.508 2.139 . . . . 0.0 108.447 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.638 ' CD1' ' CD1' ' A' ' 60' ' ' ILE . 0.0 OUTLIER 85.76 75.53 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.042 -1.036 . . . . 0.0 111.707 177.661 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 161.26 -121.77 1.05 Allowed Glycine 0 C--N 1.297 -1.634 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.494 ' CD ' ' HB2' ' A' ' 100' ' ' GLN . 7.3 tttt -94.5 145.86 24.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.109 -1.23 . . . . 0.0 109.995 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 11.6 pt-20 -89.72 -33.81 16.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.168 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.439 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . -88.11 -10.83 68.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HB2' ' CD ' ' A' ' 97' ' ' LYS . 7.1 tt0 -102.65 113.2 66.02 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 121.374 -1.074 . . . . 0.0 109.381 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.29 102.62 0.33 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.041 1.827 . . . . 0.0 110.726 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -65.38 172.31 22.83 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.476 ' O ' HG21 ' A' ' 20' ' ' ILE . 4.2 pt-20 -147.0 134.22 20.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.543 -1.563 . . . . 0.0 110.14 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.599 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -81.81 94.72 7.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.448 -0.783 . . . . 0.0 109.08 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.457 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -85.04 169.51 13.88 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.082 -1.011 . . . . 0.0 109.471 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.43 145.51 25.59 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.199 -0.938 . . . . 0.0 109.596 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.474 ' HG ' HD13 ' A' ' 110' ' ' LEU . 1.8 tt -101.39 61.41 0.92 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.59 -25.95 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.565 -0.709 . . . . 0.0 109.505 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -162.58 38.04 0.35 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.474 HD13 ' HG ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -43.13 145.82 0.48 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.397 -1.061 . . . . 0.0 109.632 -179.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.454 ' ND2' ' HE2' ' A' ' 127' ' ' LYS . 2.6 t30 -156.87 163.12 39.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.082 -1.011 . . . . 0.0 110.028 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.483 ' HA ' ' CG2' ' A' ' 123' ' ' ILE . . . -61.29 -15.64 37.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 109.184 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -68.44 -33.15 73.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.425 -0.797 . . . . 0.0 109.4 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -79.13 2.09 22.07 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.041 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.605 ' CE1' ' CE2' ' A' ' 35' ' ' PHE . 10.2 m-85 -130.97 104.72 15.28 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.443 -0.786 . . . . 0.0 109.179 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.436 ' HG3' ' HB2' ' A' ' 32' ' ' LYS . 21.6 Cg_exo -43.18 160.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.513 2.142 . . . . 0.0 110.831 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.525 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 5.0 Cg_exo -58.03 130.25 37.2 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.518 2.145 . . . . 0.0 111.365 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 160.31 -56.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.549 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 16.1 m-20 -107.84 42.41 1.35 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.641 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -61.51 -38.68 54.33 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.433 -0.792 . . . . 0.0 113.004 -179.131 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 1.9 Cg_endo -65.06 -37.46 32.8 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 122.0 1.8 . . . . 0.0 111.977 -177.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.586 HG12 ' CG ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -90.23 -39.34 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.523 -1.361 . . . . 0.0 108.186 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.549 ' CG1' ' O ' ' A' ' 119' ' ' ASN . 6.6 mm -56.35 -34.31 40.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.43 -36.78 74.15 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.871 -0.731 . . . . 0.0 109.271 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -55.1 8.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.91 . . . . 0.0 109.967 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.428 ' HG ' ' HA ' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -50.65 -17.66 0.56 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.199 -0.938 . . . . 0.0 110.126 -179.475 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.454 ' HE2' ' ND2' ' A' ' 111' ' ' ASN . 15.2 mttt -47.59 -46.37 28.2 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.825 -1.172 . . . . 0.0 108.923 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -95.98 47.71 1.1 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.459 -0.775 . . . . 0.0 109.319 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.464 ' CD2' HD22 ' A' ' 86' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.305 -1.345 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.658 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.357 0.599 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.65 -174.52 3.67 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.193 -0.942 . . . . 0.0 109.457 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -106.17 85.06 2.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.358 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.4 tp -83.89 127.05 33.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -0.852 . . . . 0.0 109.508 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.558 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . 2.0 mt-30 -118.12 159.25 23.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 0.0 109.177 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.475 ' CG2' ' HG ' ' A' ' 82' ' ' LEU . 2.1 tt -134.4 -173.94 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.132 -0.98 . . . . 0.0 109.365 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.466 ' N ' HG22 ' A' ' 6' ' ' ILE . . . -138.31 104.92 5.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.198 -0.939 . . . . 0.0 109.311 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 7.6 p -113.08 139.96 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.428 -0.795 . . . . 0.0 109.567 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.609 ' CA ' ' NE1' ' A' ' 85' ' ' TRP . . . -121.77 126.32 6.44 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.639 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.581 HD12 ' CE2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -107.17 144.27 16.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.085 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.604 HG21 ' CE3' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -123.69 156.04 30.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.866 -1.146 . . . . 0.0 109.253 179.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -157.44 125.25 5.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.474 -0.766 . . . . 0.0 109.451 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.577 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 26.9 p-10 -156.63 -168.48 2.7 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.879 -1.138 . . . . 0.0 111.169 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 13' ' ' ASN . 3.8 mt-10 66.16 -83.44 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.863 0.84 . . . . 0.0 110.048 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -132.68 -59.21 0.91 Allowed 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 122.004 0.907 . . . . 0.0 109.593 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -164.72 32.55 0.07 Allowed 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 3.7 mt-10 -89.39 148.95 23.21 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.535 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 0.9 OUTLIER -131.21 154.91 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.06 -1.025 . . . . 0.0 109.582 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.586 ' CZ ' ' OE1' ' A' ' 100' ' ' GLN . 9.6 t80 -116.63 84.87 2.21 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.455 ' CD1' ' HE2' ' A' ' 105' ' ' MET . 0.6 OUTLIER -107.3 -152.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 108.619 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.546 ' CG2' ' HD3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -131.23 151.32 51.59 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.015 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -131.22 -159.59 0.98 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.43 -0.794 . . . . 0.0 109.818 -179.399 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.46 ' HD3' ' HB1' ' A' ' 27' ' ' ALA . 5.3 ptt180 -73.08 81.82 1.26 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.421 -0.799 . . . . 0.0 109.874 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.77 7.68 25.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.286 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.08 -42.01 0.15 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.36 -0.838 . . . . 0.0 109.577 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -169.76 133.84 1.29 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.98 . . . . 0.0 109.738 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.46 ' HB1' ' HD3' ' A' ' 23' ' ' ARG . . . -121.69 122.61 39.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.343 -0.848 . . . . 0.0 109.243 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -48.44 -28.07 3.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.843 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 17.9 mtt -126.97 -152.92 0.54 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.049 -1.032 . . . . 0.0 109.797 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.56 -88.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.34 -0.85 . . . . 0.0 109.505 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -100.78 129.65 46.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.938 . . . . 0.0 109.327 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.499 ' HB2' ' HG3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -148.81 132.31 16.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.206 -0.934 . . . . 0.0 109.339 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.59 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -93.6 -176.86 4.21 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 120.93 -1.106 . . . . 0.0 108.389 179.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.482 ' O ' ' CG ' ' A' ' 35' ' ' PHE . 4.8 tt0 -163.44 -158.9 0.49 Allowed 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 118.804 -1.159 . . . . 0.0 111.067 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.656 ' CZ ' ' CZ ' ' A' ' 115' ' ' PHE . 57.8 m-85 -161.64 64.75 1.85 Allowed Pre-proline 0 C--N 1.299 -1.601 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 34' ' ' GLU . 2.3 Cg_endo -60.62 -84.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.235 1.957 . . . . 0.0 110.706 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 97' ' ' LYS . . . 105.6 -120.64 6.51 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -156.46 -77.85 0.02 OUTLIER Glycine 0 N--CA 1.488 2.1 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 6.0 tttp 177.41 132.31 0.06 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.483 -1.01 . . . . 0.0 109.318 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.558 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 14.2 tt -118.93 120.04 62.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.378 -0.826 . . . . 0.0 108.978 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -85.55 144.73 27.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.033 -1.042 . . . . 0.0 109.826 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.17 165.15 23.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.372 -0.83 . . . . 0.0 109.406 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.67 -17.23 57.08 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.24 -153.95 0.44 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.588 -0.948 . . . . 0.0 108.816 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.572 ' CG2' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -122.1 176.96 1.74 Allowed Pre-proline 0 C--N 1.307 -1.277 0 O-C-N 120.791 -1.193 . . . . 0.0 108.526 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.572 ' CD ' ' CG2' ' A' ' 45' ' ' THR . 10.2 Cg_endo -76.96 -7.57 17.42 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.052 1.835 . . . . 0.0 110.986 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.505 ' O ' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -113.59 -62.34 1.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.934 -1.104 . . . . 0.0 110.609 -178.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.518 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 2.5 tt0 -39.29 -36.22 0.32 Allowed 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.658 1.218 . . . . 0.0 109.502 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 47' ' ' GLU . . . -60.42 -67.08 0.43 Allowed 'General case' 0 C--N 1.271 -2.824 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.313 -178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -81.55 -44.0 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.271 -0.893 . . . . 0.0 110.447 -178.468 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.548 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 7.4 p -39.95 -45.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.548 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -73.94 -37.36 64.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.114 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 50' ' ' VAL . 5.1 mm-40 -67.4 -7.06 22.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.197 -0.939 . . . . 0.0 109.446 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.598 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -76.45 -54.76 6.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.957 -1.089 . . . . 0.0 109.62 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -80.02 -29.77 39.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.009 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.457 ' HG3' ' HG3' ' A' ' 52' ' ' ARG . 11.9 mm-40 -81.55 35.37 0.4 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.136 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.491 ' HB2' ' CD1' ' A' ' 95' ' ' TRP . 12.3 mt-10 -150.53 -66.52 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.901 -1.124 . . . . 0.0 109.613 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.59 ' CG2' ' O ' ' A' ' 93' ' ' GLU . 1.4 p -122.56 -27.21 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 O-C-N 121.043 -1.035 . . . . 0.0 109.788 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.51 ' N ' HG11 ' A' ' 58' ' ' VAL . . . 69.02 70.23 1.21 Allowed Glycine 0 N--CA 1.489 2.177 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.26 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.478 HG12 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -90.12 172.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.671 ' CB ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -123.36 -70.02 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 120.201 -1.562 . . . . 0.0 111.221 -178.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.671 ' HD3' ' CB ' ' A' ' 61' ' ' THR . 12.3 Cg_endo -75.35 49.04 2.24 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 122.057 1.838 . . . . 0.0 111.251 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.641 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 11.7 tt0 -101.52 72.3 1.39 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.672 -1.267 . . . . 0.0 109.276 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -65.59 105.13 1.14 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.541 ' HB3' ' CG1' ' A' ' 87' ' ' VAL . 30.5 p90 -125.41 179.58 5.05 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.758 1.266 . . . . 0.0 111.97 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 68' ' ' PHE . 4.9 m -162.19 131.82 4.54 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.556 ' CD1' ' O ' ' A' ' 84' ' ' PHE . 43.5 tp -49.04 94.76 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.726 -1.234 . . . . 0.0 109.578 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.586 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 1.0 OUTLIER -42.93 -77.15 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.586 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 3.3 mm-40 -156.67 -173.5 4.51 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.486 ' CE ' HD23 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -140.43 147.81 40.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.065 -1.022 . . . . 0.0 109.845 -179.542 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.538 ' CG ' ' HB ' ' A' ' 122' ' ' VAL . 0.5 OUTLIER -124.32 -178.45 4.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.15 -0.969 . . . . 0.0 109.671 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -160.88 146.77 14.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.478 -0.764 . . . . 0.0 109.398 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -129.3 -163.53 1.3 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.957 . . . . 0.0 109.29 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -157.44 117.6 3.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 0.0 109.187 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.586 ' CD2' HD12 ' A' ' 80' ' ' ILE . 1.4 m-85 -79.62 170.37 16.24 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.511 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.0 Cg_exo -56.89 -6.34 1.7 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.063 1.842 . . . . 0.0 111.983 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.63 -17.04 0.32 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.566 -1.334 . . . . 0.0 112.113 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -131.44 -177.76 4.55 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.446 -1.409 . . . . 0.0 110.507 -178.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -121.67 121.69 37.91 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.586 HD12 ' CD2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -101.92 161.38 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.083 -1.011 . . . . 0.0 109.734 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.4 m -152.42 105.28 3.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.417 -0.802 . . . . 0.0 109.354 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.528 ' CB ' HD12 ' A' ' 71' ' ' LEU . 1.2 mp -85.94 149.93 24.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 109.821 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.592 ' CE2' ' HB3' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -110.35 115.97 30.62 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.584 ' CD2' HG12 ' A' ' 122' ' ' VAL . 2.2 m-85 -97.55 100.72 12.14 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.327 -0.858 . . . . 0.0 111.695 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.612 ' O ' ' CG ' ' A' ' 85' ' ' TRP . 29.1 p-90 -105.72 82.8 1.84 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.8 -1.188 . . . . 0.0 108.263 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.471 HD11 ' HB ' ' A' ' 10' ' ' ILE . 24.7 tp -78.06 146.01 35.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.434 -0.791 . . . . 0.0 110.673 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.564 ' CG2' ' CG2' ' A' ' 11' ' ' ILE . 17.7 m -113.13 -163.01 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.548 -0.72 . . . . 0.0 109.642 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 7.3 mt-10 -141.35 -29.72 0.63 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -0.981 . . . . 0.0 111.041 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.672 ' O ' ' HB3' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -143.78 -172.85 3.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.745 -1.222 . . . . 0.0 109.432 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.672 ' HB3' ' O ' ' A' ' 89' ' ' ARG . 17.2 p90 154.47 162.59 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 122.72 1.248 . . . . 0.0 110.968 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.574 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 46.8 tt0 -126.11 90.11 3.13 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.186 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 157.66 -158.1 28.74 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.59 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -121.37 78.68 35.98 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.57 ' CD ' ' NE1' ' A' ' 90' ' ' TRP . 16.7 Cg_exo -40.02 156.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.064 2.509 . . . . 0.0 112.906 -177.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.598 ' CZ2' ' HA ' ' A' ' 54' ' ' LEU . 45.4 p-90 -98.91 -163.4 1.03 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.476 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . 161.1 -21.99 0.22 Allowed Glycine 0 C--N 1.295 -1.708 0 C-N-CA 119.233 -1.46 . . . . 0.0 109.738 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.546 ' HD3' ' CG2' ' A' ' 21' ' ' THR . 29.6 tttt -146.44 160.03 42.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.418 -1.048 . . . . 0.0 109.312 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -44.24 104.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 108.587 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.98 -133.09 11.61 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.586 ' OE1' ' CZ ' ' A' ' 19' ' ' PHE . 0.1 OUTLIER -150.09 53.58 1.31 Allowed Pre-proline 0 C--N 1.306 -1.322 0 O-C-N 120.926 -1.338 . . . . 0.0 110.24 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.583 ' HD3' ' N ' ' A' ' 100' ' ' GLN . 9.4 Cg_endo -71.16 -15.95 31.87 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.0 1.8 . . . . 0.0 110.236 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -64.04 -173.64 3.06 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.408 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 2.0 pm0 -156.96 169.62 24.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -1.148 . . . . 0.0 109.753 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -99.48 105.27 17.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -0.838 . . . . 0.0 109.228 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.455 ' HE2' ' CD1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -83.44 163.26 20.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 109.506 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.89 91.48 3.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.315 -0.866 . . . . 0.0 109.302 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 mt 49.55 51.59 16.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 109.735 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.403 ' O ' ' CG1' ' A' ' 108' ' ' VAL . 44.6 t -104.33 26.74 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 108.955 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 114' ' ' ASP . . . 104.22 60.03 0.68 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.541 ' CD1' ' O ' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -64.25 -13.99 52.82 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.201 -1.176 . . . . 0.0 108.663 179.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.27 -177.35 5.12 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.363 -0.836 . . . . 0.0 109.462 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.53 ' CB ' HG23 ' A' ' 123' ' ' ILE . . . -62.32 -12.15 19.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 109.712 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -60.04 -52.63 64.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.845 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 13.6 t0 -79.17 -2.87 42.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.351 -0.843 . . . . 0.0 108.908 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.656 ' CZ ' ' CZ ' ' A' ' 35' ' ' PHE . 18.1 m-85 -109.27 108.19 60.08 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.288 -0.882 . . . . 0.0 108.816 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.499 ' HG3' ' HB2' ' A' ' 32' ' ' LYS . 10.0 Cg_exo -49.83 160.35 1.26 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.516 2.144 . . . . 0.0 111.152 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.537 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 4.8 Cg_exo -59.17 118.08 4.91 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.397 2.065 . . . . 0.0 110.232 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 161.28 -36.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.559 ' OD1' ' CZ ' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -118.49 39.53 3.44 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.348 -0.845 . . . . 0.0 109.193 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.688 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.9 mt-10 -69.92 -34.65 4.51 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.411 -0.806 . . . . 0.0 112.575 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.3 Cg_exo -59.56 -37.2 90.1 Favored 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 121.644 1.563 . . . . 0.0 112.012 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.584 HG12 ' CD2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -102.18 -42.75 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.441 -1.412 . . . . 0.0 108.128 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.588 HD13 ' CD2' ' A' ' 115' ' ' PHE . 14.7 mm -54.05 -28.66 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.55 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -73.1 -36.35 66.76 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.518 -0.739 . . . . 0.0 109.571 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -70.49 -48.3 56.37 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.209 -0.932 . . . . 0.0 110.51 -179.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.559 ' HB2' ' CD1' ' A' ' 129' ' ' LEU . 0.9 OUTLIER -80.59 20.59 0.71 Allowed 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.842 -1.161 . . . . 0.0 110.741 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.55 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 17.2 mttt -63.63 -40.6 97.31 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.9 -1.125 . . . . 0.0 108.394 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.493 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -79.11 7.43 7.49 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.903 -0.498 . . . . 0.0 110.125 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.559 ' CD1' ' HB2' ' A' ' 126' ' ' LEU . 4.7 tp . . . . . 0 N--CA 1.499 2.011 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.447 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttm . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? 48.03 -144.37 0.38 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 109.337 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? -142.98 168.83 18.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.997 . . . . 0.0 109.635 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.519 ' N ' ' HB2' ' A' ' 79' ' ' HIS . 2.5 pp -87.46 121.39 29.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.892 . . . . 0.0 109.984 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.491 ' CG ' ' C ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER 169.84 99.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 109.81 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.533 HD12 ' CG2' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -122.02 167.1 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.485 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . -134.15 81.8 1.94 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.341 -0.849 . . . . 0.0 109.133 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.615 HG11 ' HA ' ' A' ' 84' ' ' PHE . 12.1 p -88.84 139.28 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.359 -0.838 . . . . 0.0 108.751 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.27 117.22 2.23 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.567 ' CD1' ' CD1' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -100.28 170.06 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.246 -1.15 . . . . 0.0 108.692 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.59 HG21 ' CZ3' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -147.58 154.71 11.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.981 -1.075 . . . . 0.0 110.479 -179.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.459 ' HD2' ' HG ' ' A' ' 107' ' ' LEU . 1.4 ttp180 -161.32 117.76 2.2 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.531 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 1.9 t-20 -105.54 -153.32 0.49 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.873 -1.142 . . . . 0.0 110.831 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -80.45 -5.4 56.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.748 -0.595 . . . . 0.0 109.536 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -79.71 5.57 13.05 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.233 -0.917 . . . . 0.0 108.952 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 21.9 t-20 52.86 42.91 32.06 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.467 -0.77 . . . . 0.0 109.338 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -134.82 150.1 50.45 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.529 HD12 ' CD1' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -110.48 155.09 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.025 -1.047 . . . . 0.0 109.459 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.559 ' HB3' ' CG1' ' A' ' 11' ' ' ILE . 45.0 t80 -103.36 71.68 1.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 0.0 109.29 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.471 HG13 HD13 ' A' ' 33' ' ' LEU . 2.5 mm -81.16 -177.73 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.542 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.543 ' CB ' ' HG3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -155.89 144.14 19.99 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.144 -0.972 . . . . 0.0 109.15 179.127 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.438 ' HG2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -156.64 124.97 5.7 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.994 -178.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 16.5 ptt180 -84.76 46.96 1.31 Allowed 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.178 -0.952 . . . . 0.0 109.372 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.31 122.1 27.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.163 -0.96 . . . . 0.0 109.687 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.58 -32.97 21.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.366 -0.834 . . . . 0.0 109.192 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 58.7 p30 -102.22 -141.6 0.35 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.401 -0.812 . . . . 0.0 108.977 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 63.97 82.41 0.18 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.009 -1.057 . . . . 0.0 109.111 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -84.61 144.77 28.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.282 -0.886 . . . . 0.0 109.697 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.3 ttt 63.7 97.65 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.353 -0.842 . . . . 0.0 109.808 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 63.7 131.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.896 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.439 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 1.8 m-20 -119.34 -171.83 2.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 0.0 109.422 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.538 ' HD3' ' CG ' ' A' ' 116' ' ' PRO . 12.1 mttp -92.09 170.19 10.03 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.363 -0.836 . . . . 0.0 108.754 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.635 ' N ' ' CD2' ' A' ' 33' ' ' LEU . 3.0 mm? -105.5 176.66 5.09 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 109.58 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.438 ' HB2' ' HG2' ' A' ' 22' ' ' ARG . 2.8 tt0 -160.97 -160.9 0.78 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 122.246 1.022 . . . . 0.0 110.577 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.595 ' CD1' ' HG3' ' A' ' 117' ' ' PRO . 29.3 m-85 -144.59 84.72 8.95 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.543 ' HG3' ' CB ' ' A' ' 21' ' ' THR . 3.1 Cg_exo -60.13 -150.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.405 2.07 . . . . 0.0 110.208 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 151.08 -168.71 30.75 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -147.46 18.05 1.49 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER 69.34 149.11 0.07 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.35 -1.088 . . . . 0.0 109.919 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.09 131.71 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 42' ' ' MET . 4.8 mt-10 -134.81 -147.82 0.29 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.09 -1.006 . . . . 0.0 110.052 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 41' ' ' GLU . 1.9 ptm -39.7 162.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.559 -0.713 . . . . 0.0 110.137 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.51 -157.08 27.1 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.404 ' HG3' ' OE1' ' A' ' 48' ' ' GLN . 3.7 mt-10 -125.34 -34.86 2.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -1.165 . . . . 0.0 109.426 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.511 ' OG1' ' HD2' ' A' ' 46' ' ' PRO . 0.5 OUTLIER -160.32 171.55 7.02 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.511 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 5.0 Cg_exo -59.02 -1.96 1.0 Allowed 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.536 2.157 . . . . 0.0 112.971 -178.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.475 ' O ' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -102.5 -54.24 2.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.479 -1.388 . . . . 0.0 109.056 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.499 ' O ' HG13 ' A' ' 51' ' ' VAL . 2.3 tt0 -63.79 -46.7 84.01 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 122.55 1.167 . . . . 0.0 108.738 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -45.36 -49.63 12.82 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.042 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.511 HG11 ' N ' ' A' ' 51' ' ' VAL . 3.5 p -79.94 -20.32 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.343 -0.848 . . . . 0.0 110.003 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.615 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -61.04 -50.98 78.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.615 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -57.62 -35.86 71.03 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 113.114 -1.857 . . . . 0.0 109.847 178.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.461 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 2.4 mt-10 -64.87 -24.75 67.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.816 -1.178 . . . . 0.0 109.153 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.612 ' HA ' ' CE2' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -73.53 -70.98 0.34 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.525 -0.735 . . . . 0.0 109.909 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.575 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -59.19 -21.15 58.99 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.974 -0.454 . . . . 0.0 111.504 -178.414 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 52' ' ' ARG . 8.8 pt-20 -80.74 1.52 29.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.578 -1.326 . . . . 0.0 110.549 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -135.72 -59.38 0.76 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.927 -1.108 . . . . 0.0 110.982 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.651 ' CG1' ' HB3' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -114.18 -42.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.228 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.575 ' CA ' ' HA ' ' A' ' 55' ' ' GLN . . . 59.42 72.25 0.64 Allowed Glycine 0 C--N 1.293 -1.835 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.577 HG22 ' CD1' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -79.78 163.4 3.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.81 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.606 ' CB ' ' HD3' ' A' ' 62' ' ' PRO . 1.3 m -100.91 -68.93 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 120.219 -1.55 . . . . 0.0 110.471 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.606 ' HD3' ' CB ' ' A' ' 61' ' ' THR . 5.6 Cg_endo -70.36 49.31 0.83 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.152 1.901 . . . . 0.0 111.766 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.596 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 1.3 pt20 -83.81 55.73 3.37 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.953 -1.092 . . . . 0.0 109.231 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -62.22 118.02 6.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.185 -0.947 . . . . 0.0 109.278 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.418 ' CB ' ' HA ' ' A' ' 87' ' ' VAL . 48.0 p90 -133.18 -173.52 3.23 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.171 0.986 . . . . 0.0 110.764 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 67' ' ' LEU . 8.0 t -157.51 -4.02 0.1 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.12 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.586 HD21 ' CH2' ' A' ' 83' ' ' TRP . 21.9 tp 55.18 110.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.889 -1.132 . . . . 0.0 110.164 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.58 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.9 OUTLIER -55.92 -75.07 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.58 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.3 mt-10 -155.25 -169.15 3.07 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.309 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -145.86 126.66 14.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.261 -0.9 . . . . 0.0 109.55 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.529 HD23 ' ND2' ' A' ' 119' ' ' ASN . 0.7 OUTLIER -112.48 -169.29 1.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.131 -0.981 . . . . 0.0 109.49 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -146.64 140.82 26.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.917 . . . . 0.0 109.216 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.48 ' OH ' ' O ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -129.74 169.93 14.49 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.246 -0.909 . . . . 0.0 109.923 -179.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -161.05 113.6 1.92 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.583 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -79.23 175.2 4.99 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.086 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.583 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 1.4 Cg_endo -63.87 2.69 0.94 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.149 1.899 . . . . 0.0 111.88 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.82 -24.96 0.46 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.507 -1.371 . . . . 0.0 111.899 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -131.65 179.72 5.88 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.611 -1.305 . . . . 0.0 110.974 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.519 ' HB2' ' N ' ' A' ' 4' ' ' LEU . 1.1 m170 -119.11 135.41 54.66 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.533 ' CG2' HD12 ' A' ' 6' ' ' ILE . 22.8 mm -146.27 107.99 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.032 -1.043 . . . . 0.0 110.716 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.447 ' OG1' HD12 ' A' ' 4' ' ' LEU . 3.1 m -101.67 105.26 16.15 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.435 ' CD2' ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -79.89 131.66 35.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.962 -1.086 . . . . 0.0 110.41 -178.55 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.606 ' CD1' ' O ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -121.76 124.03 43.24 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -124.1 119.99 31.07 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.444 -1.41 . . . . 0.0 110.036 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.636 ' CZ3' ' CG1' ' A' ' 87' ' ' VAL . 18.5 p-90 -100.41 87.97 3.54 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.567 ' CD1' ' CD1' ' A' ' 10' ' ' ILE . 2.8 mm? -56.35 130.29 44.03 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.571 0.701 . . . . 0.0 110.474 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.636 ' CG1' ' CZ3' ' A' ' 85' ' ' TRP . 3.7 m -103.53 -170.85 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.475 -0.766 . . . . 0.0 109.322 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 1.0 OUTLIER -138.93 -36.09 0.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.914 -1.116 . . . . 0.0 110.643 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.596 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -142.72 178.88 7.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.051 -1.031 . . . . 0.0 109.906 -179.52 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.623 ' CE2' ' HG3' ' A' ' 94' ' ' PRO . 41.3 p90 168.68 168.47 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.628 1.204 . . . . 0.0 110.74 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.551 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 9.9 tt0 -125.9 99.17 5.82 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.905 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.472 ' O ' ' HD3' ' A' ' 94' ' ' PRO . . . 135.12 -169.25 23.4 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.558 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 0.7 OUTLIER -99.23 104.98 29.7 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.623 ' HG3' ' CE2' ' A' ' 90' ' ' TRP . 4.5 Cg_exo -55.73 178.5 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.257 1.971 . . . . 0.0 112.256 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.651 ' HB3' ' CG1' ' A' ' 58' ' ' VAL . 3.7 p-90 -125.58 -167.32 1.67 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.797 0.808 . . . . 0.0 109.468 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.35 -32.12 0.08 OUTLIER Glycine 0 N--CA 1.482 1.759 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.523 ' HG3' ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -126.0 -145.27 0.32 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -115.09 38.56 3.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.133 -0.979 . . . . 0.0 108.834 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.31 55.53 0.76 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.483 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -119.85 151.99 53.17 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.275 -1.132 . . . . 0.0 109.8 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -67.08 98.61 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.355 2.037 . . . . 0.0 110.339 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.52 ' HA2' ' CG2' ' A' ' 21' ' ' THR . . . -82.35 -171.35 46.44 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -147.46 123.44 10.71 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.957 -1.319 . . . . 0.0 109.471 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.483 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 26.8 m95 -77.99 84.2 4.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.039 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.528 ' CE ' HD13 ' A' ' 33' ' ' LEU . 12.6 ttp -80.46 148.55 30.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 0.0 109.224 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.52 160.7 6.68 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.119 -0.988 . . . . 0.0 109.976 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.549 ' O ' ' CD1' ' A' ' 107' ' ' LEU . 1.6 tm? -130.63 70.91 1.45 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.2 t -103.14 -43.7 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 109.78 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -139.95 50.91 0.75 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.529 ' CD1' HD12 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -42.79 141.61 1.05 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.424 -1.045 . . . . 0.0 109.732 -179.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.467 ' HB3' ' OD2' ' A' ' 113' ' ' ASP . 4.4 t30 -157.41 -173.88 4.62 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.466 -0.771 . . . . 0.0 108.995 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.529 ' CB ' HG23 ' A' ' 123' ' ' ILE . . . -80.77 -10.34 59.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.731 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -66.57 -37.58 85.25 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.067 -1.021 . . . . 0.0 110.637 -179.167 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.562 ' O ' ' CG ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER -96.85 27.7 3.84 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.968 -1.083 . . . . 0.0 109.483 -179.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.625 ' C ' ' CD ' ' A' ' 117' ' ' PRO . 0.5 OUTLIER -146.26 89.81 5.85 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.939 . . . . 0.0 109.207 179.593 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.558 ' N ' ' HD3' ' A' ' 117' ' ' PRO . 36.9 Cg_endo -98.93 36.18 0.09 OUTLIER 'Trans proline' 0 CA--C 1.556 1.6 0 C-N-CA 123.58 2.854 . . . . 0.0 115.941 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.625 ' CD ' ' C ' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -73.55 -1.05 10.14 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 121.686 1.591 . . . . 0.0 110.06 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 80.35 24.98 0.34 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.568 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 10.4 m120 -107.22 42.0 1.39 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.593 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.2 mt-10 -47.09 -44.12 47.22 Favored Pre-proline 0 C--N 1.296 -1.735 0 O-C-N 121.164 -0.96 . . . . 0.0 112.083 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 5.3 Cg_exo -61.88 -39.18 53.39 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.881 1.721 . . . . 0.0 112.562 -178.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 71' ' ' LEU . 1.6 t -90.23 -54.95 6.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 O-C-N 120.291 -1.506 . . . . 0.0 107.842 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.529 HG23 ' CB ' ' A' ' 112' ' ' ALA . 11.4 mm -43.84 -33.96 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.474 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -52.33 -52.94 50.38 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -42.86 98.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.51 -0.744 . . . . 0.0 109.787 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.574 HD23 ' CD2' ' A' ' 68' ' ' PHE . 1.9 mt -66.42 -5.32 10.51 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.104 -0.997 . . . . 0.0 110.328 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.482 ' CE ' ' HB1' ' A' ' 112' ' ' ALA . 22.3 mttt -56.41 -49.65 73.88 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.051 -1.031 . . . . 0.0 108.351 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 129' ' ' LEU . 11.6 mtp180 -90.3 34.89 0.86 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.451 -0.781 . . . . 0.0 108.984 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 126' ' ' LEU . 1.2 mt . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.893 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.423 ' HA ' ' HE3' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 1' ' ' MET . 34.5 mmtt 60.09 -114.74 0.67 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 0.0 109.334 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -166.72 146.87 5.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.706 -1.246 . . . . 0.0 109.84 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.456 HD13 HG22 ' A' ' 80' ' ' ILE . 2.6 pp -153.77 120.78 5.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 109.406 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.513 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . 26.1 mt-30 -133.01 150.61 52.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.201 -0.937 . . . . 0.0 109.853 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.577 ' O ' ' CD1' ' A' ' 83' ' ' TRP . 9.9 mt -121.76 167.15 15.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.357 -0.839 . . . . 0.0 109.495 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.548 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . -132.82 106.02 7.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -0.952 . . . . 0.0 109.543 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 36' ' ' PRO . 8.5 p -122.08 83.88 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.216 -0.927 . . . . 0.0 109.778 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.471 ' HA2' ' HB2' ' A' ' 85' ' ' TRP . . . -68.97 117.22 7.86 Favored Glycine 0 C--N 1.294 -1.786 0 N-CA-C 107.496 -2.242 . . . . 0.0 107.496 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.549 ' HB ' HD11 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -76.42 -172.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.071 -1.253 . . . . 0.0 107.688 -179.104 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.65 ' CD1' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -144.97 149.53 16.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 117.864 -1.534 . . . . 0.0 111.371 -176.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 17' ' ' GLU . 10.4 ttp180 -148.53 128.27 13.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.634 ' ND2' ' CH2' ' A' ' 90' ' ' TRP . 1.2 m-20 -98.07 -160.68 0.82 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.817 -1.177 . . . . 0.0 110.74 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -91.56 -6.05 53.04 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.393 0.616 . . . . 0.0 109.367 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.495 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 3.2 t-20 -85.21 14.5 5.13 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.48 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 13.6 t30 58.41 48.24 12.56 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.571 -0.706 . . . . 0.0 109.908 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 105' ' ' MET . 1.4 pt-20 -136.73 171.84 13.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.251 -0.906 . . . . 0.0 109.235 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.487 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 1.3 mt -125.35 157.67 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.932 . . . . 0.0 109.427 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.65 ' CD2' ' CD1' ' A' ' 11' ' ' ILE . 46.0 t80 -106.87 83.13 1.79 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.492 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -79.81 -173.68 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 120.988 -1.07 . . . . 0.0 110.163 -178.292 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.554 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -130.75 142.85 50.43 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.199 -0.601 . . . . 0.0 109.815 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.563 ' HG3' ' CD2' ' A' ' 33' ' ' LEU . 6.1 ttm180 -142.46 161.73 37.29 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.247 -0.908 . . . . 0.0 109.91 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.498 ' NH1' ' CG ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -85.43 56.54 4.0 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.421 -0.799 . . . . 0.0 109.527 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.414 ' O ' ' CB ' ' A' ' 25' ' ' ALA . . . 59.13 176.4 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.063 -1.023 . . . . 0.0 109.296 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 24' ' ' ALA . . . 69.03 -177.1 0.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 109.531 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -125.08 99.07 5.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.232 -0.918 . . . . 0.0 109.4 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.468 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . . . -66.61 129.85 41.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.871 . . . . 0.0 109.546 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -73.39 -149.3 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.257 -0.902 . . . . 0.0 109.402 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.6 mtp -65.01 -17.77 64.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 109.565 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.486 ' O ' ' CB ' ' A' ' 31' ' ' ASN . . . -104.53 -141.39 0.36 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -0.856 . . . . 0.0 109.456 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 0.4 OUTLIER 74.12 -163.97 0.09 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.072 -1.018 . . . . 0.0 109.569 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.56 139.28 34.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 109.881 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.574 ' HB2' ' CD1' ' A' ' 115' ' ' PHE . 25.3 mt -105.77 -174.3 2.5 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.379 -0.825 . . . . 0.0 108.943 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.492 ' O ' ' CD1' ' A' ' 20' ' ' ILE . 3.1 tt0 -161.39 -157.5 0.51 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.564 -1.335 . . . . 0.0 110.732 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.687 ' CZ ' ' CZ ' ' A' ' 115' ' ' PHE . 81.1 m-85 -152.65 152.51 28.85 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.522 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 2.0 Cg_endo -63.08 -151.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.17 1.913 . . . . 0.0 109.861 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 91.79 179.21 41.95 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.45 -40.59 0.05 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -167.19 169.85 12.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.18 -1.188 . . . . 0.0 109.765 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.513 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 14.1 tt -133.69 123.94 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.379 -0.825 . . . . 0.0 109.1 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -80.26 130.92 35.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 110.027 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 42' ' ' MET . 31.1 ttp -117.32 72.22 0.83 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 109.105 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.67 1.53 5.18 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -151.59 -71.1 0.16 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.114 -1.227 . . . . 0.0 110.026 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.484 ' OG1' ' HD2' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -154.62 168.19 12.44 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 120.904 -1.122 . . . . 0.0 109.776 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.484 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 2.1 Cg_endo -67.88 -27.93 36.62 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.786 2.324 . . . . 0.0 112.103 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.533 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 0.4 OUTLIER -78.56 -69.75 0.54 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.832 -1.167 . . . . 0.0 109.197 -179.208 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.671 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 12.7 tt0 -37.63 -34.66 0.11 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 122.938 1.352 . . . . 0.0 109.078 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.517 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -52.64 -67.72 0.23 Allowed 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.254 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.493 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 9.0 p -80.99 -43.87 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.096 -1.003 . . . . 0.0 111.274 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.671 ' CG1' ' HA ' ' A' ' 48' ' ' GLN . 2.3 p -43.6 -48.88 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.449 -0.782 . . . . 0.0 109.168 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 48' ' ' GLN . 1.2 ttt180 -81.39 -26.12 35.71 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.308 -0.87 . . . . 0.0 110.506 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.517 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 3.4 mm-40 -72.88 -67.23 0.58 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.748 -1.22 . . . . 0.0 110.674 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.651 ' CB ' ' CE2' ' A' ' 95' ' ' TRP . 14.1 mt -54.06 -38.18 64.99 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.303 -0.873 . . . . 0.0 110.726 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.488 ' O ' ' HA2' ' A' ' 59' ' ' GLY . 3.7 pt20 -67.89 -32.12 72.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.971 -1.08 . . . . 0.0 110.075 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.493 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 1.3 pt-20 -78.59 -4.7 50.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.878 -1.139 . . . . 0.0 109.596 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.34 -49.19 5.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.174 -0.954 . . . . 0.0 109.538 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.538 HG12 ' CA ' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -114.04 -30.07 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.182 -0.949 . . . . 0.0 108.49 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 55' ' ' GLN . . . 74.25 90.2 0.17 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.445 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.678 ' CG2' ' O ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -114.54 170.53 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.367 -1.078 . . . . 0.0 108.48 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.685 ' CB ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -118.17 -70.4 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.807 -1.183 . . . . 0.0 109.596 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.685 ' HD3' ' CB ' ' A' ' 61' ' ' THR . 10.0 Cg_endo -74.73 40.69 0.65 Allowed 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 122.006 1.804 . . . . 0.0 111.325 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 0.9 OUTLIER -81.68 59.07 4.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 109.783 -179.219 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -65.62 126.54 28.7 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.559 ' CB ' ' HA ' ' A' ' 87' ' ' VAL . 4.0 p90 -146.63 -177.42 5.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.738 -1.226 . . . . 0.0 111.755 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.4 m -161.77 143.53 11.33 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 36.8 tp -71.49 97.13 1.6 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.604 -1.31 . . . . 0.0 109.792 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.666 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -44.79 -77.96 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.666 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -158.94 125.19 4.53 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -90.57 151.96 21.1 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.141 -0.974 . . . . 0.0 110.112 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.54 ' CD2' ' HB ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -116.43 -167.25 1.25 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -160.04 161.9 34.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.896 -1.128 . . . . 0.0 110.275 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -154.46 127.22 8.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.493 -0.754 . . . . 0.0 109.205 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -99.88 122.26 42.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 109.735 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.547 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -84.01 177.97 2.68 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 3.9 Cg_exo -56.71 -10.4 5.28 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.828 1.686 . . . . 0.0 111.736 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -161.7 -3.3 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.728 -1.232 . . . . 0.0 112.484 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.488 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -128.1 -172.38 2.67 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.212 -1.555 . . . . 0.0 110.041 -179.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -132.03 91.94 3.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.395 -0.816 . . . . 0.0 109.613 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.456 HG22 HD13 ' A' ' 4' ' ' LEU . 11.4 mt -81.84 102.5 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 109.462 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.23 126.05 52.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.738 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.458 HD23 HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -120.31 150.04 41.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.29 -0.881 . . . . 0.0 109.073 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.577 ' CD1' ' O ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -120.06 149.04 42.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.054 -1.029 . . . . 0.0 109.574 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.566 ' CG ' HG12 ' A' ' 122' ' ' VAL . 6.5 m-85 -113.35 94.41 4.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.222 -0.924 . . . . 0.0 109.221 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.471 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 77.7 m95 -88.51 90.37 8.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.043 -1.036 . . . . 0.0 108.948 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.549 HD11 ' HB ' ' A' ' 10' ' ' ILE . 10.7 tp -79.28 117.45 20.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.478 -0.763 . . . . 0.0 109.442 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.561 HG23 ' CG2' ' A' ' 11' ' ' ILE . 3.1 m -88.46 -161.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 O-C-N 121.213 -0.93 . . . . 0.0 110.33 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 20.7 mt-10 -147.67 -33.97 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.987 . . . . 0.0 111.231 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -147.21 164.39 33.32 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.658 -1.276 . . . . 0.0 110.479 -179.134 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.634 ' CH2' ' ND2' ' A' ' 13' ' ' ASN . 13.6 p90 179.19 171.44 0.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 122.029 0.918 . . . . 0.0 109.644 178.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.539 ' O ' ' C ' ' A' ' 92' ' ' GLY . 77.2 tt0 -116.34 -92.86 0.51 Allowed 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.509 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . -23.76 -91.47 0.01 OUTLIER Glycine 0 N--CA 1.499 2.866 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.678 ' O ' ' CG2' ' A' ' 60' ' ' ILE . 1.6 mt-10 -131.19 166.09 30.34 Favored Pre-proline 0 C--O 1.188 -2.138 0 O-C-N 121.647 -0.913 . . . . 0.0 108.862 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.616 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 6.1 Cg_exo -36.7 -93.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.281 -3.023 0 C-N-CA 123.106 2.537 . . . . 0.0 112.091 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.651 ' CE2' ' CB ' ' A' ' 54' ' ' LEU . 4.0 t90 171.03 -21.6 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.132 -0.98 . . . . 0.0 111.265 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.481 ' HA3' ' CB ' ' A' ' 36' ' ' PRO . . . -107.21 -101.21 2.7 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.469 -1.348 . . . . 0.0 109.821 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.477 ' N ' ' HB3' ' A' ' 36' ' ' PRO . 3.0 tttt 41.07 94.12 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.493 -1.004 . . . . 0.0 110.215 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -116.52 52.56 0.92 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.88 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.57 2.35 53.2 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -124.61 123.34 25.73 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.205 -1.173 . . . . 0.0 109.701 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -60.85 111.4 1.05 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.939 1.759 . . . . 0.0 109.899 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -93.41 -179.81 39.34 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -138.07 161.18 37.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.073 -1.251 . . . . 0.0 111.137 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.464 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 34.7 m0 -94.73 93.37 7.48 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.526 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -82.45 -173.89 4.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.016 -1.052 . . . . 0.0 109.674 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.05 160.77 15.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.891 . . . . 0.0 109.153 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 1.8 tp -108.9 45.84 1.01 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.145 -0.972 . . . . 0.0 109.795 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 108' ' ' VAL . 18.2 t -103.39 19.06 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.082 -1.011 . . . . 0.0 108.83 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 132.82 74.05 0.1 OUTLIER Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.466 ' HG ' HD13 ' A' ' 18' ' ' ILE . 2.7 mt -43.49 138.77 2.33 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.372 -1.075 . . . . 0.0 109.626 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.44 98.79 11.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.439 -0.788 . . . . 0.0 109.777 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.525 ' CB ' HG21 ' A' ' 123' ' ' ILE . . . -64.59 -21.76 66.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 108.971 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -68.6 -27.79 66.36 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.488 -0.758 . . . . 0.0 109.506 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.498 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 2.8 t0 -78.43 -9.99 59.52 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.687 ' CZ ' ' CZ ' ' A' ' 35' ' ' PHE . 11.0 m-85 -94.03 154.98 40.59 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 108.83 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.53 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 1.2 Cg_endo -71.42 144.7 46.06 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.994 1.796 . . . . 0.0 110.211 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.522 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 1.2 Cg_endo -64.71 112.71 2.06 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.341 2.028 . . . . 0.0 110.41 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 162.35 -22.56 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 109.84 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.551 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 0.7 OUTLIER -119.76 45.25 2.2 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.092 -1.005 . . . . 0.0 109.314 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.68 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 7.1 mt-10 -68.87 -32.77 3.7 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.5 Cg_exo -58.83 -38.78 86.8 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.409 1.406 . . . . 0.0 111.992 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.566 HG12 ' CG ' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -104.37 -38.06 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 120.434 -1.416 . . . . 0.0 108.784 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.551 ' CG1' ' O ' ' A' ' 119' ' ' ASN . 7.4 mm -55.25 -38.81 48.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.471 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -55.32 -46.27 76.32 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.522 -0.736 . . . . 0.0 109.292 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -66.85 -33.92 76.67 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.424 -0.798 . . . . 0.0 109.563 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.499 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 4.2 mp -54.32 -25.78 25.84 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.192 -0.942 . . . . 0.0 109.551 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.476 ' HE2' ' HB2' ' A' ' 112' ' ' ALA . 33.7 mttt -58.2 -49.45 77.0 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.454 ' O ' ' C ' ' A' ' 129' ' ' LEU . 6.5 mtp180 -84.62 -1.47 56.05 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.699 -0.625 . . . . 0.0 109.532 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.523 HD23 ' CD2' ' A' ' 86' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.824 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.519 ' CE ' ' O ' ' A' ' 77' ' ' ASP . 10.2 mtm . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -70.22 -82.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.968 -1.083 . . . . 0.0 109.231 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.639 ' N ' ' CE1' ' A' ' 79' ' ' HIS . 0.0 OUTLIER 176.87 117.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.467 -0.77 . . . . 0.0 110.031 179.46 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.479 ' O ' ' HG3' ' A' ' 5' ' ' GLN . 14.8 tp -97.23 155.87 16.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.325 -0.86 . . . . 0.0 108.885 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.541 ' HG2' ' CZ2' ' A' ' 83' ' ' TRP . 0.9 OUTLIER -145.35 128.38 16.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.041 -1.037 . . . . 0.0 110.834 -179.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.588 ' O ' ' CD1' ' A' ' 83' ' ' TRP . 5.3 mm -102.93 -163.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.319 -0.863 . . . . 0.0 108.807 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.461 ' HB3' HG13 ' A' ' 40' ' ' ILE . . . -144.86 117.29 8.52 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.739 -1.225 . . . . 0.0 110.605 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.611 ' CG2' ' O ' ' A' ' 35' ' ' PHE . 3.2 p -133.45 129.74 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.108 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.578 ' CA ' ' NE1' ' A' ' 85' ' ' TRP . . . -117.04 119.32 4.43 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.62 ' CD1' ' CD1' ' A' ' 86' ' ' LEU . 1.2 mt -96.98 159.16 3.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.265 -1.138 . . . . 0.0 108.781 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.613 ' CD1' ' CB ' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -154.24 146.62 13.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 108.822 -178.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.519 ' HB2' HG22 ' A' ' 18' ' ' ILE . 20.9 ttp180 -157.96 84.26 0.87 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.406 -0.809 . . . . 0.0 110.626 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.566 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 10.9 m-80 -160.59 179.46 8.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.924 -1.11 . . . . 0.0 109.662 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 2.9 mm-40 81.44 -68.94 0.09 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.888 0.851 . . . . 0.0 109.219 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.474 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 38.4 t-20 -111.15 22.94 14.67 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.431 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 23.4 t-20 49.71 47.52 22.78 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 15' ' ' ASN . 3.7 mt-10 -140.69 147.61 39.52 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.5 mt -96.97 151.94 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.904 -1.123 . . . . 0.0 110.56 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -100.07 76.96 1.96 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.574 HD12 ' CE1' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -79.7 -178.02 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.952 0.882 . . . . 0.0 110.611 -177.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.527 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -114.3 137.17 52.13 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.034 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.428 ' HG3' ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -125.88 133.55 51.88 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.963 -1.086 . . . . 0.0 109.683 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.498 ' CZ ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -49.1 102.09 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.398 -0.814 . . . . 0.0 110.221 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 44.71 -154.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.448 -0.782 . . . . 0.0 109.951 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.7 -79.09 0.21 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.912 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -83.35 169.4 15.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.027 -1.046 . . . . 0.0 109.647 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.498 ' HB1' ' CZ ' ' A' ' 23' ' ' ARG . . . -115.18 163.92 14.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.738 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -93.04 68.96 4.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.214 -0.929 . . . . 0.0 109.344 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.418 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 5.1 mtt 57.28 60.88 2.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 109.572 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 29' ' ' MET . . . 169.77 115.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.343 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.432 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 36.1 m120 -77.0 120.92 22.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 109.355 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -146.6 126.85 13.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.172 -0.955 . . . . 0.0 109.488 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.515 ' O ' ' CG ' ' A' ' 116' ' ' PRO . 7.2 mt -93.45 -165.17 1.28 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.436 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -149.53 -163.86 1.89 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.68 -1.263 . . . . 0.0 110.194 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.615 ' CZ ' ' CZ ' ' A' ' 115' ' ' PHE . 6.5 m-85 -162.25 -66.62 0.01 OUTLIER Pre-proline 0 C--N 1.292 -1.909 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.769 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 35' ' ' PHE . 15.3 Cg_exo -40.26 153.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.775 1.65 . . . . 0.0 110.467 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.98 -86.59 1.69 Allowed Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -117.18 -61.07 0.31 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 170.93 175.84 0.06 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.179 -1.189 . . . . 0.0 110.069 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.544 ' O ' ' CG2' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -144.25 102.4 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.53 -3.43 5.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.971 -1.081 . . . . 0.0 109.725 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.429 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 1.2 mpt? -53.06 -27.36 19.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.0 108.976 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.48 15.97 26.92 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 42' ' ' MET . 45.3 mm-40 -86.32 -80.68 0.23 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.539 -0.977 . . . . 0.0 109.782 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.583 ' CB ' ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -148.51 177.5 1.77 Allowed Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 120.949 -1.094 . . . . 0.0 109.968 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 45' ' ' THR . 6.3 Cg_endo -73.77 -40.24 1.51 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.694 2.263 . . . . 0.0 111.063 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.01 -52.85 5.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.324 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.535 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 2.1 tt0 -45.01 -29.1 0.78 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 122.441 1.115 . . . . 0.0 110.026 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . -72.86 -59.84 2.52 Favored 'General case' 0 C--N 1.271 -2.834 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.576 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.56 HG23 ' CE2' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -81.82 -3.08 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.016 -1.052 . . . . 0.0 111.029 -178.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 4.5 p -81.8 -45.3 20.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.571 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -70.64 -28.57 64.91 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.168 177.515 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.56 ' O ' ' NE1' ' A' ' 95' ' ' TRP . 3.0 mt-10 -76.6 -17.81 58.99 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.594 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.585 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 5.7 mt -71.1 -54.96 9.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.482 -0.761 . . . . 0.0 110.432 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.485 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -82.64 -37.11 25.37 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.705 -1.247 . . . . 0.0 111.355 -178.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -80.66 35.03 0.34 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.722 -1.236 . . . . 0.0 111.52 -178.36 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 1.1 mm-40 -149.8 -58.23 0.19 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.581 -1.324 . . . . 0.0 110.098 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.637 ' CG1' ' CD1' ' A' ' 95' ' ' TRP . 5.2 p -123.07 -10.75 7.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.287 -0.883 . . . . 0.0 108.677 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 60.84 73.09 0.53 Allowed Glycine 0 N--CA 1.486 1.98 0 O-C-N 121.775 -0.578 . . . . 0.0 112.901 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.552 HD13 ' CD2' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -112.26 179.97 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.289 -1.124 . . . . 0.0 108.428 177.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 47.2 m -131.34 86.88 48.95 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.461 ' HG3' ' CD1' ' A' ' 54' ' ' LEU . 1.0 OUTLIER -59.72 129.04 29.07 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.107 1.871 . . . . 0.0 110.572 -177.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.456 ' HG3' ' HB3' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -83.69 -37.58 22.57 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.499 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 65' ' ' PHE . 0.8 OUTLIER -168.47 51.6 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.779 -1.2 . . . . 0.0 111.49 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.575 ' CB ' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -46.75 173.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.601 -1.312 . . . . 0.0 109.475 179.19 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -161.26 157.14 25.1 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.565 -0.709 . . . . 0.0 109.651 179.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 50.0 tp -112.01 92.85 4.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.186 -0.946 . . . . 0.0 109.19 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.7 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -53.76 -59.52 4.51 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.605 0.717 . . . . 0.0 109.635 -179.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.7 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.8 tp10 -168.28 141.41 3.1 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.643 -0.66 . . . . 0.0 110.032 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.425 ' HG3' ' HA ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -121.14 138.94 53.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.426 -0.796 . . . . 0.0 109.008 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.503 ' CD1' ' C ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -109.88 -171.49 1.85 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.078 -1.014 . . . . 0.0 109.941 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -143.83 175.04 10.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.472 -0.767 . . . . 0.0 108.971 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 80' ' ' ILE . 1.6 t80 -150.13 163.44 38.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.934 -1.103 . . . . 0.0 110.155 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.0 tt0 -142.45 109.14 5.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.409 -0.807 . . . . 0.0 109.19 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.603 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -78.83 173.52 7.57 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.066 -1.021 . . . . 0.0 108.901 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.603 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 5.7 Cg_exo -51.4 -26.07 20.24 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.723 1.615 . . . . 0.0 109.543 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.519 ' O ' ' CE ' ' A' ' 1' ' ' MET . 30.1 t0 -148.16 2.22 0.66 Allowed 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.888 -0.508 . . . . 0.0 110.071 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.473 ' HG3' ' HB3' ' A' ' 75' ' ' PHE . 4.8 mtp180 -122.68 -161.58 0.96 Allowed 'General case' 0 C--N 1.31 -1.142 0 O-C-N 120.9 -1.125 . . . . 0.0 109.547 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.639 ' CE1' ' N ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -162.01 109.46 1.37 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.005 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 73' ' ' TYR . 25.2 mm -99.3 124.85 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.031 -1.043 . . . . 0.0 110.038 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.476 ' HB ' ' HG3' ' A' ' 5' ' ' GLN . 67.6 m -130.08 116.51 18.61 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.544 ' CD1' ' CG1' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -107.98 153.52 22.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.068 -1.02 . . . . 0.0 110.229 -179.135 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.596 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 3.2 m95 -110.54 118.17 35.51 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.587 ' CD2' HG12 ' A' ' 122' ' ' VAL . 4.1 m-85 -99.97 70.71 1.61 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.123 -0.986 . . . . 0.0 109.362 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.578 ' NE1' ' CA ' ' A' ' 9' ' ' GLY . 46.5 p-90 -80.28 84.18 5.99 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.138 -1.425 . . . . 0.0 108.889 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.62 ' CD1' ' CD1' ' A' ' 10' ' ' ILE . 1.6 tp -64.1 121.51 14.35 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.152 0.501 . . . . 0.0 109.918 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.575 ' HB ' ' CB ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -102.96 161.59 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 119.095 -1.042 . . . . 0.0 108.986 179.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.46 ' N ' ' CG2' ' A' ' 87' ' ' VAL . 9.0 pm0 -118.35 -24.0 7.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.919 . . . . 0.0 110.768 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.456 ' HB3' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -146.81 152.88 39.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.807 -1.183 . . . . 0.0 110.56 -179.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.566 ' CZ3' ' HB2' ' A' ' 13' ' ' ASN . 28.2 p90 -168.64 -173.41 1.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.842 0.829 . . . . 0.0 109.367 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.496 ' HB3' ' HB ' ' A' ' 61' ' ' THR . 9.4 tt0 -137.18 113.63 10.13 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.357 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' ' 94' ' ' PRO . . . 106.65 169.45 22.64 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.6 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -79.13 115.0 49.41 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.296 -1.12 . . . . 0.0 108.935 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.613 ' CB ' ' CD1' ' A' ' 11' ' ' ILE . 5.5 Cg_endo -73.77 177.03 8.59 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.672 2.248 . . . . 0.0 112.571 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.637 ' CD1' ' CG1' ' A' ' 58' ' ' VAL . 3.1 p-90 -115.1 -163.01 0.85 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.407 ' N ' ' HE3' ' A' ' 95' ' ' TRP . . . 179.61 -32.7 0.06 OUTLIER Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HG3' HG23 ' A' ' 21' ' ' THR . 0.3 OUTLIER -129.2 -163.96 1.35 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 9.9 pt-20 -55.15 -46.13 75.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.956 -1.09 . . . . 0.0 108.554 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . -124.84 -129.73 3.42 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.64 ' N ' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -125.24 42.78 0.79 Allowed Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.01 -1.288 . . . . 0.0 110.971 179.191 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.64 ' HD3' ' N ' ' A' ' 100' ' ' GLN . 6.2 Cg_endo -67.56 -12.9 37.25 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 C-N-CA 121.471 1.448 . . . . 0.0 110.011 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -61.09 179.84 3.05 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -141.99 160.93 39.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.076 -1.249 . . . . 0.0 110.3 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -89.03 103.49 16.1 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.394 -0.817 . . . . 0.0 109.576 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 13.9 ttm -87.44 129.51 35.02 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.306 -0.871 . . . . 0.0 109.515 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.475 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -92.96 72.67 4.76 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.314 -0.867 . . . . 0.0 109.452 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.0 tp 49.85 50.92 17.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.134 -0.979 . . . . 0.0 109.565 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 106' ' ' SER . 29.3 t -139.2 101.3 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.261 -0.9 . . . . 0.0 109.473 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.478 ' HA3' ' HB2' ' A' ' 114' ' ' ASP . . . 92.99 17.24 44.5 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.516 ' CD1' ' O ' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -62.64 -18.03 61.49 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.296 -1.12 . . . . 0.0 108.987 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.504 ' ND2' ' HD3' ' A' ' 127' ' ' LYS . 10.2 m-20 -78.3 178.33 7.74 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.738 -0.601 . . . . 0.0 109.461 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.566 ' CB ' HG23 ' A' ' 123' ' ' ILE . . . -67.51 -6.85 21.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.47 -53.03 60.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.249 -0.907 . . . . 0.0 110.11 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.478 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -79.33 -12.78 59.93 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.1 -1.0 . . . . 0.0 108.817 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.615 ' CZ ' ' CZ ' ' A' ' 35' ' ' PHE . 12.8 m-85 -94.59 140.41 22.63 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.515 ' CG ' ' O ' ' A' ' 33' ' ' LEU . 5.7 Cg_exo -63.31 148.4 92.93 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.99 1.794 . . . . 0.0 110.037 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.53 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 3.9 Cg_exo -58.87 118.61 5.52 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.13 1.886 . . . . 0.0 110.33 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 162.37 -24.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.491 -0.756 . . . . 0.0 109.132 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.533 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 0.9 OUTLIER -123.14 43.97 2.8 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.307 -0.871 . . . . 0.0 109.732 -179.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.678 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 7.0 mt-10 -66.34 -39.14 24.74 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 112.161 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 2.9 Cg_endo -64.51 -34.55 52.63 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 122.117 1.878 . . . . 0.0 112.371 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.587 HG12 ' CD2' ' A' ' 84' ' ' PHE . 1.1 t -93.76 -50.04 12.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.585 HD13 ' CD2' ' A' ' 115' ' ' PHE . 8.8 mm -49.53 -33.73 7.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.486 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -53.24 -47.11 69.32 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -66.73 -28.76 68.67 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.322 -0.861 . . . . 0.0 109.524 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.518 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 11.4 mt -70.74 -10.69 60.01 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.143 -0.973 . . . . 0.0 109.646 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.504 ' HD3' ' ND2' ' A' ' 111' ' ' ASN . 1.3 mmtp -56.76 -52.92 63.14 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.251 -0.906 . . . . 0.0 109.195 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -98.42 26.76 5.21 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.406 -0.809 . . . . 0.0 109.049 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.518 ' CD1' ' HA ' ' A' ' 126' ' ' LEU . 2.4 tp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.558 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.453 ' HE1' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.93 176.65 5.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.299 -0.875 . . . . 0.0 109.348 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.77 136.15 47.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.525 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -105.56 95.34 5.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.243 -0.911 . . . . 0.0 109.306 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.481 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 7.0 mt-30 -96.42 114.03 25.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.229 -0.92 . . . . 0.0 109.509 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.477 ' O ' HD11 ' A' ' 40' ' ' ILE . 3.1 mm -99.42 -175.99 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.248 -0.908 . . . . 0.0 109.231 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.543 ' HA ' ' CD1' ' A' ' 83' ' ' TRP . . . -149.39 101.83 3.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.719 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.513 ' O ' HG11 ' A' ' 8' ' ' VAL . 10.2 p -108.51 135.06 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.154 -0.966 . . . . 0.0 108.538 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.28 106.56 1.43 Allowed Glycine 0 N--CA 1.484 1.87 0 C-N-CA 119.372 -1.394 . . . . 0.0 109.696 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.582 ' CD1' ' CD1' ' A' ' 86' ' ' LEU . 1.7 mt -82.89 143.99 10.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.598 HG21 ' CZ3' ' A' ' 90' ' ' TRP . 1.8 mt -131.51 128.97 61.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.819 -177.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 88' ' ' GLU . 5.9 ttp180 -139.75 125.99 20.04 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.464 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 6.0 p30 -118.72 -167.16 1.33 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.983 . . . . 0.0 109.985 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -71.64 -2.39 17.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 109.944 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.459 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 1.5 t30 -79.78 5.66 12.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.176 -0.952 . . . . 0.0 109.136 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.467 ' OD1' ' HB ' ' A' ' 108' ' ' VAL . 22.6 t30 54.95 46.57 24.07 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.264 -0.898 . . . . 0.0 109.619 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 4.5 mt-10 -146.5 133.63 20.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 108.892 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -102.16 160.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.221 -0.924 . . . . 0.0 108.801 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 25.8 t80 -118.55 82.03 1.78 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.922 -1.111 . . . . 0.0 108.565 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.44 ' C ' ' HE3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -121.04 -160.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.556 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -117.31 138.48 51.73 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.39 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.49 ' CG ' ' OD1' ' A' ' 31' ' ' ASN . 4.9 ttp180 -133.95 121.49 21.73 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.288 -0.882 . . . . 0.0 109.465 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.584 ' O ' ' CG ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -50.79 106.4 0.13 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.248 -0.907 . . . . 0.0 109.164 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.32 109.98 0.99 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.984 -1.073 . . . . 0.0 109.45 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 27' ' ' ALA . . . -170.0 60.83 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.167 -0.958 . . . . 0.0 109.528 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 28' ' ' HIS . 67.5 m-20 53.39 -90.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.179 -0.951 . . . . 0.0 109.477 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.591 ' CB ' ' ND2' ' A' ' 31' ' ' ASN . . . 43.14 -92.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.408 -0.808 . . . . 0.0 109.727 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.54 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER 78.69 135.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.368 -0.832 . . . . 0.0 109.412 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 28' ' ' HIS . 7.4 mtt 65.56 -92.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.327 -0.858 . . . . 0.0 109.406 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.47 95.55 9.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.234 -0.916 . . . . 0.0 109.283 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.591 ' ND2' ' CB ' ' A' ' 27' ' ' ALA . 3.0 t-20 -130.74 175.29 9.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.588 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HB3' ' HG3' ' A' ' 116' ' ' PRO . 6.8 mmmt -95.29 125.03 39.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.641 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.581 HD11 ' CE2' ' A' ' 115' ' ' PHE . 56.5 mt -107.8 -174.59 2.56 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -160.69 -162.11 0.91 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.027 -1.045 . . . . 0.0 110.878 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.694 ' CZ ' ' CE1' ' A' ' 115' ' ' PHE . 65.5 m-85 -155.18 69.27 5.51 Favored Pre-proline 0 C--N 1.295 -1.788 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.522 ' CD ' ' OG1' ' A' ' 21' ' ' THR . 2.4 Cg_endo -61.74 -81.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.173 1.915 . . . . 0.0 110.409 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 100.49 -150.02 18.74 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -139.8 24.15 2.75 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 2.5 mptt 70.25 148.2 0.07 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -1.143 . . . . 0.0 110.034 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.654 ' CD1' ' CZ2' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -101.57 119.27 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.459 ' O ' ' C ' ' A' ' 42' ' ' MET . 0.6 OUTLIER -79.06 -159.58 0.19 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.008 -1.058 . . . . 0.0 108.845 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.459 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -42.04 -52.78 4.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.372 -0.83 . . . . 0.0 108.997 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 42' ' ' MET . . . 58.38 122.77 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.236 -1.145 . . . . 0.0 110.236 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -106.53 -9.72 16.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -1.106 . . . . 0.0 108.785 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.506 ' OG1' ' HD2' ' A' ' 46' ' ' PRO . 0.5 OUTLIER -160.55 171.54 6.98 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.506 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 3.7 Cg_exo -61.36 -37.2 74.16 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.294 1.996 . . . . 0.0 111.706 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.494 ' O ' HG11 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -86.45 -56.98 3.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.809 -1.182 . . . . 0.0 109.583 -179.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.547 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 1.7 tt0 -38.13 -32.28 0.06 Allowed 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.252 1.025 . . . . 0.0 110.049 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 47' ' ' GLU . . . -64.82 -65.29 0.69 Allowed 'General case' 0 C--N 1.272 -2.797 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.66 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.523 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 1.2 p -81.21 -45.45 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.898 -1.126 . . . . 0.0 110.301 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 6.1 p -40.62 -47.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.653 -0.654 . . . . 0.0 109.332 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.558 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -74.61 -34.57 62.85 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.498 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 2.4 mt-10 -60.07 -19.95 55.65 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.903 -1.123 . . . . 0.0 108.363 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.631 ' CD2' ' CH2' ' A' ' 95' ' ' TRP . 13.8 mt -75.31 -68.61 0.54 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.197 0.522 . . . . 0.0 110.381 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.41 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 2.4 pt20 -61.3 -28.62 69.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.775 -1.203 . . . . 0.0 111.637 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.498 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 1.2 pp20? -72.88 1.02 9.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.701 -1.249 . . . . 0.0 109.56 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.416 ' HB3' ' HD1' ' A' ' 95' ' ' TRP . 3.5 mm-40 -143.78 -68.74 0.33 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.415 -0.803 . . . . 0.0 109.96 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.667 ' CG1' ' CG ' ' A' ' 95' ' ' TRP . 2.4 p -111.55 -54.59 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.691 -1.255 . . . . 0.0 107.62 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.585 ' N ' ' CG1' ' A' ' 58' ' ' VAL . . . 81.84 47.2 6.36 Favored Glycine 0 N--CA 1.479 1.567 0 O-C-N 121.438 -0.789 . . . . 0.0 113.86 175.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.558 ' O ' ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -79.68 124.53 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 120.12 1.96 . . . . 0.0 106.403 176.362 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.645 ' N ' ' CD ' ' A' ' 62' ' ' PRO . 8.4 t -149.26 23.77 0.04 OUTLIER Pre-proline 0 C--N 1.279 -2.5 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 61' ' ' THR . 2.2 Cg_endo -62.35 -47.15 10.37 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 CA-C-N 120.072 1.061 . . . . 0.0 109.725 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 89' ' ' ARG . 1.2 pt20 -162.88 -31.24 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.962 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.612 ' CG ' ' O ' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -42.76 113.73 0.5 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 122.214 1.007 . . . . 0.0 112.962 -177.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.409 ' CB ' ' O ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER 171.74 130.58 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.159 -0.963 . . . . 0.0 110.044 177.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -163.67 -35.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 110.574 179.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.583 HD11 ' CG ' ' A' ' 85' ' ' TRP . 37.7 tp 39.35 96.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.765 0.793 . . . . 0.0 109.273 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.61 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 30.2 p90 -66.62 -54.03 27.74 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.446 -0.784 . . . . 0.0 110.705 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.61 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER 178.35 134.11 0.08 Allowed 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.247 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.545 ' CB ' ' HB3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -94.69 168.55 10.76 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.498 -0.751 . . . . 0.0 109.79 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.516 ' CD2' ' HB ' ' A' ' 122' ' ' VAL . 1.2 pp -126.41 -166.53 1.59 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.096 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -160.0 142.62 13.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 109.625 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.407 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -130.03 96.12 4.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.343 -0.848 . . . . 0.0 109.41 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.434 ' HG2' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -84.15 109.39 17.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.4 -0.813 . . . . 0.0 109.297 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.571 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -79.63 179.63 1.76 Allowed Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.571 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 6.0 Cg_endo -75.81 40.76 0.75 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.329 2.019 . . . . 0.0 111.198 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.453 ' O ' ' HE1' ' A' ' 1' ' ' MET . 0.1 OUTLIER 172.3 -25.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.712 -1.243 . . . . 0.0 110.214 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.5 ' HG2' ' NH1' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -124.44 170.45 10.84 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 109.977 -178.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.434 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 6.1 m80 -126.01 92.11 3.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.438 -0.789 . . . . 0.0 108.969 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.417 ' CD1' HD13 ' A' ' 4' ' ' LEU . 27.1 mm -79.4 137.19 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.29 -0.881 . . . . 0.0 109.503 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.54 84.52 1.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.299 -0.876 . . . . 0.0 109.454 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.476 ' O ' HD11 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -108.09 158.58 17.28 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.348 -0.845 . . . . 0.0 109.407 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.654 ' CZ2' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -131.03 151.91 50.9 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.964 -1.085 . . . . 0.0 110.75 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.618 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -119.71 120.98 38.18 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.583 ' CG ' HD11 ' A' ' 67' ' ' LEU . 10.9 m95 -96.4 98.09 9.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.002 -1.061 . . . . 0.0 110.202 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.582 ' CD1' ' CD1' ' A' ' 10' ' ' ILE . 1.0 OUTLIER -68.61 89.5 0.37 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.539 HG22 ' CG2' ' A' ' 11' ' ' ILE . 0.9 OUTLIER -60.52 174.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.633 0.73 . . . . 0.0 110.533 -178.106 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' A' ' 12' ' ' ARG . 11.0 mm-40 -97.05 -72.29 0.65 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.049 -0.661 . . . . 0.0 109.371 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -159.2 148.85 18.77 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.614 ' HA ' ' HG2' ' A' ' 62' ' ' PRO . 3.7 p90 -136.95 -171.41 2.93 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.833 -1.167 . . . . 0.0 111.243 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.507 ' H ' ' CG ' ' A' ' 62' ' ' PRO . 15.6 tt0 -128.88 -33.69 2.0 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.68 -134.82 0.11 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.539 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 1.0 OUTLIER -121.66 132.51 24.21 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.197 -1.178 . . . . 0.0 110.156 -179.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.537 ' CB ' HD13 ' A' ' 11' ' ' ILE . 2.4 Cg_endo -71.82 119.53 6.27 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.581 2.187 . . . . 0.0 109.814 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.667 ' CG ' ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -126.31 38.64 4.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.02 -1.05 . . . . 0.0 112.923 -177.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -49.71 -20.42 2.79 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.464 ' HD2' ' HG2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.73 -171.9 1.94 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.422 -1.046 . . . . 0.0 109.912 -179.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -141.5 -41.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.441 -0.787 . . . . 0.0 109.045 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.28 23.87 1.1 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.426 ' CB ' ' CD ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -102.61 172.05 4.67 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.417 -1.049 . . . . 0.0 109.639 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' A' ' 102' ' ' GLY . 4.9 Cg_endo -70.88 5.54 2.08 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.538 2.159 . . . . 0.0 111.443 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -39.77 146.91 0.23 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 9.8 pt-20 -161.33 -171.51 3.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.614 -0.933 . . . . 0.0 110.434 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.563 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 20.6 m0 -94.53 100.56 12.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.569 -0.707 . . . . 0.0 109.772 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -84.42 -163.17 0.76 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.142 -0.974 . . . . 0.0 108.908 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.58 103.21 4.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.315 -0.865 . . . . 0.0 109.369 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.515 ' O ' HG11 ' A' ' 108' ' ' VAL . 18.4 mt -139.57 -78.28 0.32 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.527 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 0.4 OUTLIER 67.53 25.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.002 0.906 . . . . 0.0 108.814 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 178.39 44.74 0.07 OUTLIER Glycine 0 N--CA 1.485 1.902 0 N-CA-C 107.187 -2.365 . . . . 0.0 107.187 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.52 ' CD2' ' OD1' ' A' ' 114' ' ' ASP . 1.1 mt -36.42 153.69 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 O-C-N 122.103 -0.645 . . . . 0.0 109.886 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.508 ' O ' ' HE2' ' A' ' 127' ' ' LYS . 0.7 OUTLIER -134.81 9.01 3.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.139 -0.976 . . . . 0.0 109.667 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 111' ' ' ASN . . . 73.91 -9.94 1.17 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.062 -1.024 . . . . 0.0 110.47 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -74.71 -42.1 58.97 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.833 -1.167 . . . . 0.0 109.101 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' CD2' ' A' ' 110' ' ' LEU . 3.4 p30 -78.62 0.61 25.73 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.694 ' CE1' ' CZ ' ' A' ' 35' ' ' PHE . 10.1 m-85 -120.0 106.29 41.44 Favored Pre-proline 0 N--CA 1.485 1.323 0 O-C-N 121.441 -0.787 . . . . 0.0 109.073 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 115' ' ' PHE . 35.4 Cg_exo -40.17 152.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.281 1.988 . . . . 0.0 110.71 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.558 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 5.9 Cg_exo -56.19 -160.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.622 2.215 . . . . 0.0 111.357 -178.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 82.97 -42.67 0.11 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.73 -0.606 . . . . 0.0 109.674 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.544 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 2.9 m120 -98.0 33.66 2.09 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.087 -1.008 . . . . 0.0 109.357 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.645 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 4.2 mt-10 -62.49 -38.85 49.84 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.374 -0.829 . . . . 0.0 112.688 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.3 Cg_exo -58.89 -41.97 57.12 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.776 1.651 . . . . 0.0 112.314 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.538 HG12 ' CE2' ' A' ' 84' ' ' PHE . 1.1 t -97.43 -47.98 12.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 120.44 -1.412 . . . . 0.0 108.295 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.544 ' CG1' ' O ' ' A' ' 119' ' ' ASN . 7.5 mm -47.61 -34.35 3.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.364 -0.835 . . . . 0.0 108.802 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.492 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -54.34 -45.15 72.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.494 -0.754 . . . . 0.0 109.598 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.65 -52.36 65.48 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.228 -0.92 . . . . 0.0 109.849 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.577 HD22 ' CE2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -53.98 -15.83 1.6 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.182 -0.949 . . . . 0.0 110.347 -179.234 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.508 ' HE2' ' O ' ' A' ' 111' ' ' ASN . 12.6 mttt -51.41 -51.42 54.91 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.815 -1.178 . . . . 0.0 108.715 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -94.89 46.45 1.13 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.511 ' CD1' ' HB2' ' A' ' 110' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.777 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.47 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 64.48 72.13 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -0.835 . . . . 0.0 109.551 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 2' ' ' LYS . 0.2 OUTLIER 167.86 92.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.871 . . . . 0.0 109.693 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -157.85 97.58 1.57 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.36 -0.838 . . . . 0.0 108.887 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.493 ' C ' ' HB ' ' A' ' 40' ' ' ILE . 72.1 mt-30 -133.59 142.51 48.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.188 -0.945 . . . . 0.0 110.0 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.536 HG23 ' CD1' ' A' ' 82' ' ' LEU . 4.5 mt -149.26 157.7 6.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.462 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -111.84 126.63 55.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.123 -0.986 . . . . 0.0 108.973 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.534 HG21 ' CB ' ' A' ' 36' ' ' PRO . 1.4 p -125.46 83.89 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.918 . . . . 0.0 110.202 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.471 ' HA2' ' CD1' ' A' ' 85' ' ' TRP . . . -74.21 117.42 5.59 Favored Glycine 0 C--N 1.291 -1.952 0 N-CA-C 107.732 -2.147 . . . . 0.0 107.732 178.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.564 ' HB ' HD12 ' A' ' 86' ' ' LEU . 0.6 OUTLIER -97.21 172.19 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 120.973 -1.31 . . . . 0.0 109.755 -178.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.616 ' CD1' ' CB ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -140.49 154.82 22.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.438 -0.788 . . . . 0.0 109.211 -179.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.484 ' HD3' ' CD2' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -160.34 68.19 0.36 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.343 -0.848 . . . . 0.0 110.281 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.599 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 52.1 m-80 -163.83 -171.58 2.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.185 -0.947 . . . . 0.0 109.628 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 6.1 tt0 83.95 -46.15 0.11 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.86 0.838 . . . . 0.0 109.542 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.444 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 47.7 t30 -142.13 25.2 1.93 Allowed 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.474 ' OD1' HG22 ' A' ' 108' ' ' VAL . 12.4 t30 55.64 45.85 23.9 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 105' ' ' MET . 4.0 mt-10 -140.41 149.85 43.14 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.099 -1.0 . . . . 0.0 109.386 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.555 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 0.4 OUTLIER -97.95 151.67 4.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.305 -0.872 . . . . 0.0 109.22 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.511 ' HB3' HG12 ' A' ' 11' ' ' ILE . 50.3 t80 -88.54 82.5 6.91 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 21' ' ' THR . 42.2 mm -78.28 167.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.295 -0.878 . . . . 0.0 110.122 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.516 ' CG2' ' HB2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -121.73 128.36 51.7 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.525 ' N ' ' OE1' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -160.55 106.99 1.51 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.512 -0.743 . . . . 0.0 109.193 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.543 ' O ' ' CG ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -49.65 105.89 0.1 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.103 -0.998 . . . . 0.0 109.691 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 23' ' ' ARG . . . 73.45 -169.73 0.12 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.156 -0.965 . . . . 0.0 109.465 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 26' ' ' ASP . . . -133.83 -144.34 0.22 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.232 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 3.1 m-20 64.45 -118.4 0.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.191 -0.943 . . . . 0.0 109.348 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 26' ' ' ASP . . . 68.41 100.89 0.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.735 -1.228 . . . . 0.0 109.408 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -110.78 -44.41 3.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.425 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -45.92 -60.93 1.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.138 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.78 112.92 6.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.11 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -80.25 128.39 33.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.931 . . . . 0.0 109.728 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -134.63 137.74 43.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 109.264 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.537 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 3.1 mt -99.13 -169.68 1.8 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.259 -0.901 . . . . 0.0 108.722 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.49 -156.52 0.48 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.12 -0.987 . . . . 0.0 109.837 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -144.57 158.27 54.08 Favored Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.534 ' CB ' HG21 ' A' ' 8' ' ' VAL . 3.1 Cg_exo -55.71 -153.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.186 1.924 . . . . 0.0 109.816 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 163.24 -166.98 37.33 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.564 -1.303 . . . . 0.0 110.009 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . 173.95 -80.12 0.08 OUTLIER Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 9.0 tttt 166.72 136.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.494 -1.004 . . . . 0.0 109.198 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.523 HD13 ' NE1' ' A' ' 83' ' ' TRP . 3.8 mt -115.2 105.77 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 109.158 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.543 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -108.23 17.2 22.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.086 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.543 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 78.85 -137.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.47 -112.27 1.66 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.476 ' HB3' ' OE1' ' A' ' 48' ' ' GLN . 9.7 tt0 -127.99 -38.99 1.79 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.315 -1.109 . . . . 0.0 109.467 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.502 ' OG1' ' HD2' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -156.97 167.76 13.88 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.072 -1.017 . . . . 0.0 108.957 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.502 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 3.3 Cg_exo -60.25 -18.1 50.27 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.879 2.386 . . . . 0.0 112.851 -177.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.534 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -79.74 -63.12 1.49 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.795 -1.191 . . . . 0.0 109.251 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.597 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 3.2 tt0 -38.02 -32.71 0.07 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.578 1.18 . . . . 0.0 109.626 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 47' ' ' GLU . . . -61.79 -65.51 0.68 Allowed 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.537 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.54 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 4.3 p -80.86 -43.97 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.927 -1.108 . . . . 0.0 110.79 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.597 ' CG1' ' HA ' ' A' ' 48' ' ' GLN . 7.5 p -42.6 -33.52 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.502 ' NH1' ' HG2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -75.82 -43.74 44.57 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.566 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.54 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 2.7 pt-20 -70.84 -7.3 44.46 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 118.74 -1.184 . . . . 0.0 108.5 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.567 ' HA ' ' CE2' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -64.99 -62.56 1.48 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.477 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 25.5 mt-30 -81.56 -24.19 36.7 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.569 -0.707 . . . . 0.0 109.458 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 52' ' ' ARG . 4.1 mm-40 -81.66 31.04 0.35 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.28 -0.887 . . . . 0.0 110.813 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.544 ' HB3' ' CB ' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -148.67 -64.01 0.24 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.696 -1.253 . . . . 0.0 109.863 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.659 HG11 ' HB3' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -118.78 -36.79 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.061 -1.025 . . . . 0.0 108.263 178.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 89.93 55.08 2.06 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.656 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -82.08 -179.28 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.183 -1.186 . . . . 0.0 109.834 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.546 ' N ' ' HD3' ' A' ' 62' ' ' PRO . 8.6 t -135.41 58.31 25.03 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.656 ' HD3' ' HB ' ' A' ' 60' ' ' ILE . 4.6 Cg_exo -53.8 129.17 32.72 Favored 'Trans proline' 0 C--N 1.29 -2.541 0 C-N-CA 122.35 2.033 . . . . 0.0 111.08 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.52 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 0.7 OUTLIER -81.21 -42.91 20.04 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.463 -179.198 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -160.85 114.96 2.08 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.676 -1.21 . . . . 0.0 111.018 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.473 ' CB ' ' HA ' ' A' ' 87' ' ' VAL . 1.8 p90 -121.98 177.89 5.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -0.846 . . . . 0.0 109.088 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 m -161.31 158.68 27.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 47.5 tp -84.76 96.25 9.2 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.876 -1.14 . . . . 0.0 109.536 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.64 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -41.76 -76.09 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.837 0.827 . . . . 0.0 108.904 179.267 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.64 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 4.0 tp10 -171.09 126.95 0.69 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 83' ' ' TRP . 8.9 ptpt -89.41 153.49 20.8 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.339 -0.85 . . . . 0.0 110.051 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.554 HD23 ' CG2' ' A' ' 122' ' ' VAL . 0.5 OUTLIER -127.41 -157.36 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.333 -0.854 . . . . 0.0 109.114 178.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -161.02 165.09 30.39 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.359 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.452 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . 1.1 t80 -152.82 175.39 12.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.543 -0.723 . . . . 0.0 109.174 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -160.43 109.33 1.69 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.665 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.573 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -79.71 177.16 3.09 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.184 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.573 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 6.3 Cg_endo -74.34 31.31 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.496 2.13 . . . . 0.0 111.335 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.436 ' O ' ' HE2' ' A' ' 1' ' ' MET . 0.2 OUTLIER -160.29 -39.1 0.05 Allowed 'General case' 0 N--CA 1.482 1.157 0 O-C-N 120.509 -1.369 . . . . 0.0 110.112 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -135.99 -177.22 4.59 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.363 -0.835 . . . . 0.0 110.299 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.475 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 3.5 m170 -113.55 126.72 55.6 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 80' ' ' ILE . 1.6 mm -94.6 149.22 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.168 -0.958 . . . . 0.0 109.652 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.1 m -157.21 107.51 2.26 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.536 ' CD1' HG23 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -136.34 129.02 30.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.149 -0.969 . . . . 0.0 110.1 -178.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.523 ' NE1' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -119.05 149.21 42.05 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.237 -0.914 . . . . 0.0 110.108 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -127.67 123.03 34.53 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.667 ' CD1' ' O ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -91.13 80.9 5.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.616 -1.303 . . . . 0.0 109.209 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.564 HD12 ' HB ' ' A' ' 10' ' ' ILE . 0.5 OUTLIER -42.43 121.15 1.85 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.249 -0.907 . . . . 0.0 110.306 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.546 ' CG2' HG21 ' A' ' 11' ' ' ILE . 18.9 m -87.61 170.19 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.494 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 5.2 mt-10 -122.54 -19.79 6.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.854 -1.153 . . . . 0.0 111.078 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.52 ' HG3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.93 156.64 20.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.597 -1.314 . . . . 0.0 110.238 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.643 ' CD1' ' N ' ' A' ' 91' ' ' GLU . 6.2 p90 177.27 -169.38 0.07 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.096 0.951 . . . . 0.0 110.445 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.643 ' N ' ' CD1' ' A' ' 90' ' ' TRP . 7.2 tt0 -147.53 128.28 14.31 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.839 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 119.85 -165.92 13.48 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.848 -1.167 . . . . 0.0 110.279 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 58' ' ' VAL . 0.5 OUTLIER -111.01 105.07 56.98 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.166 -1.196 . . . . 0.0 109.05 179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.616 ' CB ' ' CD1' ' A' ' 11' ' ' ILE . 4.8 Cg_exo -58.96 176.38 0.47 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.782 2.321 . . . . 0.0 113.066 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.659 ' HB3' HG11 ' A' ' 58' ' ' VAL . 3.8 p-90 -122.57 -161.28 0.93 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.764 0.793 . . . . 0.0 109.834 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.519 ' HA3' ' HB3' ' A' ' 36' ' ' PRO . . . 165.79 -107.31 0.29 Allowed Glycine 0 N--CA 1.481 1.696 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.521 ' HD3' ' CB ' ' A' ' 100' ' ' GLN . 11.1 tttp -60.99 -178.94 0.11 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.981 -1.305 . . . . 0.0 108.568 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.58 -73.35 0.66 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.952 -1.092 . . . . 0.0 109.713 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.96 10.81 56.81 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -110.33 121.99 39.9 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 121.033 -1.275 . . . . 0.0 109.447 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.43 -53.51 0.78 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.144 1.896 . . . . 0.0 111.155 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . 90.29 172.0 44.38 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 7.4 pt-20 -140.5 144.92 36.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.715 -1.462 . . . . 0.0 110.246 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.599 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -89.94 107.25 19.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.332 -0.855 . . . . 0.0 109.208 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 7.4 ttm -96.25 152.08 18.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.128 -0.982 . . . . 0.0 109.671 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.457 ' O ' ' HG ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -108.12 105.47 15.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 109.372 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.531 ' O ' ' CG1' ' A' ' 108' ' ' VAL . 49.1 mt -147.98 -65.66 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.15 -0.969 . . . . 0.0 109.651 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER 77.15 -1.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.484 -0.76 . . . . 0.0 109.821 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -138.99 25.77 2.77 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 107.072 -2.411 . . . . 0.0 107.072 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 109' ' ' GLY . 0.9 OUTLIER -40.11 145.18 0.17 Allowed 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.935 -0.744 . . . . 0.0 110.149 -179.134 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.9 -171.71 1.95 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.371 -0.831 . . . . 0.0 108.991 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.502 ' HA ' HG22 ' A' ' 123' ' ' ILE . . . -91.12 10.26 27.64 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.238 -0.914 . . . . 0.0 109.3 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -85.99 -43.83 12.84 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.26 -0.9 . . . . 0.0 109.894 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.486 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -79.31 -14.89 58.71 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.256 -0.903 . . . . 0.0 108.744 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.537 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 1.4 m-85 -96.53 140.0 21.95 Favored Pre-proline 0 N--CA 1.489 1.516 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.854 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.482 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 1.8 Cg_endo -67.01 145.07 72.49 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.028 1.819 . . . . 0.0 110.446 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.543 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 1.8 Cg_endo -63.13 127.48 20.34 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.376 2.051 . . . . 0.0 110.574 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 156.9 -32.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.538 ' OD1' ' CD2' ' A' ' 71' ' ' LEU . 41.0 m-80 -112.81 46.85 1.16 Allowed 'General case' 0 C--O 1.201 -1.49 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.633 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 15.5 mt-10 -61.14 -41.39 80.56 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.237 -0.914 . . . . 0.0 112.901 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 1.3 Cg_endo -67.3 -29.05 39.15 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.544 2.162 . . . . 0.0 111.736 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.554 ' CG2' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -95.08 -41.25 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.021 -1.049 . . . . 0.0 108.444 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 119' ' ' ASN . 8.8 mm -58.36 -35.42 53.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.02 -39.25 63.02 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . 20.2 mmtt -80.63 -31.56 36.51 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.41 -0.806 . . . . 0.0 109.803 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 4.3 mp -56.9 -25.13 56.53 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.3 -0.875 . . . . 0.0 109.212 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -56.43 -46.5 80.23 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 129' ' ' LEU . 7.3 mtt180 -84.72 -7.02 59.37 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.721 -0.612 . . . . 0.0 109.476 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 126' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.812 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mmt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.66 169.26 15.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.406 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.8 107.12 9.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.359 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.508 ' HG ' ' CG2' ' A' ' 80' ' ' ILE . 0.9 OUTLIER -115.48 -177.46 3.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.321 -0.862 . . . . 0.0 109.476 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.542 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -152.9 159.44 42.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.881 . . . . 0.0 109.387 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 7' ' ' ALA . 11.6 mm -116.89 168.44 8.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.226 -0.921 . . . . 0.0 109.353 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.545 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . -125.74 115.25 19.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.096 -1.002 . . . . 0.0 110.167 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.598 ' CG2' ' O ' ' A' ' 35' ' ' PHE . 5.8 p -129.54 146.13 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.53 112.33 1.08 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.616 ' CD1' ' CD1' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -94.25 162.12 2.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.61 ' CG2' ' CZ3' ' A' ' 90' ' ' TRP . 2.2 mt -146.03 135.95 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 118.319 -1.352 . . . . 0.0 112.037 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 35.1 ttp180 -126.98 129.57 48.36 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.536 ' OD1' ' CZ2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -98.48 -156.95 0.57 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.895 -1.128 . . . . 0.0 111.012 -178.062 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -85.67 -5.51 59.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.753 -0.592 . . . . 0.0 109.758 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.547 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 6.6 t-20 -91.34 23.12 3.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.919 . . . . 0.0 108.839 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 48.32 46.38 20.19 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.615 -0.678 . . . . 0.0 110.897 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.547 ' CG ' ' HB3' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -134.2 165.94 23.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.197 -0.94 . . . . 0.0 108.649 178.562 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.54 HG13 ' CD2' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -116.66 167.65 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.113 -0.992 . . . . 0.0 109.439 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 94' ' ' PRO . 57.3 t80 -120.13 88.21 2.89 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 121.028 -1.045 . . . . 0.0 108.963 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.522 HG22 ' CD1' ' A' ' 33' ' ' LEU . 9.4 mm -77.81 174.57 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -118.16 128.51 54.78 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.863 -1.148 . . . . 0.0 108.67 178.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 1.4 tpt180 -160.67 122.9 3.17 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.155 -0.966 . . . . 0.0 109.865 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -86.73 43.51 1.09 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.169 -0.957 . . . . 0.0 109.134 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 23' ' ' ARG . . . 167.24 -159.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -0.892 . . . . 0.0 109.659 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -173.21 -170.0 0.59 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 109.631 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.61 154.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.875 . . . . 0.0 109.611 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -178.46 -62.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.139 -0.976 . . . . 0.0 109.698 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 46.79 40.71 9.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.955 . . . . 0.0 109.543 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.94 -41.41 0.06 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 0.0 109.581 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 31' ' ' ASN . . . -140.62 -38.27 0.44 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.144 -0.972 . . . . 0.0 109.653 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.412 ' O ' ' O ' ' A' ' 30' ' ' ALA . 68.3 m-20 57.57 104.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 109.074 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -137.67 128.89 27.74 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.699 -179.538 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.576 HD11 ' CE1' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -96.51 -174.57 3.07 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 21' ' ' THR . 5.6 mm-40 -119.37 172.88 7.31 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.936 -1.103 . . . . 0.0 110.271 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.608 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -161.12 -66.02 0.02 OUTLIER Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 35' ' ' PHE . 11.5 Cg_exo -42.81 150.08 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.115 1.21 . . . . 0.0 109.489 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -116.17 -85.89 1.23 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.72 53.52 0.48 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.403 ' HA ' HD11 ' A' ' 6' ' ' ILE . 4.6 mptt 64.75 175.52 0.2 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.44 -1.035 . . . . 0.0 109.716 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.542 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 1.3 tt -148.44 79.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.385 -0.822 . . . . 0.0 109.78 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 42' ' ' MET . 0.6 OUTLIER -150.22 148.95 29.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.92 -1.113 . . . . 0.0 110.05 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.49 ' HB3' ' O ' ' A' ' 41' ' ' GLU . 0.5 OUTLIER 164.31 -33.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.19 37.04 0.2 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 48' ' ' GLN . 39.9 mt-10 -131.84 -148.12 0.34 Allowed 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.487 -1.007 . . . . 0.0 109.915 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.599 ' CB ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -142.66 -176.77 0.59 Allowed Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.215 -0.928 . . . . 0.0 108.695 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 45' ' ' THR . 1.1 Cg_endo -69.12 -3.17 11.05 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.808 1.672 . . . . 0.0 110.68 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.469 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -108.14 -45.5 3.93 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.001 -1.062 . . . . 0.0 109.165 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.514 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -75.67 -54.83 6.35 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.341 1.067 . . . . 0.0 109.396 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 45' ' ' THR . . . -38.02 -54.29 1.33 Allowed 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.176 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 5.3 p -76.12 -31.55 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.141 -0.975 . . . . 0.0 109.119 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.627 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -44.53 -58.05 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.627 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -67.92 -28.87 67.87 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.339 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.539 ' HA ' ' CG ' ' A' ' 56' ' ' GLU . 3.9 mt-10 -56.47 -18.79 12.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.831 -1.168 . . . . 0.0 108.301 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.52 ' CD1' ' HG3' ' A' ' 62' ' ' PRO . 14.6 mt -68.9 -42.73 76.51 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.372 -0.83 . . . . 0.0 109.056 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -81.25 -41.82 21.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 110.485 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 14.6 pt-20 -80.94 37.82 0.44 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.023 -1.048 . . . . 0.0 110.98 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.576 ' HB3' ' CG ' ' A' ' 95' ' ' TRP . 58.0 mm-40 -146.69 -55.76 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.881 -1.137 . . . . 0.0 109.204 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.62 ' CG1' ' HB3' ' A' ' 95' ' ' TRP . 1.6 m -143.83 -33.08 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.523 -0.736 . . . . 0.0 109.279 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.533 ' N ' HG21 ' A' ' 58' ' ' VAL . . . 84.46 59.77 1.98 Allowed Glycine 0 N--CA 1.479 1.558 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.61 HG12 ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -95.6 164.91 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.489 -1.006 . . . . 0.0 109.012 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 97.4 m -112.53 83.98 5.95 Favored Pre-proline 0 C--N 1.3 -1.577 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 2.4 Cg_endo -59.48 117.63 4.39 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.439 2.093 . . . . 0.0 110.246 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.52 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 1.2 mt-30 -79.55 -28.02 41.25 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.559 -0.713 . . . . 0.0 109.183 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 12.5 t-160 -171.1 117.17 0.45 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.936 -1.102 . . . . 0.0 111.037 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.509 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . 11.3 p90 -129.66 171.19 12.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.245 -0.909 . . . . 0.0 109.586 178.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.18 161.4 24.97 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.382 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.52 ' CD1' ' HA ' ' A' ' 85' ' ' TRP . 27.0 tp -109.31 108.78 19.49 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.645 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 27.1 p90 -69.62 -56.62 6.78 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.308 -0.87 . . . . 0.0 111.117 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.645 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 3.3 tp10 -172.23 144.68 1.63 Allowed 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.348 -0.845 . . . . 0.0 109.857 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.58 ' HD3' ' CE3' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -111.59 158.11 19.61 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.336 -0.853 . . . . 0.0 110.549 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.524 ' CD2' ' HB ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -113.02 -165.08 0.96 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 1.7 pt-20 -149.07 133.96 17.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.822 -1.174 . . . . 0.0 110.353 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.518 ' HB3' ' CG1' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -96.29 117.74 31.42 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.277 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -110.94 99.76 8.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.156 -0.965 . . . . 0.0 109.547 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.506 ' HB2' ' HG3' ' A' ' 78' ' ' ARG . 5.1 m-85 -79.49 170.17 17.15 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 2.2 Cg_endo -62.87 -2.39 3.54 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.01 1.807 . . . . 0.0 111.516 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -143.18 -20.62 0.63 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.692 -1.255 . . . . 0.0 111.764 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.506 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -126.63 163.18 24.02 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.663 -1.273 . . . . 0.0 110.642 -178.495 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -127.35 74.24 1.5 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.518 ' CG1' ' HB3' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -78.91 -174.85 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.352 -0.843 . . . . 0.0 110.576 -178.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 72' ' ' GLU . 3.0 m -151.01 153.62 35.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.421 -0.799 . . . . 0.0 109.209 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -129.34 143.1 50.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.083 -1.011 . . . . 0.0 109.324 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.638 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -133.11 128.91 37.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 109.837 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.612 ' CE1' HG12 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -121.83 101.16 7.4 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.702 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.594 ' CD1' ' O ' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -79.89 83.44 5.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.188 -0.945 . . . . 0.0 110.594 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.616 ' CD1' ' CD1' ' A' ' 10' ' ' ILE . 3.4 tp -52.38 114.02 1.23 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 109.574 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.586 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 8.5 m -85.11 -163.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.218 -0.926 . . . . 0.0 109.581 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 12' ' ' ARG . 76.3 mt-10 -137.57 -31.82 0.78 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.113 -0.992 . . . . 0.0 110.355 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.52 ' HG3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -161.95 175.5 11.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.82 -1.175 . . . . 0.0 110.019 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.643 ' CZ2' ' HG3' ' A' ' 94' ' ' PRO . 42.3 p90 -179.6 -168.24 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.081 0.943 . . . . 0.0 110.362 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.461 ' HB3' ' HB ' ' A' ' 61' ' ' THR . 17.4 tt0 -141.27 96.46 2.99 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.913 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.574 ' CA ' HG21 ' A' ' 60' ' ' ILE . . . 144.34 -152.12 24.05 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.273 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.555 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -106.51 112.36 63.76 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.22 -1.165 . . . . 0.0 109.601 -179.5 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.643 ' HG3' ' CZ2' ' A' ' 90' ' ' TRP . 3.6 Cg_endo -56.81 130.71 41.35 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.155 2.57 . . . . 0.0 113.661 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.62 ' HB3' ' CG1' ' A' ' 58' ' ' VAL . 33.7 p-90 -107.01 -168.96 1.47 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 165.11 -15.72 0.09 OUTLIER Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.988 -1.577 . . . . 0.0 111.242 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.525 ' CB ' HG23 ' A' ' 21' ' ' THR . 11.3 tttp -117.49 -99.15 0.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.829 -1.395 . . . . 0.0 109.765 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 97' ' ' LYS . 1.3 tt0 -134.81 28.11 3.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.22 -0.925 . . . . 0.0 109.407 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.79 22.9 19.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.453 ' HG2' ' HD2' ' A' ' 101' ' ' PRO . 2.0 mt-30 -103.15 166.88 11.06 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.136 -1.214 . . . . 0.0 109.619 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.453 ' HD2' ' HG2' ' A' ' 100' ' ' GLN . 1.1 Cg_endo -64.94 128.19 20.23 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.346 2.031 . . . . 0.0 110.513 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.557 ' HA3' ' CZ ' ' A' ' 19' ' ' PHE . . . -104.05 174.14 22.1 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.463 ' OE1' ' HA ' ' A' ' 103' ' ' GLU . 45.6 mm-40 -112.87 151.56 30.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.891 -1.358 . . . . 0.0 110.672 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.602 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -103.25 101.09 11.01 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.042 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.518 ' HE3' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -100.55 -166.81 1.36 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.974 -1.079 . . . . 0.0 110.002 -179.437 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -111.9 151.86 28.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 109.825 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 tt -61.94 -27.58 68.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.44 -0.787 . . . . 0.0 110.183 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 109' ' ' GLY . 62.6 t -65.24 112.7 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.189 -0.945 . . . . 0.0 109.433 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 108' ' ' VAL . . . 45.1 40.71 7.42 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.588 ' HG ' ' N ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -51.82 -42.69 62.72 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.476 -1.014 . . . . 0.0 110.127 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.588 ' N ' ' HG ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -130.28 -165.68 1.57 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.378 -0.826 . . . . 0.0 110.071 -179.436 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 111' ' ' ASN . . . 87.48 -25.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -120.43 -37.72 3.0 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.334 -0.854 . . . . 0.0 108.937 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.407 ' OD1' HD22 ' A' ' 33' ' ' LEU . 9.8 t0 -96.3 0.86 51.42 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.414 -0.804 . . . . 0.0 109.002 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.583 ' CE1' ' HB3' ' A' ' 111' ' ' ASN . 1.7 m-85 -91.46 164.57 24.01 Favored Pre-proline 0 N--CA 1.489 1.501 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.498 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.496 ' HD2' ' CD2' ' A' ' 115' ' ' PHE . 1.3 Cg_endo -67.7 142.21 57.39 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.949 1.766 . . . . 0.0 109.794 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.543 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 1.6 Cg_endo -64.53 96.78 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.26 1.973 . . . . 0.0 110.31 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 161.3 -21.42 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.387 -0.821 . . . . 0.0 109.765 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.544 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 0.8 OUTLIER -97.51 29.88 3.11 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.135 -0.978 . . . . 0.0 109.411 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.672 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 22.5 mt-10 -68.79 -34.2 5.08 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.47 -0.769 . . . . 0.0 112.891 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.0 Cg_exo -58.6 -37.38 94.69 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.545 1.497 . . . . 0.0 111.674 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.612 HG12 ' CE1' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -101.79 -47.83 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.633 -1.292 . . . . 0.0 107.863 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.573 ' CG2' ' CA ' ' A' ' 112' ' ' ALA . 12.4 mm -47.81 -31.1 2.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.507 -0.745 . . . . 0.0 109.013 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 127' ' ' LYS . . . -52.92 -49.86 65.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.388 -0.82 . . . . 0.0 108.857 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -41.31 92.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.453 -0.78 . . . . 0.0 109.263 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 10.9 mt -57.13 -13.78 3.31 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.232 -0.917 . . . . 0.0 109.768 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 124' ' ' ALA . 25.1 mttt -61.7 -46.04 91.37 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.701 -1.249 . . . . 0.0 108.816 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 129' ' ' LEU . 14.9 mtm180 -88.45 11.87 15.84 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.425 -0.797 . . . . 0.0 109.563 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.556 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.402 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.46 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.6 mmtm -67.44 -99.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.356 -0.84 . . . . 0.0 110.204 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.89 -159.38 0.86 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 110.19 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.53 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -157.13 -97.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.443 -0.786 . . . . 0.0 109.895 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.487 ' HA ' ' HB ' ' A' ' 81' ' ' THR . 1.8 mt-30 -63.66 154.25 33.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.151 -0.968 . . . . 0.0 110.847 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.549 ' CG2' ' N ' ' A' ' 7' ' ' ALA . 5.1 mm -141.79 171.26 11.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.549 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . -132.23 89.96 2.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.797 -1.189 . . . . 0.0 109.848 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 35' ' ' PHE . 7.2 p -100.98 164.41 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.229 -0.919 . . . . 0.0 109.67 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.514 ' HA2' ' CD1' ' A' ' 85' ' ' TRP . . . -147.87 114.43 0.69 Allowed Glycine 0 N--CA 1.48 1.603 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.598 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -97.21 123.43 49.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.66 ' CD1' ' HB3' ' A' ' 94' ' ' PRO . 3.4 mt -117.8 153.21 19.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.201 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.516 ' CZ ' ' OE2' ' A' ' 88' ' ' GLU . 9.1 tpp180 -78.08 -147.41 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.912 0 O-C-N 120.965 -1.085 . . . . 0.0 108.763 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.56 ' CB ' ' HB2' ' A' ' 17' ' ' GLU . 0.9 OUTLIER -146.55 -11.46 0.46 Allowed 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.34 -0.85 . . . . 0.0 111.656 -179.174 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 13' ' ' ASN . 0.6 OUTLIER 82.97 -36.23 0.08 Allowed 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.603 -0.686 . . . . 0.0 109.274 -178.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.54 ' O ' ' HB3' ' A' ' 16' ' ' ASN . 14.9 t-20 -94.45 26.14 3.56 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.54 ' HB3' ' O ' ' A' ' 15' ' ' ASN . 18.8 t-20 71.16 37.17 1.25 Allowed 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.815 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.56 ' HB2' ' CB ' ' A' ' 13' ' ' ASN . 3.6 mt-10 -127.86 -163.5 1.27 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.639 -1.288 . . . . 0.0 109.353 178.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.588 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 1.1 mt -151.65 154.33 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.816 -1.178 . . . . 0.0 109.737 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 82.7 t80 -95.19 66.28 2.91 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.565 HG22 ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -81.73 -156.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.849 0.833 . . . . 0.0 110.736 -177.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.598 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.1 OUTLIER -145.51 147.1 31.77 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.385 0.612 . . . . 0.0 109.721 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 24' ' ' ALA . 0.7 OUTLIER -109.89 -158.14 0.64 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.293 -0.879 . . . . 0.0 110.144 -179.453 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.491 ' NH1' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -49.62 88.87 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.567 -0.708 . . . . 0.0 110.047 -179.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . -114.18 -2.33 13.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.517 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.36 -57.41 1.48 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.159 -0.963 . . . . 0.0 109.405 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.12 -71.98 0.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.878 . . . . 0.0 109.679 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . . . 57.75 77.03 0.3 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.12 -0.987 . . . . 0.0 109.054 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -86.81 131.76 34.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 110.205 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.2 mtp 66.32 119.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.811 . . . . 0.0 110.21 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 63.55 169.43 0.15 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.37 -0.831 . . . . 0.0 109.634 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.453 ' O ' ' HE3' ' A' ' 32' ' ' LYS . 1.5 m-20 -83.62 149.65 26.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.39 -0.819 . . . . 0.0 109.418 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.48 ' HG3' ' HG3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -137.38 146.14 44.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.292 179.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.565 ' CD2' HG22 ' A' ' 20' ' ' ILE . 0.7 OUTLIER -105.1 -174.15 2.47 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.209 -0.932 . . . . 0.0 109.341 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.466 ' O ' HD13 ' A' ' 20' ' ' ILE . 1.6 tt0 -162.02 -155.34 0.37 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.988 0.899 . . . . 0.0 109.985 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.546 ' HB3' HG22 ' A' ' 8' ' ' VAL . 17.9 m-85 -132.26 131.32 22.33 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.543 ' HA ' ' NE2' ' A' ' 100' ' ' GLN . 5.3 Cg_exo -57.41 -157.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.071 1.847 . . . . 0.0 111.004 -178.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.537 ' CA ' ' HA ' ' A' ' 8' ' ' VAL . . . 85.2 154.55 22.63 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.99 -31.82 0.15 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -171.15 161.94 6.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.815 -1.403 . . . . 0.0 110.529 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 40' ' ' ILE . 2.9 tt -136.25 98.29 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.474 -0.766 . . . . 0.0 109.151 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 42' ' ' MET . 7.0 mt-10 -81.56 -173.51 4.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.207 -0.933 . . . . 0.0 110.122 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 12.8 mtt 63.62 -94.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.47 -0.769 . . . . 0.0 109.594 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.01 31.73 4.64 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -71.54 0.44 Allowed 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.601 -0.94 . . . . 0.0 109.463 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.591 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 24.2 m -133.84 144.01 49.97 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.054 -1.029 . . . . 0.0 109.08 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.591 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.0 Cg_endo -55.66 -8.63 2.14 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.69 2.26 . . . . 0.0 112.33 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' H ' HG21 ' A' ' 45' ' ' THR . 0.5 OUTLIER -103.06 -36.26 8.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.762 -1.211 . . . . 0.0 108.686 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.559 ' O ' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -62.0 -50.72 70.93 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.598 1.19 . . . . 0.0 108.811 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' GLN . . . -38.23 -60.61 0.76 Allowed 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.339 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.582 HG22 ' CD1' ' A' ' 85' ' ' TRP . 2.3 p -71.95 -29.84 34.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.018 -1.051 . . . . 0.0 109.923 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.626 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -42.55 -56.33 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 122.039 0.923 . . . . 0.0 108.781 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.626 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -65.87 -33.34 75.63 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.39 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 5.8 mt-10 -73.08 -5.02 36.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.113 -0.992 . . . . 0.0 109.416 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.585 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 3.7 mt -79.92 -62.88 1.55 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 0.0 109.43 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.506 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 3.0 mm100 -81.94 -23.64 36.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.205 -0.935 . . . . 0.0 110.999 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -80.58 17.79 1.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.688 -1.257 . . . . 0.0 110.816 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.57 ' HB3' ' CD1' ' A' ' 95' ' ' TRP . 1.6 mt-10 -130.59 -65.3 0.8 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.673 -1.267 . . . . 0.0 110.003 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.714 ' CG2' HG12 ' A' ' 60' ' ' ILE . 2.8 m -121.92 -26.47 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 108.907 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.512 ' N ' HG21 ' A' ' 58' ' ' VAL . . . 95.99 59.7 1.05 Allowed Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.714 HG12 ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -95.84 174.01 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -1.172 . . . . 0.0 110.7 -179.527 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.722 ' N ' ' CD ' ' A' ' 62' ' ' PRO . 10.3 t -144.99 41.22 0.3 Allowed Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.722 ' CD ' ' N ' ' A' ' 61' ' ' THR . 4.8 Cg_exo -43.29 122.39 2.94 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.711 2.274 . . . . 0.0 110.852 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -98.89 -5.85 30.07 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.352 -178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.71 39.31 2.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.165 -1.584 . . . . 0.0 111.952 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.561 ' CB ' ' HB ' ' A' ' 87' ' ' VAL . 45.0 p90 -79.9 168.07 19.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.63 -1.294 . . . . 0.0 110.52 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.5 m -164.38 145.23 8.15 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.571 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 44.7 tp -73.91 98.1 2.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.562 -1.336 . . . . 0.0 108.897 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.586 ' CE2' HG13 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -44.77 -80.14 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.748 0.785 . . . . 0.0 108.981 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.582 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 16.0 mt-10 -152.9 164.45 37.88 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.297 0.57 . . . . 0.0 109.809 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 13.4 ttpp -134.33 108.87 8.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.996 -1.065 . . . . 0.0 110.214 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.535 ' CD2' HG21 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -98.55 -167.82 1.55 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.177 -0.952 . . . . 0.0 109.32 179.284 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -149.62 146.32 27.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.92 . . . . 0.0 109.689 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 74' ' ' GLU . 47.7 t80 -136.01 152.69 51.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 108.988 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 52.6 tt0 -143.2 115.05 8.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.527 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 3.9 m-85 -78.94 172.31 10.23 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.3 Cg_exo -59.61 -7.37 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.814 1.676 . . . . 0.0 111.453 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.46 ' O ' ' CG ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -154.27 -8.51 0.14 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.819 -1.175 . . . . 0.0 112.186 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.512 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -130.93 178.52 6.61 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.282 -1.511 . . . . 0.0 109.92 -179.158 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 4' ' ' LEU . 27.6 m80 -125.4 161.99 25.81 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.355 -0.84 . . . . 0.0 108.977 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 34.7 mm -149.99 74.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 110.005 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.487 ' HB ' ' HA ' ' A' ' 5' ' ' GLN . 18.7 m -79.64 136.91 36.94 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.479 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 12.5 tp -132.98 150.26 52.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.965 -1.085 . . . . 0.0 110.676 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.637 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -123.45 109.67 14.14 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.139 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.593 ' CZ ' HG23 ' A' ' 122' ' ' VAL . 3.0 m-85 -79.73 88.41 5.2 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.14 -0.975 . . . . 0.0 109.865 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.694 ' O ' ' CG ' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -86.59 74.91 9.79 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 123.514 1.626 . . . . 0.0 107.135 178.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.598 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 8.0 tp -67.17 133.85 50.59 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.431 -177.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.561 ' HB ' ' CB ' ' A' ' 65' ' ' PHE . 7.3 p -144.28 168.61 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.476 -0.765 . . . . 0.0 109.197 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.516 ' OE2' ' CZ ' ' A' ' 12' ' ' ARG . 7.0 mt-10 -144.36 -18.95 0.55 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.916 -1.115 . . . . 0.0 111.923 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -110.85 141.88 43.63 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.313 -1.492 . . . . 0.0 109.303 -179.526 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.616 ' CD1' ' CG2' ' A' ' 60' ' ' ILE . 14.3 p90 178.62 -172.57 0.14 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.502 1.144 . . . . 0.0 111.002 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.475 ' N ' ' CD1' ' A' ' 90' ' ' TRP . 15.3 tt0 -147.14 85.98 1.62 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.798 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 168.46 -156.04 27.17 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.577 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -117.04 102.42 52.84 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.281 -1.129 . . . . 0.0 109.889 -179.296 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.66 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 31.9 Cg_exo -39.26 128.27 1.51 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 123.388 2.725 . . . . 0.0 113.289 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.667 ' HB3' ' CG1' ' A' ' 58' ' ' VAL . 2.0 p-90 -105.09 -164.83 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 154.61 92.95 0.09 OUTLIER Glycine 0 C--N 1.298 -1.537 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.525 ' HB2' ' N ' ' A' ' 37' ' ' GLY . 17.8 tttm 58.89 105.99 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.365 -1.08 . . . . 0.0 109.907 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -68.76 105.51 2.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.255 -0.903 . . . . 0.0 109.345 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 132.1 -11.75 5.32 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.543 ' NE2' ' HA ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -101.46 108.58 56.01 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 121.347 -1.09 . . . . 0.0 109.157 179.734 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.89 89.99 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.068 1.845 . . . . 0.0 110.62 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -86.99 177.56 47.92 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.414 ' OE2' ' CZ ' ' A' ' 22' ' ' ARG . 14.1 pt-20 -159.11 177.6 10.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.65 -1.5 . . . . 0.0 111.108 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.47 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 35.0 m0 -87.88 110.95 20.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.698 -0.627 . . . . 0.0 109.799 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 30.5 ttp -101.75 144.46 30.41 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.273 -0.892 . . . . 0.0 108.804 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.36 131.1 41.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.937 . . . . 0.0 109.869 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.515 HD11 ' CD1' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -107.08 57.5 0.63 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.297 -0.877 . . . . 0.0 109.247 179.653 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.407 HG11 ' O ' ' A' ' 108' ' ' VAL . 61.8 t -81.98 -19.35 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 178.29 49.01 0.07 OUTLIER Glycine 0 N--CA 1.487 2.04 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.474 HD13 HD13 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -37.31 143.31 0.1 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.954 -0.733 . . . . 0.0 110.441 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -148.67 -174.5 4.63 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.461 -0.775 . . . . 0.0 109.092 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.426 ' CB ' HG23 ' A' ' 123' ' ' ILE . . . -80.41 5.56 14.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 109.325 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -74.08 -48.54 29.07 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.305 -0.872 . . . . 0.0 110.079 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.542 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -79.66 -15.24 57.95 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.228 -0.92 . . . . 0.0 108.941 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.613 ' CG ' HD13 ' A' ' 123' ' ' ILE . 4.9 m-85 -102.86 130.77 23.13 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.624 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.534 ' CG ' ' O ' ' A' ' 33' ' ' LEU . 1.8 Cg_endo -62.93 158.97 40.33 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.035 1.824 . . . . 0.0 110.082 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.492 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 3.1 Cg_exo -59.49 -172.8 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.43 2.087 . . . . 0.0 110.937 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 77.73 -0.71 2.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.502 -0.749 . . . . 0.0 109.775 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.548 ' HB3' HG12 ' A' ' 123' ' ' ILE . 2.0 m-80 -133.66 49.03 2.31 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.103 -0.998 . . . . 0.0 109.776 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.647 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 4.6 mm-40 -75.46 -39.98 3.24 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 112.52 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 2.1 Cg_endo -64.54 -25.85 62.38 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.948 1.765 . . . . 0.0 111.837 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.593 HG23 ' CZ ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -104.01 -50.85 8.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 120.79 -1.194 . . . . 0.0 109.115 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.613 HD13 ' CG ' ' A' ' 115' ' ' PHE . 19.7 mm -55.15 -37.98 45.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 120' ' ' GLU . . . -49.57 -40.61 39.07 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.51 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -80.1 -35.23 37.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.53 -0.731 . . . . 0.0 109.776 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 9.5 mt -73.25 -4.12 31.08 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.191 -0.943 . . . . 0.0 109.825 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 110' ' ' LEU . 11.1 mttt -64.23 -49.05 73.48 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.277 -0.889 . . . . 0.0 109.185 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.27 -0.75 42.22 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.373 -0.83 . . . . 0.0 109.339 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.508 HD22 ' NH1' ' A' ' 12' ' ' ARG . 2.3 tp . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.716 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.446 ' HE1' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.153 0.501 . . . . 0.0 109.664 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.69 33.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.829 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.4 74.21 0.68 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.95 . . . . 0.0 109.895 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.2 tp -131.84 103.58 6.4 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.576 -0.703 . . . . 0.0 109.29 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.508 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . 0.3 OUTLIER -125.31 148.49 48.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.081 -1.012 . . . . 0.0 109.558 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.525 ' O ' ' CD1' ' A' ' 83' ' ' TRP . 5.5 mm -107.04 178.37 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.248 -0.908 . . . . 0.0 109.409 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.47 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -139.29 96.63 3.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 109.616 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 11.8 p -121.22 135.36 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 110.257 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.32 115.94 2.79 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.556 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 1.5 mt -84.28 157.83 3.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.6 ' CD1' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -127.29 148.72 32.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.897 -1.127 . . . . 0.0 110.137 -178.068 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 88' ' ' GLU . 32.9 ttp180 -153.26 115.87 4.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.699 -0.625 . . . . 0.0 109.319 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.74 -153.65 0.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.087 -1.008 . . . . 0.0 109.751 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.587 ' CG ' ' NH1' ' A' ' 89' ' ' ARG . 51.8 mt-10 -89.07 -5.13 58.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.749 . . . . 0.0 109.882 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.538 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 55.6 t30 -94.72 33.64 1.43 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 15' ' ' ASN . 1.8 m120 33.74 41.46 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.59 0.71 . . . . 0.0 110.814 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 15' ' ' ASN . 5.0 mt-10 -119.94 128.81 53.94 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.581 ' N ' ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -105.7 150.21 8.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.643 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 13.6 t80 -98.24 81.7 2.82 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.518 HD11 ' N ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -93.09 -157.9 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 110.177 -178.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.602 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.2 OUTLIER -125.01 169.2 12.35 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.201 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -160.57 -154.33 0.37 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 120.821 -1.174 . . . . 0.0 110.453 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.471 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -44.22 103.47 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.648 -0.657 . . . . 0.0 109.971 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -138.63 22.87 2.69 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.454 -0.779 . . . . 0.0 109.244 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 26' ' ' ASP . . . 179.21 92.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.267 -0.896 . . . . 0.0 109.433 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER 44.97 76.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 109.307 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 23' ' ' ARG . . . -170.8 86.73 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.192 -0.942 . . . . 0.0 109.584 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -116.39 -14.32 10.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.08 -1.012 . . . . 0.0 109.622 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.562 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 3.5 ttm -107.17 134.62 50.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.138 -0.976 . . . . 0.0 109.575 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 29' ' ' MET . . . 83.99 -22.27 0.23 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.7 -0.625 . . . . 0.0 110.084 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 30' ' ' ALA . 3.4 m-20 59.52 116.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.017 -1.052 . . . . 0.0 109.477 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -131.08 136.15 48.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.361 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.566 ' CB ' ' O ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -135.59 -179.53 5.7 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.151 -0.968 . . . . 0.0 109.41 179.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.49 ' O ' HD13 ' A' ' 20' ' ' ILE . 2.0 tt0 -164.53 -154.96 0.26 Allowed 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.545 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -122.95 93.39 48.4 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.511 ' CD ' ' OG1' ' A' ' 21' ' ' THR . 5.9 Cg_exo -57.11 -153.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.501 2.134 . . . . 0.0 110.749 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 140.1 -153.84 23.58 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -148.94 23.62 1.28 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 73.58 160.58 0.23 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.134 . . . . 0.0 109.215 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.508 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 2.9 tt -102.07 129.24 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.197 -0.939 . . . . 0.0 109.347 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -126.54 -70.54 0.72 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.945 . . . . 0.0 109.554 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.48 108.61 20.13 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.405 0.622 . . . . 0.0 109.376 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.12 141.28 3.43 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.1 -10.59 15.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -1.142 . . . . 0.0 109.984 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.583 ' CB ' ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -146.24 177.23 1.84 Allowed Pre-proline 0 N--CA 1.486 1.353 0 O-C-N 120.963 -1.086 . . . . 0.0 109.87 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 45' ' ' THR . 6.3 Cg_endo -74.55 -4.93 16.18 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.466 2.111 . . . . 0.0 110.548 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.474 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 2.9 mt-10 -105.36 -37.28 6.9 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.202 -0.936 . . . . 0.0 108.884 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.435 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -73.04 -57.52 3.98 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.362 1.077 . . . . 0.0 108.868 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 53' ' ' GLU . . . -46.11 -43.12 14.57 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.52 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.609 ' CG2' ' CE3' ' A' ' 85' ' ' TRP . 14.5 p -79.79 -27.64 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.378 -0.827 . . . . 0.0 109.175 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.631 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -54.44 -57.93 5.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.631 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -81.22 -25.01 37.02 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.418 -178.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.579 ' CG ' ' HA ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -81.08 -31.58 34.31 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.003 -1.686 . . . . 0.0 111.457 -177.564 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.578 ' HG ' ' CD2' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -79.86 -42.34 24.44 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.008 -1.058 . . . . 0.0 109.995 -179.321 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.491 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 1.7 mt-30 -67.96 -34.45 76.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.013 -1.054 . . . . 0.0 109.901 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.52 -9.68 58.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.033 -1.042 . . . . 0.0 110.132 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.495 ' CA ' ' OE1' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -101.2 -64.06 1.08 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.089 -1.007 . . . . 0.0 109.675 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.597 HG22 ' HA ' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -101.85 -29.16 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.457 -0.777 . . . . 0.0 109.158 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 59.5 53.48 45.74 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.571 ' CD1' ' C ' ' A' ' 94' ' ' PRO . 0.7 OUTLIER -92.43 -165.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.535 ' HB ' ' CB ' ' A' ' 91' ' ' GLU . 98.8 m -137.51 91.04 14.38 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.595 -1.316 . . . . 0.0 109.418 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.594 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 1.8 Cg_endo -63.93 157.22 53.88 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.33 2.02 . . . . 0.0 110.809 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -120.73 -45.39 2.4 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 110.037 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.87 104.24 3.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.997 -1.064 . . . . 0.0 109.759 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.8 OUTLIER -134.84 172.29 13.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.197 -0.94 . . . . 0.0 110.317 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.59 151.99 17.5 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.535 ' CD1' ' O ' ' A' ' 84' ' ' PHE . 27.1 tp -70.27 100.64 1.74 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.906 -1.121 . . . . 0.0 109.594 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.635 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.7 OUTLIER -43.43 -77.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.635 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 2.3 tt0 -169.15 114.87 0.58 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.775 -0.578 . . . . 0.0 109.572 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.456 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -86.35 163.65 17.53 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.371 -0.831 . . . . 0.0 110.119 -179.623 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.531 ' CD2' ' HB ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -126.13 -165.69 1.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -153.42 145.92 24.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.011 -1.056 . . . . 0.0 110.278 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.59 174.44 10.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 109.06 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 13.9 tt0 -155.63 113.68 3.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.147 -0.97 . . . . 0.0 109.623 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.565 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -79.59 -178.35 1.09 Allowed Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.724 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.565 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 4.8 Cg_endo -73.2 30.51 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.109 1.873 . . . . 0.0 111.486 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.447 ' OD2' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -162.52 -44.69 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.376 -1.452 . . . . 0.0 110.51 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.447 ' HG2' ' OD2' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -133.16 -178.18 4.86 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.163 -0.961 . . . . 0.0 110.069 -178.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -108.3 121.52 45.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.355 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.412 HD13 ' CD1' ' A' ' 75' ' ' PHE . 4.9 mt -90.28 88.26 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.052 -1.03 . . . . 0.0 109.639 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 5' ' ' GLN . 1.3 m -85.28 120.63 26.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.288 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.462 ' HG ' ' HB ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -120.77 138.21 54.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.552 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.525 ' CD1' ' O ' ' A' ' 6' ' ' ILE . 1.4 m95 -96.43 165.27 12.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.371 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.535 ' O ' ' CD1' ' A' ' 67' ' ' LEU . 2.5 m-85 -130.59 74.62 1.61 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.915 . . . . 0.0 109.261 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.609 ' CE3' ' CG2' ' A' ' 50' ' ' VAL . 2.9 m0 -79.68 86.43 5.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.193 -0.942 . . . . 0.0 109.741 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.556 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 28.4 tp -88.37 106.32 18.17 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 65' ' ' PHE . 16.3 m -87.75 177.21 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.028 -1.045 . . . . 0.0 110.235 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -132.58 -23.44 2.08 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.395 -0.816 . . . . 0.0 110.118 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.587 ' NH1' ' CG ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -147.87 148.84 31.28 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 120.841 -1.162 . . . . 0.0 110.944 -179.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.634 ' NE1' ' O ' ' A' ' 92' ' ' GLY . 4.1 p90 -166.4 -172.26 2.16 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.663 0.744 . . . . 0.0 109.579 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.535 ' CB ' ' HB ' ' A' ' 61' ' ' THR . 5.3 tt0 -92.76 -84.1 0.29 Allowed 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.837 -178.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.634 ' O ' ' NE1' ' A' ' 90' ' ' TRP . . . -46.59 178.83 0.01 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.802 ' N ' ' CD ' ' A' ' 94' ' ' PRO . 1.6 tt0 -87.32 -25.5 0.33 Allowed Pre-proline 0 N--CA 1.502 2.168 0 O-C-N 121.222 -1.164 . . . . 0.0 114.078 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.802 ' CD ' ' N ' ' A' ' 93' ' ' GLU . 49.3 Cg_endo -94.51 -159.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.951 0 C-N-CA 124.333 3.355 . . . . 0.0 110.566 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.677 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 3.1 t90 150.59 35.88 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 123.551 0.741 . . . . 0.0 110.815 176.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -135.13 -105.85 0.84 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -93.92 146.1 24.15 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.358 -1.084 . . . . 0.0 108.884 179.34 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -101.54 133.44 46.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 109.369 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.25 -11.09 72.15 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.458 ' CG ' ' HD2' ' A' ' 101' ' ' PRO . 8.4 tp60 -88.64 138.94 29.6 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.433 -1.039 . . . . 0.0 108.888 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 102' ' ' GLY . 6.3 Cg_exo -57.48 -78.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.98 1.787 . . . . 0.0 110.916 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . 51.87 174.49 0.03 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.6 OUTLIER -160.27 176.57 11.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.606 -1.526 . . . . 0.0 111.437 -178.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.545 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 3.9 m0 -95.8 144.85 25.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.783 -0.573 . . . . 0.0 109.869 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.523 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.6 ttm -110.37 -176.0 2.87 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.503 ' O ' ' C ' ' A' ' 107' ' ' LEU . 29.1 t -131.57 32.79 4.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.846 -1.159 . . . . 0.0 110.342 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.503 ' C ' ' O ' ' A' ' 106' ' ' SER . 1.0 OUTLIER 33.04 59.4 0.44 Allowed 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.141 0.496 . . . . 0.0 109.988 179.419 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.9 t -108.87 -40.42 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.163 -0.961 . . . . 0.0 109.779 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -149.79 35.71 1.0 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 109' ' ' GLY . 1.0 OUTLIER -45.48 138.45 4.34 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.208 -1.172 . . . . 0.0 109.207 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -160.91 154.13 21.59 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.256 -0.902 . . . . 0.0 109.852 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.47 -14.64 20.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -0.892 . . . . 0.0 109.039 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.94 -41.85 97.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.898 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.539 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.5 t0 -77.82 -10.57 59.62 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.591 ' CD1' HD13 ' A' ' 123' ' ' ILE . 8.6 m-85 -103.79 106.53 53.02 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.494 ' HG2' ' O ' ' A' ' 33' ' ' LEU . 11.7 Cg_exo -48.37 158.47 1.01 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.804 1.67 . . . . 0.0 110.047 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 6.1 Cg_exo -56.71 -173.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.185 1.923 . . . . 0.0 110.86 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 84.39 -21.08 0.27 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.81 -0.556 . . . . 0.0 110.118 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.554 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 0.8 OUTLIER -124.27 39.89 3.86 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.932 -1.105 . . . . 0.0 109.869 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.694 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.9 mm-40 -71.76 -33.99 2.83 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 112.712 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.9 Cg_exo -61.79 -36.31 74.33 Favored 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 121.842 1.695 . . . . 0.0 112.088 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.54 ' O ' HD21 ' A' ' 126' ' ' LEU . 1.2 t -100.92 -43.53 10.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 O-C-N 120.498 -1.376 . . . . 0.0 108.399 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.591 HD13 ' CD1' ' A' ' 115' ' ' PHE . 22.5 mm -54.6 -32.92 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 O-C-N 121.494 -0.754 . . . . 0.0 109.41 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.92 -39.55 26.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.544 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.45 -33.17 36.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.361 -0.837 . . . . 0.0 110.909 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.549 ' CA ' HD13 ' A' ' 129' ' ' LEU . 4.4 mm? -47.86 -31.4 5.02 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.907 -1.121 . . . . 0.0 109.801 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -60.78 -52.28 65.77 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.53 ' O ' ' C ' ' A' ' 129' ' ' LEU . 4.7 mtt180 -82.19 10.1 7.46 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.472 -0.767 . . . . 0.0 109.275 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.549 HD13 ' CA ' ' A' ' 126' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 117.937 -1.03 . . . . 0.0 111.023 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.53 ' CB ' ' NE2' ' A' ' 79' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 1' ' ' MET . 2.7 mptt 71.45 105.75 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.58 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.51 117.07 2.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.484 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.3 tp -119.6 139.23 52.51 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.274 -0.892 . . . . 0.0 109.131 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.495 ' HB3' HG22 ' A' ' 40' ' ' ILE . 3.4 tt0 -143.68 158.95 43.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.208 -0.933 . . . . 0.0 109.433 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.551 ' CG2' ' N ' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -123.04 167.43 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.097 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.551 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . -129.93 93.23 3.46 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.07 -1.019 . . . . 0.0 109.609 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.567 HG11 ' HA ' ' A' ' 84' ' ' PHE . 7.5 p -102.32 155.65 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.209 -0.932 . . . . 0.0 109.861 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.4 125.49 2.91 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.563 HD11 ' CD2' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -104.37 155.85 5.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.006 -1.291 . . . . 0.0 107.565 -179.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.629 ' CG2' ' CZ3' ' A' ' 90' ' ' TRP . 2.0 mt -147.03 138.39 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.518 -1.364 . . . . 0.0 111.504 -176.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 23.4 ttp180 -140.46 127.53 20.86 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.57 ' OD1' ' CZ2' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -108.09 -169.46 1.52 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.258 -0.901 . . . . 0.0 110.66 -178.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.68 -5.3 19.48 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.56 -0.712 . . . . 0.0 110.075 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -79.1 7.32 7.66 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.457 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 5.4 t-20 53.75 44.56 29.44 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.776 0.798 . . . . 0.0 109.759 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 4.9 mt-10 -140.85 153.41 45.74 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.9 mt -119.56 163.71 16.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.99 -1.069 . . . . 0.0 109.453 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -116.78 98.59 6.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.835 -1.166 . . . . 0.0 109.192 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.518 ' CD1' ' HE3' ' A' ' 105' ' ' MET . 0.8 OUTLIER -119.76 -159.72 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.475 ' OG1' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -121.08 132.86 55.13 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.023 -1.048 . . . . 0.0 109.521 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.445 ' HD2' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -145.21 132.16 20.24 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.304 -0.873 . . . . 0.0 109.682 -179.49 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -69.55 87.02 0.47 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.264 -0.898 . . . . 0.0 109.555 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.87 87.69 0.25 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.839 . . . . 0.0 109.512 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.468 ' O ' ' CB ' ' A' ' 26' ' ' ASP . . . -154.77 54.94 0.67 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.952 . . . . 0.0 109.447 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.558 ' OD2' ' CD2' ' A' ' 28' ' ' HIS . 10.3 t70 74.01 74.52 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.671 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.85 53.68 0.68 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.938 . . . . 0.0 109.365 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.558 ' CD2' ' OD2' ' A' ' 26' ' ' ASP . 31.7 p80 -93.81 -33.01 13.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.327 -0.858 . . . . 0.0 109.493 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.9 ppp? -69.56 -23.1 63.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.906 . . . . 0.0 109.584 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -165.85 121.24 1.26 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 109.7 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -83.3 144.43 29.71 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.271 -0.893 . . . . 0.0 108.941 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HB2' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -159.0 134.96 8.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.018 -1.051 . . . . 0.0 110.059 -179.425 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.541 ' CD1' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -115.11 -170.11 1.69 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.274 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.496 ' O ' HG23 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -162.97 -164.48 0.98 Allowed 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.868 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.515 ' CE2' ' CD2' ' A' ' 84' ' ' PHE . 48.7 m-85 -132.37 106.37 13.32 Favored Pre-proline 0 C--N 1.291 -1.949 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.486 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 2.8 Cg_exo -54.94 -149.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.986 1.79 . . . . 0.0 110.659 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 151.67 154.53 6.62 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -130.15 28.27 3.89 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 4.3 mptp? 74.35 160.18 0.23 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.615 -0.933 . . . . 0.0 109.238 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.516 HG23 ' N ' ' A' ' 6' ' ' ILE . 2.4 tt -155.34 58.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.322 -0.861 . . . . 0.0 109.222 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 42' ' ' MET . 3.9 mm-40 -84.32 -127.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.298 -0.877 . . . . 0.0 109.314 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.425 ' C ' ' O ' ' A' ' 41' ' ' GLU . 4.6 mtp -44.66 163.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.858 -1.151 . . . . 0.0 109.629 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.6 -131.08 3.43 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.531 ' CB ' ' OE1' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -132.3 -64.44 0.77 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.144 -1.209 . . . . 0.0 109.553 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.598 ' CB ' ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -146.19 -178.09 0.74 Allowed Pre-proline 0 C--N 1.305 -1.369 0 O-C-N 121.369 -0.832 . . . . 0.0 108.821 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.598 ' CD ' ' CB ' ' A' ' 45' ' ' THR . 1.8 Cg_endo -68.09 -10.76 29.89 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.945 1.763 . . . . 0.0 110.338 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -100.76 -56.15 2.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.335 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.577 ' O ' HG13 ' A' ' 51' ' ' VAL . 2.9 tt0 -58.5 -40.18 82.11 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.608 1.194 . . . . 0.0 108.741 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.462 ' HB2' HG13 ' A' ' 40' ' ' ILE . . . -43.38 -60.02 1.88 Allowed 'General case' 0 C--N 1.273 -2.719 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.446 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.58 HG12 ' CH2' ' A' ' 85' ' ' TRP . 9.8 p -81.45 -11.52 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.473 -0.767 . . . . 0.0 110.88 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.608 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -66.04 -50.44 69.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.608 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -59.55 -35.73 74.8 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.279 177.171 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HA ' ' HB2' ' A' ' 56' ' ' GLU . 25.7 mt-10 -73.02 -21.23 60.86 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.539 ' CD2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -60.84 -55.89 27.65 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.501 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 10.6 mt-30 -80.79 -22.57 39.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 109.742 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 53' ' ' GLU . 2.5 mt-10 -80.67 17.31 1.16 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.096 -1.003 . . . . 0.0 110.455 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.597 ' HB3' ' CD1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -137.75 -61.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.873 -1.142 . . . . 0.0 109.892 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.572 HG22 ' CG2' ' A' ' 60' ' ' ILE . 4.3 m -128.59 -34.03 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 109.704 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 90.94 36.2 6.83 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.596 ' O ' ' CB ' ' A' ' 61' ' ' THR . 17.1 pt -92.53 -166.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.053 -1.263 . . . . 0.0 109.521 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.759 ' N ' ' CD ' ' A' ' 62' ' ' PRO . 0.6 OUTLIER 93.05 13.77 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.292 -179.274 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.759 ' CD ' ' N ' ' A' ' 61' ' ' THR . 3.5 Cg_endo -63.75 -22.84 69.52 Favored 'Trans proline' 0 C--N 1.326 -0.615 0 CA-C-N 119.909 1.003 . . . . 0.0 110.401 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.611 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 7.1 mm100 -86.78 -68.7 0.73 Allowed 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.611 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 3.8 t-160 167.52 158.27 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.21 0.529 . . . . 0.0 110.545 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.651 ' CE2' ' CZ3' ' A' ' 85' ' ' TRP . 29.4 p90 -141.99 171.22 14.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.318 -0.864 . . . . 0.0 109.118 177.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' O ' ' A' ' 86' ' ' LEU . 73.2 m -163.77 128.76 2.91 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.036 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.598 HD12 ' CE3' ' A' ' 83' ' ' TRP . 0.6 OUTLIER -80.21 124.95 29.25 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.604 -1.31 . . . . 0.0 108.898 179.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.653 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 27.9 p90 -73.2 -52.18 15.05 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.55 -0.719 . . . . 0.0 109.701 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.653 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 2.4 tt0 176.74 138.74 0.06 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.656 -0.652 . . . . 0.0 109.808 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.41 165.6 11.15 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.07 -1.019 . . . . 0.0 109.029 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.547 ' CD2' ' HB ' ' A' ' 122' ' ' VAL . 0.4 OUTLIER -129.44 -170.1 2.23 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.352 -0.842 . . . . 0.0 109.456 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.492 ' HG2' ' N ' ' A' ' 73' ' ' TYR . 19.1 tt0 -145.6 146.6 31.42 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.423 -0.798 . . . . 0.0 109.194 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.492 ' N ' ' HG2' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -144.84 79.92 1.61 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.422 -0.799 . . . . 0.0 109.36 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.4 OUTLIER -81.69 114.58 20.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 109.34 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.53 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -79.45 176.69 3.49 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 1.7 Cg_endo -63.3 -8.77 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 121.67 1.58 . . . . 0.0 109.734 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -102.69 -66.87 0.9 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.402 -0.811 . . . . 0.0 110.881 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.405 ' HA ' ' HB3' ' A' ' 1' ' ' MET . 0.1 OUTLIER -129.04 -171.62 2.53 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.192 -0.942 . . . . 0.0 110.686 -177.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.557 ' N ' ' CD2' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -105.49 88.18 2.78 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.3 mm -81.71 118.2 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 109.474 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.459 HG21 ' HA ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -119.05 146.56 44.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.496 HD11 ' N ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -131.14 123.94 29.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 108.893 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.603 ' CD1' ' O ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -119.0 124.29 46.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.363 -0.835 . . . . 0.0 110.082 -177.759 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.682 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -129.07 103.17 6.84 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 120.489 -1.382 . . . . 0.0 109.975 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.652 ' CD1' ' O ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -82.42 98.9 9.12 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.706 0.765 . . . . 0.0 109.156 179.331 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.563 ' CD2' HD11 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -63.14 118.52 8.03 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.735 -1.228 . . . . 0.0 109.712 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.606 ' CG2' ' CG2' ' A' ' 11' ' ' ILE . 19.3 m -81.24 -167.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 120.95 -1.094 . . . . 0.0 109.686 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.508 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 8.9 mt-10 -125.14 -45.76 1.84 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.165 -0.959 . . . . 0.0 110.49 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.518 ' HB3' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -160.94 171.2 19.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.183 -0.948 . . . . 0.0 109.963 -179.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.629 ' CZ3' ' CG2' ' A' ' 11' ' ' ILE . 38.8 p90 -170.14 -175.02 1.88 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.2 1.0 . . . . 0.0 111.052 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.59 ' N ' ' HG2' ' A' ' 62' ' ' PRO . 2.6 tt0 -120.69 -34.5 3.57 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.381 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.479 ' O ' ' CD1' ' A' ' 90' ' ' TRP . . . -80.18 -155.93 11.78 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 121.092 -1.005 . . . . 0.0 110.911 -178.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.567 ' O ' ' CB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -105.31 127.97 27.54 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.437 -1.037 . . . . 0.0 109.456 -179.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.587 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 2.8 Cg_endo -58.74 133.83 56.58 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.432 2.088 . . . . 0.0 111.705 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.597 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 4.8 p-90 -110.56 -171.74 1.89 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.923 -1.111 . . . . 0.0 108.49 178.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 36' ' ' PRO . . . 146.18 -42.91 0.92 Allowed Glycine 0 C--N 1.296 -1.679 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 100' ' ' GLN . 1.1 ptmm? -66.08 126.48 28.76 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.651 -0.911 . . . . 0.0 109.781 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -93.57 -49.56 5.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.198 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.91 5.58 5.42 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 1.3 mt-30 -109.09 160.57 27.0 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.27 -1.135 . . . . 0.0 109.43 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 102' ' ' GLY . 1.9 Cg_endo -66.21 -30.43 46.05 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.156 1.904 . . . . 0.0 111.427 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 101' ' ' PRO . . . 56.66 162.55 0.03 OUTLIER Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -161.58 -168.7 2.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.66 -1.494 . . . . 0.0 110.503 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.493 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 31.9 m95 -107.47 132.34 53.32 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.556 -0.715 . . . . 0.0 109.219 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.518 ' HE3' ' CD1' ' A' ' 20' ' ' ILE . 30.2 ttp -108.29 147.63 31.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.268 -0.895 . . . . 0.0 109.217 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.436 ' OG ' HG22 ' A' ' 108' ' ' VAL . 45.6 t -83.66 138.71 33.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.891 -1.131 . . . . 0.0 109.126 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.44 ' O ' HD21 ' A' ' 107' ' ' LEU . 3.1 tt -108.29 59.73 0.61 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.211 -0.931 . . . . 0.0 109.411 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.436 HG22 ' OG ' ' A' ' 106' ' ' SER . 2.1 t -93.44 19.31 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 145.03 49.85 0.03 OUTLIER Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.495 ' CD2' ' OD2' ' A' ' 114' ' ' ASP . 1.1 mt -41.59 142.59 0.6 Allowed 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.694 -0.886 . . . . 0.0 109.317 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 2.4 t-20 -133.71 155.9 48.92 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 109.51 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.479 ' HB3' HG21 ' A' ' 123' ' ' ILE . . . -63.64 -19.02 64.53 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.271 -0.893 . . . . 0.0 108.747 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.437 ' O ' ' CG ' ' A' ' 113' ' ' ASP . 26.3 t0 -93.0 22.5 4.9 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.429 -0.795 . . . . 0.0 109.487 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.541 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -78.16 -1.61 33.5 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.551 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.68 ' N ' ' CD1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -160.5 160.32 25.89 Favored Pre-proline 0 C--N 1.3 -1.553 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.291 177.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 74.7 Cg_exo -36.69 124.6 0.39 Allowed 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.828 2.352 . . . . 0.0 110.403 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.562 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 4.6 Cg_exo -58.55 144.2 97.42 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 122.561 2.174 . . . . 0.0 111.382 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 156.67 -19.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.581 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 0.8 OUTLIER -119.88 42.15 2.99 Favored 'General case' 0 C--O 1.205 -1.286 0 O-C-N 121.316 -0.865 . . . . 0.0 109.368 -179.364 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.639 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 6.0 mt-10 -60.16 -39.12 66.05 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 120.949 -1.094 . . . . 0.0 113.243 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 5.2 Cg_exo -62.29 -46.8 11.38 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.229 1.953 . . . . 0.0 113.011 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.579 HG12 ' CE2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -90.22 -30.09 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.417 -1.427 . . . . 0.0 108.95 -178.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.626 HD13 ' CE1' ' A' ' 115' ' ' PHE . 1.6 mm -64.06 -34.38 68.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.465 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -60.95 -20.38 62.19 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.419 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.73 -61.75 1.88 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.399 -0.813 . . . . 0.0 110.985 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 123' ' ' ILE . 0.6 OUTLIER -78.82 22.69 0.36 Allowed 'General case' 0 C--N 1.31 -1.137 0 O-C-N 120.803 -1.186 . . . . 0.0 111.403 -178.672 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.465 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 5.3 mtmt -65.91 -35.57 81.0 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.652 -1.28 . . . . 0.0 107.932 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.534 ' O ' ' C ' ' A' ' 129' ' ' LEU . 9.0 mtm180 -78.77 -0.03 28.76 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.897 -0.502 . . . . 0.0 110.03 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.554 ' CD2' HD22 ' A' ' 86' ' ' LEU . 4.3 tp . . . . . 0 N--CA 1.5 2.032 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.882 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.483 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -116.51 -141.99 0.37 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 109.432 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -158.51 119.49 3.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.052 -1.03 . . . . 0.0 109.699 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 79' ' ' HIS . 0.7 OUTLIER -119.67 138.29 53.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 109.169 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.441 ' HB2' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -133.09 147.41 52.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.735 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 7' ' ' ALA . 4.4 mt -121.98 168.61 14.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.325 -0.86 . . . . 0.0 108.895 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.559 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . -135.74 98.31 3.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.123 -0.986 . . . . 0.0 109.618 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.499 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 7.3 p -106.92 161.89 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.811 . . . . 0.0 109.366 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.581 ' HA3' ' CZ3' ' A' ' 95' ' ' TRP . . . -141.33 121.21 1.83 Allowed Glycine 0 C--N 1.297 -1.621 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.569 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -94.33 156.6 3.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.613 ' CG2' ' CE3' ' A' ' 90' ' ' TRP . 2.2 mt -143.15 124.1 10.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 118.486 -1.286 . . . . 0.0 111.308 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.536 ' HD3' ' CG1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -122.21 136.31 54.89 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.268 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -109.12 -169.37 1.47 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 0.0 110.179 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -81.12 0.21 37.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.682 -0.636 . . . . 0.0 109.327 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.446 ' OD1' ' OE2' ' A' ' 17' ' ' GLU . 6.5 t-20 -89.34 12.82 15.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.282 -0.886 . . . . 0.0 109.063 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.466 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 18.4 t30 57.41 44.07 22.1 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.768 0.795 . . . . 0.0 109.224 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 3.4 mt-10 -143.25 149.21 37.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.091 -1.006 . . . . 0.0 109.038 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.539 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -128.19 151.24 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.094 -1.004 . . . . 0.0 109.864 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.582 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 21.8 t80 -85.97 66.83 9.78 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.567 ' CG2' ' N ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -83.91 -155.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.102 -0.999 . . . . 0.0 110.303 -178.592 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.567 ' N ' ' CG2' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -132.11 142.16 49.4 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.558 ' HG2' ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.04 -161.33 0.89 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.039 -1.038 . . . . 0.0 110.675 -178.011 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.97 94.27 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.541 -0.724 . . . . 0.0 110.18 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.519 ' O ' ' CB ' ' A' ' 25' ' ' ALA . . . -110.74 94.4 4.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.277 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 24' ' ' ALA . . . 79.3 153.64 0.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.417 -0.802 . . . . 0.0 109.549 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 27' ' ' ALA . 24.1 m-20 49.87 -106.29 0.21 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.335 -0.853 . . . . 0.0 109.351 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 26' ' ' ASP . . . 42.41 86.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.984 -1.073 . . . . 0.0 109.591 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -84.53 -84.88 0.14 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 109.793 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -107.48 178.25 4.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 109.566 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 31' ' ' ASN . . . 48.48 92.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.917 . . . . 0.0 109.603 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 30' ' ' ALA . 82.3 m-20 -43.71 113.74 0.55 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.309 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -100.79 140.78 34.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.843 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.558 ' CD2' ' HG2' ' A' ' 22' ' ' ARG . 5.3 mt -103.7 -172.72 2.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.452 -0.78 . . . . 0.0 109.026 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.467 ' O ' HD13 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -160.68 -154.68 0.38 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.626 ' CE2' ' CZ ' ' A' ' 84' ' ' PHE . 3.6 m-85 -150.65 137.49 11.43 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.436 ' HD2' HG22 ' A' ' 8' ' ' VAL . 2.6 Cg_endo -61.19 -160.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.87 1.713 . . . . 0.0 109.582 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.518 ' N ' ' HB2' ' A' ' 97' ' ' LYS . . . 152.87 158.42 8.51 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.096 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.78 20.85 2.88 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.18 158.51 0.16 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.509 -0.995 . . . . 0.0 109.516 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.441 HG22 ' HB2' ' A' ' 5' ' ' GLN . 11.2 tt -138.43 101.61 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.349 -0.844 . . . . 0.0 109.222 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -111.77 -7.45 14.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.81 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.56 -76.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.167 -0.958 . . . . 0.0 109.307 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.78 4.82 18.86 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.09 -79.4 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.046 -1.267 . . . . 0.0 109.585 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.499 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -160.8 169.07 10.61 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.846 -1.159 . . . . 0.0 109.762 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.499 ' HD2' HG22 ' A' ' 45' ' ' THR . 8.5 Cg_endo -74.59 19.21 0.47 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 123.255 2.637 . . . . 0.0 112.004 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.492 ' HB2' ' CG2' ' A' ' 45' ' ' THR . 2.0 mt-10 -111.5 -46.07 3.31 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.857 -1.152 . . . . 0.0 108.789 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.523 ' O ' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -73.28 -55.06 6.92 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.245 1.021 . . . . 0.0 109.1 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.481 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . -38.3 -59.94 0.83 Allowed 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.089 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 51' ' ' VAL . 7.1 p -66.26 -33.11 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.214 -0.929 . . . . 0.0 108.936 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.629 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -45.5 -58.2 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.428 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.629 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -66.37 -28.93 69.03 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.308 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.525 ' HA ' ' CG ' ' A' ' 56' ' ' GLU . 4.2 mm-40 -72.64 -6.79 46.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.016 -1.053 . . . . 0.0 109.058 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.601 HD13 ' CH2' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -80.5 -60.64 2.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.555 -0.716 . . . . 0.0 109.659 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.468 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 5.7 mt-30 -80.57 -23.44 39.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.294 -0.879 . . . . 0.0 110.708 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 1.4 pp20? -80.86 20.15 0.79 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.024 -1.048 . . . . 0.0 110.615 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 95' ' ' TRP . 3.0 mt-10 -142.18 -63.18 0.44 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.742 -1.224 . . . . 0.0 110.061 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.589 ' CG1' ' HB3' ' A' ' 95' ' ' TRP . 2.0 m -123.52 -31.78 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.985 -1.072 . . . . 0.0 109.154 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.57 ' N ' HG21 ' A' ' 58' ' ' VAL . . . 67.88 66.2 2.42 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.586 ' CG2' ' HB2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -83.19 155.67 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.55 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.594 ' OG1' ' HD3' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -107.46 -60.99 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.263 0 O-C-N 120.527 -1.358 . . . . 0.0 111.834 -177.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.594 ' HD3' ' OG1' ' A' ' 61' ' ' THR . 7.0 Cg_endo -73.7 52.7 2.57 Favored 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 122.031 1.821 . . . . 0.0 110.875 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.648 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -105.82 69.28 0.81 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.867 -1.146 . . . . 0.0 110.054 -178.535 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -63.68 115.08 4.41 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.554 ' CD1' ' CZ3' ' A' ' 85' ' ' TRP . 39.3 p90 -131.14 176.0 8.63 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 122.941 1.353 . . . . 0.0 112.209 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 68' ' ' PHE . 19.1 m -163.04 130.16 3.53 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 68' ' ' PHE . 26.6 tp -50.31 96.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.486 -1.384 . . . . 0.0 109.162 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.599 ' CZ ' HD21 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -43.06 -74.33 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.597 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 3.3 tt0 -162.61 161.83 26.86 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.352 0.596 . . . . 0.0 109.704 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.544 ' HG2' ' N ' ' A' ' 71' ' ' LEU . 22.3 ttmt -116.16 154.3 30.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 0.0 109.174 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.577 HD23 ' CE1' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -126.67 -174.89 3.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.078 -1.014 . . . . 0.0 109.642 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -157.29 151.22 24.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.389 -0.819 . . . . 0.0 109.2 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.46 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . 6.8 t80 -154.39 165.13 37.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.058 -1.026 . . . . 0.0 110.082 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -148.14 122.24 9.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.414 -0.803 . . . . 0.0 109.365 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.524 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -82.32 172.27 9.96 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.524 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 6.0 Cg_exo -58.38 -15.77 25.87 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.934 1.756 . . . . 0.0 110.01 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -156.81 7.28 0.18 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.513 -0.742 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.496 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 1.8 mmm180 -129.18 -169.59 2.12 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 120.659 -1.276 . . . . 0.0 109.613 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.483 ' ND1' ' O ' ' A' ' 2' ' ' LYS . 35.5 m80 -144.48 129.74 18.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.333 -0.854 . . . . 0.0 108.969 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 2.7 mm -116.26 83.98 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.93 . . . . 0.0 110.03 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.26 86.62 6.2 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.435 ' O ' HD13 ' A' ' 71' ' ' LEU . 1.4 mp -102.31 167.52 9.92 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.181 -0.949 . . . . 0.0 110.364 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.541 ' CD1' ' O ' ' A' ' 6' ' ' ILE . 1.7 m95 -122.65 164.26 18.56 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.626 ' CZ ' ' CE2' ' A' ' 35' ' ' PHE . 1.8 m-85 -136.51 88.94 2.42 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.07 -1.019 . . . . 0.0 109.557 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.645 ' CZ2' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.04 151.53 21.61 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.388 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.569 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 14.7 tp -142.55 127.67 18.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.787 -1.195 . . . . 0.0 109.615 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.645 ' CG1' ' CZ2' ' A' ' 85' ' ' TRP . 9.1 m -99.07 -161.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.314 -0.866 . . . . 0.0 109.997 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -141.99 -23.42 0.7 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.287 -0.883 . . . . 0.0 111.484 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.648 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -159.96 -167.43 1.96 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.343 -1.473 . . . . 0.0 110.672 -179.186 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.62 ' HB3' ' O ' ' A' ' 89' ' ' ARG . 28.6 p90 158.68 171.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.517 1.151 . . . . 0.0 110.294 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.593 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 8.9 tt0 -111.93 -63.19 1.45 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.743 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.5 ' N ' HG23 ' A' ' 60' ' ' ILE . . . -56.74 -156.39 0.01 OUTLIER Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.573 ' O ' ' CB ' ' A' ' 58' ' ' VAL . 1.2 pm0 -105.8 128.09 27.14 Favored Pre-proline 0 C--N 1.307 -1.244 0 O-C-N 121.38 -1.07 . . . . 0.0 109.348 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.585 ' HG3' ' CZ2' ' A' ' 90' ' ' TRP . 13.5 Cg_exo -46.77 144.91 7.32 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.465 2.11 . . . . 0.0 112.05 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.589 ' HB3' ' CG1' ' A' ' 58' ' ' VAL . 11.1 p-90 -107.51 -167.72 1.3 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.61 -96.18 0.14 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.518 ' HB2' ' N ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -118.0 138.74 51.99 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.506 -0.996 . . . . 0.0 109.25 179.515 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 98' ' ' GLU . 12.0 tm-20 -92.66 68.88 4.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 109.202 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.436 ' O ' ' HD3' ' A' ' 101' ' ' PRO . . . 175.13 -31.89 0.09 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.413 ' HG2' HG23 ' A' ' 21' ' ' THR . 0.0 OUTLIER -92.74 111.19 49.94 Favored Pre-proline 0 C--N 1.297 -1.689 0 O-C-N 121.65 -0.912 . . . . 0.0 108.745 179.363 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 99' ' ' GLY . 1.1 Cg_endo -63.25 82.14 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.059 1.839 . . . . 0.0 110.935 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -86.12 170.61 43.41 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -161.33 172.88 15.81 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.586 -1.538 . . . . 0.0 111.504 -179.282 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.482 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 4.6 m0 -84.91 106.86 16.74 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.458 ' HE3' HG23 ' A' ' 20' ' ' ILE . 3.7 ttp -107.8 136.56 47.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.335 -0.853 . . . . 0.0 109.067 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.86 85.81 4.9 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.227 -0.921 . . . . 0.0 109.359 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.523 ' O ' ' CG1' ' A' ' 108' ' ' VAL . 1.4 mt -76.96 -52.58 9.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.916 . . . . 0.0 109.59 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 0.4 OUTLIER 72.52 27.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 122.155 0.979 . . . . 0.0 108.579 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 163.63 50.6 0.02 OUTLIER Glycine 0 N--CA 1.485 1.944 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 109' ' ' GLY . 0.7 OUTLIER -38.12 144.28 0.1 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.769 -0.842 . . . . 0.0 109.98 -178.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -156.43 151.87 26.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.122 -0.986 . . . . 0.0 109.801 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.527 ' CB ' HG23 ' A' ' 123' ' ' ILE . . . -68.36 -7.5 31.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.264 -0.898 . . . . 0.0 109.403 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -61.02 -42.73 99.01 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.256 -0.902 . . . . 0.0 109.93 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.484 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -79.12 -9.2 59.49 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.096 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.534 ' CE2' ' CE2' ' A' ' 35' ' ' PHE . 9.6 m-85 -98.43 137.43 20.71 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.005 -1.059 . . . . 0.0 109.456 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 115' ' ' PHE . 1.9 Cg_endo -68.8 164.19 34.35 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.256 1.97 . . . . 0.0 110.281 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.537 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 1.5 Cg_endo -63.29 119.07 5.99 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.404 2.07 . . . . 0.0 110.434 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 161.74 -51.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 109.831 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.562 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 28.2 m-20 -106.19 38.38 2.05 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.234 -0.916 . . . . 0.0 109.347 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.68 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 20.2 mt-10 -65.89 -36.71 14.59 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.346 -0.846 . . . . 0.0 112.704 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.8 Cg_exo -63.34 -36.2 57.42 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.099 1.866 . . . . 0.0 112.425 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.581 HG12 ' CG ' ' A' ' 84' ' ' PHE . 1.2 t -98.51 -39.3 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 120.449 -1.407 . . . . 0.0 108.003 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.562 ' CG1' ' O ' ' A' ' 119' ' ' ASN . 25.2 mm -58.66 -30.57 42.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.517 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -70.3 -26.37 63.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.468 -0.77 . . . . 0.0 110.688 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.427 ' HG2' ' OE1' ' A' ' 69' ' ' GLU . 16.9 tptt -76.19 -57.21 4.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.882 -1.136 . . . . 0.0 110.522 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.599 HD21 ' CZ ' ' A' ' 68' ' ' PHE . 2.4 pt? -74.84 11.78 0.99 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.054 -1.029 . . . . 0.0 111.219 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.517 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 37.4 mttt -49.51 -43.05 45.22 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.353 -1.467 . . . . 0.0 107.695 178.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.477 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -109.84 46.15 1.04 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.797 -0.565 . . . . 0.0 110.842 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.539 ' CD2' ' HB2' ' A' ' 126' ' ' LEU . 1.3 mp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.336 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.449 ' O ' ' HE3' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.57 144.2 48.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.62 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.463 ' O ' HD21 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -57.1 148.46 21.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.351 -0.843 . . . . 0.0 109.321 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.482 HD11 HD12 ' A' ' 80' ' ' ILE . 23.5 mt -134.32 73.67 1.5 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 109.801 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.459 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . 1.1 mp0 -87.46 116.47 25.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.228 -0.92 . . . . 0.0 108.869 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 38' ' ' GLY . 1.4 mp -112.47 141.18 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.094 -1.004 . . . . 0.0 109.791 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.408 ' O ' ' CA ' ' A' ' 37' ' ' GLY . . . -103.8 110.72 22.94 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.533 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 3.0 p -127.78 100.09 5.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.131 -0.981 . . . . 0.0 110.352 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.531 ' HA2' ' CD1' ' A' ' 85' ' ' TRP . . . -84.58 118.5 4.74 Favored Glycine 0 C--N 1.296 -1.683 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.564 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 1.8 mt -81.49 173.49 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 120.867 -1.373 . . . . 0.0 107.541 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.556 ' HA ' ' CG2' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -144.56 153.54 14.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 118.039 -1.464 . . . . 0.0 110.435 -178.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 17' ' ' GLU . 37.7 ttp180 -159.3 131.52 6.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.517 -0.739 . . . . 0.0 109.24 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.31 -162.69 0.97 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.14 -0.975 . . . . 0.0 110.577 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.36 -7.32 58.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.626 -0.671 . . . . 0.0 109.713 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.536 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 5.2 t30 -84.53 12.61 6.68 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.124 -0.985 . . . . 0.0 108.667 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' A' ' 107' ' ' LEU . 11.6 t-20 60.03 43.38 14.57 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.64 -0.662 . . . . 0.0 110.522 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.536 ' CG ' ' HB3' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -127.37 154.27 45.19 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.512 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 1.6 mt -119.78 156.34 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.859 -1.15 . . . . 0.0 110.203 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 26.0 t80 -103.15 86.11 2.63 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.627 ' CG2' ' N ' ' A' ' 21' ' ' THR . 0.5 OUTLIER -78.73 176.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.187 0.994 . . . . 0.0 110.101 -178.319 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.627 ' N ' ' CG2' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -153.46 144.24 22.7 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.581 ' CG ' ' HA ' ' A' ' 33' ' ' LEU . 6.4 tpm_? -154.6 106.23 2.7 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 110.062 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.467 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -60.64 100.81 0.11 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.196 -0.94 . . . . 0.0 109.231 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -37.52 109.13 0.09 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.639 -0.663 . . . . 0.0 109.89 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.45 ' O ' ' CB ' ' A' ' 26' ' ' ASP . . . -125.9 36.41 4.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.21 -0.931 . . . . 0.0 109.65 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 1.2 m-20 71.2 4.95 5.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 109.791 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 45.13 -159.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.942 . . . . 0.0 109.623 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.493 ' O ' ' CB ' ' A' ' 29' ' ' MET . 1.4 t60 -176.16 49.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.525 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.493 ' CB ' ' O ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER 163.57 -87.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.4 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.64 -88.75 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 109.228 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -104.8 114.0 27.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.258 -0.901 . . . . 0.0 108.918 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 22' ' ' ARG . 5.9 mmtp -114.55 129.08 56.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.195 -0.941 . . . . 0.0 109.991 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.581 ' HA ' ' CG ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -146.21 -175.71 4.87 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.797 0.808 . . . . 0.0 109.544 179.6 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.57 ' O ' ' CD1' ' A' ' 20' ' ' ILE . 2.3 tt0 -163.06 -154.21 0.28 Allowed 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.634 ' CE2' ' CE2' ' A' ' 84' ' ' PHE . 85.4 m-85 -114.02 158.97 37.92 Favored Pre-proline 0 C--N 1.285 -2.206 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.507 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 3.3 Cg_exo -58.21 -154.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 121.854 1.703 . . . . 0.0 110.167 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.408 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 82.48 -170.65 50.7 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 6' ' ' ILE . . . 177.66 -37.61 0.09 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -168.79 143.61 3.25 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.562 -0.964 . . . . 0.0 109.076 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.524 ' CG2' ' O ' ' A' ' 40' ' ' ILE . 15.5 tt -100.35 115.32 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.103 -0.998 . . . . 0.0 109.705 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 42' ' ' MET . 4.7 mt-10 -101.85 -175.93 2.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.337 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.47 ' O ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 49.16 -178.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.913 . . . . 0.0 109.331 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.98 148.21 10.91 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.444 ' OE1' ' N ' ' A' ' 44' ' ' GLU . 39.6 mp0 -91.47 121.75 33.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.177 -1.19 . . . . 0.0 109.75 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.585 ' CB ' ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -159.96 178.61 1.61 Allowed Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.428 -0.795 . . . . 0.0 109.642 179.738 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 45' ' ' THR . 6.1 Cg_endo -73.62 -20.1 20.73 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.596 2.198 . . . . 0.0 110.903 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.504 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -124.12 -59.04 1.52 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.075 -1.016 . . . . 0.0 110.085 -179.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.563 ' O ' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -44.14 -32.99 1.36 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.285 1.04 . . . . 0.0 110.596 -179.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 45' ' ' THR . . . -81.76 -57.17 3.55 Favored 'General case' 0 C--N 1.272 -2.8 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.988 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -81.9 4.98 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.395 -0.816 . . . . 0.0 110.513 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.563 HG11 ' O ' ' A' ' 48' ' ' GLN . 13.2 p -82.75 -37.65 14.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.501 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -74.65 -31.1 61.85 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.879 -1.509 . . . . 0.0 108.659 178.575 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -72.0 -7.12 46.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.122 -0.986 . . . . 0.0 109.075 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.62 HD21 ' CZ2' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -76.55 -68.11 0.63 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.651 -0.656 . . . . 0.0 109.428 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -82.33 -17.52 45.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.493 -0.754 . . . . 0.0 111.335 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.494 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 2.3 mm-40 -80.28 18.22 0.92 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.791 -1.193 . . . . 0.0 110.461 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.536 ' CB ' ' HB2' ' A' ' 95' ' ' TRP . 7.1 mm-40 -146.76 -65.38 0.28 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.734 -1.229 . . . . 0.0 110.565 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.596 ' CG2' ' O ' ' A' ' 93' ' ' GLU . 3.7 m -124.8 -32.56 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.156 -0.965 . . . . 0.0 108.979 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.445 ' N ' HG21 ' A' ' 58' ' ' VAL . . . 72.16 67.64 1.79 Allowed Glycine 0 N--CA 1.483 1.815 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.572 HG12 ' CG2' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -95.52 171.11 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.351 -1.087 . . . . 0.0 108.17 178.439 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.527 ' HB ' ' CB ' ' A' ' 91' ' ' GLU . 2.7 m -112.99 89.36 13.57 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 1.4 Cg_endo -59.3 131.12 39.17 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.093 1.862 . . . . 0.0 110.177 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.475 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -92.71 -55.48 3.36 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.553 -0.717 . . . . 0.0 110.164 -178.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.45 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 12.0 t-160 -142.27 112.47 7.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.91 -1.119 . . . . 0.0 110.2 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.683 ' CD1' ' CH2' ' A' ' 85' ' ' TRP . 5.5 p90 -135.25 175.26 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.141 -0.974 . . . . 0.0 110.368 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.3 m -162.39 -179.71 7.19 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.54 ' CD1' ' HA ' ' A' ' 85' ' ' TRP . 34.8 tp -105.95 107.63 18.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.953 -1.092 . . . . 0.0 109.014 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.625 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 3.3 t80 -47.33 -83.53 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.625 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -147.12 175.56 10.63 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.492 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.518 ' HD3' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.33 129.02 38.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 0.0 109.61 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.476 HD21 HG22 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -120.94 -176.89 3.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 109.505 179.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.18 158.87 33.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.363 -0.836 . . . . 0.0 109.388 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.0 147.15 31.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 0.0 109.737 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.73 116.74 10.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.077 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.495 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 1.1 m-85 -83.99 172.99 7.98 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.348 -0.845 . . . . 0.0 109.379 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 4.0 Cg_exo -59.17 -12.95 17.54 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.152 1.901 . . . . 0.0 110.791 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -165.16 16.18 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 110.585 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.493 ' HG3' ' NH1' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -131.17 -172.89 2.95 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 120.632 -1.293 . . . . 0.0 109.445 -179.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -146.32 136.64 23.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.352 -0.843 . . . . 0.0 109.018 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.482 HD12 HD11 ' A' ' 4' ' ' LEU . 22.4 mm -140.04 80.31 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.093 -1.004 . . . . 0.0 110.169 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.61 130.57 34.99 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.497 ' CD1' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -136.86 113.58 10.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.955 -1.091 . . . . 0.0 110.366 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -79.86 156.04 27.54 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.634 ' CE2' ' CE2' ' A' ' 35' ' ' PHE . 2.0 m-85 -135.87 71.12 1.42 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.94 -1.1 . . . . 0.0 109.838 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.683 ' CH2' ' CD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -84.05 145.17 28.62 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.564 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 20.9 tp -134.8 127.25 30.49 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.951 -1.093 . . . . 0.0 110.139 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.643 ' CG1' ' CZ2' ' A' ' 85' ' ' TRP . 34.5 m -98.1 -174.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.73 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' ARG . 2.9 mt-10 -126.43 -29.88 2.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.845 . . . . 0.0 109.428 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.72 169.3 20.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.195 -0.941 . . . . 0.0 109.326 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.512 ' CD1' HG22 ' A' ' 60' ' ' ILE . 46.1 p90 -164.95 -169.83 1.79 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.102 -0.999 . . . . 0.0 110.015 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.527 ' CB ' ' HB ' ' A' ' 61' ' ' THR . 30.6 tt0 -131.34 99.13 4.74 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.972 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.52 ' CA ' HG23 ' A' ' 60' ' ' ILE . . . 128.88 -152.13 19.27 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.627 -1.273 . . . . 0.0 109.946 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.596 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 14.5 tp10 -99.96 127.06 34.61 Favored Pre-proline 0 N--CA 1.486 1.339 0 O-C-N 121.324 -1.103 . . . . 0.0 109.187 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.528 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 4.0 Cg_exo -52.36 144.96 37.93 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.665 2.244 . . . . 0.0 111.706 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.62 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 23.4 p-90 -113.15 -175.55 2.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.523 -0.736 . . . . 0.0 109.09 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.503 ' HA3' ' CB ' ' A' ' 36' ' ' PRO . . . 158.06 -62.36 0.32 Allowed Glycine 0 N--CA 1.484 1.843 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.296 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -105.31 171.47 7.31 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.355 -1.085 . . . . 0.0 109.631 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.46 ' HA ' ' OE2' ' A' ' 57' ' ' GLU . 2.9 tp10 -39.23 -37.41 0.41 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.65 -0.656 . . . . 0.0 109.438 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.488 ' C ' ' CD ' ' A' ' 101' ' ' PRO . . . -126.18 -160.42 10.6 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.626 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -117.85 40.15 0.32 Allowed Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.137 -1.213 . . . . 0.0 111.541 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 100' ' ' GLN . 6.9 Cg_endo -68.13 -6.81 18.16 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 C-N-CA 121.327 1.351 . . . . 0.0 110.106 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -41.83 163.53 0.02 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -119.17 131.08 55.81 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.405 -1.056 . . . . 0.0 109.175 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.46 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 10.8 m0 -78.21 95.77 5.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.199 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.31 -163.35 0.6 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.403 -0.811 . . . . 0.0 109.653 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 t -141.33 158.08 44.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.628 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.459 HD12 HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -113.4 63.0 0.64 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.347 -0.846 . . . . 0.0 108.974 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.481 HG11 ' N ' ' A' ' 109' ' ' GLY . 8.2 p -104.33 -26.55 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.367 -0.833 . . . . 0.0 109.208 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.481 ' N ' HG11 ' A' ' 108' ' ' VAL . . . -168.25 43.92 0.23 Allowed Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 109' ' ' GLY . 1.1 mt -45.46 145.79 1.16 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.217 -1.166 . . . . 0.0 108.676 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -125.24 9.98 8.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 110.182 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.518 ' CB ' HG23 ' A' ' 123' ' ' ILE . . . 52.59 19.64 1.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.902 -1.124 . . . . 0.0 108.39 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -100.82 -34.41 9.83 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.358 -0.839 . . . . 0.0 109.747 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.477 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -76.69 -3.66 39.17 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.31 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.575 ' CD2' HD11 ' A' ' 123' ' ' ILE . 22.3 m-85 -96.44 109.99 50.53 Favored Pre-proline 0 N--CA 1.485 1.281 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.539 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 7.1 Cg_exo -50.14 154.96 4.98 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.166 1.911 . . . . 0.0 110.512 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.539 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 5.4 Cg_exo -58.38 121.2 9.59 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.553 2.169 . . . . 0.0 110.995 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 117' ' ' PRO . . . 158.54 -37.21 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.566 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 18.2 m120 -115.36 41.25 2.5 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.507 -0.746 . . . . 0.0 109.472 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.66 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 20.0 mt-10 -66.53 -41.48 40.43 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.95 -1.094 . . . . 0.0 112.427 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 1.1 Cg_endo -67.7 -30.89 33.79 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.581 2.187 . . . . 0.0 112.231 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.583 HG12 ' CD2' ' A' ' 84' ' ' PHE . 2.1 t -95.32 -43.77 12.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 120.593 -1.317 . . . . 0.0 107.493 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.575 HD11 ' CD2' ' A' ' 115' ' ' PHE . 12.2 mm -56.67 -29.0 28.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.22 -35.12 63.88 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.703 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -80.4 -61.73 1.89 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.916 -1.115 . . . . 0.0 110.945 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.579 ' HG ' ' CE2' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -80.87 27.38 0.38 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.918 -1.114 . . . . 0.0 110.522 -179.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.586 ' HG3' ' N ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -71.33 -31.48 67.44 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.586 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 2.2 ptt180 -119.63 44.74 2.31 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.632 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.532 ' CD1' ' O ' ' A' ' 126' ' ' LEU . 1.1 mp . . . . . 0 C--N 1.308 -1.228 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.971 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.412 ' HA ' HD12 ' A' ' 4' ' ' LEU . 49.5 tp . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.935 ' O ' HG22 ' A' ' 40' ' ' ILE . 12.4 mt-30 -137.86 119.51 15.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.035 . . . . 0.0 109.809 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.706 HG22 ' H ' ' A' ' 7' ' ' ALA . 12.9 mm -102.46 179.66 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.431 -0.793 . . . . 0.0 109.665 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.706 ' H ' HG22 ' A' ' 6' ' ' ILE . . . -142.38 108.21 5.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.197 -0.939 . . . . 0.0 108.849 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.652 HG23 ' C ' ' A' ' 36' ' ' PRO . 7.8 p -113.07 164.15 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.024 . . . . 0.0 110.221 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -149.73 120.63 1.17 Allowed Glycine 0 N--CA 1.482 1.719 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.115 HD12 ' CD2' ' A' ' 86' ' ' LEU . 1.2 mt -98.99 152.91 4.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 121.181 -1.188 . . . . 0.0 108.793 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.903 ' O ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -120.62 153.44 23.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 118.902 -1.119 . . . . 0.0 109.138 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.506 ' O ' ' O ' ' A' ' 88' ' ' GLU . 38.2 ttp180 -155.76 114.13 3.43 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.565 -0.709 . . . . 0.0 109.823 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.602 ' HB3' ' CZ3' ' A' ' 90' ' ' TRP . 43.4 p-10 -158.76 -159.59 0.8 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.975 . . . . 0.0 109.883 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER 77.89 -72.52 0.09 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.991 0.9 . . . . 0.0 108.759 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -147.41 -47.3 0.17 Allowed 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 122.286 1.041 . . . . 0.0 108.236 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 108' ' ' VAL . 6.1 t-20 179.15 35.44 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.527 ' C ' HD13 ' A' ' 18' ' ' ILE . 3.0 mt-10 -107.29 148.93 28.37 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.637 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.903 HG22 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -116.8 156.1 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 109.857 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.575 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 11.5 t80 -92.5 69.48 4.94 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 176.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.716 HG23 ' N ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -82.05 -161.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 122.126 0.965 . . . . 0.0 112.093 -176.078 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.716 ' N ' HG23 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -141.01 132.21 26.46 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.454 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 9.9 ttp180 . . . . . 0 C--N 1.302 -1.49 0 O-C-N 121.373 -0.829 . . . . 0.0 109.929 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.47 141.51 43.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.09 -1.006 . . . . 0.0 109.781 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.827 HD21 ' HB3' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -136.79 -178.02 5.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -0.8 . . . . 0.0 109.679 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.625 ' O ' HD11 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -161.66 -155.86 0.41 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.716 0.769 . . . . 0.0 109.771 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.683 ' CZ ' ' CZ ' ' A' ' 115' ' ' PHE . 95.0 m-85 -117.3 150.3 46.11 Favored Pre-proline 0 C--N 1.296 -1.721 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.652 ' C ' HG23 ' A' ' 8' ' ' VAL . 6.2 Cg_exo -58.01 -152.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 121.884 1.723 . . . . 0.0 109.671 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 134.96 170.02 12.06 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.119 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -164.8 -61.3 0.02 OUTLIER Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 1.3 tttt 178.15 153.46 0.32 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.507 -0.996 . . . . 0.0 109.369 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.935 HG22 ' O ' ' A' ' 5' ' ' GLN . 7.6 tt -129.78 50.97 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.869 . . . . 0.0 109.623 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.424 ' HG3' ' HG2' ' A' ' 39' ' ' LYS . 2.2 mt-10 -118.63 7.2 11.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 109.654 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.2 tpp -108.57 -3.01 18.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.174 -0.954 . . . . 0.0 109.729 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.18 172.68 14.6 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.81 -13.5 13.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.166 -1.197 . . . . 0.0 109.808 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.816 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -144.38 179.53 1.15 Allowed Pre-proline 0 C--N 1.305 -1.335 0 O-C-N 121.044 -1.035 . . . . 0.0 109.496 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.816 ' CD ' HG22 ' A' ' 45' ' ' THR . 4.9 Cg_endo -72.94 1.61 6.32 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.347 2.031 . . . . 0.0 110.843 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.528 ' O ' HG12 ' A' ' 51' ' ' VAL . 1.9 mt-10 -124.02 -51.88 1.78 Allowed 'General case' 0 C--O 1.198 -1.654 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.524 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -49.62 -34.81 19.09 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 122.388 1.09 . . . . 0.0 108.378 178.537 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.486 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -67.63 -60.74 2.31 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.323 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.694 HG22 ' HH2' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -75.95 -48.01 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.123 -0.986 . . . . 0.0 109.162 -179.059 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.581 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 3.1 p -39.48 -48.92 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 121.533 0.682 . . . . 0.0 109.163 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.581 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -75.73 -33.15 60.26 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 3.1 mm-40 -67.07 -10.64 52.07 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.739 HD21 ' OE1' ' A' ' 63' ' ' GLN . 0.3 OUTLIER -60.4 -64.6 0.89 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.44 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -81.79 -25.77 34.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.556 -0.715 . . . . 0.0 109.37 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.514 ' HG3' ' HG3' ' A' ' 52' ' ' ARG . 29.3 mm-40 -81.57 32.14 0.35 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.168 -0.958 . . . . 0.0 110.479 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.586 ' HB3' ' CB ' ' A' ' 95' ' ' TRP . 5.3 mm-40 -147.03 -67.78 0.26 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.965 -1.085 . . . . 0.0 109.27 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.679 ' HB ' ' HB3' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -114.27 -46.59 4.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.647 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.469 ' N ' ' CG1' ' A' ' 58' ' ' VAL . . . 100.48 53.49 1.06 Allowed Glycine 0 N--CA 1.482 1.713 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.458 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.648 HG21 ' CD1' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -90.33 167.73 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.685 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.665 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.2 m -119.02 -65.13 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.587 -1.32 . . . . 0.0 111.299 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.665 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 18.8 Cg_endo -77.5 33.66 0.45 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.628 1.552 . . . . 0.0 110.905 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.739 ' OE1' HD21 ' A' ' 54' ' ' LEU . 55.8 tt0 -82.27 65.74 7.54 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.584 0.707 . . . . 0.0 109.636 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -51.28 144.85 8.98 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.623 ' HB3' HG12 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -153.93 170.94 19.85 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.596 -1.315 . . . . 0.0 111.21 -179.128 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.0 -177.51 6.16 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.0 tp -105.71 127.04 52.84 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.732 -1.23 . . . . 0.0 109.728 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.785 ' CE2' HD21 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -86.18 -70.48 0.6 Allowed 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.666 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -173.96 117.19 0.24 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.112 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -87.4 138.36 31.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.33 -0.856 . . . . 0.0 109.137 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.938 HD23 HG22 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -96.9 -170.93 2.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.244 -0.91 . . . . 0.0 110.63 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -154.4 137.24 15.35 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.413 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -131.11 175.39 9.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.934 -1.103 . . . . 0.0 110.407 -179.105 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -158.55 126.29 5.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.473 -0.767 . . . . 0.0 109.175 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.641 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -88.5 177.9 2.36 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.846 . . . . 0.0 109.258 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.641 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 2.6 Cg_exo -56.24 -16.82 18.52 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.864 1.709 . . . . 0.0 110.408 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -165.99 15.09 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.345 -0.847 . . . . 0.0 110.623 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.533 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 6.4 mmm180 -124.49 178.94 5.15 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 120.818 -1.176 . . . . 0.0 109.097 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -129.41 110.76 12.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.0 109.26 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.413 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 24.3 mm -106.16 109.27 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 109.695 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.9 m -116.69 142.35 47.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.336 -0.852 . . . . 0.0 109.139 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.483 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -149.87 167.0 27.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.68 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.64 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 1.1 m95 -124.48 155.63 38.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.375 -0.828 . . . . 0.0 109.402 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.499 ' CZ ' ' CD2' ' A' ' 35' ' ' PHE . 3.0 m-85 -133.43 88.38 2.48 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.438 -0.789 . . . . 0.0 109.046 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.583 ' O ' ' CG ' ' A' ' 85' ' ' TRP . 1.2 p-90 -111.39 104.43 12.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.474 -1.391 . . . . 0.0 109.55 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.115 ' CD2' HD12 ' A' ' 10' ' ' ILE . 1.9 mm? -80.97 141.43 34.46 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.282 0.563 . . . . 0.0 111.178 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.801 HG22 ' HA ' ' A' ' 11' ' ' ILE . 5.0 m -99.53 -174.33 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 O-C-N 121.217 -0.927 . . . . 0.0 108.906 178.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.506 ' O ' ' O ' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -120.8 -46.87 2.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.986 -1.071 . . . . 0.0 111.444 -179.039 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.63 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.35 150.5 14.49 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.366 -1.459 . . . . 0.0 110.75 -179.222 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.787 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 11.6 p90 -151.41 178.4 9.33 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 122.066 0.936 . . . . 0.0 109.896 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.577 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 22.6 tt0 -128.66 86.74 2.48 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.484 ' O ' ' CD1' ' A' ' 90' ' ' TRP . . . 148.99 175.07 21.12 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.609 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.2 mt-10 -80.26 118.55 72.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.141 -1.211 . . . . 0.0 108.21 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.717 ' HB3' HD12 ' A' ' 11' ' ' ILE . 3.4 Cg_endo -70.3 167.44 25.14 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.516 2.144 . . . . 0.0 112.064 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.694 ' HH2' HG22 ' A' ' 50' ' ' VAL . 29.2 p-90 -113.64 -167.86 1.26 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 36' ' ' PRO . . . 162.01 -78.86 0.16 Allowed Glycine 0 N--CA 1.481 1.669 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.563 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -101.88 -174.86 2.68 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.726 -0.867 . . . . 0.0 108.701 179.149 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -125.24 -53.8 1.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.937 -1.102 . . . . 0.0 109.575 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.48 -0.09 89.61 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.643 ' OE1' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -113.07 128.92 25.05 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.178 -1.19 . . . . 0.0 109.452 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.69 -71.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.116 1.877 . . . . 0.0 110.503 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . 95.74 166.18 34.64 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -159.27 159.49 34.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.566 -1.549 . . . . 0.0 111.08 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.553 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -84.37 94.74 8.55 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 1.1 ttm -86.77 132.11 33.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.225 -0.922 . . . . 0.0 109.662 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.442 ' HB3' ' CD ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -111.26 99.3 8.15 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.419 -0.8 . . . . 0.0 109.43 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.931 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.0 mt -122.75 -85.97 0.65 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 109.575 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 107' ' ' LEU . 1.5 t -177.82 -55.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -159.68 88.2 0.11 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.748 HD13 ' CE2' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -40.39 143.74 0.29 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.518 -0.989 . . . . 0.0 110.015 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.454 ' ND2' ' HA ' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -128.64 -171.02 2.36 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.451 -0.781 . . . . 0.0 109.184 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . . . -75.98 -9.34 58.53 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.197 -0.939 . . . . 0.0 109.431 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -62.81 -56.66 15.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.871 . . . . 0.0 109.687 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.827 ' HB3' HD21 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -81.3 -13.63 58.22 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.785 ' CG ' HD12 ' A' ' 123' ' ' ILE . 3.1 m-85 -90.58 110.6 42.39 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.514 ' CG ' ' O ' ' A' ' 33' ' ' LEU . 6.6 Cg_exo -50.96 141.19 37.51 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.953 1.769 . . . . 0.0 110.094 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.723 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 4.4 Cg_exo -59.35 126.52 21.03 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.195 1.93 . . . . 0.0 110.804 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.723 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 152.97 -18.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.559 ' HB3' HG12 ' A' ' 123' ' ' ILE . 0.9 OUTLIER -123.33 48.52 1.82 Allowed 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.655 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.2 mm-40 -65.99 -35.88 12.07 Favored Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.655 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 6.2 Cg_exo -60.59 -35.11 91.32 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 121.678 1.585 . . . . 0.0 112.094 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.938 HG22 HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -102.67 -46.66 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 120.588 -1.32 . . . . 0.0 108.672 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.785 HD12 ' CG ' ' A' ' 115' ' ' PHE . 24.8 mm -50.15 -38.35 14.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 127' ' ' LYS . . . -52.06 -44.35 64.25 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -71.08 -42.63 69.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.41 -0.806 . . . . 0.0 109.782 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.785 HD21 ' CE2' ' A' ' 68' ' ' PHE . 1.4 mt -63.01 -9.73 11.21 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.276 -0.89 . . . . 0.0 109.732 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.454 ' HA ' ' ND2' ' A' ' 111' ' ' ASN . 55.6 mttt -56.81 -48.7 77.35 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.14 -0.975 . . . . 0.0 108.69 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 129' ' ' LEU . 1.8 ptt180 -89.33 0.95 56.42 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.407 -0.808 . . . . 0.0 109.27 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 126' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.851 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.58 HD23 ' HB2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 122.112 0.958 . . . . 0.0 110.546 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.447 ' O ' ' O ' ' A' ' 4' ' ' LEU . 8.8 mt-30 58.36 126.53 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.568 0.699 . . . . 0.0 110.485 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.603 HG23 ' N ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -129.89 176.05 9.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.603 ' N ' HG23 ' A' ' 6' ' ' ILE . . . -117.79 80.26 1.48 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.841 -1.162 . . . . 0.0 110.283 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.742 HG23 ' CB ' ' A' ' 36' ' ' PRO . 3.2 p -100.18 145.27 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 118.896 -1.122 . . . . 0.0 108.485 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -129.37 110.36 1.06 Allowed Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.14 HD12 ' CD1' ' A' ' 86' ' ' LEU . 1.3 mt -92.49 166.19 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.024 HG23 HG21 ' A' ' 87' ' ' VAL . 0.7 OUTLIER -154.48 146.42 13.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.271 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.545 ' CZ ' HD23 ' A' ' 129' ' ' LEU . 38.2 ttp180 -161.5 77.27 0.54 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.532 -0.73 . . . . 0.0 110.039 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 88' ' ' GLU . 13.9 m120 -160.1 -162.04 0.95 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -0.893 . . . . 0.0 109.543 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.37 -85.98 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.619 0.723 . . . . 0.0 109.528 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 13' ' ' ASN . 28.9 t-20 -94.75 28.68 2.59 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.529 -0.732 . . . . 0.0 109.335 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 15' ' ' ASN . 30.1 t30 42.31 43.73 3.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.475 -0.766 . . . . 0.0 109.318 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 105' ' ' MET . 2.5 mt-10 -129.41 149.33 51.24 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.689 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 3.0 mt -101.12 156.99 4.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 118.326 -1.35 . . . . 0.0 110.672 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.519 ' HB3' HG13 ' A' ' 11' ' ' ILE . 60.3 t80 -97.03 78.25 2.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.97 HG21 HD13 ' A' ' 33' ' ' LEU . 11.3 mm -78.09 167.14 2.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.404 -0.81 . . . . 0.0 110.084 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.665 HG21 ' HB2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -128.01 139.88 52.3 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.848 178.585 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' A' ' 32' ' ' LYS . 1.2 ttp180 . . . . . 0 C--N 1.307 -1.277 0 O-C-N 121.055 -1.028 . . . . 0.0 109.433 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.767 HD21 ' N ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.469 ' O ' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -108.13 135.0 50.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.317 -0.864 . . . . 0.0 109.375 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.97 HD13 HG21 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -104.63 -176.94 3.22 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.351 -0.843 . . . . 0.0 109.073 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -162.17 -155.91 0.39 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 110.073 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.461 ' HB3' HG21 ' A' ' 8' ' ' VAL . 21.8 m-85 -142.31 141.41 21.06 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.742 ' CB ' HG23 ' A' ' 8' ' ' VAL . 5.9 Cg_exo -57.54 -150.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.87 1.714 . . . . 0.0 110.074 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.567 ' HA2' ' CA ' ' A' ' 8' ' ' VAL . . . 148.78 -149.08 21.04 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.086 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . 144.93 -79.93 0.23 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.464 ' HG2' ' HG3' ' A' ' 41' ' ' GLU . 0.2 OUTLIER 178.07 133.87 0.07 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.395 -1.061 . . . . 0.0 109.652 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.677 ' O ' HG23 ' A' ' 40' ' ' ILE . 9.0 tt -121.84 74.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.253 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.464 ' HG3' ' HG2' ' A' ' 39' ' ' LYS . 1.9 mm-40 -113.04 -179.71 3.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.611 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.2 ttm 44.09 83.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.31 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 168.85 124.31 0.72 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.21 -11.17 39.09 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.19 -1.183 . . . . 0.0 110.192 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.848 HG22 ' H ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -125.18 149.03 62.53 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 120.927 -1.108 . . . . 0.0 108.715 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.721 ' HD2' HG23 ' A' ' 45' ' ' THR . 9.3 Cg_endo -71.12 14.98 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.753 2.302 . . . . 0.0 112.343 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.848 ' H ' HG22 ' A' ' 45' ' ' THR . 0.8 OUTLIER -124.01 -60.92 1.4 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.508 -1.37 . . . . 0.0 109.766 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.575 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -48.12 -28.5 2.95 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.823 1.296 . . . . 0.0 109.379 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . -67.54 -67.17 0.48 Allowed 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.374 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.745 HG13 ' CZ3' ' A' ' 85' ' ' TRP . 10.0 p -83.29 3.55 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.259 -0.901 . . . . 0.0 111.463 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.582 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 4.9 p -81.92 -43.67 19.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.582 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -69.34 -29.08 66.82 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 113.745 -1.571 . . . . 0.0 108.101 177.834 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 49' ' ' ALA . 69.9 mt-10 -70.36 -22.78 62.74 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.128 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.034 HD13 ' HG3' ' A' ' 62' ' ' PRO . 3.4 mt -63.43 -48.09 79.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -0.908 . . . . 0.0 109.467 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.513 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 2.1 pt20 -81.37 -30.64 33.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.937 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 9.1 mm-40 -81.88 32.56 0.37 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.219 -0.926 . . . . 0.0 111.014 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.655 ' CB ' ' CD1' ' A' ' 95' ' ' TRP . 25.6 mm-40 -155.3 -57.63 0.1 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.629 -1.294 . . . . 0.0 109.985 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.053 HG22 ' CD1' ' A' ' 95' ' ' TRP . 10.6 m -113.92 -49.8 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.587 ' N ' HG23 ' A' ' 58' ' ' VAL . . . 92.4 37.69 5.82 Favored Glycine 0 C--N 1.299 -1.482 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -79.83 174.67 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -1.092 . . . . 0.0 108.255 178.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.565 ' HB ' ' CB ' ' A' ' 91' ' ' GLU . 8.1 m -115.3 90.13 23.59 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 1.034 ' HG3' HD13 ' A' ' 54' ' ' LEU . 4.3 Cg_endo -61.0 122.75 11.66 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 121.809 1.672 . . . . 0.0 110.11 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.528 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 5.8 mt-30 -86.89 -34.18 19.5 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.834 -0.541 . . . . 0.0 109.773 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.46 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 45.5 t60 -176.42 97.48 0.06 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.179 -0.951 . . . . 0.0 110.315 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.477 ' HB2' HG12 ' A' ' 87' ' ' VAL . 13.7 p90 -111.7 175.5 5.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.908 -1.12 . . . . 0.0 109.307 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.1 m -161.97 173.18 14.81 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.624 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.941 HD22 ' CZ3' ' A' ' 83' ' ' TRP . 4.6 tp -116.09 114.16 24.15 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.215 -0.928 . . . . 0.0 109.153 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.641 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 2.6 p90 -73.78 -53.76 9.57 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.294 -0.879 . . . . 0.0 109.876 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.641 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 0.5 OUTLIER 176.45 149.59 0.13 Allowed 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.039 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -111.66 163.46 14.09 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.312 -0.868 . . . . 0.0 109.895 -179.466 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.941 HD23 ' CG2' ' A' ' 122' ' ' VAL . 0.3 OUTLIER -113.93 -164.6 0.94 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 109.145 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -136.03 156.28 48.96 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.133 -0.979 . . . . 0.0 109.557 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.57 82.85 1.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 1.0 OUTLIER -103.12 114.2 28.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 110.327 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.522 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -81.69 177.04 3.25 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 1.9 Cg_endo -63.95 2.67 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.926 1.751 . . . . 0.0 111.42 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -125.52 -55.05 1.55 Allowed 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.623 -1.298 . . . . 0.0 111.162 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -118.49 -179.42 3.78 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.253 -0.904 . . . . 0.0 110.387 -178.114 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.58 ' HB2' HD23 ' A' ' 4' ' ' LEU . 1.0 OUTLIER -128.51 96.44 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 12.6 mt -97.74 128.68 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.506 -0.746 . . . . 0.0 110.815 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.445 ' CB ' ' H ' ' A' ' 5' ' ' GLN . 3.7 m -115.85 118.43 32.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 108.769 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.581 ' CB ' HD11 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -81.93 132.15 35.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.154 -0.966 . . . . 0.0 109.81 -179.502 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.941 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -122.9 113.64 19.39 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.31 -0.869 . . . . 0.0 109.575 -178.688 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.657 ' CE1' HG11 ' A' ' 122' ' ' VAL . 0.1 OUTLIER -122.37 113.54 19.52 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 120.358 -1.464 . . . . 0.0 109.955 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.837 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -83.34 87.05 6.97 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.363 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.14 ' CD1' HD12 ' A' ' 10' ' ' ILE . 0.6 OUTLIER -44.39 107.87 0.1 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.038 -1.039 . . . . 0.0 109.21 -179.812 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.024 HG21 HG23 ' A' ' 11' ' ' ILE . 19.8 m -81.0 174.66 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.531 -0.73 . . . . 0.0 110.308 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.514 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 1.0 OUTLIER -129.22 -18.48 3.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 110.422 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.495 ' HD3' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -162.16 174.08 13.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.89 -1.131 . . . . 0.0 110.252 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.881 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 35.1 p90 174.65 -179.71 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.093 0.949 . . . . 0.0 109.883 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.633 ' O ' HG22 ' A' ' 60' ' ' ILE . 1.4 tt0 -134.7 109.17 8.43 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.727 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.52 ' CA ' HG22 ' A' ' 60' ' ' ILE . . . 114.37 -156.97 15.28 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.333 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.476 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 1.9 mt-10 -107.29 102.22 42.65 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.344 -1.092 . . . . 0.0 109.067 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 1.038 ' C ' HG11 ' A' ' 58' ' ' VAL . 3.4 Cg_endo -66.46 -169.82 0.19 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.118 1.879 . . . . 0.0 111.972 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 1.053 ' CD1' HG22 ' A' ' 58' ' ' VAL . 4.8 p-90 -136.01 -168.27 2.19 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.69 0.757 . . . . 0.0 108.986 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 36' ' ' PRO . . . -159.98 -77.86 0.03 OUTLIER Glycine 0 C--N 1.295 -1.742 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.665 ' HB2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -87.06 -179.27 6.44 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.524 -0.986 . . . . 0.0 109.494 179.54 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -92.59 -36.04 13.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.346 -0.846 . . . . 0.0 109.819 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -139.76 9.61 3.12 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.543 ' HB3' ' CB ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -99.04 109.59 54.64 Favored Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 121.189 -1.183 . . . . 0.0 109.694 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.97 122.2 11.03 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.949 1.766 . . . . 0.0 109.679 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -98.22 168.58 23.29 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -125.81 154.61 42.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.857 -1.378 . . . . 0.0 110.086 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.443 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -94.65 104.01 15.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.543 -0.723 . . . . 0.0 109.351 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 1.2 ttm -92.51 168.73 11.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.178 -0.951 . . . . 0.0 109.257 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.4 t -116.21 65.63 0.71 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.176 -0.953 . . . . 0.0 109.567 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.505 ' CD1' ' HD2' ' A' ' 12' ' ' ARG . 3.1 tp 48.03 59.52 4.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.274 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.34 -72.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 109.555 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.501 ' HA3' ' HB2' ' A' ' 114' ' ' ASP . . . -100.75 30.92 9.27 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.964 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -67.24 -20.6 65.69 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.311 -1.111 . . . . 0.0 109.33 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -78.93 -177.89 5.77 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.427 -0.795 . . . . 0.0 109.731 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.656 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . -68.76 -6.81 28.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.378 -0.826 . . . . 0.0 109.656 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -62.91 -54.77 33.53 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.257 -0.902 . . . . 0.0 109.944 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.501 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 19.8 t0 -90.56 -6.7 54.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.872 . . . . 0.0 109.811 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.629 ' CD2' HD11 ' A' ' 123' ' ' ILE . 1.8 m-85 -89.32 142.13 29.57 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.026 -1.046 . . . . 0.0 109.388 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.538 ' CG ' ' O ' ' A' ' 33' ' ' LEU . 2.1 Cg_endo -71.65 158.13 54.19 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.303 2.002 . . . . 0.0 110.584 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.641 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 2.8 Cg_endo -60.62 -177.04 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.484 2.123 . . . . 0.0 110.563 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.641 ' HB3' ' O ' ' A' ' 117' ' ' PRO . . . 74.43 -1.85 2.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.458 -0.776 . . . . 0.0 109.902 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.589 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 0.9 OUTLIER -127.15 41.7 3.47 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.032 -1.042 . . . . 0.0 109.511 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.675 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 26.6 mt-10 -74.94 -39.12 3.24 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.299 -0.875 . . . . 0.0 112.065 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.6 Cg_exo -62.37 -32.36 81.26 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.954 1.769 . . . . 0.0 112.089 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.941 ' CG2' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -101.4 -50.4 10.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 120.508 -1.37 . . . . 0.0 109.288 -179.592 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.656 HG21 ' HA ' ' A' ' 112' ' ' ALA . 14.1 mm -50.95 -36.88 16.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -58.73 -43.85 90.3 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -63.01 -41.46 99.57 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.293 -0.88 . . . . 0.0 109.465 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.549 HD12 HD13 ' A' ' 129' ' ' LEU . 5.3 mp -58.06 -17.21 16.29 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.233 -0.917 . . . . 0.0 109.678 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.446 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 13.8 mmtt -57.07 -53.46 57.87 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -91.25 9.77 29.96 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.009 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.991 HD11 ' CD2' ' A' ' 86' ' ' LEU . 3.4 tp . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.748 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.471 ' C ' HG12 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -164.26 119.66 1.52 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.695 -1.253 . . . . 0.0 110.713 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.992 HG22 HD13 ' A' ' 82' ' ' LEU . 6.0 mm -152.02 157.49 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.507 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -146.42 119.31 8.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.762 -1.211 . . . . 0.0 110.465 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.976 HG12 HD11 ' A' ' 82' ' ' LEU . 7.5 p -122.2 147.17 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.576 ' HA3' ' CZ3' ' A' ' 95' ' ' TRP . . . -129.1 119.55 2.99 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.09 HD12 HD13 ' A' ' 86' ' ' LEU . 1.2 mt -92.2 166.15 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.967 HD11 ' CB ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -149.19 153.38 10.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 118.584 -1.246 . . . . 0.0 110.492 -178.3 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 88' ' ' GLU . 11.0 ttp180 -129.39 122.23 29.01 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -98.39 -169.46 1.8 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.098 -1.001 . . . . 0.0 110.632 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -78.36 -6.93 56.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.558 -0.714 . . . . 0.0 110.302 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.489 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 24.3 t30 -88.43 21.35 2.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.443 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 20.2 t30 48.46 42.92 19.35 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.413 -0.804 . . . . 0.0 109.339 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 15' ' ' ASN . 2.9 mt-10 -140.45 147.65 39.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 108.835 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.881 HG22 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.09 153.92 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.111 -0.993 . . . . 0.0 109.415 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 56.6 t80 -88.84 73.15 8.46 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.696 HG13 HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -80.06 -161.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.344 -0.848 . . . . 0.0 109.354 -178.626 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.851 HG23 ' HA2' ' A' ' 102' ' ' GLY . 0.2 OUTLIER -159.96 152.66 21.31 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.823 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.52 ' HG3' ' HA ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.246 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.337 0.589 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.517 ' O ' ' CD ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -151.55 125.88 9.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.424 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.696 HD23 HG13 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -121.17 -165.38 1.22 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.349 -0.844 . . . . 0.0 109.36 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.2 -160.89 0.82 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.337 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.69 ' CE2' ' CZ ' ' A' ' 84' ' ' PHE . 5.8 m-85 -156.12 70.47 5.09 Favored Pre-proline 0 C--N 1.294 -1.833 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.706 ' O ' HG23 ' A' ' 8' ' ' VAL . 4.3 Cg_exo -55.19 164.69 3.5 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.046 1.831 . . . . 0.0 109.588 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . -161.57 -147.71 5.07 Favored Glycine 0 N--CA 1.486 1.969 0 C-N-CA 119.325 -1.417 . . . . 0.0 109.814 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -134.51 -76.03 0.09 OUTLIER Glycine 0 N--CA 1.484 1.887 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 13.1 tttt 176.38 155.7 0.23 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.628 -0.924 . . . . 0.0 109.822 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.831 HD11 ' O ' ' A' ' 6' ' ' ILE . 15.2 mm -78.92 107.5 11.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.465 ' OE1' ' HD3' ' A' ' 52' ' ' ARG . 5.6 mt-10 -116.63 177.78 4.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.963 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.437 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 54.3 mmm 71.38 -164.99 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.863 . . . . 0.0 109.732 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.8 -26.53 3.29 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.511 ' C ' HG22 ' A' ' 45' ' ' THR . 0.9 OUTLIER -79.61 -154.91 0.09 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.399 -1.059 . . . . 0.0 109.19 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.73 HG23 ' HD3' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -160.82 -58.09 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.032 -1.043 . . . . 0.0 111.374 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.73 ' HD3' HG23 ' A' ' 45' ' ' THR . 1.3 Cg_endo -67.62 3.88 1.62 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 121.492 1.461 . . . . 0.0 112.765 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.534 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -148.91 -69.28 0.21 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.331 -1.48 . . . . 0.0 109.157 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.61 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 35.0 mt-30 -51.37 -27.57 10.2 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 122.54 1.162 . . . . 0.0 110.116 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 45' ' ' THR . . . -65.65 -66.18 0.58 Allowed 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.671 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.499 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 9.9 p -81.9 -6.59 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 111.25 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.61 ' CG1' ' HA ' ' A' ' 48' ' ' GLN . 3.1 p -72.38 -48.3 48.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.58 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -75.09 -22.5 58.23 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.39 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -52.98 -21.45 4.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.89 -1.131 . . . . 0.0 108.808 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.621 HD21 ' HG3' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -66.08 -59.44 3.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.419 -0.801 . . . . 0.0 110.401 -179.435 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.544 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 7.2 pt20 -79.97 -30.22 39.73 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.177 -0.952 . . . . 0.0 111.891 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.544 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 1.1 pp20? -79.64 -29.17 40.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.869 -1.144 . . . . 0.0 111.377 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 1.052 ' HG3' HG12 ' A' ' 58' ' ' VAL . 4.4 pt-20 -91.59 -46.63 7.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.684 -1.26 . . . . 0.0 110.428 -178.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.052 HG12 ' HG3' ' A' ' 57' ' ' GLU . 0.5 OUTLIER -147.96 -67.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.353 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.736 ' H ' HG13 ' A' ' 58' ' ' VAL . . . 119.99 71.36 0.33 Allowed Glycine 0 N--CA 1.48 1.589 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.841 HG22 ' N ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -107.52 -156.49 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.114 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 91' ' ' GLU . 2.3 m -146.51 91.87 5.27 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.621 ' HG3' HD21 ' A' ' 54' ' ' LEU . 1.8 Cg_endo -66.05 150.55 85.23 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.34 2.027 . . . . 0.0 110.729 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -121.28 -40.07 2.62 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.592 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -128.69 -179.56 5.13 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.486 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.665 ' CD2' HG12 ' A' ' 87' ' ' VAL . 22.9 m-85 -148.7 170.65 17.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.144 -0.972 . . . . 0.0 110.053 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.523 ' HB3' ' O ' ' A' ' 86' ' ' LEU . 3.8 t -159.24 0.84 0.09 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.296 -0.877 . . . . 0.0 111.96 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.058 HD22 ' CZ3' ' A' ' 85' ' ' TRP . 9.6 tp -29.0 148.52 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 CA-C-O 121.911 0.863 . . . . 0.0 110.991 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.651 ' HE2' HG22 ' A' ' 122' ' ' VAL . 14.3 p90 -116.46 -51.19 2.61 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.811 0.815 . . . . 0.0 109.431 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.528 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.3 pt-20 -179.18 161.84 1.15 Allowed 'General case' 0 C--N 1.291 -1.946 0 O-C-N 121.743 -0.598 . . . . 0.0 110.135 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.619 ' HD3' ' CE3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -105.59 -175.8 2.9 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.311 -0.868 . . . . 0.0 110.221 -179.142 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.81 HD12 ' N ' ' A' ' 72' ' ' GLU . 3.8 pp -147.51 -161.52 1.35 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.262 -0.899 . . . . 0.0 109.564 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.81 ' N ' HD12 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -143.45 162.16 36.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.461 -0.775 . . . . 0.0 109.425 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -141.09 164.07 31.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.709 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -158.5 108.69 2.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.427 -0.796 . . . . 0.0 109.097 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.58 ' HB2' ' HG3' ' A' ' 78' ' ' ARG . 2.1 m-85 -79.31 170.6 15.36 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.2 Cg_exo -57.84 -10.52 7.69 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.905 1.737 . . . . 0.0 111.204 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -153.54 -5.69 0.18 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.87 -1.144 . . . . 0.0 112.204 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.58 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 3.7 ptt180 -133.34 -176.91 4.3 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.406 -1.434 . . . . 0.0 109.548 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.435 ' O ' HD13 ' A' ' 80' ' ' ILE . 12.3 m-70 -134.99 156.11 49.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.157 -0.965 . . . . 0.0 109.381 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.435 HD13 ' O ' ' A' ' 79' ' ' HIS . 33.1 mm -148.87 92.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.084 -1.01 . . . . 0.0 109.897 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.0 m -79.33 90.52 4.99 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.992 HD13 HG22 ' A' ' 6' ' ' ILE . 11.0 tp -108.24 141.57 39.82 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.315 -0.866 . . . . 0.0 109.614 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.833 ' H ' HD12 ' A' ' 82' ' ' LEU . 8.7 m95 -89.56 -174.54 4.38 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.521 -0.737 . . . . 0.0 109.388 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.69 ' CZ ' ' CE2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -144.05 76.13 1.49 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 1.058 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 55.7 m95 -81.46 157.89 24.74 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 122.218 1.008 . . . . 0.0 110.628 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.09 HD13 HD12 ' A' ' 10' ' ' ILE . 6.2 tp -150.24 98.12 2.64 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.812 ' CG2' HG23 ' A' ' 11' ' ' ILE . 15.8 m -93.64 178.46 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.8 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -110.59 -28.15 8.62 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.23 -0.919 . . . . 0.0 112.32 -178.094 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -161.68 153.77 19.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.547 -1.346 . . . . 0.0 110.788 -178.625 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.7 ' NE1' ' O ' ' A' ' 92' ' ' GLY . 0.9 OUTLIER -161.96 -167.43 1.66 Allowed 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.582 -0.699 . . . . 0.0 109.564 178.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.535 ' O ' ' O ' ' A' ' 92' ' ' GLY . 22.7 tt0 -90.89 -105.82 0.1 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.274 -0.891 . . . . 0.0 110.062 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.841 ' N ' HG22 ' A' ' 60' ' ' ILE . . . -45.18 173.25 0.01 OUTLIER Glycine 0 N--CA 1.495 2.598 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.852 ' N ' ' HD3' ' A' ' 94' ' ' PRO . 1.5 pt-20 -115.26 28.53 0.11 Allowed Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 119.354 1.577 . . . . 0.0 113.29 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.998 ' CG ' HG21 ' A' ' 58' ' ' VAL . 60.6 Cg_endo -90.41 -123.54 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 122.508 2.139 . . . . 0.0 108.447 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.967 ' CB ' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER 85.76 75.53 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.042 -1.036 . . . . 0.0 111.707 177.661 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 161.26 -121.77 1.05 Allowed Glycine 0 C--N 1.297 -1.634 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.514 ' CD ' ' HB2' ' A' ' 100' ' ' GLN . 7.3 tttt -94.5 145.86 24.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.109 -1.23 . . . . 0.0 109.995 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.454 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 11.6 pt-20 -89.72 -33.81 16.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.168 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.454 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . -88.11 -10.83 68.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.632 ' HG2' HG22 ' A' ' 21' ' ' THR . 7.1 tt0 -102.65 113.2 66.02 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 121.374 -1.074 . . . . 0.0 109.381 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.29 102.62 0.33 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.041 1.827 . . . . 0.0 110.726 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.851 ' HA2' HG23 ' A' ' 21' ' ' THR . . . -65.38 172.31 22.83 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.536 ' O ' HG22 ' A' ' 20' ' ' ILE . 4.2 pt-20 -147.0 134.22 20.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.543 -1.563 . . . . 0.0 110.14 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.599 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -81.81 94.72 7.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.448 -0.783 . . . . 0.0 109.08 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.443 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -85.04 169.51 13.88 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.082 -1.011 . . . . 0.0 109.471 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.406 ' HB3' HG23 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -96.43 145.51 25.59 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.199 -0.938 . . . . 0.0 109.596 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.492 ' HG ' HD12 ' A' ' 110' ' ' LEU . 1.8 tt -101.39 61.41 0.92 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.406 HG23 ' HB3' ' A' ' 106' ' ' SER . 21.2 t -98.59 -25.95 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.565 -0.709 . . . . 0.0 109.505 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -162.58 38.04 0.35 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.492 HD12 ' HG ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -43.13 145.82 0.48 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.397 -1.061 . . . . 0.0 109.632 -179.589 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.457 ' ND2' ' HE2' ' A' ' 127' ' ' LYS . 2.6 t30 -156.87 163.12 39.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.082 -1.011 . . . . 0.0 110.028 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.647 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . -61.29 -15.64 37.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 109.184 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -68.44 -33.15 73.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.425 -0.797 . . . . 0.0 109.4 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -79.13 2.09 22.07 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.041 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.605 ' CE1' ' CE2' ' A' ' 35' ' ' PHE . 10.2 m-85 -130.97 104.72 15.28 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.443 -0.786 . . . . 0.0 109.179 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.464 ' HG3' ' HB2' ' A' ' 32' ' ' LYS . 21.6 Cg_exo -43.18 160.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.513 2.142 . . . . 0.0 110.831 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.703 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 5.0 Cg_exo -58.03 130.25 37.2 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.518 2.145 . . . . 0.0 111.365 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 160.31 -56.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.549 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 16.1 m-20 -107.84 42.41 1.35 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.641 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -61.51 -38.68 54.33 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.433 -0.792 . . . . 0.0 113.004 -179.131 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 1.9 Cg_endo -65.06 -37.46 32.8 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 122.0 1.8 . . . . 0.0 111.977 -177.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.651 HG22 ' HE2' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -90.23 -39.34 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.523 -1.361 . . . . 0.0 108.186 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.647 HG21 ' HA ' ' A' ' 112' ' ' ALA . 6.6 mm -56.35 -34.31 40.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.43 -36.78 74.15 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.871 -0.731 . . . . 0.0 109.271 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -55.1 8.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.91 . . . . 0.0 109.967 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -50.65 -17.66 0.56 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.199 -0.938 . . . . 0.0 110.126 -179.475 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.457 ' HE2' ' ND2' ' A' ' 111' ' ' ASN . 15.2 mttt -47.59 -46.37 28.2 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.825 -1.172 . . . . 0.0 108.923 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -95.98 47.71 1.1 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.459 -0.775 . . . . 0.0 109.319 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.821 HD21 ' CD2' ' A' ' 86' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.305 -1.345 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.658 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.4 tp . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.351 0.595 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.771 ' C ' HG22 ' A' ' 40' ' ' ILE . 2.0 mt-30 -118.12 159.25 23.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 0.0 109.177 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.695 HG23 ' N ' ' A' ' 7' ' ' ALA . 2.1 tt -134.4 -173.94 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.132 -0.98 . . . . 0.0 109.365 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.695 ' N ' HG23 ' A' ' 6' ' ' ILE . . . -138.31 104.92 5.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.198 -0.939 . . . . 0.0 109.311 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 7.6 p -113.08 139.96 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.428 -0.795 . . . . 0.0 109.567 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.609 ' CA ' ' NE1' ' A' ' 85' ' ' TRP . . . -121.77 126.32 6.44 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.639 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.931 HD11 ' CD2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -107.17 144.27 16.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.085 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.843 HG23 HG21 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -123.69 156.04 30.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.866 -1.146 . . . . 0.0 109.253 179.417 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -157.44 125.25 5.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.474 -0.766 . . . . 0.0 109.451 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.577 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 26.9 p-10 -156.63 -168.48 2.7 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.879 -1.138 . . . . 0.0 111.169 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 13' ' ' ASN . 3.8 mt-10 66.16 -83.44 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.863 0.84 . . . . 0.0 110.048 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -132.68 -59.21 0.91 Allowed 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 122.004 0.907 . . . . 0.0 109.593 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -164.72 32.55 0.07 Allowed 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 3.7 mt-10 -89.39 148.95 23.21 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.903 HD11 ' HB2' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -131.21 154.91 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.06 -1.025 . . . . 0.0 109.582 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.74 ' HZ ' HE21 ' A' ' 100' ' ' GLN . 9.6 t80 -116.63 84.87 2.21 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.632 HD11 ' HB ' ' A' ' 18' ' ' ILE . 0.6 OUTLIER -107.3 -152.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 108.619 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.966 HG21 ' HD3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -131.23 151.32 51.59 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.015 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.306 -1.305 0 O-C-N 121.43 -0.794 . . . . 0.0 109.818 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.533 ' HB2' ' HG3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -148.81 132.31 16.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.206 -0.934 . . . . 0.0 109.339 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.587 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -93.6 -176.86 4.21 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 120.93 -1.106 . . . . 0.0 108.389 179.476 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.491 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 4.8 tt0 -163.44 -158.9 0.49 Allowed 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 118.804 -1.159 . . . . 0.0 111.067 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 1.051 ' CE2' HD11 ' A' ' 123' ' ' ILE . 57.8 m-85 -161.64 64.75 1.85 Allowed Pre-proline 0 C--N 1.299 -1.601 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 34' ' ' GLU . 2.3 Cg_endo -60.62 -84.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.235 1.957 . . . . 0.0 110.706 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 105.6 -120.64 6.51 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -156.46 -77.85 0.02 OUTLIER Glycine 0 N--CA 1.488 2.1 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 6.0 tttp 177.41 132.31 0.06 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.483 -1.01 . . . . 0.0 109.318 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.771 HG22 ' C ' ' A' ' 5' ' ' GLN . 14.2 tt -118.93 120.04 62.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.378 -0.826 . . . . 0.0 108.978 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -85.55 144.73 27.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.033 -1.042 . . . . 0.0 109.826 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.17 165.15 23.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.372 -0.83 . . . . 0.0 109.406 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.67 -17.23 57.08 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.24 -153.95 0.44 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.588 -0.948 . . . . 0.0 108.816 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.852 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -122.1 176.96 1.74 Allowed Pre-proline 0 C--N 1.307 -1.277 0 O-C-N 120.791 -1.193 . . . . 0.0 108.526 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.852 ' CD ' HG22 ' A' ' 45' ' ' THR . 10.2 Cg_endo -76.96 -7.57 17.42 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.052 1.835 . . . . 0.0 110.986 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.593 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -113.59 -62.34 1.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.934 -1.104 . . . . 0.0 110.609 -178.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.54 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 2.5 tt0 -39.29 -36.22 0.32 Allowed 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.658 1.218 . . . . 0.0 109.502 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 47' ' ' GLU . . . -60.42 -67.08 0.43 Allowed 'General case' 0 C--N 1.271 -2.824 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.313 -178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.545 HG22 ' HH2' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -81.55 -44.0 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.271 -0.893 . . . . 0.0 110.447 -178.468 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 47' ' ' GLU . 7.4 p -39.95 -45.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.571 ' N ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -73.94 -37.36 64.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.114 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 50' ' ' VAL . 5.1 mm-40 -67.4 -7.06 22.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.197 -0.939 . . . . 0.0 109.446 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.891 HD23 ' HE1' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -76.45 -54.76 6.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.957 -1.089 . . . . 0.0 109.62 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -80.02 -29.77 39.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.009 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.493 ' HG3' ' HG3' ' A' ' 52' ' ' ARG . 11.9 mm-40 -81.55 35.37 0.4 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.136 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.516 ' HB2' ' CD1' ' A' ' 95' ' ' TRP . 12.3 mt-10 -150.53 -66.52 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.901 -1.124 . . . . 0.0 109.613 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.071 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.4 p -122.56 -27.21 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 O-C-N 121.043 -1.035 . . . . 0.0 109.788 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.02 70.23 1.21 Allowed Glycine 0 N--CA 1.489 2.177 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.26 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.649 HD12 ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -90.12 172.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.886 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.716 ' CB ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -123.36 -70.02 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 120.201 -1.562 . . . . 0.0 111.221 -178.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.716 ' HD3' ' CB ' ' A' ' 61' ' ' THR . 12.3 Cg_endo -75.35 49.04 2.24 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 122.057 1.838 . . . . 0.0 111.251 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.666 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 53.5 tt0 -101.52 72.3 1.39 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.672 -1.267 . . . . 0.0 109.276 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -65.59 105.13 1.14 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.792 ' CB ' HG12 ' A' ' 87' ' ' VAL . 30.5 p90 -125.41 179.58 5.05 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.758 1.266 . . . . 0.0 111.97 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 68' ' ' PHE . 4.9 m -162.19 131.82 4.54 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.777 HD21 ' HE3' ' A' ' 70' ' ' LYS . 43.5 tp -49.04 94.76 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.726 -1.234 . . . . 0.0 109.578 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.713 ' HE2' HG13 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -42.93 -77.15 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.586 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 3.3 mm-40 -156.67 -173.5 4.51 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.777 ' HE3' HD21 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -140.43 147.81 40.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.065 -1.022 . . . . 0.0 109.845 -179.542 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.719 HD23 ' HB ' ' A' ' 122' ' ' VAL . 0.5 OUTLIER -124.32 -178.45 4.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.15 -0.969 . . . . 0.0 109.671 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -160.88 146.77 14.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.478 -0.764 . . . . 0.0 109.398 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -129.3 -163.53 1.3 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.957 . . . . 0.0 109.29 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -157.44 117.6 3.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 0.0 109.187 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.74 ' CE2' HD13 ' A' ' 80' ' ' ILE . 1.4 m-85 -79.62 170.37 16.24 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.0 Cg_exo -56.89 -6.34 1.7 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.063 1.842 . . . . 0.0 111.983 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.63 -17.04 0.32 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.566 -1.334 . . . . 0.0 112.113 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.526 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -131.44 -177.76 4.55 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.446 -1.409 . . . . 0.0 110.507 -178.569 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -121.67 121.69 37.91 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.74 HD13 ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -101.92 161.38 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.083 -1.011 . . . . 0.0 109.734 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.4 m -152.42 105.28 3.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.417 -0.802 . . . . 0.0 109.354 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.65 ' HG ' HG22 ' A' ' 6' ' ' ILE . 1.2 mp -85.94 149.93 24.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 109.821 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.603 ' CE2' ' HB3' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -110.35 115.97 30.62 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.931 ' CD2' HD11 ' A' ' 10' ' ' ILE . 2.2 m-85 -97.55 100.72 12.14 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.327 -0.858 . . . . 0.0 111.695 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.612 ' O ' ' CG ' ' A' ' 85' ' ' TRP . 29.1 p-90 -105.72 82.8 1.84 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.8 -1.188 . . . . 0.0 108.263 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.715 HD13 ' HB ' ' A' ' 10' ' ' ILE . 24.7 tp -78.06 146.01 35.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.434 -0.791 . . . . 0.0 110.673 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.843 HG21 HG23 ' A' ' 11' ' ' ILE . 17.7 m -113.13 -163.01 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.548 -0.72 . . . . 0.0 109.642 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 7.3 mt-10 -141.35 -29.72 0.63 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -0.981 . . . . 0.0 111.041 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.707 ' O ' ' HB3' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -143.78 -172.85 3.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.745 -1.222 . . . . 0.0 109.432 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.715 ' CE3' HG22 ' A' ' 11' ' ' ILE . 17.2 p90 154.47 162.59 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 122.72 1.248 . . . . 0.0 110.968 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.595 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 46.8 tt0 -126.11 90.11 3.13 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.186 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 157.66 -158.1 28.74 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 1.071 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -121.37 78.68 35.98 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 1.003 ' HA ' HG11 ' A' ' 58' ' ' VAL . 16.7 Cg_exo -40.02 156.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.064 2.509 . . . . 0.0 112.906 -177.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.891 ' HE1' HD23 ' A' ' 54' ' ' LEU . 45.4 p-90 -98.91 -163.4 1.03 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.461 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . 161.1 -21.99 0.22 Allowed Glycine 0 C--N 1.295 -1.708 0 C-N-CA 119.233 -1.46 . . . . 0.0 109.738 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.966 ' HD3' HG21 ' A' ' 21' ' ' THR . 29.6 tttt -146.44 160.03 42.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.418 -1.048 . . . . 0.0 109.312 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -44.24 104.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 108.587 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.98 -133.09 11.61 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.74 HE21 ' HZ ' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -150.09 53.58 1.31 Allowed Pre-proline 0 C--N 1.306 -1.322 0 O-C-N 120.926 -1.338 . . . . 0.0 110.24 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.604 ' HD3' ' N ' ' A' ' 100' ' ' GLN . 9.4 Cg_endo -71.16 -15.95 31.87 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.0 1.8 . . . . 0.0 110.236 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -64.04 -173.64 3.06 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.43 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 2.0 pm0 -156.96 169.62 24.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -1.148 . . . . 0.0 109.753 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -99.48 105.27 17.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -0.838 . . . . 0.0 109.228 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.491 ' HE3' ' HB2' ' A' ' 105' ' ' MET . 0.1 OUTLIER -83.44 163.26 20.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 109.506 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.89 91.48 3.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.315 -0.866 . . . . 0.0 109.302 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 mt 49.55 51.59 16.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 109.735 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.658 ' O ' HG12 ' A' ' 108' ' ' VAL . 44.6 t -104.33 26.74 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 108.955 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 114' ' ' ASP . . . 104.22 60.03 0.68 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.911 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -64.25 -13.99 52.82 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.201 -1.176 . . . . 0.0 108.663 179.83 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.27 -177.35 5.12 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.363 -0.836 . . . . 0.0 109.462 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.796 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . -62.32 -12.15 19.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 109.712 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -60.04 -52.63 64.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.845 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 13.6 t0 -79.17 -2.87 42.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.351 -0.843 . . . . 0.0 108.908 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.656 ' CZ ' ' CZ ' ' A' ' 35' ' ' PHE . 18.1 m-85 -109.27 108.19 60.08 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.288 -0.882 . . . . 0.0 108.816 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.533 ' HG3' ' HB2' ' A' ' 32' ' ' LYS . 10.0 Cg_exo -49.83 160.35 1.26 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.516 2.144 . . . . 0.0 111.152 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.71 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 4.8 Cg_exo -59.17 118.08 4.91 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.397 2.065 . . . . 0.0 110.232 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 161.28 -36.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.559 ' OD1' ' CZ ' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -118.49 39.53 3.44 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.348 -0.845 . . . . 0.0 109.193 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.688 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.9 mt-10 -69.92 -34.65 4.51 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.411 -0.806 . . . . 0.0 112.575 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.3 Cg_exo -59.56 -37.2 90.1 Favored 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 121.644 1.563 . . . . 0.0 112.012 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.719 ' HB ' HD23 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -102.18 -42.75 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.441 -1.412 . . . . 0.0 108.128 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 1.051 HD11 ' CE2' ' A' ' 35' ' ' PHE . 14.7 mm -54.05 -28.66 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.571 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -73.1 -36.35 66.76 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.518 -0.739 . . . . 0.0 109.571 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -70.49 -48.3 56.37 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.209 -0.932 . . . . 0.0 110.51 -179.586 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 1.045 ' HB2' HD13 ' A' ' 129' ' ' LEU . 0.9 OUTLIER -80.59 20.59 0.71 Allowed 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.842 -1.161 . . . . 0.0 110.741 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.571 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 17.2 mttt -63.63 -40.6 97.31 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.9 -1.125 . . . . 0.0 108.394 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.493 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -79.11 7.43 7.49 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.903 -0.498 . . . . 0.0 110.125 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 1.045 HD13 ' HB2' ' A' ' 126' ' ' LEU . 4.7 tp . . . . . 0 N--CA 1.499 2.011 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.447 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.837 HD13 ' OG1' ' A' ' 81' ' ' THR . 2.5 pp . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.24 0.543 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.491 ' CG ' ' C ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER 169.84 99.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 109.81 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.842 HD13 HG23 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -122.02 167.1 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.716 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -134.15 81.8 1.94 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.341 -0.849 . . . . 0.0 109.133 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 83' ' ' TRP . 12.1 p -88.84 139.28 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.359 -0.838 . . . . 0.0 108.751 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.27 117.22 2.23 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.061 HD12 ' CD1' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -100.28 170.06 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.246 -1.15 . . . . 0.0 108.692 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.869 ' HA ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -147.58 154.71 11.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.981 -1.075 . . . . 0.0 110.479 -179.553 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.472 ' HD2' ' HG ' ' A' ' 107' ' ' LEU . 1.4 ttp180 -161.32 117.76 2.2 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.524 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 1.9 t-20 -105.54 -153.32 0.49 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.873 -1.142 . . . . 0.0 110.831 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -80.45 -5.4 56.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.748 -0.595 . . . . 0.0 109.536 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -79.71 5.57 13.05 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.233 -0.917 . . . . 0.0 108.952 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 21.9 t-20 52.86 42.91 32.06 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.467 -0.77 . . . . 0.0 109.338 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 2.6 mt-10 -134.82 150.1 50.45 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.865 HD13 HD11 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -110.48 155.09 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.025 -1.047 . . . . 0.0 109.459 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.582 ' HB3' ' CG1' ' A' ' 11' ' ' ILE . 45.0 t80 -103.36 71.68 1.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 0.0 109.29 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.879 HG21 HD12 ' A' ' 33' ' ' LEU . 2.5 mm -81.16 -177.73 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.542 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.797 HG23 ' CA ' ' A' ' 102' ' ' GLY . 0.1 OUTLIER -155.89 144.14 19.99 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.144 -0.972 . . . . 0.0 109.15 179.127 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.485 ' HG2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.994 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.84 HD21 ' N ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.432 0.634 . . . . 0.0 109.422 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.683 ' C ' HD22 ' A' ' 33' ' ' LEU . 12.1 mttp -92.09 170.19 10.03 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.363 -0.836 . . . . 0.0 108.754 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.879 HD12 HG21 ' A' ' 20' ' ' ILE . 3.0 mm? -105.5 176.66 5.09 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 109.58 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 22' ' ' ARG . 2.8 tt0 -160.97 -160.9 0.78 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 122.246 1.022 . . . . 0.0 110.577 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.636 ' CD1' ' HG3' ' A' ' 117' ' ' PRO . 29.3 m-85 -144.59 84.72 8.95 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.573 ' HG3' ' CB ' ' A' ' 21' ' ' THR . 3.1 Cg_exo -60.13 -150.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.405 2.07 . . . . 0.0 110.208 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 151.08 -168.71 30.75 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -147.46 18.05 1.49 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER 69.34 149.11 0.07 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.35 -1.088 . . . . 0.0 109.919 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.09 131.71 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 42' ' ' MET . 4.8 mt-10 -134.81 -147.82 0.29 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.09 -1.006 . . . . 0.0 110.052 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 41' ' ' GLU . 1.9 ptm -39.7 162.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.559 -0.713 . . . . 0.0 110.137 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.51 -157.08 27.1 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -125.34 -34.86 2.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -1.165 . . . . 0.0 109.426 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.544 ' OG1' ' HD2' ' A' ' 46' ' ' PRO . 0.5 OUTLIER -160.32 171.55 7.02 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 5.0 Cg_exo -59.02 -1.96 1.0 Allowed 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.536 2.157 . . . . 0.0 112.971 -178.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.576 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -102.5 -54.24 2.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.479 -1.388 . . . . 0.0 109.056 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.489 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 2.3 tt0 -63.79 -46.7 84.01 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 122.55 1.167 . . . . 0.0 108.738 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -45.36 -49.63 12.82 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.042 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.729 HG22 ' HH2' ' A' ' 95' ' ' TRP . 3.5 p -79.94 -20.32 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.343 -0.848 . . . . 0.0 110.003 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.615 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -61.04 -50.98 78.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.615 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -57.62 -35.86 71.03 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 113.114 -1.857 . . . . 0.0 109.847 178.691 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.464 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 2.4 mt-10 -64.87 -24.75 67.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.816 -1.178 . . . . 0.0 109.153 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.916 HD13 ' NE1' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -73.53 -70.98 0.34 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.525 -0.735 . . . . 0.0 109.909 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.595 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -59.19 -21.15 58.99 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.974 -0.454 . . . . 0.0 111.504 -178.414 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.464 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 8.8 pt-20 -80.74 1.52 29.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.578 -1.326 . . . . 0.0 110.549 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -135.72 -59.38 0.76 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.927 -1.108 . . . . 0.0 110.982 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.657 ' CG1' ' HB3' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -114.18 -42.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.228 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.595 ' CA ' ' HA ' ' A' ' 55' ' ' GLN . . . 59.42 72.25 0.64 Allowed Glycine 0 C--N 1.293 -1.835 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.85 ' H ' HD11 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -79.78 163.4 3.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.81 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.652 ' CB ' ' HD3' ' A' ' 62' ' ' PRO . 1.3 m -100.91 -68.93 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 120.219 -1.55 . . . . 0.0 110.471 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.652 ' HD3' ' CB ' ' A' ' 61' ' ' THR . 5.6 Cg_endo -70.36 49.31 0.83 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.152 1.901 . . . . 0.0 111.766 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.612 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 1.3 pt20 -83.81 55.73 3.37 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.953 -1.092 . . . . 0.0 109.231 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -62.22 118.02 6.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.185 -0.947 . . . . 0.0 109.278 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.42 ' CB ' ' HA ' ' A' ' 87' ' ' VAL . 48.0 p90 -133.18 -173.52 3.23 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.171 0.986 . . . . 0.0 110.764 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 67' ' ' LEU . 8.0 t -157.51 -4.02 0.1 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.12 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.852 HD22 ' CH2' ' A' ' 83' ' ' TRP . 21.9 tp 55.18 110.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.889 -1.132 . . . . 0.0 110.164 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.837 ' CD2' HD21 ' A' ' 126' ' ' LEU . 0.9 OUTLIER -55.92 -75.07 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.889 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.58 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.3 mt-10 -155.25 -169.15 3.07 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.309 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.406 ' HE2' ' CE3' ' A' ' 83' ' ' TRP . 8.0 ttmt -145.86 126.66 14.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.261 -0.9 . . . . 0.0 109.55 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.808 HD23 ' HB ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -112.48 -169.29 1.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.131 -0.981 . . . . 0.0 109.49 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -146.64 140.82 26.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.917 . . . . 0.0 109.216 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.401 ' OH ' ' O ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -129.74 169.93 14.49 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.246 -0.909 . . . . 0.0 109.923 -179.407 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 2.2 tt0 -161.05 113.6 1.92 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.609 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -79.23 175.2 4.99 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.086 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.609 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 1.4 Cg_endo -63.87 2.69 0.94 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.149 1.899 . . . . 0.0 111.88 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.82 -24.96 0.46 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.507 -1.371 . . . . 0.0 111.899 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 1.3 ptt180 -131.65 179.72 5.88 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.611 -1.305 . . . . 0.0 110.974 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.533 ' HB2' ' N ' ' A' ' 4' ' ' LEU . 1.7 m-70 -119.11 135.41 54.66 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.842 HG23 HD13 ' A' ' 6' ' ' ILE . 22.8 mm -146.27 107.99 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.032 -1.043 . . . . 0.0 110.716 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.837 ' OG1' HD13 ' A' ' 4' ' ' LEU . 3.1 m -101.67 105.26 16.15 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.55 HD22 ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -79.89 131.66 35.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.962 -1.086 . . . . 0.0 110.41 -178.55 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.852 ' CH2' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -121.76 124.03 43.24 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.68 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -124.1 119.99 31.07 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.444 -1.41 . . . . 0.0 110.036 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.813 ' CZ3' HG12 ' A' ' 87' ' ' VAL . 18.5 p-90 -100.41 87.97 3.54 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.061 ' CD1' HD12 ' A' ' 10' ' ' ILE . 2.8 mm? -56.35 130.29 44.03 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.571 0.701 . . . . 0.0 110.474 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.869 HG22 ' HA ' ' A' ' 11' ' ' ILE . 3.7 m -103.53 -170.85 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.475 -0.766 . . . . 0.0 109.322 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 1.0 OUTLIER -138.93 -36.09 0.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.914 -1.116 . . . . 0.0 110.643 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -142.72 178.88 7.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.051 -1.031 . . . . 0.0 109.906 -179.52 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.823 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 41.3 p90 168.68 168.47 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.628 1.204 . . . . 0.0 110.74 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.565 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 9.9 tt0 -125.9 99.17 5.82 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.905 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.489 ' O ' ' HD3' ' A' ' 94' ' ' PRO . . . 135.12 -169.25 23.4 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.568 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -99.23 104.98 29.7 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.318 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.652 ' HB3' HD12 ' A' ' 11' ' ' ILE . 4.5 Cg_exo -55.73 178.5 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.257 1.971 . . . . 0.0 112.256 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.916 ' NE1' HD13 ' A' ' 54' ' ' LEU . 3.7 p-90 -125.58 -167.32 1.67 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.797 0.808 . . . . 0.0 109.468 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.35 -32.12 0.08 OUTLIER Glycine 0 N--CA 1.482 1.759 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.552 ' HG3' ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -126.0 -145.27 0.32 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.749 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -115.09 38.56 3.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.133 -0.979 . . . . 0.0 108.834 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.31 55.53 0.76 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.506 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -119.85 151.99 53.17 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.275 -1.132 . . . . 0.0 109.8 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -67.08 98.61 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.355 2.037 . . . . 0.0 110.339 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.797 ' CA ' HG23 ' A' ' 21' ' ' THR . . . -82.35 -171.35 46.44 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -147.46 123.44 10.71 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.957 -1.319 . . . . 0.0 109.471 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.49 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 26.8 m95 -77.99 84.2 4.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.039 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.818 ' HE2' HD11 ' A' ' 33' ' ' LEU . 12.6 ttp -80.46 148.55 30.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 0.0 109.224 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.52 160.7 6.68 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.119 -0.988 . . . . 0.0 109.976 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.928 ' O ' HD13 ' A' ' 107' ' ' LEU . 1.6 tm? -130.63 70.91 1.45 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.2 t -103.14 -43.7 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 109.78 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -139.95 50.91 0.75 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.865 HD11 HD13 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -42.79 141.61 1.05 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.424 -1.045 . . . . 0.0 109.732 -179.632 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.491 ' HB3' ' OD2' ' A' ' 113' ' ' ASP . 4.4 t30 -157.41 -173.88 4.62 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.466 -0.771 . . . . 0.0 108.995 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.458 ' HB2' ' HE3' ' A' ' 127' ' ' LYS . . . -80.77 -10.34 59.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.731 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.491 ' OD2' ' HB3' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -66.57 -37.58 85.25 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.067 -1.021 . . . . 0.0 110.637 -179.167 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.682 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -96.85 27.7 3.84 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.968 -1.083 . . . . 0.0 109.483 -179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.64 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -146.26 89.81 5.85 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.939 . . . . 0.0 109.207 179.593 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.597 ' N ' ' HD3' ' A' ' 117' ' ' PRO . 36.9 Cg_endo -98.93 36.18 0.09 OUTLIER 'Trans proline' 0 CA--C 1.556 1.6 0 C-N-CA 123.58 2.854 . . . . 0.0 115.941 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.727 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 10.5 Cg_endo -73.55 -1.05 10.14 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 121.686 1.591 . . . . 0.0 110.06 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 117' ' ' PRO . . . 80.35 24.98 0.34 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.589 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 66.7 m-20 -107.22 42.0 1.39 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.593 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.2 mt-10 -47.09 -44.12 47.22 Favored Pre-proline 0 C--N 1.296 -1.735 0 O-C-N 121.164 -0.96 . . . . 0.0 112.083 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 5.3 Cg_exo -61.88 -39.18 53.39 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.881 1.721 . . . . 0.0 112.562 -178.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.808 ' HB ' HD23 ' A' ' 71' ' ' LEU . 1.6 t -90.23 -54.95 6.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 O-C-N 120.291 -1.506 . . . . 0.0 107.842 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.89 ' HA ' HD12 ' A' ' 126' ' ' LEU . 11.4 mm -43.84 -33.96 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.47 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -52.33 -52.94 50.38 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -42.86 98.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.51 -0.744 . . . . 0.0 109.787 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.89 HD12 ' HA ' ' A' ' 123' ' ' ILE . 1.9 mt -66.42 -5.32 10.51 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.104 -0.997 . . . . 0.0 110.328 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.47 ' HE3' ' HA ' ' A' ' 124' ' ' ALA . 22.3 mttt -56.41 -49.65 73.88 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.051 -1.031 . . . . 0.0 108.351 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 129' ' ' LEU . 11.6 mtp180 -90.3 34.89 0.86 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.451 -0.781 . . . . 0.0 108.984 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 126' ' ' LEU . 1.2 mt . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.893 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.592 HD11 HG12 ' A' ' 80' ' ' ILE . 2.6 pp . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.535 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . 26.1 mt-30 -133.01 150.61 52.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.201 -0.937 . . . . 0.0 109.853 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.591 HG22 ' N ' ' A' ' 7' ' ' ALA . 9.9 mt -121.76 167.15 15.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.357 -0.839 . . . . 0.0 109.495 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.591 ' N ' HG22 ' A' ' 6' ' ' ILE . . . -132.82 106.02 7.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -0.952 . . . . 0.0 109.543 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.788 HG13 ' O ' ' A' ' 8' ' ' VAL . 8.5 p -122.08 83.88 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.216 -0.927 . . . . 0.0 109.778 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.97 ' H ' HD11 ' A' ' 54' ' ' LEU . . . -68.97 117.22 7.86 Favored Glycine 0 C--N 1.294 -1.786 0 N-CA-C 107.496 -2.242 . . . . 0.0 107.496 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.595 HG22 ' H ' ' A' ' 11' ' ' ILE . 0.7 OUTLIER -76.42 -172.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.071 -1.253 . . . . 0.0 107.688 -179.104 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.963 ' HA ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -144.97 149.53 16.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 117.864 -1.534 . . . . 0.0 111.371 -176.895 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.51 ' HD2' HD13 ' A' ' 107' ' ' LEU . 10.4 ttp180 -148.53 128.27 13.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.634 ' ND2' ' CH2' ' A' ' 90' ' ' TRP . 1.2 m-20 -98.07 -160.68 0.82 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.817 -1.177 . . . . 0.0 110.74 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 81.3 tt0 -91.56 -6.05 53.04 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.393 0.616 . . . . 0.0 109.367 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.504 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 3.2 t-20 -85.21 14.5 5.13 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.48 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 13.6 t30 58.41 48.24 12.56 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.571 -0.706 . . . . 0.0 109.908 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 105' ' ' MET . 1.4 pt-20 -136.73 171.84 13.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.251 -0.906 . . . . 0.0 109.235 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.487 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 1.3 mt -125.35 157.67 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.932 . . . . 0.0 109.427 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.65 ' CD2' ' CD1' ' A' ' 11' ' ' ILE . 46.0 t80 -106.87 83.13 1.79 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.686 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -79.81 -173.68 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 120.988 -1.07 . . . . 0.0 110.163 -178.292 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.603 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -130.75 142.85 50.43 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.199 -0.601 . . . . 0.0 109.815 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.572 ' HG3' ' CD2' ' A' ' 33' ' ' LEU . 6.1 ttm180 . . . . . 0 C--N 1.305 -1.331 0 O-C-N 121.247 -0.908 . . . . 0.0 109.91 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.56 139.28 34.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 109.881 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.595 ' HB2' ' CD1' ' A' ' 115' ' ' PHE . 25.3 mt -105.77 -174.3 2.5 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.379 -0.825 . . . . 0.0 108.943 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.686 ' O ' HD11 ' A' ' 20' ' ' ILE . 3.1 tt0 -161.39 -157.5 0.51 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.564 -1.335 . . . . 0.0 110.732 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.78 ' HB3' HG21 ' A' ' 8' ' ' VAL . 81.1 m-85 -152.65 152.51 28.85 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.758 ' C ' HG23 ' A' ' 8' ' ' VAL . 2.0 Cg_endo -63.08 -151.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.17 1.913 . . . . 0.0 109.861 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 91.79 179.21 41.95 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.45 -40.59 0.05 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -167.19 169.85 12.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.18 -1.188 . . . . 0.0 109.765 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.785 HD12 ' NE1' ' A' ' 83' ' ' TRP . 14.1 tt -133.69 123.94 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.379 -0.825 . . . . 0.0 109.1 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -80.26 130.92 35.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 110.027 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 42' ' ' MET . 31.1 ttp -117.32 72.22 0.83 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 109.105 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.67 1.53 5.18 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -151.59 -71.1 0.16 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.114 -1.227 . . . . 0.0 110.026 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.787 HG23 ' H ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -154.62 168.19 12.44 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 120.904 -1.122 . . . . 0.0 109.776 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.516 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 2.1 Cg_endo -67.88 -27.93 36.62 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.786 2.324 . . . . 0.0 112.103 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 1.06 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -78.56 -69.75 0.54 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.832 -1.167 . . . . 0.0 109.197 -179.208 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.708 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 12.7 tt0 -37.63 -34.66 0.11 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 122.938 1.352 . . . . 0.0 109.078 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.517 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -52.64 -67.72 0.23 Allowed 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.254 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.737 ' CG2' HD12 ' A' ' 54' ' ' LEU . 9.0 p -80.99 -43.87 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.096 -1.003 . . . . 0.0 111.274 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.06 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.3 p -43.6 -48.88 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.449 -0.782 . . . . 0.0 109.168 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.492 ' N ' HG13 ' A' ' 51' ' ' VAL . 1.2 ttt180 -81.39 -26.12 35.71 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.308 -0.87 . . . . 0.0 110.506 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 3.4 mm-40 -72.88 -67.23 0.58 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.748 -1.22 . . . . 0.0 110.674 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.97 HD11 ' H ' ' A' ' 9' ' ' GLY . 14.1 mt -54.06 -38.18 64.99 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.303 -0.873 . . . . 0.0 110.726 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.494 ' O ' ' HA2' ' A' ' 59' ' ' GLY . 10.7 pt20 -67.89 -32.12 72.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.971 -1.08 . . . . 0.0 110.075 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.493 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 1.3 pt-20 -78.59 -4.7 50.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.878 -1.139 . . . . 0.0 109.596 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.34 -49.19 5.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.174 -0.954 . . . . 0.0 109.538 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.838 HG22 HD13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -114.04 -30.07 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.182 -0.949 . . . . 0.0 108.49 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 55' ' ' GLN . . . 74.25 90.2 0.17 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.445 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.02 HD12 ' O ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -114.54 170.53 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.367 -1.078 . . . . 0.0 108.48 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.729 ' CB ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -118.17 -70.4 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.807 -1.183 . . . . 0.0 109.596 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.729 ' HD3' ' CB ' ' A' ' 61' ' ' THR . 10.0 Cg_endo -74.73 40.69 0.65 Allowed 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 122.006 1.804 . . . . 0.0 111.325 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.628 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 0.9 OUTLIER -81.68 59.07 4.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 109.783 -179.219 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -65.62 126.54 28.7 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.734 ' CB ' HG12 ' A' ' 87' ' ' VAL . 4.0 p90 -146.63 -177.42 5.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.738 -1.226 . . . . 0.0 111.755 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.4 m -161.77 143.53 11.33 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 84' ' ' PHE . 36.8 tp -71.49 97.13 1.6 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.604 -1.31 . . . . 0.0 109.792 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.666 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -44.79 -77.96 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.658 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.728 ' O ' HG21 ' A' ' 122' ' ' VAL . 0.6 OUTLIER -158.94 125.19 4.53 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -90.57 151.96 21.1 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.141 -0.974 . . . . 0.0 110.112 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.94 HD21 ' OD1' ' A' ' 119' ' ' ASN . 0.7 OUTLIER -116.43 -167.25 1.25 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -160.04 161.9 34.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.896 -1.128 . . . . 0.0 110.275 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -154.46 127.22 8.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.493 -0.754 . . . . 0.0 109.205 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -99.88 122.26 42.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 109.735 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.579 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -84.01 177.97 2.68 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.56 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.579 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 3.9 Cg_exo -56.71 -10.4 5.28 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.828 1.686 . . . . 0.0 111.736 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -161.7 -3.3 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.728 -1.232 . . . . 0.0 112.484 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.543 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -128.1 -172.38 2.67 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.212 -1.555 . . . . 0.0 110.041 -179.111 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -132.03 91.94 3.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.395 -0.816 . . . . 0.0 109.613 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.592 HG12 HD11 ' A' ' 4' ' ' LEU . 11.4 mt -81.84 102.5 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 109.462 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.23 126.05 52.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.738 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.31 150.04 41.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.29 -0.881 . . . . 0.0 109.073 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.785 ' NE1' HD12 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -120.06 149.04 42.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.054 -1.029 . . . . 0.0 109.574 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.563 ' CG ' HG11 ' A' ' 122' ' ' VAL . 6.5 m-85 -113.35 94.41 4.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.222 -0.924 . . . . 0.0 109.221 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.502 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 77.7 m95 -88.51 90.37 8.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.043 -1.036 . . . . 0.0 108.948 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.014 HD21 HD21 ' A' ' 129' ' ' LEU . 10.7 tp -79.28 117.45 20.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.478 -0.763 . . . . 0.0 109.442 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.963 HG22 ' HA ' ' A' ' 11' ' ' ILE . 3.1 m -88.46 -161.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 O-C-N 121.213 -0.93 . . . . 0.0 110.33 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 20.7 mt-10 -147.67 -33.97 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.987 . . . . 0.0 111.231 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.628 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -147.21 164.39 33.32 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.658 -1.276 . . . . 0.0 110.479 -179.134 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.634 ' CH2' ' ND2' ' A' ' 13' ' ' ASN . 13.6 p90 179.19 171.44 0.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 122.029 0.918 . . . . 0.0 109.644 178.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.55 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 77.2 tt0 -116.34 -92.86 0.51 Allowed 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.509 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . -23.76 -91.47 0.01 OUTLIER Glycine 0 N--CA 1.499 2.866 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 1.02 ' O ' HD12 ' A' ' 60' ' ' ILE . 1.6 mt-10 -131.19 166.09 30.34 Favored Pre-proline 0 C--O 1.188 -2.138 0 O-C-N 121.647 -0.913 . . . . 0.0 108.862 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.638 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 6.1 Cg_exo -36.7 -93.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.281 -3.023 0 C-N-CA 123.106 2.537 . . . . 0.0 112.091 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.815 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.0 t90 171.03 -21.6 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.132 -0.98 . . . . 0.0 111.265 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' A' ' 36' ' ' PRO . . . -107.21 -101.21 2.7 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.469 -1.348 . . . . 0.0 109.821 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.487 ' N ' ' HB3' ' A' ' 36' ' ' PRO . 3.0 tttt 41.07 94.12 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.493 -1.004 . . . . 0.0 110.215 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -116.52 52.56 0.92 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.88 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.57 2.35 53.2 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.61 123.34 25.73 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.205 -1.173 . . . . 0.0 109.701 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -60.85 111.4 1.05 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.939 1.759 . . . . 0.0 109.899 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.603 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -93.41 -179.81 39.34 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -138.07 161.18 37.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.073 -1.251 . . . . 0.0 111.137 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.464 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 34.7 m0 -94.73 93.37 7.48 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.526 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -82.45 -173.89 4.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.016 -1.052 . . . . 0.0 109.674 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.05 160.77 15.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.891 . . . . 0.0 109.153 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.877 HD11 HD23 ' A' ' 129' ' ' LEU . 1.8 tp -108.9 45.84 1.01 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.145 -0.972 . . . . 0.0 109.795 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.547 ' O ' HG12 ' A' ' 108' ' ' VAL . 18.2 t -103.39 19.06 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.082 -1.011 . . . . 0.0 108.83 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 132.82 74.05 0.1 OUTLIER Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 110' ' ' LEU . 2.7 mt -43.49 138.77 2.33 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.372 -1.075 . . . . 0.0 109.626 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.44 98.79 11.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.439 -0.788 . . . . 0.0 109.777 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.583 ' CB ' HG22 ' A' ' 123' ' ' ILE . . . -64.59 -21.76 66.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 108.971 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -68.6 -27.79 66.36 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.488 -0.758 . . . . 0.0 109.506 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.506 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 2.8 t0 -78.43 -9.99 59.52 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.687 ' CZ ' ' CZ ' ' A' ' 35' ' ' PHE . 11.0 m-85 -94.03 154.98 40.59 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 108.83 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.545 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 1.2 Cg_endo -71.42 144.7 46.06 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.994 1.796 . . . . 0.0 110.211 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.721 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.2 Cg_endo -64.71 112.71 2.06 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.341 2.028 . . . . 0.0 110.41 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 162.35 -22.56 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 109.84 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.94 ' OD1' HD21 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -119.76 45.25 2.2 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.092 -1.005 . . . . 0.0 109.314 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.68 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 7.1 mt-10 -68.87 -32.77 3.7 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.5 Cg_exo -58.83 -38.78 86.8 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.409 1.406 . . . . 0.0 111.992 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.899 ' HB ' HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -104.37 -38.06 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 120.434 -1.416 . . . . 0.0 108.784 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.583 HG22 ' CB ' ' A' ' 112' ' ' ALA . 7.4 mm -55.25 -38.81 48.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.483 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -55.32 -46.27 76.32 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.522 -0.736 . . . . 0.0 109.292 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -66.85 -33.92 76.67 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.424 -0.798 . . . . 0.0 109.563 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.516 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 4.2 mp -54.32 -25.78 25.84 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.192 -0.942 . . . . 0.0 109.551 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.547 ' HE2' ' HB3' ' A' ' 112' ' ' ALA . 33.7 mttt -58.2 -49.45 77.0 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.454 ' O ' ' C ' ' A' ' 129' ' ' LEU . 6.5 mtp180 -84.62 -1.47 56.05 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.699 -0.625 . . . . 0.0 109.532 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 1.014 HD21 HD21 ' A' ' 86' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.824 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 4' ' ' LEU . 14.8 tp . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.529 ' HG2' ' CZ2' ' A' ' 83' ' ' TRP . 0.9 OUTLIER -145.35 128.38 16.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.041 -1.037 . . . . 0.0 110.834 -179.306 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.701 HG22 ' H ' ' A' ' 7' ' ' ALA . 5.3 mm -102.93 -163.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.319 -0.863 . . . . 0.0 108.807 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.701 ' H ' HG22 ' A' ' 6' ' ' ILE . . . -144.86 117.29 8.52 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.739 -1.225 . . . . 0.0 110.605 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.915 ' CG1' HD12 ' A' ' 82' ' ' LEU . 3.2 p -133.45 129.74 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.108 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.6 ' HA2' ' NE1' ' A' ' 85' ' ' TRP . . . -117.04 119.32 4.43 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.061 HD12 ' CD1' ' A' ' 86' ' ' LEU . 1.2 mt -96.98 159.16 3.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.265 -1.138 . . . . 0.0 108.781 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.907 HD12 ' HG2' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -154.24 146.62 13.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 108.822 -178.773 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.5 ' HB2' HG23 ' A' ' 18' ' ' ILE . 20.9 ttp180 -157.96 84.26 0.87 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.406 -0.809 . . . . 0.0 110.626 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.574 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 11.7 m120 -160.59 179.46 8.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.924 -1.11 . . . . 0.0 109.662 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 2.9 mm-40 81.44 -68.94 0.09 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.888 0.851 . . . . 0.0 109.219 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.502 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 38.4 t-20 -111.15 22.94 14.67 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.431 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 23.4 t-20 49.71 47.52 22.78 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 15' ' ' ASN . 3.7 mt-10 -140.69 147.61 39.52 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 11' ' ' ILE . 1.5 mt -96.97 151.94 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.904 -1.123 . . . . 0.0 110.56 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -100.07 76.96 1.96 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.545 HD11 ' CE1' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -79.7 -178.02 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.952 0.882 . . . . 0.0 110.611 -177.456 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.559 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -114.3 137.17 52.13 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.034 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.505 ' HG3' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.597 0 O-C-N 120.963 -1.086 . . . . 0.0 109.683 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.424 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 36.1 m120 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -146.6 126.85 13.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.172 -0.955 . . . . 0.0 109.488 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.517 ' O ' ' HG3' ' A' ' 116' ' ' PRO . 7.2 mt -93.45 -165.17 1.28 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -149.53 -163.86 1.89 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.68 -1.263 . . . . 0.0 110.194 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.781 ' CE2' HD11 ' A' ' 123' ' ' ILE . 6.5 m-85 -162.25 -66.62 0.01 OUTLIER Pre-proline 0 C--N 1.292 -1.909 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.769 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.797 ' HA ' HD11 ' A' ' 82' ' ' LEU . 15.3 Cg_exo -40.26 153.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.775 1.65 . . . . 0.0 110.467 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 97' ' ' LYS . . . -110.98 -86.59 1.69 Allowed Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -117.18 -61.07 0.31 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 170.93 175.84 0.06 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.179 -1.189 . . . . 0.0 110.069 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -144.25 102.4 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.53 -3.43 5.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.971 -1.081 . . . . 0.0 109.725 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.441 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 1.2 mpt? -53.06 -27.36 19.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.0 108.976 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.48 15.97 26.92 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 42' ' ' MET . 45.3 mm-40 -86.32 -80.68 0.23 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.539 -0.977 . . . . 0.0 109.782 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.798 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -148.51 177.5 1.77 Allowed Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 120.949 -1.094 . . . . 0.0 109.968 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.798 ' CD ' HG22 ' A' ' 45' ' ' THR . 6.3 Cg_endo -73.77 -40.24 1.51 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.694 2.263 . . . . 0.0 111.063 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.01 -52.85 5.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.324 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.57 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 2.1 tt0 -45.01 -29.1 0.78 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 122.441 1.115 . . . . 0.0 110.026 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.48 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . -72.86 -59.84 2.52 Favored 'General case' 0 C--N 1.271 -2.834 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.576 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.909 HG21 ' NE1' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -81.82 -3.08 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.016 -1.052 . . . . 0.0 111.029 -178.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 4.5 p -81.8 -45.3 20.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.571 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -70.64 -28.57 64.91 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.168 177.515 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.56 ' O ' ' NE1' ' A' ' 95' ' ' TRP . 3.0 mt-10 -76.6 -17.81 58.99 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.594 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.024 HD13 ' HG3' ' A' ' 62' ' ' PRO . 5.7 mt -71.1 -54.96 9.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.482 -0.761 . . . . 0.0 110.432 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.476 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -82.64 -37.11 25.37 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.705 -1.247 . . . . 0.0 111.355 -178.97 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -80.66 35.03 0.34 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.722 -1.236 . . . . 0.0 111.52 -178.36 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 1.1 mm-40 -149.8 -58.23 0.19 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.581 -1.324 . . . . 0.0 110.098 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.813 HG12 ' CD1' ' A' ' 95' ' ' TRP . 5.2 p -123.07 -10.75 7.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.287 -0.883 . . . . 0.0 108.677 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 60.84 73.09 0.53 Allowed Glycine 0 N--CA 1.486 1.98 0 O-C-N 121.775 -0.578 . . . . 0.0 112.901 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -112.26 179.97 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.289 -1.124 . . . . 0.0 108.428 177.404 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 47.2 m -131.34 86.88 48.95 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 1.024 ' HG3' HD13 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -59.72 129.04 29.07 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.107 1.871 . . . . 0.0 110.572 -177.535 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.452 ' HG3' ' HB3' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -83.69 -37.58 22.57 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.499 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 65' ' ' PHE . 0.8 OUTLIER -168.47 51.6 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.779 -1.2 . . . . 0.0 111.49 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.597 ' CB ' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -46.75 173.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.601 -1.312 . . . . 0.0 109.475 179.19 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -161.26 157.14 25.1 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.565 -0.709 . . . . 0.0 109.651 179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.777 HD12 ' HA ' ' A' ' 85' ' ' TRP . 50.0 tp -112.01 92.85 4.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.186 -0.946 . . . . 0.0 109.19 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.7 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -53.76 -59.52 4.51 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.605 0.717 . . . . 0.0 109.635 -179.471 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.7 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.8 tp10 -168.28 141.41 3.1 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.643 -0.66 . . . . 0.0 110.032 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.451 ' HG3' ' HA ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -121.14 138.94 53.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.426 -0.796 . . . . 0.0 109.008 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -109.88 -171.49 1.85 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.078 -1.014 . . . . 0.0 109.941 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -143.83 175.04 10.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.472 -0.767 . . . . 0.0 108.971 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 80' ' ' ILE . 1.6 t80 -150.13 163.44 38.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.934 -1.103 . . . . 0.0 110.155 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.0 tt0 -142.45 109.14 5.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.409 -0.807 . . . . 0.0 109.19 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.632 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -78.83 173.52 7.57 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.066 -1.021 . . . . 0.0 108.901 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.632 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 5.7 Cg_exo -51.4 -26.07 20.24 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.723 1.615 . . . . 0.0 109.543 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -148.16 2.22 0.66 Allowed 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.888 -0.508 . . . . 0.0 110.071 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.503 ' HG3' ' HB3' ' A' ' 75' ' ' PHE . 4.8 mtp180 -122.68 -161.58 0.96 Allowed 'General case' 0 C--N 1.31 -1.142 0 O-C-N 120.9 -1.125 . . . . 0.0 109.547 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -162.01 109.46 1.37 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.005 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 73' ' ' TYR . 25.2 mm -99.3 124.85 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.031 -1.043 . . . . 0.0 110.038 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.511 ' HB ' ' HG3' ' A' ' 5' ' ' GLN . 67.6 m -130.08 116.51 18.61 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.915 HD12 ' CG1' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -107.98 153.52 22.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.068 -1.02 . . . . 0.0 110.229 -179.135 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.625 ' O ' HG13 ' A' ' 8' ' ' VAL . 3.2 m95 -110.54 118.17 35.51 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.654 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.1 m-85 -99.97 70.71 1.61 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.123 -0.986 . . . . 0.0 109.362 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.909 ' NE1' HG21 ' A' ' 50' ' ' VAL . 46.5 p-90 -80.28 84.18 5.99 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.138 -1.425 . . . . 0.0 108.889 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.061 ' CD1' HD12 ' A' ' 10' ' ' ILE . 1.6 tp -64.1 121.51 14.35 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.152 0.501 . . . . 0.0 109.918 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.85 HG13 HG23 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -102.96 161.59 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 119.095 -1.042 . . . . 0.0 108.986 179.006 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.46 ' N ' ' CG2' ' A' ' 87' ' ' VAL . 9.0 pm0 -118.35 -24.0 7.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.919 . . . . 0.0 110.768 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.452 ' HB3' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -146.81 152.88 39.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.807 -1.183 . . . . 0.0 110.56 -179.323 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.574 ' CZ3' ' HB2' ' A' ' 13' ' ' ASN . 28.2 p90 -168.64 -173.41 1.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.842 0.829 . . . . 0.0 109.367 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.655 ' O ' HG22 ' A' ' 60' ' ' ILE . 9.4 tt0 -137.18 113.63 10.13 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.357 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.452 ' O ' ' HD3' ' A' ' 94' ' ' PRO . . . 106.65 169.45 22.64 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.6 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -79.13 115.0 49.41 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.296 -1.12 . . . . 0.0 108.935 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.907 ' HG2' HD12 ' A' ' 11' ' ' ILE . 5.5 Cg_endo -73.77 177.03 8.59 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.672 2.248 . . . . 0.0 112.571 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.813 ' CD1' HG12 ' A' ' 58' ' ' VAL . 3.1 p-90 -115.1 -163.01 0.85 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.415 ' N ' ' HE3' ' A' ' 95' ' ' TRP . . . 179.61 -32.7 0.06 OUTLIER Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.418 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -129.2 -163.96 1.35 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.823 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 9.9 pt-20 -55.15 -46.13 75.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.956 -1.09 . . . . 0.0 108.554 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.444 ' C ' ' HD3' ' A' ' 101' ' ' PRO . . . -124.84 -129.73 3.42 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.668 ' N ' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -125.24 42.78 0.79 Allowed Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.01 -1.288 . . . . 0.0 110.971 179.191 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.668 ' HD3' ' N ' ' A' ' 100' ' ' GLN . 6.2 Cg_endo -67.56 -12.9 37.25 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 C-N-CA 121.471 1.448 . . . . 0.0 110.011 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -61.09 179.84 3.05 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -141.99 160.93 39.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.076 -1.249 . . . . 0.0 110.3 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -89.03 103.49 16.1 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.394 -0.817 . . . . 0.0 109.576 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 13.9 ttm -87.44 129.51 35.02 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.306 -0.871 . . . . 0.0 109.515 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.792 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -92.96 72.67 4.76 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.314 -0.867 . . . . 0.0 109.452 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 107' ' ' LEU . 6.0 tp 49.85 50.92 17.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.134 -0.979 . . . . 0.0 109.565 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 106' ' ' SER . 29.3 t -139.2 101.3 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.261 -0.9 . . . . 0.0 109.473 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 114' ' ' ASP . . . 92.99 17.24 44.5 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.92 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -62.64 -18.03 61.49 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.296 -1.12 . . . . 0.0 108.987 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.494 ' ND2' ' HD3' ' A' ' 127' ' ' LYS . 10.2 m-20 -78.3 178.33 7.74 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.738 -0.601 . . . . 0.0 109.461 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.962 ' CA ' HG21 ' A' ' 123' ' ' ILE . . . -67.51 -6.85 21.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.47 -53.03 60.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.249 -0.907 . . . . 0.0 110.11 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.517 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -79.33 -12.78 59.93 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.1 -1.0 . . . . 0.0 108.817 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.615 ' CZ ' ' CZ ' ' A' ' 35' ' ' PHE . 12.8 m-85 -94.59 140.41 22.63 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.517 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 5.7 Cg_exo -63.31 148.4 92.93 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.99 1.794 . . . . 0.0 110.037 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.704 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 3.9 Cg_exo -58.87 118.61 5.52 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.13 1.886 . . . . 0.0 110.33 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 162.37 -24.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.491 -0.756 . . . . 0.0 109.132 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.533 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 0.9 OUTLIER -123.14 43.97 2.8 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.307 -0.871 . . . . 0.0 109.732 -179.583 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.678 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 7.0 mt-10 -66.34 -39.14 24.74 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 112.161 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 2.9 Cg_endo -64.51 -34.55 52.63 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 122.117 1.878 . . . . 0.0 112.371 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.654 HG11 ' CD2' ' A' ' 84' ' ' PHE . 1.1 t -93.76 -50.04 12.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.962 HG21 ' CA ' ' A' ' 112' ' ' ALA . 8.8 mm -49.53 -33.73 7.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -53.24 -47.11 69.32 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -66.73 -28.76 68.67 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.322 -0.861 . . . . 0.0 109.524 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.808 HD12 HD13 ' A' ' 123' ' ' ILE . 11.4 mt -70.74 -10.69 60.01 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.143 -0.973 . . . . 0.0 109.646 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 124' ' ' ALA . 1.3 mmtp -56.76 -52.92 63.14 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.251 -0.906 . . . . 0.0 109.195 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -98.42 26.76 5.21 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.406 -0.809 . . . . 0.0 109.049 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.642 HD21 HD21 ' A' ' 86' ' ' LEU . 2.4 tp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.558 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.713 ' N ' HD23 ' A' ' 4' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.578 ' HB2' HG21 ' A' ' 40' ' ' ILE . 7.0 mt-30 -96.42 114.03 25.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.229 -0.92 . . . . 0.0 109.509 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.621 HG22 ' H ' ' A' ' 7' ' ' ALA . 3.1 mm -99.42 -175.99 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.248 -0.908 . . . . 0.0 109.231 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.621 ' H ' HG22 ' A' ' 6' ' ' ILE . . . -149.39 101.83 3.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.719 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.826 HG11 ' HB3' ' A' ' 35' ' ' PHE . 10.2 p -108.51 135.06 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.154 -0.966 . . . . 0.0 108.538 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.28 106.56 1.43 Allowed Glycine 0 N--CA 1.484 1.87 0 C-N-CA 119.372 -1.394 . . . . 0.0 109.696 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.826 ' HB ' HD12 ' A' ' 86' ' ' LEU . 1.7 mt -82.89 143.99 10.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.876 HG22 ' CZ3' ' A' ' 90' ' ' TRP . 1.8 mt -131.51 128.97 61.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.819 -177.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 88' ' ' GLU . 5.9 ttp180 -139.75 125.99 20.04 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.464 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 6.0 p30 -118.72 -167.16 1.33 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.983 . . . . 0.0 109.985 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -71.64 -2.39 17.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 109.944 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.486 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 2.3 t-20 -79.78 5.66 12.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.176 -0.952 . . . . 0.0 109.136 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.478 ' OD1' ' HB ' ' A' ' 108' ' ' VAL . 22.6 t30 54.95 46.57 24.07 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.264 -0.898 . . . . 0.0 109.619 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 15' ' ' ASN . 4.5 mt-10 -146.5 133.63 20.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 108.892 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.855 HD11 ' HB2' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -102.16 160.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.221 -0.924 . . . . 0.0 108.801 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 25.8 t80 -118.55 82.03 1.78 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.922 -1.111 . . . . 0.0 108.565 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.627 HD11 ' HB ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -121.04 -160.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.592 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -117.31 138.48 51.73 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.39 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HG3' ' OD1' ' A' ' 31' ' ' ASN . 4.9 ttp180 . . . . . 0 C--N 1.306 -1.326 0 O-C-N 121.288 -0.882 . . . . 0.0 109.465 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.501 ' OD1' ' HG3' ' A' ' 22' ' ' ARG . 3.0 t-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.325 0.583 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.44 ' HB3' ' HG3' ' A' ' 116' ' ' PRO . 6.8 mmmt -95.29 125.03 39.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.641 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.571 ' CD1' ' CE2' ' A' ' 115' ' ' PHE . 56.5 mt -107.8 -174.59 2.56 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -160.69 -162.11 0.91 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.027 -1.045 . . . . 0.0 110.878 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.826 ' HB3' HG11 ' A' ' 8' ' ' VAL . 65.5 m-85 -155.18 69.27 5.51 Favored Pre-proline 0 C--N 1.295 -1.788 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.522 ' CD ' ' OG1' ' A' ' 21' ' ' THR . 2.4 Cg_endo -61.74 -81.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.173 1.915 . . . . 0.0 110.409 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 100.49 -150.02 18.74 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -139.8 24.15 2.75 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.614 ' HD2' HG23 ' A' ' 6' ' ' ILE . 2.5 mptt 70.25 148.2 0.07 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -1.143 . . . . 0.0 110.034 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.166 HD11 ' CZ2' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -101.57 119.27 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.459 ' O ' ' C ' ' A' ' 42' ' ' MET . 0.6 OUTLIER -79.06 -159.58 0.19 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.008 -1.058 . . . . 0.0 108.845 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.459 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -42.04 -52.78 4.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.372 -0.83 . . . . 0.0 108.997 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 42' ' ' MET . . . 58.38 122.77 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.236 -1.145 . . . . 0.0 110.236 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -106.53 -9.72 16.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -1.106 . . . . 0.0 108.785 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.678 HG23 ' H ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -160.55 171.54 6.98 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.546 ' HA ' ' CH2' ' A' ' 83' ' ' TRP . 3.7 Cg_exo -61.36 -37.2 74.16 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.294 1.996 . . . . 0.0 111.706 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.678 ' H ' HG23 ' A' ' 45' ' ' THR . 1.0 OUTLIER -86.45 -56.98 3.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.809 -1.182 . . . . 0.0 109.583 -179.624 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.664 ' H ' HG22 ' A' ' 45' ' ' THR . 1.7 tt0 -38.13 -32.28 0.06 Allowed 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.252 1.025 . . . . 0.0 110.049 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 47' ' ' GLU . . . -64.82 -65.29 0.69 Allowed 'General case' 0 C--N 1.272 -2.797 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.66 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.523 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 1.2 p -81.21 -45.45 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.898 -1.126 . . . . 0.0 110.301 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.601 HG13 ' N ' ' A' ' 52' ' ' ARG . 6.1 p -40.62 -47.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.653 -0.654 . . . . 0.0 109.332 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.601 ' N ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -74.61 -34.57 62.85 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.52 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 2.4 mt-10 -60.07 -19.95 55.65 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.903 -1.123 . . . . 0.0 108.363 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.631 ' CD2' ' CH2' ' A' ' 95' ' ' TRP . 13.8 mt -75.31 -68.61 0.54 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.197 0.522 . . . . 0.0 110.381 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.403 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 2.4 pt20 -61.3 -28.62 69.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.775 -1.203 . . . . 0.0 111.637 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 1.2 pp20? -72.88 1.02 9.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.701 -1.249 . . . . 0.0 109.56 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.457 ' HB3' ' HD1' ' A' ' 95' ' ' TRP . 3.5 mm-40 -143.78 -68.74 0.33 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.415 -0.803 . . . . 0.0 109.96 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.701 HG21 ' O ' ' A' ' 93' ' ' GLU . 2.4 p -111.55 -54.59 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.691 -1.255 . . . . 0.0 107.62 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.585 ' N ' ' CG1' ' A' ' 58' ' ' VAL . . . 81.84 47.2 6.36 Favored Glycine 0 N--CA 1.479 1.567 0 O-C-N 121.438 -0.789 . . . . 0.0 113.86 175.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.731 HG21 ' CD1' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -79.68 124.53 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 120.12 1.96 . . . . 0.0 106.403 176.362 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.718 ' H ' ' HD3' ' A' ' 62' ' ' PRO . 8.4 t -149.26 23.77 0.04 OUTLIER Pre-proline 0 C--N 1.279 -2.5 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.718 ' HD3' ' H ' ' A' ' 61' ' ' THR . 2.2 Cg_endo -62.35 -47.15 10.37 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 CA-C-N 120.072 1.061 . . . . 0.0 109.725 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 89' ' ' ARG . 6.2 pt20 -162.88 -31.24 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.962 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.612 ' O ' ' CG ' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -42.76 113.73 0.5 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 122.214 1.007 . . . . 0.0 112.962 -177.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.409 ' CB ' ' O ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER 171.74 130.58 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.159 -0.963 . . . . 0.0 110.044 177.608 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -163.67 -35.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 110.574 179.561 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.601 ' HB2' ' CE3' ' A' ' 85' ' ' TRP . 37.7 tp 39.35 96.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.765 0.793 . . . . 0.0 109.273 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.663 ' CZ ' HD21 ' A' ' 126' ' ' LEU . 30.2 p90 -66.62 -54.03 27.74 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.446 -0.784 . . . . 0.0 110.705 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.61 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER 178.35 134.11 0.08 Allowed 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.247 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.551 ' CB ' ' HB3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -94.69 168.55 10.76 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.498 -0.751 . . . . 0.0 109.79 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.966 HD23 ' HB ' ' A' ' 122' ' ' VAL . 1.2 pp -126.41 -166.53 1.59 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.096 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -160.0 142.62 13.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 109.625 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.416 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -130.03 96.12 4.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.343 -0.848 . . . . 0.0 109.41 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.465 ' HG2' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -84.15 109.39 17.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.4 -0.813 . . . . 0.0 109.297 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.599 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -79.63 179.63 1.76 Allowed Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.599 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 6.0 Cg_endo -75.81 40.76 0.75 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.329 2.019 . . . . 0.0 111.198 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 76' ' ' PRO . 0.1 OUTLIER 172.3 -25.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.712 -1.243 . . . . 0.0 110.214 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -124.44 170.45 10.84 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 109.977 -178.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.465 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 8.5 m-70 -126.01 92.11 3.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.438 -0.789 . . . . 0.0 108.969 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.441 ' CD1' HD12 ' A' ' 4' ' ' LEU . 27.1 mm -79.4 137.19 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.29 -0.881 . . . . 0.0 109.503 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.54 84.52 1.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.299 -0.876 . . . . 0.0 109.454 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.625 ' CD1' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -108.09 158.58 17.28 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.348 -0.845 . . . . 0.0 109.407 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 1.166 ' CZ2' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -131.03 151.91 50.9 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.964 -1.085 . . . . 0.0 110.75 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.784 ' CB ' HD11 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.71 120.98 38.18 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.679 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.601 ' CE3' ' HB2' ' A' ' 67' ' ' LEU . 10.9 m95 -96.4 98.09 9.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.002 -1.061 . . . . 0.0 110.202 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.826 HD12 ' HB ' ' A' ' 10' ' ' ILE . 1.0 OUTLIER -68.61 89.5 0.37 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.623 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.827 HG21 HG23 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -60.52 174.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.633 0.73 . . . . 0.0 110.533 -178.106 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' A' ' 12' ' ' ARG . 11.0 mm-40 -97.05 -72.29 0.65 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.049 -0.661 . . . . 0.0 109.371 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.533 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -159.2 148.85 18.77 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.876 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 3.7 p90 -136.95 -171.41 2.93 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.833 -1.167 . . . . 0.0 111.243 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.512 ' H ' ' CG ' ' A' ' 62' ' ' PRO . 15.6 tt0 -128.88 -33.69 2.0 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.68 -134.82 0.11 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.701 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.0 OUTLIER -121.66 132.51 24.21 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.197 -1.178 . . . . 0.0 110.156 -179.378 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.867 ' CB ' HD12 ' A' ' 11' ' ' ILE . 2.4 Cg_endo -71.82 119.53 6.27 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.581 2.187 . . . . 0.0 109.814 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.667 ' CG ' ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -126.31 38.64 4.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.02 -1.05 . . . . 0.0 112.923 -177.859 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -49.71 -20.42 2.79 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HG2' HG23 ' A' ' 21' ' ' THR . 0.0 OUTLIER -108.73 -171.9 1.94 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.422 -1.046 . . . . 0.0 109.912 -179.646 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -141.5 -41.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.441 -0.787 . . . . 0.0 109.045 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.28 23.87 1.1 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.434 ' CG ' ' HD2' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -102.61 172.05 4.67 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.417 -1.049 . . . . 0.0 109.639 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' A' ' 102' ' ' GLY . 4.9 Cg_endo -70.88 5.54 2.08 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.538 2.159 . . . . 0.0 111.443 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.592 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -39.77 146.91 0.23 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 9.8 pt-20 -161.33 -171.51 3.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.614 -0.933 . . . . 0.0 110.434 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.563 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 20.6 m0 -94.53 100.56 12.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.569 -0.707 . . . . 0.0 109.772 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -84.42 -163.17 0.76 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.142 -0.974 . . . . 0.0 108.908 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.58 103.21 4.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.315 -0.865 . . . . 0.0 109.369 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.855 ' HB2' HD11 ' A' ' 18' ' ' ILE . 18.4 mt -139.57 -78.28 0.32 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.527 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER 67.53 25.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.002 0.906 . . . . 0.0 108.814 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 178.39 44.74 0.07 OUTLIER Glycine 0 N--CA 1.485 1.902 0 N-CA-C 107.187 -2.365 . . . . 0.0 107.187 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.705 HD11 ' CE2' ' A' ' 115' ' ' PHE . 1.1 mt -36.42 153.69 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 O-C-N 122.103 -0.645 . . . . 0.0 109.886 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.667 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 0.7 OUTLIER -134.81 9.01 3.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.139 -0.976 . . . . 0.0 109.667 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 73.91 -9.94 1.17 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.062 -1.024 . . . . 0.0 110.47 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -74.71 -42.1 58.97 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.833 -1.167 . . . . 0.0 109.101 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' CD2' ' A' ' 110' ' ' LEU . 3.4 p30 -78.62 0.61 25.73 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.705 ' CE2' HD11 ' A' ' 110' ' ' LEU . 10.1 m-85 -120.0 106.29 41.44 Favored Pre-proline 0 N--CA 1.485 1.323 0 O-C-N 121.441 -0.787 . . . . 0.0 109.073 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 115' ' ' PHE . 35.4 Cg_exo -40.17 152.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.281 1.988 . . . . 0.0 110.71 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.717 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 5.9 Cg_exo -56.19 -160.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.622 2.215 . . . . 0.0 111.357 -178.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 117' ' ' PRO . . . 82.97 -42.67 0.11 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.73 -0.606 . . . . 0.0 109.674 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.544 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 2.9 m120 -98.0 33.66 2.09 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.087 -1.008 . . . . 0.0 109.357 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.645 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 4.2 mt-10 -62.49 -38.85 49.84 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.374 -0.829 . . . . 0.0 112.688 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.3 Cg_exo -58.89 -41.97 57.12 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.776 1.651 . . . . 0.0 112.314 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.966 ' HB ' HD23 ' A' ' 71' ' ' LEU . 1.1 t -97.43 -47.98 12.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 120.44 -1.412 . . . . 0.0 108.295 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.64 HG22 ' HB2' ' A' ' 112' ' ' ALA . 7.5 mm -47.61 -34.35 3.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.364 -0.835 . . . . 0.0 108.802 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.34 -45.15 72.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.494 -0.754 . . . . 0.0 109.598 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.65 -52.36 65.48 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.228 -0.92 . . . . 0.0 109.849 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.663 HD21 ' CZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -53.98 -15.83 1.6 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.182 -0.949 . . . . 0.0 110.347 -179.234 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.528 ' HE2' ' O ' ' A' ' 111' ' ' ASN . 12.6 mttt -51.41 -51.42 54.91 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.815 -1.178 . . . . 0.0 108.715 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -94.89 46.45 1.13 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.65 HD21 ' CD2' ' A' ' 86' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.777 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.631 ' HB3' HG21 ' A' ' 40' ' ' ILE . 72.1 mt-30 -133.59 142.51 48.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.188 -0.945 . . . . 0.0 110.0 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.636 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.5 mt -149.26 157.7 6.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.462 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -111.84 126.63 55.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.123 -0.986 . . . . 0.0 108.973 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 1.062 HG11 HD21 ' A' ' 82' ' ' LEU . 1.4 p -125.46 83.89 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.918 . . . . 0.0 110.202 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.504 ' HA2' ' CD1' ' A' ' 85' ' ' TRP . . . -74.21 117.42 5.59 Favored Glycine 0 C--N 1.291 -1.952 0 N-CA-C 107.732 -2.147 . . . . 0.0 107.732 178.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.759 HD12 ' CD1' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -97.21 172.19 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 120.973 -1.31 . . . . 0.0 109.755 -178.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.837 HD12 ' HB3' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -140.49 154.82 22.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.438 -0.788 . . . . 0.0 109.211 -179.624 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.501 ' CD ' HD23 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -160.34 68.19 0.36 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.343 -0.848 . . . . 0.0 110.281 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.6 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 20.2 m120 -163.83 -171.58 2.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.185 -0.947 . . . . 0.0 109.628 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 6.1 tt0 83.95 -46.15 0.11 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.86 0.838 . . . . 0.0 109.542 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.427 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 47.7 t30 -142.13 25.2 1.93 Allowed 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.472 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 12.4 t30 55.64 45.85 23.9 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 105' ' ' MET . 4.0 mt-10 -140.41 149.85 43.14 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.099 -1.0 . . . . 0.0 109.386 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.555 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 0.4 OUTLIER -97.95 151.67 4.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.305 -0.872 . . . . 0.0 109.22 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.547 ' HB3' HG12 ' A' ' 11' ' ' ILE . 50.3 t80 -88.54 82.5 6.91 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.605 HG22 ' N ' ' A' ' 21' ' ' THR . 42.2 mm -78.28 167.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.295 -0.878 . . . . 0.0 110.122 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.849 HG21 ' HB2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -121.73 128.36 51.7 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.525 ' N ' ' OE1' ' A' ' 100' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.677 0 O-C-N 121.512 -0.743 . . . . 0.0 109.193 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.327 0.584 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -134.63 137.74 43.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 109.264 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.561 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 3.1 mt -99.13 -169.68 1.8 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.259 -0.901 . . . . 0.0 108.722 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.49 -156.52 0.48 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.12 -0.987 . . . . 0.0 109.837 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -144.57 158.27 54.08 Favored Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.721 ' C ' HG23 ' A' ' 8' ' ' VAL . 3.1 Cg_exo -55.71 -153.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.186 1.924 . . . . 0.0 109.816 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 163.24 -166.98 37.33 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.564 -1.303 . . . . 0.0 110.009 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . 173.95 -80.12 0.08 OUTLIER Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 9.0 tttt 166.72 136.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.494 -1.004 . . . . 0.0 109.198 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.814 HD11 ' NE1' ' A' ' 83' ' ' TRP . 3.8 mt -115.2 105.77 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 109.158 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.543 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -108.23 17.2 22.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.086 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.543 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 78.85 -137.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.47 -112.27 1.66 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.495 ' HB3' ' OE1' ' A' ' 48' ' ' GLN . 9.7 tt0 -127.99 -38.99 1.79 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.315 -1.109 . . . . 0.0 109.467 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.656 HG23 ' H ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -156.97 167.76 13.88 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.072 -1.017 . . . . 0.0 108.957 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 3.3 Cg_exo -60.25 -18.1 50.27 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.879 2.386 . . . . 0.0 112.851 -177.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.994 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -79.74 -63.12 1.49 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.795 -1.191 . . . . 0.0 109.251 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.629 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 3.2 tt0 -38.02 -32.71 0.07 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.578 1.18 . . . . 0.0 109.626 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 47' ' ' GLU . . . -61.79 -65.51 0.68 Allowed 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.537 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.57 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 4.3 p -80.86 -43.97 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.927 -1.108 . . . . 0.0 110.79 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.994 HG12 ' O ' ' A' ' 47' ' ' GLU . 7.5 p -42.6 -33.52 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HB3' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -75.82 -43.74 44.57 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.566 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.57 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 2.7 pt-20 -70.84 -7.3 44.46 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 118.74 -1.184 . . . . 0.0 108.5 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.718 HD23 ' HE1' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -64.99 -62.56 1.48 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.495 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 25.5 mt-30 -81.56 -24.19 36.7 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.569 -0.707 . . . . 0.0 109.458 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 52' ' ' ARG . 4.1 mm-40 -81.66 31.04 0.35 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.28 -0.887 . . . . 0.0 110.813 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.568 ' HB3' ' CB ' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -148.67 -64.01 0.24 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.696 -1.253 . . . . 0.0 109.863 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.918 HG11 ' C ' ' A' ' 94' ' ' PRO . 1.0 OUTLIER -118.78 -36.79 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.061 -1.025 . . . . 0.0 108.263 178.863 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 89.93 55.08 2.06 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.704 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -82.08 -179.28 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.183 -1.186 . . . . 0.0 109.834 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.795 ' O ' HG23 ' A' ' 61' ' ' THR . 8.6 t -135.41 58.31 25.03 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.704 ' HD3' ' HB ' ' A' ' 60' ' ' ILE . 4.6 Cg_exo -53.8 129.17 32.72 Favored 'Trans proline' 0 C--N 1.29 -2.541 0 C-N-CA 122.35 2.033 . . . . 0.0 111.08 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.554 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 0.7 OUTLIER -81.21 -42.91 20.04 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.463 -179.198 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -160.85 114.96 2.08 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.676 -1.21 . . . . 0.0 111.018 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.488 ' CB ' ' HA ' ' A' ' 87' ' ' VAL . 1.8 p90 -121.98 177.89 5.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -0.846 . . . . 0.0 109.088 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 m -161.31 158.68 27.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.863 HD12 ' HA ' ' A' ' 85' ' ' TRP . 47.5 tp -84.76 96.25 9.2 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.876 -1.14 . . . . 0.0 109.536 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.666 ' HB3' HD23 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -41.76 -76.09 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.837 0.827 . . . . 0.0 108.904 179.267 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.64 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 4.0 tp10 -171.09 126.95 0.69 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 83' ' ' TRP . 8.9 ptpt -89.41 153.49 20.8 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.339 -0.85 . . . . 0.0 110.051 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.907 HD22 ' CG2' ' A' ' 122' ' ' VAL . 0.5 OUTLIER -127.41 -157.36 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.333 -0.854 . . . . 0.0 109.114 178.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.531 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -161.02 165.09 30.39 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.359 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.482 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . 1.1 t80 -152.82 175.39 12.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.543 -0.723 . . . . 0.0 109.174 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -160.43 109.33 1.69 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.665 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.604 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -79.71 177.16 3.09 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.184 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.604 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 6.3 Cg_endo -74.34 31.31 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.496 2.13 . . . . 0.0 111.335 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.29 -39.1 0.05 Allowed 'General case' 0 N--CA 1.482 1.157 0 O-C-N 120.509 -1.369 . . . . 0.0 110.112 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -135.99 -177.22 4.59 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.363 -0.835 . . . . 0.0 110.299 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.499 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 4.7 m-70 -113.55 126.72 55.6 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.496 HD13 ' N ' ' A' ' 80' ' ' ILE . 1.6 mm -94.6 149.22 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.168 -0.958 . . . . 0.0 109.652 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.1 m -157.21 107.51 2.26 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 1.062 HD21 HG11 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -136.34 129.02 30.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.149 -0.969 . . . . 0.0 110.1 -178.88 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.814 ' NE1' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -119.05 149.21 42.05 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.237 -0.914 . . . . 0.0 110.108 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.602 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -127.67 123.03 34.53 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.863 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -91.13 80.9 5.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.616 -1.303 . . . . 0.0 109.209 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.759 ' CD1' HD12 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -42.43 121.15 1.85 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.249 -0.907 . . . . 0.0 110.306 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.763 HG22 ' HA ' ' A' ' 11' ' ' ILE . 18.9 m -87.61 170.19 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.517 ' HB3' ' HD2' ' A' ' 89' ' ' ARG . 5.2 mt-10 -122.54 -19.79 6.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.854 -1.153 . . . . 0.0 111.078 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.554 ' HG3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.93 156.64 20.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.597 -1.314 . . . . 0.0 110.238 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.788 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 6.2 p90 177.27 -169.38 0.07 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.096 0.951 . . . . 0.0 110.445 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.643 ' N ' ' CD1' ' A' ' 90' ' ' TRP . 7.2 tt0 -147.53 128.28 14.31 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.839 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 119.85 -165.92 13.48 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.848 -1.167 . . . . 0.0 110.279 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.58 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -111.01 105.07 56.98 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.166 -1.196 . . . . 0.0 109.05 179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.918 ' C ' HG11 ' A' ' 58' ' ' VAL . 4.8 Cg_exo -58.96 176.38 0.47 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.782 2.321 . . . . 0.0 113.066 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.911 ' CD1' HG13 ' A' ' 58' ' ' VAL . 3.8 p-90 -122.57 -161.28 0.93 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.764 0.793 . . . . 0.0 109.834 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.569 ' HA3' ' HB3' ' A' ' 36' ' ' PRO . . . 165.79 -107.31 0.29 Allowed Glycine 0 N--CA 1.481 1.696 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.849 ' HB2' HG21 ' A' ' 21' ' ' THR . 11.1 tttp -60.99 -178.94 0.11 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.981 -1.305 . . . . 0.0 108.568 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.58 -73.35 0.66 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.952 -1.092 . . . . 0.0 109.713 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.96 10.81 56.81 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -110.33 121.99 39.9 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 121.033 -1.275 . . . . 0.0 109.447 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.43 -53.51 0.78 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.144 1.896 . . . . 0.0 111.155 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . 90.29 172.0 44.38 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 7.4 pt-20 -140.5 144.92 36.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.715 -1.462 . . . . 0.0 110.246 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.599 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -89.94 107.25 19.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.332 -0.855 . . . . 0.0 109.208 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 7.4 ttm -96.25 152.08 18.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.128 -0.982 . . . . 0.0 109.671 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.463 ' O ' ' HG ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -108.12 105.47 15.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 109.372 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.757 ' O ' HG12 ' A' ' 108' ' ' VAL . 49.1 mt -147.98 -65.66 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.15 -0.969 . . . . 0.0 109.651 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.757 HG12 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER 77.15 -1.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.484 -0.76 . . . . 0.0 109.821 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -138.99 25.77 2.77 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 107.072 -2.411 . . . . 0.0 107.072 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.712 HD13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -40.11 145.18 0.17 Allowed 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.935 -0.744 . . . . 0.0 110.149 -179.134 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.9 -171.71 1.95 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.371 -0.831 . . . . 0.0 108.991 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.547 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -91.12 10.26 27.64 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.238 -0.914 . . . . 0.0 109.3 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -85.99 -43.83 12.84 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.26 -0.9 . . . . 0.0 109.894 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.498 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -79.31 -14.89 58.71 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.256 -0.903 . . . . 0.0 108.744 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.712 ' CE2' HD13 ' A' ' 110' ' ' LEU . 1.4 m-85 -96.53 140.0 21.95 Favored Pre-proline 0 N--CA 1.489 1.516 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.854 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.505 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 1.8 Cg_endo -67.01 145.07 72.49 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.028 1.819 . . . . 0.0 110.446 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.715 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.8 Cg_endo -63.13 127.48 20.34 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.376 2.051 . . . . 0.0 110.574 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 156.9 -32.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.841 ' OD1' HD21 ' A' ' 71' ' ' LEU . 41.0 m-80 -112.81 46.85 1.16 Allowed 'General case' 0 C--O 1.201 -1.49 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.633 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 15.5 mt-10 -61.14 -41.39 80.56 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.237 -0.914 . . . . 0.0 112.901 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 1.3 Cg_endo -67.3 -29.05 39.15 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.544 2.162 . . . . 0.0 111.736 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.907 ' CG2' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -95.08 -41.25 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.021 -1.049 . . . . 0.0 108.444 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.547 HG22 ' HB2' ' A' ' 112' ' ' ALA . 8.8 mm -58.36 -35.42 53.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.02 -39.25 63.02 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . 20.2 mmtt -80.63 -31.56 36.51 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.41 -0.806 . . . . 0.0 109.803 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 4.3 mp -56.9 -25.13 56.53 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.3 -0.875 . . . . 0.0 109.212 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -56.43 -46.5 80.23 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 129' ' ' LEU . 7.3 mtt180 -84.72 -7.02 59.37 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.721 -0.612 . . . . 0.0 109.476 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 126' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.812 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.754 ' HG ' HG22 ' A' ' 80' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.751 ' HG3' HG23 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -152.9 159.44 42.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.881 . . . . 0.0 109.387 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.658 HD13 ' HA ' ' A' ' 39' ' ' LYS . 11.6 mm -116.89 168.44 8.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.226 -0.921 . . . . 0.0 109.353 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.61 ' N ' HG22 ' A' ' 6' ' ' ILE . . . -125.74 115.25 19.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.096 -1.002 . . . . 0.0 110.167 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 35' ' ' PHE . 5.8 p -129.54 146.13 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.53 112.33 1.08 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.024 HD12 ' CD1' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -94.25 162.12 2.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.043 HG22 ' CZ3' ' A' ' 90' ' ' TRP . 2.2 mt -146.03 135.95 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 118.319 -1.352 . . . . 0.0 112.037 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 35.1 ttp180 -126.98 129.57 48.36 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.536 ' OD1' ' CZ2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -98.48 -156.95 0.57 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.895 -1.128 . . . . 0.0 111.012 -178.062 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -85.67 -5.51 59.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.753 -0.592 . . . . 0.0 109.758 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.553 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 6.6 t-20 -91.34 23.12 3.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.919 . . . . 0.0 108.839 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.9 t30 48.32 46.38 20.19 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.615 -0.678 . . . . 0.0 110.897 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.553 ' CG ' ' HB3' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -134.2 165.94 23.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.197 -0.94 . . . . 0.0 108.649 178.562 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.826 HG13 HD22 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -116.66 167.65 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.113 -0.992 . . . . 0.0 109.439 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 94' ' ' PRO . 57.3 t80 -120.13 88.21 2.89 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 121.028 -1.045 . . . . 0.0 108.963 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.898 HG21 HD13 ' A' ' 33' ' ' LEU . 9.4 mm -77.81 174.57 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.644 HG21 ' N ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -118.16 128.51 54.78 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.863 -1.148 . . . . 0.0 108.67 178.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.407 ' NH1' ' HD2' ' A' ' 32' ' ' LYS . 1.4 tpt180 . . . . . 0 C--N 1.298 -1.64 0 O-C-N 121.155 -0.966 . . . . 0.0 109.865 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -137.67 128.89 27.74 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.699 -179.538 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.898 HD13 HG21 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -96.51 -174.57 3.07 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 21' ' ' THR . 5.6 mm-40 -119.37 172.88 7.31 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.936 -1.103 . . . . 0.0 110.271 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.657 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -161.12 -66.02 0.02 OUTLIER Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.132 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 35' ' ' PHE . 11.5 Cg_exo -42.81 150.08 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.115 1.21 . . . . 0.0 109.489 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -116.17 -85.89 1.23 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.72 53.52 0.48 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.658 ' HA ' HD13 ' A' ' 6' ' ' ILE . 4.6 mptt 64.75 175.52 0.2 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.44 -1.035 . . . . 0.0 109.716 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.751 HG23 ' HG3' ' A' ' 5' ' ' GLN . 1.3 tt -148.44 79.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.385 -0.822 . . . . 0.0 109.78 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 42' ' ' MET . 0.6 OUTLIER -150.22 148.95 29.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.92 -1.113 . . . . 0.0 110.05 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.476 ' HB3' ' O ' ' A' ' 41' ' ' GLU . 0.5 OUTLIER 164.31 -33.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.19 37.04 0.2 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 48' ' ' GLN . 39.9 mt-10 -131.84 -148.12 0.34 Allowed 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.487 -1.007 . . . . 0.0 109.915 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.821 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -142.66 -176.77 0.59 Allowed Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.215 -0.928 . . . . 0.0 108.695 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.821 ' CD ' HG22 ' A' ' 45' ' ' THR . 1.1 Cg_endo -69.12 -3.17 11.05 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.808 1.672 . . . . 0.0 110.68 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.461 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -108.14 -45.5 3.93 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.001 -1.062 . . . . 0.0 109.165 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.539 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -75.67 -54.83 6.35 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.341 1.067 . . . . 0.0 109.396 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 48' ' ' GLN . . . -38.02 -54.29 1.33 Allowed 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.176 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.499 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 5.3 p -76.12 -31.55 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.141 -0.975 . . . . 0.0 109.119 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.627 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -44.53 -58.05 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.627 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -67.92 -28.87 67.87 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.339 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.541 ' OE2' ' HB1' ' A' ' 7' ' ' ALA . 3.9 mt-10 -56.47 -18.79 12.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.831 -1.168 . . . . 0.0 108.301 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.722 HD13 ' HG3' ' A' ' 62' ' ' PRO . 14.6 mt -68.9 -42.73 76.51 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.372 -0.83 . . . . 0.0 109.056 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -81.25 -41.82 21.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 110.485 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.534 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 14.6 pt-20 -80.94 37.82 0.44 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.023 -1.048 . . . . 0.0 110.98 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.601 ' HB3' ' CG ' ' A' ' 95' ' ' TRP . 58.0 mm-40 -146.69 -55.76 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.881 -1.137 . . . . 0.0 109.204 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.854 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.6 m -143.83 -33.08 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.523 -0.736 . . . . 0.0 109.279 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.46 59.77 1.98 Allowed Glycine 0 N--CA 1.479 1.558 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.617 HG12 ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -95.6 164.91 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.489 -1.006 . . . . 0.0 109.012 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 97.4 m -112.53 83.98 5.95 Favored Pre-proline 0 C--N 1.3 -1.577 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.722 ' HG3' HD13 ' A' ' 54' ' ' LEU . 2.4 Cg_endo -59.48 117.63 4.39 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.439 2.093 . . . . 0.0 110.246 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.561 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 1.2 mt-30 -79.55 -28.02 41.25 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.559 -0.713 . . . . 0.0 109.183 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.437 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 12.5 t-160 -171.1 117.17 0.45 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.936 -1.102 . . . . 0.0 111.037 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.613 ' HB2' HG12 ' A' ' 87' ' ' VAL . 11.3 p90 -129.66 171.19 12.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.245 -0.909 . . . . 0.0 109.586 178.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.18 161.4 24.97 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.382 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.793 HD12 ' HA ' ' A' ' 85' ' ' TRP . 27.0 tp -109.31 108.78 19.49 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.87 ' CZ ' HD21 ' A' ' 126' ' ' LEU . 27.1 p90 -69.62 -56.62 6.78 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.308 -0.87 . . . . 0.0 111.117 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.645 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 3.3 tp10 -172.23 144.68 1.63 Allowed 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.348 -0.845 . . . . 0.0 109.857 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.591 ' HD3' ' CE3' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -111.59 158.11 19.61 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.336 -0.853 . . . . 0.0 110.549 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.806 HD23 ' HB ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -113.02 -165.08 0.96 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.428 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 1.7 pt-20 -149.07 133.96 17.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.822 -1.174 . . . . 0.0 110.353 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.617 ' HB2' HD11 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -96.29 117.74 31.42 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.277 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -110.94 99.76 8.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.156 -0.965 . . . . 0.0 109.547 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.55 ' HB2' ' HG3' ' A' ' 78' ' ' ARG . 5.1 m-85 -79.49 170.17 17.15 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 2.2 Cg_endo -62.87 -2.39 3.54 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.01 1.807 . . . . 0.0 111.516 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -143.18 -20.62 0.63 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.692 -1.255 . . . . 0.0 111.764 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.55 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -126.63 163.18 24.02 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.663 -1.273 . . . . 0.0 110.642 -178.495 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -127.35 74.24 1.5 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.754 HG22 ' HG ' ' A' ' 4' ' ' LEU . 0.9 OUTLIER -78.91 -174.85 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.352 -0.843 . . . . 0.0 110.576 -178.83 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 72' ' ' GLU . 3.0 m -151.01 153.62 35.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.421 -0.799 . . . . 0.0 109.209 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.528 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -129.34 143.1 50.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.083 -1.011 . . . . 0.0 109.324 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.638 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -133.11 128.91 37.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 109.837 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.734 ' CE1' HG11 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -121.83 101.16 7.4 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.702 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.793 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -79.89 83.44 5.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.188 -0.945 . . . . 0.0 110.594 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.024 ' CD1' HD12 ' A' ' 10' ' ' ILE . 3.4 tp -52.38 114.02 1.23 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 109.574 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.033 HG21 HG23 ' A' ' 11' ' ' ILE . 8.5 m -85.11 -163.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.218 -0.926 . . . . 0.0 109.581 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 12' ' ' ARG . 76.3 mt-10 -137.57 -31.82 0.78 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.113 -0.992 . . . . 0.0 110.355 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.561 ' HG3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -161.95 175.5 11.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.82 -1.175 . . . . 0.0 110.019 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 1.043 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 42.3 p90 -179.6 -168.24 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.081 0.943 . . . . 0.0 110.362 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.512 ' HB3' ' HB ' ' A' ' 61' ' ' THR . 17.4 tt0 -141.27 96.46 2.99 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.913 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.56 ' CA ' HG22 ' A' ' 60' ' ' ILE . . . 144.34 -152.12 24.05 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.273 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.854 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -106.51 112.36 63.76 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.22 -1.165 . . . . 0.0 109.601 -179.5 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.997 ' CB ' HD12 ' A' ' 11' ' ' ILE . 3.6 Cg_endo -56.81 130.71 41.35 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.155 2.57 . . . . 0.0 113.661 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.638 ' HE1' HD23 ' A' ' 54' ' ' LEU . 33.7 p-90 -107.01 -168.96 1.47 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 165.11 -15.72 0.09 OUTLIER Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.988 -1.577 . . . . 0.0 111.242 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.644 ' N ' HG21 ' A' ' 21' ' ' THR . 11.3 tttp -117.49 -99.15 0.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.829 -1.395 . . . . 0.0 109.765 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 97' ' ' LYS . 1.3 tt0 -134.81 28.11 3.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.22 -0.925 . . . . 0.0 109.407 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.79 22.9 19.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.483 ' HG2' ' HD2' ' A' ' 101' ' ' PRO . 2.0 mt-30 -103.15 166.88 11.06 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.136 -1.214 . . . . 0.0 109.619 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.483 ' HD2' ' HG2' ' A' ' 100' ' ' GLN . 1.1 Cg_endo -64.94 128.19 20.23 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.346 2.031 . . . . 0.0 110.513 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.553 ' HA3' ' CZ ' ' A' ' 19' ' ' PHE . . . -104.05 174.14 22.1 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.453 ' HA ' ' OE1' ' A' ' 103' ' ' GLU . 45.6 mm-40 -112.87 151.56 30.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.891 -1.358 . . . . 0.0 110.672 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.602 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -103.25 101.09 11.01 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.042 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.517 ' SD ' ' N ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -100.55 -166.81 1.36 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.974 -1.079 . . . . 0.0 110.002 -179.437 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -111.9 151.86 28.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 109.825 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.904 HD21 ' O ' ' A' ' 129' ' ' LEU . 7.0 tt -61.94 -27.58 68.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.44 -0.787 . . . . 0.0 110.183 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 109' ' ' GLY . 62.6 t -65.24 112.7 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.189 -0.945 . . . . 0.0 109.433 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 108' ' ' VAL . . . 45.1 40.71 7.42 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.826 HD22 HG13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -51.82 -42.69 62.72 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.476 -1.014 . . . . 0.0 110.127 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.781 ' HB2' HD12 ' A' ' 123' ' ' ILE . 1.6 p30 -130.28 -165.68 1.57 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.378 -0.826 . . . . 0.0 110.071 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.844 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . 87.48 -25.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -120.43 -37.72 3.0 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.334 -0.854 . . . . 0.0 108.937 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.465 ' O ' HD23 ' A' ' 33' ' ' LEU . 9.8 t0 -96.3 0.86 51.42 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.414 -0.804 . . . . 0.0 109.002 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.608 ' CE1' ' HB3' ' A' ' 111' ' ' ASN . 1.7 m-85 -91.46 164.57 24.01 Favored Pre-proline 0 N--CA 1.489 1.501 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.498 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.529 ' HD2' ' CD2' ' A' ' 115' ' ' PHE . 1.3 Cg_endo -67.7 142.21 57.39 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.949 1.766 . . . . 0.0 109.794 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.699 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.6 Cg_endo -64.53 96.78 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.26 1.973 . . . . 0.0 110.31 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 161.3 -21.42 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.387 -0.821 . . . . 0.0 109.765 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.552 ' HB3' HG13 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -97.51 29.88 3.11 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.135 -0.978 . . . . 0.0 109.411 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.672 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 22.5 mt-10 -68.79 -34.2 5.08 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.47 -0.769 . . . . 0.0 112.891 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.0 Cg_exo -58.6 -37.38 94.69 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.545 1.497 . . . . 0.0 111.674 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.806 ' HB ' HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -101.79 -47.83 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.633 -1.292 . . . . 0.0 107.863 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.844 HG21 ' HA ' ' A' ' 112' ' ' ALA . 12.4 mm -47.81 -31.1 2.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.507 -0.745 . . . . 0.0 109.013 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 127' ' ' LYS . . . -52.92 -49.86 65.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.388 -0.82 . . . . 0.0 108.857 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -41.31 92.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.453 -0.78 . . . . 0.0 109.263 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.87 HD21 ' CZ ' ' A' ' 68' ' ' PHE . 10.9 mt -57.13 -13.78 3.31 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.232 -0.917 . . . . 0.0 109.768 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.612 ' HE2' ' HB1' ' A' ' 112' ' ' ALA . 25.1 mttt -61.7 -46.04 91.37 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.701 -1.249 . . . . 0.0 108.816 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 129' ' ' LEU . 14.9 mtm180 -88.45 11.87 15.84 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.425 -0.797 . . . . 0.0 109.563 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.904 ' O ' HD21 ' A' ' 107' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.402 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.224 0.535 . . . . 0.0 109.895 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.709 ' OE1' HG21 ' A' ' 81' ' ' THR . 1.8 mt-30 -63.66 154.25 33.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.151 -0.968 . . . . 0.0 110.847 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.549 ' CG2' ' N ' ' A' ' 7' ' ' ALA . 5.1 mm -141.79 171.26 11.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.549 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . -132.23 89.96 2.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.797 -1.189 . . . . 0.0 109.848 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.644 HG23 ' C ' ' A' ' 36' ' ' PRO . 7.2 p -100.98 164.41 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.229 -0.919 . . . . 0.0 109.67 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -147.87 114.43 0.69 Allowed Glycine 0 N--CA 1.48 1.603 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.693 HD12 HD13 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -97.21 123.43 49.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.69 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.063 HD12 ' HB3' ' A' ' 94' ' ' PRO . 3.4 mt -117.8 153.21 19.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.201 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.516 ' CZ ' ' OE2' ' A' ' 88' ' ' GLU . 9.1 tpp180 -78.08 -147.41 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.912 0 O-C-N 120.965 -1.085 . . . . 0.0 108.763 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.564 ' CB ' ' HB2' ' A' ' 17' ' ' GLU . 0.9 OUTLIER -146.55 -11.46 0.46 Allowed 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.34 -0.85 . . . . 0.0 111.656 -179.174 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 13' ' ' ASN . 0.6 OUTLIER 82.97 -36.23 0.08 Allowed 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.603 -0.686 . . . . 0.0 109.274 -178.256 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 16' ' ' ASN . 14.9 t-20 -94.45 26.14 3.56 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.542 ' HB3' ' O ' ' A' ' 15' ' ' ASN . 18.8 t-20 71.16 37.17 1.25 Allowed 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.815 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.564 ' HB2' ' CB ' ' A' ' 13' ' ' ASN . 3.6 mt-10 -127.86 -163.5 1.27 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.639 -1.288 . . . . 0.0 109.353 178.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.588 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 1.1 mt -151.65 154.33 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.816 -1.178 . . . . 0.0 109.737 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 82.7 t80 -95.19 66.28 2.91 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.782 HG23 ' N ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -81.73 -156.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.849 0.833 . . . . 0.0 110.736 -177.826 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.98 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -145.51 147.1 31.77 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.385 0.612 . . . . 0.0 109.721 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.293 -0.879 . . . . 0.0 110.144 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.452 ' O ' ' HE3' ' A' ' 32' ' ' LYS . 1.5 m-20 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HG3' ' HG3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -137.38 146.14 44.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.292 179.804 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.98 HD23 ' O ' ' A' ' 21' ' ' THR . 0.7 OUTLIER -105.1 -174.15 2.47 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.209 -0.932 . . . . 0.0 109.341 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -162.02 -155.34 0.37 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.988 0.899 . . . . 0.0 109.985 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.594 ' HB3' HG21 ' A' ' 8' ' ' VAL . 17.9 m-85 -132.26 131.32 22.33 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.644 ' C ' HG23 ' A' ' 8' ' ' VAL . 5.3 Cg_exo -57.41 -157.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.071 1.847 . . . . 0.0 111.004 -178.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.556 ' CA ' ' HA ' ' A' ' 8' ' ' VAL . . . 85.2 154.55 22.63 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.99 -31.82 0.15 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.412 ' HA ' HD13 ' A' ' 6' ' ' ILE . 6.5 ttpt -171.15 161.94 6.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.815 -1.403 . . . . 0.0 110.529 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.742 HG13 ' HB1' ' A' ' 49' ' ' ALA . 2.9 tt -136.25 98.29 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.474 -0.766 . . . . 0.0 109.151 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 42' ' ' MET . 7.0 mt-10 -81.56 -173.51 4.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.207 -0.933 . . . . 0.0 110.122 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 12.8 mtt 63.62 -94.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.47 -0.769 . . . . 0.0 109.594 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.01 31.73 4.64 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -71.54 0.44 Allowed 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.601 -0.94 . . . . 0.0 109.463 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.853 HG23 ' HD2' ' A' ' 46' ' ' PRO . 24.2 m -133.84 144.01 49.97 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.054 -1.029 . . . . 0.0 109.08 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.853 ' HD2' HG23 ' A' ' 45' ' ' THR . 2.0 Cg_endo -55.66 -8.63 2.14 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.69 2.26 . . . . 0.0 112.33 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.713 ' H ' HG22 ' A' ' 45' ' ' THR . 0.5 OUTLIER -103.06 -36.26 8.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.762 -1.211 . . . . 0.0 108.686 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.499 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -62.0 -50.72 70.93 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.598 1.19 . . . . 0.0 108.811 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.742 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -38.23 -60.61 0.76 Allowed 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.339 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.715 HG21 ' CD1' ' A' ' 85' ' ' TRP . 2.3 p -71.95 -29.84 34.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.018 -1.051 . . . . 0.0 109.923 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.626 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -42.55 -56.33 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 122.039 0.923 . . . . 0.0 108.781 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.626 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -65.87 -33.34 75.63 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.39 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 5.8 mt-10 -73.08 -5.02 36.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.113 -0.992 . . . . 0.0 109.416 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.782 HD11 ' CH2' ' A' ' 85' ' ' TRP . 3.7 mt -79.92 -62.88 1.55 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 0.0 109.43 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.511 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 3.0 mm100 -81.94 -23.64 36.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.205 -0.935 . . . . 0.0 110.999 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -80.58 17.79 1.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.688 -1.257 . . . . 0.0 110.816 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.597 ' HB3' ' CD1' ' A' ' 95' ' ' TRP . 1.6 mt-10 -130.59 -65.3 0.8 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.673 -1.267 . . . . 0.0 110.003 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.852 HG21 ' O ' ' A' ' 93' ' ' GLU . 2.8 m -121.92 -26.47 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 108.907 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 95.99 59.7 1.05 Allowed Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.746 HG12 ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -95.84 174.01 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -1.172 . . . . 0.0 110.7 -179.527 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.722 ' N ' ' CD ' ' A' ' 62' ' ' PRO . 10.3 t -144.99 41.22 0.3 Allowed Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.722 ' CD ' ' N ' ' A' ' 61' ' ' THR . 4.8 Cg_exo -43.29 122.39 2.94 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.711 2.274 . . . . 0.0 110.852 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -98.89 -5.85 30.07 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.352 -178.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.71 39.31 2.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.165 -1.584 . . . . 0.0 111.952 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.593 ' CA ' HG23 ' A' ' 87' ' ' VAL . 45.0 p90 -79.9 168.07 19.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.63 -1.294 . . . . 0.0 110.52 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.5 m -164.38 145.23 8.15 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.571 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 84' ' ' PHE . 44.7 tp -73.91 98.1 2.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.562 -1.336 . . . . 0.0 108.897 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.712 ' CE2' HG12 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -44.77 -80.14 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.748 0.785 . . . . 0.0 108.981 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.582 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 16.0 mt-10 -152.9 164.45 37.88 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.297 0.57 . . . . 0.0 109.809 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 13.4 ttpp -134.33 108.87 8.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.996 -1.065 . . . . 0.0 110.214 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.77 HD23 HG22 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -98.55 -167.82 1.55 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.177 -0.952 . . . . 0.0 109.32 179.284 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -149.62 146.32 27.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.92 . . . . 0.0 109.689 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 74' ' ' GLU . 47.7 t80 -136.01 152.69 51.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 108.988 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 52.6 tt0 -143.2 115.05 8.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.552 ' HB2' ' HG3' ' A' ' 78' ' ' ARG . 3.9 m-85 -78.94 172.31 10.23 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.3 Cg_exo -59.61 -7.37 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.814 1.676 . . . . 0.0 111.453 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.27 -8.51 0.14 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.819 -1.175 . . . . 0.0 112.186 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.552 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -130.93 178.52 6.61 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.282 -1.511 . . . . 0.0 109.92 -179.158 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.55 ' O ' ' HA ' ' A' ' 4' ' ' LEU . 27.6 m80 -125.4 161.99 25.81 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.355 -0.84 . . . . 0.0 108.977 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 80' ' ' ILE . 34.7 mm -149.99 74.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 110.005 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.709 HG21 ' OE1' ' A' ' 5' ' ' GLN . 18.7 m -79.64 136.91 36.94 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.714 HD23 ' CE1' ' A' ' 84' ' ' PHE . 12.5 tp -132.98 150.26 52.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.965 -1.085 . . . . 0.0 110.676 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.637 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -123.45 109.67 14.14 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.139 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.714 ' CE1' HD23 ' A' ' 82' ' ' LEU . 3.0 m-85 -79.73 88.41 5.2 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.14 -0.975 . . . . 0.0 109.865 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.782 ' CH2' HD11 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -86.59 74.91 9.79 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 123.514 1.626 . . . . 0.0 107.135 178.323 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.693 HD13 HD12 ' A' ' 10' ' ' ILE . 8.0 tp -67.17 133.85 50.59 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.431 -177.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.629 HG22 ' N ' ' A' ' 88' ' ' GLU . 7.3 p -144.28 168.61 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.476 -0.765 . . . . 0.0 109.197 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.629 ' N ' HG22 ' A' ' 87' ' ' VAL . 7.0 mt-10 -144.36 -18.95 0.55 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.916 -1.115 . . . . 0.0 111.923 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -110.85 141.88 43.63 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.313 -1.492 . . . . 0.0 109.303 -179.526 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.616 ' CD1' ' CG2' ' A' ' 60' ' ' ILE . 14.3 p90 178.62 -172.57 0.14 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.502 1.144 . . . . 0.0 111.002 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.475 ' N ' ' CD1' ' A' ' 90' ' ' TRP . 15.3 tt0 -147.14 85.98 1.62 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.798 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 168.46 -156.04 27.17 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.852 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -117.04 102.42 52.84 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.281 -1.129 . . . . 0.0 109.889 -179.296 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 1.063 ' HB3' HD12 ' A' ' 11' ' ' ILE . 31.9 Cg_exo -39.26 128.27 1.51 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 123.388 2.725 . . . . 0.0 113.289 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.794 ' HB3' HG13 ' A' ' 58' ' ' VAL . 2.0 p-90 -105.09 -164.83 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 154.61 92.95 0.09 OUTLIER Glycine 0 C--N 1.298 -1.537 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.541 ' HB2' ' N ' ' A' ' 37' ' ' GLY . 17.8 tttm 58.89 105.99 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.365 -1.08 . . . . 0.0 109.907 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -68.76 105.51 2.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.255 -0.903 . . . . 0.0 109.345 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.403 ' O ' ' HD3' ' A' ' 101' ' ' PRO . . . 132.1 -11.75 5.32 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.427 ' OE1' ' HA ' ' A' ' 36' ' ' PRO . 1.5 tt0 -101.46 108.58 56.01 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 121.347 -1.09 . . . . 0.0 109.157 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 99' ' ' GLY . 2.0 Cg_endo -61.89 89.99 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.068 1.845 . . . . 0.0 110.62 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -86.99 177.56 47.92 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.414 ' OE2' ' CZ ' ' A' ' 22' ' ' ARG . 14.1 pt-20 -159.11 177.6 10.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.65 -1.5 . . . . 0.0 111.108 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.485 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 35.0 m0 -87.88 110.95 20.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.698 -0.627 . . . . 0.0 109.799 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 30.5 ttp -101.75 144.46 30.41 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.273 -0.892 . . . . 0.0 108.804 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.36 131.1 41.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.937 . . . . 0.0 109.869 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.649 ' CD1' HD23 ' A' ' 129' ' ' LEU . 0.4 OUTLIER -107.08 57.5 0.63 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.297 -0.877 . . . . 0.0 109.247 179.653 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.98 -19.35 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 178.29 49.01 0.07 OUTLIER Glycine 0 N--CA 1.487 2.04 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 109' ' ' GLY . 0.7 OUTLIER -37.31 143.31 0.1 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.954 -0.733 . . . . 0.0 110.441 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -148.67 -174.5 4.63 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.461 -0.775 . . . . 0.0 109.092 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.623 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . -80.41 5.56 14.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 109.325 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -74.08 -48.54 29.07 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.305 -0.872 . . . . 0.0 110.079 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.755 ' O ' HD12 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -79.66 -15.24 57.95 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.228 -0.92 . . . . 0.0 108.941 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -102.86 130.77 23.13 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.624 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.534 ' CG ' ' O ' ' A' ' 33' ' ' LEU . 1.8 Cg_endo -62.93 158.97 40.33 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.035 1.824 . . . . 0.0 110.082 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.7 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 3.1 Cg_exo -59.49 -172.8 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.43 2.087 . . . . 0.0 110.937 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' A' ' 117' ' ' PRO . . . 77.73 -0.71 2.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.502 -0.749 . . . . 0.0 109.775 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.606 ' HB3' HG12 ' A' ' 123' ' ' ILE . 2.0 m-80 -133.66 49.03 2.31 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.103 -0.998 . . . . 0.0 109.776 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.647 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 4.6 mm-40 -75.46 -39.98 3.24 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 112.52 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 2.1 Cg_endo -64.54 -25.85 62.38 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.948 1.765 . . . . 0.0 111.837 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.77 HG22 HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -104.01 -50.85 8.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 120.79 -1.194 . . . . 0.0 109.115 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.71 ' HA ' HD12 ' A' ' 126' ' ' LEU . 19.7 mm -55.15 -37.98 45.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -49.57 -40.61 39.07 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.529 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -80.1 -35.23 37.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.53 -0.731 . . . . 0.0 109.776 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' A' ' 123' ' ' ILE . 9.5 mt -73.25 -4.12 31.08 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.191 -0.943 . . . . 0.0 109.825 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 110' ' ' LEU . 11.1 mttt -64.23 -49.05 73.48 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.277 -0.889 . . . . 0.0 109.185 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.27 -0.75 42.22 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.373 -0.83 . . . . 0.0 109.339 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.649 HD23 ' CD1' ' A' ' 107' ' ' LEU . 2.3 tp . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.716 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 4' ' ' LEU . 28.2 tp . . . . . 0 N--CA 1.485 1.298 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.544 ' HB2' HG21 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -125.31 148.49 48.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.081 -1.012 . . . . 0.0 109.558 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.645 HG22 ' H ' ' A' ' 7' ' ' ALA . 5.5 mm -107.04 178.37 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.248 -0.908 . . . . 0.0 109.409 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.645 ' H ' HG22 ' A' ' 6' ' ' ILE . . . -139.29 96.63 3.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 109.616 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.812 HG21 ' HB3' ' A' ' 35' ' ' PHE . 11.8 p -121.22 135.36 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 110.257 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.32 115.94 2.79 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.587 ' HB ' HD13 ' A' ' 86' ' ' LEU . 1.5 mt -84.28 157.83 3.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.792 ' O ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -127.29 148.72 32.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.897 -1.127 . . . . 0.0 110.137 -178.068 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.484 ' HD3' HD12 ' A' ' 18' ' ' ILE . 32.9 ttp180 -153.26 115.87 4.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.699 -0.625 . . . . 0.0 109.319 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.74 -153.65 0.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.087 -1.008 . . . . 0.0 109.751 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.587 ' CG ' ' NH1' ' A' ' 89' ' ' ARG . 51.8 mt-10 -89.07 -5.13 58.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.749 . . . . 0.0 109.882 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.538 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 55.6 t30 -94.72 33.64 1.43 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 15' ' ' ASN . 1.8 m120 33.74 41.46 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.59 0.71 . . . . 0.0 110.814 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 15' ' ' ASN . 5.0 mt-10 -119.94 128.81 53.94 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.792 HG22 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -105.7 150.21 8.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.643 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 13.6 t80 -98.24 81.7 2.82 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.721 HG23 ' N ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -93.09 -157.9 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 110.177 -178.58 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.721 ' N ' HG23 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -125.01 169.2 12.35 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.201 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 . . . . . 0 C--N 1.306 -1.311 0 O-C-N 120.821 -1.174 . . . . 0.0 110.453 -179.566 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -131.08 136.15 48.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.361 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.566 ' CB ' ' O ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -135.59 -179.53 5.7 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.151 -0.968 . . . . 0.0 109.41 179.633 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -164.53 -154.96 0.26 Allowed 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.545 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.812 ' HB3' HG21 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -122.95 93.39 48.4 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.511 ' CD ' ' OG1' ' A' ' 21' ' ' THR . 5.9 Cg_exo -57.11 -153.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.501 2.134 . . . . 0.0 110.749 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 140.1 -153.84 23.58 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -148.94 23.62 1.28 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 73.58 160.58 0.23 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.134 . . . . 0.0 109.215 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.544 HG21 ' HB2' ' A' ' 5' ' ' GLN . 2.9 tt -102.07 129.24 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.197 -0.939 . . . . 0.0 109.347 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -126.54 -70.54 0.72 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.945 . . . . 0.0 109.554 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.48 108.61 20.13 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.405 0.622 . . . . 0.0 109.376 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.12 141.28 3.43 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.1 -10.59 15.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -1.142 . . . . 0.0 109.984 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.791 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -146.24 177.23 1.84 Allowed Pre-proline 0 N--CA 1.486 1.353 0 O-C-N 120.963 -1.086 . . . . 0.0 109.87 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.791 ' CD ' HG22 ' A' ' 45' ' ' THR . 6.3 Cg_endo -74.55 -4.93 16.18 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.466 2.111 . . . . 0.0 110.548 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.477 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 2.9 mt-10 -105.36 -37.28 6.9 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.202 -0.936 . . . . 0.0 108.884 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.453 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -73.04 -57.52 3.98 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.362 1.077 . . . . 0.0 108.868 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 53' ' ' GLU . . . -46.11 -43.12 14.57 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.52 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.609 ' CG2' ' CE3' ' A' ' 85' ' ' TRP . 14.5 p -79.79 -27.64 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.378 -0.827 . . . . 0.0 109.175 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.631 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -54.44 -57.93 5.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.631 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -81.22 -25.01 37.02 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.418 -178.385 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.597 ' CG ' ' HA ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -81.08 -31.58 34.31 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.003 -1.686 . . . . 0.0 111.457 -177.564 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.895 HD11 ' C ' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -79.86 -42.34 24.44 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.008 -1.058 . . . . 0.0 109.995 -179.321 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.483 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 1.7 mt-30 -67.96 -34.45 76.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.013 -1.054 . . . . 0.0 109.901 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.52 -9.68 58.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.033 -1.042 . . . . 0.0 110.132 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.495 ' OE1' ' CA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -101.2 -64.06 1.08 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.089 -1.007 . . . . 0.0 109.675 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.583 HG21 ' HA ' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -101.85 -29.16 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.457 -0.777 . . . . 0.0 109.158 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 59.5 53.48 45.74 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.691 HG22 ' H ' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -92.43 -165.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.547 ' HB ' ' CB ' ' A' ' 91' ' ' GLU . 98.8 m -137.51 91.04 14.38 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.595 -1.316 . . . . 0.0 109.418 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.611 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 1.8 Cg_endo -63.93 157.22 53.88 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.33 2.02 . . . . 0.0 110.809 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -120.73 -45.39 2.4 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 110.037 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.87 104.24 3.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.997 -1.064 . . . . 0.0 109.759 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.8 OUTLIER -134.84 172.29 13.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.197 -0.94 . . . . 0.0 110.317 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.59 151.99 17.5 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.897 HD12 ' O ' ' A' ' 84' ' ' PHE . 27.1 tp -70.27 100.64 1.74 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.906 -1.121 . . . . 0.0 109.594 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.651 ' HE2' HG13 ' A' ' 122' ' ' VAL . 0.7 OUTLIER -43.43 -77.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.74 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.662 ' O ' HG21 ' A' ' 122' ' ' VAL . 2.3 tt0 -169.15 114.87 0.58 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.775 -0.578 . . . . 0.0 109.572 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -86.35 163.65 17.53 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.371 -0.831 . . . . 0.0 110.119 -179.623 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.984 HD23 ' HB ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -126.13 -165.69 1.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.702 ' HG3' HG23 ' A' ' 81' ' ' THR . 3.5 tt0 -153.42 145.92 24.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.011 -1.056 . . . . 0.0 110.278 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.59 174.44 10.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 109.06 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 13.9 tt0 -155.63 113.68 3.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.147 -0.97 . . . . 0.0 109.623 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.595 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -79.59 -178.35 1.09 Allowed Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.724 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.595 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 4.8 Cg_endo -73.2 30.51 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.109 1.873 . . . . 0.0 111.486 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.464 ' OD2' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -162.52 -44.69 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.376 -1.452 . . . . 0.0 110.51 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.464 ' HG2' ' OD2' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -133.16 -178.18 4.86 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.163 -0.961 . . . . 0.0 110.069 -178.662 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 1.5 m-70 -108.3 121.52 45.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.9 mt -90.28 88.26 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.052 -1.03 . . . . 0.0 109.639 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.702 HG23 ' HG3' ' A' ' 72' ' ' GLU . 1.3 m -85.28 120.63 26.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.288 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.48 ' HG ' ' HB ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -120.77 138.21 54.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.552 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.525 ' CD1' ' O ' ' A' ' 6' ' ' ILE . 1.4 m95 -96.43 165.27 12.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.371 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.897 ' O ' HD12 ' A' ' 67' ' ' LEU . 2.5 m-85 -130.59 74.62 1.61 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.915 . . . . 0.0 109.261 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.696 ' HD1' HD13 ' A' ' 67' ' ' LEU . 2.9 m0 -79.68 86.43 5.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.193 -0.942 . . . . 0.0 109.741 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.587 HD13 ' HB ' ' A' ' 10' ' ' ILE . 28.4 tp -88.37 106.32 18.17 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 10' ' ' ILE . 16.3 m -87.75 177.21 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.028 -1.045 . . . . 0.0 110.235 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -132.58 -23.44 2.08 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.395 -0.816 . . . . 0.0 110.118 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.587 ' NH1' ' CG ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -147.87 148.84 31.28 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 120.841 -1.162 . . . . 0.0 110.944 -179.503 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.634 ' NE1' ' O ' ' A' ' 92' ' ' GLY . 4.1 p90 -166.4 -172.26 2.16 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.663 0.744 . . . . 0.0 109.579 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' CB ' ' HB ' ' A' ' 61' ' ' THR . 5.3 tt0 -92.76 -84.1 0.29 Allowed 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.837 -178.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.691 ' H ' HG22 ' A' ' 60' ' ' ILE . . . -46.59 178.83 0.01 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.802 ' N ' ' CD ' ' A' ' 94' ' ' PRO . 1.6 tt0 -87.32 -25.5 0.33 Allowed Pre-proline 0 N--CA 1.502 2.168 0 O-C-N 121.222 -1.164 . . . . 0.0 114.078 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.802 ' CD ' ' N ' ' A' ' 93' ' ' GLU . 49.3 Cg_endo -94.51 -159.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.951 0 C-N-CA 124.333 3.355 . . . . 0.0 110.566 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.895 ' C ' HD11 ' A' ' 54' ' ' LEU . 3.1 t90 150.59 35.88 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 123.551 0.741 . . . . 0.0 110.815 176.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -135.13 -105.85 0.84 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -93.92 146.1 24.15 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.358 -1.084 . . . . 0.0 108.884 179.34 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -101.54 133.44 46.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 109.369 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.25 -11.09 72.15 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.463 ' CG ' ' HD2' ' A' ' 101' ' ' PRO . 8.4 tp60 -88.64 138.94 29.6 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.433 -1.039 . . . . 0.0 108.888 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 102' ' ' GLY . 6.3 Cg_exo -57.48 -78.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.98 1.787 . . . . 0.0 110.916 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.671 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . 51.87 174.49 0.03 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.6 OUTLIER -160.27 176.57 11.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.606 -1.526 . . . . 0.0 111.437 -178.934 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.562 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 3.9 m0 -95.8 144.85 25.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.783 -0.573 . . . . 0.0 109.869 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.523 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.6 ttm -110.37 -176.0 2.87 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.512 ' O ' HG23 ' A' ' 108' ' ' VAL . 29.1 t -131.57 32.79 4.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.846 -1.159 . . . . 0.0 110.342 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.503 ' C ' ' O ' ' A' ' 106' ' ' SER . 1.0 OUTLIER 33.04 59.4 0.44 Allowed 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.141 0.496 . . . . 0.0 109.988 179.419 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 106' ' ' SER . 70.9 t -108.87 -40.42 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.163 -0.961 . . . . 0.0 109.779 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -149.79 35.71 1.0 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 109' ' ' GLY . 1.0 OUTLIER -45.48 138.45 4.34 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.208 -1.172 . . . . 0.0 109.207 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -160.91 154.13 21.59 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.256 -0.902 . . . . 0.0 109.852 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.429 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -60.47 -14.64 20.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -0.892 . . . . 0.0 109.039 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.94 -41.85 97.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.898 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.539 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.5 t0 -77.82 -10.57 59.62 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.445 ' CG ' HD12 ' A' ' 123' ' ' ILE . 8.6 m-85 -103.79 106.53 53.02 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.506 ' HG2' ' O ' ' A' ' 33' ' ' LEU . 11.7 Cg_exo -48.37 158.47 1.01 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.804 1.67 . . . . 0.0 110.047 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.725 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 6.1 Cg_exo -56.71 -173.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.185 1.923 . . . . 0.0 110.86 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 117' ' ' PRO . . . 84.39 -21.08 0.27 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.81 -0.556 . . . . 0.0 110.118 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.884 ' OD1' HD21 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -124.27 39.89 3.86 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.932 -1.105 . . . . 0.0 109.869 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.694 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.9 mm-40 -71.76 -33.99 2.83 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 112.712 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.9 Cg_exo -61.79 -36.31 74.33 Favored 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 121.842 1.695 . . . . 0.0 112.088 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.984 ' HB ' HD23 ' A' ' 71' ' ' LEU . 1.2 t -100.92 -43.53 10.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 O-C-N 120.498 -1.376 . . . . 0.0 108.399 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.694 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 22.5 mm -54.6 -32.92 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 O-C-N 121.494 -0.754 . . . . 0.0 109.41 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.92 -39.55 26.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.544 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.45 -33.17 36.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.361 -0.837 . . . . 0.0 110.909 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.943 HD12 HD11 ' A' ' 129' ' ' LEU . 4.4 mm? -47.86 -31.4 5.02 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.907 -1.121 . . . . 0.0 109.801 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -60.78 -52.28 65.77 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.53 ' O ' ' C ' ' A' ' 129' ' ' LEU . 4.7 mtt180 -82.19 10.1 7.46 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.472 -0.767 . . . . 0.0 109.275 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.943 HD11 HD12 ' A' ' 126' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 117.937 -1.03 . . . . 0.0 111.023 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 4' ' ' LEU . 12.3 tp . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.899 ' HG2' HG21 ' A' ' 40' ' ' ILE . 3.4 tt0 -143.68 158.95 43.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.208 -0.933 . . . . 0.0 109.433 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.606 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -123.04 167.43 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.097 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.734 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -129.93 93.23 3.46 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.07 -1.019 . . . . 0.0 109.609 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.694 HG13 ' HB3' ' A' ' 84' ' ' PHE . 7.5 p -102.32 155.65 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.209 -0.932 . . . . 0.0 109.861 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.464 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -140.4 125.49 2.91 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.097 HD12 HD22 ' A' ' 86' ' ' LEU . 1.0 OUTLIER -104.37 155.85 5.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.006 -1.291 . . . . 0.0 107.565 -179.632 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.136 HG22 ' CZ3' ' A' ' 90' ' ' TRP . 2.0 mt -147.03 138.39 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.518 -1.364 . . . . 0.0 111.504 -176.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 23.4 ttp180 -140.46 127.53 20.86 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.72 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.5 p30 -108.09 -169.46 1.52 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.258 -0.901 . . . . 0.0 110.66 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.68 -5.3 19.48 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.56 -0.712 . . . . 0.0 110.075 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.1 7.32 7.66 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.457 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 18.0 t30 53.75 44.56 29.44 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.776 0.798 . . . . 0.0 109.759 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 4.9 mt-10 -140.85 153.41 45.74 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.9 mt -119.56 163.71 16.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.99 -1.069 . . . . 0.0 109.453 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -116.78 98.59 6.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.835 -1.166 . . . . 0.0 109.192 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 21' ' ' THR . 0.8 OUTLIER -119.76 -159.72 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.618 ' H ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -121.08 132.86 55.13 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.023 -1.048 . . . . 0.0 109.521 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.46 ' HD2' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.39 0 O-C-N 121.304 -0.873 . . . . 0.0 109.682 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.505 ' HB2' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -159.0 134.96 8.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.018 -1.051 . . . . 0.0 110.059 -179.425 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.541 ' CD1' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -115.11 -170.11 1.69 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.274 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.4 ' O ' ' CG2' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -162.97 -164.48 0.98 Allowed 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.868 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.515 ' CE2' ' CD2' ' A' ' 84' ' ' PHE . 48.7 m-85 -132.37 106.37 13.32 Favored Pre-proline 0 C--N 1.291 -1.949 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.495 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 2.8 Cg_exo -54.94 -149.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.986 1.79 . . . . 0.0 110.659 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 151.67 154.53 6.62 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -130.15 28.27 3.89 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 4.3 mptp? 74.35 160.18 0.23 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.615 -0.933 . . . . 0.0 109.238 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.899 HG21 ' HG2' ' A' ' 5' ' ' GLN . 2.4 tt -155.34 58.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.322 -0.861 . . . . 0.0 109.222 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 42' ' ' MET . 3.9 mm-40 -84.32 -127.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.298 -0.877 . . . . 0.0 109.314 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.425 ' C ' ' O ' ' A' ' 41' ' ' GLU . 4.6 mtp -44.66 163.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.858 -1.151 . . . . 0.0 109.629 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.6 -131.08 3.43 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.531 ' CB ' ' OE1' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -132.3 -64.44 0.77 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.144 -1.209 . . . . 0.0 109.553 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.828 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -146.19 -178.09 0.74 Allowed Pre-proline 0 C--N 1.305 -1.369 0 O-C-N 121.369 -0.832 . . . . 0.0 108.821 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.828 ' CD ' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -68.09 -10.76 29.89 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.945 1.763 . . . . 0.0 110.338 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -100.76 -56.15 2.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.335 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.564 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.9 tt0 -58.5 -40.18 82.11 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.608 1.194 . . . . 0.0 108.741 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.59 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -43.38 -60.02 1.88 Allowed 'General case' 0 C--N 1.273 -2.719 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.446 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.574 HG13 ' CH2' ' A' ' 85' ' ' TRP . 9.8 p -81.45 -11.52 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.473 -0.767 . . . . 0.0 110.88 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.608 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -66.04 -50.44 69.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.608 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -59.55 -35.73 74.8 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.279 177.171 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.45 ' HA ' ' HB2' ' A' ' 56' ' ' GLU . 25.7 mt-10 -73.02 -21.23 60.86 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.767 HD23 ' HE1' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -60.84 -55.89 27.65 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.523 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 10.6 mt-30 -80.79 -22.57 39.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 109.742 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 53' ' ' GLU . 2.5 mt-10 -80.67 17.31 1.16 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.096 -1.003 . . . . 0.0 110.455 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.627 ' HB3' ' CD1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -137.75 -61.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.873 -1.142 . . . . 0.0 109.892 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.737 HG22 ' CD1' ' A' ' 95' ' ' TRP . 4.3 m -128.59 -34.03 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 109.704 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 90.94 36.2 6.83 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.746 ' CD1' HD13 ' A' ' 11' ' ' ILE . 17.1 pt -92.53 -166.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.053 -1.263 . . . . 0.0 109.521 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.759 ' N ' ' CD ' ' A' ' 62' ' ' PRO . 0.6 OUTLIER 93.05 13.77 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.292 -179.274 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.759 ' CD ' ' N ' ' A' ' 61' ' ' THR . 3.5 Cg_endo -63.75 -22.84 69.52 Favored 'Trans proline' 0 C--N 1.326 -0.615 0 CA-C-N 119.909 1.003 . . . . 0.0 110.401 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.617 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 7.1 mm100 -86.78 -68.7 0.73 Allowed 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.617 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 0.4 OUTLIER 167.52 158.27 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.21 0.529 . . . . 0.0 110.545 179.739 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.689 ' HB2' HG12 ' A' ' 87' ' ' VAL . 29.4 p90 -141.99 171.22 14.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.318 -0.864 . . . . 0.0 109.118 177.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' O ' ' A' ' 86' ' ' LEU . 73.2 m -163.77 128.76 2.91 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.036 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.946 HD13 ' CZ3' ' A' ' 83' ' ' TRP . 0.6 OUTLIER -80.21 124.95 29.25 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.604 -1.31 . . . . 0.0 108.898 179.08 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.653 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 27.9 p90 -73.2 -52.18 15.05 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.55 -0.719 . . . . 0.0 109.701 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.653 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 2.4 tt0 176.74 138.74 0.06 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.656 -0.652 . . . . 0.0 109.808 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.41 165.6 11.15 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.07 -1.019 . . . . 0.0 109.029 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.031 HD21 ' OD1' ' A' ' 119' ' ' ASN . 0.4 OUTLIER -129.44 -170.1 2.23 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.352 -0.842 . . . . 0.0 109.456 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.738 ' HG3' HG23 ' A' ' 81' ' ' THR . 19.1 tt0 -145.6 146.6 31.42 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.423 -0.798 . . . . 0.0 109.194 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.499 ' N ' ' HG2' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -144.84 79.92 1.61 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.422 -0.799 . . . . 0.0 109.36 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.4 OUTLIER -81.69 114.58 20.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 109.34 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.547 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -79.45 176.69 3.49 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 1.7 Cg_endo -63.3 -8.77 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 121.67 1.58 . . . . 0.0 109.734 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -102.69 -66.87 0.9 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.402 -0.811 . . . . 0.0 110.881 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.04 -171.62 2.53 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.192 -0.942 . . . . 0.0 110.686 -177.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -105.49 88.18 2.78 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.3 mm -81.71 118.2 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 109.474 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.738 HG23 ' HG3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -119.05 146.56 44.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.606 HD22 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -131.14 123.94 29.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 108.893 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.946 ' CZ3' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -119.0 124.29 46.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.363 -0.835 . . . . 0.0 110.082 -177.759 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.694 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -129.07 103.17 6.84 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 120.489 -1.382 . . . . 0.0 109.975 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.78 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -82.42 98.9 9.12 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.706 0.765 . . . . 0.0 109.156 179.331 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.097 HD22 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -63.14 118.52 8.03 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.735 -1.228 . . . . 0.0 109.712 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.067 ' CG2' HG23 ' A' ' 11' ' ' ILE . 19.3 m -81.24 -167.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 120.95 -1.094 . . . . 0.0 109.686 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 8.9 mt-10 -125.14 -45.76 1.84 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.165 -0.959 . . . . 0.0 110.49 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.541 ' HB3' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -160.94 171.2 19.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.183 -0.948 . . . . 0.0 109.963 -179.245 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 1.136 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 38.8 p90 -170.14 -175.02 1.88 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.2 1.0 . . . . 0.0 111.052 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.617 ' N ' ' HG2' ' A' ' 62' ' ' PRO . 2.6 tt0 -120.69 -34.5 3.57 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.381 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.678 ' CA ' HG22 ' A' ' 60' ' ' ILE . . . -80.18 -155.93 11.78 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 121.092 -1.005 . . . . 0.0 110.911 -178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.696 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -105.31 127.97 27.54 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.437 -1.037 . . . . 0.0 109.456 -179.648 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.967 ' HB3' HD12 ' A' ' 11' ' ' ILE . 2.8 Cg_endo -58.74 133.83 56.58 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.432 2.088 . . . . 0.0 111.705 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.767 ' HE1' HD23 ' A' ' 54' ' ' LEU . 4.8 p-90 -110.56 -171.74 1.89 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.923 -1.111 . . . . 0.0 108.49 178.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . 146.18 -42.91 0.92 Allowed Glycine 0 C--N 1.296 -1.679 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 100' ' ' GLN . 1.1 ptmm? -66.08 126.48 28.76 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.651 -0.911 . . . . 0.0 109.781 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -93.57 -49.56 5.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.198 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.91 5.58 5.42 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.528 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 1.3 mt-30 -109.09 160.57 27.0 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.27 -1.135 . . . . 0.0 109.43 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 102' ' ' GLY . 1.9 Cg_endo -66.21 -30.43 46.05 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.156 1.904 . . . . 0.0 111.427 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . 56.66 162.55 0.03 OUTLIER Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -161.58 -168.7 2.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.66 -1.494 . . . . 0.0 110.503 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.505 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 31.9 m95 -107.47 132.34 53.32 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.556 -0.715 . . . . 0.0 109.219 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.493 ' HE1' HD22 ' A' ' 33' ' ' LEU . 30.2 ttp -108.29 147.63 31.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.268 -0.895 . . . . 0.0 109.217 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.528 ' OG ' HG23 ' A' ' 108' ' ' VAL . 45.6 t -83.66 138.71 33.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.891 -1.131 . . . . 0.0 109.126 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.446 HD12 HD11 ' A' ' 18' ' ' ILE . 3.1 tt -108.29 59.73 0.61 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.211 -0.931 . . . . 0.0 109.411 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.528 HG23 ' OG ' ' A' ' 106' ' ' SER . 2.1 t -93.44 19.31 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 145.03 49.85 0.03 OUTLIER Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.848 HD23 ' OD2' ' A' ' 114' ' ' ASP . 1.1 mt -41.59 142.59 0.6 Allowed 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.694 -0.886 . . . . 0.0 109.317 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 2.4 t-20 -133.71 155.9 48.92 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 109.51 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.563 ' HB2' ' HE2' ' A' ' 127' ' ' LYS . . . -63.64 -19.02 64.53 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.271 -0.893 . . . . 0.0 108.747 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 113' ' ' ASP . 26.3 t0 -93.0 22.5 4.9 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.429 -0.795 . . . . 0.0 109.487 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.848 ' OD2' HD23 ' A' ' 110' ' ' LEU . 0.5 OUTLIER -78.16 -1.61 33.5 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.551 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -160.5 160.32 25.89 Favored Pre-proline 0 C--N 1.3 -1.553 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.291 177.814 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 32' ' ' LYS . 74.7 Cg_exo -36.69 124.6 0.39 Allowed 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.828 2.352 . . . . 0.0 110.403 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.716 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 4.6 Cg_exo -58.55 144.2 97.42 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 122.561 2.174 . . . . 0.0 111.382 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 156.67 -19.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 1.031 ' OD1' HD21 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -119.88 42.15 2.99 Favored 'General case' 0 C--O 1.205 -1.286 0 O-C-N 121.316 -0.865 . . . . 0.0 109.368 -179.364 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.639 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 6.0 mt-10 -60.16 -39.12 66.05 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 120.949 -1.094 . . . . 0.0 113.243 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 5.2 Cg_exo -62.29 -46.8 11.38 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.229 1.953 . . . . 0.0 113.011 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.859 ' HB ' HD23 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -90.22 -30.09 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.417 -1.427 . . . . 0.0 108.95 -178.972 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.644 HD12 ' CE1' ' A' ' 115' ' ' PHE . 1.6 mm -64.06 -34.38 68.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.502 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -60.95 -20.38 62.19 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.419 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.73 -61.75 1.88 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.399 -0.813 . . . . 0.0 110.985 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 1.009 ' HB2' HD13 ' A' ' 129' ' ' LEU . 0.6 OUTLIER -78.82 22.69 0.36 Allowed 'General case' 0 C--N 1.31 -1.137 0 O-C-N 120.803 -1.186 . . . . 0.0 111.403 -178.672 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.563 ' HE2' ' HB2' ' A' ' 112' ' ' ALA . 5.3 mtmt -65.91 -35.57 81.0 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.652 -1.28 . . . . 0.0 107.932 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.534 ' O ' ' C ' ' A' ' 129' ' ' LEU . 9.0 mtm180 -78.77 -0.03 28.76 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.897 -0.502 . . . . 0.0 110.03 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 1.009 HD13 ' HB2' ' A' ' 126' ' ' LEU . 4.3 tp . . . . . 0 N--CA 1.5 2.032 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.882 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 79' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.678 ' O ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -133.09 147.41 52.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.735 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 7' ' ' ALA . 4.4 mt -121.98 168.61 14.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.325 -0.86 . . . . 0.0 108.895 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.559 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . -135.74 98.31 3.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.123 -0.986 . . . . 0.0 109.618 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.599 HG22 ' N ' ' A' ' 9' ' ' GLY . 7.3 p -106.92 161.89 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.811 . . . . 0.0 109.366 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.599 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -141.33 121.21 1.83 Allowed Glycine 0 C--N 1.297 -1.621 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.582 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -94.33 156.6 3.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.034 HG22 ' CZ3' ' A' ' 90' ' ' TRP . 2.2 mt -143.15 124.1 10.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 118.486 -1.286 . . . . 0.0 111.308 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.548 ' HD3' ' CG1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -122.21 136.31 54.89 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.268 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.401 ' N ' ' HG3' ' A' ' 12' ' ' ARG . 25.0 p30 -109.12 -169.37 1.47 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 0.0 110.179 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -81.12 0.21 37.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.682 -0.636 . . . . 0.0 109.327 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.446 ' OD1' ' OE2' ' A' ' 17' ' ' GLU . 6.5 t-20 -89.34 12.82 15.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.282 -0.886 . . . . 0.0 109.063 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.582 ' ND2' HG23 ' A' ' 108' ' ' VAL . 18.4 t30 57.41 44.07 22.1 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.768 0.795 . . . . 0.0 109.224 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 3.4 mt-10 -143.25 149.21 37.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.091 -1.006 . . . . 0.0 109.038 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.548 ' CG1' ' HD3' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -128.19 151.24 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.094 -1.004 . . . . 0.0 109.864 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.582 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 21.8 t80 -85.97 66.83 9.78 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.839 HG23 ' N ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -83.91 -155.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.102 -0.999 . . . . 0.0 110.303 -178.592 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.839 ' N ' HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -132.11 142.16 49.4 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.743 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.557 ' HG2' ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 O-C-N 121.039 -1.038 . . . . 0.0 110.675 -178.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.79 140.78 34.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.843 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.557 ' CD2' ' HG2' ' A' ' 22' ' ' ARG . 5.3 mt -103.7 -172.72 2.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.452 -0.78 . . . . 0.0 109.026 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -160.68 -154.68 0.38 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.626 ' CE2' ' CZ ' ' A' ' 84' ' ' PHE . 3.6 m-85 -150.65 137.49 11.43 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.415 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 2.6 Cg_endo -61.19 -160.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.87 1.713 . . . . 0.0 109.582 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 152.87 158.42 8.51 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.096 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.78 20.85 2.88 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.18 158.51 0.16 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.509 -0.995 . . . . 0.0 109.516 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.678 HG22 ' O ' ' A' ' 5' ' ' GLN . 11.2 tt -138.43 101.61 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.349 -0.844 . . . . 0.0 109.222 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -111.77 -7.45 14.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.81 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.56 -76.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.167 -0.958 . . . . 0.0 109.307 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.78 4.82 18.86 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.09 -79.4 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.046 -1.267 . . . . 0.0 109.585 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.508 ' OG1' ' HD2' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -160.8 169.07 10.61 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.846 -1.159 . . . . 0.0 109.762 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 8.5 Cg_endo -74.59 19.21 0.47 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 123.255 2.637 . . . . 0.0 112.004 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.496 ' HB2' ' CG2' ' A' ' 45' ' ' THR . 2.0 mt-10 -111.5 -46.07 3.31 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.857 -1.152 . . . . 0.0 108.789 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.537 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -73.28 -55.06 6.92 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.245 1.021 . . . . 0.0 109.1 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . -38.3 -59.94 0.83 Allowed 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.089 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 51' ' ' VAL . 7.1 p -66.26 -33.11 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.214 -0.929 . . . . 0.0 108.936 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.629 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -45.5 -58.2 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.428 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.629 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -66.37 -28.93 69.03 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.308 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.532 ' HA ' ' CG ' ' A' ' 56' ' ' GLU . 4.2 mm-40 -72.64 -6.79 46.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.016 -1.053 . . . . 0.0 109.058 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.585 ' HG ' ' CZ2' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -80.5 -60.64 2.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.555 -0.716 . . . . 0.0 109.659 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.498 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 5.7 mt-30 -80.57 -23.44 39.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.294 -0.879 . . . . 0.0 110.708 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.532 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 1.4 pp20? -80.86 20.15 0.79 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.024 -1.048 . . . . 0.0 110.615 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 95' ' ' TRP . 3.0 mt-10 -142.18 -63.18 0.44 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.742 -1.224 . . . . 0.0 110.061 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.021 HG13 ' HB3' ' A' ' 95' ' ' TRP . 2.0 m -123.52 -31.78 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.985 -1.072 . . . . 0.0 109.154 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 67.88 66.2 2.42 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.6 ' CG2' ' HB2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -83.19 155.67 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.55 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.701 HG23 ' HD3' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -107.46 -60.99 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.263 0 O-C-N 120.527 -1.358 . . . . 0.0 111.834 -177.913 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.701 ' HD3' HG23 ' A' ' 61' ' ' THR . 7.0 Cg_endo -73.7 52.7 2.57 Favored 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 122.031 1.821 . . . . 0.0 110.875 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.669 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 3.9 tt0 -105.82 69.28 0.81 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.867 -1.146 . . . . 0.0 110.054 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -63.68 115.08 4.41 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.671 ' HB3' HG12 ' A' ' 87' ' ' VAL . 39.3 p90 -131.14 176.0 8.63 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 122.941 1.353 . . . . 0.0 112.209 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 68' ' ' PHE . 19.1 m -163.04 130.16 3.53 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 85' ' ' TRP . 26.6 tp -50.31 96.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.486 -1.384 . . . . 0.0 109.162 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.683 ' HE2' HG13 ' A' ' 122' ' ' VAL . 0.1 OUTLIER -43.06 -74.33 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.85 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.618 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 3.3 tt0 -162.61 161.83 26.86 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.352 0.596 . . . . 0.0 109.704 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HG2' ' N ' ' A' ' 71' ' ' LEU . 22.3 ttmt -116.16 154.3 30.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 0.0 109.174 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.021 HD21 ' CE1' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -126.67 -174.89 3.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.078 -1.014 . . . . 0.0 109.642 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -157.29 151.22 24.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.389 -0.819 . . . . 0.0 109.2 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.496 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . 6.8 t80 -154.39 165.13 37.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.058 -1.026 . . . . 0.0 110.082 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -148.14 122.24 9.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.414 -0.803 . . . . 0.0 109.365 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -82.32 172.27 9.96 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.55 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 6.0 Cg_exo -58.38 -15.77 25.87 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.934 1.756 . . . . 0.0 110.01 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -156.81 7.28 0.18 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.513 -0.742 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.539 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 1.8 mmm180 -129.18 -169.59 2.12 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 120.659 -1.276 . . . . 0.0 109.613 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.49 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 35.5 m80 -144.48 129.74 18.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.333 -0.854 . . . . 0.0 108.969 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.728 HG22 HD13 ' A' ' 82' ' ' LEU . 2.7 mm -116.26 83.98 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.93 . . . . 0.0 110.03 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.26 86.62 6.2 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.728 HD13 HG22 ' A' ' 80' ' ' ILE . 1.4 mp -102.31 167.52 9.92 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.181 -0.949 . . . . 0.0 110.364 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.541 ' CD1' ' O ' ' A' ' 6' ' ' ILE . 1.7 m95 -122.65 164.26 18.56 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 1.021 ' CE1' HD21 ' A' ' 71' ' ' LEU . 1.8 m-85 -136.51 88.94 2.42 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.07 -1.019 . . . . 0.0 109.557 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.645 ' CZ2' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.04 151.53 21.61 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.388 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.582 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 14.7 tp -142.55 127.67 18.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.787 -1.195 . . . . 0.0 109.615 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.979 ' CG2' HG23 ' A' ' 11' ' ' ILE . 9.1 m -99.07 -161.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.314 -0.866 . . . . 0.0 109.997 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -141.99 -23.42 0.7 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.287 -0.883 . . . . 0.0 111.484 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.669 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -159.96 -167.43 1.96 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.343 -1.473 . . . . 0.0 110.672 -179.186 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 1.034 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 28.6 p90 158.68 171.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.517 1.151 . . . . 0.0 110.294 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.607 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 8.9 tt0 -111.93 -63.19 1.45 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.743 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.587 ' N ' HG22 ' A' ' 60' ' ' ILE . . . -56.74 -156.39 0.01 OUTLIER Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.747 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.2 pm0 -105.8 128.09 27.14 Favored Pre-proline 0 C--N 1.307 -1.244 0 O-C-N 121.38 -1.07 . . . . 0.0 109.348 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.97 ' HB3' HD12 ' A' ' 11' ' ' ILE . 13.5 Cg_exo -46.77 144.91 7.32 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.465 2.11 . . . . 0.0 112.05 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 1.021 ' HB3' HG13 ' A' ' 58' ' ' VAL . 11.1 p-90 -107.51 -167.72 1.3 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.61 -96.18 0.14 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.525 ' HB2' ' N ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -118.0 138.74 51.99 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.506 -0.996 . . . . 0.0 109.25 179.515 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.444 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 12.0 tm-20 -92.66 68.88 4.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 109.202 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.45 ' O ' ' HD3' ' A' ' 101' ' ' PRO . . . 175.13 -31.89 0.09 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.424 ' HB3' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -92.74 111.19 49.94 Favored Pre-proline 0 C--N 1.297 -1.689 0 O-C-N 121.65 -0.912 . . . . 0.0 108.745 179.363 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 99' ' ' GLY . 1.1 Cg_endo -63.25 82.14 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.059 1.839 . . . . 0.0 110.935 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -86.12 170.61 43.41 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -161.33 172.88 15.81 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.586 -1.538 . . . . 0.0 111.504 -179.282 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.493 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 4.6 m0 -84.91 106.86 16.74 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.44 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 3.7 ttp -107.8 136.56 47.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.335 -0.853 . . . . 0.0 109.067 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.86 85.81 4.9 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.227 -0.921 . . . . 0.0 109.359 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.891 HD13 ' HA ' ' A' ' 110' ' ' LEU . 1.4 mt -76.96 -52.58 9.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.916 . . . . 0.0 109.59 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.783 HG12 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER 72.52 27.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 122.155 0.979 . . . . 0.0 108.579 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 163.63 50.6 0.02 OUTLIER Glycine 0 N--CA 1.485 1.944 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.891 ' HA ' HD13 ' A' ' 107' ' ' LEU . 0.7 OUTLIER -38.12 144.28 0.1 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.769 -0.842 . . . . 0.0 109.98 -178.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -156.43 151.87 26.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.122 -0.986 . . . . 0.0 109.801 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.887 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -68.36 -7.5 31.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.264 -0.898 . . . . 0.0 109.403 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -61.02 -42.73 99.01 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.256 -0.902 . . . . 0.0 109.93 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.506 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -79.12 -9.2 59.49 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.096 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.534 ' CE2' ' CE2' ' A' ' 35' ' ' PHE . 9.6 m-85 -98.43 137.43 20.71 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.005 -1.059 . . . . 0.0 109.456 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 115' ' ' PHE . 1.9 Cg_endo -68.8 164.19 34.35 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.256 1.97 . . . . 0.0 110.281 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.721 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.5 Cg_endo -63.29 119.07 5.99 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.404 2.07 . . . . 0.0 110.434 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 161.74 -51.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 109.831 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.562 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 28.2 m-20 -106.19 38.38 2.05 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.234 -0.916 . . . . 0.0 109.347 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.68 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 20.2 mt-10 -65.89 -36.71 14.59 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.346 -0.846 . . . . 0.0 112.704 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.8 Cg_exo -63.34 -36.2 57.42 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.099 1.866 . . . . 0.0 112.425 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.948 ' HB ' HD23 ' A' ' 71' ' ' LEU . 1.2 t -98.51 -39.3 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 120.449 -1.407 . . . . 0.0 108.003 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.961 ' HA ' HD21 ' A' ' 126' ' ' LEU . 25.2 mm -58.66 -30.57 42.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.553 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -70.3 -26.37 63.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.468 -0.77 . . . . 0.0 110.688 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.417 ' HG2' ' OE1' ' A' ' 69' ' ' GLU . 16.9 tptt -76.19 -57.21 4.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.882 -1.136 . . . . 0.0 110.522 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.961 HD21 ' HA ' ' A' ' 123' ' ' ILE . 2.4 pt? -74.84 11.78 0.99 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.054 -1.029 . . . . 0.0 111.219 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.553 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 37.4 mttt -49.51 -43.05 45.22 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.353 -1.467 . . . . 0.0 107.695 178.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.477 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -109.84 46.15 1.04 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.797 -0.565 . . . . 0.0 110.842 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.565 ' CD2' ' HB2' ' A' ' 126' ' ' LEU . 1.3 mp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.336 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.646 HD12 ' O ' ' A' ' 79' ' ' HIS . 23.5 mt . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.251 0.548 . . . . 0.0 109.801 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.478 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . 1.1 mp0 -87.46 116.47 25.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.228 -0.92 . . . . 0.0 108.869 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 38' ' ' GLY . 1.4 mp -112.47 141.18 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.094 -1.004 . . . . 0.0 109.791 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.408 ' O ' ' CA ' ' A' ' 37' ' ' GLY . . . -103.8 110.72 22.94 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.765 HG23 ' C ' ' A' ' 36' ' ' PRO . 3.0 p -127.78 100.09 5.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.131 -0.981 . . . . 0.0 110.352 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.566 ' HA2' ' CD1' ' A' ' 85' ' ' TRP . . . -84.58 118.5 4.74 Favored Glycine 0 C--N 1.296 -1.683 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.568 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 1.8 mt -81.49 173.49 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 120.867 -1.373 . . . . 0.0 107.541 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.926 HD12 ' CB ' ' A' ' 94' ' ' PRO . 0.4 OUTLIER -144.56 153.54 14.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 118.039 -1.464 . . . . 0.0 110.435 -178.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 17' ' ' GLU . 37.7 ttp180 -159.3 131.52 6.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.517 -0.739 . . . . 0.0 109.24 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.31 -162.69 0.97 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.14 -0.975 . . . . 0.0 110.577 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.36 -7.32 58.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.626 -0.671 . . . . 0.0 109.713 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.536 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 5.2 t30 -84.53 12.61 6.68 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.124 -0.985 . . . . 0.0 108.667 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.5 t30 60.03 43.38 14.57 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.64 -0.662 . . . . 0.0 110.522 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.536 ' CG ' ' HB3' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -127.37 154.27 45.19 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.862 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.568 HD11 HD11 ' A' ' 107' ' ' LEU . 1.6 mt -119.78 156.34 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.859 -1.15 . . . . 0.0 110.203 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 26.0 t80 -103.15 86.11 2.63 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.049 HD12 ' O ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -78.73 176.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.187 0.994 . . . . 0.0 110.101 -178.319 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.627 ' N ' ' CG2' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -153.46 144.24 22.7 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.604 ' CG ' ' HA ' ' A' ' 33' ' ' LEU . 6.4 tpm_? . . . . . 0 C--N 1.3 -1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 110.062 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.8 m120 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.491 ' O ' ' HG2' ' A' ' 22' ' ' ARG . 5.9 mmtp -114.55 129.08 56.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.195 -0.941 . . . . 0.0 109.991 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.659 HD21 ' CB ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -146.21 -175.71 4.87 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.797 0.808 . . . . 0.0 109.544 179.6 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.049 ' O ' HD12 ' A' ' 20' ' ' ILE . 2.3 tt0 -163.06 -154.21 0.28 Allowed 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.757 ' HB3' HG21 ' A' ' 8' ' ' VAL . 85.4 m-85 -114.02 158.97 37.92 Favored Pre-proline 0 C--N 1.285 -2.206 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.765 ' C ' HG23 ' A' ' 8' ' ' VAL . 3.3 Cg_exo -58.21 -154.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 121.854 1.703 . . . . 0.0 110.167 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.408 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 82.48 -170.65 50.7 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.453 ' O ' HG13 ' A' ' 6' ' ' ILE . . . 177.66 -37.61 0.09 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -168.79 143.61 3.25 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.562 -0.964 . . . . 0.0 109.076 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.666 ' O ' HG23 ' A' ' 40' ' ' ILE . 15.5 tt -100.35 115.32 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.103 -0.998 . . . . 0.0 109.705 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 42' ' ' MET . 4.7 mt-10 -101.85 -175.93 2.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.337 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.47 ' O ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 49.16 -178.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.913 . . . . 0.0 109.331 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.98 148.21 10.91 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.444 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 39.6 mp0 -91.47 121.75 33.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.177 -1.19 . . . . 0.0 109.75 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.782 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -159.96 178.61 1.61 Allowed Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.428 -0.795 . . . . 0.0 109.642 179.738 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.782 ' CD ' HG22 ' A' ' 45' ' ' THR . 6.1 Cg_endo -73.62 -20.1 20.73 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.596 2.198 . . . . 0.0 110.903 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.503 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -124.12 -59.04 1.52 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.075 -1.016 . . . . 0.0 110.085 -179.108 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.628 ' O ' HG12 ' A' ' 51' ' ' VAL . 1.2 tt0 -44.14 -32.99 1.36 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.285 1.04 . . . . 0.0 110.596 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.445 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -81.76 -57.17 3.55 Favored 'General case' 0 C--N 1.272 -2.8 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.988 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.421 HG22 ' CH2' ' A' ' 95' ' ' TRP . 1.3 p -81.9 4.98 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.395 -0.816 . . . . 0.0 110.513 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 48' ' ' GLN . 13.2 p -82.75 -37.65 14.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.523 ' N ' HG13 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -74.65 -31.1 61.85 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.879 -1.509 . . . . 0.0 108.659 178.575 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -72.0 -7.12 46.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.122 -0.986 . . . . 0.0 109.075 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.781 HD22 ' CZ2' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -76.55 -68.11 0.63 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.651 -0.656 . . . . 0.0 109.428 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -82.33 -17.52 45.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.493 -0.754 . . . . 0.0 111.335 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.513 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 2.3 mm-40 -80.28 18.22 0.92 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.791 -1.193 . . . . 0.0 110.461 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 95' ' ' TRP . 7.1 mm-40 -146.76 -65.38 0.28 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.734 -1.229 . . . . 0.0 110.565 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.856 HG21 ' O ' ' A' ' 93' ' ' GLU . 3.7 m -124.8 -32.56 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.156 -0.965 . . . . 0.0 108.979 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.407 ' N ' HG23 ' A' ' 58' ' ' VAL . . . 72.16 67.64 1.79 Allowed Glycine 0 N--CA 1.483 1.815 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.616 HG21 ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -95.52 171.11 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.351 -1.087 . . . . 0.0 108.17 178.439 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.552 ' HB ' ' CB ' ' A' ' 91' ' ' GLU . 2.7 m -112.99 89.36 13.57 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 1.4 Cg_endo -59.3 131.12 39.17 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.093 1.862 . . . . 0.0 110.177 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.507 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -92.71 -55.48 3.36 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.553 -0.717 . . . . 0.0 110.164 -178.844 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 12.0 t-160 -142.27 112.47 7.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.91 -1.119 . . . . 0.0 110.2 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.832 ' CB ' HG12 ' A' ' 87' ' ' VAL . 5.5 p90 -135.25 175.26 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.141 -0.974 . . . . 0.0 110.368 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.3 m -162.39 -179.71 7.19 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.976 HD21 ' HD3' ' A' ' 70' ' ' LYS . 34.8 tp -105.95 107.63 18.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.953 -1.092 . . . . 0.0 109.014 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.764 ' CE2' HG13 ' A' ' 122' ' ' VAL . 3.3 t80 -47.33 -83.53 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.625 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -147.12 175.56 10.63 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.492 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.976 ' HD3' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.33 129.02 38.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 0.0 109.61 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.507 ' HG ' HG21 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -120.94 -176.89 3.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 109.505 179.669 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.18 158.87 33.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.363 -0.836 . . . . 0.0 109.388 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.0 147.15 31.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 0.0 109.737 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.73 116.74 10.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.077 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 1.1 m-85 -83.99 172.99 7.98 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.348 -0.845 . . . . 0.0 109.379 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 4.0 Cg_exo -59.17 -12.95 17.54 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.152 1.901 . . . . 0.0 110.791 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -165.16 16.18 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 110.585 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.526 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -131.17 -172.89 2.95 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 120.632 -1.293 . . . . 0.0 109.445 -179.502 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.646 ' O ' HD12 ' A' ' 4' ' ' LEU . 21.9 m80 -146.32 136.64 23.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.352 -0.843 . . . . 0.0 109.018 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 80' ' ' ILE . 22.4 mm -140.04 80.31 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.093 -1.004 . . . . 0.0 110.169 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.61 130.57 34.99 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.586 HD11 HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -136.86 113.58 10.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.955 -1.091 . . . . 0.0 110.366 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -79.86 156.04 27.54 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.98 ' CD2' HG11 ' A' ' 122' ' ' VAL . 2.0 m-85 -135.87 71.12 1.42 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.94 -1.1 . . . . 0.0 109.838 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.836 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -84.05 145.17 28.62 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.707 ' CD2' HD22 ' A' ' 129' ' ' LEU . 20.9 tp -134.8 127.25 30.49 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.951 -1.093 . . . . 0.0 110.139 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.832 HG12 ' CB ' ' A' ' 65' ' ' PHE . 34.5 m -98.1 -174.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.73 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' ARG . 2.9 mt-10 -126.43 -29.88 2.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.845 . . . . 0.0 109.428 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.507 ' HG3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.72 169.3 20.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.195 -0.941 . . . . 0.0 109.326 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.767 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 46.1 p90 -164.95 -169.83 1.79 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.102 -0.999 . . . . 0.0 110.015 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.552 ' CB ' ' HB ' ' A' ' 61' ' ' THR . 30.6 tt0 -131.34 99.13 4.74 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.972 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.557 ' CA ' HG22 ' A' ' 60' ' ' ILE . . . 128.88 -152.13 19.27 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.627 -1.273 . . . . 0.0 109.946 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.856 ' O ' HG21 ' A' ' 58' ' ' VAL . 14.5 tp10 -99.96 127.06 34.61 Favored Pre-proline 0 N--CA 1.486 1.339 0 O-C-N 121.324 -1.103 . . . . 0.0 109.187 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.926 ' CB ' HD12 ' A' ' 11' ' ' ILE . 4.0 Cg_exo -52.36 144.96 37.93 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.665 2.244 . . . . 0.0 111.706 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.813 ' HB3' HG13 ' A' ' 58' ' ' VAL . 23.4 p-90 -113.15 -175.55 2.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.523 -0.736 . . . . 0.0 109.09 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.56 ' HA3' ' HB3' ' A' ' 36' ' ' PRO . . . 158.06 -62.36 0.32 Allowed Glycine 0 N--CA 1.484 1.843 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.296 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -105.31 171.47 7.31 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.355 -1.085 . . . . 0.0 109.631 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.467 ' HA ' ' OE2' ' A' ' 57' ' ' GLU . 2.9 tp10 -39.23 -37.41 0.41 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.65 -0.656 . . . . 0.0 109.438 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.511 ' C ' ' HD3' ' A' ' 101' ' ' PRO . . . -126.18 -160.42 10.6 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.643 ' N ' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -117.85 40.15 0.32 Allowed Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.137 -1.213 . . . . 0.0 111.541 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.643 ' HD3' ' N ' ' A' ' 100' ' ' GLN . 6.9 Cg_endo -68.13 -6.81 18.16 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 C-N-CA 121.327 1.351 . . . . 0.0 110.106 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -41.83 163.53 0.02 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.458 ' CD ' HG22 ' A' ' 20' ' ' ILE . 6.1 pm0 -119.17 131.08 55.81 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.405 -1.056 . . . . 0.0 109.175 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.46 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 10.8 m0 -78.21 95.77 5.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.199 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.31 -163.35 0.6 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.403 -0.811 . . . . 0.0 109.653 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 t -141.33 158.08 44.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.628 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.691 HD21 HD12 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -113.4 63.0 0.64 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.347 -0.846 . . . . 0.0 108.974 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.2 p -104.33 -26.55 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.367 -0.833 . . . . 0.0 109.208 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -168.25 43.92 0.23 Allowed Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 109' ' ' GLY . 1.1 mt -45.46 145.79 1.16 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.217 -1.166 . . . . 0.0 108.676 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -125.24 9.98 8.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 110.182 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.435 ' CB ' HG22 ' A' ' 123' ' ' ILE . . . 52.59 19.64 1.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.902 -1.124 . . . . 0.0 108.39 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -100.82 -34.41 9.83 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.358 -0.839 . . . . 0.0 109.747 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.659 ' CB ' HD21 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -76.69 -3.66 39.17 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.31 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.647 ' CD2' HD12 ' A' ' 123' ' ' ILE . 22.3 m-85 -96.44 109.99 50.53 Favored Pre-proline 0 N--CA 1.485 1.281 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.539 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 7.1 Cg_exo -50.14 154.96 4.98 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.166 1.911 . . . . 0.0 110.512 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.714 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 5.4 Cg_exo -58.38 121.2 9.59 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.553 2.169 . . . . 0.0 110.995 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 158.54 -37.21 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.566 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 86.8 m-20 -115.36 41.25 2.5 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.507 -0.746 . . . . 0.0 109.472 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.66 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 20.0 mt-10 -66.53 -41.48 40.43 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.95 -1.094 . . . . 0.0 112.427 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 1.1 Cg_endo -67.7 -30.89 33.79 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.581 2.187 . . . . 0.0 112.231 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.98 HG11 ' CD2' ' A' ' 84' ' ' PHE . 2.1 t -95.32 -43.77 12.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 120.593 -1.317 . . . . 0.0 107.493 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.647 HD12 ' CD2' ' A' ' 115' ' ' PHE . 12.2 mm -56.67 -29.0 28.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.22 -35.12 63.88 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.703 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -80.4 -61.73 1.89 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.916 -1.115 . . . . 0.0 110.945 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.655 ' HB2' HD21 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -80.87 27.38 0.38 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.918 -1.114 . . . . 0.0 110.522 -179.281 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.592 ' HG3' ' N ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -71.33 -31.48 67.44 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.592 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 2.2 ptt180 -119.63 44.74 2.31 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.632 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.707 HD22 ' CD2' ' A' ' 86' ' ' LEU . 1.1 mp . . . . . 0 C--N 1.308 -1.228 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.971 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -118.27 162.31 18.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.717 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.63 119.08 31.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -0.874 . . . . 0.0 109.52 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.412 ' HA ' HD12 ' A' ' 4' ' ' LEU . 49.5 tp -116.43 128.57 55.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.581 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.935 ' O ' HG22 ' A' ' 40' ' ' ILE . 12.4 mt-30 -137.86 119.51 15.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.035 . . . . 0.0 109.809 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.706 HG22 ' H ' ' A' ' 7' ' ' ALA . 12.9 mm -102.46 179.66 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.431 -0.793 . . . . 0.0 109.665 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.706 ' H ' HG22 ' A' ' 6' ' ' ILE . . . -142.38 108.21 5.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.197 -0.939 . . . . 0.0 108.849 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.652 HG23 ' C ' ' A' ' 36' ' ' PRO . 7.8 p -113.07 164.15 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.024 . . . . 0.0 110.221 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -149.73 120.63 1.17 Allowed Glycine 0 N--CA 1.482 1.719 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.115 HD12 ' CD2' ' A' ' 86' ' ' LEU . 1.2 mt -98.99 152.91 4.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 121.181 -1.188 . . . . 0.0 108.793 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.903 ' O ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -120.62 153.44 23.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 118.902 -1.119 . . . . 0.0 109.138 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.506 ' O ' ' O ' ' A' ' 88' ' ' GLU . 38.2 ttp180 -155.76 114.13 3.43 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.565 -0.709 . . . . 0.0 109.823 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.602 ' HB3' ' CZ3' ' A' ' 90' ' ' TRP . 43.4 p-10 -158.76 -159.59 0.8 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.975 . . . . 0.0 109.883 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER 77.89 -72.52 0.09 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.991 0.9 . . . . 0.0 108.759 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -147.41 -47.3 0.17 Allowed 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 122.286 1.041 . . . . 0.0 108.236 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 108' ' ' VAL . 6.1 t-20 179.15 35.44 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.527 ' C ' HD13 ' A' ' 18' ' ' ILE . 3.0 mt-10 -107.29 148.93 28.37 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.637 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.903 HG22 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -116.8 156.1 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 109.857 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.575 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 11.5 t80 -92.5 69.48 4.94 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 176.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.716 HG23 ' N ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -82.05 -161.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 122.126 0.965 . . . . 0.0 112.093 -176.078 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.716 ' N ' HG23 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -141.01 132.21 26.46 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.454 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 9.9 ttp180 -136.96 -175.52 4.06 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.373 -0.829 . . . . 0.0 109.929 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.461 ' HD3' ' CB ' ' A' ' 27' ' ' ALA . 1.7 ptt180 -72.32 99.18 2.35 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.35 -0.844 . . . . 0.0 109.832 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -44.86 -85.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 108.958 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.91 52.57 2.04 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.554 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 31.8 t0 -145.67 -128.8 0.07 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.195 -0.94 . . . . 0.0 109.451 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 26' ' ' ASP . . . 67.8 154.03 0.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.758 -1.214 . . . . 0.0 109.238 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -103.27 -70.39 0.76 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 0.0 109.605 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.31 151.85 40.71 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.297 -0.877 . . . . 0.0 109.524 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.82 174.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.63 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -104.77 145.35 30.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.396 -0.815 . . . . 0.0 109.376 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.47 141.51 43.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.09 -1.006 . . . . 0.0 109.781 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.827 HD21 ' HB3' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -136.79 -178.02 5.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -0.8 . . . . 0.0 109.679 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.625 ' O ' HD11 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -161.66 -155.86 0.41 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.716 0.769 . . . . 0.0 109.771 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.683 ' CZ ' ' CZ ' ' A' ' 115' ' ' PHE . 95.0 m-85 -117.3 150.3 46.11 Favored Pre-proline 0 C--N 1.296 -1.721 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.652 ' C ' HG23 ' A' ' 8' ' ' VAL . 6.2 Cg_exo -58.01 -152.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 121.884 1.723 . . . . 0.0 109.671 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 134.96 170.02 12.06 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.119 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -164.8 -61.3 0.02 OUTLIER Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 1.3 tttt 178.15 153.46 0.32 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.507 -0.996 . . . . 0.0 109.369 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.935 HG22 ' O ' ' A' ' 5' ' ' GLN . 7.6 tt -129.78 50.97 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.869 . . . . 0.0 109.623 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.424 ' HG3' ' HG2' ' A' ' 39' ' ' LYS . 2.2 mt-10 -118.63 7.2 11.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 109.654 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.2 tpp -108.57 -3.01 18.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.174 -0.954 . . . . 0.0 109.729 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.18 172.68 14.6 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.81 -13.5 13.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.166 -1.197 . . . . 0.0 109.808 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.816 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -144.38 179.53 1.15 Allowed Pre-proline 0 C--N 1.305 -1.335 0 O-C-N 121.044 -1.035 . . . . 0.0 109.496 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.816 ' CD ' HG22 ' A' ' 45' ' ' THR . 4.9 Cg_endo -72.94 1.61 6.32 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.347 2.031 . . . . 0.0 110.843 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.528 ' O ' HG12 ' A' ' 51' ' ' VAL . 1.9 mt-10 -124.02 -51.88 1.78 Allowed 'General case' 0 C--O 1.198 -1.654 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.524 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -49.62 -34.81 19.09 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 122.388 1.09 . . . . 0.0 108.378 178.537 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.486 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -67.63 -60.74 2.31 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.323 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.694 HG22 ' HH2' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -75.95 -48.01 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.123 -0.986 . . . . 0.0 109.162 -179.059 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.581 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 3.1 p -39.48 -48.92 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 121.533 0.682 . . . . 0.0 109.163 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.581 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -75.73 -33.15 60.26 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 3.1 mm-40 -67.07 -10.64 52.07 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.739 HD21 ' OE1' ' A' ' 63' ' ' GLN . 0.3 OUTLIER -60.4 -64.6 0.89 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.44 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -81.79 -25.77 34.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.556 -0.715 . . . . 0.0 109.37 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.514 ' HG3' ' HG3' ' A' ' 52' ' ' ARG . 29.3 mm-40 -81.57 32.14 0.35 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.168 -0.958 . . . . 0.0 110.479 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.586 ' HB3' ' CB ' ' A' ' 95' ' ' TRP . 5.3 mm-40 -147.03 -67.78 0.26 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.965 -1.085 . . . . 0.0 109.27 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.679 ' HB ' ' HB3' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -114.27 -46.59 4.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.647 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.469 ' N ' ' CG1' ' A' ' 58' ' ' VAL . . . 100.48 53.49 1.06 Allowed Glycine 0 N--CA 1.482 1.713 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.458 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.648 HG21 ' CD1' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -90.33 167.73 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.685 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.665 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.2 m -119.02 -65.13 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.587 -1.32 . . . . 0.0 111.299 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.665 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 18.8 Cg_endo -77.5 33.66 0.45 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.628 1.552 . . . . 0.0 110.905 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.739 ' OE1' HD21 ' A' ' 54' ' ' LEU . 55.8 tt0 -82.27 65.74 7.54 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.584 0.707 . . . . 0.0 109.636 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -51.28 144.85 8.98 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.623 ' HB3' HG12 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -153.93 170.94 19.85 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.596 -1.315 . . . . 0.0 111.21 -179.128 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.0 -177.51 6.16 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.0 tp -105.71 127.04 52.84 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.732 -1.23 . . . . 0.0 109.728 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.785 ' CE2' HD21 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -86.18 -70.48 0.6 Allowed 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.666 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -173.96 117.19 0.24 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.112 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -87.4 138.36 31.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.33 -0.856 . . . . 0.0 109.137 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.938 HD23 HG22 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -96.9 -170.93 2.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.244 -0.91 . . . . 0.0 110.63 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -154.4 137.24 15.35 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.413 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -131.11 175.39 9.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.934 -1.103 . . . . 0.0 110.407 -179.105 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -158.55 126.29 5.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.473 -0.767 . . . . 0.0 109.175 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.641 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -88.5 177.9 2.36 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.846 . . . . 0.0 109.258 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.641 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 2.6 Cg_exo -56.24 -16.82 18.52 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.864 1.709 . . . . 0.0 110.408 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -165.99 15.09 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.345 -0.847 . . . . 0.0 110.623 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.533 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 6.4 mmm180 -124.49 178.94 5.15 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 120.818 -1.176 . . . . 0.0 109.097 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -129.41 110.76 12.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.0 109.26 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.413 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 24.3 mm -106.16 109.27 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 109.695 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.9 m -116.69 142.35 47.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.336 -0.852 . . . . 0.0 109.139 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.483 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -149.87 167.0 27.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.68 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.64 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 1.1 m95 -124.48 155.63 38.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.375 -0.828 . . . . 0.0 109.402 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.499 ' CZ ' ' CD2' ' A' ' 35' ' ' PHE . 3.0 m-85 -133.43 88.38 2.48 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.438 -0.789 . . . . 0.0 109.046 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.583 ' O ' ' CG ' ' A' ' 85' ' ' TRP . 1.2 p-90 -111.39 104.43 12.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.474 -1.391 . . . . 0.0 109.55 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.115 ' CD2' HD12 ' A' ' 10' ' ' ILE . 1.9 mm? -80.97 141.43 34.46 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.282 0.563 . . . . 0.0 111.178 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.801 HG22 ' HA ' ' A' ' 11' ' ' ILE . 5.0 m -99.53 -174.33 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 O-C-N 121.217 -0.927 . . . . 0.0 108.906 178.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.506 ' O ' ' O ' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -120.8 -46.87 2.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.986 -1.071 . . . . 0.0 111.444 -179.039 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.63 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.35 150.5 14.49 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.366 -1.459 . . . . 0.0 110.75 -179.222 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.787 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 11.6 p90 -151.41 178.4 9.33 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 122.066 0.936 . . . . 0.0 109.896 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.577 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 22.6 tt0 -128.66 86.74 2.48 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.484 ' O ' ' CD1' ' A' ' 90' ' ' TRP . . . 148.99 175.07 21.12 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.609 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.2 mt-10 -80.26 118.55 72.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.141 -1.211 . . . . 0.0 108.21 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.717 ' HB3' HD12 ' A' ' 11' ' ' ILE . 3.4 Cg_endo -70.3 167.44 25.14 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.516 2.144 . . . . 0.0 112.064 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.694 ' HH2' HG22 ' A' ' 50' ' ' VAL . 29.2 p-90 -113.64 -167.86 1.26 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 36' ' ' PRO . . . 162.01 -78.86 0.16 Allowed Glycine 0 N--CA 1.481 1.669 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.563 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -101.88 -174.86 2.68 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.726 -0.867 . . . . 0.0 108.701 179.149 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -125.24 -53.8 1.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.937 -1.102 . . . . 0.0 109.575 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.48 -0.09 89.61 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.643 ' OE1' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -113.07 128.92 25.05 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.178 -1.19 . . . . 0.0 109.452 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.69 -71.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.116 1.877 . . . . 0.0 110.503 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . 95.74 166.18 34.64 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -159.27 159.49 34.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.566 -1.549 . . . . 0.0 111.08 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.553 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -84.37 94.74 8.55 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 1.1 ttm -86.77 132.11 33.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.225 -0.922 . . . . 0.0 109.662 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.442 ' HB3' ' CD ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -111.26 99.3 8.15 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.419 -0.8 . . . . 0.0 109.43 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.931 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.0 mt -122.75 -85.97 0.65 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 109.575 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 107' ' ' LEU . 1.5 t -177.82 -55.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -159.68 88.2 0.11 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.748 HD13 ' CE2' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -40.39 143.74 0.29 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.518 -0.989 . . . . 0.0 110.015 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.454 ' ND2' ' HA ' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -128.64 -171.02 2.36 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.451 -0.781 . . . . 0.0 109.184 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . . . -75.98 -9.34 58.53 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.197 -0.939 . . . . 0.0 109.431 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -62.81 -56.66 15.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.871 . . . . 0.0 109.687 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.827 ' HB3' HD21 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -81.3 -13.63 58.22 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.785 ' CG ' HD12 ' A' ' 123' ' ' ILE . 3.1 m-85 -90.58 110.6 42.39 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.514 ' CG ' ' O ' ' A' ' 33' ' ' LEU . 6.6 Cg_exo -50.96 141.19 37.51 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.953 1.769 . . . . 0.0 110.094 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.723 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 4.4 Cg_exo -59.35 126.52 21.03 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.195 1.93 . . . . 0.0 110.804 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.723 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 152.97 -18.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.559 ' HB3' HG12 ' A' ' 123' ' ' ILE . 0.9 OUTLIER -123.33 48.52 1.82 Allowed 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.655 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.2 mm-40 -65.99 -35.88 12.07 Favored Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.655 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 6.2 Cg_exo -60.59 -35.11 91.32 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 121.678 1.585 . . . . 0.0 112.094 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.938 HG22 HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -102.67 -46.66 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 120.588 -1.32 . . . . 0.0 108.672 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.785 HD12 ' CG ' ' A' ' 115' ' ' PHE . 24.8 mm -50.15 -38.35 14.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 127' ' ' LYS . . . -52.06 -44.35 64.25 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -71.08 -42.63 69.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.41 -0.806 . . . . 0.0 109.782 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.785 HD21 ' CE2' ' A' ' 68' ' ' PHE . 1.4 mt -63.01 -9.73 11.21 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.276 -0.89 . . . . 0.0 109.732 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.454 ' HA ' ' ND2' ' A' ' 111' ' ' ASN . 55.6 mttt -56.81 -48.7 77.35 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.14 -0.975 . . . . 0.0 108.69 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 129' ' ' LEU . 1.8 ptt180 -89.33 0.95 56.42 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.407 -0.808 . . . . 0.0 109.27 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 126' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.851 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.427 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 2' ' ' LYS . 6.8 ptmm? -179.34 46.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.151 -0.968 . . . . 0.0 109.653 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -110.57 89.82 3.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.977 . . . . 0.0 109.229 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.772 ' H ' HD12 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -115.61 176.94 4.85 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.112 0.958 . . . . 0.0 110.546 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.447 ' O ' ' O ' ' A' ' 4' ' ' LEU . 8.8 mt-30 58.36 126.53 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.568 0.699 . . . . 0.0 110.485 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.603 HG23 ' N ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -129.89 176.05 9.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.603 ' N ' HG23 ' A' ' 6' ' ' ILE . . . -117.79 80.26 1.48 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.841 -1.162 . . . . 0.0 110.283 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.742 HG23 ' CB ' ' A' ' 36' ' ' PRO . 3.2 p -100.18 145.27 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 118.896 -1.122 . . . . 0.0 108.485 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -129.37 110.36 1.06 Allowed Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.14 HD12 ' CD1' ' A' ' 86' ' ' LEU . 1.3 mt -92.49 166.19 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.024 HG23 HG21 ' A' ' 87' ' ' VAL . 0.7 OUTLIER -154.48 146.42 13.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.271 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.545 ' CZ ' HD23 ' A' ' 129' ' ' LEU . 38.2 ttp180 -161.5 77.27 0.54 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.532 -0.73 . . . . 0.0 110.039 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 88' ' ' GLU . 13.9 m120 -160.1 -162.04 0.95 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -0.893 . . . . 0.0 109.543 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.37 -85.98 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.619 0.723 . . . . 0.0 109.528 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 13' ' ' ASN . 28.9 t-20 -94.75 28.68 2.59 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.529 -0.732 . . . . 0.0 109.335 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 15' ' ' ASN . 30.1 t30 42.31 43.73 3.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.475 -0.766 . . . . 0.0 109.318 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 105' ' ' MET . 2.5 mt-10 -129.41 149.33 51.24 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.689 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 3.0 mt -101.12 156.99 4.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 118.326 -1.35 . . . . 0.0 110.672 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.519 ' HB3' HG13 ' A' ' 11' ' ' ILE . 60.3 t80 -97.03 78.25 2.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.97 HG21 HD13 ' A' ' 33' ' ' LEU . 11.3 mm -78.09 167.14 2.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.404 -0.81 . . . . 0.0 110.084 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.665 HG21 ' HB2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -128.01 139.88 52.3 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.848 178.585 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' A' ' 32' ' ' LYS . 1.2 ttp180 -145.71 144.73 30.55 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.055 -1.028 . . . . 0.0 109.433 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.703 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -64.41 109.25 1.87 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.27 -0.894 . . . . 0.0 110.658 -179.499 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 23' ' ' ARG . . . 79.22 -6.03 1.91 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.727 -0.608 . . . . 0.0 110.034 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 58.71 21.27 8.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.973 . . . . 0.0 109.686 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.98 154.05 48.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.171 -0.956 . . . . 0.0 109.419 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.62 143.61 33.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 109.847 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -103.28 -31.0 10.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.573 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -133.45 137.86 45.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 109.524 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.425 ' C ' ' OD1' ' A' ' 31' ' ' ASN . . . 48.98 -172.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.306 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.425 ' OD1' ' C ' ' A' ' 30' ' ' ALA . 1.5 m120 -134.39 114.19 12.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 109.612 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.469 ' O ' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -108.13 135.0 50.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.317 -0.864 . . . . 0.0 109.375 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.97 HD13 HG21 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -104.63 -176.94 3.22 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.351 -0.843 . . . . 0.0 109.073 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -162.17 -155.91 0.39 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 110.073 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.461 ' HB3' HG21 ' A' ' 8' ' ' VAL . 21.8 m-85 -142.31 141.41 21.06 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.742 ' CB ' HG23 ' A' ' 8' ' ' VAL . 5.9 Cg_exo -57.54 -150.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.87 1.714 . . . . 0.0 110.074 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.567 ' HA2' ' CA ' ' A' ' 8' ' ' VAL . . . 148.78 -149.08 21.04 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.086 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . 144.93 -79.93 0.23 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.464 ' HG2' ' HG3' ' A' ' 41' ' ' GLU . 0.2 OUTLIER 178.07 133.87 0.07 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.395 -1.061 . . . . 0.0 109.652 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.677 ' O ' HG23 ' A' ' 40' ' ' ILE . 9.0 tt -121.84 74.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.253 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.464 ' HG3' ' HG2' ' A' ' 39' ' ' LYS . 1.9 mm-40 -113.04 -179.71 3.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.611 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.2 ttm 44.09 83.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.31 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 168.85 124.31 0.72 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.21 -11.17 39.09 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.19 -1.183 . . . . 0.0 110.192 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.848 HG22 ' H ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -125.18 149.03 62.53 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 120.927 -1.108 . . . . 0.0 108.715 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.721 ' HD2' HG23 ' A' ' 45' ' ' THR . 9.3 Cg_endo -71.12 14.98 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.753 2.302 . . . . 0.0 112.343 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.848 ' H ' HG22 ' A' ' 45' ' ' THR . 0.8 OUTLIER -124.01 -60.92 1.4 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.508 -1.37 . . . . 0.0 109.766 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.575 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -48.12 -28.5 2.95 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.823 1.296 . . . . 0.0 109.379 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . -67.54 -67.17 0.48 Allowed 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.374 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.745 HG13 ' CZ3' ' A' ' 85' ' ' TRP . 10.0 p -83.29 3.55 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.259 -0.901 . . . . 0.0 111.463 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.582 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 4.9 p -81.92 -43.67 19.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.582 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -69.34 -29.08 66.82 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 113.745 -1.571 . . . . 0.0 108.101 177.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 49' ' ' ALA . 69.9 mt-10 -70.36 -22.78 62.74 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.128 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.034 HD13 ' HG3' ' A' ' 62' ' ' PRO . 3.4 mt -63.43 -48.09 79.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -0.908 . . . . 0.0 109.467 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.513 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 2.1 pt20 -81.37 -30.64 33.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.937 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 9.1 mm-40 -81.88 32.56 0.37 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.219 -0.926 . . . . 0.0 111.014 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.655 ' CB ' ' CD1' ' A' ' 95' ' ' TRP . 25.6 mm-40 -155.3 -57.63 0.1 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.629 -1.294 . . . . 0.0 109.985 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.053 HG22 ' CD1' ' A' ' 95' ' ' TRP . 10.6 m -113.92 -49.8 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.587 ' N ' HG23 ' A' ' 58' ' ' VAL . . . 92.4 37.69 5.82 Favored Glycine 0 C--N 1.299 -1.482 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -79.83 174.67 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -1.092 . . . . 0.0 108.255 178.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.565 ' HB ' ' CB ' ' A' ' 91' ' ' GLU . 8.1 m -115.3 90.13 23.59 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 1.034 ' HG3' HD13 ' A' ' 54' ' ' LEU . 4.3 Cg_endo -61.0 122.75 11.66 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 121.809 1.672 . . . . 0.0 110.11 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.528 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 5.8 mt-30 -86.89 -34.18 19.5 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.834 -0.541 . . . . 0.0 109.773 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.46 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 45.5 t60 -176.42 97.48 0.06 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.179 -0.951 . . . . 0.0 110.315 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.477 ' HB2' HG12 ' A' ' 87' ' ' VAL . 13.7 p90 -111.7 175.5 5.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.908 -1.12 . . . . 0.0 109.307 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.1 m -161.97 173.18 14.81 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.624 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.941 HD22 ' CZ3' ' A' ' 83' ' ' TRP . 4.6 tp -116.09 114.16 24.15 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.215 -0.928 . . . . 0.0 109.153 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.641 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 2.6 p90 -73.78 -53.76 9.57 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.294 -0.879 . . . . 0.0 109.876 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.641 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 0.5 OUTLIER 176.45 149.59 0.13 Allowed 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.039 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -111.66 163.46 14.09 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.312 -0.868 . . . . 0.0 109.895 -179.466 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.941 HD23 ' CG2' ' A' ' 122' ' ' VAL . 0.3 OUTLIER -113.93 -164.6 0.94 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 109.145 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -136.03 156.28 48.96 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.133 -0.979 . . . . 0.0 109.557 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.57 82.85 1.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 1.0 OUTLIER -103.12 114.2 28.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 110.327 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.522 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -81.69 177.04 3.25 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 1.9 Cg_endo -63.95 2.67 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.926 1.751 . . . . 0.0 111.42 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -125.52 -55.05 1.55 Allowed 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.623 -1.298 . . . . 0.0 111.162 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -118.49 -179.42 3.78 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.253 -0.904 . . . . 0.0 110.387 -178.114 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.58 ' HB2' HD23 ' A' ' 4' ' ' LEU . 1.0 OUTLIER -128.51 96.44 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 12.6 mt -97.74 128.68 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.506 -0.746 . . . . 0.0 110.815 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.445 ' CB ' ' H ' ' A' ' 5' ' ' GLN . 3.7 m -115.85 118.43 32.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 108.769 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.581 ' CB ' HD11 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -81.93 132.15 35.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.154 -0.966 . . . . 0.0 109.81 -179.502 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.941 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -122.9 113.64 19.39 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.31 -0.869 . . . . 0.0 109.575 -178.688 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.657 ' CE1' HG11 ' A' ' 122' ' ' VAL . 0.1 OUTLIER -122.37 113.54 19.52 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 120.358 -1.464 . . . . 0.0 109.955 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.837 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -83.34 87.05 6.97 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.363 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.14 ' CD1' HD12 ' A' ' 10' ' ' ILE . 0.6 OUTLIER -44.39 107.87 0.1 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.038 -1.039 . . . . 0.0 109.21 -179.812 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.024 HG21 HG23 ' A' ' 11' ' ' ILE . 19.8 m -81.0 174.66 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.531 -0.73 . . . . 0.0 110.308 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.514 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 1.0 OUTLIER -129.22 -18.48 3.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 110.422 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.495 ' HD3' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -162.16 174.08 13.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.89 -1.131 . . . . 0.0 110.252 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.881 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 35.1 p90 174.65 -179.71 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.093 0.949 . . . . 0.0 109.883 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.633 ' O ' HG22 ' A' ' 60' ' ' ILE . 1.4 tt0 -134.7 109.17 8.43 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.727 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.52 ' CA ' HG22 ' A' ' 60' ' ' ILE . . . 114.37 -156.97 15.28 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.333 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.476 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 1.9 mt-10 -107.29 102.22 42.65 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.344 -1.092 . . . . 0.0 109.067 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 1.038 ' C ' HG11 ' A' ' 58' ' ' VAL . 3.4 Cg_endo -66.46 -169.82 0.19 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.118 1.879 . . . . 0.0 111.972 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 1.053 ' CD1' HG22 ' A' ' 58' ' ' VAL . 4.8 p-90 -136.01 -168.27 2.19 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.69 0.757 . . . . 0.0 108.986 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 36' ' ' PRO . . . -159.98 -77.86 0.03 OUTLIER Glycine 0 C--N 1.295 -1.742 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.665 ' HB2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -87.06 -179.27 6.44 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.524 -0.986 . . . . 0.0 109.494 179.54 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -92.59 -36.04 13.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.346 -0.846 . . . . 0.0 109.819 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -139.76 9.61 3.12 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.543 ' HB3' ' CB ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -99.04 109.59 54.64 Favored Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 121.189 -1.183 . . . . 0.0 109.694 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.97 122.2 11.03 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.949 1.766 . . . . 0.0 109.679 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -98.22 168.58 23.29 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -125.81 154.61 42.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.857 -1.378 . . . . 0.0 110.086 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.443 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -94.65 104.01 15.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.543 -0.723 . . . . 0.0 109.351 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 1.2 ttm -92.51 168.73 11.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.178 -0.951 . . . . 0.0 109.257 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.4 t -116.21 65.63 0.71 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.176 -0.953 . . . . 0.0 109.567 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.505 ' CD1' ' HD2' ' A' ' 12' ' ' ARG . 3.1 tp 48.03 59.52 4.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.274 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.34 -72.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 109.555 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.501 ' HA3' ' HB2' ' A' ' 114' ' ' ASP . . . -100.75 30.92 9.27 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.964 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -67.24 -20.6 65.69 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.311 -1.111 . . . . 0.0 109.33 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -78.93 -177.89 5.77 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.427 -0.795 . . . . 0.0 109.731 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.656 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . -68.76 -6.81 28.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.378 -0.826 . . . . 0.0 109.656 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -62.91 -54.77 33.53 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.257 -0.902 . . . . 0.0 109.944 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.501 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 19.8 t0 -90.56 -6.7 54.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.872 . . . . 0.0 109.811 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.629 ' CD2' HD11 ' A' ' 123' ' ' ILE . 1.8 m-85 -89.32 142.13 29.57 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.026 -1.046 . . . . 0.0 109.388 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.538 ' CG ' ' O ' ' A' ' 33' ' ' LEU . 2.1 Cg_endo -71.65 158.13 54.19 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.303 2.002 . . . . 0.0 110.584 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.641 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 2.8 Cg_endo -60.62 -177.04 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.484 2.123 . . . . 0.0 110.563 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.641 ' HB3' ' O ' ' A' ' 117' ' ' PRO . . . 74.43 -1.85 2.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.458 -0.776 . . . . 0.0 109.902 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.589 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 0.9 OUTLIER -127.15 41.7 3.47 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.032 -1.042 . . . . 0.0 109.511 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.675 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 26.6 mt-10 -74.94 -39.12 3.24 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.299 -0.875 . . . . 0.0 112.065 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.6 Cg_exo -62.37 -32.36 81.26 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.954 1.769 . . . . 0.0 112.089 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.941 ' CG2' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -101.4 -50.4 10.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 120.508 -1.37 . . . . 0.0 109.288 -179.592 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.656 HG21 ' HA ' ' A' ' 112' ' ' ALA . 14.1 mm -50.95 -36.88 16.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -58.73 -43.85 90.3 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -63.01 -41.46 99.57 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.293 -0.88 . . . . 0.0 109.465 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.549 HD12 HD13 ' A' ' 129' ' ' LEU . 5.3 mp -58.06 -17.21 16.29 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.233 -0.917 . . . . 0.0 109.678 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.446 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 13.8 mmtt -57.07 -53.46 57.87 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -91.25 9.77 29.96 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.009 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.991 HD11 ' CD2' ' A' ' 86' ' ' LEU . 3.4 tp . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.748 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.44 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 2.7 ttt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.3 10.51 2.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 0.0 109.16 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.5 ' O ' ' O ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -103.27 131.34 50.4 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -162.43 48.55 0.17 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.387 -0.821 . . . . 0.0 109.83 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.471 ' C ' HG12 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -164.26 119.66 1.52 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.695 -1.253 . . . . 0.0 110.713 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.992 HG22 HD13 ' A' ' 82' ' ' LEU . 6.0 mm -152.02 157.49 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.507 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -146.42 119.31 8.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.762 -1.211 . . . . 0.0 110.465 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.976 HG12 HD11 ' A' ' 82' ' ' LEU . 7.5 p -122.2 147.17 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.576 ' HA3' ' CZ3' ' A' ' 95' ' ' TRP . . . -129.1 119.55 2.99 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.09 HD12 HD13 ' A' ' 86' ' ' LEU . 1.2 mt -92.2 166.15 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.967 HD11 ' CB ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -149.19 153.38 10.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 118.584 -1.246 . . . . 0.0 110.492 -178.3 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 88' ' ' GLU . 11.0 ttp180 -129.39 122.23 29.01 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -98.39 -169.46 1.8 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.098 -1.001 . . . . 0.0 110.632 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -78.36 -6.93 56.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.558 -0.714 . . . . 0.0 110.302 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.489 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 24.3 t30 -88.43 21.35 2.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.443 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 20.2 t30 48.46 42.92 19.35 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.413 -0.804 . . . . 0.0 109.339 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 15' ' ' ASN . 2.9 mt-10 -140.45 147.65 39.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 108.835 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.881 HG22 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.09 153.92 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.111 -0.993 . . . . 0.0 109.415 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 56.6 t80 -88.84 73.15 8.46 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.696 HG13 HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -80.06 -161.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.344 -0.848 . . . . 0.0 109.354 -178.626 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.851 HG23 ' HA2' ' A' ' 102' ' ' GLY . 0.2 OUTLIER -159.96 152.66 21.31 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.823 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.52 ' HG3' ' HA ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -136.33 161.21 36.42 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.518 ' NH2' ' HB2' ' A' ' 23' ' ' ARG . 0.2 OUTLIER -85.36 61.35 6.81 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.92 -1.113 . . . . 0.0 109.991 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.619 ' O ' ' HB3' ' A' ' 25' ' ' ALA . . . 51.21 174.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.905 . . . . 0.0 109.887 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . 71.36 86.34 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.877 . . . . 0.0 109.64 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.94 122.26 20.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.181 -0.95 . . . . 0.0 109.185 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.19 155.18 39.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 109.561 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -125.32 11.32 8.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.893 . . . . 0.0 109.45 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 19.0 mtt -155.57 -48.79 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 109.358 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.14 -153.26 0.26 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.144 -0.973 . . . . 0.0 109.534 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.39 127.2 3.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.286 -0.884 . . . . 0.0 109.536 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.517 ' O ' ' CD ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -151.55 125.88 9.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.424 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.696 HD23 HG13 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -121.17 -165.38 1.22 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.349 -0.844 . . . . 0.0 109.36 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.2 -160.89 0.82 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.337 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.69 ' CE2' ' CZ ' ' A' ' 84' ' ' PHE . 5.8 m-85 -156.12 70.47 5.09 Favored Pre-proline 0 C--N 1.294 -1.833 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.706 ' O ' HG23 ' A' ' 8' ' ' VAL . 4.3 Cg_exo -55.19 164.69 3.5 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.046 1.831 . . . . 0.0 109.588 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . -161.57 -147.71 5.07 Favored Glycine 0 N--CA 1.486 1.969 0 C-N-CA 119.325 -1.417 . . . . 0.0 109.814 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -134.51 -76.03 0.09 OUTLIER Glycine 0 N--CA 1.484 1.887 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 13.1 tttt 176.38 155.7 0.23 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.628 -0.924 . . . . 0.0 109.822 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.831 HD11 ' O ' ' A' ' 6' ' ' ILE . 15.2 mm -78.92 107.5 11.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.465 ' OE1' ' HD3' ' A' ' 52' ' ' ARG . 5.6 mt-10 -116.63 177.78 4.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.963 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.437 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 54.3 mmm 71.38 -164.99 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.863 . . . . 0.0 109.732 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.8 -26.53 3.29 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.511 ' C ' HG22 ' A' ' 45' ' ' THR . 0.9 OUTLIER -79.61 -154.91 0.09 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.399 -1.059 . . . . 0.0 109.19 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.73 HG23 ' HD3' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -160.82 -58.09 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.032 -1.043 . . . . 0.0 111.374 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.73 ' HD3' HG23 ' A' ' 45' ' ' THR . 1.3 Cg_endo -67.62 3.88 1.62 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 121.492 1.461 . . . . 0.0 112.765 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.534 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -148.91 -69.28 0.21 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.331 -1.48 . . . . 0.0 109.157 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.61 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 35.0 mt-30 -51.37 -27.57 10.2 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 122.54 1.162 . . . . 0.0 110.116 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 45' ' ' THR . . . -65.65 -66.18 0.58 Allowed 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.671 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.499 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 9.9 p -81.9 -6.59 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 111.25 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.61 ' CG1' ' HA ' ' A' ' 48' ' ' GLN . 3.1 p -72.38 -48.3 48.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.58 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -75.09 -22.5 58.23 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.39 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -52.98 -21.45 4.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.89 -1.131 . . . . 0.0 108.808 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.621 HD21 ' HG3' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -66.08 -59.44 3.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.419 -0.801 . . . . 0.0 110.401 -179.435 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.544 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 7.2 pt20 -79.97 -30.22 39.73 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.177 -0.952 . . . . 0.0 111.891 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.544 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 1.1 pp20? -79.64 -29.17 40.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.869 -1.144 . . . . 0.0 111.377 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 1.052 ' HG3' HG12 ' A' ' 58' ' ' VAL . 4.4 pt-20 -91.59 -46.63 7.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.684 -1.26 . . . . 0.0 110.428 -178.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.052 HG12 ' HG3' ' A' ' 57' ' ' GLU . 0.5 OUTLIER -147.96 -67.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.353 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.736 ' H ' HG13 ' A' ' 58' ' ' VAL . . . 119.99 71.36 0.33 Allowed Glycine 0 N--CA 1.48 1.589 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.841 HG22 ' N ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -107.52 -156.49 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.114 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 91' ' ' GLU . 2.3 m -146.51 91.87 5.27 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.621 ' HG3' HD21 ' A' ' 54' ' ' LEU . 1.8 Cg_endo -66.05 150.55 85.23 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.34 2.027 . . . . 0.0 110.729 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -121.28 -40.07 2.62 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.592 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -128.69 -179.56 5.13 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.486 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.665 ' CD2' HG12 ' A' ' 87' ' ' VAL . 22.9 m-85 -148.7 170.65 17.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.144 -0.972 . . . . 0.0 110.053 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.523 ' HB3' ' O ' ' A' ' 86' ' ' LEU . 3.8 t -159.24 0.84 0.09 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.296 -0.877 . . . . 0.0 111.96 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.058 HD22 ' CZ3' ' A' ' 85' ' ' TRP . 9.6 tp -29.0 148.52 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 CA-C-O 121.911 0.863 . . . . 0.0 110.991 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.651 ' HE2' HG22 ' A' ' 122' ' ' VAL . 14.3 p90 -116.46 -51.19 2.61 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.811 0.815 . . . . 0.0 109.431 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.528 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.3 pt-20 -179.18 161.84 1.15 Allowed 'General case' 0 C--N 1.291 -1.946 0 O-C-N 121.743 -0.598 . . . . 0.0 110.135 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.619 ' HD3' ' CE3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -105.59 -175.8 2.9 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.311 -0.868 . . . . 0.0 110.221 -179.142 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.81 HD12 ' N ' ' A' ' 72' ' ' GLU . 3.8 pp -147.51 -161.52 1.35 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.262 -0.899 . . . . 0.0 109.564 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.81 ' N ' HD12 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -143.45 162.16 36.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.461 -0.775 . . . . 0.0 109.425 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -141.09 164.07 31.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.709 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -158.5 108.69 2.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.427 -0.796 . . . . 0.0 109.097 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.58 ' HB2' ' HG3' ' A' ' 78' ' ' ARG . 2.1 m-85 -79.31 170.6 15.36 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.2 Cg_exo -57.84 -10.52 7.69 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.905 1.737 . . . . 0.0 111.204 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 1' ' ' MET . 2.1 t0 -153.54 -5.69 0.18 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.87 -1.144 . . . . 0.0 112.204 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.58 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 3.7 ptt180 -133.34 -176.91 4.3 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.406 -1.434 . . . . 0.0 109.548 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.5 ' O ' ' O ' ' A' ' 3' ' ' LYS . 5.9 m80 -134.99 156.11 49.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.157 -0.965 . . . . 0.0 109.381 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.435 HD13 ' O ' ' A' ' 79' ' ' HIS . 33.1 mm -148.87 92.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.084 -1.01 . . . . 0.0 109.897 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.0 m -79.33 90.52 4.99 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.992 HD13 HG22 ' A' ' 6' ' ' ILE . 11.0 tp -108.24 141.57 39.82 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.315 -0.866 . . . . 0.0 109.614 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.833 ' H ' HD12 ' A' ' 82' ' ' LEU . 8.7 m95 -89.56 -174.54 4.38 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.521 -0.737 . . . . 0.0 109.388 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.69 ' CZ ' ' CE2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -144.05 76.13 1.49 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 1.058 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 55.7 m95 -81.46 157.89 24.74 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 122.218 1.008 . . . . 0.0 110.628 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.09 HD13 HD12 ' A' ' 10' ' ' ILE . 6.2 tp -150.24 98.12 2.64 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.812 ' CG2' HG23 ' A' ' 11' ' ' ILE . 15.8 m -93.64 178.46 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.8 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -110.59 -28.15 8.62 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.23 -0.919 . . . . 0.0 112.32 -178.094 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -161.68 153.77 19.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.547 -1.346 . . . . 0.0 110.788 -178.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.7 ' NE1' ' O ' ' A' ' 92' ' ' GLY . 0.9 OUTLIER -161.96 -167.43 1.66 Allowed 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.582 -0.699 . . . . 0.0 109.564 178.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.535 ' O ' ' O ' ' A' ' 92' ' ' GLY . 22.7 tt0 -90.89 -105.82 0.1 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.274 -0.891 . . . . 0.0 110.062 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.841 ' N ' HG22 ' A' ' 60' ' ' ILE . . . -45.18 173.25 0.01 OUTLIER Glycine 0 N--CA 1.495 2.598 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.852 ' N ' ' HD3' ' A' ' 94' ' ' PRO . 1.5 pt-20 -115.26 28.53 0.11 Allowed Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 119.354 1.577 . . . . 0.0 113.29 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.998 ' CG ' HG21 ' A' ' 58' ' ' VAL . 60.6 Cg_endo -90.41 -123.54 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 122.508 2.139 . . . . 0.0 108.447 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.967 ' CB ' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER 85.76 75.53 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.042 -1.036 . . . . 0.0 111.707 177.661 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 161.26 -121.77 1.05 Allowed Glycine 0 C--N 1.297 -1.634 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.514 ' CD ' ' HB2' ' A' ' 100' ' ' GLN . 7.3 tttt -94.5 145.86 24.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.109 -1.23 . . . . 0.0 109.995 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.454 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 11.6 pt-20 -89.72 -33.81 16.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.168 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.454 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . -88.11 -10.83 68.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.632 ' HG2' HG22 ' A' ' 21' ' ' THR . 7.1 tt0 -102.65 113.2 66.02 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 121.374 -1.074 . . . . 0.0 109.381 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.29 102.62 0.33 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.041 1.827 . . . . 0.0 110.726 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.851 ' HA2' HG23 ' A' ' 21' ' ' THR . . . -65.38 172.31 22.83 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.536 ' O ' HG22 ' A' ' 20' ' ' ILE . 4.2 pt-20 -147.0 134.22 20.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.543 -1.563 . . . . 0.0 110.14 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.599 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -81.81 94.72 7.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.448 -0.783 . . . . 0.0 109.08 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.443 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -85.04 169.51 13.88 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.082 -1.011 . . . . 0.0 109.471 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.406 ' HB3' HG23 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -96.43 145.51 25.59 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.199 -0.938 . . . . 0.0 109.596 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.492 ' HG ' HD12 ' A' ' 110' ' ' LEU . 1.8 tt -101.39 61.41 0.92 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.406 HG23 ' HB3' ' A' ' 106' ' ' SER . 21.2 t -98.59 -25.95 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.565 -0.709 . . . . 0.0 109.505 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -162.58 38.04 0.35 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.492 HD12 ' HG ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -43.13 145.82 0.48 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.397 -1.061 . . . . 0.0 109.632 -179.589 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.457 ' ND2' ' HE2' ' A' ' 127' ' ' LYS . 2.6 t30 -156.87 163.12 39.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.082 -1.011 . . . . 0.0 110.028 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.647 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . -61.29 -15.64 37.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 109.184 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -68.44 -33.15 73.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.425 -0.797 . . . . 0.0 109.4 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -79.13 2.09 22.07 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.041 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.605 ' CE1' ' CE2' ' A' ' 35' ' ' PHE . 10.2 m-85 -130.97 104.72 15.28 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.443 -0.786 . . . . 0.0 109.179 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.464 ' HG3' ' HB2' ' A' ' 32' ' ' LYS . 21.6 Cg_exo -43.18 160.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.513 2.142 . . . . 0.0 110.831 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.703 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 5.0 Cg_exo -58.03 130.25 37.2 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.518 2.145 . . . . 0.0 111.365 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 160.31 -56.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.549 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 16.1 m-20 -107.84 42.41 1.35 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.641 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -61.51 -38.68 54.33 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.433 -0.792 . . . . 0.0 113.004 -179.131 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 1.9 Cg_endo -65.06 -37.46 32.8 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 122.0 1.8 . . . . 0.0 111.977 -177.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.651 HG22 ' HE2' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -90.23 -39.34 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.523 -1.361 . . . . 0.0 108.186 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.647 HG21 ' HA ' ' A' ' 112' ' ' ALA . 6.6 mm -56.35 -34.31 40.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.43 -36.78 74.15 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.871 -0.731 . . . . 0.0 109.271 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -55.1 8.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.91 . . . . 0.0 109.967 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -50.65 -17.66 0.56 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.199 -0.938 . . . . 0.0 110.126 -179.475 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.457 ' HE2' ' ND2' ' A' ' 111' ' ' ASN . 15.2 mttt -47.59 -46.37 28.2 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.825 -1.172 . . . . 0.0 108.923 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -95.98 47.71 1.1 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.459 -0.775 . . . . 0.0 109.319 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.821 HD21 ' CD2' ' A' ' 86' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.305 -1.345 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.658 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.357 0.599 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.65 -174.52 3.67 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.193 -0.942 . . . . 0.0 109.457 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -106.17 85.06 2.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.358 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.4 tp -83.89 127.05 33.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -0.852 . . . . 0.0 109.508 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.771 ' C ' HG22 ' A' ' 40' ' ' ILE . 2.0 mt-30 -118.12 159.25 23.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 0.0 109.177 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.695 HG23 ' N ' ' A' ' 7' ' ' ALA . 2.1 tt -134.4 -173.94 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.132 -0.98 . . . . 0.0 109.365 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.695 ' N ' HG23 ' A' ' 6' ' ' ILE . . . -138.31 104.92 5.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.198 -0.939 . . . . 0.0 109.311 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 7.6 p -113.08 139.96 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.428 -0.795 . . . . 0.0 109.567 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.609 ' CA ' ' NE1' ' A' ' 85' ' ' TRP . . . -121.77 126.32 6.44 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.639 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.931 HD11 ' CD2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -107.17 144.27 16.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.085 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.843 HG23 HG21 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -123.69 156.04 30.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.866 -1.146 . . . . 0.0 109.253 179.417 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -157.44 125.25 5.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.474 -0.766 . . . . 0.0 109.451 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.577 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 26.9 p-10 -156.63 -168.48 2.7 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.879 -1.138 . . . . 0.0 111.169 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 13' ' ' ASN . 3.8 mt-10 66.16 -83.44 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.863 0.84 . . . . 0.0 110.048 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -132.68 -59.21 0.91 Allowed 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 122.004 0.907 . . . . 0.0 109.593 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -164.72 32.55 0.07 Allowed 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 3.7 mt-10 -89.39 148.95 23.21 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.903 HD11 ' HB2' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -131.21 154.91 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.06 -1.025 . . . . 0.0 109.582 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.74 ' HZ ' HE21 ' A' ' 100' ' ' GLN . 9.6 t80 -116.63 84.87 2.21 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.632 HD11 ' HB ' ' A' ' 18' ' ' ILE . 0.6 OUTLIER -107.3 -152.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 108.619 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.966 HG21 ' HD3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -131.23 151.32 51.59 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.015 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -131.22 -159.59 0.98 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.43 -0.794 . . . . 0.0 109.818 -179.399 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.965 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 5.3 ptt180 -73.08 81.82 1.26 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.421 -0.799 . . . . 0.0 109.874 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.77 7.68 25.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.286 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.08 -42.01 0.15 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.36 -0.838 . . . . 0.0 109.577 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -169.76 133.84 1.29 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.98 . . . . 0.0 109.738 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.965 ' HB2' ' HB3' ' A' ' 23' ' ' ARG . . . -121.69 122.61 39.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.343 -0.848 . . . . 0.0 109.243 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -48.44 -28.07 3.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.843 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 17.9 mtt -126.97 -152.92 0.54 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.049 -1.032 . . . . 0.0 109.797 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.56 -88.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.34 -0.85 . . . . 0.0 109.505 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -100.78 129.65 46.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.938 . . . . 0.0 109.327 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.533 ' HB2' ' HG3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -148.81 132.31 16.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.206 -0.934 . . . . 0.0 109.339 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.587 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -93.6 -176.86 4.21 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 120.93 -1.106 . . . . 0.0 108.389 179.476 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.491 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 4.8 tt0 -163.44 -158.9 0.49 Allowed 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 118.804 -1.159 . . . . 0.0 111.067 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 1.051 ' CE2' HD11 ' A' ' 123' ' ' ILE . 57.8 m-85 -161.64 64.75 1.85 Allowed Pre-proline 0 C--N 1.299 -1.601 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 34' ' ' GLU . 2.3 Cg_endo -60.62 -84.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.235 1.957 . . . . 0.0 110.706 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 105.6 -120.64 6.51 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -156.46 -77.85 0.02 OUTLIER Glycine 0 N--CA 1.488 2.1 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 6.0 tttp 177.41 132.31 0.06 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.483 -1.01 . . . . 0.0 109.318 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.771 HG22 ' C ' ' A' ' 5' ' ' GLN . 14.2 tt -118.93 120.04 62.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.378 -0.826 . . . . 0.0 108.978 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -85.55 144.73 27.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.033 -1.042 . . . . 0.0 109.826 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.17 165.15 23.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.372 -0.83 . . . . 0.0 109.406 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.67 -17.23 57.08 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.24 -153.95 0.44 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.588 -0.948 . . . . 0.0 108.816 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.852 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -122.1 176.96 1.74 Allowed Pre-proline 0 C--N 1.307 -1.277 0 O-C-N 120.791 -1.193 . . . . 0.0 108.526 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.852 ' CD ' HG22 ' A' ' 45' ' ' THR . 10.2 Cg_endo -76.96 -7.57 17.42 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.052 1.835 . . . . 0.0 110.986 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.593 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -113.59 -62.34 1.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.934 -1.104 . . . . 0.0 110.609 -178.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.54 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 2.5 tt0 -39.29 -36.22 0.32 Allowed 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.658 1.218 . . . . 0.0 109.502 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 47' ' ' GLU . . . -60.42 -67.08 0.43 Allowed 'General case' 0 C--N 1.271 -2.824 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.313 -178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.545 HG22 ' HH2' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -81.55 -44.0 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.271 -0.893 . . . . 0.0 110.447 -178.468 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 47' ' ' GLU . 7.4 p -39.95 -45.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.571 ' N ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -73.94 -37.36 64.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.114 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 50' ' ' VAL . 5.1 mm-40 -67.4 -7.06 22.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.197 -0.939 . . . . 0.0 109.446 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.891 HD23 ' HE1' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -76.45 -54.76 6.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.957 -1.089 . . . . 0.0 109.62 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -80.02 -29.77 39.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.009 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.493 ' HG3' ' HG3' ' A' ' 52' ' ' ARG . 11.9 mm-40 -81.55 35.37 0.4 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.136 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.516 ' HB2' ' CD1' ' A' ' 95' ' ' TRP . 12.3 mt-10 -150.53 -66.52 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.901 -1.124 . . . . 0.0 109.613 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.071 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.4 p -122.56 -27.21 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 O-C-N 121.043 -1.035 . . . . 0.0 109.788 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.02 70.23 1.21 Allowed Glycine 0 N--CA 1.489 2.177 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.26 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.649 HD12 ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -90.12 172.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.716 ' CB ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -123.36 -70.02 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 120.201 -1.562 . . . . 0.0 111.221 -178.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.716 ' HD3' ' CB ' ' A' ' 61' ' ' THR . 12.3 Cg_endo -75.35 49.04 2.24 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 122.057 1.838 . . . . 0.0 111.251 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.666 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 53.5 tt0 -101.52 72.3 1.39 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.672 -1.267 . . . . 0.0 109.276 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -65.59 105.13 1.14 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.792 ' CB ' HG12 ' A' ' 87' ' ' VAL . 30.5 p90 -125.41 179.58 5.05 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.758 1.266 . . . . 0.0 111.97 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 68' ' ' PHE . 4.9 m -162.19 131.82 4.54 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.777 HD21 ' HE3' ' A' ' 70' ' ' LYS . 43.5 tp -49.04 94.76 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.726 -1.234 . . . . 0.0 109.578 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.713 ' HE2' HG13 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -42.93 -77.15 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.586 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 3.3 mm-40 -156.67 -173.5 4.51 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.777 ' HE3' HD21 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -140.43 147.81 40.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.065 -1.022 . . . . 0.0 109.845 -179.542 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.719 HD23 ' HB ' ' A' ' 122' ' ' VAL . 0.5 OUTLIER -124.32 -178.45 4.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.15 -0.969 . . . . 0.0 109.671 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -160.88 146.77 14.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.478 -0.764 . . . . 0.0 109.398 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -129.3 -163.53 1.3 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.957 . . . . 0.0 109.29 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -157.44 117.6 3.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 0.0 109.187 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.74 ' CE2' HD13 ' A' ' 80' ' ' ILE . 1.4 m-85 -79.62 170.37 16.24 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.0 Cg_exo -56.89 -6.34 1.7 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.063 1.842 . . . . 0.0 111.983 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.63 -17.04 0.32 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.566 -1.334 . . . . 0.0 112.113 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.526 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -131.44 -177.76 4.55 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.446 -1.409 . . . . 0.0 110.507 -178.569 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -121.67 121.69 37.91 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.74 HD13 ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -101.92 161.38 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.083 -1.011 . . . . 0.0 109.734 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.4 m -152.42 105.28 3.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.417 -0.802 . . . . 0.0 109.354 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.65 ' HG ' HG22 ' A' ' 6' ' ' ILE . 1.2 mp -85.94 149.93 24.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 109.821 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.603 ' CE2' ' HB3' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -110.35 115.97 30.62 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.931 ' CD2' HD11 ' A' ' 10' ' ' ILE . 2.2 m-85 -97.55 100.72 12.14 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.327 -0.858 . . . . 0.0 111.695 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.612 ' O ' ' CG ' ' A' ' 85' ' ' TRP . 29.1 p-90 -105.72 82.8 1.84 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.8 -1.188 . . . . 0.0 108.263 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.715 HD13 ' HB ' ' A' ' 10' ' ' ILE . 24.7 tp -78.06 146.01 35.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.434 -0.791 . . . . 0.0 110.673 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.843 HG21 HG23 ' A' ' 11' ' ' ILE . 17.7 m -113.13 -163.01 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.548 -0.72 . . . . 0.0 109.642 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 7.3 mt-10 -141.35 -29.72 0.63 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -0.981 . . . . 0.0 111.041 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.707 ' O ' ' HB3' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -143.78 -172.85 3.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.745 -1.222 . . . . 0.0 109.432 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.715 ' CE3' HG22 ' A' ' 11' ' ' ILE . 17.2 p90 154.47 162.59 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 122.72 1.248 . . . . 0.0 110.968 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.595 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 46.8 tt0 -126.11 90.11 3.13 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.186 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 157.66 -158.1 28.74 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 1.071 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -121.37 78.68 35.98 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 1.003 ' HA ' HG11 ' A' ' 58' ' ' VAL . 16.7 Cg_exo -40.02 156.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.064 2.509 . . . . 0.0 112.906 -177.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.891 ' HE1' HD23 ' A' ' 54' ' ' LEU . 45.4 p-90 -98.91 -163.4 1.03 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.461 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . 161.1 -21.99 0.22 Allowed Glycine 0 C--N 1.295 -1.708 0 C-N-CA 119.233 -1.46 . . . . 0.0 109.738 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.966 ' HD3' HG21 ' A' ' 21' ' ' THR . 29.6 tttt -146.44 160.03 42.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.418 -1.048 . . . . 0.0 109.312 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -44.24 104.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 108.587 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.98 -133.09 11.61 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.74 HE21 ' HZ ' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -150.09 53.58 1.31 Allowed Pre-proline 0 C--N 1.306 -1.322 0 O-C-N 120.926 -1.338 . . . . 0.0 110.24 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.604 ' HD3' ' N ' ' A' ' 100' ' ' GLN . 9.4 Cg_endo -71.16 -15.95 31.87 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.0 1.8 . . . . 0.0 110.236 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -64.04 -173.64 3.06 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.43 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 2.0 pm0 -156.96 169.62 24.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -1.148 . . . . 0.0 109.753 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -99.48 105.27 17.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -0.838 . . . . 0.0 109.228 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.491 ' HE3' ' HB2' ' A' ' 105' ' ' MET . 0.1 OUTLIER -83.44 163.26 20.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 109.506 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.89 91.48 3.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.315 -0.866 . . . . 0.0 109.302 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 mt 49.55 51.59 16.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 109.735 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.658 ' O ' HG12 ' A' ' 108' ' ' VAL . 44.6 t -104.33 26.74 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 108.955 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 114' ' ' ASP . . . 104.22 60.03 0.68 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.911 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -64.25 -13.99 52.82 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.201 -1.176 . . . . 0.0 108.663 179.83 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.27 -177.35 5.12 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.363 -0.836 . . . . 0.0 109.462 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.796 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . -62.32 -12.15 19.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 109.712 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -60.04 -52.63 64.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.845 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 13.6 t0 -79.17 -2.87 42.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.351 -0.843 . . . . 0.0 108.908 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.656 ' CZ ' ' CZ ' ' A' ' 35' ' ' PHE . 18.1 m-85 -109.27 108.19 60.08 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.288 -0.882 . . . . 0.0 108.816 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.533 ' HG3' ' HB2' ' A' ' 32' ' ' LYS . 10.0 Cg_exo -49.83 160.35 1.26 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.516 2.144 . . . . 0.0 111.152 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.71 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 4.8 Cg_exo -59.17 118.08 4.91 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.397 2.065 . . . . 0.0 110.232 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 161.28 -36.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.559 ' OD1' ' CZ ' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -118.49 39.53 3.44 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.348 -0.845 . . . . 0.0 109.193 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.688 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.9 mt-10 -69.92 -34.65 4.51 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.411 -0.806 . . . . 0.0 112.575 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.3 Cg_exo -59.56 -37.2 90.1 Favored 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 121.644 1.563 . . . . 0.0 112.012 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.719 ' HB ' HD23 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -102.18 -42.75 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.441 -1.412 . . . . 0.0 108.128 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 1.051 HD11 ' CE2' ' A' ' 35' ' ' PHE . 14.7 mm -54.05 -28.66 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.571 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -73.1 -36.35 66.76 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.518 -0.739 . . . . 0.0 109.571 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -70.49 -48.3 56.37 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.209 -0.932 . . . . 0.0 110.51 -179.586 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 1.045 ' HB2' HD13 ' A' ' 129' ' ' LEU . 0.9 OUTLIER -80.59 20.59 0.71 Allowed 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.842 -1.161 . . . . 0.0 110.741 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.571 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 17.2 mttt -63.63 -40.6 97.31 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.9 -1.125 . . . . 0.0 108.394 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.493 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -79.11 7.43 7.49 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.903 -0.498 . . . . 0.0 110.125 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 1.045 HD13 ' HB2' ' A' ' 126' ' ' LEU . 4.7 tp . . . . . 0 N--CA 1.499 2.011 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.447 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttm . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? 48.03 -144.37 0.38 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 109.337 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? -142.98 168.83 18.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.997 . . . . 0.0 109.635 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.837 HD13 ' OG1' ' A' ' 81' ' ' THR . 2.5 pp -87.46 121.39 29.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.892 . . . . 0.0 109.984 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.491 ' CG ' ' C ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER 169.84 99.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 109.81 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.842 HD13 HG23 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -122.02 167.1 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.716 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -134.15 81.8 1.94 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.341 -0.849 . . . . 0.0 109.133 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 83' ' ' TRP . 12.1 p -88.84 139.28 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.359 -0.838 . . . . 0.0 108.751 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.27 117.22 2.23 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.061 HD12 ' CD1' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -100.28 170.06 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.246 -1.15 . . . . 0.0 108.692 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.869 ' HA ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -147.58 154.71 11.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.981 -1.075 . . . . 0.0 110.479 -179.553 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.472 ' HD2' ' HG ' ' A' ' 107' ' ' LEU . 1.4 ttp180 -161.32 117.76 2.2 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.524 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 1.9 t-20 -105.54 -153.32 0.49 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.873 -1.142 . . . . 0.0 110.831 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -80.45 -5.4 56.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.748 -0.595 . . . . 0.0 109.536 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -79.71 5.57 13.05 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.233 -0.917 . . . . 0.0 108.952 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 21.9 t-20 52.86 42.91 32.06 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.467 -0.77 . . . . 0.0 109.338 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 2.6 mt-10 -134.82 150.1 50.45 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.865 HD13 HD11 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -110.48 155.09 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.025 -1.047 . . . . 0.0 109.459 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.582 ' HB3' ' CG1' ' A' ' 11' ' ' ILE . 45.0 t80 -103.36 71.68 1.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 0.0 109.29 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.879 HG21 HD12 ' A' ' 33' ' ' LEU . 2.5 mm -81.16 -177.73 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.542 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.797 HG23 ' CA ' ' A' ' 102' ' ' GLY . 0.1 OUTLIER -155.89 144.14 19.99 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.144 -0.972 . . . . 0.0 109.15 179.127 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.65 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -156.64 124.97 5.7 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.994 -178.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 16.5 ptt180 -84.76 46.96 1.31 Allowed 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.178 -0.952 . . . . 0.0 109.372 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.65 ' HB2' ' CZ ' ' A' ' 22' ' ' ARG . . . -82.31 122.1 27.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.163 -0.96 . . . . 0.0 109.687 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.58 -32.97 21.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.366 -0.834 . . . . 0.0 109.192 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 58.7 p30 -102.22 -141.6 0.35 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.401 -0.812 . . . . 0.0 108.977 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 26' ' ' ASP . . . 63.97 82.41 0.18 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.009 -1.057 . . . . 0.0 109.111 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -84.61 144.77 28.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.282 -0.886 . . . . 0.0 109.697 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.471 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 1.3 ttt 63.7 97.65 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.353 -0.842 . . . . 0.0 109.808 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 29' ' ' MET . . . 63.7 131.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.896 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.439 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 1.8 m-20 -119.34 -171.83 2.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 0.0 109.422 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.683 ' C ' HD22 ' A' ' 33' ' ' LEU . 12.1 mttp -92.09 170.19 10.03 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.363 -0.836 . . . . 0.0 108.754 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.879 HD12 HG21 ' A' ' 20' ' ' ILE . 3.0 mm? -105.5 176.66 5.09 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 109.58 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 22' ' ' ARG . 2.8 tt0 -160.97 -160.9 0.78 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 122.246 1.022 . . . . 0.0 110.577 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.636 ' CD1' ' HG3' ' A' ' 117' ' ' PRO . 29.3 m-85 -144.59 84.72 8.95 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.573 ' HG3' ' CB ' ' A' ' 21' ' ' THR . 3.1 Cg_exo -60.13 -150.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.405 2.07 . . . . 0.0 110.208 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 151.08 -168.71 30.75 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -147.46 18.05 1.49 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER 69.34 149.11 0.07 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.35 -1.088 . . . . 0.0 109.919 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.09 131.71 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 42' ' ' MET . 4.8 mt-10 -134.81 -147.82 0.29 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.09 -1.006 . . . . 0.0 110.052 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 41' ' ' GLU . 1.9 ptm -39.7 162.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.559 -0.713 . . . . 0.0 110.137 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.51 -157.08 27.1 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -125.34 -34.86 2.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -1.165 . . . . 0.0 109.426 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.544 ' OG1' ' HD2' ' A' ' 46' ' ' PRO . 0.5 OUTLIER -160.32 171.55 7.02 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 5.0 Cg_exo -59.02 -1.96 1.0 Allowed 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.536 2.157 . . . . 0.0 112.971 -178.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.576 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -102.5 -54.24 2.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.479 -1.388 . . . . 0.0 109.056 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.489 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 2.3 tt0 -63.79 -46.7 84.01 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 122.55 1.167 . . . . 0.0 108.738 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -45.36 -49.63 12.82 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.042 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.729 HG22 ' HH2' ' A' ' 95' ' ' TRP . 3.5 p -79.94 -20.32 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.343 -0.848 . . . . 0.0 110.003 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.615 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -61.04 -50.98 78.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.615 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -57.62 -35.86 71.03 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 113.114 -1.857 . . . . 0.0 109.847 178.691 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.464 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 2.4 mt-10 -64.87 -24.75 67.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.816 -1.178 . . . . 0.0 109.153 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.916 HD13 ' NE1' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -73.53 -70.98 0.34 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.525 -0.735 . . . . 0.0 109.909 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.595 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -59.19 -21.15 58.99 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.974 -0.454 . . . . 0.0 111.504 -178.414 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.464 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 8.8 pt-20 -80.74 1.52 29.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.578 -1.326 . . . . 0.0 110.549 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -135.72 -59.38 0.76 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.927 -1.108 . . . . 0.0 110.982 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.657 ' CG1' ' HB3' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -114.18 -42.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.228 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.595 ' CA ' ' HA ' ' A' ' 55' ' ' GLN . . . 59.42 72.25 0.64 Allowed Glycine 0 C--N 1.293 -1.835 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.85 ' H ' HD11 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -79.78 163.4 3.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.81 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.652 ' CB ' ' HD3' ' A' ' 62' ' ' PRO . 1.3 m -100.91 -68.93 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 120.219 -1.55 . . . . 0.0 110.471 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.652 ' HD3' ' CB ' ' A' ' 61' ' ' THR . 5.6 Cg_endo -70.36 49.31 0.83 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.152 1.901 . . . . 0.0 111.766 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.612 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 1.3 pt20 -83.81 55.73 3.37 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.953 -1.092 . . . . 0.0 109.231 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -62.22 118.02 6.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.185 -0.947 . . . . 0.0 109.278 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.42 ' CB ' ' HA ' ' A' ' 87' ' ' VAL . 48.0 p90 -133.18 -173.52 3.23 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.171 0.986 . . . . 0.0 110.764 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 67' ' ' LEU . 8.0 t -157.51 -4.02 0.1 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.12 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.852 HD22 ' CH2' ' A' ' 83' ' ' TRP . 21.9 tp 55.18 110.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.889 -1.132 . . . . 0.0 110.164 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.837 ' CD2' HD21 ' A' ' 126' ' ' LEU . 0.9 OUTLIER -55.92 -75.07 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.58 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.3 mt-10 -155.25 -169.15 3.07 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.309 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.406 ' HE2' ' CE3' ' A' ' 83' ' ' TRP . 8.0 ttmt -145.86 126.66 14.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.261 -0.9 . . . . 0.0 109.55 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.808 HD23 ' HB ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -112.48 -169.29 1.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.131 -0.981 . . . . 0.0 109.49 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -146.64 140.82 26.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.917 . . . . 0.0 109.216 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.401 ' OH ' ' O ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -129.74 169.93 14.49 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.246 -0.909 . . . . 0.0 109.923 -179.407 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 2.2 tt0 -161.05 113.6 1.92 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.609 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -79.23 175.2 4.99 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.086 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.609 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 1.4 Cg_endo -63.87 2.69 0.94 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.149 1.899 . . . . 0.0 111.88 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.82 -24.96 0.46 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.507 -1.371 . . . . 0.0 111.899 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 1.3 ptt180 -131.65 179.72 5.88 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.611 -1.305 . . . . 0.0 110.974 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.533 ' HB2' ' N ' ' A' ' 4' ' ' LEU . 1.7 m-70 -119.11 135.41 54.66 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.842 HG23 HD13 ' A' ' 6' ' ' ILE . 22.8 mm -146.27 107.99 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.032 -1.043 . . . . 0.0 110.716 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.837 ' OG1' HD13 ' A' ' 4' ' ' LEU . 3.1 m -101.67 105.26 16.15 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.55 HD22 ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -79.89 131.66 35.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.962 -1.086 . . . . 0.0 110.41 -178.55 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.852 ' CH2' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -121.76 124.03 43.24 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.68 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -124.1 119.99 31.07 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.444 -1.41 . . . . 0.0 110.036 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.813 ' CZ3' HG12 ' A' ' 87' ' ' VAL . 18.5 p-90 -100.41 87.97 3.54 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.061 ' CD1' HD12 ' A' ' 10' ' ' ILE . 2.8 mm? -56.35 130.29 44.03 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.571 0.701 . . . . 0.0 110.474 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.869 HG22 ' HA ' ' A' ' 11' ' ' ILE . 3.7 m -103.53 -170.85 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.475 -0.766 . . . . 0.0 109.322 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 1.0 OUTLIER -138.93 -36.09 0.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.914 -1.116 . . . . 0.0 110.643 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -142.72 178.88 7.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.051 -1.031 . . . . 0.0 109.906 -179.52 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.823 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 41.3 p90 168.68 168.47 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.628 1.204 . . . . 0.0 110.74 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.565 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 9.9 tt0 -125.9 99.17 5.82 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.905 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.489 ' O ' ' HD3' ' A' ' 94' ' ' PRO . . . 135.12 -169.25 23.4 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.568 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -99.23 104.98 29.7 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.318 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.652 ' HB3' HD12 ' A' ' 11' ' ' ILE . 4.5 Cg_exo -55.73 178.5 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.257 1.971 . . . . 0.0 112.256 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.916 ' NE1' HD13 ' A' ' 54' ' ' LEU . 3.7 p-90 -125.58 -167.32 1.67 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.797 0.808 . . . . 0.0 109.468 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.35 -32.12 0.08 OUTLIER Glycine 0 N--CA 1.482 1.759 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.552 ' HG3' ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -126.0 -145.27 0.32 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.749 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -115.09 38.56 3.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.133 -0.979 . . . . 0.0 108.834 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.31 55.53 0.76 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.506 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -119.85 151.99 53.17 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.275 -1.132 . . . . 0.0 109.8 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -67.08 98.61 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.355 2.037 . . . . 0.0 110.339 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.797 ' CA ' HG23 ' A' ' 21' ' ' THR . . . -82.35 -171.35 46.44 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -147.46 123.44 10.71 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.957 -1.319 . . . . 0.0 109.471 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.49 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 26.8 m95 -77.99 84.2 4.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.039 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.818 ' HE2' HD11 ' A' ' 33' ' ' LEU . 12.6 ttp -80.46 148.55 30.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 0.0 109.224 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.52 160.7 6.68 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.119 -0.988 . . . . 0.0 109.976 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.928 ' O ' HD13 ' A' ' 107' ' ' LEU . 1.6 tm? -130.63 70.91 1.45 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.2 t -103.14 -43.7 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 109.78 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -139.95 50.91 0.75 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.865 HD11 HD13 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -42.79 141.61 1.05 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.424 -1.045 . . . . 0.0 109.732 -179.632 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.491 ' HB3' ' OD2' ' A' ' 113' ' ' ASP . 4.4 t30 -157.41 -173.88 4.62 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.466 -0.771 . . . . 0.0 108.995 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.458 ' HB2' ' HE3' ' A' ' 127' ' ' LYS . . . -80.77 -10.34 59.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.731 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.491 ' OD2' ' HB3' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -66.57 -37.58 85.25 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.067 -1.021 . . . . 0.0 110.637 -179.167 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.682 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -96.85 27.7 3.84 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.968 -1.083 . . . . 0.0 109.483 -179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.64 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -146.26 89.81 5.85 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.939 . . . . 0.0 109.207 179.593 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.597 ' N ' ' HD3' ' A' ' 117' ' ' PRO . 36.9 Cg_endo -98.93 36.18 0.09 OUTLIER 'Trans proline' 0 CA--C 1.556 1.6 0 C-N-CA 123.58 2.854 . . . . 0.0 115.941 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.727 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 10.5 Cg_endo -73.55 -1.05 10.14 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 121.686 1.591 . . . . 0.0 110.06 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 117' ' ' PRO . . . 80.35 24.98 0.34 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.589 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 66.7 m-20 -107.22 42.0 1.39 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.593 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.2 mt-10 -47.09 -44.12 47.22 Favored Pre-proline 0 C--N 1.296 -1.735 0 O-C-N 121.164 -0.96 . . . . 0.0 112.083 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 5.3 Cg_exo -61.88 -39.18 53.39 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.881 1.721 . . . . 0.0 112.562 -178.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.808 ' HB ' HD23 ' A' ' 71' ' ' LEU . 1.6 t -90.23 -54.95 6.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 O-C-N 120.291 -1.506 . . . . 0.0 107.842 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.89 ' HA ' HD12 ' A' ' 126' ' ' LEU . 11.4 mm -43.84 -33.96 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.47 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -52.33 -52.94 50.38 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -42.86 98.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.51 -0.744 . . . . 0.0 109.787 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.89 HD12 ' HA ' ' A' ' 123' ' ' ILE . 1.9 mt -66.42 -5.32 10.51 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.104 -0.997 . . . . 0.0 110.328 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.47 ' HE3' ' HA ' ' A' ' 124' ' ' ALA . 22.3 mttt -56.41 -49.65 73.88 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.051 -1.031 . . . . 0.0 108.351 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 129' ' ' LEU . 11.6 mtp180 -90.3 34.89 0.86 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.451 -0.781 . . . . 0.0 108.984 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 126' ' ' LEU . 1.2 mt . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.893 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HA ' ' HE2' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 1' ' ' MET . 34.5 mmtt 60.09 -114.74 0.67 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 0.0 109.334 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -166.72 146.87 5.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.706 -1.246 . . . . 0.0 109.84 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.592 HD11 HG12 ' A' ' 80' ' ' ILE . 2.6 pp -153.77 120.78 5.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 109.406 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.535 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . 26.1 mt-30 -133.01 150.61 52.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.201 -0.937 . . . . 0.0 109.853 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.591 HG22 ' N ' ' A' ' 7' ' ' ALA . 9.9 mt -121.76 167.15 15.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.357 -0.839 . . . . 0.0 109.495 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.591 ' N ' HG22 ' A' ' 6' ' ' ILE . . . -132.82 106.02 7.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -0.952 . . . . 0.0 109.543 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.788 HG13 ' O ' ' A' ' 8' ' ' VAL . 8.5 p -122.08 83.88 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.216 -0.927 . . . . 0.0 109.778 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.97 ' H ' HD11 ' A' ' 54' ' ' LEU . . . -68.97 117.22 7.86 Favored Glycine 0 C--N 1.294 -1.786 0 N-CA-C 107.496 -2.242 . . . . 0.0 107.496 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.595 HG22 ' H ' ' A' ' 11' ' ' ILE . 0.7 OUTLIER -76.42 -172.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.071 -1.253 . . . . 0.0 107.688 -179.104 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.963 ' HA ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -144.97 149.53 16.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 117.864 -1.534 . . . . 0.0 111.371 -176.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.51 ' HD2' HD13 ' A' ' 107' ' ' LEU . 10.4 ttp180 -148.53 128.27 13.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.634 ' ND2' ' CH2' ' A' ' 90' ' ' TRP . 1.2 m-20 -98.07 -160.68 0.82 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.817 -1.177 . . . . 0.0 110.74 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 81.3 tt0 -91.56 -6.05 53.04 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.393 0.616 . . . . 0.0 109.367 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.504 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 3.2 t-20 -85.21 14.5 5.13 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.48 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 13.6 t30 58.41 48.24 12.56 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.571 -0.706 . . . . 0.0 109.908 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 105' ' ' MET . 1.4 pt-20 -136.73 171.84 13.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.251 -0.906 . . . . 0.0 109.235 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.487 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 1.3 mt -125.35 157.67 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.932 . . . . 0.0 109.427 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.65 ' CD2' ' CD1' ' A' ' 11' ' ' ILE . 46.0 t80 -106.87 83.13 1.79 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.686 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -79.81 -173.68 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 120.988 -1.07 . . . . 0.0 110.163 -178.292 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.603 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -130.75 142.85 50.43 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.199 -0.601 . . . . 0.0 109.815 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.572 ' HG3' ' CD2' ' A' ' 33' ' ' LEU . 6.1 ttm180 -142.46 161.73 37.29 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.247 -0.908 . . . . 0.0 109.91 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.498 ' NH1' ' CG ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -85.43 56.54 4.0 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.421 -0.799 . . . . 0.0 109.527 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.583 ' O ' ' HB3' ' A' ' 25' ' ' ALA . . . 59.13 176.4 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.063 -1.023 . . . . 0.0 109.296 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . 69.03 -177.1 0.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 109.531 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -125.08 99.07 5.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.232 -0.918 . . . . 0.0 109.4 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.778 ' HB1' ' CB ' ' A' ' 31' ' ' ASN . . . -66.61 129.85 41.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.871 . . . . 0.0 109.546 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -73.39 -149.3 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.257 -0.902 . . . . 0.0 109.402 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.6 mtp -65.01 -17.77 64.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 109.565 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.486 ' O ' ' CB ' ' A' ' 31' ' ' ASN . . . -104.53 -141.39 0.36 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -0.856 . . . . 0.0 109.456 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.778 ' CB ' ' HB1' ' A' ' 27' ' ' ALA . 0.4 OUTLIER 74.12 -163.97 0.09 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.072 -1.018 . . . . 0.0 109.569 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.56 139.28 34.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 109.881 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.595 ' HB2' ' CD1' ' A' ' 115' ' ' PHE . 25.3 mt -105.77 -174.3 2.5 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.379 -0.825 . . . . 0.0 108.943 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.686 ' O ' HD11 ' A' ' 20' ' ' ILE . 3.1 tt0 -161.39 -157.5 0.51 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.564 -1.335 . . . . 0.0 110.732 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.78 ' HB3' HG21 ' A' ' 8' ' ' VAL . 81.1 m-85 -152.65 152.51 28.85 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.758 ' C ' HG23 ' A' ' 8' ' ' VAL . 2.0 Cg_endo -63.08 -151.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.17 1.913 . . . . 0.0 109.861 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 91.79 179.21 41.95 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.45 -40.59 0.05 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -167.19 169.85 12.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.18 -1.188 . . . . 0.0 109.765 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.785 HD12 ' NE1' ' A' ' 83' ' ' TRP . 14.1 tt -133.69 123.94 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.379 -0.825 . . . . 0.0 109.1 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -80.26 130.92 35.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 110.027 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 42' ' ' MET . 31.1 ttp -117.32 72.22 0.83 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 109.105 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.67 1.53 5.18 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -151.59 -71.1 0.16 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.114 -1.227 . . . . 0.0 110.026 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.787 HG23 ' H ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -154.62 168.19 12.44 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 120.904 -1.122 . . . . 0.0 109.776 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.516 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 2.1 Cg_endo -67.88 -27.93 36.62 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.786 2.324 . . . . 0.0 112.103 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 1.06 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -78.56 -69.75 0.54 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.832 -1.167 . . . . 0.0 109.197 -179.208 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.708 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 12.7 tt0 -37.63 -34.66 0.11 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 122.938 1.352 . . . . 0.0 109.078 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.517 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -52.64 -67.72 0.23 Allowed 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.254 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.737 ' CG2' HD12 ' A' ' 54' ' ' LEU . 9.0 p -80.99 -43.87 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.096 -1.003 . . . . 0.0 111.274 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.06 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.3 p -43.6 -48.88 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.449 -0.782 . . . . 0.0 109.168 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.492 ' N ' HG13 ' A' ' 51' ' ' VAL . 1.2 ttt180 -81.39 -26.12 35.71 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.308 -0.87 . . . . 0.0 110.506 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 3.4 mm-40 -72.88 -67.23 0.58 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.748 -1.22 . . . . 0.0 110.674 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.97 HD11 ' H ' ' A' ' 9' ' ' GLY . 14.1 mt -54.06 -38.18 64.99 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.303 -0.873 . . . . 0.0 110.726 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.494 ' O ' ' HA2' ' A' ' 59' ' ' GLY . 10.7 pt20 -67.89 -32.12 72.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.971 -1.08 . . . . 0.0 110.075 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.493 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 1.3 pt-20 -78.59 -4.7 50.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.878 -1.139 . . . . 0.0 109.596 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.34 -49.19 5.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.174 -0.954 . . . . 0.0 109.538 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.838 HG22 HD13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -114.04 -30.07 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.182 -0.949 . . . . 0.0 108.49 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 55' ' ' GLN . . . 74.25 90.2 0.17 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.445 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.02 HD12 ' O ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -114.54 170.53 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.367 -1.078 . . . . 0.0 108.48 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.729 ' CB ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -118.17 -70.4 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.807 -1.183 . . . . 0.0 109.596 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.729 ' HD3' ' CB ' ' A' ' 61' ' ' THR . 10.0 Cg_endo -74.73 40.69 0.65 Allowed 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 122.006 1.804 . . . . 0.0 111.325 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.628 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 0.9 OUTLIER -81.68 59.07 4.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 109.783 -179.219 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -65.62 126.54 28.7 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.734 ' CB ' HG12 ' A' ' 87' ' ' VAL . 4.0 p90 -146.63 -177.42 5.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.738 -1.226 . . . . 0.0 111.755 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.4 m -161.77 143.53 11.33 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 84' ' ' PHE . 36.8 tp -71.49 97.13 1.6 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.604 -1.31 . . . . 0.0 109.792 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.666 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -44.79 -77.96 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.728 ' O ' HG21 ' A' ' 122' ' ' VAL . 0.6 OUTLIER -158.94 125.19 4.53 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -90.57 151.96 21.1 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.141 -0.974 . . . . 0.0 110.112 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.94 HD21 ' OD1' ' A' ' 119' ' ' ASN . 0.7 OUTLIER -116.43 -167.25 1.25 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -160.04 161.9 34.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.896 -1.128 . . . . 0.0 110.275 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -154.46 127.22 8.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.493 -0.754 . . . . 0.0 109.205 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -99.88 122.26 42.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 109.735 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.579 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -84.01 177.97 2.68 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.56 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.579 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 3.9 Cg_exo -56.71 -10.4 5.28 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.828 1.686 . . . . 0.0 111.736 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -161.7 -3.3 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.728 -1.232 . . . . 0.0 112.484 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.543 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -128.1 -172.38 2.67 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.212 -1.555 . . . . 0.0 110.041 -179.111 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -132.03 91.94 3.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.395 -0.816 . . . . 0.0 109.613 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.592 HG12 HD11 ' A' ' 4' ' ' LEU . 11.4 mt -81.84 102.5 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 109.462 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.23 126.05 52.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.738 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.31 150.04 41.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.29 -0.881 . . . . 0.0 109.073 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.785 ' NE1' HD12 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -120.06 149.04 42.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.054 -1.029 . . . . 0.0 109.574 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.563 ' CG ' HG11 ' A' ' 122' ' ' VAL . 6.5 m-85 -113.35 94.41 4.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.222 -0.924 . . . . 0.0 109.221 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.502 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 77.7 m95 -88.51 90.37 8.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.043 -1.036 . . . . 0.0 108.948 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.014 HD21 HD21 ' A' ' 129' ' ' LEU . 10.7 tp -79.28 117.45 20.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.478 -0.763 . . . . 0.0 109.442 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.963 HG22 ' HA ' ' A' ' 11' ' ' ILE . 3.1 m -88.46 -161.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 O-C-N 121.213 -0.93 . . . . 0.0 110.33 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 20.7 mt-10 -147.67 -33.97 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.987 . . . . 0.0 111.231 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.628 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -147.21 164.39 33.32 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.658 -1.276 . . . . 0.0 110.479 -179.134 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.634 ' CH2' ' ND2' ' A' ' 13' ' ' ASN . 13.6 p90 179.19 171.44 0.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 122.029 0.918 . . . . 0.0 109.644 178.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.55 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 77.2 tt0 -116.34 -92.86 0.51 Allowed 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.509 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . -23.76 -91.47 0.01 OUTLIER Glycine 0 N--CA 1.499 2.866 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 1.02 ' O ' HD12 ' A' ' 60' ' ' ILE . 1.6 mt-10 -131.19 166.09 30.34 Favored Pre-proline 0 C--O 1.188 -2.138 0 O-C-N 121.647 -0.913 . . . . 0.0 108.862 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.638 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 6.1 Cg_exo -36.7 -93.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.281 -3.023 0 C-N-CA 123.106 2.537 . . . . 0.0 112.091 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.815 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.0 t90 171.03 -21.6 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.132 -0.98 . . . . 0.0 111.265 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' A' ' 36' ' ' PRO . . . -107.21 -101.21 2.7 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.469 -1.348 . . . . 0.0 109.821 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.487 ' N ' ' HB3' ' A' ' 36' ' ' PRO . 3.0 tttt 41.07 94.12 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.493 -1.004 . . . . 0.0 110.215 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -116.52 52.56 0.92 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.88 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.57 2.35 53.2 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.61 123.34 25.73 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.205 -1.173 . . . . 0.0 109.701 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -60.85 111.4 1.05 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.939 1.759 . . . . 0.0 109.899 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.603 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -93.41 -179.81 39.34 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -138.07 161.18 37.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.073 -1.251 . . . . 0.0 111.137 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.464 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 34.7 m0 -94.73 93.37 7.48 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.526 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -82.45 -173.89 4.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.016 -1.052 . . . . 0.0 109.674 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.05 160.77 15.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.891 . . . . 0.0 109.153 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.877 HD11 HD23 ' A' ' 129' ' ' LEU . 1.8 tp -108.9 45.84 1.01 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.145 -0.972 . . . . 0.0 109.795 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.547 ' O ' HG12 ' A' ' 108' ' ' VAL . 18.2 t -103.39 19.06 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.082 -1.011 . . . . 0.0 108.83 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 132.82 74.05 0.1 OUTLIER Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 110' ' ' LEU . 2.7 mt -43.49 138.77 2.33 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.372 -1.075 . . . . 0.0 109.626 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.44 98.79 11.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.439 -0.788 . . . . 0.0 109.777 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.583 ' CB ' HG22 ' A' ' 123' ' ' ILE . . . -64.59 -21.76 66.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 108.971 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -68.6 -27.79 66.36 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.488 -0.758 . . . . 0.0 109.506 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.506 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 2.8 t0 -78.43 -9.99 59.52 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.687 ' CZ ' ' CZ ' ' A' ' 35' ' ' PHE . 11.0 m-85 -94.03 154.98 40.59 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 108.83 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.545 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 1.2 Cg_endo -71.42 144.7 46.06 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.994 1.796 . . . . 0.0 110.211 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.721 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.2 Cg_endo -64.71 112.71 2.06 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.341 2.028 . . . . 0.0 110.41 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 162.35 -22.56 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 109.84 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.94 ' OD1' HD21 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -119.76 45.25 2.2 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.092 -1.005 . . . . 0.0 109.314 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.68 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 7.1 mt-10 -68.87 -32.77 3.7 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.5 Cg_exo -58.83 -38.78 86.8 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.409 1.406 . . . . 0.0 111.992 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.899 ' HB ' HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -104.37 -38.06 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 120.434 -1.416 . . . . 0.0 108.784 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.583 HG22 ' CB ' ' A' ' 112' ' ' ALA . 7.4 mm -55.25 -38.81 48.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.483 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -55.32 -46.27 76.32 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.522 -0.736 . . . . 0.0 109.292 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -66.85 -33.92 76.67 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.424 -0.798 . . . . 0.0 109.563 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.516 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 4.2 mp -54.32 -25.78 25.84 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.192 -0.942 . . . . 0.0 109.551 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.547 ' HE2' ' HB3' ' A' ' 112' ' ' ALA . 33.7 mttt -58.2 -49.45 77.0 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.454 ' O ' ' C ' ' A' ' 129' ' ' LEU . 6.5 mtp180 -84.62 -1.47 56.05 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.699 -0.625 . . . . 0.0 109.532 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 1.014 HD21 HD21 ' A' ' 86' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.824 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.519 ' CE ' ' O ' ' A' ' 77' ' ' ASP . 10.2 mtm . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -70.22 -82.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.968 -1.083 . . . . 0.0 109.231 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.639 ' N ' ' CE1' ' A' ' 79' ' ' HIS . 0.0 OUTLIER 176.87 117.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.467 -0.77 . . . . 0.0 110.031 179.46 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 4' ' ' LEU . 14.8 tp -97.23 155.87 16.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.325 -0.86 . . . . 0.0 108.885 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.529 ' HG2' ' CZ2' ' A' ' 83' ' ' TRP . 0.9 OUTLIER -145.35 128.38 16.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.041 -1.037 . . . . 0.0 110.834 -179.306 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.701 HG22 ' H ' ' A' ' 7' ' ' ALA . 5.3 mm -102.93 -163.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.319 -0.863 . . . . 0.0 108.807 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.701 ' H ' HG22 ' A' ' 6' ' ' ILE . . . -144.86 117.29 8.52 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.739 -1.225 . . . . 0.0 110.605 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.915 ' CG1' HD12 ' A' ' 82' ' ' LEU . 3.2 p -133.45 129.74 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.108 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.6 ' HA2' ' NE1' ' A' ' 85' ' ' TRP . . . -117.04 119.32 4.43 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.061 HD12 ' CD1' ' A' ' 86' ' ' LEU . 1.2 mt -96.98 159.16 3.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.265 -1.138 . . . . 0.0 108.781 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.907 HD12 ' HG2' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -154.24 146.62 13.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 108.822 -178.773 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.5 ' HB2' HG23 ' A' ' 18' ' ' ILE . 20.9 ttp180 -157.96 84.26 0.87 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.406 -0.809 . . . . 0.0 110.626 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.574 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 11.7 m120 -160.59 179.46 8.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.924 -1.11 . . . . 0.0 109.662 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 2.9 mm-40 81.44 -68.94 0.09 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.888 0.851 . . . . 0.0 109.219 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.502 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 38.4 t-20 -111.15 22.94 14.67 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.431 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 23.4 t-20 49.71 47.52 22.78 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 15' ' ' ASN . 3.7 mt-10 -140.69 147.61 39.52 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 11' ' ' ILE . 1.5 mt -96.97 151.94 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.904 -1.123 . . . . 0.0 110.56 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -100.07 76.96 1.96 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.545 HD11 ' CE1' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -79.7 -178.02 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.952 0.882 . . . . 0.0 110.611 -177.456 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.559 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -114.3 137.17 52.13 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.034 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.505 ' HG3' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -125.88 133.55 51.88 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.963 -1.086 . . . . 0.0 109.683 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.882 ' CZ ' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -49.1 102.09 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.398 -0.814 . . . . 0.0 110.221 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 44.71 -154.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.448 -0.782 . . . . 0.0 109.951 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.7 -79.09 0.21 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.912 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -83.35 169.4 15.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.027 -1.046 . . . . 0.0 109.647 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.882 ' HB2' ' CZ ' ' A' ' 23' ' ' ARG . . . -115.18 163.92 14.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.738 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -93.04 68.96 4.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.214 -0.929 . . . . 0.0 109.344 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.598 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 5.1 mtt 57.28 60.88 2.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 109.572 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 169.77 115.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.343 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.424 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 36.1 m120 -77.0 120.92 22.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 109.355 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -146.6 126.85 13.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.172 -0.955 . . . . 0.0 109.488 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.517 ' O ' ' HG3' ' A' ' 116' ' ' PRO . 7.2 mt -93.45 -165.17 1.28 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -149.53 -163.86 1.89 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.68 -1.263 . . . . 0.0 110.194 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.781 ' CE2' HD11 ' A' ' 123' ' ' ILE . 6.5 m-85 -162.25 -66.62 0.01 OUTLIER Pre-proline 0 C--N 1.292 -1.909 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.769 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.797 ' HA ' HD11 ' A' ' 82' ' ' LEU . 15.3 Cg_exo -40.26 153.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.775 1.65 . . . . 0.0 110.467 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 97' ' ' LYS . . . -110.98 -86.59 1.69 Allowed Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -117.18 -61.07 0.31 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 170.93 175.84 0.06 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.179 -1.189 . . . . 0.0 110.069 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -144.25 102.4 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.53 -3.43 5.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.971 -1.081 . . . . 0.0 109.725 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.441 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 1.2 mpt? -53.06 -27.36 19.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.0 108.976 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.48 15.97 26.92 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 42' ' ' MET . 45.3 mm-40 -86.32 -80.68 0.23 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.539 -0.977 . . . . 0.0 109.782 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.798 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -148.51 177.5 1.77 Allowed Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 120.949 -1.094 . . . . 0.0 109.968 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.798 ' CD ' HG22 ' A' ' 45' ' ' THR . 6.3 Cg_endo -73.77 -40.24 1.51 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.694 2.263 . . . . 0.0 111.063 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.01 -52.85 5.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.324 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.57 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 2.1 tt0 -45.01 -29.1 0.78 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 122.441 1.115 . . . . 0.0 110.026 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.48 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . -72.86 -59.84 2.52 Favored 'General case' 0 C--N 1.271 -2.834 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.576 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.909 HG21 ' NE1' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -81.82 -3.08 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.016 -1.052 . . . . 0.0 111.029 -178.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 4.5 p -81.8 -45.3 20.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.571 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -70.64 -28.57 64.91 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.168 177.515 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.56 ' O ' ' NE1' ' A' ' 95' ' ' TRP . 3.0 mt-10 -76.6 -17.81 58.99 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.594 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.024 HD13 ' HG3' ' A' ' 62' ' ' PRO . 5.7 mt -71.1 -54.96 9.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.482 -0.761 . . . . 0.0 110.432 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.476 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -82.64 -37.11 25.37 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.705 -1.247 . . . . 0.0 111.355 -178.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -80.66 35.03 0.34 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.722 -1.236 . . . . 0.0 111.52 -178.36 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 1.1 mm-40 -149.8 -58.23 0.19 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.581 -1.324 . . . . 0.0 110.098 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.813 HG12 ' CD1' ' A' ' 95' ' ' TRP . 5.2 p -123.07 -10.75 7.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.287 -0.883 . . . . 0.0 108.677 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 60.84 73.09 0.53 Allowed Glycine 0 N--CA 1.486 1.98 0 O-C-N 121.775 -0.578 . . . . 0.0 112.901 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -112.26 179.97 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.289 -1.124 . . . . 0.0 108.428 177.404 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 47.2 m -131.34 86.88 48.95 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 1.024 ' HG3' HD13 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -59.72 129.04 29.07 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.107 1.871 . . . . 0.0 110.572 -177.535 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.452 ' HG3' ' HB3' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -83.69 -37.58 22.57 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.499 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 65' ' ' PHE . 0.8 OUTLIER -168.47 51.6 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.779 -1.2 . . . . 0.0 111.49 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.597 ' CB ' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -46.75 173.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.601 -1.312 . . . . 0.0 109.475 179.19 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -161.26 157.14 25.1 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.565 -0.709 . . . . 0.0 109.651 179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.777 HD12 ' HA ' ' A' ' 85' ' ' TRP . 50.0 tp -112.01 92.85 4.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.186 -0.946 . . . . 0.0 109.19 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.7 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -53.76 -59.52 4.51 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.605 0.717 . . . . 0.0 109.635 -179.471 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.7 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.8 tp10 -168.28 141.41 3.1 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.643 -0.66 . . . . 0.0 110.032 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.451 ' HG3' ' HA ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -121.14 138.94 53.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.426 -0.796 . . . . 0.0 109.008 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -109.88 -171.49 1.85 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.078 -1.014 . . . . 0.0 109.941 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -143.83 175.04 10.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.472 -0.767 . . . . 0.0 108.971 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 80' ' ' ILE . 1.6 t80 -150.13 163.44 38.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.934 -1.103 . . . . 0.0 110.155 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.0 tt0 -142.45 109.14 5.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.409 -0.807 . . . . 0.0 109.19 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.632 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -78.83 173.52 7.57 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.066 -1.021 . . . . 0.0 108.901 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.632 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 5.7 Cg_exo -51.4 -26.07 20.24 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.723 1.615 . . . . 0.0 109.543 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.519 ' O ' ' CE ' ' A' ' 1' ' ' MET . 30.1 t0 -148.16 2.22 0.66 Allowed 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.888 -0.508 . . . . 0.0 110.071 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.503 ' HG3' ' HB3' ' A' ' 75' ' ' PHE . 4.8 mtp180 -122.68 -161.58 0.96 Allowed 'General case' 0 C--N 1.31 -1.142 0 O-C-N 120.9 -1.125 . . . . 0.0 109.547 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.639 ' CE1' ' N ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -162.01 109.46 1.37 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.005 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 73' ' ' TYR . 25.2 mm -99.3 124.85 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.031 -1.043 . . . . 0.0 110.038 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.511 ' HB ' ' HG3' ' A' ' 5' ' ' GLN . 67.6 m -130.08 116.51 18.61 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.915 HD12 ' CG1' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -107.98 153.52 22.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.068 -1.02 . . . . 0.0 110.229 -179.135 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.625 ' O ' HG13 ' A' ' 8' ' ' VAL . 3.2 m95 -110.54 118.17 35.51 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.654 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.1 m-85 -99.97 70.71 1.61 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.123 -0.986 . . . . 0.0 109.362 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.909 ' NE1' HG21 ' A' ' 50' ' ' VAL . 46.5 p-90 -80.28 84.18 5.99 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.138 -1.425 . . . . 0.0 108.889 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.061 ' CD1' HD12 ' A' ' 10' ' ' ILE . 1.6 tp -64.1 121.51 14.35 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.152 0.501 . . . . 0.0 109.918 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.85 HG13 HG23 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -102.96 161.59 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 119.095 -1.042 . . . . 0.0 108.986 179.006 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.46 ' N ' ' CG2' ' A' ' 87' ' ' VAL . 9.0 pm0 -118.35 -24.0 7.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.919 . . . . 0.0 110.768 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.452 ' HB3' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -146.81 152.88 39.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.807 -1.183 . . . . 0.0 110.56 -179.323 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.574 ' CZ3' ' HB2' ' A' ' 13' ' ' ASN . 28.2 p90 -168.64 -173.41 1.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.842 0.829 . . . . 0.0 109.367 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.655 ' O ' HG22 ' A' ' 60' ' ' ILE . 9.4 tt0 -137.18 113.63 10.13 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.357 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.452 ' O ' ' HD3' ' A' ' 94' ' ' PRO . . . 106.65 169.45 22.64 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.6 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -79.13 115.0 49.41 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.296 -1.12 . . . . 0.0 108.935 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.907 ' HG2' HD12 ' A' ' 11' ' ' ILE . 5.5 Cg_endo -73.77 177.03 8.59 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.672 2.248 . . . . 0.0 112.571 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.813 ' CD1' HG12 ' A' ' 58' ' ' VAL . 3.1 p-90 -115.1 -163.01 0.85 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.415 ' N ' ' HE3' ' A' ' 95' ' ' TRP . . . 179.61 -32.7 0.06 OUTLIER Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.418 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -129.2 -163.96 1.35 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.823 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 9.9 pt-20 -55.15 -46.13 75.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.956 -1.09 . . . . 0.0 108.554 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.444 ' C ' ' HD3' ' A' ' 101' ' ' PRO . . . -124.84 -129.73 3.42 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.668 ' N ' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -125.24 42.78 0.79 Allowed Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.01 -1.288 . . . . 0.0 110.971 179.191 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.668 ' HD3' ' N ' ' A' ' 100' ' ' GLN . 6.2 Cg_endo -67.56 -12.9 37.25 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 C-N-CA 121.471 1.448 . . . . 0.0 110.011 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -61.09 179.84 3.05 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -141.99 160.93 39.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.076 -1.249 . . . . 0.0 110.3 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -89.03 103.49 16.1 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.394 -0.817 . . . . 0.0 109.576 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 13.9 ttm -87.44 129.51 35.02 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.306 -0.871 . . . . 0.0 109.515 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.792 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -92.96 72.67 4.76 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.314 -0.867 . . . . 0.0 109.452 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 107' ' ' LEU . 6.0 tp 49.85 50.92 17.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.134 -0.979 . . . . 0.0 109.565 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 106' ' ' SER . 29.3 t -139.2 101.3 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.261 -0.9 . . . . 0.0 109.473 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 114' ' ' ASP . . . 92.99 17.24 44.5 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.92 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -62.64 -18.03 61.49 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.296 -1.12 . . . . 0.0 108.987 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.494 ' ND2' ' HD3' ' A' ' 127' ' ' LYS . 10.2 m-20 -78.3 178.33 7.74 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.738 -0.601 . . . . 0.0 109.461 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.962 ' CA ' HG21 ' A' ' 123' ' ' ILE . . . -67.51 -6.85 21.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.47 -53.03 60.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.249 -0.907 . . . . 0.0 110.11 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.517 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -79.33 -12.78 59.93 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.1 -1.0 . . . . 0.0 108.817 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.615 ' CZ ' ' CZ ' ' A' ' 35' ' ' PHE . 12.8 m-85 -94.59 140.41 22.63 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.517 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 5.7 Cg_exo -63.31 148.4 92.93 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.99 1.794 . . . . 0.0 110.037 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.704 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 3.9 Cg_exo -58.87 118.61 5.52 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.13 1.886 . . . . 0.0 110.33 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 162.37 -24.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.491 -0.756 . . . . 0.0 109.132 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.533 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 0.9 OUTLIER -123.14 43.97 2.8 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.307 -0.871 . . . . 0.0 109.732 -179.583 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.678 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 7.0 mt-10 -66.34 -39.14 24.74 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 112.161 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 2.9 Cg_endo -64.51 -34.55 52.63 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 122.117 1.878 . . . . 0.0 112.371 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.654 HG11 ' CD2' ' A' ' 84' ' ' PHE . 1.1 t -93.76 -50.04 12.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.962 HG21 ' CA ' ' A' ' 112' ' ' ALA . 8.8 mm -49.53 -33.73 7.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -53.24 -47.11 69.32 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -66.73 -28.76 68.67 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.322 -0.861 . . . . 0.0 109.524 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.808 HD12 HD13 ' A' ' 123' ' ' ILE . 11.4 mt -70.74 -10.69 60.01 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.143 -0.973 . . . . 0.0 109.646 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 124' ' ' ALA . 1.3 mmtp -56.76 -52.92 63.14 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.251 -0.906 . . . . 0.0 109.195 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -98.42 26.76 5.21 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.406 -0.809 . . . . 0.0 109.049 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.642 HD21 HD21 ' A' ' 86' ' ' LEU . 2.4 tp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.558 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.93 176.65 5.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.299 -0.875 . . . . 0.0 109.348 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.72 ' C ' HD23 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -106.77 136.15 47.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.525 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.72 HD23 ' C ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -105.56 95.34 5.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.243 -0.911 . . . . 0.0 109.306 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.578 ' HB2' HG21 ' A' ' 40' ' ' ILE . 7.0 mt-30 -96.42 114.03 25.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.229 -0.92 . . . . 0.0 109.509 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.621 HG22 ' H ' ' A' ' 7' ' ' ALA . 3.1 mm -99.42 -175.99 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.248 -0.908 . . . . 0.0 109.231 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.621 ' H ' HG22 ' A' ' 6' ' ' ILE . . . -149.39 101.83 3.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.719 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.826 HG11 ' HB3' ' A' ' 35' ' ' PHE . 10.2 p -108.51 135.06 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.154 -0.966 . . . . 0.0 108.538 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.28 106.56 1.43 Allowed Glycine 0 N--CA 1.484 1.87 0 C-N-CA 119.372 -1.394 . . . . 0.0 109.696 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.826 ' HB ' HD12 ' A' ' 86' ' ' LEU . 1.7 mt -82.89 143.99 10.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.876 HG22 ' CZ3' ' A' ' 90' ' ' TRP . 1.8 mt -131.51 128.97 61.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.819 -177.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 88' ' ' GLU . 5.9 ttp180 -139.75 125.99 20.04 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.464 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 6.0 p30 -118.72 -167.16 1.33 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.983 . . . . 0.0 109.985 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -71.64 -2.39 17.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 109.944 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.486 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 2.3 t-20 -79.78 5.66 12.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.176 -0.952 . . . . 0.0 109.136 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.478 ' OD1' ' HB ' ' A' ' 108' ' ' VAL . 22.6 t30 54.95 46.57 24.07 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.264 -0.898 . . . . 0.0 109.619 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 15' ' ' ASN . 4.5 mt-10 -146.5 133.63 20.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 108.892 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.855 HD11 ' HB2' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -102.16 160.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.221 -0.924 . . . . 0.0 108.801 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 25.8 t80 -118.55 82.03 1.78 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.922 -1.111 . . . . 0.0 108.565 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.627 HD11 ' HB ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -121.04 -160.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.592 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -117.31 138.48 51.73 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.39 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HG3' ' OD1' ' A' ' 31' ' ' ASN . 4.9 ttp180 -133.95 121.49 21.73 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.288 -0.882 . . . . 0.0 109.465 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.584 ' O ' ' CG ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -50.79 106.4 0.13 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.248 -0.907 . . . . 0.0 109.164 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.32 109.98 0.99 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.984 -1.073 . . . . 0.0 109.45 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 27' ' ' ALA . . . -170.0 60.83 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.167 -0.958 . . . . 0.0 109.528 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 28' ' ' HIS . 67.5 m-20 53.39 -90.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.179 -0.951 . . . . 0.0 109.477 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.591 ' CB ' ' ND2' ' A' ' 31' ' ' ASN . . . 43.14 -92.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.408 -0.808 . . . . 0.0 109.727 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.54 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER 78.69 135.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.368 -0.832 . . . . 0.0 109.412 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' A' ' 28' ' ' HIS . 7.4 mtt 65.56 -92.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.327 -0.858 . . . . 0.0 109.406 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.47 95.55 9.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.234 -0.916 . . . . 0.0 109.283 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.591 ' ND2' ' CB ' ' A' ' 27' ' ' ALA . 3.0 t-20 -130.74 175.29 9.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.588 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.44 ' HB3' ' HG3' ' A' ' 116' ' ' PRO . 6.8 mmmt -95.29 125.03 39.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.641 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.571 ' CD1' ' CE2' ' A' ' 115' ' ' PHE . 56.5 mt -107.8 -174.59 2.56 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -160.69 -162.11 0.91 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.027 -1.045 . . . . 0.0 110.878 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.826 ' HB3' HG11 ' A' ' 8' ' ' VAL . 65.5 m-85 -155.18 69.27 5.51 Favored Pre-proline 0 C--N 1.295 -1.788 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.522 ' CD ' ' OG1' ' A' ' 21' ' ' THR . 2.4 Cg_endo -61.74 -81.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.173 1.915 . . . . 0.0 110.409 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 100.49 -150.02 18.74 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -139.8 24.15 2.75 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.614 ' HD2' HG23 ' A' ' 6' ' ' ILE . 2.5 mptt 70.25 148.2 0.07 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -1.143 . . . . 0.0 110.034 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.166 HD11 ' CZ2' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -101.57 119.27 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.459 ' O ' ' C ' ' A' ' 42' ' ' MET . 0.6 OUTLIER -79.06 -159.58 0.19 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.008 -1.058 . . . . 0.0 108.845 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.459 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -42.04 -52.78 4.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.372 -0.83 . . . . 0.0 108.997 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 42' ' ' MET . . . 58.38 122.77 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.236 -1.145 . . . . 0.0 110.236 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -106.53 -9.72 16.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -1.106 . . . . 0.0 108.785 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.678 HG23 ' H ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -160.55 171.54 6.98 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.546 ' HA ' ' CH2' ' A' ' 83' ' ' TRP . 3.7 Cg_exo -61.36 -37.2 74.16 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.294 1.996 . . . . 0.0 111.706 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.678 ' H ' HG23 ' A' ' 45' ' ' THR . 1.0 OUTLIER -86.45 -56.98 3.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.809 -1.182 . . . . 0.0 109.583 -179.624 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.664 ' H ' HG22 ' A' ' 45' ' ' THR . 1.7 tt0 -38.13 -32.28 0.06 Allowed 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.252 1.025 . . . . 0.0 110.049 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 47' ' ' GLU . . . -64.82 -65.29 0.69 Allowed 'General case' 0 C--N 1.272 -2.797 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.66 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.523 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 1.2 p -81.21 -45.45 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.898 -1.126 . . . . 0.0 110.301 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.601 HG13 ' N ' ' A' ' 52' ' ' ARG . 6.1 p -40.62 -47.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.653 -0.654 . . . . 0.0 109.332 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.601 ' N ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -74.61 -34.57 62.85 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.52 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 2.4 mt-10 -60.07 -19.95 55.65 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.903 -1.123 . . . . 0.0 108.363 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.631 ' CD2' ' CH2' ' A' ' 95' ' ' TRP . 13.8 mt -75.31 -68.61 0.54 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.197 0.522 . . . . 0.0 110.381 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.403 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 2.4 pt20 -61.3 -28.62 69.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.775 -1.203 . . . . 0.0 111.637 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 1.2 pp20? -72.88 1.02 9.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.701 -1.249 . . . . 0.0 109.56 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.457 ' HB3' ' HD1' ' A' ' 95' ' ' TRP . 3.5 mm-40 -143.78 -68.74 0.33 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.415 -0.803 . . . . 0.0 109.96 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.701 HG21 ' O ' ' A' ' 93' ' ' GLU . 2.4 p -111.55 -54.59 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.691 -1.255 . . . . 0.0 107.62 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.585 ' N ' ' CG1' ' A' ' 58' ' ' VAL . . . 81.84 47.2 6.36 Favored Glycine 0 N--CA 1.479 1.567 0 O-C-N 121.438 -0.789 . . . . 0.0 113.86 175.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.731 HG21 ' CD1' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -79.68 124.53 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 120.12 1.96 . . . . 0.0 106.403 176.362 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.718 ' H ' ' HD3' ' A' ' 62' ' ' PRO . 8.4 t -149.26 23.77 0.04 OUTLIER Pre-proline 0 C--N 1.279 -2.5 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.718 ' HD3' ' H ' ' A' ' 61' ' ' THR . 2.2 Cg_endo -62.35 -47.15 10.37 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 CA-C-N 120.072 1.061 . . . . 0.0 109.725 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 89' ' ' ARG . 6.2 pt20 -162.88 -31.24 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.962 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.612 ' O ' ' CG ' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -42.76 113.73 0.5 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 122.214 1.007 . . . . 0.0 112.962 -177.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.409 ' CB ' ' O ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER 171.74 130.58 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.159 -0.963 . . . . 0.0 110.044 177.608 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -163.67 -35.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 110.574 179.561 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.601 ' HB2' ' CE3' ' A' ' 85' ' ' TRP . 37.7 tp 39.35 96.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.765 0.793 . . . . 0.0 109.273 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.663 ' CZ ' HD21 ' A' ' 126' ' ' LEU . 30.2 p90 -66.62 -54.03 27.74 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.446 -0.784 . . . . 0.0 110.705 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.61 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER 178.35 134.11 0.08 Allowed 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.247 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.551 ' CB ' ' HB3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -94.69 168.55 10.76 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.498 -0.751 . . . . 0.0 109.79 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.966 HD23 ' HB ' ' A' ' 122' ' ' VAL . 1.2 pp -126.41 -166.53 1.59 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.096 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -160.0 142.62 13.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 109.625 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.416 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -130.03 96.12 4.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.343 -0.848 . . . . 0.0 109.41 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.465 ' HG2' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -84.15 109.39 17.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.4 -0.813 . . . . 0.0 109.297 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.599 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -79.63 179.63 1.76 Allowed Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.599 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 6.0 Cg_endo -75.81 40.76 0.75 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.329 2.019 . . . . 0.0 111.198 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 76' ' ' PRO . 0.1 OUTLIER 172.3 -25.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.712 -1.243 . . . . 0.0 110.214 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -124.44 170.45 10.84 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 109.977 -178.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.465 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 6.1 m80 -126.01 92.11 3.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.438 -0.789 . . . . 0.0 108.969 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.441 ' CD1' HD12 ' A' ' 4' ' ' LEU . 27.1 mm -79.4 137.19 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.29 -0.881 . . . . 0.0 109.503 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.54 84.52 1.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.299 -0.876 . . . . 0.0 109.454 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.625 ' CD1' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -108.09 158.58 17.28 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.348 -0.845 . . . . 0.0 109.407 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 1.166 ' CZ2' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -131.03 151.91 50.9 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.964 -1.085 . . . . 0.0 110.75 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.784 ' CB ' HD11 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.71 120.98 38.18 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.679 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.601 ' CE3' ' HB2' ' A' ' 67' ' ' LEU . 10.9 m95 -96.4 98.09 9.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.002 -1.061 . . . . 0.0 110.202 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.826 HD12 ' HB ' ' A' ' 10' ' ' ILE . 1.0 OUTLIER -68.61 89.5 0.37 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.623 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.827 HG21 HG23 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -60.52 174.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.633 0.73 . . . . 0.0 110.533 -178.106 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' A' ' 12' ' ' ARG . 11.0 mm-40 -97.05 -72.29 0.65 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.049 -0.661 . . . . 0.0 109.371 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.533 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -159.2 148.85 18.77 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.876 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 3.7 p90 -136.95 -171.41 2.93 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.833 -1.167 . . . . 0.0 111.243 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.512 ' H ' ' CG ' ' A' ' 62' ' ' PRO . 15.6 tt0 -128.88 -33.69 2.0 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.68 -134.82 0.11 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.701 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.0 OUTLIER -121.66 132.51 24.21 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.197 -1.178 . . . . 0.0 110.156 -179.378 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.867 ' CB ' HD12 ' A' ' 11' ' ' ILE . 2.4 Cg_endo -71.82 119.53 6.27 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.581 2.187 . . . . 0.0 109.814 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.667 ' CG ' ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -126.31 38.64 4.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.02 -1.05 . . . . 0.0 112.923 -177.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -49.71 -20.42 2.79 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HG2' HG23 ' A' ' 21' ' ' THR . 0.0 OUTLIER -108.73 -171.9 1.94 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.422 -1.046 . . . . 0.0 109.912 -179.646 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -141.5 -41.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.441 -0.787 . . . . 0.0 109.045 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.28 23.87 1.1 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.434 ' CG ' ' HD2' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -102.61 172.05 4.67 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.417 -1.049 . . . . 0.0 109.639 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' A' ' 102' ' ' GLY . 4.9 Cg_endo -70.88 5.54 2.08 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.538 2.159 . . . . 0.0 111.443 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.592 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -39.77 146.91 0.23 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 9.8 pt-20 -161.33 -171.51 3.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.614 -0.933 . . . . 0.0 110.434 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.563 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 20.6 m0 -94.53 100.56 12.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.569 -0.707 . . . . 0.0 109.772 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -84.42 -163.17 0.76 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.142 -0.974 . . . . 0.0 108.908 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.58 103.21 4.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.315 -0.865 . . . . 0.0 109.369 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.855 ' HB2' HD11 ' A' ' 18' ' ' ILE . 18.4 mt -139.57 -78.28 0.32 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.527 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER 67.53 25.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.002 0.906 . . . . 0.0 108.814 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 178.39 44.74 0.07 OUTLIER Glycine 0 N--CA 1.485 1.902 0 N-CA-C 107.187 -2.365 . . . . 0.0 107.187 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.705 HD11 ' CE2' ' A' ' 115' ' ' PHE . 1.1 mt -36.42 153.69 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 O-C-N 122.103 -0.645 . . . . 0.0 109.886 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.667 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 0.7 OUTLIER -134.81 9.01 3.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.139 -0.976 . . . . 0.0 109.667 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 73.91 -9.94 1.17 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.062 -1.024 . . . . 0.0 110.47 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -74.71 -42.1 58.97 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.833 -1.167 . . . . 0.0 109.101 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' CD2' ' A' ' 110' ' ' LEU . 3.4 p30 -78.62 0.61 25.73 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.705 ' CE2' HD11 ' A' ' 110' ' ' LEU . 10.1 m-85 -120.0 106.29 41.44 Favored Pre-proline 0 N--CA 1.485 1.323 0 O-C-N 121.441 -0.787 . . . . 0.0 109.073 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 115' ' ' PHE . 35.4 Cg_exo -40.17 152.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.281 1.988 . . . . 0.0 110.71 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.717 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 5.9 Cg_exo -56.19 -160.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.622 2.215 . . . . 0.0 111.357 -178.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 117' ' ' PRO . . . 82.97 -42.67 0.11 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.73 -0.606 . . . . 0.0 109.674 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.544 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 2.9 m120 -98.0 33.66 2.09 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.087 -1.008 . . . . 0.0 109.357 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.645 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 4.2 mt-10 -62.49 -38.85 49.84 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.374 -0.829 . . . . 0.0 112.688 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.3 Cg_exo -58.89 -41.97 57.12 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.776 1.651 . . . . 0.0 112.314 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.966 ' HB ' HD23 ' A' ' 71' ' ' LEU . 1.1 t -97.43 -47.98 12.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 120.44 -1.412 . . . . 0.0 108.295 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.64 HG22 ' HB2' ' A' ' 112' ' ' ALA . 7.5 mm -47.61 -34.35 3.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.364 -0.835 . . . . 0.0 108.802 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.34 -45.15 72.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.494 -0.754 . . . . 0.0 109.598 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.65 -52.36 65.48 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.228 -0.92 . . . . 0.0 109.849 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.663 HD21 ' CZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -53.98 -15.83 1.6 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.182 -0.949 . . . . 0.0 110.347 -179.234 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.528 ' HE2' ' O ' ' A' ' 111' ' ' ASN . 12.6 mttt -51.41 -51.42 54.91 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.815 -1.178 . . . . 0.0 108.715 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -94.89 46.45 1.13 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.65 HD21 ' CD2' ' A' ' 86' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.777 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.474 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.509 ' HA ' ' CD2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER 64.48 72.13 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -0.835 . . . . 0.0 109.551 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 2' ' ' LYS . 0.2 OUTLIER 167.86 92.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.871 . . . . 0.0 109.693 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -157.85 97.58 1.57 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.36 -0.838 . . . . 0.0 108.887 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.631 ' HB3' HG21 ' A' ' 40' ' ' ILE . 72.1 mt-30 -133.59 142.51 48.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.188 -0.945 . . . . 0.0 110.0 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.636 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.5 mt -149.26 157.7 6.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.462 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -111.84 126.63 55.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.123 -0.986 . . . . 0.0 108.973 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 1.062 HG11 HD21 ' A' ' 82' ' ' LEU . 1.4 p -125.46 83.89 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.918 . . . . 0.0 110.202 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.504 ' HA2' ' CD1' ' A' ' 85' ' ' TRP . . . -74.21 117.42 5.59 Favored Glycine 0 C--N 1.291 -1.952 0 N-CA-C 107.732 -2.147 . . . . 0.0 107.732 178.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.759 HD12 ' CD1' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -97.21 172.19 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 120.973 -1.31 . . . . 0.0 109.755 -178.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.837 HD12 ' HB3' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -140.49 154.82 22.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.438 -0.788 . . . . 0.0 109.211 -179.624 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.501 ' CD ' HD23 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -160.34 68.19 0.36 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.343 -0.848 . . . . 0.0 110.281 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.6 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 20.2 m120 -163.83 -171.58 2.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.185 -0.947 . . . . 0.0 109.628 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 6.1 tt0 83.95 -46.15 0.11 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.86 0.838 . . . . 0.0 109.542 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.427 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 47.7 t30 -142.13 25.2 1.93 Allowed 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.472 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 12.4 t30 55.64 45.85 23.9 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 105' ' ' MET . 4.0 mt-10 -140.41 149.85 43.14 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.099 -1.0 . . . . 0.0 109.386 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.555 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 0.4 OUTLIER -97.95 151.67 4.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.305 -0.872 . . . . 0.0 109.22 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.547 ' HB3' HG12 ' A' ' 11' ' ' ILE . 50.3 t80 -88.54 82.5 6.91 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.605 HG22 ' N ' ' A' ' 21' ' ' THR . 42.2 mm -78.28 167.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.295 -0.878 . . . . 0.0 110.122 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.849 HG21 ' HB2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -121.73 128.36 51.7 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.525 ' N ' ' OE1' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -160.55 106.99 1.51 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.512 -0.743 . . . . 0.0 109.193 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.671 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -49.65 105.89 0.1 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.103 -0.998 . . . . 0.0 109.691 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' A' ' 23' ' ' ARG . . . 73.45 -169.73 0.12 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.156 -0.965 . . . . 0.0 109.465 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 26' ' ' ASP . . . -133.83 -144.34 0.22 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.232 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.592 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 3.1 m-20 64.45 -118.4 0.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.191 -0.943 . . . . 0.0 109.348 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 26' ' ' ASP . . . 68.41 100.89 0.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.735 -1.228 . . . . 0.0 109.408 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -110.78 -44.41 3.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.425 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -45.92 -60.93 1.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.138 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.78 112.92 6.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.11 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -80.25 128.39 33.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.931 . . . . 0.0 109.728 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -134.63 137.74 43.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 109.264 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.561 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 3.1 mt -99.13 -169.68 1.8 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.259 -0.901 . . . . 0.0 108.722 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.49 -156.52 0.48 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.12 -0.987 . . . . 0.0 109.837 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -144.57 158.27 54.08 Favored Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.721 ' C ' HG23 ' A' ' 8' ' ' VAL . 3.1 Cg_exo -55.71 -153.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.186 1.924 . . . . 0.0 109.816 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 163.24 -166.98 37.33 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.564 -1.303 . . . . 0.0 110.009 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . 173.95 -80.12 0.08 OUTLIER Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 9.0 tttt 166.72 136.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.494 -1.004 . . . . 0.0 109.198 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.814 HD11 ' NE1' ' A' ' 83' ' ' TRP . 3.8 mt -115.2 105.77 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 109.158 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.543 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -108.23 17.2 22.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.086 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.543 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 78.85 -137.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.47 -112.27 1.66 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.495 ' HB3' ' OE1' ' A' ' 48' ' ' GLN . 9.7 tt0 -127.99 -38.99 1.79 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.315 -1.109 . . . . 0.0 109.467 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.656 HG23 ' H ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -156.97 167.76 13.88 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.072 -1.017 . . . . 0.0 108.957 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 3.3 Cg_exo -60.25 -18.1 50.27 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.879 2.386 . . . . 0.0 112.851 -177.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.994 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -79.74 -63.12 1.49 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.795 -1.191 . . . . 0.0 109.251 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.629 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 3.2 tt0 -38.02 -32.71 0.07 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.578 1.18 . . . . 0.0 109.626 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 47' ' ' GLU . . . -61.79 -65.51 0.68 Allowed 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.537 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.57 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 4.3 p -80.86 -43.97 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.927 -1.108 . . . . 0.0 110.79 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.994 HG12 ' O ' ' A' ' 47' ' ' GLU . 7.5 p -42.6 -33.52 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HB3' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -75.82 -43.74 44.57 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.566 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.57 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 2.7 pt-20 -70.84 -7.3 44.46 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 118.74 -1.184 . . . . 0.0 108.5 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.718 HD23 ' HE1' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -64.99 -62.56 1.48 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.495 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 25.5 mt-30 -81.56 -24.19 36.7 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.569 -0.707 . . . . 0.0 109.458 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 52' ' ' ARG . 4.1 mm-40 -81.66 31.04 0.35 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.28 -0.887 . . . . 0.0 110.813 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.568 ' HB3' ' CB ' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -148.67 -64.01 0.24 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.696 -1.253 . . . . 0.0 109.863 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.918 HG11 ' C ' ' A' ' 94' ' ' PRO . 1.0 OUTLIER -118.78 -36.79 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.061 -1.025 . . . . 0.0 108.263 178.863 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 89.93 55.08 2.06 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.704 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -82.08 -179.28 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.183 -1.186 . . . . 0.0 109.834 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.795 ' O ' HG23 ' A' ' 61' ' ' THR . 8.6 t -135.41 58.31 25.03 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.704 ' HD3' ' HB ' ' A' ' 60' ' ' ILE . 4.6 Cg_exo -53.8 129.17 32.72 Favored 'Trans proline' 0 C--N 1.29 -2.541 0 C-N-CA 122.35 2.033 . . . . 0.0 111.08 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.554 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 0.7 OUTLIER -81.21 -42.91 20.04 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.463 -179.198 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -160.85 114.96 2.08 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.676 -1.21 . . . . 0.0 111.018 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.488 ' CB ' ' HA ' ' A' ' 87' ' ' VAL . 1.8 p90 -121.98 177.89 5.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -0.846 . . . . 0.0 109.088 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 m -161.31 158.68 27.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.863 HD12 ' HA ' ' A' ' 85' ' ' TRP . 47.5 tp -84.76 96.25 9.2 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.876 -1.14 . . . . 0.0 109.536 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.666 ' HB3' HD23 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -41.76 -76.09 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.837 0.827 . . . . 0.0 108.904 179.267 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.64 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 4.0 tp10 -171.09 126.95 0.69 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 83' ' ' TRP . 8.9 ptpt -89.41 153.49 20.8 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.339 -0.85 . . . . 0.0 110.051 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.907 HD22 ' CG2' ' A' ' 122' ' ' VAL . 0.5 OUTLIER -127.41 -157.36 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.333 -0.854 . . . . 0.0 109.114 178.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.531 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -161.02 165.09 30.39 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.359 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.482 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . 1.1 t80 -152.82 175.39 12.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.543 -0.723 . . . . 0.0 109.174 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -160.43 109.33 1.69 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.665 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.604 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -79.71 177.16 3.09 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.184 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.604 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 6.3 Cg_endo -74.34 31.31 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.496 2.13 . . . . 0.0 111.335 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.29 -39.1 0.05 Allowed 'General case' 0 N--CA 1.482 1.157 0 O-C-N 120.509 -1.369 . . . . 0.0 110.112 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -135.99 -177.22 4.59 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.363 -0.835 . . . . 0.0 110.299 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.509 ' CD2' ' HA ' ' A' ' 2' ' ' LYS . 4.7 m-70 -113.55 126.72 55.6 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.496 HD13 ' N ' ' A' ' 80' ' ' ILE . 1.6 mm -94.6 149.22 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.168 -0.958 . . . . 0.0 109.652 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.1 m -157.21 107.51 2.26 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.062 HD21 HG11 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -136.34 129.02 30.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.149 -0.969 . . . . 0.0 110.1 -178.88 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.814 ' NE1' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -119.05 149.21 42.05 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.237 -0.914 . . . . 0.0 110.108 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.602 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -127.67 123.03 34.53 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.863 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -91.13 80.9 5.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.616 -1.303 . . . . 0.0 109.209 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.759 ' CD1' HD12 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -42.43 121.15 1.85 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.249 -0.907 . . . . 0.0 110.306 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.763 HG22 ' HA ' ' A' ' 11' ' ' ILE . 18.9 m -87.61 170.19 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.517 ' HB3' ' HD2' ' A' ' 89' ' ' ARG . 5.2 mt-10 -122.54 -19.79 6.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.854 -1.153 . . . . 0.0 111.078 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.554 ' HG3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.93 156.64 20.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.597 -1.314 . . . . 0.0 110.238 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.788 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 6.2 p90 177.27 -169.38 0.07 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.096 0.951 . . . . 0.0 110.445 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.643 ' N ' ' CD1' ' A' ' 90' ' ' TRP . 7.2 tt0 -147.53 128.28 14.31 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.839 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 119.85 -165.92 13.48 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.848 -1.167 . . . . 0.0 110.279 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.58 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -111.01 105.07 56.98 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.166 -1.196 . . . . 0.0 109.05 179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.918 ' C ' HG11 ' A' ' 58' ' ' VAL . 4.8 Cg_exo -58.96 176.38 0.47 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.782 2.321 . . . . 0.0 113.066 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.911 ' CD1' HG13 ' A' ' 58' ' ' VAL . 3.8 p-90 -122.57 -161.28 0.93 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.764 0.793 . . . . 0.0 109.834 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.569 ' HA3' ' HB3' ' A' ' 36' ' ' PRO . . . 165.79 -107.31 0.29 Allowed Glycine 0 N--CA 1.481 1.696 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.849 ' HB2' HG21 ' A' ' 21' ' ' THR . 11.1 tttp -60.99 -178.94 0.11 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.981 -1.305 . . . . 0.0 108.568 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.58 -73.35 0.66 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.952 -1.092 . . . . 0.0 109.713 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.96 10.81 56.81 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -110.33 121.99 39.9 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 121.033 -1.275 . . . . 0.0 109.447 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.43 -53.51 0.78 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.144 1.896 . . . . 0.0 111.155 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . 90.29 172.0 44.38 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 7.4 pt-20 -140.5 144.92 36.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.715 -1.462 . . . . 0.0 110.246 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.599 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -89.94 107.25 19.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.332 -0.855 . . . . 0.0 109.208 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 7.4 ttm -96.25 152.08 18.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.128 -0.982 . . . . 0.0 109.671 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.463 ' O ' ' HG ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -108.12 105.47 15.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 109.372 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.757 ' O ' HG12 ' A' ' 108' ' ' VAL . 49.1 mt -147.98 -65.66 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.15 -0.969 . . . . 0.0 109.651 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.757 HG12 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER 77.15 -1.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.484 -0.76 . . . . 0.0 109.821 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -138.99 25.77 2.77 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 107.072 -2.411 . . . . 0.0 107.072 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.712 HD13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -40.11 145.18 0.17 Allowed 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.935 -0.744 . . . . 0.0 110.149 -179.134 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.9 -171.71 1.95 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.371 -0.831 . . . . 0.0 108.991 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.547 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -91.12 10.26 27.64 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.238 -0.914 . . . . 0.0 109.3 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -85.99 -43.83 12.84 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.26 -0.9 . . . . 0.0 109.894 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.498 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -79.31 -14.89 58.71 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.256 -0.903 . . . . 0.0 108.744 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.712 ' CE2' HD13 ' A' ' 110' ' ' LEU . 1.4 m-85 -96.53 140.0 21.95 Favored Pre-proline 0 N--CA 1.489 1.516 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.854 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.505 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 1.8 Cg_endo -67.01 145.07 72.49 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.028 1.819 . . . . 0.0 110.446 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.715 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.8 Cg_endo -63.13 127.48 20.34 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.376 2.051 . . . . 0.0 110.574 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 156.9 -32.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.841 ' OD1' HD21 ' A' ' 71' ' ' LEU . 41.0 m-80 -112.81 46.85 1.16 Allowed 'General case' 0 C--O 1.201 -1.49 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.633 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 15.5 mt-10 -61.14 -41.39 80.56 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.237 -0.914 . . . . 0.0 112.901 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 1.3 Cg_endo -67.3 -29.05 39.15 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.544 2.162 . . . . 0.0 111.736 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.907 ' CG2' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -95.08 -41.25 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.021 -1.049 . . . . 0.0 108.444 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.547 HG22 ' HB2' ' A' ' 112' ' ' ALA . 8.8 mm -58.36 -35.42 53.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.02 -39.25 63.02 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . 20.2 mmtt -80.63 -31.56 36.51 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.41 -0.806 . . . . 0.0 109.803 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 4.3 mp -56.9 -25.13 56.53 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.3 -0.875 . . . . 0.0 109.212 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -56.43 -46.5 80.23 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 129' ' ' LEU . 7.3 mtt180 -84.72 -7.02 59.37 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.721 -0.612 . . . . 0.0 109.476 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 126' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.812 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mmt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.437 ' HD2' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -130.66 169.26 15.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.406 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.8 107.12 9.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.359 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.754 ' HG ' HG22 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -115.48 -177.46 3.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.321 -0.862 . . . . 0.0 109.476 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.751 ' HG3' HG23 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -152.9 159.44 42.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.881 . . . . 0.0 109.387 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.658 HD13 ' HA ' ' A' ' 39' ' ' LYS . 11.6 mm -116.89 168.44 8.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.226 -0.921 . . . . 0.0 109.353 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.61 ' N ' HG22 ' A' ' 6' ' ' ILE . . . -125.74 115.25 19.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.096 -1.002 . . . . 0.0 110.167 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 35' ' ' PHE . 5.8 p -129.54 146.13 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.53 112.33 1.08 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.024 HD12 ' CD1' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -94.25 162.12 2.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.043 HG22 ' CZ3' ' A' ' 90' ' ' TRP . 2.2 mt -146.03 135.95 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 118.319 -1.352 . . . . 0.0 112.037 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 35.1 ttp180 -126.98 129.57 48.36 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.536 ' OD1' ' CZ2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -98.48 -156.95 0.57 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.895 -1.128 . . . . 0.0 111.012 -178.062 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -85.67 -5.51 59.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.753 -0.592 . . . . 0.0 109.758 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.553 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 6.6 t-20 -91.34 23.12 3.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.919 . . . . 0.0 108.839 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.9 t30 48.32 46.38 20.19 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.615 -0.678 . . . . 0.0 110.897 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.553 ' CG ' ' HB3' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -134.2 165.94 23.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.197 -0.94 . . . . 0.0 108.649 178.562 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.826 HG13 HD22 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -116.66 167.65 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.113 -0.992 . . . . 0.0 109.439 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 94' ' ' PRO . 57.3 t80 -120.13 88.21 2.89 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 121.028 -1.045 . . . . 0.0 108.963 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.898 HG21 HD13 ' A' ' 33' ' ' LEU . 9.4 mm -77.81 174.57 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.644 HG21 ' N ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -118.16 128.51 54.78 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.863 -1.148 . . . . 0.0 108.67 178.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 1.4 tpt180 -160.67 122.9 3.17 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.155 -0.966 . . . . 0.0 109.865 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.649 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.3 OUTLIER -86.73 43.51 1.09 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.169 -0.957 . . . . 0.0 109.134 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 167.24 -159.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -0.892 . . . . 0.0 109.659 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -173.21 -170.0 0.59 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 109.631 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.61 154.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.875 . . . . 0.0 109.611 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.567 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . . . -178.46 -62.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.139 -0.976 . . . . 0.0 109.698 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 46.79 40.71 9.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.955 . . . . 0.0 109.543 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.94 -41.41 0.06 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 0.0 109.581 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 31' ' ' ASN . . . -140.62 -38.27 0.44 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.144 -0.972 . . . . 0.0 109.653 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.567 ' OD1' ' HB3' ' A' ' 27' ' ' ALA . 68.3 m-20 57.57 104.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 109.074 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -137.67 128.89 27.74 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.699 -179.538 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.898 HD13 HG21 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -96.51 -174.57 3.07 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 21' ' ' THR . 5.6 mm-40 -119.37 172.88 7.31 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.936 -1.103 . . . . 0.0 110.271 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.657 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -161.12 -66.02 0.02 OUTLIER Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.132 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 35' ' ' PHE . 11.5 Cg_exo -42.81 150.08 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.115 1.21 . . . . 0.0 109.489 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -116.17 -85.89 1.23 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.72 53.52 0.48 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.658 ' HA ' HD13 ' A' ' 6' ' ' ILE . 4.6 mptt 64.75 175.52 0.2 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.44 -1.035 . . . . 0.0 109.716 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.751 HG23 ' HG3' ' A' ' 5' ' ' GLN . 1.3 tt -148.44 79.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.385 -0.822 . . . . 0.0 109.78 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 42' ' ' MET . 0.6 OUTLIER -150.22 148.95 29.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.92 -1.113 . . . . 0.0 110.05 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.476 ' HB3' ' O ' ' A' ' 41' ' ' GLU . 0.5 OUTLIER 164.31 -33.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.19 37.04 0.2 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 48' ' ' GLN . 39.9 mt-10 -131.84 -148.12 0.34 Allowed 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.487 -1.007 . . . . 0.0 109.915 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.821 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -142.66 -176.77 0.59 Allowed Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.215 -0.928 . . . . 0.0 108.695 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.821 ' CD ' HG22 ' A' ' 45' ' ' THR . 1.1 Cg_endo -69.12 -3.17 11.05 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.808 1.672 . . . . 0.0 110.68 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.461 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -108.14 -45.5 3.93 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.001 -1.062 . . . . 0.0 109.165 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.539 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -75.67 -54.83 6.35 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.341 1.067 . . . . 0.0 109.396 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 48' ' ' GLN . . . -38.02 -54.29 1.33 Allowed 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.176 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.499 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 5.3 p -76.12 -31.55 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.141 -0.975 . . . . 0.0 109.119 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.627 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -44.53 -58.05 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.627 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -67.92 -28.87 67.87 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.339 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.541 ' OE2' ' HB1' ' A' ' 7' ' ' ALA . 3.9 mt-10 -56.47 -18.79 12.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.831 -1.168 . . . . 0.0 108.301 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.722 HD13 ' HG3' ' A' ' 62' ' ' PRO . 14.6 mt -68.9 -42.73 76.51 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.372 -0.83 . . . . 0.0 109.056 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -81.25 -41.82 21.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 110.485 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.534 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 14.6 pt-20 -80.94 37.82 0.44 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.023 -1.048 . . . . 0.0 110.98 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.601 ' HB3' ' CG ' ' A' ' 95' ' ' TRP . 58.0 mm-40 -146.69 -55.76 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.881 -1.137 . . . . 0.0 109.204 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.854 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.6 m -143.83 -33.08 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.523 -0.736 . . . . 0.0 109.279 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.46 59.77 1.98 Allowed Glycine 0 N--CA 1.479 1.558 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.617 HG12 ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -95.6 164.91 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.489 -1.006 . . . . 0.0 109.012 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 97.4 m -112.53 83.98 5.95 Favored Pre-proline 0 C--N 1.3 -1.577 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.722 ' HG3' HD13 ' A' ' 54' ' ' LEU . 2.4 Cg_endo -59.48 117.63 4.39 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.439 2.093 . . . . 0.0 110.246 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.561 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 1.2 mt-30 -79.55 -28.02 41.25 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.559 -0.713 . . . . 0.0 109.183 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.437 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 12.5 t-160 -171.1 117.17 0.45 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.936 -1.102 . . . . 0.0 111.037 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.613 ' HB2' HG12 ' A' ' 87' ' ' VAL . 11.3 p90 -129.66 171.19 12.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.245 -0.909 . . . . 0.0 109.586 178.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.18 161.4 24.97 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.382 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.793 HD12 ' HA ' ' A' ' 85' ' ' TRP . 27.0 tp -109.31 108.78 19.49 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.87 ' CZ ' HD21 ' A' ' 126' ' ' LEU . 27.1 p90 -69.62 -56.62 6.78 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.308 -0.87 . . . . 0.0 111.117 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.645 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 3.3 tp10 -172.23 144.68 1.63 Allowed 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.348 -0.845 . . . . 0.0 109.857 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.591 ' HD3' ' CE3' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -111.59 158.11 19.61 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.336 -0.853 . . . . 0.0 110.549 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.806 HD23 ' HB ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -113.02 -165.08 0.96 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.428 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 1.7 pt-20 -149.07 133.96 17.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.822 -1.174 . . . . 0.0 110.353 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.617 ' HB2' HD11 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -96.29 117.74 31.42 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.277 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -110.94 99.76 8.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.156 -0.965 . . . . 0.0 109.547 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.55 ' HB2' ' HG3' ' A' ' 78' ' ' ARG . 5.1 m-85 -79.49 170.17 17.15 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 2.2 Cg_endo -62.87 -2.39 3.54 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.01 1.807 . . . . 0.0 111.516 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -143.18 -20.62 0.63 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.692 -1.255 . . . . 0.0 111.764 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.55 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -126.63 163.18 24.02 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.663 -1.273 . . . . 0.0 110.642 -178.495 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -127.35 74.24 1.5 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.754 HG22 ' HG ' ' A' ' 4' ' ' LEU . 0.9 OUTLIER -78.91 -174.85 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.352 -0.843 . . . . 0.0 110.576 -178.83 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 72' ' ' GLU . 3.0 m -151.01 153.62 35.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.421 -0.799 . . . . 0.0 109.209 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.528 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -129.34 143.1 50.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.083 -1.011 . . . . 0.0 109.324 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.638 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -133.11 128.91 37.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 109.837 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.734 ' CE1' HG11 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -121.83 101.16 7.4 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.702 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.793 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -79.89 83.44 5.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.188 -0.945 . . . . 0.0 110.594 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.024 ' CD1' HD12 ' A' ' 10' ' ' ILE . 3.4 tp -52.38 114.02 1.23 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 109.574 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.033 HG21 HG23 ' A' ' 11' ' ' ILE . 8.5 m -85.11 -163.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.218 -0.926 . . . . 0.0 109.581 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 12' ' ' ARG . 76.3 mt-10 -137.57 -31.82 0.78 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.113 -0.992 . . . . 0.0 110.355 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.561 ' HG3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -161.95 175.5 11.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.82 -1.175 . . . . 0.0 110.019 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 1.043 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 42.3 p90 -179.6 -168.24 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.081 0.943 . . . . 0.0 110.362 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.512 ' HB3' ' HB ' ' A' ' 61' ' ' THR . 17.4 tt0 -141.27 96.46 2.99 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.913 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.56 ' CA ' HG22 ' A' ' 60' ' ' ILE . . . 144.34 -152.12 24.05 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.273 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.854 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -106.51 112.36 63.76 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.22 -1.165 . . . . 0.0 109.601 -179.5 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.997 ' CB ' HD12 ' A' ' 11' ' ' ILE . 3.6 Cg_endo -56.81 130.71 41.35 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.155 2.57 . . . . 0.0 113.661 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.638 ' HE1' HD23 ' A' ' 54' ' ' LEU . 33.7 p-90 -107.01 -168.96 1.47 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 165.11 -15.72 0.09 OUTLIER Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.988 -1.577 . . . . 0.0 111.242 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.644 ' N ' HG21 ' A' ' 21' ' ' THR . 11.3 tttp -117.49 -99.15 0.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.829 -1.395 . . . . 0.0 109.765 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 97' ' ' LYS . 1.3 tt0 -134.81 28.11 3.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.22 -0.925 . . . . 0.0 109.407 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.79 22.9 19.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.483 ' HG2' ' HD2' ' A' ' 101' ' ' PRO . 2.0 mt-30 -103.15 166.88 11.06 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.136 -1.214 . . . . 0.0 109.619 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.483 ' HD2' ' HG2' ' A' ' 100' ' ' GLN . 1.1 Cg_endo -64.94 128.19 20.23 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.346 2.031 . . . . 0.0 110.513 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.553 ' HA3' ' CZ ' ' A' ' 19' ' ' PHE . . . -104.05 174.14 22.1 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.453 ' HA ' ' OE1' ' A' ' 103' ' ' GLU . 45.6 mm-40 -112.87 151.56 30.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.891 -1.358 . . . . 0.0 110.672 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.602 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -103.25 101.09 11.01 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.042 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.517 ' SD ' ' N ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -100.55 -166.81 1.36 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.974 -1.079 . . . . 0.0 110.002 -179.437 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -111.9 151.86 28.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 109.825 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.904 HD21 ' O ' ' A' ' 129' ' ' LEU . 7.0 tt -61.94 -27.58 68.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.44 -0.787 . . . . 0.0 110.183 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 109' ' ' GLY . 62.6 t -65.24 112.7 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.189 -0.945 . . . . 0.0 109.433 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 108' ' ' VAL . . . 45.1 40.71 7.42 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.826 HD22 HG13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -51.82 -42.69 62.72 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.476 -1.014 . . . . 0.0 110.127 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.781 ' HB2' HD12 ' A' ' 123' ' ' ILE . 1.6 p30 -130.28 -165.68 1.57 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.378 -0.826 . . . . 0.0 110.071 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.844 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . 87.48 -25.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -120.43 -37.72 3.0 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.334 -0.854 . . . . 0.0 108.937 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.465 ' O ' HD23 ' A' ' 33' ' ' LEU . 9.8 t0 -96.3 0.86 51.42 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.414 -0.804 . . . . 0.0 109.002 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.608 ' CE1' ' HB3' ' A' ' 111' ' ' ASN . 1.7 m-85 -91.46 164.57 24.01 Favored Pre-proline 0 N--CA 1.489 1.501 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.498 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.529 ' HD2' ' CD2' ' A' ' 115' ' ' PHE . 1.3 Cg_endo -67.7 142.21 57.39 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.949 1.766 . . . . 0.0 109.794 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.699 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.6 Cg_endo -64.53 96.78 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.26 1.973 . . . . 0.0 110.31 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 161.3 -21.42 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.387 -0.821 . . . . 0.0 109.765 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.552 ' HB3' HG13 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -97.51 29.88 3.11 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.135 -0.978 . . . . 0.0 109.411 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.672 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 22.5 mt-10 -68.79 -34.2 5.08 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.47 -0.769 . . . . 0.0 112.891 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.0 Cg_exo -58.6 -37.38 94.69 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.545 1.497 . . . . 0.0 111.674 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.806 ' HB ' HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -101.79 -47.83 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.633 -1.292 . . . . 0.0 107.863 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.844 HG21 ' HA ' ' A' ' 112' ' ' ALA . 12.4 mm -47.81 -31.1 2.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.507 -0.745 . . . . 0.0 109.013 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 127' ' ' LYS . . . -52.92 -49.86 65.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.388 -0.82 . . . . 0.0 108.857 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -41.31 92.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.453 -0.78 . . . . 0.0 109.263 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.87 HD21 ' CZ ' ' A' ' 68' ' ' PHE . 10.9 mt -57.13 -13.78 3.31 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.232 -0.917 . . . . 0.0 109.768 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.612 ' HE2' ' HB1' ' A' ' 112' ' ' ALA . 25.1 mttt -61.7 -46.04 91.37 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.701 -1.249 . . . . 0.0 108.816 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 129' ' ' LEU . 14.9 mtm180 -88.45 11.87 15.84 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.425 -0.797 . . . . 0.0 109.563 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.904 ' O ' HD21 ' A' ' 107' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.402 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.46 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.6 mmtm -67.44 -99.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.356 -0.84 . . . . 0.0 110.204 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.64 ' C ' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -123.89 -159.38 0.86 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 110.19 -179.084 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.64 HD23 ' C ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -157.13 -97.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.443 -0.786 . . . . 0.0 109.895 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.709 ' OE1' HG21 ' A' ' 81' ' ' THR . 1.8 mt-30 -63.66 154.25 33.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.151 -0.968 . . . . 0.0 110.847 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.549 ' CG2' ' N ' ' A' ' 7' ' ' ALA . 5.1 mm -141.79 171.26 11.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.549 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . -132.23 89.96 2.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.797 -1.189 . . . . 0.0 109.848 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.644 HG23 ' C ' ' A' ' 36' ' ' PRO . 7.2 p -100.98 164.41 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.229 -0.919 . . . . 0.0 109.67 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -147.87 114.43 0.69 Allowed Glycine 0 N--CA 1.48 1.603 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.693 HD12 HD13 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -97.21 123.43 49.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.69 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.063 HD12 ' HB3' ' A' ' 94' ' ' PRO . 3.4 mt -117.8 153.21 19.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.201 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.516 ' CZ ' ' OE2' ' A' ' 88' ' ' GLU . 9.1 tpp180 -78.08 -147.41 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.912 0 O-C-N 120.965 -1.085 . . . . 0.0 108.763 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.564 ' CB ' ' HB2' ' A' ' 17' ' ' GLU . 0.9 OUTLIER -146.55 -11.46 0.46 Allowed 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.34 -0.85 . . . . 0.0 111.656 -179.174 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 13' ' ' ASN . 0.6 OUTLIER 82.97 -36.23 0.08 Allowed 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.603 -0.686 . . . . 0.0 109.274 -178.256 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 16' ' ' ASN . 14.9 t-20 -94.45 26.14 3.56 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.542 ' HB3' ' O ' ' A' ' 15' ' ' ASN . 18.8 t-20 71.16 37.17 1.25 Allowed 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.815 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.564 ' HB2' ' CB ' ' A' ' 13' ' ' ASN . 3.6 mt-10 -127.86 -163.5 1.27 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.639 -1.288 . . . . 0.0 109.353 178.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.588 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 1.1 mt -151.65 154.33 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.816 -1.178 . . . . 0.0 109.737 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 82.7 t80 -95.19 66.28 2.91 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.782 HG23 ' N ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -81.73 -156.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.849 0.833 . . . . 0.0 110.736 -177.826 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.98 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -145.51 147.1 31.77 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.385 0.612 . . . . 0.0 109.721 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 24' ' ' ALA . 0.7 OUTLIER -109.89 -158.14 0.64 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.293 -0.879 . . . . 0.0 110.144 -179.453 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.491 ' NH1' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -49.62 88.87 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.567 -0.708 . . . . 0.0 110.047 -179.729 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . -114.18 -2.33 13.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.517 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.36 -57.41 1.48 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.159 -0.963 . . . . 0.0 109.405 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.12 -71.98 0.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.878 . . . . 0.0 109.679 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.48 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . . . 57.75 77.03 0.3 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.12 -0.987 . . . . 0.0 109.054 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -86.81 131.76 34.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 110.205 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.479 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 1.2 mtp 66.32 119.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.811 . . . . 0.0 110.21 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 29' ' ' MET . . . 63.55 169.43 0.15 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.37 -0.831 . . . . 0.0 109.634 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.452 ' O ' ' HE3' ' A' ' 32' ' ' LYS . 1.5 m-20 -83.62 149.65 26.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.39 -0.819 . . . . 0.0 109.418 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HG3' ' HG3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -137.38 146.14 44.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.292 179.804 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.98 HD23 ' O ' ' A' ' 21' ' ' THR . 0.7 OUTLIER -105.1 -174.15 2.47 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.209 -0.932 . . . . 0.0 109.341 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -162.02 -155.34 0.37 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.988 0.899 . . . . 0.0 109.985 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.594 ' HB3' HG21 ' A' ' 8' ' ' VAL . 17.9 m-85 -132.26 131.32 22.33 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.644 ' C ' HG23 ' A' ' 8' ' ' VAL . 5.3 Cg_exo -57.41 -157.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.071 1.847 . . . . 0.0 111.004 -178.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.556 ' CA ' ' HA ' ' A' ' 8' ' ' VAL . . . 85.2 154.55 22.63 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.99 -31.82 0.15 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.412 ' HA ' HD13 ' A' ' 6' ' ' ILE . 6.5 ttpt -171.15 161.94 6.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.815 -1.403 . . . . 0.0 110.529 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.742 HG13 ' HB1' ' A' ' 49' ' ' ALA . 2.9 tt -136.25 98.29 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.474 -0.766 . . . . 0.0 109.151 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 42' ' ' MET . 7.0 mt-10 -81.56 -173.51 4.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.207 -0.933 . . . . 0.0 110.122 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 12.8 mtt 63.62 -94.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.47 -0.769 . . . . 0.0 109.594 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.01 31.73 4.64 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -71.54 0.44 Allowed 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.601 -0.94 . . . . 0.0 109.463 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.853 HG23 ' HD2' ' A' ' 46' ' ' PRO . 24.2 m -133.84 144.01 49.97 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.054 -1.029 . . . . 0.0 109.08 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.853 ' HD2' HG23 ' A' ' 45' ' ' THR . 2.0 Cg_endo -55.66 -8.63 2.14 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.69 2.26 . . . . 0.0 112.33 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.713 ' H ' HG22 ' A' ' 45' ' ' THR . 0.5 OUTLIER -103.06 -36.26 8.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.762 -1.211 . . . . 0.0 108.686 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.499 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -62.0 -50.72 70.93 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.598 1.19 . . . . 0.0 108.811 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.742 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -38.23 -60.61 0.76 Allowed 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.339 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.715 HG21 ' CD1' ' A' ' 85' ' ' TRP . 2.3 p -71.95 -29.84 34.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.018 -1.051 . . . . 0.0 109.923 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.626 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -42.55 -56.33 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 122.039 0.923 . . . . 0.0 108.781 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.626 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -65.87 -33.34 75.63 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.39 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 5.8 mt-10 -73.08 -5.02 36.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.113 -0.992 . . . . 0.0 109.416 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.782 HD11 ' CH2' ' A' ' 85' ' ' TRP . 3.7 mt -79.92 -62.88 1.55 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 0.0 109.43 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.511 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 3.0 mm100 -81.94 -23.64 36.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.205 -0.935 . . . . 0.0 110.999 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -80.58 17.79 1.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.688 -1.257 . . . . 0.0 110.816 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.597 ' HB3' ' CD1' ' A' ' 95' ' ' TRP . 1.6 mt-10 -130.59 -65.3 0.8 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.673 -1.267 . . . . 0.0 110.003 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.852 HG21 ' O ' ' A' ' 93' ' ' GLU . 2.8 m -121.92 -26.47 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 108.907 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 95.99 59.7 1.05 Allowed Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.746 HG12 ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -95.84 174.01 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -1.172 . . . . 0.0 110.7 -179.527 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.722 ' N ' ' CD ' ' A' ' 62' ' ' PRO . 10.3 t -144.99 41.22 0.3 Allowed Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.722 ' CD ' ' N ' ' A' ' 61' ' ' THR . 4.8 Cg_exo -43.29 122.39 2.94 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.711 2.274 . . . . 0.0 110.852 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -98.89 -5.85 30.07 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.352 -178.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.71 39.31 2.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.165 -1.584 . . . . 0.0 111.952 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.593 ' CA ' HG23 ' A' ' 87' ' ' VAL . 45.0 p90 -79.9 168.07 19.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.63 -1.294 . . . . 0.0 110.52 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.5 m -164.38 145.23 8.15 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.571 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 84' ' ' PHE . 44.7 tp -73.91 98.1 2.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.562 -1.336 . . . . 0.0 108.897 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.712 ' CE2' HG12 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -44.77 -80.14 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.748 0.785 . . . . 0.0 108.981 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.582 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 16.0 mt-10 -152.9 164.45 37.88 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.297 0.57 . . . . 0.0 109.809 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 13.4 ttpp -134.33 108.87 8.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.996 -1.065 . . . . 0.0 110.214 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.77 HD23 HG22 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -98.55 -167.82 1.55 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.177 -0.952 . . . . 0.0 109.32 179.284 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -149.62 146.32 27.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.92 . . . . 0.0 109.689 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 74' ' ' GLU . 47.7 t80 -136.01 152.69 51.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 108.988 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 52.6 tt0 -143.2 115.05 8.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.552 ' HB2' ' HG3' ' A' ' 78' ' ' ARG . 3.9 m-85 -78.94 172.31 10.23 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.3 Cg_exo -59.61 -7.37 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.814 1.676 . . . . 0.0 111.453 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.46 ' O ' ' CG ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -154.27 -8.51 0.14 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.819 -1.175 . . . . 0.0 112.186 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.552 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -130.93 178.52 6.61 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.282 -1.511 . . . . 0.0 109.92 -179.158 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.55 ' O ' ' HA ' ' A' ' 4' ' ' LEU . 27.6 m80 -125.4 161.99 25.81 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.355 -0.84 . . . . 0.0 108.977 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 80' ' ' ILE . 34.7 mm -149.99 74.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 110.005 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.709 HG21 ' OE1' ' A' ' 5' ' ' GLN . 18.7 m -79.64 136.91 36.94 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.714 HD23 ' CE1' ' A' ' 84' ' ' PHE . 12.5 tp -132.98 150.26 52.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.965 -1.085 . . . . 0.0 110.676 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.637 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -123.45 109.67 14.14 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.139 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.714 ' CE1' HD23 ' A' ' 82' ' ' LEU . 3.0 m-85 -79.73 88.41 5.2 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.14 -0.975 . . . . 0.0 109.865 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.782 ' CH2' HD11 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -86.59 74.91 9.79 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 123.514 1.626 . . . . 0.0 107.135 178.323 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.693 HD13 HD12 ' A' ' 10' ' ' ILE . 8.0 tp -67.17 133.85 50.59 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.431 -177.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.629 HG22 ' N ' ' A' ' 88' ' ' GLU . 7.3 p -144.28 168.61 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.476 -0.765 . . . . 0.0 109.197 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.629 ' N ' HG22 ' A' ' 87' ' ' VAL . 7.0 mt-10 -144.36 -18.95 0.55 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.916 -1.115 . . . . 0.0 111.923 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -110.85 141.88 43.63 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.313 -1.492 . . . . 0.0 109.303 -179.526 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.616 ' CD1' ' CG2' ' A' ' 60' ' ' ILE . 14.3 p90 178.62 -172.57 0.14 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.502 1.144 . . . . 0.0 111.002 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.475 ' N ' ' CD1' ' A' ' 90' ' ' TRP . 15.3 tt0 -147.14 85.98 1.62 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.798 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 168.46 -156.04 27.17 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.852 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -117.04 102.42 52.84 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.281 -1.129 . . . . 0.0 109.889 -179.296 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 1.063 ' HB3' HD12 ' A' ' 11' ' ' ILE . 31.9 Cg_exo -39.26 128.27 1.51 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 123.388 2.725 . . . . 0.0 113.289 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.794 ' HB3' HG13 ' A' ' 58' ' ' VAL . 2.0 p-90 -105.09 -164.83 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 154.61 92.95 0.09 OUTLIER Glycine 0 C--N 1.298 -1.537 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.541 ' HB2' ' N ' ' A' ' 37' ' ' GLY . 17.8 tttm 58.89 105.99 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.365 -1.08 . . . . 0.0 109.907 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -68.76 105.51 2.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.255 -0.903 . . . . 0.0 109.345 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.403 ' O ' ' HD3' ' A' ' 101' ' ' PRO . . . 132.1 -11.75 5.32 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.447 ' HG2' ' CB ' ' A' ' 24' ' ' ALA . 1.5 tt0 -101.46 108.58 56.01 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 121.347 -1.09 . . . . 0.0 109.157 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 99' ' ' GLY . 2.0 Cg_endo -61.89 89.99 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.068 1.845 . . . . 0.0 110.62 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -86.99 177.56 47.92 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.414 ' OE2' ' CZ ' ' A' ' 22' ' ' ARG . 14.1 pt-20 -159.11 177.6 10.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.65 -1.5 . . . . 0.0 111.108 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.485 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 35.0 m0 -87.88 110.95 20.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.698 -0.627 . . . . 0.0 109.799 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 30.5 ttp -101.75 144.46 30.41 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.273 -0.892 . . . . 0.0 108.804 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.36 131.1 41.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.937 . . . . 0.0 109.869 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.649 ' CD1' HD23 ' A' ' 129' ' ' LEU . 0.4 OUTLIER -107.08 57.5 0.63 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.297 -0.877 . . . . 0.0 109.247 179.653 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.98 -19.35 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 178.29 49.01 0.07 OUTLIER Glycine 0 N--CA 1.487 2.04 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 109' ' ' GLY . 0.7 OUTLIER -37.31 143.31 0.1 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.954 -0.733 . . . . 0.0 110.441 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -148.67 -174.5 4.63 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.461 -0.775 . . . . 0.0 109.092 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.623 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . -80.41 5.56 14.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 109.325 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -74.08 -48.54 29.07 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.305 -0.872 . . . . 0.0 110.079 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.755 ' O ' HD12 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -79.66 -15.24 57.95 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.228 -0.92 . . . . 0.0 108.941 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -102.86 130.77 23.13 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.624 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.534 ' CG ' ' O ' ' A' ' 33' ' ' LEU . 1.8 Cg_endo -62.93 158.97 40.33 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.035 1.824 . . . . 0.0 110.082 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.7 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 3.1 Cg_exo -59.49 -172.8 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.43 2.087 . . . . 0.0 110.937 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' A' ' 117' ' ' PRO . . . 77.73 -0.71 2.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.502 -0.749 . . . . 0.0 109.775 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.606 ' HB3' HG12 ' A' ' 123' ' ' ILE . 2.0 m-80 -133.66 49.03 2.31 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.103 -0.998 . . . . 0.0 109.776 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.647 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 4.6 mm-40 -75.46 -39.98 3.24 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 112.52 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 2.1 Cg_endo -64.54 -25.85 62.38 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.948 1.765 . . . . 0.0 111.837 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.77 HG22 HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -104.01 -50.85 8.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 120.79 -1.194 . . . . 0.0 109.115 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.71 ' HA ' HD12 ' A' ' 126' ' ' LEU . 19.7 mm -55.15 -37.98 45.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -49.57 -40.61 39.07 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.529 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -80.1 -35.23 37.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.53 -0.731 . . . . 0.0 109.776 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' A' ' 123' ' ' ILE . 9.5 mt -73.25 -4.12 31.08 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.191 -0.943 . . . . 0.0 109.825 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 110' ' ' LEU . 11.1 mttt -64.23 -49.05 73.48 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.277 -0.889 . . . . 0.0 109.185 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.27 -0.75 42.22 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.373 -0.83 . . . . 0.0 109.339 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.649 HD23 ' CD1' ' A' ' 107' ' ' LEU . 2.3 tp . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.716 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.153 0.501 . . . . 0.0 109.664 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.69 33.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.829 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.4 74.21 0.68 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.95 . . . . 0.0 109.895 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 4' ' ' LEU . 28.2 tp -131.84 103.58 6.4 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.576 -0.703 . . . . 0.0 109.29 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.544 ' HB2' HG21 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -125.31 148.49 48.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.081 -1.012 . . . . 0.0 109.558 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.645 HG22 ' H ' ' A' ' 7' ' ' ALA . 5.5 mm -107.04 178.37 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.248 -0.908 . . . . 0.0 109.409 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.645 ' H ' HG22 ' A' ' 6' ' ' ILE . . . -139.29 96.63 3.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 109.616 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.812 HG21 ' HB3' ' A' ' 35' ' ' PHE . 11.8 p -121.22 135.36 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 110.257 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.32 115.94 2.79 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.587 ' HB ' HD13 ' A' ' 86' ' ' LEU . 1.5 mt -84.28 157.83 3.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.792 ' O ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -127.29 148.72 32.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.897 -1.127 . . . . 0.0 110.137 -178.068 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.484 ' HD3' HD12 ' A' ' 18' ' ' ILE . 32.9 ttp180 -153.26 115.87 4.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.699 -0.625 . . . . 0.0 109.319 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.74 -153.65 0.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.087 -1.008 . . . . 0.0 109.751 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.587 ' CG ' ' NH1' ' A' ' 89' ' ' ARG . 51.8 mt-10 -89.07 -5.13 58.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.749 . . . . 0.0 109.882 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.538 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 55.6 t30 -94.72 33.64 1.43 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 15' ' ' ASN . 1.8 m120 33.74 41.46 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.59 0.71 . . . . 0.0 110.814 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 15' ' ' ASN . 5.0 mt-10 -119.94 128.81 53.94 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.792 HG22 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -105.7 150.21 8.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.643 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 13.6 t80 -98.24 81.7 2.82 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.721 HG23 ' N ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -93.09 -157.9 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 110.177 -178.58 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.721 ' N ' HG23 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -125.01 169.2 12.35 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.201 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -160.57 -154.33 0.37 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 120.821 -1.174 . . . . 0.0 110.453 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -44.22 103.47 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.648 -0.657 . . . . 0.0 109.971 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -138.63 22.87 2.69 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.454 -0.779 . . . . 0.0 109.244 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 24' ' ' ALA . . . 179.21 92.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.267 -0.896 . . . . 0.0 109.433 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER 44.97 76.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 109.307 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 23' ' ' ARG . . . -170.8 86.73 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.192 -0.942 . . . . 0.0 109.584 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -116.39 -14.32 10.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.08 -1.012 . . . . 0.0 109.622 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.729 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 3.5 ttm -107.17 134.62 50.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.138 -0.976 . . . . 0.0 109.575 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 29' ' ' MET . . . 83.99 -22.27 0.23 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.7 -0.625 . . . . 0.0 110.084 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 30' ' ' ALA . 3.4 m-20 59.52 116.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.017 -1.052 . . . . 0.0 109.477 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -131.08 136.15 48.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.361 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.566 ' CB ' ' O ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -135.59 -179.53 5.7 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.151 -0.968 . . . . 0.0 109.41 179.633 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -164.53 -154.96 0.26 Allowed 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.545 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.812 ' HB3' HG21 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -122.95 93.39 48.4 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.511 ' CD ' ' OG1' ' A' ' 21' ' ' THR . 5.9 Cg_exo -57.11 -153.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.501 2.134 . . . . 0.0 110.749 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 140.1 -153.84 23.58 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -148.94 23.62 1.28 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 73.58 160.58 0.23 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.134 . . . . 0.0 109.215 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.544 HG21 ' HB2' ' A' ' 5' ' ' GLN . 2.9 tt -102.07 129.24 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.197 -0.939 . . . . 0.0 109.347 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -126.54 -70.54 0.72 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.945 . . . . 0.0 109.554 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.48 108.61 20.13 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.405 0.622 . . . . 0.0 109.376 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.12 141.28 3.43 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.1 -10.59 15.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -1.142 . . . . 0.0 109.984 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.791 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -146.24 177.23 1.84 Allowed Pre-proline 0 N--CA 1.486 1.353 0 O-C-N 120.963 -1.086 . . . . 0.0 109.87 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.791 ' CD ' HG22 ' A' ' 45' ' ' THR . 6.3 Cg_endo -74.55 -4.93 16.18 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.466 2.111 . . . . 0.0 110.548 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.477 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 2.9 mt-10 -105.36 -37.28 6.9 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.202 -0.936 . . . . 0.0 108.884 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.453 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -73.04 -57.52 3.98 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.362 1.077 . . . . 0.0 108.868 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 53' ' ' GLU . . . -46.11 -43.12 14.57 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.52 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.609 ' CG2' ' CE3' ' A' ' 85' ' ' TRP . 14.5 p -79.79 -27.64 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.378 -0.827 . . . . 0.0 109.175 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.631 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -54.44 -57.93 5.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.631 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -81.22 -25.01 37.02 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.418 -178.385 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.597 ' CG ' ' HA ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -81.08 -31.58 34.31 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.003 -1.686 . . . . 0.0 111.457 -177.564 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.895 HD11 ' C ' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -79.86 -42.34 24.44 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.008 -1.058 . . . . 0.0 109.995 -179.321 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.483 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 1.7 mt-30 -67.96 -34.45 76.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.013 -1.054 . . . . 0.0 109.901 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.52 -9.68 58.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.033 -1.042 . . . . 0.0 110.132 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.495 ' OE1' ' CA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -101.2 -64.06 1.08 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.089 -1.007 . . . . 0.0 109.675 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.583 HG21 ' HA ' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -101.85 -29.16 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.457 -0.777 . . . . 0.0 109.158 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 59.5 53.48 45.74 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.691 HG22 ' H ' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -92.43 -165.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.547 ' HB ' ' CB ' ' A' ' 91' ' ' GLU . 98.8 m -137.51 91.04 14.38 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.595 -1.316 . . . . 0.0 109.418 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.611 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 1.8 Cg_endo -63.93 157.22 53.88 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.33 2.02 . . . . 0.0 110.809 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -120.73 -45.39 2.4 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 110.037 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.87 104.24 3.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.997 -1.064 . . . . 0.0 109.759 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.8 OUTLIER -134.84 172.29 13.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.197 -0.94 . . . . 0.0 110.317 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.59 151.99 17.5 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.897 HD12 ' O ' ' A' ' 84' ' ' PHE . 27.1 tp -70.27 100.64 1.74 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.906 -1.121 . . . . 0.0 109.594 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.651 ' HE2' HG13 ' A' ' 122' ' ' VAL . 0.7 OUTLIER -43.43 -77.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.74 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.662 ' O ' HG21 ' A' ' 122' ' ' VAL . 2.3 tt0 -169.15 114.87 0.58 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.775 -0.578 . . . . 0.0 109.572 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -86.35 163.65 17.53 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.371 -0.831 . . . . 0.0 110.119 -179.623 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.984 HD23 ' HB ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -126.13 -165.69 1.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.702 ' HG3' HG23 ' A' ' 81' ' ' THR . 3.5 tt0 -153.42 145.92 24.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.011 -1.056 . . . . 0.0 110.278 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.59 174.44 10.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 109.06 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 13.9 tt0 -155.63 113.68 3.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.147 -0.97 . . . . 0.0 109.623 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.595 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -79.59 -178.35 1.09 Allowed Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.724 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.595 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 4.8 Cg_endo -73.2 30.51 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.109 1.873 . . . . 0.0 111.486 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.464 ' OD2' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -162.52 -44.69 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.376 -1.452 . . . . 0.0 110.51 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.464 ' HG2' ' OD2' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -133.16 -178.18 4.86 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.163 -0.961 . . . . 0.0 110.069 -178.662 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 1.5 m-70 -108.3 121.52 45.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.9 mt -90.28 88.26 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.052 -1.03 . . . . 0.0 109.639 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.702 HG23 ' HG3' ' A' ' 72' ' ' GLU . 1.3 m -85.28 120.63 26.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.288 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.48 ' HG ' ' HB ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -120.77 138.21 54.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.552 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.525 ' CD1' ' O ' ' A' ' 6' ' ' ILE . 1.4 m95 -96.43 165.27 12.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.371 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.897 ' O ' HD12 ' A' ' 67' ' ' LEU . 2.5 m-85 -130.59 74.62 1.61 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.915 . . . . 0.0 109.261 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.696 ' HD1' HD13 ' A' ' 67' ' ' LEU . 2.9 m0 -79.68 86.43 5.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.193 -0.942 . . . . 0.0 109.741 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.587 HD13 ' HB ' ' A' ' 10' ' ' ILE . 28.4 tp -88.37 106.32 18.17 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 10' ' ' ILE . 16.3 m -87.75 177.21 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.028 -1.045 . . . . 0.0 110.235 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -132.58 -23.44 2.08 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.395 -0.816 . . . . 0.0 110.118 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.587 ' NH1' ' CG ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -147.87 148.84 31.28 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 120.841 -1.162 . . . . 0.0 110.944 -179.503 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.634 ' NE1' ' O ' ' A' ' 92' ' ' GLY . 4.1 p90 -166.4 -172.26 2.16 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.663 0.744 . . . . 0.0 109.579 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' CB ' ' HB ' ' A' ' 61' ' ' THR . 5.3 tt0 -92.76 -84.1 0.29 Allowed 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.837 -178.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.691 ' H ' HG22 ' A' ' 60' ' ' ILE . . . -46.59 178.83 0.01 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.802 ' N ' ' CD ' ' A' ' 94' ' ' PRO . 1.6 tt0 -87.32 -25.5 0.33 Allowed Pre-proline 0 N--CA 1.502 2.168 0 O-C-N 121.222 -1.164 . . . . 0.0 114.078 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.802 ' CD ' ' N ' ' A' ' 93' ' ' GLU . 49.3 Cg_endo -94.51 -159.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.951 0 C-N-CA 124.333 3.355 . . . . 0.0 110.566 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.895 ' C ' HD11 ' A' ' 54' ' ' LEU . 3.1 t90 150.59 35.88 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 123.551 0.741 . . . . 0.0 110.815 176.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -135.13 -105.85 0.84 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -93.92 146.1 24.15 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.358 -1.084 . . . . 0.0 108.884 179.34 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -101.54 133.44 46.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 109.369 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.25 -11.09 72.15 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.463 ' CG ' ' HD2' ' A' ' 101' ' ' PRO . 8.4 tp60 -88.64 138.94 29.6 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.433 -1.039 . . . . 0.0 108.888 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 102' ' ' GLY . 6.3 Cg_exo -57.48 -78.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.98 1.787 . . . . 0.0 110.916 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.671 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . 51.87 174.49 0.03 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.6 OUTLIER -160.27 176.57 11.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.606 -1.526 . . . . 0.0 111.437 -178.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.562 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 3.9 m0 -95.8 144.85 25.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.783 -0.573 . . . . 0.0 109.869 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.523 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.6 ttm -110.37 -176.0 2.87 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.512 ' O ' HG23 ' A' ' 108' ' ' VAL . 29.1 t -131.57 32.79 4.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.846 -1.159 . . . . 0.0 110.342 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.503 ' C ' ' O ' ' A' ' 106' ' ' SER . 1.0 OUTLIER 33.04 59.4 0.44 Allowed 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.141 0.496 . . . . 0.0 109.988 179.419 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 106' ' ' SER . 70.9 t -108.87 -40.42 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.163 -0.961 . . . . 0.0 109.779 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -149.79 35.71 1.0 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 109' ' ' GLY . 1.0 OUTLIER -45.48 138.45 4.34 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.208 -1.172 . . . . 0.0 109.207 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -160.91 154.13 21.59 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.256 -0.902 . . . . 0.0 109.852 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.429 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -60.47 -14.64 20.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -0.892 . . . . 0.0 109.039 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.94 -41.85 97.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.898 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.539 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.5 t0 -77.82 -10.57 59.62 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.445 ' CG ' HD12 ' A' ' 123' ' ' ILE . 8.6 m-85 -103.79 106.53 53.02 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.506 ' HG2' ' O ' ' A' ' 33' ' ' LEU . 11.7 Cg_exo -48.37 158.47 1.01 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.804 1.67 . . . . 0.0 110.047 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.725 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 6.1 Cg_exo -56.71 -173.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.185 1.923 . . . . 0.0 110.86 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 117' ' ' PRO . . . 84.39 -21.08 0.27 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.81 -0.556 . . . . 0.0 110.118 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.884 ' OD1' HD21 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -124.27 39.89 3.86 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.932 -1.105 . . . . 0.0 109.869 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.694 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.9 mm-40 -71.76 -33.99 2.83 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 112.712 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.9 Cg_exo -61.79 -36.31 74.33 Favored 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 121.842 1.695 . . . . 0.0 112.088 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.984 ' HB ' HD23 ' A' ' 71' ' ' LEU . 1.2 t -100.92 -43.53 10.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 O-C-N 120.498 -1.376 . . . . 0.0 108.399 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.694 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 22.5 mm -54.6 -32.92 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 O-C-N 121.494 -0.754 . . . . 0.0 109.41 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.92 -39.55 26.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.544 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.45 -33.17 36.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.361 -0.837 . . . . 0.0 110.909 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.943 HD12 HD11 ' A' ' 129' ' ' LEU . 4.4 mm? -47.86 -31.4 5.02 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.907 -1.121 . . . . 0.0 109.801 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -60.78 -52.28 65.77 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.53 ' O ' ' C ' ' A' ' 129' ' ' LEU . 4.7 mtt180 -82.19 10.1 7.46 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.472 -0.767 . . . . 0.0 109.275 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.943 HD11 HD12 ' A' ' 126' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 117.937 -1.03 . . . . 0.0 111.023 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.53 ' CB ' ' NE2' ' A' ' 79' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 1' ' ' MET . 2.7 mptt 71.45 105.75 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.58 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.51 117.07 2.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.484 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 4' ' ' LEU . 12.3 tp -119.6 139.23 52.51 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.274 -0.892 . . . . 0.0 109.131 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.899 ' HG2' HG21 ' A' ' 40' ' ' ILE . 3.4 tt0 -143.68 158.95 43.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.208 -0.933 . . . . 0.0 109.433 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.606 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -123.04 167.43 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.097 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.734 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -129.93 93.23 3.46 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.07 -1.019 . . . . 0.0 109.609 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.694 HG13 ' HB3' ' A' ' 84' ' ' PHE . 7.5 p -102.32 155.65 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.209 -0.932 . . . . 0.0 109.861 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.464 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -140.4 125.49 2.91 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.097 HD12 HD22 ' A' ' 86' ' ' LEU . 1.0 OUTLIER -104.37 155.85 5.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.006 -1.291 . . . . 0.0 107.565 -179.632 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.136 HG22 ' CZ3' ' A' ' 90' ' ' TRP . 2.0 mt -147.03 138.39 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.518 -1.364 . . . . 0.0 111.504 -176.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 23.4 ttp180 -140.46 127.53 20.86 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.72 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.5 p30 -108.09 -169.46 1.52 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.258 -0.901 . . . . 0.0 110.66 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.68 -5.3 19.48 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.56 -0.712 . . . . 0.0 110.075 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.1 7.32 7.66 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.457 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 18.0 t30 53.75 44.56 29.44 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.776 0.798 . . . . 0.0 109.759 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 4.9 mt-10 -140.85 153.41 45.74 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.9 mt -119.56 163.71 16.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.99 -1.069 . . . . 0.0 109.453 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -116.78 98.59 6.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.835 -1.166 . . . . 0.0 109.192 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 21' ' ' THR . 0.8 OUTLIER -119.76 -159.72 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.618 ' H ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -121.08 132.86 55.13 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.023 -1.048 . . . . 0.0 109.521 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.46 ' HD2' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -145.21 132.16 20.24 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.304 -0.873 . . . . 0.0 109.682 -179.49 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -69.55 87.02 0.47 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.264 -0.898 . . . . 0.0 109.555 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.87 87.69 0.25 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.839 . . . . 0.0 109.512 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 26' ' ' ASP . . . -154.77 54.94 0.67 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.952 . . . . 0.0 109.447 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.558 ' OD2' ' CD2' ' A' ' 28' ' ' HIS . 10.3 t70 74.01 74.52 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.671 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.85 53.68 0.68 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.938 . . . . 0.0 109.365 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.558 ' CD2' ' OD2' ' A' ' 26' ' ' ASP . 31.7 p80 -93.81 -33.01 13.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.327 -0.858 . . . . 0.0 109.493 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.9 ppp? -69.56 -23.1 63.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.906 . . . . 0.0 109.584 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -165.85 121.24 1.26 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 109.7 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -83.3 144.43 29.71 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.271 -0.893 . . . . 0.0 108.941 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.505 ' HB2' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -159.0 134.96 8.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.018 -1.051 . . . . 0.0 110.059 -179.425 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.541 ' CD1' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -115.11 -170.11 1.69 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.274 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.4 ' O ' ' CG2' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -162.97 -164.48 0.98 Allowed 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.868 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.515 ' CE2' ' CD2' ' A' ' 84' ' ' PHE . 48.7 m-85 -132.37 106.37 13.32 Favored Pre-proline 0 C--N 1.291 -1.949 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.495 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 2.8 Cg_exo -54.94 -149.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.986 1.79 . . . . 0.0 110.659 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 151.67 154.53 6.62 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -130.15 28.27 3.89 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 4.3 mptp? 74.35 160.18 0.23 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.615 -0.933 . . . . 0.0 109.238 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.899 HG21 ' HG2' ' A' ' 5' ' ' GLN . 2.4 tt -155.34 58.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.322 -0.861 . . . . 0.0 109.222 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 42' ' ' MET . 3.9 mm-40 -84.32 -127.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.298 -0.877 . . . . 0.0 109.314 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.425 ' C ' ' O ' ' A' ' 41' ' ' GLU . 4.6 mtp -44.66 163.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.858 -1.151 . . . . 0.0 109.629 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.6 -131.08 3.43 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.531 ' CB ' ' OE1' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -132.3 -64.44 0.77 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.144 -1.209 . . . . 0.0 109.553 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.828 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -146.19 -178.09 0.74 Allowed Pre-proline 0 C--N 1.305 -1.369 0 O-C-N 121.369 -0.832 . . . . 0.0 108.821 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.828 ' CD ' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -68.09 -10.76 29.89 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.945 1.763 . . . . 0.0 110.338 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -100.76 -56.15 2.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.335 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.564 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.9 tt0 -58.5 -40.18 82.11 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.608 1.194 . . . . 0.0 108.741 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.59 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -43.38 -60.02 1.88 Allowed 'General case' 0 C--N 1.273 -2.719 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.446 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.574 HG13 ' CH2' ' A' ' 85' ' ' TRP . 9.8 p -81.45 -11.52 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.473 -0.767 . . . . 0.0 110.88 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.608 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -66.04 -50.44 69.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.608 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -59.55 -35.73 74.8 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.279 177.171 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.45 ' HA ' ' HB2' ' A' ' 56' ' ' GLU . 25.7 mt-10 -73.02 -21.23 60.86 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.767 HD23 ' HE1' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -60.84 -55.89 27.65 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.523 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 10.6 mt-30 -80.79 -22.57 39.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 109.742 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 53' ' ' GLU . 2.5 mt-10 -80.67 17.31 1.16 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.096 -1.003 . . . . 0.0 110.455 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.627 ' HB3' ' CD1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -137.75 -61.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.873 -1.142 . . . . 0.0 109.892 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.737 HG22 ' CD1' ' A' ' 95' ' ' TRP . 4.3 m -128.59 -34.03 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 109.704 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 90.94 36.2 6.83 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.746 ' CD1' HD13 ' A' ' 11' ' ' ILE . 17.1 pt -92.53 -166.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.053 -1.263 . . . . 0.0 109.521 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.759 ' N ' ' CD ' ' A' ' 62' ' ' PRO . 0.6 OUTLIER 93.05 13.77 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.292 -179.274 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.759 ' CD ' ' N ' ' A' ' 61' ' ' THR . 3.5 Cg_endo -63.75 -22.84 69.52 Favored 'Trans proline' 0 C--N 1.326 -0.615 0 CA-C-N 119.909 1.003 . . . . 0.0 110.401 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.617 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 7.1 mm100 -86.78 -68.7 0.73 Allowed 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.617 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 0.4 OUTLIER 167.52 158.27 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.21 0.529 . . . . 0.0 110.545 179.739 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.689 ' HB2' HG12 ' A' ' 87' ' ' VAL . 29.4 p90 -141.99 171.22 14.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.318 -0.864 . . . . 0.0 109.118 177.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' O ' ' A' ' 86' ' ' LEU . 73.2 m -163.77 128.76 2.91 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.036 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.946 HD13 ' CZ3' ' A' ' 83' ' ' TRP . 0.6 OUTLIER -80.21 124.95 29.25 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.604 -1.31 . . . . 0.0 108.898 179.08 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.653 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 27.9 p90 -73.2 -52.18 15.05 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.55 -0.719 . . . . 0.0 109.701 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.653 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 2.4 tt0 176.74 138.74 0.06 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.656 -0.652 . . . . 0.0 109.808 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.41 165.6 11.15 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.07 -1.019 . . . . 0.0 109.029 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.031 HD21 ' OD1' ' A' ' 119' ' ' ASN . 0.4 OUTLIER -129.44 -170.1 2.23 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.352 -0.842 . . . . 0.0 109.456 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.738 ' HG3' HG23 ' A' ' 81' ' ' THR . 19.1 tt0 -145.6 146.6 31.42 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.423 -0.798 . . . . 0.0 109.194 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.499 ' N ' ' HG2' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -144.84 79.92 1.61 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.422 -0.799 . . . . 0.0 109.36 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.4 OUTLIER -81.69 114.58 20.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 109.34 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.547 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -79.45 176.69 3.49 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 1.7 Cg_endo -63.3 -8.77 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 121.67 1.58 . . . . 0.0 109.734 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -102.69 -66.87 0.9 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.402 -0.811 . . . . 0.0 110.881 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.418 ' HA ' ' HB3' ' A' ' 1' ' ' MET . 0.1 OUTLIER -129.04 -171.62 2.53 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.192 -0.942 . . . . 0.0 110.686 -177.865 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.557 ' N ' ' CD2' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -105.49 88.18 2.78 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.3 mm -81.71 118.2 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 109.474 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.738 HG23 ' HG3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -119.05 146.56 44.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.606 HD22 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -131.14 123.94 29.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 108.893 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.946 ' CZ3' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -119.0 124.29 46.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.363 -0.835 . . . . 0.0 110.082 -177.759 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.694 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -129.07 103.17 6.84 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 120.489 -1.382 . . . . 0.0 109.975 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.78 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -82.42 98.9 9.12 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.706 0.765 . . . . 0.0 109.156 179.331 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.097 HD22 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -63.14 118.52 8.03 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.735 -1.228 . . . . 0.0 109.712 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.067 ' CG2' HG23 ' A' ' 11' ' ' ILE . 19.3 m -81.24 -167.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 120.95 -1.094 . . . . 0.0 109.686 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 8.9 mt-10 -125.14 -45.76 1.84 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.165 -0.959 . . . . 0.0 110.49 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.541 ' HB3' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -160.94 171.2 19.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.183 -0.948 . . . . 0.0 109.963 -179.245 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 1.136 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 38.8 p90 -170.14 -175.02 1.88 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.2 1.0 . . . . 0.0 111.052 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.617 ' N ' ' HG2' ' A' ' 62' ' ' PRO . 2.6 tt0 -120.69 -34.5 3.57 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.381 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.678 ' CA ' HG22 ' A' ' 60' ' ' ILE . . . -80.18 -155.93 11.78 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 121.092 -1.005 . . . . 0.0 110.911 -178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.696 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -105.31 127.97 27.54 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.437 -1.037 . . . . 0.0 109.456 -179.648 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.967 ' HB3' HD12 ' A' ' 11' ' ' ILE . 2.8 Cg_endo -58.74 133.83 56.58 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.432 2.088 . . . . 0.0 111.705 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.767 ' HE1' HD23 ' A' ' 54' ' ' LEU . 4.8 p-90 -110.56 -171.74 1.89 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.923 -1.111 . . . . 0.0 108.49 178.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . 146.18 -42.91 0.92 Allowed Glycine 0 C--N 1.296 -1.679 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 100' ' ' GLN . 1.1 ptmm? -66.08 126.48 28.76 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.651 -0.911 . . . . 0.0 109.781 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -93.57 -49.56 5.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.198 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.91 5.58 5.42 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.528 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 1.3 mt-30 -109.09 160.57 27.0 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.27 -1.135 . . . . 0.0 109.43 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 102' ' ' GLY . 1.9 Cg_endo -66.21 -30.43 46.05 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.156 1.904 . . . . 0.0 111.427 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . 56.66 162.55 0.03 OUTLIER Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -161.58 -168.7 2.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.66 -1.494 . . . . 0.0 110.503 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.505 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 31.9 m95 -107.47 132.34 53.32 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.556 -0.715 . . . . 0.0 109.219 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.493 ' HE1' HD22 ' A' ' 33' ' ' LEU . 30.2 ttp -108.29 147.63 31.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.268 -0.895 . . . . 0.0 109.217 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.528 ' OG ' HG23 ' A' ' 108' ' ' VAL . 45.6 t -83.66 138.71 33.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.891 -1.131 . . . . 0.0 109.126 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.446 HD12 HD11 ' A' ' 18' ' ' ILE . 3.1 tt -108.29 59.73 0.61 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.211 -0.931 . . . . 0.0 109.411 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.528 HG23 ' OG ' ' A' ' 106' ' ' SER . 2.1 t -93.44 19.31 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 145.03 49.85 0.03 OUTLIER Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.848 HD23 ' OD2' ' A' ' 114' ' ' ASP . 1.1 mt -41.59 142.59 0.6 Allowed 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.694 -0.886 . . . . 0.0 109.317 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 2.4 t-20 -133.71 155.9 48.92 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 109.51 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.563 ' HB2' ' HE2' ' A' ' 127' ' ' LYS . . . -63.64 -19.02 64.53 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.271 -0.893 . . . . 0.0 108.747 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 113' ' ' ASP . 26.3 t0 -93.0 22.5 4.9 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.429 -0.795 . . . . 0.0 109.487 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.848 ' OD2' HD23 ' A' ' 110' ' ' LEU . 0.5 OUTLIER -78.16 -1.61 33.5 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.551 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -160.5 160.32 25.89 Favored Pre-proline 0 C--N 1.3 -1.553 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.291 177.814 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 32' ' ' LYS . 74.7 Cg_exo -36.69 124.6 0.39 Allowed 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.828 2.352 . . . . 0.0 110.403 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.716 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 4.6 Cg_exo -58.55 144.2 97.42 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 122.561 2.174 . . . . 0.0 111.382 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 156.67 -19.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 1.031 ' OD1' HD21 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -119.88 42.15 2.99 Favored 'General case' 0 C--O 1.205 -1.286 0 O-C-N 121.316 -0.865 . . . . 0.0 109.368 -179.364 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.639 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 6.0 mt-10 -60.16 -39.12 66.05 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 120.949 -1.094 . . . . 0.0 113.243 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 5.2 Cg_exo -62.29 -46.8 11.38 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.229 1.953 . . . . 0.0 113.011 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.859 ' HB ' HD23 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -90.22 -30.09 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.417 -1.427 . . . . 0.0 108.95 -178.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.644 HD12 ' CE1' ' A' ' 115' ' ' PHE . 1.6 mm -64.06 -34.38 68.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.502 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -60.95 -20.38 62.19 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.419 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.73 -61.75 1.88 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.399 -0.813 . . . . 0.0 110.985 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 1.009 ' HB2' HD13 ' A' ' 129' ' ' LEU . 0.6 OUTLIER -78.82 22.69 0.36 Allowed 'General case' 0 C--N 1.31 -1.137 0 O-C-N 120.803 -1.186 . . . . 0.0 111.403 -178.672 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.563 ' HE2' ' HB2' ' A' ' 112' ' ' ALA . 5.3 mtmt -65.91 -35.57 81.0 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.652 -1.28 . . . . 0.0 107.932 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.534 ' O ' ' C ' ' A' ' 129' ' ' LEU . 9.0 mtm180 -78.77 -0.03 28.76 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.897 -0.502 . . . . 0.0 110.03 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 1.009 HD13 ' HB2' ' A' ' 126' ' ' LEU . 4.3 tp . . . . . 0 N--CA 1.5 2.032 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.882 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.483 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -116.51 -141.99 0.37 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 109.432 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -158.51 119.49 3.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.052 -1.03 . . . . 0.0 109.699 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 79' ' ' HIS . 0.7 OUTLIER -119.67 138.29 53.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 109.169 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.678 ' O ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -133.09 147.41 52.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.735 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 7' ' ' ALA . 4.4 mt -121.98 168.61 14.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.325 -0.86 . . . . 0.0 108.895 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.559 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . -135.74 98.31 3.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.123 -0.986 . . . . 0.0 109.618 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.599 HG22 ' N ' ' A' ' 9' ' ' GLY . 7.3 p -106.92 161.89 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.811 . . . . 0.0 109.366 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.599 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -141.33 121.21 1.83 Allowed Glycine 0 C--N 1.297 -1.621 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.582 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -94.33 156.6 3.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.034 HG22 ' CZ3' ' A' ' 90' ' ' TRP . 2.2 mt -143.15 124.1 10.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 118.486 -1.286 . . . . 0.0 111.308 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.548 ' HD3' ' CG1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -122.21 136.31 54.89 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.268 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.401 ' N ' ' HG3' ' A' ' 12' ' ' ARG . 25.0 p30 -109.12 -169.37 1.47 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 0.0 110.179 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -81.12 0.21 37.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.682 -0.636 . . . . 0.0 109.327 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.446 ' OD1' ' OE2' ' A' ' 17' ' ' GLU . 6.5 t-20 -89.34 12.82 15.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.282 -0.886 . . . . 0.0 109.063 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.582 ' ND2' HG23 ' A' ' 108' ' ' VAL . 18.4 t30 57.41 44.07 22.1 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.768 0.795 . . . . 0.0 109.224 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 3.4 mt-10 -143.25 149.21 37.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.091 -1.006 . . . . 0.0 109.038 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.548 ' CG1' ' HD3' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -128.19 151.24 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.094 -1.004 . . . . 0.0 109.864 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.582 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 21.8 t80 -85.97 66.83 9.78 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.839 HG23 ' N ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -83.91 -155.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.102 -0.999 . . . . 0.0 110.303 -178.592 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.839 ' N ' HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -132.11 142.16 49.4 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.743 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.557 ' HG2' ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.04 -161.33 0.89 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.039 -1.038 . . . . 0.0 110.675 -178.011 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.97 94.27 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.541 -0.724 . . . . 0.0 110.18 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.713 ' O ' ' HB3' ' A' ' 25' ' ' ALA . . . -110.74 94.4 4.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.277 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . 79.3 153.64 0.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.417 -0.802 . . . . 0.0 109.549 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 27' ' ' ALA . 24.1 m-20 49.87 -106.29 0.21 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.335 -0.853 . . . . 0.0 109.351 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 26' ' ' ASP . . . 42.41 86.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.984 -1.073 . . . . 0.0 109.591 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -84.53 -84.88 0.14 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 109.793 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -107.48 178.25 4.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 109.566 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 31' ' ' ASN . . . 48.48 92.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.917 . . . . 0.0 109.603 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 30' ' ' ALA . 82.3 m-20 -43.71 113.74 0.55 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.309 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.79 140.78 34.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.843 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.557 ' CD2' ' HG2' ' A' ' 22' ' ' ARG . 5.3 mt -103.7 -172.72 2.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.452 -0.78 . . . . 0.0 109.026 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -160.68 -154.68 0.38 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.626 ' CE2' ' CZ ' ' A' ' 84' ' ' PHE . 3.6 m-85 -150.65 137.49 11.43 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 2.6 Cg_endo -61.19 -160.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.87 1.713 . . . . 0.0 109.582 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 152.87 158.42 8.51 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.096 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.78 20.85 2.88 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.18 158.51 0.16 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.509 -0.995 . . . . 0.0 109.516 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.678 HG22 ' O ' ' A' ' 5' ' ' GLN . 11.2 tt -138.43 101.61 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.349 -0.844 . . . . 0.0 109.222 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -111.77 -7.45 14.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.81 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.56 -76.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.167 -0.958 . . . . 0.0 109.307 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.78 4.82 18.86 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.09 -79.4 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.046 -1.267 . . . . 0.0 109.585 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.508 ' OG1' ' HD2' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -160.8 169.07 10.61 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.846 -1.159 . . . . 0.0 109.762 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 8.5 Cg_endo -74.59 19.21 0.47 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 123.255 2.637 . . . . 0.0 112.004 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.496 ' HB2' ' CG2' ' A' ' 45' ' ' THR . 2.0 mt-10 -111.5 -46.07 3.31 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.857 -1.152 . . . . 0.0 108.789 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.537 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -73.28 -55.06 6.92 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.245 1.021 . . . . 0.0 109.1 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . -38.3 -59.94 0.83 Allowed 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.089 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 51' ' ' VAL . 7.1 p -66.26 -33.11 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.214 -0.929 . . . . 0.0 108.936 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.629 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -45.5 -58.2 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.428 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.629 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -66.37 -28.93 69.03 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.308 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.532 ' HA ' ' CG ' ' A' ' 56' ' ' GLU . 4.2 mm-40 -72.64 -6.79 46.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.016 -1.053 . . . . 0.0 109.058 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.585 ' HG ' ' CZ2' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -80.5 -60.64 2.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.555 -0.716 . . . . 0.0 109.659 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.498 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 5.7 mt-30 -80.57 -23.44 39.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.294 -0.879 . . . . 0.0 110.708 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.532 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 1.4 pp20? -80.86 20.15 0.79 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.024 -1.048 . . . . 0.0 110.615 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 95' ' ' TRP . 3.0 mt-10 -142.18 -63.18 0.44 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.742 -1.224 . . . . 0.0 110.061 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.021 HG13 ' HB3' ' A' ' 95' ' ' TRP . 2.0 m -123.52 -31.78 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.985 -1.072 . . . . 0.0 109.154 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 67.88 66.2 2.42 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.6 ' CG2' ' HB2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -83.19 155.67 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.55 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.701 HG23 ' HD3' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -107.46 -60.99 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.263 0 O-C-N 120.527 -1.358 . . . . 0.0 111.834 -177.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.701 ' HD3' HG23 ' A' ' 61' ' ' THR . 7.0 Cg_endo -73.7 52.7 2.57 Favored 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 122.031 1.821 . . . . 0.0 110.875 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.669 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 3.9 tt0 -105.82 69.28 0.81 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.867 -1.146 . . . . 0.0 110.054 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -63.68 115.08 4.41 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.671 ' HB3' HG12 ' A' ' 87' ' ' VAL . 39.3 p90 -131.14 176.0 8.63 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 122.941 1.353 . . . . 0.0 112.209 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 68' ' ' PHE . 19.1 m -163.04 130.16 3.53 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 85' ' ' TRP . 26.6 tp -50.31 96.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.486 -1.384 . . . . 0.0 109.162 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.683 ' HE2' HG13 ' A' ' 122' ' ' VAL . 0.1 OUTLIER -43.06 -74.33 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.85 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.618 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 3.3 tt0 -162.61 161.83 26.86 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.352 0.596 . . . . 0.0 109.704 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HG2' ' N ' ' A' ' 71' ' ' LEU . 22.3 ttmt -116.16 154.3 30.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 0.0 109.174 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.021 HD21 ' CE1' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -126.67 -174.89 3.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.078 -1.014 . . . . 0.0 109.642 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -157.29 151.22 24.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.389 -0.819 . . . . 0.0 109.2 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.496 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . 6.8 t80 -154.39 165.13 37.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.058 -1.026 . . . . 0.0 110.082 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -148.14 122.24 9.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.414 -0.803 . . . . 0.0 109.365 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -82.32 172.27 9.96 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.55 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 6.0 Cg_exo -58.38 -15.77 25.87 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.934 1.756 . . . . 0.0 110.01 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -156.81 7.28 0.18 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.513 -0.742 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.539 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 1.8 mmm180 -129.18 -169.59 2.12 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 120.659 -1.276 . . . . 0.0 109.613 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.49 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 35.5 m80 -144.48 129.74 18.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.333 -0.854 . . . . 0.0 108.969 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.728 HG22 HD13 ' A' ' 82' ' ' LEU . 2.7 mm -116.26 83.98 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.93 . . . . 0.0 110.03 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.26 86.62 6.2 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.728 HD13 HG22 ' A' ' 80' ' ' ILE . 1.4 mp -102.31 167.52 9.92 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.181 -0.949 . . . . 0.0 110.364 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.541 ' CD1' ' O ' ' A' ' 6' ' ' ILE . 1.7 m95 -122.65 164.26 18.56 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 1.021 ' CE1' HD21 ' A' ' 71' ' ' LEU . 1.8 m-85 -136.51 88.94 2.42 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.07 -1.019 . . . . 0.0 109.557 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.645 ' CZ2' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.04 151.53 21.61 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.388 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.582 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 14.7 tp -142.55 127.67 18.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.787 -1.195 . . . . 0.0 109.615 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.979 ' CG2' HG23 ' A' ' 11' ' ' ILE . 9.1 m -99.07 -161.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.314 -0.866 . . . . 0.0 109.997 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -141.99 -23.42 0.7 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.287 -0.883 . . . . 0.0 111.484 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.669 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -159.96 -167.43 1.96 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.343 -1.473 . . . . 0.0 110.672 -179.186 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 1.034 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 28.6 p90 158.68 171.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.517 1.151 . . . . 0.0 110.294 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.607 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 8.9 tt0 -111.93 -63.19 1.45 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.743 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.587 ' N ' HG22 ' A' ' 60' ' ' ILE . . . -56.74 -156.39 0.01 OUTLIER Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.747 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.2 pm0 -105.8 128.09 27.14 Favored Pre-proline 0 C--N 1.307 -1.244 0 O-C-N 121.38 -1.07 . . . . 0.0 109.348 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.97 ' HB3' HD12 ' A' ' 11' ' ' ILE . 13.5 Cg_exo -46.77 144.91 7.32 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.465 2.11 . . . . 0.0 112.05 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 1.021 ' HB3' HG13 ' A' ' 58' ' ' VAL . 11.1 p-90 -107.51 -167.72 1.3 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.61 -96.18 0.14 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.525 ' HB2' ' N ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -118.0 138.74 51.99 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.506 -0.996 . . . . 0.0 109.25 179.515 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.444 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 12.0 tm-20 -92.66 68.88 4.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 109.202 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.45 ' O ' ' HD3' ' A' ' 101' ' ' PRO . . . 175.13 -31.89 0.09 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.424 ' HB3' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -92.74 111.19 49.94 Favored Pre-proline 0 C--N 1.297 -1.689 0 O-C-N 121.65 -0.912 . . . . 0.0 108.745 179.363 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 99' ' ' GLY . 1.1 Cg_endo -63.25 82.14 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.059 1.839 . . . . 0.0 110.935 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -86.12 170.61 43.41 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -161.33 172.88 15.81 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.586 -1.538 . . . . 0.0 111.504 -179.282 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.493 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 4.6 m0 -84.91 106.86 16.74 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.44 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 3.7 ttp -107.8 136.56 47.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.335 -0.853 . . . . 0.0 109.067 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.86 85.81 4.9 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.227 -0.921 . . . . 0.0 109.359 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.891 HD13 ' HA ' ' A' ' 110' ' ' LEU . 1.4 mt -76.96 -52.58 9.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.916 . . . . 0.0 109.59 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.783 HG12 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER 72.52 27.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 122.155 0.979 . . . . 0.0 108.579 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 163.63 50.6 0.02 OUTLIER Glycine 0 N--CA 1.485 1.944 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.891 ' HA ' HD13 ' A' ' 107' ' ' LEU . 0.7 OUTLIER -38.12 144.28 0.1 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.769 -0.842 . . . . 0.0 109.98 -178.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -156.43 151.87 26.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.122 -0.986 . . . . 0.0 109.801 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.887 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -68.36 -7.5 31.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.264 -0.898 . . . . 0.0 109.403 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -61.02 -42.73 99.01 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.256 -0.902 . . . . 0.0 109.93 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.506 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -79.12 -9.2 59.49 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.096 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.534 ' CE2' ' CE2' ' A' ' 35' ' ' PHE . 9.6 m-85 -98.43 137.43 20.71 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.005 -1.059 . . . . 0.0 109.456 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 115' ' ' PHE . 1.9 Cg_endo -68.8 164.19 34.35 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.256 1.97 . . . . 0.0 110.281 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.721 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.5 Cg_endo -63.29 119.07 5.99 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.404 2.07 . . . . 0.0 110.434 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 161.74 -51.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 109.831 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.562 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 28.2 m-20 -106.19 38.38 2.05 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.234 -0.916 . . . . 0.0 109.347 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.68 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 20.2 mt-10 -65.89 -36.71 14.59 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.346 -0.846 . . . . 0.0 112.704 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.8 Cg_exo -63.34 -36.2 57.42 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.099 1.866 . . . . 0.0 112.425 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.948 ' HB ' HD23 ' A' ' 71' ' ' LEU . 1.2 t -98.51 -39.3 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 120.449 -1.407 . . . . 0.0 108.003 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.961 ' HA ' HD21 ' A' ' 126' ' ' LEU . 25.2 mm -58.66 -30.57 42.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.553 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -70.3 -26.37 63.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.468 -0.77 . . . . 0.0 110.688 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.417 ' HG2' ' OE1' ' A' ' 69' ' ' GLU . 16.9 tptt -76.19 -57.21 4.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.882 -1.136 . . . . 0.0 110.522 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.961 HD21 ' HA ' ' A' ' 123' ' ' ILE . 2.4 pt? -74.84 11.78 0.99 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.054 -1.029 . . . . 0.0 111.219 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.553 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 37.4 mttt -49.51 -43.05 45.22 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.353 -1.467 . . . . 0.0 107.695 178.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.477 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -109.84 46.15 1.04 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.797 -0.565 . . . . 0.0 110.842 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.565 ' CD2' ' HB2' ' A' ' 126' ' ' LEU . 1.3 mp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.336 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.57 144.2 48.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.62 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.613 ' O ' HD23 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -57.1 148.46 21.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.351 -0.843 . . . . 0.0 109.321 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.646 HD12 ' O ' ' A' ' 79' ' ' HIS . 23.5 mt -134.32 73.67 1.5 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 109.801 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.478 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . 1.1 mp0 -87.46 116.47 25.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.228 -0.92 . . . . 0.0 108.869 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 38' ' ' GLY . 1.4 mp -112.47 141.18 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.094 -1.004 . . . . 0.0 109.791 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.408 ' O ' ' CA ' ' A' ' 37' ' ' GLY . . . -103.8 110.72 22.94 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.765 HG23 ' C ' ' A' ' 36' ' ' PRO . 3.0 p -127.78 100.09 5.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.131 -0.981 . . . . 0.0 110.352 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.566 ' HA2' ' CD1' ' A' ' 85' ' ' TRP . . . -84.58 118.5 4.74 Favored Glycine 0 C--N 1.296 -1.683 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.568 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 1.8 mt -81.49 173.49 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 120.867 -1.373 . . . . 0.0 107.541 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.926 HD12 ' CB ' ' A' ' 94' ' ' PRO . 0.4 OUTLIER -144.56 153.54 14.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 118.039 -1.464 . . . . 0.0 110.435 -178.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 17' ' ' GLU . 37.7 ttp180 -159.3 131.52 6.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.517 -0.739 . . . . 0.0 109.24 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.31 -162.69 0.97 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.14 -0.975 . . . . 0.0 110.577 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.36 -7.32 58.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.626 -0.671 . . . . 0.0 109.713 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.536 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 5.2 t30 -84.53 12.61 6.68 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.124 -0.985 . . . . 0.0 108.667 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.5 t30 60.03 43.38 14.57 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.64 -0.662 . . . . 0.0 110.522 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.536 ' CG ' ' HB3' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -127.37 154.27 45.19 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.862 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.568 HD11 HD11 ' A' ' 107' ' ' LEU . 1.6 mt -119.78 156.34 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.859 -1.15 . . . . 0.0 110.203 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 26.0 t80 -103.15 86.11 2.63 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.049 HD12 ' O ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -78.73 176.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.187 0.994 . . . . 0.0 110.101 -178.319 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.627 ' N ' ' CG2' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -153.46 144.24 22.7 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.604 ' CG ' ' HA ' ' A' ' 33' ' ' LEU . 6.4 tpm_? -154.6 106.23 2.7 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 110.062 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.467 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -60.64 100.81 0.11 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.196 -0.94 . . . . 0.0 109.231 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -37.52 109.13 0.09 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.639 -0.663 . . . . 0.0 109.89 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.45 ' O ' ' CB ' ' A' ' 26' ' ' ASP . . . -125.9 36.41 4.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.21 -0.931 . . . . 0.0 109.65 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 1.2 m-20 71.2 4.95 5.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 109.791 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 45.13 -159.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.942 . . . . 0.0 109.623 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.493 ' O ' ' CB ' ' A' ' 29' ' ' MET . 1.4 t60 -176.16 49.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.525 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.493 ' CB ' ' O ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER 163.57 -87.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.4 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.64 -88.75 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 109.228 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -104.8 114.0 27.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.258 -0.901 . . . . 0.0 108.918 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.491 ' O ' ' HG2' ' A' ' 22' ' ' ARG . 5.9 mmtp -114.55 129.08 56.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.195 -0.941 . . . . 0.0 109.991 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.659 HD21 ' CB ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -146.21 -175.71 4.87 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.797 0.808 . . . . 0.0 109.544 179.6 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.049 ' O ' HD12 ' A' ' 20' ' ' ILE . 2.3 tt0 -163.06 -154.21 0.28 Allowed 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.757 ' HB3' HG21 ' A' ' 8' ' ' VAL . 85.4 m-85 -114.02 158.97 37.92 Favored Pre-proline 0 C--N 1.285 -2.206 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.765 ' C ' HG23 ' A' ' 8' ' ' VAL . 3.3 Cg_exo -58.21 -154.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 121.854 1.703 . . . . 0.0 110.167 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.408 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 82.48 -170.65 50.7 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.453 ' O ' HG13 ' A' ' 6' ' ' ILE . . . 177.66 -37.61 0.09 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -168.79 143.61 3.25 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.562 -0.964 . . . . 0.0 109.076 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.666 ' O ' HG23 ' A' ' 40' ' ' ILE . 15.5 tt -100.35 115.32 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.103 -0.998 . . . . 0.0 109.705 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 42' ' ' MET . 4.7 mt-10 -101.85 -175.93 2.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.337 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.47 ' O ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 49.16 -178.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.913 . . . . 0.0 109.331 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.98 148.21 10.91 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.444 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 39.6 mp0 -91.47 121.75 33.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.177 -1.19 . . . . 0.0 109.75 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.782 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -159.96 178.61 1.61 Allowed Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.428 -0.795 . . . . 0.0 109.642 179.738 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.782 ' CD ' HG22 ' A' ' 45' ' ' THR . 6.1 Cg_endo -73.62 -20.1 20.73 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.596 2.198 . . . . 0.0 110.903 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.503 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -124.12 -59.04 1.52 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.075 -1.016 . . . . 0.0 110.085 -179.108 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.628 ' O ' HG12 ' A' ' 51' ' ' VAL . 1.2 tt0 -44.14 -32.99 1.36 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.285 1.04 . . . . 0.0 110.596 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.445 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -81.76 -57.17 3.55 Favored 'General case' 0 C--N 1.272 -2.8 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.988 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.421 HG22 ' CH2' ' A' ' 95' ' ' TRP . 1.3 p -81.9 4.98 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.395 -0.816 . . . . 0.0 110.513 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 48' ' ' GLN . 13.2 p -82.75 -37.65 14.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.523 ' N ' HG13 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -74.65 -31.1 61.85 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.879 -1.509 . . . . 0.0 108.659 178.575 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -72.0 -7.12 46.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.122 -0.986 . . . . 0.0 109.075 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.781 HD22 ' CZ2' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -76.55 -68.11 0.63 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.651 -0.656 . . . . 0.0 109.428 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -82.33 -17.52 45.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.493 -0.754 . . . . 0.0 111.335 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.513 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 2.3 mm-40 -80.28 18.22 0.92 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.791 -1.193 . . . . 0.0 110.461 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 95' ' ' TRP . 7.1 mm-40 -146.76 -65.38 0.28 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.734 -1.229 . . . . 0.0 110.565 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.856 HG21 ' O ' ' A' ' 93' ' ' GLU . 3.7 m -124.8 -32.56 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.156 -0.965 . . . . 0.0 108.979 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.407 ' N ' HG23 ' A' ' 58' ' ' VAL . . . 72.16 67.64 1.79 Allowed Glycine 0 N--CA 1.483 1.815 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.616 HG21 ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -95.52 171.11 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.351 -1.087 . . . . 0.0 108.17 178.439 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.552 ' HB ' ' CB ' ' A' ' 91' ' ' GLU . 2.7 m -112.99 89.36 13.57 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 1.4 Cg_endo -59.3 131.12 39.17 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.093 1.862 . . . . 0.0 110.177 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.507 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -92.71 -55.48 3.36 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.553 -0.717 . . . . 0.0 110.164 -178.844 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 12.0 t-160 -142.27 112.47 7.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.91 -1.119 . . . . 0.0 110.2 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.832 ' CB ' HG12 ' A' ' 87' ' ' VAL . 5.5 p90 -135.25 175.26 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.141 -0.974 . . . . 0.0 110.368 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.3 m -162.39 -179.71 7.19 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.976 HD21 ' HD3' ' A' ' 70' ' ' LYS . 34.8 tp -105.95 107.63 18.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.953 -1.092 . . . . 0.0 109.014 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.764 ' CE2' HG13 ' A' ' 122' ' ' VAL . 3.3 t80 -47.33 -83.53 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.625 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -147.12 175.56 10.63 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.492 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.976 ' HD3' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.33 129.02 38.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 0.0 109.61 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.507 ' HG ' HG21 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -120.94 -176.89 3.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 109.505 179.669 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.18 158.87 33.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.363 -0.836 . . . . 0.0 109.388 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.0 147.15 31.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 0.0 109.737 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.73 116.74 10.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.077 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 1.1 m-85 -83.99 172.99 7.98 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.348 -0.845 . . . . 0.0 109.379 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 4.0 Cg_exo -59.17 -12.95 17.54 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.152 1.901 . . . . 0.0 110.791 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -165.16 16.18 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 110.585 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.526 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -131.17 -172.89 2.95 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 120.632 -1.293 . . . . 0.0 109.445 -179.502 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.646 ' O ' HD12 ' A' ' 4' ' ' LEU . 39.3 m-70 -146.32 136.64 23.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.352 -0.843 . . . . 0.0 109.018 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 80' ' ' ILE . 22.4 mm -140.04 80.31 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.093 -1.004 . . . . 0.0 110.169 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.61 130.57 34.99 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.586 HD11 HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -136.86 113.58 10.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.955 -1.091 . . . . 0.0 110.366 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -79.86 156.04 27.54 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.98 ' CD2' HG11 ' A' ' 122' ' ' VAL . 2.0 m-85 -135.87 71.12 1.42 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.94 -1.1 . . . . 0.0 109.838 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.836 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -84.05 145.17 28.62 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.707 ' CD2' HD22 ' A' ' 129' ' ' LEU . 20.9 tp -134.8 127.25 30.49 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.951 -1.093 . . . . 0.0 110.139 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.832 HG12 ' CB ' ' A' ' 65' ' ' PHE . 34.5 m -98.1 -174.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.73 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' ARG . 2.9 mt-10 -126.43 -29.88 2.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.845 . . . . 0.0 109.428 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.507 ' HG3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.72 169.3 20.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.195 -0.941 . . . . 0.0 109.326 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.767 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 46.1 p90 -164.95 -169.83 1.79 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.102 -0.999 . . . . 0.0 110.015 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.552 ' CB ' ' HB ' ' A' ' 61' ' ' THR . 30.6 tt0 -131.34 99.13 4.74 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.972 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.557 ' CA ' HG22 ' A' ' 60' ' ' ILE . . . 128.88 -152.13 19.27 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.627 -1.273 . . . . 0.0 109.946 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.856 ' O ' HG21 ' A' ' 58' ' ' VAL . 14.5 tp10 -99.96 127.06 34.61 Favored Pre-proline 0 N--CA 1.486 1.339 0 O-C-N 121.324 -1.103 . . . . 0.0 109.187 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.926 ' CB ' HD12 ' A' ' 11' ' ' ILE . 4.0 Cg_exo -52.36 144.96 37.93 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.665 2.244 . . . . 0.0 111.706 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.813 ' HB3' HG13 ' A' ' 58' ' ' VAL . 23.4 p-90 -113.15 -175.55 2.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.523 -0.736 . . . . 0.0 109.09 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.56 ' HA3' ' HB3' ' A' ' 36' ' ' PRO . . . 158.06 -62.36 0.32 Allowed Glycine 0 N--CA 1.484 1.843 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.296 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -105.31 171.47 7.31 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.355 -1.085 . . . . 0.0 109.631 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.467 ' HA ' ' OE2' ' A' ' 57' ' ' GLU . 2.9 tp10 -39.23 -37.41 0.41 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.65 -0.656 . . . . 0.0 109.438 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.511 ' C ' ' HD3' ' A' ' 101' ' ' PRO . . . -126.18 -160.42 10.6 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.643 ' N ' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -117.85 40.15 0.32 Allowed Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.137 -1.213 . . . . 0.0 111.541 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.643 ' HD3' ' N ' ' A' ' 100' ' ' GLN . 6.9 Cg_endo -68.13 -6.81 18.16 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 C-N-CA 121.327 1.351 . . . . 0.0 110.106 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -41.83 163.53 0.02 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.458 ' CD ' HG22 ' A' ' 20' ' ' ILE . 6.1 pm0 -119.17 131.08 55.81 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.405 -1.056 . . . . 0.0 109.175 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.46 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 10.8 m0 -78.21 95.77 5.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.199 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.31 -163.35 0.6 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.403 -0.811 . . . . 0.0 109.653 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 t -141.33 158.08 44.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.628 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.691 HD21 HD12 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -113.4 63.0 0.64 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.347 -0.846 . . . . 0.0 108.974 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.2 p -104.33 -26.55 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.367 -0.833 . . . . 0.0 109.208 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -168.25 43.92 0.23 Allowed Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 109' ' ' GLY . 1.1 mt -45.46 145.79 1.16 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.217 -1.166 . . . . 0.0 108.676 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -125.24 9.98 8.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 110.182 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.435 ' CB ' HG22 ' A' ' 123' ' ' ILE . . . 52.59 19.64 1.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.902 -1.124 . . . . 0.0 108.39 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -100.82 -34.41 9.83 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.358 -0.839 . . . . 0.0 109.747 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.659 ' CB ' HD21 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -76.69 -3.66 39.17 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.31 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.647 ' CD2' HD12 ' A' ' 123' ' ' ILE . 22.3 m-85 -96.44 109.99 50.53 Favored Pre-proline 0 N--CA 1.485 1.281 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.539 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 7.1 Cg_exo -50.14 154.96 4.98 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.166 1.911 . . . . 0.0 110.512 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.714 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 5.4 Cg_exo -58.38 121.2 9.59 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.553 2.169 . . . . 0.0 110.995 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 158.54 -37.21 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.566 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 86.8 m-20 -115.36 41.25 2.5 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.507 -0.746 . . . . 0.0 109.472 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.66 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 20.0 mt-10 -66.53 -41.48 40.43 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.95 -1.094 . . . . 0.0 112.427 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 1.1 Cg_endo -67.7 -30.89 33.79 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.581 2.187 . . . . 0.0 112.231 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.98 HG11 ' CD2' ' A' ' 84' ' ' PHE . 2.1 t -95.32 -43.77 12.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 120.593 -1.317 . . . . 0.0 107.493 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.647 HD12 ' CD2' ' A' ' 115' ' ' PHE . 12.2 mm -56.67 -29.0 28.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.22 -35.12 63.88 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.703 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -80.4 -61.73 1.89 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.916 -1.115 . . . . 0.0 110.945 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.655 ' HB2' HD21 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -80.87 27.38 0.38 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.918 -1.114 . . . . 0.0 110.522 -179.281 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.592 ' HG3' ' N ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -71.33 -31.48 67.44 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.592 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 2.2 ptt180 -119.63 44.74 2.31 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.632 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.707 HD22 ' CD2' ' A' ' 86' ' ' LEU . 1.1 mp . . . . . 0 C--N 1.308 -1.228 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.971 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.412 ' HA ' HD12 ' A' ' 4' ' ' LEU . 49.5 tp . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.935 ' O ' HG22 ' A' ' 40' ' ' ILE . 12.4 mt-30 -137.86 119.51 15.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.035 . . . . 0.0 109.809 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.706 HG22 ' H ' ' A' ' 7' ' ' ALA . 12.9 mm -102.46 179.66 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.431 -0.793 . . . . 0.0 109.665 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.706 ' H ' HG22 ' A' ' 6' ' ' ILE . . . -142.38 108.21 5.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.197 -0.939 . . . . 0.0 108.849 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.652 HG23 ' C ' ' A' ' 36' ' ' PRO . 7.8 p -113.07 164.15 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.024 . . . . 0.0 110.221 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -149.73 120.63 1.17 Allowed Glycine 0 N--CA 1.482 1.719 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.115 HD12 ' CD2' ' A' ' 86' ' ' LEU . 1.2 mt -98.99 152.91 4.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 121.181 -1.188 . . . . 0.0 108.793 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.903 ' O ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -120.62 153.44 23.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 118.902 -1.119 . . . . 0.0 109.138 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.506 ' O ' ' O ' ' A' ' 88' ' ' GLU . 38.2 ttp180 -155.76 114.13 3.43 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.565 -0.709 . . . . 0.0 109.823 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.602 ' HB3' ' CZ3' ' A' ' 90' ' ' TRP . 43.4 p-10 -158.76 -159.59 0.8 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.975 . . . . 0.0 109.883 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER 77.89 -72.52 0.09 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.991 0.9 . . . . 0.0 108.759 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.41 -47.3 0.17 Allowed 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 122.286 1.041 . . . . 0.0 108.236 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 108' ' ' VAL . 6.1 t-20 179.15 35.44 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.527 ' C ' HD13 ' A' ' 18' ' ' ILE . 3.0 mt-10 -107.29 148.93 28.37 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.637 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.903 HG22 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -116.8 156.1 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 109.857 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.575 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 11.5 t80 -92.5 69.48 4.94 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 176.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.716 HG23 ' N ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -82.05 -161.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 122.126 0.965 . . . . 0.0 112.093 -176.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.716 ' N ' HG23 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -141.01 132.21 26.46 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.454 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 9.9 ttp180 . . . . . 0 C--N 1.302 -1.49 0 O-C-N 121.373 -0.829 . . . . 0.0 109.929 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.8 m120 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.47 141.51 43.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.09 -1.006 . . . . 0.0 109.781 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.827 HD21 ' HB3' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -136.79 -178.02 5.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -0.8 . . . . 0.0 109.679 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.625 ' O ' HD11 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -161.66 -155.86 0.41 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.716 0.769 . . . . 0.0 109.771 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.683 ' CZ ' ' CZ ' ' A' ' 115' ' ' PHE . 95.0 m-85 -117.3 150.3 46.11 Favored Pre-proline 0 C--N 1.296 -1.721 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.652 ' C ' HG23 ' A' ' 8' ' ' VAL . 6.2 Cg_exo -58.01 -152.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 121.884 1.723 . . . . 0.0 109.671 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 134.96 170.02 12.06 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.119 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -164.8 -61.3 0.02 OUTLIER Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 1.3 tttt 178.15 153.46 0.32 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.507 -0.996 . . . . 0.0 109.369 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.935 HG22 ' O ' ' A' ' 5' ' ' GLN . 7.6 tt -129.78 50.97 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.869 . . . . 0.0 109.623 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.424 ' HG3' ' HG2' ' A' ' 39' ' ' LYS . 2.2 mt-10 -118.63 7.2 11.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 109.654 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.2 tpp -108.57 -3.01 18.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.174 -0.954 . . . . 0.0 109.729 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.18 172.68 14.6 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.81 -13.5 13.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.166 -1.197 . . . . 0.0 109.808 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.816 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -144.38 179.53 1.15 Allowed Pre-proline 0 C--N 1.305 -1.335 0 O-C-N 121.044 -1.035 . . . . 0.0 109.496 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.816 ' CD ' HG22 ' A' ' 45' ' ' THR . 4.9 Cg_endo -72.94 1.61 6.32 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.347 2.031 . . . . 0.0 110.843 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.528 ' O ' HG12 ' A' ' 51' ' ' VAL . 1.9 mt-10 -124.02 -51.88 1.78 Allowed 'General case' 0 C--O 1.198 -1.654 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.524 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -49.62 -34.81 19.09 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 122.388 1.09 . . . . 0.0 108.378 178.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.486 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -67.63 -60.74 2.31 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.323 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.694 HG22 ' HH2' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -75.95 -48.01 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.123 -0.986 . . . . 0.0 109.162 -179.059 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.581 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 3.1 p -39.48 -48.92 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 121.533 0.682 . . . . 0.0 109.163 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.581 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -75.73 -33.15 60.26 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 3.1 mm-40 -67.07 -10.64 52.07 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.739 HD21 ' OE1' ' A' ' 63' ' ' GLN . 0.3 OUTLIER -60.4 -64.6 0.89 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.44 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -81.79 -25.77 34.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.556 -0.715 . . . . 0.0 109.37 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.514 ' HG3' ' HG3' ' A' ' 52' ' ' ARG . 29.3 mm-40 -81.57 32.14 0.35 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.168 -0.958 . . . . 0.0 110.479 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.586 ' HB3' ' CB ' ' A' ' 95' ' ' TRP . 5.3 mm-40 -147.03 -67.78 0.26 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.965 -1.085 . . . . 0.0 109.27 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.679 ' HB ' ' HB3' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -114.27 -46.59 4.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.469 ' N ' ' CG1' ' A' ' 58' ' ' VAL . . . 100.48 53.49 1.06 Allowed Glycine 0 N--CA 1.482 1.713 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.458 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.648 HG21 ' CD1' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -90.33 167.73 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.665 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.2 m -119.02 -65.13 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.587 -1.32 . . . . 0.0 111.299 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.665 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 18.8 Cg_endo -77.5 33.66 0.45 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.628 1.552 . . . . 0.0 110.905 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.739 ' OE1' HD21 ' A' ' 54' ' ' LEU . 55.8 tt0 -82.27 65.74 7.54 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.584 0.707 . . . . 0.0 109.636 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -51.28 144.85 8.98 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.623 ' HB3' HG12 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -153.93 170.94 19.85 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.596 -1.315 . . . . 0.0 111.21 -179.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.0 -177.51 6.16 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.0 tp -105.71 127.04 52.84 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.732 -1.23 . . . . 0.0 109.728 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.785 ' CE2' HD21 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -86.18 -70.48 0.6 Allowed 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.666 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -173.96 117.19 0.24 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.112 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -87.4 138.36 31.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.33 -0.856 . . . . 0.0 109.137 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.938 HD23 HG22 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -96.9 -170.93 2.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.244 -0.91 . . . . 0.0 110.63 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -154.4 137.24 15.35 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.413 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -131.11 175.39 9.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.934 -1.103 . . . . 0.0 110.407 -179.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -158.55 126.29 5.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.473 -0.767 . . . . 0.0 109.175 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.641 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -88.5 177.9 2.36 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.846 . . . . 0.0 109.258 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.641 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 2.6 Cg_exo -56.24 -16.82 18.52 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.864 1.709 . . . . 0.0 110.408 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -165.99 15.09 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.345 -0.847 . . . . 0.0 110.623 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.533 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 6.4 mmm180 -124.49 178.94 5.15 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 120.818 -1.176 . . . . 0.0 109.097 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -129.41 110.76 12.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.0 109.26 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.413 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 24.3 mm -106.16 109.27 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 109.695 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.9 m -116.69 142.35 47.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.336 -0.852 . . . . 0.0 109.139 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.483 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -149.87 167.0 27.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.68 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.64 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 1.1 m95 -124.48 155.63 38.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.375 -0.828 . . . . 0.0 109.402 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.499 ' CZ ' ' CD2' ' A' ' 35' ' ' PHE . 3.0 m-85 -133.43 88.38 2.48 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.438 -0.789 . . . . 0.0 109.046 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.583 ' O ' ' CG ' ' A' ' 85' ' ' TRP . 1.2 p-90 -111.39 104.43 12.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.474 -1.391 . . . . 0.0 109.55 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.115 ' CD2' HD12 ' A' ' 10' ' ' ILE . 1.9 mm? -80.97 141.43 34.46 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.282 0.563 . . . . 0.0 111.178 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.801 HG22 ' HA ' ' A' ' 11' ' ' ILE . 5.0 m -99.53 -174.33 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 O-C-N 121.217 -0.927 . . . . 0.0 108.906 178.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.506 ' O ' ' O ' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -120.8 -46.87 2.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.986 -1.071 . . . . 0.0 111.444 -179.039 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.63 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.35 150.5 14.49 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.366 -1.459 . . . . 0.0 110.75 -179.222 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.787 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 11.6 p90 -151.41 178.4 9.33 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 122.066 0.936 . . . . 0.0 109.896 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.577 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 22.6 tt0 -128.66 86.74 2.48 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.484 ' O ' ' CD1' ' A' ' 90' ' ' TRP . . . 148.99 175.07 21.12 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.609 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.2 mt-10 -80.26 118.55 72.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.141 -1.211 . . . . 0.0 108.21 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.717 ' HB3' HD12 ' A' ' 11' ' ' ILE . 3.4 Cg_endo -70.3 167.44 25.14 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.516 2.144 . . . . 0.0 112.064 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.694 ' HH2' HG22 ' A' ' 50' ' ' VAL . 29.2 p-90 -113.64 -167.86 1.26 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 36' ' ' PRO . . . 162.01 -78.86 0.16 Allowed Glycine 0 N--CA 1.481 1.669 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.563 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -101.88 -174.86 2.68 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.726 -0.867 . . . . 0.0 108.701 179.149 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -125.24 -53.8 1.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.937 -1.102 . . . . 0.0 109.575 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.48 -0.09 89.61 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.643 ' OE1' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -113.07 128.92 25.05 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.178 -1.19 . . . . 0.0 109.452 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.69 -71.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.116 1.877 . . . . 0.0 110.503 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . 95.74 166.18 34.64 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -159.27 159.49 34.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.566 -1.549 . . . . 0.0 111.08 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.553 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -84.37 94.74 8.55 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 1.1 ttm -86.77 132.11 33.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.225 -0.922 . . . . 0.0 109.662 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.442 ' HB3' ' CD ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -111.26 99.3 8.15 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.419 -0.8 . . . . 0.0 109.43 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.931 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.0 mt -122.75 -85.97 0.65 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 109.575 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 107' ' ' LEU . 1.5 t -177.82 -55.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -159.68 88.2 0.11 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.748 HD13 ' CE2' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -40.39 143.74 0.29 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.518 -0.989 . . . . 0.0 110.015 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.454 ' ND2' ' HA ' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -128.64 -171.02 2.36 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.451 -0.781 . . . . 0.0 109.184 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . . . -75.98 -9.34 58.53 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.197 -0.939 . . . . 0.0 109.431 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -62.81 -56.66 15.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.871 . . . . 0.0 109.687 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.827 ' HB3' HD21 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -81.3 -13.63 58.22 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.785 ' CG ' HD12 ' A' ' 123' ' ' ILE . 3.1 m-85 -90.58 110.6 42.39 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.514 ' CG ' ' O ' ' A' ' 33' ' ' LEU . 6.6 Cg_exo -50.96 141.19 37.51 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.953 1.769 . . . . 0.0 110.094 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.723 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 4.4 Cg_exo -59.35 126.52 21.03 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.195 1.93 . . . . 0.0 110.804 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.723 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 152.97 -18.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.559 ' HB3' HG12 ' A' ' 123' ' ' ILE . 0.9 OUTLIER -123.33 48.52 1.82 Allowed 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.655 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.2 mm-40 -65.99 -35.88 12.07 Favored Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.655 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 6.2 Cg_exo -60.59 -35.11 91.32 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 121.678 1.585 . . . . 0.0 112.094 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.938 HG22 HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -102.67 -46.66 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 120.588 -1.32 . . . . 0.0 108.672 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.785 HD12 ' CG ' ' A' ' 115' ' ' PHE . 24.8 mm -50.15 -38.35 14.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 127' ' ' LYS . . . -52.06 -44.35 64.25 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -71.08 -42.63 69.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.41 -0.806 . . . . 0.0 109.782 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.785 HD21 ' CE2' ' A' ' 68' ' ' PHE . 1.4 mt -63.01 -9.73 11.21 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.276 -0.89 . . . . 0.0 109.732 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.454 ' HA ' ' ND2' ' A' ' 111' ' ' ASN . 55.6 mttt -56.81 -48.7 77.35 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.14 -0.975 . . . . 0.0 108.69 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 129' ' ' LEU . 1.8 ptt180 -89.33 0.95 56.42 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.407 -0.808 . . . . 0.0 109.27 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 126' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.851 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.58 HD23 ' HB2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 122.112 0.958 . . . . 0.0 110.546 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.447 ' O ' ' O ' ' A' ' 4' ' ' LEU . 8.8 mt-30 58.36 126.53 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.568 0.699 . . . . 0.0 110.485 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.603 HG23 ' N ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -129.89 176.05 9.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.603 ' N ' HG23 ' A' ' 6' ' ' ILE . . . -117.79 80.26 1.48 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.841 -1.162 . . . . 0.0 110.283 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.742 HG23 ' CB ' ' A' ' 36' ' ' PRO . 3.2 p -100.18 145.27 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 118.896 -1.122 . . . . 0.0 108.485 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -129.37 110.36 1.06 Allowed Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.14 HD12 ' CD1' ' A' ' 86' ' ' LEU . 1.3 mt -92.49 166.19 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.024 HG23 HG21 ' A' ' 87' ' ' VAL . 0.7 OUTLIER -154.48 146.42 13.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.271 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.545 ' CZ ' HD23 ' A' ' 129' ' ' LEU . 38.2 ttp180 -161.5 77.27 0.54 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.532 -0.73 . . . . 0.0 110.039 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.512 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 20.2 m-80 -160.1 -162.04 0.95 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -0.893 . . . . 0.0 109.543 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.37 -85.98 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.619 0.723 . . . . 0.0 109.528 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 13' ' ' ASN . 28.9 t-20 -94.75 28.68 2.59 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.529 -0.732 . . . . 0.0 109.335 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 15' ' ' ASN . 30.1 t30 42.31 43.73 3.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.475 -0.766 . . . . 0.0 109.318 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 105' ' ' MET . 2.5 mt-10 -129.41 149.33 51.24 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.689 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 3.0 mt -101.12 156.99 4.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 118.326 -1.35 . . . . 0.0 110.672 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.519 ' HB3' HG13 ' A' ' 11' ' ' ILE . 60.3 t80 -97.03 78.25 2.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.97 HG21 HD13 ' A' ' 33' ' ' LEU . 11.3 mm -78.09 167.14 2.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.404 -0.81 . . . . 0.0 110.084 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.665 HG21 ' HB2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -128.01 139.88 52.3 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.848 178.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' A' ' 32' ' ' LYS . 1.2 ttp180 . . . . . 0 C--N 1.307 -1.277 0 O-C-N 121.055 -1.028 . . . . 0.0 109.433 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.425 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 1.5 m120 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.469 ' O ' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -108.13 135.0 50.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.317 -0.864 . . . . 0.0 109.375 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.97 HD13 HG21 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -104.63 -176.94 3.22 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.351 -0.843 . . . . 0.0 109.073 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -162.17 -155.91 0.39 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 110.073 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.461 ' HB3' HG21 ' A' ' 8' ' ' VAL . 21.8 m-85 -142.31 141.41 21.06 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.742 ' CB ' HG23 ' A' ' 8' ' ' VAL . 5.9 Cg_exo -57.54 -150.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.87 1.714 . . . . 0.0 110.074 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.567 ' HA2' ' CA ' ' A' ' 8' ' ' VAL . . . 148.78 -149.08 21.04 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.086 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . 144.93 -79.93 0.23 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.464 ' HG2' ' HG3' ' A' ' 41' ' ' GLU . 0.2 OUTLIER 178.07 133.87 0.07 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.395 -1.061 . . . . 0.0 109.652 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.677 ' O ' HG23 ' A' ' 40' ' ' ILE . 9.0 tt -121.84 74.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.253 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.464 ' HG3' ' HG2' ' A' ' 39' ' ' LYS . 1.9 mm-40 -113.04 -179.71 3.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.611 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.2 ttm 44.09 83.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.31 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 168.85 124.31 0.72 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.21 -11.17 39.09 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.19 -1.183 . . . . 0.0 110.192 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.848 HG22 ' H ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -125.18 149.03 62.53 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 120.927 -1.108 . . . . 0.0 108.715 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.721 ' HD2' HG23 ' A' ' 45' ' ' THR . 9.3 Cg_endo -71.12 14.98 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.753 2.302 . . . . 0.0 112.343 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.848 ' H ' HG22 ' A' ' 45' ' ' THR . 0.8 OUTLIER -124.01 -60.92 1.4 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.508 -1.37 . . . . 0.0 109.766 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.575 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -48.12 -28.5 2.95 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.823 1.296 . . . . 0.0 109.379 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . -67.54 -67.17 0.48 Allowed 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.374 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.745 HG13 ' CZ3' ' A' ' 85' ' ' TRP . 10.0 p -83.29 3.55 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.259 -0.901 . . . . 0.0 111.463 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.582 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 4.9 p -81.92 -43.67 19.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.582 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -69.34 -29.08 66.82 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 113.745 -1.571 . . . . 0.0 108.101 177.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 49' ' ' ALA . 69.9 mt-10 -70.36 -22.78 62.74 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.128 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.034 HD13 ' HG3' ' A' ' 62' ' ' PRO . 3.4 mt -63.43 -48.09 79.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -0.908 . . . . 0.0 109.467 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.513 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 2.1 pt20 -81.37 -30.64 33.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.937 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 9.1 mm-40 -81.88 32.56 0.37 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.219 -0.926 . . . . 0.0 111.014 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.655 ' CB ' ' CD1' ' A' ' 95' ' ' TRP . 25.6 mm-40 -155.3 -57.63 0.1 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.629 -1.294 . . . . 0.0 109.985 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.053 HG22 ' CD1' ' A' ' 95' ' ' TRP . 10.6 m -113.92 -49.8 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.587 ' N ' HG23 ' A' ' 58' ' ' VAL . . . 92.4 37.69 5.82 Favored Glycine 0 C--N 1.299 -1.482 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -79.83 174.67 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -1.092 . . . . 0.0 108.255 178.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.565 ' HB ' ' CB ' ' A' ' 91' ' ' GLU . 8.1 m -115.3 90.13 23.59 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 1.034 ' HG3' HD13 ' A' ' 54' ' ' LEU . 4.3 Cg_endo -61.0 122.75 11.66 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 121.809 1.672 . . . . 0.0 110.11 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.528 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 1.8 mt-30 -86.89 -34.18 19.5 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.834 -0.541 . . . . 0.0 109.773 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.46 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 45.5 t60 -176.42 97.48 0.06 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.179 -0.951 . . . . 0.0 110.315 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.477 ' HB2' HG12 ' A' ' 87' ' ' VAL . 13.7 p90 -111.7 175.5 5.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.908 -1.12 . . . . 0.0 109.307 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.1 m -161.97 173.18 14.81 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.624 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.941 HD22 ' CZ3' ' A' ' 83' ' ' TRP . 4.6 tp -116.09 114.16 24.15 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.215 -0.928 . . . . 0.0 109.153 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.641 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 2.6 p90 -73.78 -53.76 9.57 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.294 -0.879 . . . . 0.0 109.876 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.641 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 0.5 OUTLIER 176.45 149.59 0.13 Allowed 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.039 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -111.66 163.46 14.09 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.312 -0.868 . . . . 0.0 109.895 -179.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.941 HD23 ' CG2' ' A' ' 122' ' ' VAL . 0.3 OUTLIER -113.93 -164.6 0.94 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 109.145 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -136.03 156.28 48.96 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.133 -0.979 . . . . 0.0 109.557 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.57 82.85 1.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.616 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 1.0 OUTLIER -103.12 114.2 28.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 110.327 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.522 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -81.69 177.04 3.25 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 1.9 Cg_endo -63.95 2.67 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.926 1.751 . . . . 0.0 111.42 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -125.52 -55.05 1.55 Allowed 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.623 -1.298 . . . . 0.0 111.162 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.524 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -118.49 -179.42 3.78 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.253 -0.904 . . . . 0.0 110.387 -178.114 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.616 ' CD2' ' HG3' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -128.51 96.44 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 12.6 mt -97.74 128.68 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.506 -0.746 . . . . 0.0 110.815 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.445 ' CB ' ' H ' ' A' ' 5' ' ' GLN . 3.7 m -115.85 118.43 32.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 108.769 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.581 ' CB ' HD11 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -81.93 132.15 35.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.154 -0.966 . . . . 0.0 109.81 -179.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.941 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -122.9 113.64 19.39 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.31 -0.869 . . . . 0.0 109.575 -178.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.657 ' CE1' HG11 ' A' ' 122' ' ' VAL . 0.1 OUTLIER -122.37 113.54 19.52 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 120.358 -1.464 . . . . 0.0 109.955 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.837 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -83.34 87.05 6.97 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.363 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.14 ' CD1' HD12 ' A' ' 10' ' ' ILE . 0.6 OUTLIER -44.39 107.87 0.1 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.038 -1.039 . . . . 0.0 109.21 -179.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.024 HG21 HG23 ' A' ' 11' ' ' ILE . 19.8 m -81.0 174.66 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.531 -0.73 . . . . 0.0 110.308 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.495 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 1.0 OUTLIER -129.22 -18.48 3.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 110.422 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.495 ' HD3' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -162.16 174.08 13.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.89 -1.131 . . . . 0.0 110.252 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.881 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 35.1 p90 174.65 -179.71 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.093 0.949 . . . . 0.0 109.883 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.633 ' O ' HG22 ' A' ' 60' ' ' ILE . 1.4 tt0 -134.7 109.17 8.43 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.727 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.52 ' CA ' HG22 ' A' ' 60' ' ' ILE . . . 114.37 -156.97 15.28 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.333 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.476 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 1.9 mt-10 -107.29 102.22 42.65 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.344 -1.092 . . . . 0.0 109.067 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 1.038 ' C ' HG11 ' A' ' 58' ' ' VAL . 3.4 Cg_endo -66.46 -169.82 0.19 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.118 1.879 . . . . 0.0 111.972 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 1.053 ' CD1' HG22 ' A' ' 58' ' ' VAL . 4.8 p-90 -136.01 -168.27 2.19 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.69 0.757 . . . . 0.0 108.986 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 36' ' ' PRO . . . -159.98 -77.86 0.03 OUTLIER Glycine 0 C--N 1.295 -1.742 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.665 ' HB2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -87.06 -179.27 6.44 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.524 -0.986 . . . . 0.0 109.494 179.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -92.59 -36.04 13.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.346 -0.846 . . . . 0.0 109.819 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -139.76 9.61 3.12 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.543 ' HB3' ' CB ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -99.04 109.59 54.64 Favored Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 121.189 -1.183 . . . . 0.0 109.694 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.97 122.2 11.03 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.949 1.766 . . . . 0.0 109.679 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -98.22 168.58 23.29 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -125.81 154.61 42.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.857 -1.378 . . . . 0.0 110.086 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.443 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -94.65 104.01 15.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.543 -0.723 . . . . 0.0 109.351 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 1.2 ttm -92.51 168.73 11.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.178 -0.951 . . . . 0.0 109.257 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.4 t -116.21 65.63 0.71 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.176 -0.953 . . . . 0.0 109.567 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.505 ' CD1' ' HD2' ' A' ' 12' ' ' ARG . 3.1 tp 48.03 59.52 4.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.274 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.34 -72.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 109.555 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.501 ' HA3' ' HB2' ' A' ' 114' ' ' ASP . . . -100.75 30.92 9.27 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.964 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -67.24 -20.6 65.69 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.311 -1.111 . . . . 0.0 109.33 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -78.93 -177.89 5.77 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.427 -0.795 . . . . 0.0 109.731 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.656 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . -68.76 -6.81 28.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.378 -0.826 . . . . 0.0 109.656 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -62.91 -54.77 33.53 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.257 -0.902 . . . . 0.0 109.944 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.501 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 19.8 t0 -90.56 -6.7 54.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.872 . . . . 0.0 109.811 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.629 ' CD2' HD11 ' A' ' 123' ' ' ILE . 1.8 m-85 -89.32 142.13 29.57 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.026 -1.046 . . . . 0.0 109.388 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.538 ' CG ' ' O ' ' A' ' 33' ' ' LEU . 2.1 Cg_endo -71.65 158.13 54.19 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.303 2.002 . . . . 0.0 110.584 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.641 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 2.8 Cg_endo -60.62 -177.04 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.484 2.123 . . . . 0.0 110.563 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.641 ' HB3' ' O ' ' A' ' 117' ' ' PRO . . . 74.43 -1.85 2.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.458 -0.776 . . . . 0.0 109.902 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.589 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 0.9 OUTLIER -127.15 41.7 3.47 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.032 -1.042 . . . . 0.0 109.511 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.675 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 26.6 mt-10 -74.94 -39.12 3.24 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.299 -0.875 . . . . 0.0 112.065 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.6 Cg_exo -62.37 -32.36 81.26 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.954 1.769 . . . . 0.0 112.089 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.941 ' CG2' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -101.4 -50.4 10.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 120.508 -1.37 . . . . 0.0 109.288 -179.592 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.656 HG21 ' HA ' ' A' ' 112' ' ' ALA . 14.1 mm -50.95 -36.88 16.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -58.73 -43.85 90.3 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -63.01 -41.46 99.57 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.293 -0.88 . . . . 0.0 109.465 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.549 HD12 HD13 ' A' ' 129' ' ' LEU . 5.3 mp -58.06 -17.21 16.29 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.233 -0.917 . . . . 0.0 109.678 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.446 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 13.8 mmtt -57.07 -53.46 57.87 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -91.25 9.77 29.96 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.009 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.991 HD11 ' CD2' ' A' ' 86' ' ' LEU . 3.4 tp . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.748 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.471 ' C ' HG12 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -164.26 119.66 1.52 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.695 -1.253 . . . . 0.0 110.713 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.992 HG22 HD13 ' A' ' 82' ' ' LEU . 6.0 mm -152.02 157.49 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.507 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -146.42 119.31 8.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.762 -1.211 . . . . 0.0 110.465 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.976 HG12 HD11 ' A' ' 82' ' ' LEU . 7.5 p -122.2 147.17 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.576 ' HA3' ' CZ3' ' A' ' 95' ' ' TRP . . . -129.1 119.55 2.99 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.09 HD12 HD13 ' A' ' 86' ' ' LEU . 1.2 mt -92.2 166.15 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.967 HD11 ' CB ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -149.19 153.38 10.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 118.584 -1.246 . . . . 0.0 110.492 -178.3 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 88' ' ' GLU . 11.0 ttp180 -129.39 122.23 29.01 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.39 -169.46 1.8 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.098 -1.001 . . . . 0.0 110.632 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -78.36 -6.93 56.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.558 -0.714 . . . . 0.0 110.302 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.489 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 24.3 t30 -88.43 21.35 2.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.443 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 20.2 t30 48.46 42.92 19.35 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.413 -0.804 . . . . 0.0 109.339 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 15' ' ' ASN . 2.9 mt-10 -140.45 147.65 39.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 108.835 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.881 HG22 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.09 153.92 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.111 -0.993 . . . . 0.0 109.415 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 56.6 t80 -88.84 73.15 8.46 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.696 HG13 HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -80.06 -161.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.344 -0.848 . . . . 0.0 109.354 -178.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.851 HG23 ' HA2' ' A' ' 102' ' ' GLY . 0.2 OUTLIER -159.96 152.66 21.31 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.823 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.52 ' HG3' ' HA ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.246 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.337 0.589 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.517 ' O ' ' CD ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -151.55 125.88 9.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.424 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.696 HD23 HG13 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -121.17 -165.38 1.22 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.349 -0.844 . . . . 0.0 109.36 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.2 -160.89 0.82 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.337 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.69 ' CE2' ' CZ ' ' A' ' 84' ' ' PHE . 5.8 m-85 -156.12 70.47 5.09 Favored Pre-proline 0 C--N 1.294 -1.833 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.706 ' O ' HG23 ' A' ' 8' ' ' VAL . 4.3 Cg_exo -55.19 164.69 3.5 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.046 1.831 . . . . 0.0 109.588 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . -161.57 -147.71 5.07 Favored Glycine 0 N--CA 1.486 1.969 0 C-N-CA 119.325 -1.417 . . . . 0.0 109.814 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -134.51 -76.03 0.09 OUTLIER Glycine 0 N--CA 1.484 1.887 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 13.1 tttt 176.38 155.7 0.23 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.628 -0.924 . . . . 0.0 109.822 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.831 HD11 ' O ' ' A' ' 6' ' ' ILE . 15.2 mm -78.92 107.5 11.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.465 ' OE1' ' HD3' ' A' ' 52' ' ' ARG . 5.6 mt-10 -116.63 177.78 4.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.963 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.437 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 54.3 mmm 71.38 -164.99 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.863 . . . . 0.0 109.732 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.8 -26.53 3.29 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.551 ' HB2' ' NE2' ' A' ' 48' ' ' GLN . 0.9 OUTLIER -79.61 -154.91 0.09 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.399 -1.059 . . . . 0.0 109.19 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.73 HG23 ' HD3' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -160.82 -58.09 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.032 -1.043 . . . . 0.0 111.374 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.73 ' HD3' HG23 ' A' ' 45' ' ' THR . 1.3 Cg_endo -67.62 3.88 1.62 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 121.492 1.461 . . . . 0.0 112.765 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.534 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -148.91 -69.28 0.21 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.331 -1.48 . . . . 0.0 109.157 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.61 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 13.3 mt-30 -51.37 -27.57 10.2 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 122.54 1.162 . . . . 0.0 110.116 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 45' ' ' THR . . . -65.65 -66.18 0.58 Allowed 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.671 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.499 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 9.9 p -81.9 -6.59 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 111.25 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.61 ' CG1' ' HA ' ' A' ' 48' ' ' GLN . 3.1 p -72.38 -48.3 48.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.58 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -75.09 -22.5 58.23 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -52.98 -21.45 4.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.89 -1.131 . . . . 0.0 108.808 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.621 HD21 ' HG3' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -66.08 -59.44 3.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.419 -0.801 . . . . 0.0 110.401 -179.435 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.544 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 7.2 pt20 -79.97 -30.22 39.73 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.177 -0.952 . . . . 0.0 111.891 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.544 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 1.1 pp20? -79.64 -29.17 40.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.869 -1.144 . . . . 0.0 111.377 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 1.052 ' HG3' HG12 ' A' ' 58' ' ' VAL . 4.4 pt-20 -91.59 -46.63 7.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.684 -1.26 . . . . 0.0 110.428 -178.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.052 HG12 ' HG3' ' A' ' 57' ' ' GLU . 0.5 OUTLIER -147.96 -67.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.353 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.736 ' H ' HG13 ' A' ' 58' ' ' VAL . . . 119.99 71.36 0.33 Allowed Glycine 0 N--CA 1.48 1.589 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.841 HG22 ' N ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -107.52 -156.49 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 91' ' ' GLU . 2.3 m -146.51 91.87 5.27 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.621 ' HG3' HD21 ' A' ' 54' ' ' LEU . 1.8 Cg_endo -66.05 150.55 85.23 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.34 2.027 . . . . 0.0 110.729 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -121.28 -40.07 2.62 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.592 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -128.69 -179.56 5.13 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.665 ' CD2' HG12 ' A' ' 87' ' ' VAL . 22.9 m-85 -148.7 170.65 17.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.144 -0.972 . . . . 0.0 110.053 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.523 ' HB3' ' O ' ' A' ' 86' ' ' LEU . 3.8 t -159.24 0.84 0.09 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.296 -0.877 . . . . 0.0 111.96 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.058 HD22 ' CZ3' ' A' ' 85' ' ' TRP . 9.6 tp -29.0 148.52 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 CA-C-O 121.911 0.863 . . . . 0.0 110.991 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.651 ' HE2' HG22 ' A' ' 122' ' ' VAL . 14.3 p90 -116.46 -51.19 2.61 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.811 0.815 . . . . 0.0 109.431 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.528 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.3 pt-20 -179.18 161.84 1.15 Allowed 'General case' 0 C--N 1.291 -1.946 0 O-C-N 121.743 -0.598 . . . . 0.0 110.135 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.619 ' HD3' ' CE3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -105.59 -175.8 2.9 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.311 -0.868 . . . . 0.0 110.221 -179.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.81 HD12 ' N ' ' A' ' 72' ' ' GLU . 3.8 pp -147.51 -161.52 1.35 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.262 -0.899 . . . . 0.0 109.564 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.81 ' N ' HD12 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -143.45 162.16 36.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.461 -0.775 . . . . 0.0 109.425 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -141.09 164.07 31.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.709 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -158.5 108.69 2.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.427 -0.796 . . . . 0.0 109.097 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.58 ' HB2' ' HG3' ' A' ' 78' ' ' ARG . 2.1 m-85 -79.31 170.6 15.36 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.2 Cg_exo -57.84 -10.52 7.69 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.905 1.737 . . . . 0.0 111.204 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -153.54 -5.69 0.18 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.87 -1.144 . . . . 0.0 112.204 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.58 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 3.7 ptt180 -133.34 -176.91 4.3 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.406 -1.434 . . . . 0.0 109.548 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.435 ' O ' HD13 ' A' ' 80' ' ' ILE . 5.9 m80 -134.99 156.11 49.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.157 -0.965 . . . . 0.0 109.381 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.435 HD13 ' O ' ' A' ' 79' ' ' HIS . 33.1 mm -148.87 92.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.084 -1.01 . . . . 0.0 109.897 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.0 m -79.33 90.52 4.99 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.992 HD13 HG22 ' A' ' 6' ' ' ILE . 11.0 tp -108.24 141.57 39.82 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.315 -0.866 . . . . 0.0 109.614 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.833 ' H ' HD12 ' A' ' 82' ' ' LEU . 8.7 m95 -89.56 -174.54 4.38 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.521 -0.737 . . . . 0.0 109.388 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.69 ' CZ ' ' CE2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -144.05 76.13 1.49 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 1.058 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 55.7 m95 -81.46 157.89 24.74 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 122.218 1.008 . . . . 0.0 110.628 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.09 HD13 HD12 ' A' ' 10' ' ' ILE . 6.2 tp -150.24 98.12 2.64 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.812 ' CG2' HG23 ' A' ' 11' ' ' ILE . 15.8 m -93.64 178.46 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.8 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -110.59 -28.15 8.62 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.23 -0.919 . . . . 0.0 112.32 -178.094 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -161.68 153.77 19.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.547 -1.346 . . . . 0.0 110.788 -178.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.7 ' NE1' ' O ' ' A' ' 92' ' ' GLY . 0.9 OUTLIER -161.96 -167.43 1.66 Allowed 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.582 -0.699 . . . . 0.0 109.564 178.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.535 ' O ' ' O ' ' A' ' 92' ' ' GLY . 22.7 tt0 -90.89 -105.82 0.1 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.274 -0.891 . . . . 0.0 110.062 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.841 ' N ' HG22 ' A' ' 60' ' ' ILE . . . -45.18 173.25 0.01 OUTLIER Glycine 0 N--CA 1.495 2.598 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.852 ' N ' ' HD3' ' A' ' 94' ' ' PRO . 1.5 pt-20 -115.26 28.53 0.11 Allowed Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 119.354 1.577 . . . . 0.0 113.29 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.998 ' CG ' HG21 ' A' ' 58' ' ' VAL . 60.6 Cg_endo -90.41 -123.54 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 122.508 2.139 . . . . 0.0 108.447 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.967 ' CB ' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER 85.76 75.53 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.042 -1.036 . . . . 0.0 111.707 177.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 161.26 -121.77 1.05 Allowed Glycine 0 C--N 1.297 -1.634 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.514 ' CD ' ' HB2' ' A' ' 100' ' ' GLN . 7.3 tttt -94.5 145.86 24.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.109 -1.23 . . . . 0.0 109.995 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.454 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 11.6 pt-20 -89.72 -33.81 16.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.168 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.454 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . -88.11 -10.83 68.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.632 ' HG2' HG22 ' A' ' 21' ' ' THR . 7.1 tt0 -102.65 113.2 66.02 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 121.374 -1.074 . . . . 0.0 109.381 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.29 102.62 0.33 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.041 1.827 . . . . 0.0 110.726 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.851 ' HA2' HG23 ' A' ' 21' ' ' THR . . . -65.38 172.31 22.83 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.536 ' O ' HG22 ' A' ' 20' ' ' ILE . 4.2 pt-20 -147.0 134.22 20.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.543 -1.563 . . . . 0.0 110.14 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.599 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -81.81 94.72 7.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.448 -0.783 . . . . 0.0 109.08 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.443 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -85.04 169.51 13.88 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.082 -1.011 . . . . 0.0 109.471 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.406 ' HB3' HG23 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -96.43 145.51 25.59 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.199 -0.938 . . . . 0.0 109.596 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.492 ' HG ' HD12 ' A' ' 110' ' ' LEU . 1.8 tt -101.39 61.41 0.92 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.406 HG23 ' HB3' ' A' ' 106' ' ' SER . 21.2 t -98.59 -25.95 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.565 -0.709 . . . . 0.0 109.505 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -162.58 38.04 0.35 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.492 HD12 ' HG ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -43.13 145.82 0.48 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.397 -1.061 . . . . 0.0 109.632 -179.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.457 ' ND2' ' HE2' ' A' ' 127' ' ' LYS . 2.6 t30 -156.87 163.12 39.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.082 -1.011 . . . . 0.0 110.028 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.647 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . -61.29 -15.64 37.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 109.184 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -68.44 -33.15 73.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.425 -0.797 . . . . 0.0 109.4 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -79.13 2.09 22.07 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.605 ' CE1' ' CE2' ' A' ' 35' ' ' PHE . 10.2 m-85 -130.97 104.72 15.28 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.443 -0.786 . . . . 0.0 109.179 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.464 ' HG3' ' HB2' ' A' ' 32' ' ' LYS . 21.6 Cg_exo -43.18 160.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.513 2.142 . . . . 0.0 110.831 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.703 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 5.0 Cg_exo -58.03 130.25 37.2 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.518 2.145 . . . . 0.0 111.365 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 160.31 -56.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.549 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 16.1 m-20 -107.84 42.41 1.35 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.641 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -61.51 -38.68 54.33 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.433 -0.792 . . . . 0.0 113.004 -179.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 1.9 Cg_endo -65.06 -37.46 32.8 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 122.0 1.8 . . . . 0.0 111.977 -177.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.651 HG22 ' HE2' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -90.23 -39.34 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.523 -1.361 . . . . 0.0 108.186 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.647 HG21 ' HA ' ' A' ' 112' ' ' ALA . 6.6 mm -56.35 -34.31 40.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.43 -36.78 74.15 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.871 -0.731 . . . . 0.0 109.271 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -55.1 8.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.91 . . . . 0.0 109.967 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -50.65 -17.66 0.56 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.199 -0.938 . . . . 0.0 110.126 -179.475 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.457 ' HE2' ' ND2' ' A' ' 111' ' ' ASN . 15.2 mttt -47.59 -46.37 28.2 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.825 -1.172 . . . . 0.0 108.923 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -95.98 47.71 1.1 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.459 -0.775 . . . . 0.0 109.319 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.821 HD21 ' CD2' ' A' ' 86' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.305 -1.345 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.658 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.4 tp . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.351 0.595 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.771 ' C ' HG22 ' A' ' 40' ' ' ILE . 2.0 mt-30 -118.12 159.25 23.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 0.0 109.177 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.695 HG23 ' N ' ' A' ' 7' ' ' ALA . 2.1 tt -134.4 -173.94 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.132 -0.98 . . . . 0.0 109.365 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.695 ' N ' HG23 ' A' ' 6' ' ' ILE . . . -138.31 104.92 5.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.198 -0.939 . . . . 0.0 109.311 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 7.6 p -113.08 139.96 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.428 -0.795 . . . . 0.0 109.567 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.609 ' CA ' ' NE1' ' A' ' 85' ' ' TRP . . . -121.77 126.32 6.44 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.639 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.931 HD11 ' CD2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -107.17 144.27 16.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.085 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.843 HG23 HG21 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -123.69 156.04 30.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.866 -1.146 . . . . 0.0 109.253 179.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -157.44 125.25 5.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.474 -0.766 . . . . 0.0 109.451 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.577 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 26.9 p-10 -156.63 -168.48 2.7 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.879 -1.138 . . . . 0.0 111.169 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 13' ' ' ASN . 3.8 mt-10 66.16 -83.44 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.863 0.84 . . . . 0.0 110.048 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -132.68 -59.21 0.91 Allowed 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 122.004 0.907 . . . . 0.0 109.593 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -164.72 32.55 0.07 Allowed 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 3.7 mt-10 -89.39 148.95 23.21 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.903 HD11 ' HB2' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -131.21 154.91 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.06 -1.025 . . . . 0.0 109.582 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.586 ' CZ ' ' OE1' ' A' ' 100' ' ' GLN . 9.6 t80 -116.63 84.87 2.21 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.632 HD11 ' HB ' ' A' ' 18' ' ' ILE . 0.6 OUTLIER -107.3 -152.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 108.619 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.966 HG21 ' HD3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -131.23 151.32 51.59 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.015 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.306 -1.305 0 O-C-N 121.43 -0.794 . . . . 0.0 109.818 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.533 ' HB2' ' HG3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -148.81 132.31 16.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.206 -0.934 . . . . 0.0 109.339 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.587 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -93.6 -176.86 4.21 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 120.93 -1.106 . . . . 0.0 108.389 179.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.491 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 4.8 tt0 -163.44 -158.9 0.49 Allowed 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 118.804 -1.159 . . . . 0.0 111.067 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 1.051 ' CE2' HD11 ' A' ' 123' ' ' ILE . 57.8 m-85 -161.64 64.75 1.85 Allowed Pre-proline 0 C--N 1.299 -1.601 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 34' ' ' GLU . 2.3 Cg_endo -60.62 -84.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.235 1.957 . . . . 0.0 110.706 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 105.6 -120.64 6.51 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -156.46 -77.85 0.02 OUTLIER Glycine 0 N--CA 1.488 2.1 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 6.0 tttp 177.41 132.31 0.06 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.483 -1.01 . . . . 0.0 109.318 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.771 HG22 ' C ' ' A' ' 5' ' ' GLN . 14.2 tt -118.93 120.04 62.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.378 -0.826 . . . . 0.0 108.978 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -85.55 144.73 27.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.033 -1.042 . . . . 0.0 109.826 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.17 165.15 23.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.372 -0.83 . . . . 0.0 109.406 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.67 -17.23 57.08 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.24 -153.95 0.44 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.588 -0.948 . . . . 0.0 108.816 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.852 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -122.1 176.96 1.74 Allowed Pre-proline 0 C--N 1.307 -1.277 0 O-C-N 120.791 -1.193 . . . . 0.0 108.526 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.852 ' CD ' HG22 ' A' ' 45' ' ' THR . 10.2 Cg_endo -76.96 -7.57 17.42 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.052 1.835 . . . . 0.0 110.986 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.593 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -113.59 -62.34 1.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.934 -1.104 . . . . 0.0 110.609 -178.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.54 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 2.5 tt0 -39.29 -36.22 0.32 Allowed 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.658 1.218 . . . . 0.0 109.502 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 47' ' ' GLU . . . -60.42 -67.08 0.43 Allowed 'General case' 0 C--N 1.271 -2.824 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.313 -178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.545 HG22 ' HH2' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -81.55 -44.0 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.271 -0.893 . . . . 0.0 110.447 -178.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 47' ' ' GLU . 7.4 p -39.95 -45.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.571 ' N ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -73.94 -37.36 64.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.114 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 50' ' ' VAL . 5.1 mm-40 -67.4 -7.06 22.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.197 -0.939 . . . . 0.0 109.446 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.891 HD23 ' HE1' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -76.45 -54.76 6.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.957 -1.089 . . . . 0.0 109.62 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -80.02 -29.77 39.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.009 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.493 ' HG3' ' HG3' ' A' ' 52' ' ' ARG . 11.9 mm-40 -81.55 35.37 0.4 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.136 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.516 ' HB2' ' CD1' ' A' ' 95' ' ' TRP . 12.3 mt-10 -150.53 -66.52 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.901 -1.124 . . . . 0.0 109.613 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.071 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.4 p -122.56 -27.21 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 O-C-N 121.043 -1.035 . . . . 0.0 109.788 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.02 70.23 1.21 Allowed Glycine 0 N--CA 1.489 2.177 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.26 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.649 HD12 ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -90.12 172.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.716 ' CB ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -123.36 -70.02 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 120.201 -1.562 . . . . 0.0 111.221 -178.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.716 ' HD3' ' CB ' ' A' ' 61' ' ' THR . 12.3 Cg_endo -75.35 49.04 2.24 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 122.057 1.838 . . . . 0.0 111.251 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.815 HE22 HD21 ' A' ' 54' ' ' LEU . 11.7 tt0 -101.52 72.3 1.39 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.672 -1.267 . . . . 0.0 109.276 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -65.59 105.13 1.14 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.792 ' CB ' HG12 ' A' ' 87' ' ' VAL . 30.5 p90 -125.41 179.58 5.05 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.758 1.266 . . . . 0.0 111.97 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 68' ' ' PHE . 4.9 m -162.19 131.82 4.54 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.777 HD21 ' HE3' ' A' ' 70' ' ' LYS . 43.5 tp -49.04 94.76 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.726 -1.234 . . . . 0.0 109.578 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.713 ' HE2' HG13 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -42.93 -77.15 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.586 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 3.3 mm-40 -156.67 -173.5 4.51 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.777 ' HE3' HD21 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -140.43 147.81 40.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.065 -1.022 . . . . 0.0 109.845 -179.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.719 HD23 ' HB ' ' A' ' 122' ' ' VAL . 0.5 OUTLIER -124.32 -178.45 4.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.15 -0.969 . . . . 0.0 109.671 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -160.88 146.77 14.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.478 -0.764 . . . . 0.0 109.398 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -129.3 -163.53 1.3 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.957 . . . . 0.0 109.29 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -157.44 117.6 3.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 0.0 109.187 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.74 ' CE2' HD13 ' A' ' 80' ' ' ILE . 1.4 m-85 -79.62 170.37 16.24 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.0 Cg_exo -56.89 -6.34 1.7 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.063 1.842 . . . . 0.0 111.983 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.63 -17.04 0.32 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.566 -1.334 . . . . 0.0 112.113 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.526 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -131.44 -177.76 4.55 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.446 -1.409 . . . . 0.0 110.507 -178.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -121.67 121.69 37.91 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.74 HD13 ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -101.92 161.38 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.083 -1.011 . . . . 0.0 109.734 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.4 m -152.42 105.28 3.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.417 -0.802 . . . . 0.0 109.354 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.65 ' HG ' HG22 ' A' ' 6' ' ' ILE . 1.2 mp -85.94 149.93 24.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 109.821 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.603 ' CE2' ' HB3' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -110.35 115.97 30.62 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.931 ' CD2' HD11 ' A' ' 10' ' ' ILE . 2.2 m-85 -97.55 100.72 12.14 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.327 -0.858 . . . . 0.0 111.695 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.612 ' O ' ' CG ' ' A' ' 85' ' ' TRP . 29.1 p-90 -105.72 82.8 1.84 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.8 -1.188 . . . . 0.0 108.263 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.715 HD13 ' HB ' ' A' ' 10' ' ' ILE . 24.7 tp -78.06 146.01 35.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.434 -0.791 . . . . 0.0 110.673 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.843 HG21 HG23 ' A' ' 11' ' ' ILE . 17.7 m -113.13 -163.01 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.548 -0.72 . . . . 0.0 109.642 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 7.3 mt-10 -141.35 -29.72 0.63 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -0.981 . . . . 0.0 111.041 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.707 ' O ' ' HB3' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -143.78 -172.85 3.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.745 -1.222 . . . . 0.0 109.432 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.715 ' CE3' HG22 ' A' ' 11' ' ' ILE . 17.2 p90 154.47 162.59 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 122.72 1.248 . . . . 0.0 110.968 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.595 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 46.8 tt0 -126.11 90.11 3.13 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.186 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 157.66 -158.1 28.74 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 1.071 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -121.37 78.68 35.98 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 1.003 ' HA ' HG11 ' A' ' 58' ' ' VAL . 16.7 Cg_exo -40.02 156.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.064 2.509 . . . . 0.0 112.906 -177.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.891 ' HE1' HD23 ' A' ' 54' ' ' LEU . 45.4 p-90 -98.91 -163.4 1.03 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.461 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . 161.1 -21.99 0.22 Allowed Glycine 0 C--N 1.295 -1.708 0 C-N-CA 119.233 -1.46 . . . . 0.0 109.738 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.966 ' HD3' HG21 ' A' ' 21' ' ' THR . 29.6 tttt -146.44 160.03 42.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.418 -1.048 . . . . 0.0 109.312 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -44.24 104.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 108.587 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.98 -133.09 11.61 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.604 ' N ' ' HD3' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -150.09 53.58 1.31 Allowed Pre-proline 0 C--N 1.306 -1.322 0 O-C-N 120.926 -1.338 . . . . 0.0 110.24 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.604 ' HD3' ' N ' ' A' ' 100' ' ' GLN . 9.4 Cg_endo -71.16 -15.95 31.87 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.0 1.8 . . . . 0.0 110.236 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -64.04 -173.64 3.06 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.43 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 2.0 pm0 -156.96 169.62 24.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -1.148 . . . . 0.0 109.753 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -99.48 105.27 17.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -0.838 . . . . 0.0 109.228 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.491 ' HE3' ' HB2' ' A' ' 105' ' ' MET . 0.1 OUTLIER -83.44 163.26 20.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 109.506 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.89 91.48 3.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.315 -0.866 . . . . 0.0 109.302 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 mt 49.55 51.59 16.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 109.735 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.658 ' O ' HG12 ' A' ' 108' ' ' VAL . 44.6 t -104.33 26.74 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 108.955 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 114' ' ' ASP . . . 104.22 60.03 0.68 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.911 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -64.25 -13.99 52.82 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.201 -1.176 . . . . 0.0 108.663 179.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.27 -177.35 5.12 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.363 -0.836 . . . . 0.0 109.462 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.796 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . -62.32 -12.15 19.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 109.712 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -60.04 -52.63 64.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.845 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 13.6 t0 -79.17 -2.87 42.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.351 -0.843 . . . . 0.0 108.908 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.656 ' CZ ' ' CZ ' ' A' ' 35' ' ' PHE . 18.1 m-85 -109.27 108.19 60.08 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.288 -0.882 . . . . 0.0 108.816 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.533 ' HG3' ' HB2' ' A' ' 32' ' ' LYS . 10.0 Cg_exo -49.83 160.35 1.26 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.516 2.144 . . . . 0.0 111.152 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.71 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 4.8 Cg_exo -59.17 118.08 4.91 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.397 2.065 . . . . 0.0 110.232 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 161.28 -36.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.559 ' OD1' ' CZ ' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -118.49 39.53 3.44 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.348 -0.845 . . . . 0.0 109.193 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.688 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.9 mt-10 -69.92 -34.65 4.51 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.411 -0.806 . . . . 0.0 112.575 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.3 Cg_exo -59.56 -37.2 90.1 Favored 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 121.644 1.563 . . . . 0.0 112.012 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.719 ' HB ' HD23 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -102.18 -42.75 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.441 -1.412 . . . . 0.0 108.128 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 1.051 HD11 ' CE2' ' A' ' 35' ' ' PHE . 14.7 mm -54.05 -28.66 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.571 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -73.1 -36.35 66.76 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.518 -0.739 . . . . 0.0 109.571 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -70.49 -48.3 56.37 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.209 -0.932 . . . . 0.0 110.51 -179.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 1.045 ' HB2' HD13 ' A' ' 129' ' ' LEU . 0.9 OUTLIER -80.59 20.59 0.71 Allowed 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.842 -1.161 . . . . 0.0 110.741 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.571 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 17.2 mttt -63.63 -40.6 97.31 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.9 -1.125 . . . . 0.0 108.394 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.493 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -79.11 7.43 7.49 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.903 -0.498 . . . . 0.0 110.125 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 1.045 HD13 ' HB2' ' A' ' 126' ' ' LEU . 4.7 tp . . . . . 0 N--CA 1.499 2.011 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.447 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.837 HD13 ' OG1' ' A' ' 81' ' ' THR . 2.5 pp . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.24 0.543 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.491 ' CG ' ' C ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER 169.84 99.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 109.81 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.842 HD13 HG23 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -122.02 167.1 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.716 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -134.15 81.8 1.94 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.341 -0.849 . . . . 0.0 109.133 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 83' ' ' TRP . 12.1 p -88.84 139.28 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.359 -0.838 . . . . 0.0 108.751 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.27 117.22 2.23 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.061 HD12 ' CD1' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -100.28 170.06 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.246 -1.15 . . . . 0.0 108.692 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.869 ' HA ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -147.58 154.71 11.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.981 -1.075 . . . . 0.0 110.479 -179.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.472 ' HD2' ' HG ' ' A' ' 107' ' ' LEU . 1.4 ttp180 -161.32 117.76 2.2 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.524 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 1.9 t-20 -105.54 -153.32 0.49 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.873 -1.142 . . . . 0.0 110.831 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -80.45 -5.4 56.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.748 -0.595 . . . . 0.0 109.536 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -79.71 5.57 13.05 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.233 -0.917 . . . . 0.0 108.952 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 21.9 t-20 52.86 42.91 32.06 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.467 -0.77 . . . . 0.0 109.338 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 2.6 mt-10 -134.82 150.1 50.45 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.865 HD13 HD11 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -110.48 155.09 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.025 -1.047 . . . . 0.0 109.459 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.582 ' HB3' ' CG1' ' A' ' 11' ' ' ILE . 45.0 t80 -103.36 71.68 1.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 0.0 109.29 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.879 HG21 HD12 ' A' ' 33' ' ' LEU . 2.5 mm -81.16 -177.73 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.542 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.797 HG23 ' CA ' ' A' ' 102' ' ' GLY . 0.1 OUTLIER -155.89 144.14 19.99 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.144 -0.972 . . . . 0.0 109.15 179.127 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.485 ' HG2' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.994 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.439 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 1.8 m-20 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.432 0.634 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.683 ' C ' HD22 ' A' ' 33' ' ' LEU . 12.1 mttp -92.09 170.19 10.03 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.363 -0.836 . . . . 0.0 108.754 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.879 HD12 HG21 ' A' ' 20' ' ' ILE . 3.0 mm? -105.5 176.66 5.09 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 109.58 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 22' ' ' ARG . 2.8 tt0 -160.97 -160.9 0.78 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 122.246 1.022 . . . . 0.0 110.577 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.636 ' CD1' ' HG3' ' A' ' 117' ' ' PRO . 29.3 m-85 -144.59 84.72 8.95 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.573 ' HG3' ' CB ' ' A' ' 21' ' ' THR . 3.1 Cg_exo -60.13 -150.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.405 2.07 . . . . 0.0 110.208 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 151.08 -168.71 30.75 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -147.46 18.05 1.49 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER 69.34 149.11 0.07 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.35 -1.088 . . . . 0.0 109.919 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.09 131.71 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 42' ' ' MET . 4.8 mt-10 -134.81 -147.82 0.29 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.09 -1.006 . . . . 0.0 110.052 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 41' ' ' GLU . 1.9 ptm -39.7 162.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.559 -0.713 . . . . 0.0 110.137 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.51 -157.08 27.1 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -125.34 -34.86 2.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -1.165 . . . . 0.0 109.426 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.544 ' OG1' ' HD2' ' A' ' 46' ' ' PRO . 0.5 OUTLIER -160.32 171.55 7.02 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 5.0 Cg_exo -59.02 -1.96 1.0 Allowed 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.536 2.157 . . . . 0.0 112.971 -178.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.576 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -102.5 -54.24 2.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.479 -1.388 . . . . 0.0 109.056 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.489 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 2.3 tt0 -63.79 -46.7 84.01 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 122.55 1.167 . . . . 0.0 108.738 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -45.36 -49.63 12.82 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.042 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.729 HG22 ' HH2' ' A' ' 95' ' ' TRP . 3.5 p -79.94 -20.32 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.343 -0.848 . . . . 0.0 110.003 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.615 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -61.04 -50.98 78.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.615 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -57.62 -35.86 71.03 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 113.114 -1.857 . . . . 0.0 109.847 178.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.464 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 2.4 mt-10 -64.87 -24.75 67.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.816 -1.178 . . . . 0.0 109.153 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.916 HD13 ' NE1' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -73.53 -70.98 0.34 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.525 -0.735 . . . . 0.0 109.909 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.595 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -59.19 -21.15 58.99 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.974 -0.454 . . . . 0.0 111.504 -178.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.464 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 8.8 pt-20 -80.74 1.52 29.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.578 -1.326 . . . . 0.0 110.549 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -135.72 -59.38 0.76 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.927 -1.108 . . . . 0.0 110.982 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.657 ' CG1' ' HB3' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -114.18 -42.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.228 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.595 ' CA ' ' HA ' ' A' ' 55' ' ' GLN . . . 59.42 72.25 0.64 Allowed Glycine 0 C--N 1.293 -1.835 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.85 ' H ' HD11 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -79.78 163.4 3.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.652 ' CB ' ' HD3' ' A' ' 62' ' ' PRO . 1.3 m -100.91 -68.93 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 120.219 -1.55 . . . . 0.0 110.471 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.652 ' HD3' ' CB ' ' A' ' 61' ' ' THR . 5.6 Cg_endo -70.36 49.31 0.83 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.152 1.901 . . . . 0.0 111.766 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.612 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 1.3 pt20 -83.81 55.73 3.37 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.953 -1.092 . . . . 0.0 109.231 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -62.22 118.02 6.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.185 -0.947 . . . . 0.0 109.278 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.42 ' CB ' ' HA ' ' A' ' 87' ' ' VAL . 48.0 p90 -133.18 -173.52 3.23 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.171 0.986 . . . . 0.0 110.764 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 67' ' ' LEU . 8.0 t -157.51 -4.02 0.1 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.12 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.852 HD22 ' CH2' ' A' ' 83' ' ' TRP . 21.9 tp 55.18 110.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.889 -1.132 . . . . 0.0 110.164 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.837 ' CD2' HD21 ' A' ' 126' ' ' LEU . 0.9 OUTLIER -55.92 -75.07 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.58 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.3 mt-10 -155.25 -169.15 3.07 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.309 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.406 ' HE2' ' CE3' ' A' ' 83' ' ' TRP . 8.0 ttmt -145.86 126.66 14.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.261 -0.9 . . . . 0.0 109.55 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.808 HD23 ' HB ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -112.48 -169.29 1.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.131 -0.981 . . . . 0.0 109.49 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -146.64 140.82 26.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.917 . . . . 0.0 109.216 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.401 ' OH ' ' O ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -129.74 169.93 14.49 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.246 -0.909 . . . . 0.0 109.923 -179.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 2.2 tt0 -161.05 113.6 1.92 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.609 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -79.23 175.2 4.99 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.086 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.609 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 1.4 Cg_endo -63.87 2.69 0.94 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.149 1.899 . . . . 0.0 111.88 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.82 -24.96 0.46 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.507 -1.371 . . . . 0.0 111.899 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 1.3 ptt180 -131.65 179.72 5.88 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.611 -1.305 . . . . 0.0 110.974 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.533 ' HB2' ' N ' ' A' ' 4' ' ' LEU . 1.1 m170 -119.11 135.41 54.66 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.842 HG23 HD13 ' A' ' 6' ' ' ILE . 22.8 mm -146.27 107.99 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.032 -1.043 . . . . 0.0 110.716 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.837 ' OG1' HD13 ' A' ' 4' ' ' LEU . 3.1 m -101.67 105.26 16.15 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.55 HD22 ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -79.89 131.66 35.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.962 -1.086 . . . . 0.0 110.41 -178.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.852 ' CH2' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -121.76 124.03 43.24 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.68 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -124.1 119.99 31.07 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.444 -1.41 . . . . 0.0 110.036 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.813 ' CZ3' HG12 ' A' ' 87' ' ' VAL . 18.5 p-90 -100.41 87.97 3.54 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.061 ' CD1' HD12 ' A' ' 10' ' ' ILE . 2.8 mm? -56.35 130.29 44.03 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.571 0.701 . . . . 0.0 110.474 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.869 HG22 ' HA ' ' A' ' 11' ' ' ILE . 3.7 m -103.53 -170.85 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.475 -0.766 . . . . 0.0 109.322 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 1.0 OUTLIER -138.93 -36.09 0.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.914 -1.116 . . . . 0.0 110.643 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -142.72 178.88 7.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.051 -1.031 . . . . 0.0 109.906 -179.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.823 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 41.3 p90 168.68 168.47 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.628 1.204 . . . . 0.0 110.74 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.565 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 9.9 tt0 -125.9 99.17 5.82 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.905 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.489 ' O ' ' HD3' ' A' ' 94' ' ' PRO . . . 135.12 -169.25 23.4 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.568 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -99.23 104.98 29.7 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.652 ' HB3' HD12 ' A' ' 11' ' ' ILE . 4.5 Cg_exo -55.73 178.5 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.257 1.971 . . . . 0.0 112.256 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.916 ' NE1' HD13 ' A' ' 54' ' ' LEU . 3.7 p-90 -125.58 -167.32 1.67 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.797 0.808 . . . . 0.0 109.468 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.35 -32.12 0.08 OUTLIER Glycine 0 N--CA 1.482 1.759 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.552 ' HG3' ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -126.0 -145.27 0.32 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -115.09 38.56 3.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.133 -0.979 . . . . 0.0 108.834 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.31 55.53 0.76 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.506 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -119.85 151.99 53.17 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.275 -1.132 . . . . 0.0 109.8 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -67.08 98.61 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.355 2.037 . . . . 0.0 110.339 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.797 ' CA ' HG23 ' A' ' 21' ' ' THR . . . -82.35 -171.35 46.44 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -147.46 123.44 10.71 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.957 -1.319 . . . . 0.0 109.471 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.49 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 26.8 m95 -77.99 84.2 4.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.039 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.818 ' HE2' HD11 ' A' ' 33' ' ' LEU . 12.6 ttp -80.46 148.55 30.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 0.0 109.224 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.52 160.7 6.68 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.119 -0.988 . . . . 0.0 109.976 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.928 ' O ' HD13 ' A' ' 107' ' ' LEU . 1.6 tm? -130.63 70.91 1.45 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.2 t -103.14 -43.7 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 109.78 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -139.95 50.91 0.75 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.865 HD11 HD13 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -42.79 141.61 1.05 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.424 -1.045 . . . . 0.0 109.732 -179.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.491 ' HB3' ' OD2' ' A' ' 113' ' ' ASP . 4.4 t30 -157.41 -173.88 4.62 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.466 -0.771 . . . . 0.0 108.995 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.458 ' HB2' ' HE3' ' A' ' 127' ' ' LYS . . . -80.77 -10.34 59.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.731 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.491 ' OD2' ' HB3' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -66.57 -37.58 85.25 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.067 -1.021 . . . . 0.0 110.637 -179.167 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.682 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -96.85 27.7 3.84 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.968 -1.083 . . . . 0.0 109.483 -179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.64 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -146.26 89.81 5.85 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.939 . . . . 0.0 109.207 179.593 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.597 ' N ' ' HD3' ' A' ' 117' ' ' PRO . 36.9 Cg_endo -98.93 36.18 0.09 OUTLIER 'Trans proline' 0 CA--C 1.556 1.6 0 C-N-CA 123.58 2.854 . . . . 0.0 115.941 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.727 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 10.5 Cg_endo -73.55 -1.05 10.14 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 121.686 1.591 . . . . 0.0 110.06 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 117' ' ' PRO . . . 80.35 24.98 0.34 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.589 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 10.4 m120 -107.22 42.0 1.39 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.593 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.2 mt-10 -47.09 -44.12 47.22 Favored Pre-proline 0 C--N 1.296 -1.735 0 O-C-N 121.164 -0.96 . . . . 0.0 112.083 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 5.3 Cg_exo -61.88 -39.18 53.39 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.881 1.721 . . . . 0.0 112.562 -178.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.808 ' HB ' HD23 ' A' ' 71' ' ' LEU . 1.6 t -90.23 -54.95 6.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 O-C-N 120.291 -1.506 . . . . 0.0 107.842 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.89 ' HA ' HD12 ' A' ' 126' ' ' LEU . 11.4 mm -43.84 -33.96 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.47 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -52.33 -52.94 50.38 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -42.86 98.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.51 -0.744 . . . . 0.0 109.787 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.89 HD12 ' HA ' ' A' ' 123' ' ' ILE . 1.9 mt -66.42 -5.32 10.51 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.104 -0.997 . . . . 0.0 110.328 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.47 ' HE3' ' HA ' ' A' ' 124' ' ' ALA . 22.3 mttt -56.41 -49.65 73.88 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.051 -1.031 . . . . 0.0 108.351 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 129' ' ' LEU . 11.6 mtp180 -90.3 34.89 0.86 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.451 -0.781 . . . . 0.0 108.984 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 126' ' ' LEU . 1.2 mt . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.893 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.592 HD11 HG12 ' A' ' 80' ' ' ILE . 2.6 pp . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.535 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . 26.1 mt-30 -133.01 150.61 52.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.201 -0.937 . . . . 0.0 109.853 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.591 HG22 ' N ' ' A' ' 7' ' ' ALA . 9.9 mt -121.76 167.15 15.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.357 -0.839 . . . . 0.0 109.495 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.591 ' N ' HG22 ' A' ' 6' ' ' ILE . . . -132.82 106.02 7.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -0.952 . . . . 0.0 109.543 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.788 HG13 ' O ' ' A' ' 8' ' ' VAL . 8.5 p -122.08 83.88 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.216 -0.927 . . . . 0.0 109.778 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.97 ' H ' HD11 ' A' ' 54' ' ' LEU . . . -68.97 117.22 7.86 Favored Glycine 0 C--N 1.294 -1.786 0 N-CA-C 107.496 -2.242 . . . . 0.0 107.496 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.595 HG22 ' H ' ' A' ' 11' ' ' ILE . 0.7 OUTLIER -76.42 -172.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.071 -1.253 . . . . 0.0 107.688 -179.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.963 ' HA ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -144.97 149.53 16.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 117.864 -1.534 . . . . 0.0 111.371 -176.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.51 ' HD2' HD13 ' A' ' 107' ' ' LEU . 10.4 ttp180 -148.53 128.27 13.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.634 ' ND2' ' CH2' ' A' ' 90' ' ' TRP . 1.2 m-20 -98.07 -160.68 0.82 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.817 -1.177 . . . . 0.0 110.74 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 81.3 tt0 -91.56 -6.05 53.04 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.393 0.616 . . . . 0.0 109.367 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.504 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 3.2 t-20 -85.21 14.5 5.13 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.48 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 13.6 t30 58.41 48.24 12.56 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.571 -0.706 . . . . 0.0 109.908 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 105' ' ' MET . 1.4 pt-20 -136.73 171.84 13.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.251 -0.906 . . . . 0.0 109.235 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.487 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 1.3 mt -125.35 157.67 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.932 . . . . 0.0 109.427 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.65 ' CD2' ' CD1' ' A' ' 11' ' ' ILE . 46.0 t80 -106.87 83.13 1.79 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.686 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -79.81 -173.68 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 120.988 -1.07 . . . . 0.0 110.163 -178.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.603 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -130.75 142.85 50.43 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.199 -0.601 . . . . 0.0 109.815 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.572 ' HG3' ' CD2' ' A' ' 33' ' ' LEU . 6.1 ttm180 . . . . . 0 C--N 1.305 -1.331 0 O-C-N 121.247 -0.908 . . . . 0.0 109.91 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.56 139.28 34.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 109.881 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.595 ' HB2' ' CD1' ' A' ' 115' ' ' PHE . 25.3 mt -105.77 -174.3 2.5 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.379 -0.825 . . . . 0.0 108.943 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.686 ' O ' HD11 ' A' ' 20' ' ' ILE . 3.1 tt0 -161.39 -157.5 0.51 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.564 -1.335 . . . . 0.0 110.732 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.78 ' HB3' HG21 ' A' ' 8' ' ' VAL . 81.1 m-85 -152.65 152.51 28.85 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.758 ' C ' HG23 ' A' ' 8' ' ' VAL . 2.0 Cg_endo -63.08 -151.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.17 1.913 . . . . 0.0 109.861 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 91.79 179.21 41.95 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.45 -40.59 0.05 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -167.19 169.85 12.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.18 -1.188 . . . . 0.0 109.765 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.785 HD12 ' NE1' ' A' ' 83' ' ' TRP . 14.1 tt -133.69 123.94 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.379 -0.825 . . . . 0.0 109.1 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -80.26 130.92 35.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 110.027 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 42' ' ' MET . 31.1 ttp -117.32 72.22 0.83 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 109.105 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.67 1.53 5.18 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -151.59 -71.1 0.16 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.114 -1.227 . . . . 0.0 110.026 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.787 HG23 ' H ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -154.62 168.19 12.44 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 120.904 -1.122 . . . . 0.0 109.776 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.516 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 2.1 Cg_endo -67.88 -27.93 36.62 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.786 2.324 . . . . 0.0 112.103 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 1.06 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -78.56 -69.75 0.54 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.832 -1.167 . . . . 0.0 109.197 -179.208 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.708 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 12.7 tt0 -37.63 -34.66 0.11 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 122.938 1.352 . . . . 0.0 109.078 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.517 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -52.64 -67.72 0.23 Allowed 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.254 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.737 ' CG2' HD12 ' A' ' 54' ' ' LEU . 9.0 p -80.99 -43.87 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.096 -1.003 . . . . 0.0 111.274 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.06 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.3 p -43.6 -48.88 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.449 -0.782 . . . . 0.0 109.168 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.492 ' N ' HG13 ' A' ' 51' ' ' VAL . 1.2 ttt180 -81.39 -26.12 35.71 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.308 -0.87 . . . . 0.0 110.506 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 3.4 mm-40 -72.88 -67.23 0.58 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.748 -1.22 . . . . 0.0 110.674 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.97 HD11 ' H ' ' A' ' 9' ' ' GLY . 14.1 mt -54.06 -38.18 64.99 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.303 -0.873 . . . . 0.0 110.726 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.494 ' O ' ' HA2' ' A' ' 59' ' ' GLY . 3.7 pt20 -67.89 -32.12 72.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.971 -1.08 . . . . 0.0 110.075 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.493 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 1.3 pt-20 -78.59 -4.7 50.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.878 -1.139 . . . . 0.0 109.596 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.34 -49.19 5.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.174 -0.954 . . . . 0.0 109.538 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.838 HG22 HD13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -114.04 -30.07 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.182 -0.949 . . . . 0.0 108.49 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 55' ' ' GLN . . . 74.25 90.2 0.17 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.445 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.02 HD12 ' O ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -114.54 170.53 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.367 -1.078 . . . . 0.0 108.48 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.729 ' CB ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -118.17 -70.4 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.807 -1.183 . . . . 0.0 109.596 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.729 ' HD3' ' CB ' ' A' ' 61' ' ' THR . 10.0 Cg_endo -74.73 40.69 0.65 Allowed 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 122.006 1.804 . . . . 0.0 111.325 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.628 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 0.9 OUTLIER -81.68 59.07 4.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 109.783 -179.219 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -65.62 126.54 28.7 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.734 ' CB ' HG12 ' A' ' 87' ' ' VAL . 4.0 p90 -146.63 -177.42 5.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.738 -1.226 . . . . 0.0 111.755 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.4 m -161.77 143.53 11.33 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 84' ' ' PHE . 36.8 tp -71.49 97.13 1.6 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.604 -1.31 . . . . 0.0 109.792 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.666 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -44.79 -77.96 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.728 ' O ' HG21 ' A' ' 122' ' ' VAL . 0.6 OUTLIER -158.94 125.19 4.53 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -90.57 151.96 21.1 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.141 -0.974 . . . . 0.0 110.112 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.94 HD21 ' OD1' ' A' ' 119' ' ' ASN . 0.7 OUTLIER -116.43 -167.25 1.25 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -160.04 161.9 34.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.896 -1.128 . . . . 0.0 110.275 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -154.46 127.22 8.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.493 -0.754 . . . . 0.0 109.205 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -99.88 122.26 42.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 109.735 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.579 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -84.01 177.97 2.68 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.579 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 3.9 Cg_exo -56.71 -10.4 5.28 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.828 1.686 . . . . 0.0 111.736 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -161.7 -3.3 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.728 -1.232 . . . . 0.0 112.484 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.543 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -128.1 -172.38 2.67 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.212 -1.555 . . . . 0.0 110.041 -179.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -132.03 91.94 3.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.395 -0.816 . . . . 0.0 109.613 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.592 HG12 HD11 ' A' ' 4' ' ' LEU . 11.4 mt -81.84 102.5 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 109.462 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.23 126.05 52.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.738 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.31 150.04 41.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.29 -0.881 . . . . 0.0 109.073 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.785 ' NE1' HD12 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -120.06 149.04 42.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.054 -1.029 . . . . 0.0 109.574 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.563 ' CG ' HG11 ' A' ' 122' ' ' VAL . 6.5 m-85 -113.35 94.41 4.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.222 -0.924 . . . . 0.0 109.221 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.502 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 77.7 m95 -88.51 90.37 8.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.043 -1.036 . . . . 0.0 108.948 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.014 HD21 HD21 ' A' ' 129' ' ' LEU . 10.7 tp -79.28 117.45 20.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.478 -0.763 . . . . 0.0 109.442 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.963 HG22 ' HA ' ' A' ' 11' ' ' ILE . 3.1 m -88.46 -161.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 O-C-N 121.213 -0.93 . . . . 0.0 110.33 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 20.7 mt-10 -147.67 -33.97 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.987 . . . . 0.0 111.231 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.628 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -147.21 164.39 33.32 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.658 -1.276 . . . . 0.0 110.479 -179.134 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.634 ' CH2' ' ND2' ' A' ' 13' ' ' ASN . 13.6 p90 179.19 171.44 0.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 122.029 0.918 . . . . 0.0 109.644 178.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.55 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 77.2 tt0 -116.34 -92.86 0.51 Allowed 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.509 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . -23.76 -91.47 0.01 OUTLIER Glycine 0 N--CA 1.499 2.866 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 1.02 ' O ' HD12 ' A' ' 60' ' ' ILE . 1.6 mt-10 -131.19 166.09 30.34 Favored Pre-proline 0 C--O 1.188 -2.138 0 O-C-N 121.647 -0.913 . . . . 0.0 108.862 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.638 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 6.1 Cg_exo -36.7 -93.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.281 -3.023 0 C-N-CA 123.106 2.537 . . . . 0.0 112.091 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.815 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.0 t90 171.03 -21.6 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.132 -0.98 . . . . 0.0 111.265 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' A' ' 36' ' ' PRO . . . -107.21 -101.21 2.7 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.469 -1.348 . . . . 0.0 109.821 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.487 ' N ' ' HB3' ' A' ' 36' ' ' PRO . 3.0 tttt 41.07 94.12 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.493 -1.004 . . . . 0.0 110.215 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -116.52 52.56 0.92 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.88 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.57 2.35 53.2 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -124.61 123.34 25.73 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.205 -1.173 . . . . 0.0 109.701 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -60.85 111.4 1.05 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.939 1.759 . . . . 0.0 109.899 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.603 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -93.41 -179.81 39.34 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -138.07 161.18 37.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.073 -1.251 . . . . 0.0 111.137 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.464 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 34.7 m0 -94.73 93.37 7.48 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.526 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -82.45 -173.89 4.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.016 -1.052 . . . . 0.0 109.674 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.05 160.77 15.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.891 . . . . 0.0 109.153 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.877 HD11 HD23 ' A' ' 129' ' ' LEU . 1.8 tp -108.9 45.84 1.01 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.145 -0.972 . . . . 0.0 109.795 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.547 ' O ' HG12 ' A' ' 108' ' ' VAL . 18.2 t -103.39 19.06 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.082 -1.011 . . . . 0.0 108.83 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 132.82 74.05 0.1 OUTLIER Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 110' ' ' LEU . 2.7 mt -43.49 138.77 2.33 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.372 -1.075 . . . . 0.0 109.626 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.44 98.79 11.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.439 -0.788 . . . . 0.0 109.777 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.583 ' CB ' HG22 ' A' ' 123' ' ' ILE . . . -64.59 -21.76 66.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 108.971 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -68.6 -27.79 66.36 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.488 -0.758 . . . . 0.0 109.506 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.506 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 2.8 t0 -78.43 -9.99 59.52 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.687 ' CZ ' ' CZ ' ' A' ' 35' ' ' PHE . 11.0 m-85 -94.03 154.98 40.59 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 108.83 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.545 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 1.2 Cg_endo -71.42 144.7 46.06 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.994 1.796 . . . . 0.0 110.211 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.721 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.2 Cg_endo -64.71 112.71 2.06 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.341 2.028 . . . . 0.0 110.41 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 162.35 -22.56 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 109.84 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.94 ' OD1' HD21 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -119.76 45.25 2.2 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.092 -1.005 . . . . 0.0 109.314 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.68 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 7.1 mt-10 -68.87 -32.77 3.7 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.5 Cg_exo -58.83 -38.78 86.8 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.409 1.406 . . . . 0.0 111.992 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.899 ' HB ' HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -104.37 -38.06 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 120.434 -1.416 . . . . 0.0 108.784 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.583 HG22 ' CB ' ' A' ' 112' ' ' ALA . 7.4 mm -55.25 -38.81 48.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.483 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -55.32 -46.27 76.32 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.522 -0.736 . . . . 0.0 109.292 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -66.85 -33.92 76.67 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.424 -0.798 . . . . 0.0 109.563 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.516 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 4.2 mp -54.32 -25.78 25.84 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.192 -0.942 . . . . 0.0 109.551 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.547 ' HE2' ' HB3' ' A' ' 112' ' ' ALA . 33.7 mttt -58.2 -49.45 77.0 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.454 ' O ' ' C ' ' A' ' 129' ' ' LEU . 6.5 mtp180 -84.62 -1.47 56.05 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.699 -0.625 . . . . 0.0 109.532 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 1.014 HD21 HD21 ' A' ' 86' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.824 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 4' ' ' LEU . 14.8 tp . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.529 ' HG2' ' CZ2' ' A' ' 83' ' ' TRP . 0.9 OUTLIER -145.35 128.38 16.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.041 -1.037 . . . . 0.0 110.834 -179.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.701 HG22 ' H ' ' A' ' 7' ' ' ALA . 5.3 mm -102.93 -163.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.319 -0.863 . . . . 0.0 108.807 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.701 ' H ' HG22 ' A' ' 6' ' ' ILE . . . -144.86 117.29 8.52 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.739 -1.225 . . . . 0.0 110.605 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.915 ' CG1' HD12 ' A' ' 82' ' ' LEU . 3.2 p -133.45 129.74 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.108 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.6 ' HA2' ' NE1' ' A' ' 85' ' ' TRP . . . -117.04 119.32 4.43 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.061 HD12 ' CD1' ' A' ' 86' ' ' LEU . 1.2 mt -96.98 159.16 3.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.265 -1.138 . . . . 0.0 108.781 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.907 HD12 ' HG2' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -154.24 146.62 13.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 108.822 -178.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.518 ' C ' ' ND2' ' A' ' 13' ' ' ASN . 20.9 ttp180 -157.96 84.26 0.87 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.406 -0.809 . . . . 0.0 110.626 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.574 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 10.9 m-80 -160.59 179.46 8.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.924 -1.11 . . . . 0.0 109.662 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 2.9 mm-40 81.44 -68.94 0.09 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.888 0.851 . . . . 0.0 109.219 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.502 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 38.4 t-20 -111.15 22.94 14.67 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.431 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 23.4 t-20 49.71 47.52 22.78 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 15' ' ' ASN . 3.7 mt-10 -140.69 147.61 39.52 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 11' ' ' ILE . 1.5 mt -96.97 151.94 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.904 -1.123 . . . . 0.0 110.56 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -100.07 76.96 1.96 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.545 HD11 ' CE1' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -79.7 -178.02 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.952 0.882 . . . . 0.0 110.611 -177.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.559 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -114.3 137.17 52.13 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.505 ' HG3' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.597 0 O-C-N 120.963 -1.086 . . . . 0.0 109.683 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.424 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 36.1 m120 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -146.6 126.85 13.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.172 -0.955 . . . . 0.0 109.488 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.517 ' O ' ' HG3' ' A' ' 116' ' ' PRO . 7.2 mt -93.45 -165.17 1.28 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -149.53 -163.86 1.89 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.68 -1.263 . . . . 0.0 110.194 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.781 ' CE2' HD11 ' A' ' 123' ' ' ILE . 6.5 m-85 -162.25 -66.62 0.01 OUTLIER Pre-proline 0 C--N 1.292 -1.909 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.769 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.797 ' HA ' HD11 ' A' ' 82' ' ' LEU . 15.3 Cg_exo -40.26 153.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.775 1.65 . . . . 0.0 110.467 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 97' ' ' LYS . . . -110.98 -86.59 1.69 Allowed Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -117.18 -61.07 0.31 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 170.93 175.84 0.06 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.179 -1.189 . . . . 0.0 110.069 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -144.25 102.4 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.53 -3.43 5.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.971 -1.081 . . . . 0.0 109.725 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.441 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 1.2 mpt? -53.06 -27.36 19.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.0 108.976 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.48 15.97 26.92 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 42' ' ' MET . 45.3 mm-40 -86.32 -80.68 0.23 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.539 -0.977 . . . . 0.0 109.782 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.798 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -148.51 177.5 1.77 Allowed Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 120.949 -1.094 . . . . 0.0 109.968 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.798 ' CD ' HG22 ' A' ' 45' ' ' THR . 6.3 Cg_endo -73.77 -40.24 1.51 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.694 2.263 . . . . 0.0 111.063 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.01 -52.85 5.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.324 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.57 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 2.1 tt0 -45.01 -29.1 0.78 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 122.441 1.115 . . . . 0.0 110.026 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.48 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . -72.86 -59.84 2.52 Favored 'General case' 0 C--N 1.271 -2.834 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.576 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.909 HG21 ' NE1' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -81.82 -3.08 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.016 -1.052 . . . . 0.0 111.029 -178.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 4.5 p -81.8 -45.3 20.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.571 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -70.64 -28.57 64.91 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.168 177.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.56 ' O ' ' NE1' ' A' ' 95' ' ' TRP . 3.0 mt-10 -76.6 -17.81 58.99 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.594 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.024 HD13 ' HG3' ' A' ' 62' ' ' PRO . 5.7 mt -71.1 -54.96 9.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.482 -0.761 . . . . 0.0 110.432 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.476 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -82.64 -37.11 25.37 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.705 -1.247 . . . . 0.0 111.355 -178.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -80.66 35.03 0.34 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.722 -1.236 . . . . 0.0 111.52 -178.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 1.1 mm-40 -149.8 -58.23 0.19 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.581 -1.324 . . . . 0.0 110.098 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.813 HG12 ' CD1' ' A' ' 95' ' ' TRP . 5.2 p -123.07 -10.75 7.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.287 -0.883 . . . . 0.0 108.677 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 60.84 73.09 0.53 Allowed Glycine 0 N--CA 1.486 1.98 0 O-C-N 121.775 -0.578 . . . . 0.0 112.901 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -112.26 179.97 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.289 -1.124 . . . . 0.0 108.428 177.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 47.2 m -131.34 86.88 48.95 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 1.024 ' HG3' HD13 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -59.72 129.04 29.07 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.107 1.871 . . . . 0.0 110.572 -177.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.452 ' HG3' ' HB3' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -83.69 -37.58 22.57 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.499 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 65' ' ' PHE . 0.8 OUTLIER -168.47 51.6 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.779 -1.2 . . . . 0.0 111.49 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.597 ' CB ' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -46.75 173.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.601 -1.312 . . . . 0.0 109.475 179.19 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -161.26 157.14 25.1 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.565 -0.709 . . . . 0.0 109.651 179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.777 HD12 ' HA ' ' A' ' 85' ' ' TRP . 50.0 tp -112.01 92.85 4.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.186 -0.946 . . . . 0.0 109.19 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.7 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -53.76 -59.52 4.51 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.605 0.717 . . . . 0.0 109.635 -179.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.7 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.8 tp10 -168.28 141.41 3.1 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.643 -0.66 . . . . 0.0 110.032 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.451 ' HG3' ' HA ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -121.14 138.94 53.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.426 -0.796 . . . . 0.0 109.008 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -109.88 -171.49 1.85 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.078 -1.014 . . . . 0.0 109.941 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -143.83 175.04 10.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.472 -0.767 . . . . 0.0 108.971 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 80' ' ' ILE . 1.6 t80 -150.13 163.44 38.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.934 -1.103 . . . . 0.0 110.155 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.0 tt0 -142.45 109.14 5.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.409 -0.807 . . . . 0.0 109.19 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.632 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -78.83 173.52 7.57 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.066 -1.021 . . . . 0.0 108.901 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.632 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 5.7 Cg_exo -51.4 -26.07 20.24 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.723 1.615 . . . . 0.0 109.543 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -148.16 2.22 0.66 Allowed 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.888 -0.508 . . . . 0.0 110.071 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.503 ' HG3' ' HB3' ' A' ' 75' ' ' PHE . 4.8 mtp180 -122.68 -161.58 0.96 Allowed 'General case' 0 C--N 1.31 -1.142 0 O-C-N 120.9 -1.125 . . . . 0.0 109.547 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.625 ' N ' ' CD2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -162.01 109.46 1.37 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.005 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 73' ' ' TYR . 25.2 mm -99.3 124.85 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.031 -1.043 . . . . 0.0 110.038 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.511 ' HB ' ' HG3' ' A' ' 5' ' ' GLN . 67.6 m -130.08 116.51 18.61 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.915 HD12 ' CG1' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -107.98 153.52 22.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.068 -1.02 . . . . 0.0 110.229 -179.135 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.625 ' O ' HG13 ' A' ' 8' ' ' VAL . 3.2 m95 -110.54 118.17 35.51 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.654 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.1 m-85 -99.97 70.71 1.61 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.123 -0.986 . . . . 0.0 109.362 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.909 ' NE1' HG21 ' A' ' 50' ' ' VAL . 46.5 p-90 -80.28 84.18 5.99 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.138 -1.425 . . . . 0.0 108.889 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.061 ' CD1' HD12 ' A' ' 10' ' ' ILE . 1.6 tp -64.1 121.51 14.35 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.152 0.501 . . . . 0.0 109.918 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.85 HG13 HG23 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -102.96 161.59 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 119.095 -1.042 . . . . 0.0 108.986 179.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.46 ' N ' ' CG2' ' A' ' 87' ' ' VAL . 9.0 pm0 -118.35 -24.0 7.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.919 . . . . 0.0 110.768 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.452 ' HB3' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -146.81 152.88 39.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.807 -1.183 . . . . 0.0 110.56 -179.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.574 ' CZ3' ' HB2' ' A' ' 13' ' ' ASN . 28.2 p90 -168.64 -173.41 1.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.842 0.829 . . . . 0.0 109.367 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.655 ' O ' HG22 ' A' ' 60' ' ' ILE . 9.4 tt0 -137.18 113.63 10.13 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.357 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.452 ' O ' ' HD3' ' A' ' 94' ' ' PRO . . . 106.65 169.45 22.64 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.6 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -79.13 115.0 49.41 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.296 -1.12 . . . . 0.0 108.935 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.907 ' HG2' HD12 ' A' ' 11' ' ' ILE . 5.5 Cg_endo -73.77 177.03 8.59 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.672 2.248 . . . . 0.0 112.571 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.813 ' CD1' HG12 ' A' ' 58' ' ' VAL . 3.1 p-90 -115.1 -163.01 0.85 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.415 ' N ' ' HE3' ' A' ' 95' ' ' TRP . . . 179.61 -32.7 0.06 OUTLIER Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.418 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -129.2 -163.96 1.35 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 9.9 pt-20 -55.15 -46.13 75.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.956 -1.09 . . . . 0.0 108.554 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.444 ' C ' ' HD3' ' A' ' 101' ' ' PRO . . . -124.84 -129.73 3.42 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.668 ' N ' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -125.24 42.78 0.79 Allowed Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.01 -1.288 . . . . 0.0 110.971 179.191 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.668 ' HD3' ' N ' ' A' ' 100' ' ' GLN . 6.2 Cg_endo -67.56 -12.9 37.25 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 C-N-CA 121.471 1.448 . . . . 0.0 110.011 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -61.09 179.84 3.05 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -141.99 160.93 39.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.076 -1.249 . . . . 0.0 110.3 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -89.03 103.49 16.1 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.394 -0.817 . . . . 0.0 109.576 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 13.9 ttm -87.44 129.51 35.02 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.306 -0.871 . . . . 0.0 109.515 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.792 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -92.96 72.67 4.76 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.314 -0.867 . . . . 0.0 109.452 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 107' ' ' LEU . 6.0 tp 49.85 50.92 17.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.134 -0.979 . . . . 0.0 109.565 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 106' ' ' SER . 29.3 t -139.2 101.3 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.261 -0.9 . . . . 0.0 109.473 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 114' ' ' ASP . . . 92.99 17.24 44.5 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.92 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -62.64 -18.03 61.49 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.296 -1.12 . . . . 0.0 108.987 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.494 ' ND2' ' HD3' ' A' ' 127' ' ' LYS . 10.2 m-20 -78.3 178.33 7.74 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.738 -0.601 . . . . 0.0 109.461 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.962 ' CA ' HG21 ' A' ' 123' ' ' ILE . . . -67.51 -6.85 21.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.47 -53.03 60.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.249 -0.907 . . . . 0.0 110.11 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.517 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -79.33 -12.78 59.93 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.1 -1.0 . . . . 0.0 108.817 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.615 ' CZ ' ' CZ ' ' A' ' 35' ' ' PHE . 12.8 m-85 -94.59 140.41 22.63 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.517 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 5.7 Cg_exo -63.31 148.4 92.93 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.99 1.794 . . . . 0.0 110.037 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.704 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 3.9 Cg_exo -58.87 118.61 5.52 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.13 1.886 . . . . 0.0 110.33 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 162.37 -24.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.491 -0.756 . . . . 0.0 109.132 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.533 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 0.9 OUTLIER -123.14 43.97 2.8 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.307 -0.871 . . . . 0.0 109.732 -179.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.678 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 7.0 mt-10 -66.34 -39.14 24.74 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 112.161 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 2.9 Cg_endo -64.51 -34.55 52.63 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 122.117 1.878 . . . . 0.0 112.371 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.654 HG11 ' CD2' ' A' ' 84' ' ' PHE . 1.1 t -93.76 -50.04 12.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.962 HG21 ' CA ' ' A' ' 112' ' ' ALA . 8.8 mm -49.53 -33.73 7.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -53.24 -47.11 69.32 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -66.73 -28.76 68.67 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.322 -0.861 . . . . 0.0 109.524 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.808 HD12 HD13 ' A' ' 123' ' ' ILE . 11.4 mt -70.74 -10.69 60.01 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.143 -0.973 . . . . 0.0 109.646 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 124' ' ' ALA . 1.3 mmtp -56.76 -52.92 63.14 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.251 -0.906 . . . . 0.0 109.195 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -98.42 26.76 5.21 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.406 -0.809 . . . . 0.0 109.049 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.642 HD21 HD21 ' A' ' 86' ' ' LEU . 2.4 tp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.558 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.713 ' N ' HD23 ' A' ' 4' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.578 ' HB2' HG21 ' A' ' 40' ' ' ILE . 7.0 mt-30 -96.42 114.03 25.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.229 -0.92 . . . . 0.0 109.509 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.621 HG22 ' H ' ' A' ' 7' ' ' ALA . 3.1 mm -99.42 -175.99 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.248 -0.908 . . . . 0.0 109.231 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.621 ' H ' HG22 ' A' ' 6' ' ' ILE . . . -149.39 101.83 3.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.719 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.826 HG11 ' HB3' ' A' ' 35' ' ' PHE . 10.2 p -108.51 135.06 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.154 -0.966 . . . . 0.0 108.538 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.28 106.56 1.43 Allowed Glycine 0 N--CA 1.484 1.87 0 C-N-CA 119.372 -1.394 . . . . 0.0 109.696 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.826 ' HB ' HD12 ' A' ' 86' ' ' LEU . 1.7 mt -82.89 143.99 10.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.876 HG22 ' CZ3' ' A' ' 90' ' ' TRP . 1.8 mt -131.51 128.97 61.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.819 -177.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 88' ' ' GLU . 5.9 ttp180 -139.75 125.99 20.04 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.464 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 6.0 p30 -118.72 -167.16 1.33 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.983 . . . . 0.0 109.985 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -71.64 -2.39 17.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 109.944 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.486 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 1.5 t30 -79.78 5.66 12.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.176 -0.952 . . . . 0.0 109.136 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.478 ' OD1' ' HB ' ' A' ' 108' ' ' VAL . 22.6 t30 54.95 46.57 24.07 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.264 -0.898 . . . . 0.0 109.619 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 15' ' ' ASN . 4.5 mt-10 -146.5 133.63 20.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 108.892 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.855 HD11 ' HB2' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -102.16 160.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.221 -0.924 . . . . 0.0 108.801 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 25.8 t80 -118.55 82.03 1.78 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.922 -1.111 . . . . 0.0 108.565 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.627 HD11 ' HB ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -121.04 -160.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.592 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -117.31 138.48 51.73 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.39 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HG3' ' OD1' ' A' ' 31' ' ' ASN . 4.9 ttp180 . . . . . 0 C--N 1.306 -1.326 0 O-C-N 121.288 -0.882 . . . . 0.0 109.465 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.501 ' OD1' ' HG3' ' A' ' 22' ' ' ARG . 3.0 t-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.325 0.583 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.44 ' HB3' ' HG3' ' A' ' 116' ' ' PRO . 6.8 mmmt -95.29 125.03 39.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.641 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.571 ' CD1' ' CE2' ' A' ' 115' ' ' PHE . 56.5 mt -107.8 -174.59 2.56 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -160.69 -162.11 0.91 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.027 -1.045 . . . . 0.0 110.878 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.826 ' HB3' HG11 ' A' ' 8' ' ' VAL . 65.5 m-85 -155.18 69.27 5.51 Favored Pre-proline 0 C--N 1.295 -1.788 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.522 ' CD ' ' OG1' ' A' ' 21' ' ' THR . 2.4 Cg_endo -61.74 -81.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.173 1.915 . . . . 0.0 110.409 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 100.49 -150.02 18.74 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -139.8 24.15 2.75 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.614 ' HD2' HG23 ' A' ' 6' ' ' ILE . 2.5 mptt 70.25 148.2 0.07 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -1.143 . . . . 0.0 110.034 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.166 HD11 ' CZ2' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -101.57 119.27 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.459 ' O ' ' C ' ' A' ' 42' ' ' MET . 0.6 OUTLIER -79.06 -159.58 0.19 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.008 -1.058 . . . . 0.0 108.845 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.459 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -42.04 -52.78 4.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.372 -0.83 . . . . 0.0 108.997 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 42' ' ' MET . . . 58.38 122.77 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.236 -1.145 . . . . 0.0 110.236 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -106.53 -9.72 16.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -1.106 . . . . 0.0 108.785 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.678 HG23 ' H ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -160.55 171.54 6.98 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.546 ' HA ' ' CH2' ' A' ' 83' ' ' TRP . 3.7 Cg_exo -61.36 -37.2 74.16 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.294 1.996 . . . . 0.0 111.706 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.678 ' H ' HG23 ' A' ' 45' ' ' THR . 1.0 OUTLIER -86.45 -56.98 3.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.809 -1.182 . . . . 0.0 109.583 -179.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.664 ' H ' HG22 ' A' ' 45' ' ' THR . 1.7 tt0 -38.13 -32.28 0.06 Allowed 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.252 1.025 . . . . 0.0 110.049 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 47' ' ' GLU . . . -64.82 -65.29 0.69 Allowed 'General case' 0 C--N 1.272 -2.797 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.66 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.523 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 1.2 p -81.21 -45.45 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.898 -1.126 . . . . 0.0 110.301 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.601 HG13 ' N ' ' A' ' 52' ' ' ARG . 6.1 p -40.62 -47.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.653 -0.654 . . . . 0.0 109.332 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.601 ' N ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -74.61 -34.57 62.85 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.52 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 2.4 mt-10 -60.07 -19.95 55.65 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.903 -1.123 . . . . 0.0 108.363 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.631 ' CD2' ' CH2' ' A' ' 95' ' ' TRP . 13.8 mt -75.31 -68.61 0.54 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.197 0.522 . . . . 0.0 110.381 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.403 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 2.4 pt20 -61.3 -28.62 69.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.775 -1.203 . . . . 0.0 111.637 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 1.2 pp20? -72.88 1.02 9.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.701 -1.249 . . . . 0.0 109.56 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.457 ' HB3' ' HD1' ' A' ' 95' ' ' TRP . 3.5 mm-40 -143.78 -68.74 0.33 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.415 -0.803 . . . . 0.0 109.96 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.701 HG21 ' O ' ' A' ' 93' ' ' GLU . 2.4 p -111.55 -54.59 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.691 -1.255 . . . . 0.0 107.62 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.585 ' N ' ' CG1' ' A' ' 58' ' ' VAL . . . 81.84 47.2 6.36 Favored Glycine 0 N--CA 1.479 1.567 0 O-C-N 121.438 -0.789 . . . . 0.0 113.86 175.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.731 HG21 ' CD1' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -79.68 124.53 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 120.12 1.96 . . . . 0.0 106.403 176.362 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.718 ' H ' ' HD3' ' A' ' 62' ' ' PRO . 8.4 t -149.26 23.77 0.04 OUTLIER Pre-proline 0 C--N 1.279 -2.5 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.718 ' HD3' ' H ' ' A' ' 61' ' ' THR . 2.2 Cg_endo -62.35 -47.15 10.37 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 CA-C-N 120.072 1.061 . . . . 0.0 109.725 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 89' ' ' ARG . 1.2 pt20 -162.88 -31.24 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.962 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.612 ' O ' ' CG ' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -42.76 113.73 0.5 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 122.214 1.007 . . . . 0.0 112.962 -177.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.409 ' CB ' ' O ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER 171.74 130.58 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.159 -0.963 . . . . 0.0 110.044 177.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -163.67 -35.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 110.574 179.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.601 ' HB2' ' CE3' ' A' ' 85' ' ' TRP . 37.7 tp 39.35 96.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.765 0.793 . . . . 0.0 109.273 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.663 ' CZ ' HD21 ' A' ' 126' ' ' LEU . 30.2 p90 -66.62 -54.03 27.74 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.446 -0.784 . . . . 0.0 110.705 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.61 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER 178.35 134.11 0.08 Allowed 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.247 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.551 ' CB ' ' HB3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -94.69 168.55 10.76 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.498 -0.751 . . . . 0.0 109.79 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.966 HD23 ' HB ' ' A' ' 122' ' ' VAL . 1.2 pp -126.41 -166.53 1.59 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.096 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -160.0 142.62 13.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 109.625 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.416 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -130.03 96.12 4.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.343 -0.848 . . . . 0.0 109.41 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.465 ' HG2' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -84.15 109.39 17.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.4 -0.813 . . . . 0.0 109.297 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.599 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -79.63 179.63 1.76 Allowed Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.599 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 6.0 Cg_endo -75.81 40.76 0.75 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.329 2.019 . . . . 0.0 111.198 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 76' ' ' PRO . 0.1 OUTLIER 172.3 -25.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.712 -1.243 . . . . 0.0 110.214 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -124.44 170.45 10.84 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 109.977 -178.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.465 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 6.1 m80 -126.01 92.11 3.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.438 -0.789 . . . . 0.0 108.969 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.441 ' CD1' HD12 ' A' ' 4' ' ' LEU . 27.1 mm -79.4 137.19 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.29 -0.881 . . . . 0.0 109.503 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.54 84.52 1.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.299 -0.876 . . . . 0.0 109.454 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.625 ' CD1' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -108.09 158.58 17.28 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.348 -0.845 . . . . 0.0 109.407 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 1.166 ' CZ2' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -131.03 151.91 50.9 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.964 -1.085 . . . . 0.0 110.75 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.784 ' CB ' HD11 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.71 120.98 38.18 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.601 ' CE3' ' HB2' ' A' ' 67' ' ' LEU . 10.9 m95 -96.4 98.09 9.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.002 -1.061 . . . . 0.0 110.202 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.826 HD12 ' HB ' ' A' ' 10' ' ' ILE . 1.0 OUTLIER -68.61 89.5 0.37 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.827 HG21 HG23 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -60.52 174.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.633 0.73 . . . . 0.0 110.533 -178.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' A' ' 12' ' ' ARG . 11.0 mm-40 -97.05 -72.29 0.65 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.049 -0.661 . . . . 0.0 109.371 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.533 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -159.2 148.85 18.77 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.876 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 3.7 p90 -136.95 -171.41 2.93 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.833 -1.167 . . . . 0.0 111.243 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.512 ' H ' ' CG ' ' A' ' 62' ' ' PRO . 15.6 tt0 -128.88 -33.69 2.0 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.68 -134.82 0.11 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.701 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.0 OUTLIER -121.66 132.51 24.21 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.197 -1.178 . . . . 0.0 110.156 -179.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.867 ' CB ' HD12 ' A' ' 11' ' ' ILE . 2.4 Cg_endo -71.82 119.53 6.27 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.581 2.187 . . . . 0.0 109.814 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.667 ' CG ' ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -126.31 38.64 4.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.02 -1.05 . . . . 0.0 112.923 -177.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -49.71 -20.42 2.79 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HG2' HG23 ' A' ' 21' ' ' THR . 0.0 OUTLIER -108.73 -171.9 1.94 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.422 -1.046 . . . . 0.0 109.912 -179.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -141.5 -41.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.441 -0.787 . . . . 0.0 109.045 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.28 23.87 1.1 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.434 ' CG ' ' HD2' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -102.61 172.05 4.67 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.417 -1.049 . . . . 0.0 109.639 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' A' ' 102' ' ' GLY . 4.9 Cg_endo -70.88 5.54 2.08 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.538 2.159 . . . . 0.0 111.443 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.592 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -39.77 146.91 0.23 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 9.8 pt-20 -161.33 -171.51 3.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.614 -0.933 . . . . 0.0 110.434 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.563 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 20.6 m0 -94.53 100.56 12.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.569 -0.707 . . . . 0.0 109.772 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -84.42 -163.17 0.76 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.142 -0.974 . . . . 0.0 108.908 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.58 103.21 4.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.315 -0.865 . . . . 0.0 109.369 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.855 ' HB2' HD11 ' A' ' 18' ' ' ILE . 18.4 mt -139.57 -78.28 0.32 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.527 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER 67.53 25.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.002 0.906 . . . . 0.0 108.814 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 178.39 44.74 0.07 OUTLIER Glycine 0 N--CA 1.485 1.902 0 N-CA-C 107.187 -2.365 . . . . 0.0 107.187 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.705 HD11 ' CE2' ' A' ' 115' ' ' PHE . 1.1 mt -36.42 153.69 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 O-C-N 122.103 -0.645 . . . . 0.0 109.886 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.667 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 0.7 OUTLIER -134.81 9.01 3.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.139 -0.976 . . . . 0.0 109.667 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 73.91 -9.94 1.17 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.062 -1.024 . . . . 0.0 110.47 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -74.71 -42.1 58.97 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.833 -1.167 . . . . 0.0 109.101 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' CD2' ' A' ' 110' ' ' LEU . 3.4 p30 -78.62 0.61 25.73 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.705 ' CE2' HD11 ' A' ' 110' ' ' LEU . 10.1 m-85 -120.0 106.29 41.44 Favored Pre-proline 0 N--CA 1.485 1.323 0 O-C-N 121.441 -0.787 . . . . 0.0 109.073 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 115' ' ' PHE . 35.4 Cg_exo -40.17 152.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.281 1.988 . . . . 0.0 110.71 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.717 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 5.9 Cg_exo -56.19 -160.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.622 2.215 . . . . 0.0 111.357 -178.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 117' ' ' PRO . . . 82.97 -42.67 0.11 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.73 -0.606 . . . . 0.0 109.674 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.544 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 2.9 m120 -98.0 33.66 2.09 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.087 -1.008 . . . . 0.0 109.357 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.645 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 4.2 mt-10 -62.49 -38.85 49.84 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.374 -0.829 . . . . 0.0 112.688 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.3 Cg_exo -58.89 -41.97 57.12 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.776 1.651 . . . . 0.0 112.314 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.966 ' HB ' HD23 ' A' ' 71' ' ' LEU . 1.1 t -97.43 -47.98 12.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 120.44 -1.412 . . . . 0.0 108.295 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.64 HG22 ' HB2' ' A' ' 112' ' ' ALA . 7.5 mm -47.61 -34.35 3.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.364 -0.835 . . . . 0.0 108.802 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.34 -45.15 72.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.494 -0.754 . . . . 0.0 109.598 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.65 -52.36 65.48 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.228 -0.92 . . . . 0.0 109.849 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.663 HD21 ' CZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -53.98 -15.83 1.6 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.182 -0.949 . . . . 0.0 110.347 -179.234 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.528 ' HE2' ' O ' ' A' ' 111' ' ' ASN . 12.6 mttt -51.41 -51.42 54.91 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.815 -1.178 . . . . 0.0 108.715 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -94.89 46.45 1.13 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.65 HD21 ' CD2' ' A' ' 86' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.777 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.631 ' HB3' HG21 ' A' ' 40' ' ' ILE . 72.1 mt-30 -133.59 142.51 48.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.188 -0.945 . . . . 0.0 110.0 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.636 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.5 mt -149.26 157.7 6.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.462 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -111.84 126.63 55.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.123 -0.986 . . . . 0.0 108.973 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 1.062 HG11 HD21 ' A' ' 82' ' ' LEU . 1.4 p -125.46 83.89 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.918 . . . . 0.0 110.202 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.504 ' HA2' ' CD1' ' A' ' 85' ' ' TRP . . . -74.21 117.42 5.59 Favored Glycine 0 C--N 1.291 -1.952 0 N-CA-C 107.732 -2.147 . . . . 0.0 107.732 178.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.759 HD12 ' CD1' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -97.21 172.19 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 120.973 -1.31 . . . . 0.0 109.755 -178.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.837 HD12 ' HB3' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -140.49 154.82 22.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.438 -0.788 . . . . 0.0 109.211 -179.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.501 ' CD ' HD23 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -160.34 68.19 0.36 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.343 -0.848 . . . . 0.0 110.281 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.6 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 52.1 m-80 -163.83 -171.58 2.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.185 -0.947 . . . . 0.0 109.628 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 6.1 tt0 83.95 -46.15 0.11 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.86 0.838 . . . . 0.0 109.542 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.427 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 47.7 t30 -142.13 25.2 1.93 Allowed 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.472 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 12.4 t30 55.64 45.85 23.9 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 105' ' ' MET . 4.0 mt-10 -140.41 149.85 43.14 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.099 -1.0 . . . . 0.0 109.386 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.555 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 0.4 OUTLIER -97.95 151.67 4.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.305 -0.872 . . . . 0.0 109.22 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.547 ' HB3' HG12 ' A' ' 11' ' ' ILE . 50.3 t80 -88.54 82.5 6.91 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.605 HG22 ' N ' ' A' ' 21' ' ' THR . 42.2 mm -78.28 167.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.295 -0.878 . . . . 0.0 110.122 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.849 HG21 ' HB2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -121.73 128.36 51.7 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.525 ' N ' ' OE1' ' A' ' 100' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.677 0 O-C-N 121.512 -0.743 . . . . 0.0 109.193 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.327 0.584 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -134.63 137.74 43.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 109.264 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.561 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 3.1 mt -99.13 -169.68 1.8 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.259 -0.901 . . . . 0.0 108.722 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.49 -156.52 0.48 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.12 -0.987 . . . . 0.0 109.837 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -144.57 158.27 54.08 Favored Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.721 ' C ' HG23 ' A' ' 8' ' ' VAL . 3.1 Cg_exo -55.71 -153.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.186 1.924 . . . . 0.0 109.816 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 163.24 -166.98 37.33 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.564 -1.303 . . . . 0.0 110.009 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . 173.95 -80.12 0.08 OUTLIER Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 9.0 tttt 166.72 136.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.494 -1.004 . . . . 0.0 109.198 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.814 HD11 ' NE1' ' A' ' 83' ' ' TRP . 3.8 mt -115.2 105.77 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 109.158 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.543 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -108.23 17.2 22.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.086 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.543 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 78.85 -137.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.47 -112.27 1.66 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.495 ' HB3' ' OE1' ' A' ' 48' ' ' GLN . 9.7 tt0 -127.99 -38.99 1.79 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.315 -1.109 . . . . 0.0 109.467 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.656 HG23 ' H ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -156.97 167.76 13.88 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.072 -1.017 . . . . 0.0 108.957 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 3.3 Cg_exo -60.25 -18.1 50.27 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.879 2.386 . . . . 0.0 112.851 -177.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.994 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -79.74 -63.12 1.49 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.795 -1.191 . . . . 0.0 109.251 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.629 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 3.2 tt0 -38.02 -32.71 0.07 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.578 1.18 . . . . 0.0 109.626 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 47' ' ' GLU . . . -61.79 -65.51 0.68 Allowed 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.537 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.57 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 4.3 p -80.86 -43.97 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.927 -1.108 . . . . 0.0 110.79 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.994 HG12 ' O ' ' A' ' 47' ' ' GLU . 7.5 p -42.6 -33.52 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HB3' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -75.82 -43.74 44.57 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.57 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 2.7 pt-20 -70.84 -7.3 44.46 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 118.74 -1.184 . . . . 0.0 108.5 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.718 HD23 ' HE1' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -64.99 -62.56 1.48 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.495 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 25.5 mt-30 -81.56 -24.19 36.7 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.569 -0.707 . . . . 0.0 109.458 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 52' ' ' ARG . 4.1 mm-40 -81.66 31.04 0.35 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.28 -0.887 . . . . 0.0 110.813 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.568 ' HB3' ' CB ' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -148.67 -64.01 0.24 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.696 -1.253 . . . . 0.0 109.863 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.918 HG11 ' C ' ' A' ' 94' ' ' PRO . 1.0 OUTLIER -118.78 -36.79 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.061 -1.025 . . . . 0.0 108.263 178.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 89.93 55.08 2.06 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.704 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -82.08 -179.28 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.183 -1.186 . . . . 0.0 109.834 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.795 ' O ' HG23 ' A' ' 61' ' ' THR . 8.6 t -135.41 58.31 25.03 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.704 ' HD3' ' HB ' ' A' ' 60' ' ' ILE . 4.6 Cg_exo -53.8 129.17 32.72 Favored 'Trans proline' 0 C--N 1.29 -2.541 0 C-N-CA 122.35 2.033 . . . . 0.0 111.08 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.554 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 0.7 OUTLIER -81.21 -42.91 20.04 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.463 -179.198 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -160.85 114.96 2.08 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.676 -1.21 . . . . 0.0 111.018 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.488 ' CB ' ' HA ' ' A' ' 87' ' ' VAL . 1.8 p90 -121.98 177.89 5.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -0.846 . . . . 0.0 109.088 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 m -161.31 158.68 27.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.863 HD12 ' HA ' ' A' ' 85' ' ' TRP . 47.5 tp -84.76 96.25 9.2 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.876 -1.14 . . . . 0.0 109.536 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.666 ' HB3' HD23 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -41.76 -76.09 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.837 0.827 . . . . 0.0 108.904 179.267 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.64 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 4.0 tp10 -171.09 126.95 0.69 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 83' ' ' TRP . 8.9 ptpt -89.41 153.49 20.8 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.339 -0.85 . . . . 0.0 110.051 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.907 HD22 ' CG2' ' A' ' 122' ' ' VAL . 0.5 OUTLIER -127.41 -157.36 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.333 -0.854 . . . . 0.0 109.114 178.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.531 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -161.02 165.09 30.39 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.359 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.482 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . 1.1 t80 -152.82 175.39 12.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.543 -0.723 . . . . 0.0 109.174 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -160.43 109.33 1.69 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.665 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.604 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -79.71 177.16 3.09 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.604 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 6.3 Cg_endo -74.34 31.31 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.496 2.13 . . . . 0.0 111.335 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.29 -39.1 0.05 Allowed 'General case' 0 N--CA 1.482 1.157 0 O-C-N 120.509 -1.369 . . . . 0.0 110.112 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -135.99 -177.22 4.59 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.363 -0.835 . . . . 0.0 110.299 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.499 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 3.5 m170 -113.55 126.72 55.6 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.496 HD13 ' N ' ' A' ' 80' ' ' ILE . 1.6 mm -94.6 149.22 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.168 -0.958 . . . . 0.0 109.652 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.1 m -157.21 107.51 2.26 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 1.062 HD21 HG11 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -136.34 129.02 30.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.149 -0.969 . . . . 0.0 110.1 -178.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.814 ' NE1' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -119.05 149.21 42.05 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.237 -0.914 . . . . 0.0 110.108 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.602 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -127.67 123.03 34.53 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.863 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -91.13 80.9 5.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.616 -1.303 . . . . 0.0 109.209 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.759 ' CD1' HD12 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -42.43 121.15 1.85 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.249 -0.907 . . . . 0.0 110.306 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.763 HG22 ' HA ' ' A' ' 11' ' ' ILE . 18.9 m -87.61 170.19 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.517 ' HB3' ' HD2' ' A' ' 89' ' ' ARG . 5.2 mt-10 -122.54 -19.79 6.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.854 -1.153 . . . . 0.0 111.078 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.554 ' HG3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.93 156.64 20.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.597 -1.314 . . . . 0.0 110.238 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.788 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 6.2 p90 177.27 -169.38 0.07 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.096 0.951 . . . . 0.0 110.445 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.643 ' N ' ' CD1' ' A' ' 90' ' ' TRP . 7.2 tt0 -147.53 128.28 14.31 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.839 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 119.85 -165.92 13.48 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.848 -1.167 . . . . 0.0 110.279 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.58 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -111.01 105.07 56.98 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.166 -1.196 . . . . 0.0 109.05 179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.918 ' C ' HG11 ' A' ' 58' ' ' VAL . 4.8 Cg_exo -58.96 176.38 0.47 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.782 2.321 . . . . 0.0 113.066 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.911 ' CD1' HG13 ' A' ' 58' ' ' VAL . 3.8 p-90 -122.57 -161.28 0.93 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.764 0.793 . . . . 0.0 109.834 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.569 ' HA3' ' HB3' ' A' ' 36' ' ' PRO . . . 165.79 -107.31 0.29 Allowed Glycine 0 N--CA 1.481 1.696 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.849 ' HB2' HG21 ' A' ' 21' ' ' THR . 11.1 tttp -60.99 -178.94 0.11 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.981 -1.305 . . . . 0.0 108.568 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.58 -73.35 0.66 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.952 -1.092 . . . . 0.0 109.713 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.96 10.81 56.81 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -110.33 121.99 39.9 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 121.033 -1.275 . . . . 0.0 109.447 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.43 -53.51 0.78 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.144 1.896 . . . . 0.0 111.155 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . 90.29 172.0 44.38 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 7.4 pt-20 -140.5 144.92 36.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.715 -1.462 . . . . 0.0 110.246 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.599 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -89.94 107.25 19.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.332 -0.855 . . . . 0.0 109.208 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 7.4 ttm -96.25 152.08 18.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.128 -0.982 . . . . 0.0 109.671 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.463 ' O ' ' HG ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -108.12 105.47 15.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 109.372 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.757 ' O ' HG12 ' A' ' 108' ' ' VAL . 49.1 mt -147.98 -65.66 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.15 -0.969 . . . . 0.0 109.651 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.757 HG12 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER 77.15 -1.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.484 -0.76 . . . . 0.0 109.821 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -138.99 25.77 2.77 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 107.072 -2.411 . . . . 0.0 107.072 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.712 HD13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -40.11 145.18 0.17 Allowed 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.935 -0.744 . . . . 0.0 110.149 -179.134 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.9 -171.71 1.95 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.371 -0.831 . . . . 0.0 108.991 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.547 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -91.12 10.26 27.64 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.238 -0.914 . . . . 0.0 109.3 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -85.99 -43.83 12.84 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.26 -0.9 . . . . 0.0 109.894 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.498 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -79.31 -14.89 58.71 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.256 -0.903 . . . . 0.0 108.744 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.712 ' CE2' HD13 ' A' ' 110' ' ' LEU . 1.4 m-85 -96.53 140.0 21.95 Favored Pre-proline 0 N--CA 1.489 1.516 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.854 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.505 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 1.8 Cg_endo -67.01 145.07 72.49 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.028 1.819 . . . . 0.0 110.446 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.715 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.8 Cg_endo -63.13 127.48 20.34 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.376 2.051 . . . . 0.0 110.574 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 156.9 -32.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.841 ' OD1' HD21 ' A' ' 71' ' ' LEU . 41.0 m-80 -112.81 46.85 1.16 Allowed 'General case' 0 C--O 1.201 -1.49 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.633 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 15.5 mt-10 -61.14 -41.39 80.56 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.237 -0.914 . . . . 0.0 112.901 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 1.3 Cg_endo -67.3 -29.05 39.15 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.544 2.162 . . . . 0.0 111.736 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.907 ' CG2' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -95.08 -41.25 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.021 -1.049 . . . . 0.0 108.444 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.547 HG22 ' HB2' ' A' ' 112' ' ' ALA . 8.8 mm -58.36 -35.42 53.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.02 -39.25 63.02 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . 20.2 mmtt -80.63 -31.56 36.51 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.41 -0.806 . . . . 0.0 109.803 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 4.3 mp -56.9 -25.13 56.53 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.3 -0.875 . . . . 0.0 109.212 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -56.43 -46.5 80.23 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 129' ' ' LEU . 7.3 mtt180 -84.72 -7.02 59.37 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.721 -0.612 . . . . 0.0 109.476 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 126' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.812 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.754 ' HG ' HG22 ' A' ' 80' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.751 ' HG3' HG23 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -152.9 159.44 42.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.881 . . . . 0.0 109.387 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.658 HD13 ' HA ' ' A' ' 39' ' ' LYS . 11.6 mm -116.89 168.44 8.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.226 -0.921 . . . . 0.0 109.353 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.61 ' N ' HG22 ' A' ' 6' ' ' ILE . . . -125.74 115.25 19.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.096 -1.002 . . . . 0.0 110.167 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 35' ' ' PHE . 5.8 p -129.54 146.13 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.53 112.33 1.08 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.024 HD12 ' CD1' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -94.25 162.12 2.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.043 HG22 ' CZ3' ' A' ' 90' ' ' TRP . 2.2 mt -146.03 135.95 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 118.319 -1.352 . . . . 0.0 112.037 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 35.1 ttp180 -126.98 129.57 48.36 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.536 ' OD1' ' CZ2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -98.48 -156.95 0.57 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.895 -1.128 . . . . 0.0 111.012 -178.062 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -85.67 -5.51 59.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.753 -0.592 . . . . 0.0 109.758 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.553 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 6.6 t-20 -91.34 23.12 3.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.919 . . . . 0.0 108.839 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 48.32 46.38 20.19 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.615 -0.678 . . . . 0.0 110.897 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.553 ' CG ' ' HB3' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -134.2 165.94 23.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.197 -0.94 . . . . 0.0 108.649 178.562 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.826 HG13 HD22 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -116.66 167.65 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.113 -0.992 . . . . 0.0 109.439 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 94' ' ' PRO . 57.3 t80 -120.13 88.21 2.89 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 121.028 -1.045 . . . . 0.0 108.963 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.898 HG21 HD13 ' A' ' 33' ' ' LEU . 9.4 mm -77.81 174.57 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.644 HG21 ' N ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -118.16 128.51 54.78 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.863 -1.148 . . . . 0.0 108.67 178.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.407 ' NH1' ' HD2' ' A' ' 32' ' ' LYS . 1.4 tpt180 . . . . . 0 C--N 1.298 -1.64 0 O-C-N 121.155 -0.966 . . . . 0.0 109.865 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -137.67 128.89 27.74 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.699 -179.538 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.898 HD13 HG21 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -96.51 -174.57 3.07 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 21' ' ' THR . 5.6 mm-40 -119.37 172.88 7.31 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.936 -1.103 . . . . 0.0 110.271 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.657 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -161.12 -66.02 0.02 OUTLIER Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 35' ' ' PHE . 11.5 Cg_exo -42.81 150.08 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.115 1.21 . . . . 0.0 109.489 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -116.17 -85.89 1.23 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.72 53.52 0.48 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.658 ' HA ' HD13 ' A' ' 6' ' ' ILE . 4.6 mptt 64.75 175.52 0.2 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.44 -1.035 . . . . 0.0 109.716 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.751 HG23 ' HG3' ' A' ' 5' ' ' GLN . 1.3 tt -148.44 79.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.385 -0.822 . . . . 0.0 109.78 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 42' ' ' MET . 0.6 OUTLIER -150.22 148.95 29.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.92 -1.113 . . . . 0.0 110.05 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.476 ' HB3' ' O ' ' A' ' 41' ' ' GLU . 0.5 OUTLIER 164.31 -33.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.19 37.04 0.2 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 48' ' ' GLN . 39.9 mt-10 -131.84 -148.12 0.34 Allowed 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.487 -1.007 . . . . 0.0 109.915 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.821 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -142.66 -176.77 0.59 Allowed Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.215 -0.928 . . . . 0.0 108.695 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.821 ' CD ' HG22 ' A' ' 45' ' ' THR . 1.1 Cg_endo -69.12 -3.17 11.05 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.808 1.672 . . . . 0.0 110.68 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.461 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -108.14 -45.5 3.93 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.001 -1.062 . . . . 0.0 109.165 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.539 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -75.67 -54.83 6.35 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.341 1.067 . . . . 0.0 109.396 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 48' ' ' GLN . . . -38.02 -54.29 1.33 Allowed 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.176 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.499 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 5.3 p -76.12 -31.55 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.141 -0.975 . . . . 0.0 109.119 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.627 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -44.53 -58.05 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.627 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -67.92 -28.87 67.87 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.541 ' OE2' ' HB1' ' A' ' 7' ' ' ALA . 3.9 mt-10 -56.47 -18.79 12.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.831 -1.168 . . . . 0.0 108.301 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.722 HD13 ' HG3' ' A' ' 62' ' ' PRO . 14.6 mt -68.9 -42.73 76.51 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.372 -0.83 . . . . 0.0 109.056 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -81.25 -41.82 21.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 110.485 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.534 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 14.6 pt-20 -80.94 37.82 0.44 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.023 -1.048 . . . . 0.0 110.98 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.601 ' HB3' ' CG ' ' A' ' 95' ' ' TRP . 58.0 mm-40 -146.69 -55.76 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.881 -1.137 . . . . 0.0 109.204 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.854 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.6 m -143.83 -33.08 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.523 -0.736 . . . . 0.0 109.279 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.46 59.77 1.98 Allowed Glycine 0 N--CA 1.479 1.558 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.617 HG12 ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -95.6 164.91 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.489 -1.006 . . . . 0.0 109.012 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 97.4 m -112.53 83.98 5.95 Favored Pre-proline 0 C--N 1.3 -1.577 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.722 ' HG3' HD13 ' A' ' 54' ' ' LEU . 2.4 Cg_endo -59.48 117.63 4.39 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.439 2.093 . . . . 0.0 110.246 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.561 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 1.2 mt-30 -79.55 -28.02 41.25 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.559 -0.713 . . . . 0.0 109.183 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.437 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 12.5 t-160 -171.1 117.17 0.45 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.936 -1.102 . . . . 0.0 111.037 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.613 ' HB2' HG12 ' A' ' 87' ' ' VAL . 11.3 p90 -129.66 171.19 12.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.245 -0.909 . . . . 0.0 109.586 178.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.18 161.4 24.97 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.382 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.793 HD12 ' HA ' ' A' ' 85' ' ' TRP . 27.0 tp -109.31 108.78 19.49 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.87 ' CZ ' HD21 ' A' ' 126' ' ' LEU . 27.1 p90 -69.62 -56.62 6.78 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.308 -0.87 . . . . 0.0 111.117 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.645 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 3.3 tp10 -172.23 144.68 1.63 Allowed 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.348 -0.845 . . . . 0.0 109.857 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.591 ' HD3' ' CE3' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -111.59 158.11 19.61 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.336 -0.853 . . . . 0.0 110.549 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.806 HD23 ' HB ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -113.02 -165.08 0.96 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 1.7 pt-20 -149.07 133.96 17.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.822 -1.174 . . . . 0.0 110.353 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.617 ' HB2' HD11 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -96.29 117.74 31.42 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.277 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -110.94 99.76 8.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.156 -0.965 . . . . 0.0 109.547 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.55 ' HB2' ' HG3' ' A' ' 78' ' ' ARG . 5.1 m-85 -79.49 170.17 17.15 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 2.2 Cg_endo -62.87 -2.39 3.54 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.01 1.807 . . . . 0.0 111.516 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -143.18 -20.62 0.63 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.692 -1.255 . . . . 0.0 111.764 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.55 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -126.63 163.18 24.02 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.663 -1.273 . . . . 0.0 110.642 -178.495 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -127.35 74.24 1.5 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.754 HG22 ' HG ' ' A' ' 4' ' ' LEU . 0.9 OUTLIER -78.91 -174.85 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.352 -0.843 . . . . 0.0 110.576 -178.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 72' ' ' GLU . 3.0 m -151.01 153.62 35.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.421 -0.799 . . . . 0.0 109.209 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.528 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -129.34 143.1 50.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.083 -1.011 . . . . 0.0 109.324 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.638 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -133.11 128.91 37.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 109.837 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.734 ' CE1' HG11 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -121.83 101.16 7.4 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.702 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.793 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -79.89 83.44 5.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.188 -0.945 . . . . 0.0 110.594 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.024 ' CD1' HD12 ' A' ' 10' ' ' ILE . 3.4 tp -52.38 114.02 1.23 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 109.574 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.033 HG21 HG23 ' A' ' 11' ' ' ILE . 8.5 m -85.11 -163.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.218 -0.926 . . . . 0.0 109.581 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 12' ' ' ARG . 76.3 mt-10 -137.57 -31.82 0.78 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.113 -0.992 . . . . 0.0 110.355 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.561 ' HG3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -161.95 175.5 11.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.82 -1.175 . . . . 0.0 110.019 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 1.043 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 42.3 p90 -179.6 -168.24 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.081 0.943 . . . . 0.0 110.362 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.512 ' HB3' ' HB ' ' A' ' 61' ' ' THR . 17.4 tt0 -141.27 96.46 2.99 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.913 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.56 ' CA ' HG22 ' A' ' 60' ' ' ILE . . . 144.34 -152.12 24.05 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.273 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.854 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -106.51 112.36 63.76 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.22 -1.165 . . . . 0.0 109.601 -179.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.997 ' CB ' HD12 ' A' ' 11' ' ' ILE . 3.6 Cg_endo -56.81 130.71 41.35 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.155 2.57 . . . . 0.0 113.661 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.638 ' HE1' HD23 ' A' ' 54' ' ' LEU . 33.7 p-90 -107.01 -168.96 1.47 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 165.11 -15.72 0.09 OUTLIER Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.988 -1.577 . . . . 0.0 111.242 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.644 ' N ' HG21 ' A' ' 21' ' ' THR . 11.3 tttp -117.49 -99.15 0.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.829 -1.395 . . . . 0.0 109.765 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 97' ' ' LYS . 1.3 tt0 -134.81 28.11 3.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.22 -0.925 . . . . 0.0 109.407 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.79 22.9 19.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.483 ' HG2' ' HD2' ' A' ' 101' ' ' PRO . 2.0 mt-30 -103.15 166.88 11.06 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.136 -1.214 . . . . 0.0 109.619 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.483 ' HD2' ' HG2' ' A' ' 100' ' ' GLN . 1.1 Cg_endo -64.94 128.19 20.23 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.346 2.031 . . . . 0.0 110.513 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.553 ' HA3' ' CZ ' ' A' ' 19' ' ' PHE . . . -104.05 174.14 22.1 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.453 ' HA ' ' OE1' ' A' ' 103' ' ' GLU . 45.6 mm-40 -112.87 151.56 30.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.891 -1.358 . . . . 0.0 110.672 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.602 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -103.25 101.09 11.01 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.042 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.517 ' SD ' ' N ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -100.55 -166.81 1.36 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.974 -1.079 . . . . 0.0 110.002 -179.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -111.9 151.86 28.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 109.825 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.904 HD21 ' O ' ' A' ' 129' ' ' LEU . 7.0 tt -61.94 -27.58 68.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.44 -0.787 . . . . 0.0 110.183 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 109' ' ' GLY . 62.6 t -65.24 112.7 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.189 -0.945 . . . . 0.0 109.433 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 108' ' ' VAL . . . 45.1 40.71 7.42 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.826 HD22 HG13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -51.82 -42.69 62.72 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.476 -1.014 . . . . 0.0 110.127 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.781 ' HB2' HD12 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -130.28 -165.68 1.57 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.378 -0.826 . . . . 0.0 110.071 -179.436 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.844 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . 87.48 -25.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -120.43 -37.72 3.0 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.334 -0.854 . . . . 0.0 108.937 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.465 ' O ' HD23 ' A' ' 33' ' ' LEU . 9.8 t0 -96.3 0.86 51.42 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.414 -0.804 . . . . 0.0 109.002 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.608 ' CE1' ' HB3' ' A' ' 111' ' ' ASN . 1.7 m-85 -91.46 164.57 24.01 Favored Pre-proline 0 N--CA 1.489 1.501 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.498 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.529 ' HD2' ' CD2' ' A' ' 115' ' ' PHE . 1.3 Cg_endo -67.7 142.21 57.39 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.949 1.766 . . . . 0.0 109.794 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.699 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.6 Cg_endo -64.53 96.78 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.26 1.973 . . . . 0.0 110.31 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 161.3 -21.42 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.387 -0.821 . . . . 0.0 109.765 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.552 ' HB3' HG13 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -97.51 29.88 3.11 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.135 -0.978 . . . . 0.0 109.411 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.672 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 22.5 mt-10 -68.79 -34.2 5.08 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.47 -0.769 . . . . 0.0 112.891 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.0 Cg_exo -58.6 -37.38 94.69 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.545 1.497 . . . . 0.0 111.674 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.806 ' HB ' HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -101.79 -47.83 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.633 -1.292 . . . . 0.0 107.863 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.844 HG21 ' HA ' ' A' ' 112' ' ' ALA . 12.4 mm -47.81 -31.1 2.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.507 -0.745 . . . . 0.0 109.013 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 127' ' ' LYS . . . -52.92 -49.86 65.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.388 -0.82 . . . . 0.0 108.857 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -41.31 92.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.453 -0.78 . . . . 0.0 109.263 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.87 HD21 ' CZ ' ' A' ' 68' ' ' PHE . 10.9 mt -57.13 -13.78 3.31 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.232 -0.917 . . . . 0.0 109.768 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.612 ' HE2' ' HB1' ' A' ' 112' ' ' ALA . 25.1 mttt -61.7 -46.04 91.37 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.701 -1.249 . . . . 0.0 108.816 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 129' ' ' LEU . 14.9 mtm180 -88.45 11.87 15.84 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.425 -0.797 . . . . 0.0 109.563 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.904 ' O ' HD21 ' A' ' 107' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.402 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.224 0.535 . . . . 0.0 109.895 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.709 ' OE1' HG21 ' A' ' 81' ' ' THR . 1.8 mt-30 -63.66 154.25 33.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.151 -0.968 . . . . 0.0 110.847 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.549 ' CG2' ' N ' ' A' ' 7' ' ' ALA . 5.1 mm -141.79 171.26 11.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.549 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . -132.23 89.96 2.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.797 -1.189 . . . . 0.0 109.848 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.644 HG23 ' C ' ' A' ' 36' ' ' PRO . 7.2 p -100.98 164.41 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.229 -0.919 . . . . 0.0 109.67 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -147.87 114.43 0.69 Allowed Glycine 0 N--CA 1.48 1.603 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.693 HD12 HD13 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -97.21 123.43 49.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.063 HD12 ' HB3' ' A' ' 94' ' ' PRO . 3.4 mt -117.8 153.21 19.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.201 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.516 ' CZ ' ' OE2' ' A' ' 88' ' ' GLU . 9.1 tpp180 -78.08 -147.41 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.912 0 O-C-N 120.965 -1.085 . . . . 0.0 108.763 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.564 ' CB ' ' HB2' ' A' ' 17' ' ' GLU . 0.9 OUTLIER -146.55 -11.46 0.46 Allowed 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.34 -0.85 . . . . 0.0 111.656 -179.174 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 13' ' ' ASN . 0.6 OUTLIER 82.97 -36.23 0.08 Allowed 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.603 -0.686 . . . . 0.0 109.274 -178.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 16' ' ' ASN . 14.9 t-20 -94.45 26.14 3.56 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.542 ' HB3' ' O ' ' A' ' 15' ' ' ASN . 18.8 t-20 71.16 37.17 1.25 Allowed 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.815 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.564 ' HB2' ' CB ' ' A' ' 13' ' ' ASN . 3.6 mt-10 -127.86 -163.5 1.27 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.639 -1.288 . . . . 0.0 109.353 178.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.588 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 1.1 mt -151.65 154.33 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.816 -1.178 . . . . 0.0 109.737 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 82.7 t80 -95.19 66.28 2.91 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.782 HG23 ' N ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -81.73 -156.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.849 0.833 . . . . 0.0 110.736 -177.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.98 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -145.51 147.1 31.77 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.385 0.612 . . . . 0.0 109.721 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.293 -0.879 . . . . 0.0 110.144 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.452 ' O ' ' HE3' ' A' ' 32' ' ' LYS . 1.5 m-20 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HG3' ' HG3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -137.38 146.14 44.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.292 179.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.98 HD23 ' O ' ' A' ' 21' ' ' THR . 0.7 OUTLIER -105.1 -174.15 2.47 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.209 -0.932 . . . . 0.0 109.341 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -162.02 -155.34 0.37 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.988 0.899 . . . . 0.0 109.985 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.594 ' HB3' HG21 ' A' ' 8' ' ' VAL . 17.9 m-85 -132.26 131.32 22.33 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.644 ' C ' HG23 ' A' ' 8' ' ' VAL . 5.3 Cg_exo -57.41 -157.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.071 1.847 . . . . 0.0 111.004 -178.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.556 ' CA ' ' HA ' ' A' ' 8' ' ' VAL . . . 85.2 154.55 22.63 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.99 -31.82 0.15 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.412 ' HA ' HD13 ' A' ' 6' ' ' ILE . 6.5 ttpt -171.15 161.94 6.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.815 -1.403 . . . . 0.0 110.529 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.742 HG13 ' HB1' ' A' ' 49' ' ' ALA . 2.9 tt -136.25 98.29 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.474 -0.766 . . . . 0.0 109.151 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 42' ' ' MET . 7.0 mt-10 -81.56 -173.51 4.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.207 -0.933 . . . . 0.0 110.122 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 12.8 mtt 63.62 -94.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.47 -0.769 . . . . 0.0 109.594 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.01 31.73 4.64 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -71.54 0.44 Allowed 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.601 -0.94 . . . . 0.0 109.463 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.853 HG23 ' HD2' ' A' ' 46' ' ' PRO . 24.2 m -133.84 144.01 49.97 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.054 -1.029 . . . . 0.0 109.08 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.853 ' HD2' HG23 ' A' ' 45' ' ' THR . 2.0 Cg_endo -55.66 -8.63 2.14 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.69 2.26 . . . . 0.0 112.33 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.713 ' H ' HG22 ' A' ' 45' ' ' THR . 0.5 OUTLIER -103.06 -36.26 8.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.762 -1.211 . . . . 0.0 108.686 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.499 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -62.0 -50.72 70.93 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.598 1.19 . . . . 0.0 108.811 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.742 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -38.23 -60.61 0.76 Allowed 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.339 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.715 HG21 ' CD1' ' A' ' 85' ' ' TRP . 2.3 p -71.95 -29.84 34.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.018 -1.051 . . . . 0.0 109.923 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.626 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -42.55 -56.33 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 122.039 0.923 . . . . 0.0 108.781 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.626 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -65.87 -33.34 75.63 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.39 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 5.8 mt-10 -73.08 -5.02 36.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.113 -0.992 . . . . 0.0 109.416 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.782 HD11 ' CH2' ' A' ' 85' ' ' TRP . 3.7 mt -79.92 -62.88 1.55 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 0.0 109.43 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.511 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 3.0 mm100 -81.94 -23.64 36.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.205 -0.935 . . . . 0.0 110.999 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -80.58 17.79 1.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.688 -1.257 . . . . 0.0 110.816 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.597 ' HB3' ' CD1' ' A' ' 95' ' ' TRP . 1.6 mt-10 -130.59 -65.3 0.8 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.673 -1.267 . . . . 0.0 110.003 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.852 HG21 ' O ' ' A' ' 93' ' ' GLU . 2.8 m -121.92 -26.47 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 108.907 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 95.99 59.7 1.05 Allowed Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.746 HG12 ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -95.84 174.01 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -1.172 . . . . 0.0 110.7 -179.527 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.722 ' N ' ' CD ' ' A' ' 62' ' ' PRO . 10.3 t -144.99 41.22 0.3 Allowed Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.722 ' CD ' ' N ' ' A' ' 61' ' ' THR . 4.8 Cg_exo -43.29 122.39 2.94 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.711 2.274 . . . . 0.0 110.852 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -98.89 -5.85 30.07 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.352 -178.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.71 39.31 2.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.165 -1.584 . . . . 0.0 111.952 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.593 ' CA ' HG23 ' A' ' 87' ' ' VAL . 45.0 p90 -79.9 168.07 19.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.63 -1.294 . . . . 0.0 110.52 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.5 m -164.38 145.23 8.15 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.571 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 84' ' ' PHE . 44.7 tp -73.91 98.1 2.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.562 -1.336 . . . . 0.0 108.897 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.712 ' CE2' HG12 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -44.77 -80.14 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.748 0.785 . . . . 0.0 108.981 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.582 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 16.0 mt-10 -152.9 164.45 37.88 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.297 0.57 . . . . 0.0 109.809 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 13.4 ttpp -134.33 108.87 8.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.996 -1.065 . . . . 0.0 110.214 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.77 HD23 HG22 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -98.55 -167.82 1.55 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.177 -0.952 . . . . 0.0 109.32 179.284 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -149.62 146.32 27.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.92 . . . . 0.0 109.689 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 74' ' ' GLU . 47.7 t80 -136.01 152.69 51.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 108.988 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 52.6 tt0 -143.2 115.05 8.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.552 ' HB2' ' HG3' ' A' ' 78' ' ' ARG . 3.9 m-85 -78.94 172.31 10.23 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.3 Cg_exo -59.61 -7.37 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.814 1.676 . . . . 0.0 111.453 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.27 -8.51 0.14 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.819 -1.175 . . . . 0.0 112.186 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.552 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -130.93 178.52 6.61 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.282 -1.511 . . . . 0.0 109.92 -179.158 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.55 ' O ' ' HA ' ' A' ' 4' ' ' LEU . 27.6 m80 -125.4 161.99 25.81 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.355 -0.84 . . . . 0.0 108.977 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 80' ' ' ILE . 34.7 mm -149.99 74.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 110.005 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.709 HG21 ' OE1' ' A' ' 5' ' ' GLN . 18.7 m -79.64 136.91 36.94 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.714 HD23 ' CE1' ' A' ' 84' ' ' PHE . 12.5 tp -132.98 150.26 52.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.965 -1.085 . . . . 0.0 110.676 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.637 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -123.45 109.67 14.14 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.139 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.714 ' CE1' HD23 ' A' ' 82' ' ' LEU . 3.0 m-85 -79.73 88.41 5.2 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.14 -0.975 . . . . 0.0 109.865 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.782 ' CH2' HD11 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -86.59 74.91 9.79 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 123.514 1.626 . . . . 0.0 107.135 178.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.693 HD13 HD12 ' A' ' 10' ' ' ILE . 8.0 tp -67.17 133.85 50.59 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.431 -177.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.629 HG22 ' N ' ' A' ' 88' ' ' GLU . 7.3 p -144.28 168.61 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.476 -0.765 . . . . 0.0 109.197 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.629 ' N ' HG22 ' A' ' 87' ' ' VAL . 7.0 mt-10 -144.36 -18.95 0.55 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.916 -1.115 . . . . 0.0 111.923 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -110.85 141.88 43.63 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.313 -1.492 . . . . 0.0 109.303 -179.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.616 ' CD1' ' CG2' ' A' ' 60' ' ' ILE . 14.3 p90 178.62 -172.57 0.14 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.502 1.144 . . . . 0.0 111.002 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.475 ' N ' ' CD1' ' A' ' 90' ' ' TRP . 15.3 tt0 -147.14 85.98 1.62 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.798 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 168.46 -156.04 27.17 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.852 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -117.04 102.42 52.84 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.281 -1.129 . . . . 0.0 109.889 -179.296 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 1.063 ' HB3' HD12 ' A' ' 11' ' ' ILE . 31.9 Cg_exo -39.26 128.27 1.51 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 123.388 2.725 . . . . 0.0 113.289 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.794 ' HB3' HG13 ' A' ' 58' ' ' VAL . 2.0 p-90 -105.09 -164.83 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 154.61 92.95 0.09 OUTLIER Glycine 0 C--N 1.298 -1.537 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.541 ' HB2' ' N ' ' A' ' 37' ' ' GLY . 17.8 tttm 58.89 105.99 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.365 -1.08 . . . . 0.0 109.907 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -68.76 105.51 2.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.255 -0.903 . . . . 0.0 109.345 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.403 ' O ' ' HD3' ' A' ' 101' ' ' PRO . . . 132.1 -11.75 5.32 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.577 ' NE2' ' HA ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -101.46 108.58 56.01 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 121.347 -1.09 . . . . 0.0 109.157 179.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 99' ' ' GLY . 2.0 Cg_endo -61.89 89.99 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.068 1.845 . . . . 0.0 110.62 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -86.99 177.56 47.92 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.414 ' OE2' ' CZ ' ' A' ' 22' ' ' ARG . 14.1 pt-20 -159.11 177.6 10.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.65 -1.5 . . . . 0.0 111.108 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.485 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 35.0 m0 -87.88 110.95 20.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.698 -0.627 . . . . 0.0 109.799 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 30.5 ttp -101.75 144.46 30.41 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.273 -0.892 . . . . 0.0 108.804 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.36 131.1 41.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.937 . . . . 0.0 109.869 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.649 ' CD1' HD23 ' A' ' 129' ' ' LEU . 0.4 OUTLIER -107.08 57.5 0.63 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.297 -0.877 . . . . 0.0 109.247 179.653 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.98 -19.35 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 178.29 49.01 0.07 OUTLIER Glycine 0 N--CA 1.487 2.04 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 109' ' ' GLY . 0.7 OUTLIER -37.31 143.31 0.1 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.954 -0.733 . . . . 0.0 110.441 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -148.67 -174.5 4.63 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.461 -0.775 . . . . 0.0 109.092 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.623 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . -80.41 5.56 14.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 109.325 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -74.08 -48.54 29.07 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.305 -0.872 . . . . 0.0 110.079 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.755 ' O ' HD12 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -79.66 -15.24 57.95 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.228 -0.92 . . . . 0.0 108.941 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -102.86 130.77 23.13 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.624 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.534 ' CG ' ' O ' ' A' ' 33' ' ' LEU . 1.8 Cg_endo -62.93 158.97 40.33 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.035 1.824 . . . . 0.0 110.082 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.7 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 3.1 Cg_exo -59.49 -172.8 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.43 2.087 . . . . 0.0 110.937 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' A' ' 117' ' ' PRO . . . 77.73 -0.71 2.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.502 -0.749 . . . . 0.0 109.775 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.606 ' HB3' HG12 ' A' ' 123' ' ' ILE . 2.0 m-80 -133.66 49.03 2.31 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.103 -0.998 . . . . 0.0 109.776 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.647 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 4.6 mm-40 -75.46 -39.98 3.24 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 112.52 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 2.1 Cg_endo -64.54 -25.85 62.38 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.948 1.765 . . . . 0.0 111.837 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.77 HG22 HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -104.01 -50.85 8.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 120.79 -1.194 . . . . 0.0 109.115 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.71 ' HA ' HD12 ' A' ' 126' ' ' LEU . 19.7 mm -55.15 -37.98 45.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -49.57 -40.61 39.07 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.529 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -80.1 -35.23 37.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.53 -0.731 . . . . 0.0 109.776 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' A' ' 123' ' ' ILE . 9.5 mt -73.25 -4.12 31.08 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.191 -0.943 . . . . 0.0 109.825 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 110' ' ' LEU . 11.1 mttt -64.23 -49.05 73.48 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.277 -0.889 . . . . 0.0 109.185 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.27 -0.75 42.22 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.373 -0.83 . . . . 0.0 109.339 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.649 HD23 ' CD1' ' A' ' 107' ' ' LEU . 2.3 tp . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.716 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 4' ' ' LEU . 28.2 tp . . . . . 0 N--CA 1.485 1.298 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.544 ' HB2' HG21 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -125.31 148.49 48.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.081 -1.012 . . . . 0.0 109.558 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.645 HG22 ' H ' ' A' ' 7' ' ' ALA . 5.5 mm -107.04 178.37 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.248 -0.908 . . . . 0.0 109.409 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.645 ' H ' HG22 ' A' ' 6' ' ' ILE . . . -139.29 96.63 3.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 109.616 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.812 HG21 ' HB3' ' A' ' 35' ' ' PHE . 11.8 p -121.22 135.36 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 110.257 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.32 115.94 2.79 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.587 ' HB ' HD13 ' A' ' 86' ' ' LEU . 1.5 mt -84.28 157.83 3.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.792 ' O ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -127.29 148.72 32.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.897 -1.127 . . . . 0.0 110.137 -178.068 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.484 ' HD3' HD12 ' A' ' 18' ' ' ILE . 32.9 ttp180 -153.26 115.87 4.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.699 -0.625 . . . . 0.0 109.319 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.74 -153.65 0.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.087 -1.008 . . . . 0.0 109.751 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.587 ' CG ' ' NH1' ' A' ' 89' ' ' ARG . 51.8 mt-10 -89.07 -5.13 58.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.749 . . . . 0.0 109.882 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.538 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 55.6 t30 -94.72 33.64 1.43 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 15' ' ' ASN . 1.8 m120 33.74 41.46 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.59 0.71 . . . . 0.0 110.814 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 15' ' ' ASN . 5.0 mt-10 -119.94 128.81 53.94 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.792 HG22 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -105.7 150.21 8.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.643 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 13.6 t80 -98.24 81.7 2.82 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.721 HG23 ' N ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -93.09 -157.9 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 110.177 -178.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.721 ' N ' HG23 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -125.01 169.2 12.35 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.201 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 . . . . . 0 C--N 1.306 -1.311 0 O-C-N 120.821 -1.174 . . . . 0.0 110.453 -179.566 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -131.08 136.15 48.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.361 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.566 ' CB ' ' O ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -135.59 -179.53 5.7 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.151 -0.968 . . . . 0.0 109.41 179.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -164.53 -154.96 0.26 Allowed 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.545 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.812 ' HB3' HG21 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -122.95 93.39 48.4 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.511 ' CD ' ' OG1' ' A' ' 21' ' ' THR . 5.9 Cg_exo -57.11 -153.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.501 2.134 . . . . 0.0 110.749 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 140.1 -153.84 23.58 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -148.94 23.62 1.28 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 73.58 160.58 0.23 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.134 . . . . 0.0 109.215 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.544 HG21 ' HB2' ' A' ' 5' ' ' GLN . 2.9 tt -102.07 129.24 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.197 -0.939 . . . . 0.0 109.347 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -126.54 -70.54 0.72 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.945 . . . . 0.0 109.554 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.48 108.61 20.13 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.405 0.622 . . . . 0.0 109.376 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.12 141.28 3.43 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.1 -10.59 15.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -1.142 . . . . 0.0 109.984 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.791 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -146.24 177.23 1.84 Allowed Pre-proline 0 N--CA 1.486 1.353 0 O-C-N 120.963 -1.086 . . . . 0.0 109.87 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.791 ' CD ' HG22 ' A' ' 45' ' ' THR . 6.3 Cg_endo -74.55 -4.93 16.18 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.466 2.111 . . . . 0.0 110.548 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.477 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 2.9 mt-10 -105.36 -37.28 6.9 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.202 -0.936 . . . . 0.0 108.884 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.453 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -73.04 -57.52 3.98 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.362 1.077 . . . . 0.0 108.868 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 53' ' ' GLU . . . -46.11 -43.12 14.57 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.52 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.609 ' CG2' ' CE3' ' A' ' 85' ' ' TRP . 14.5 p -79.79 -27.64 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.378 -0.827 . . . . 0.0 109.175 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.631 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -54.44 -57.93 5.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.631 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -81.22 -25.01 37.02 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.418 -178.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.597 ' CG ' ' HA ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -81.08 -31.58 34.31 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.003 -1.686 . . . . 0.0 111.457 -177.564 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.895 HD11 ' C ' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -79.86 -42.34 24.44 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.008 -1.058 . . . . 0.0 109.995 -179.321 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.483 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 1.7 mt-30 -67.96 -34.45 76.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.013 -1.054 . . . . 0.0 109.901 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.52 -9.68 58.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.033 -1.042 . . . . 0.0 110.132 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.495 ' OE1' ' CA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -101.2 -64.06 1.08 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.089 -1.007 . . . . 0.0 109.675 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.583 HG21 ' HA ' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -101.85 -29.16 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.457 -0.777 . . . . 0.0 109.158 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 59.5 53.48 45.74 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.691 HG22 ' H ' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -92.43 -165.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.547 ' HB ' ' CB ' ' A' ' 91' ' ' GLU . 98.8 m -137.51 91.04 14.38 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.595 -1.316 . . . . 0.0 109.418 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.611 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 1.8 Cg_endo -63.93 157.22 53.88 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.33 2.02 . . . . 0.0 110.809 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -120.73 -45.39 2.4 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 110.037 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.87 104.24 3.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.997 -1.064 . . . . 0.0 109.759 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.8 OUTLIER -134.84 172.29 13.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.197 -0.94 . . . . 0.0 110.317 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.59 151.99 17.5 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.897 HD12 ' O ' ' A' ' 84' ' ' PHE . 27.1 tp -70.27 100.64 1.74 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.906 -1.121 . . . . 0.0 109.594 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.651 ' HE2' HG13 ' A' ' 122' ' ' VAL . 0.7 OUTLIER -43.43 -77.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.662 ' O ' HG21 ' A' ' 122' ' ' VAL . 2.3 tt0 -169.15 114.87 0.58 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.775 -0.578 . . . . 0.0 109.572 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -86.35 163.65 17.53 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.371 -0.831 . . . . 0.0 110.119 -179.623 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.984 HD23 ' HB ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -126.13 -165.69 1.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.702 ' HG3' HG23 ' A' ' 81' ' ' THR . 3.5 tt0 -153.42 145.92 24.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.011 -1.056 . . . . 0.0 110.278 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.59 174.44 10.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 109.06 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 13.9 tt0 -155.63 113.68 3.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.147 -0.97 . . . . 0.0 109.623 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.595 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -79.59 -178.35 1.09 Allowed Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.724 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.595 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 4.8 Cg_endo -73.2 30.51 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.109 1.873 . . . . 0.0 111.486 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.464 ' OD2' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -162.52 -44.69 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.376 -1.452 . . . . 0.0 110.51 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.464 ' HG2' ' OD2' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -133.16 -178.18 4.86 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.163 -0.961 . . . . 0.0 110.069 -178.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -108.3 121.52 45.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.355 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.9 mt -90.28 88.26 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.052 -1.03 . . . . 0.0 109.639 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.702 HG23 ' HG3' ' A' ' 72' ' ' GLU . 1.3 m -85.28 120.63 26.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.288 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.48 ' HG ' ' HB ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -120.77 138.21 54.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.552 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.525 ' CD1' ' O ' ' A' ' 6' ' ' ILE . 1.4 m95 -96.43 165.27 12.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.371 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.897 ' O ' HD12 ' A' ' 67' ' ' LEU . 2.5 m-85 -130.59 74.62 1.61 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.915 . . . . 0.0 109.261 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.696 ' HD1' HD13 ' A' ' 67' ' ' LEU . 2.9 m0 -79.68 86.43 5.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.193 -0.942 . . . . 0.0 109.741 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.587 HD13 ' HB ' ' A' ' 10' ' ' ILE . 28.4 tp -88.37 106.32 18.17 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 10' ' ' ILE . 16.3 m -87.75 177.21 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.028 -1.045 . . . . 0.0 110.235 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -132.58 -23.44 2.08 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.395 -0.816 . . . . 0.0 110.118 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.587 ' NH1' ' CG ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -147.87 148.84 31.28 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 120.841 -1.162 . . . . 0.0 110.944 -179.503 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.634 ' NE1' ' O ' ' A' ' 92' ' ' GLY . 4.1 p90 -166.4 -172.26 2.16 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.663 0.744 . . . . 0.0 109.579 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.547 ' CB ' ' HB ' ' A' ' 61' ' ' THR . 5.3 tt0 -92.76 -84.1 0.29 Allowed 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.837 -178.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.691 ' H ' HG22 ' A' ' 60' ' ' ILE . . . -46.59 178.83 0.01 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.802 ' N ' ' CD ' ' A' ' 94' ' ' PRO . 1.6 tt0 -87.32 -25.5 0.33 Allowed Pre-proline 0 N--CA 1.502 2.168 0 O-C-N 121.222 -1.164 . . . . 0.0 114.078 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.802 ' CD ' ' N ' ' A' ' 93' ' ' GLU . 49.3 Cg_endo -94.51 -159.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.951 0 C-N-CA 124.333 3.355 . . . . 0.0 110.566 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.895 ' C ' HD11 ' A' ' 54' ' ' LEU . 3.1 t90 150.59 35.88 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 123.551 0.741 . . . . 0.0 110.815 176.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -135.13 -105.85 0.84 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -93.92 146.1 24.15 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.358 -1.084 . . . . 0.0 108.884 179.34 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -101.54 133.44 46.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 109.369 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.25 -11.09 72.15 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.463 ' CG ' ' HD2' ' A' ' 101' ' ' PRO . 8.4 tp60 -88.64 138.94 29.6 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.433 -1.039 . . . . 0.0 108.888 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 102' ' ' GLY . 6.3 Cg_exo -57.48 -78.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.98 1.787 . . . . 0.0 110.916 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.671 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . 51.87 174.49 0.03 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.6 OUTLIER -160.27 176.57 11.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.606 -1.526 . . . . 0.0 111.437 -178.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.562 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 3.9 m0 -95.8 144.85 25.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.783 -0.573 . . . . 0.0 109.869 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.523 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.6 ttm -110.37 -176.0 2.87 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.512 ' O ' HG23 ' A' ' 108' ' ' VAL . 29.1 t -131.57 32.79 4.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.846 -1.159 . . . . 0.0 110.342 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.503 ' C ' ' O ' ' A' ' 106' ' ' SER . 1.0 OUTLIER 33.04 59.4 0.44 Allowed 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.141 0.496 . . . . 0.0 109.988 179.419 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 106' ' ' SER . 70.9 t -108.87 -40.42 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.163 -0.961 . . . . 0.0 109.779 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -149.79 35.71 1.0 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 109' ' ' GLY . 1.0 OUTLIER -45.48 138.45 4.34 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.208 -1.172 . . . . 0.0 109.207 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -160.91 154.13 21.59 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.256 -0.902 . . . . 0.0 109.852 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.429 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -60.47 -14.64 20.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -0.892 . . . . 0.0 109.039 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.94 -41.85 97.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.898 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.539 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.5 t0 -77.82 -10.57 59.62 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.445 ' CG ' HD12 ' A' ' 123' ' ' ILE . 8.6 m-85 -103.79 106.53 53.02 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.506 ' HG2' ' O ' ' A' ' 33' ' ' LEU . 11.7 Cg_exo -48.37 158.47 1.01 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.804 1.67 . . . . 0.0 110.047 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.725 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 6.1 Cg_exo -56.71 -173.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.185 1.923 . . . . 0.0 110.86 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 117' ' ' PRO . . . 84.39 -21.08 0.27 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.81 -0.556 . . . . 0.0 110.118 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.884 ' OD1' HD21 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -124.27 39.89 3.86 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.932 -1.105 . . . . 0.0 109.869 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.694 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.9 mm-40 -71.76 -33.99 2.83 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 112.712 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.9 Cg_exo -61.79 -36.31 74.33 Favored 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 121.842 1.695 . . . . 0.0 112.088 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.984 ' HB ' HD23 ' A' ' 71' ' ' LEU . 1.2 t -100.92 -43.53 10.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 O-C-N 120.498 -1.376 . . . . 0.0 108.399 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.694 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 22.5 mm -54.6 -32.92 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 O-C-N 121.494 -0.754 . . . . 0.0 109.41 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.92 -39.55 26.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.544 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.45 -33.17 36.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.361 -0.837 . . . . 0.0 110.909 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.943 HD12 HD11 ' A' ' 129' ' ' LEU . 4.4 mm? -47.86 -31.4 5.02 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.907 -1.121 . . . . 0.0 109.801 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -60.78 -52.28 65.77 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.53 ' O ' ' C ' ' A' ' 129' ' ' LEU . 4.7 mtt180 -82.19 10.1 7.46 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.472 -0.767 . . . . 0.0 109.275 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.943 HD11 HD12 ' A' ' 126' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 117.937 -1.03 . . . . 0.0 111.023 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 4' ' ' LEU . 12.3 tp . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.899 ' HG2' HG21 ' A' ' 40' ' ' ILE . 3.4 tt0 -143.68 158.95 43.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.208 -0.933 . . . . 0.0 109.433 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.606 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -123.04 167.43 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.097 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.734 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -129.93 93.23 3.46 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.07 -1.019 . . . . 0.0 109.609 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.694 HG13 ' HB3' ' A' ' 84' ' ' PHE . 7.5 p -102.32 155.65 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.209 -0.932 . . . . 0.0 109.861 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.464 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -140.4 125.49 2.91 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.097 HD12 HD22 ' A' ' 86' ' ' LEU . 1.0 OUTLIER -104.37 155.85 5.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.006 -1.291 . . . . 0.0 107.565 -179.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.136 HG22 ' CZ3' ' A' ' 90' ' ' TRP . 2.0 mt -147.03 138.39 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.518 -1.364 . . . . 0.0 111.504 -176.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 23.4 ttp180 -140.46 127.53 20.86 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.57 ' OD1' ' CZ2' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -108.09 -169.46 1.52 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.258 -0.901 . . . . 0.0 110.66 -178.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.68 -5.3 19.48 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.56 -0.712 . . . . 0.0 110.075 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -79.1 7.32 7.66 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.457 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 5.4 t-20 53.75 44.56 29.44 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.776 0.798 . . . . 0.0 109.759 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 4.9 mt-10 -140.85 153.41 45.74 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.9 mt -119.56 163.71 16.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.99 -1.069 . . . . 0.0 109.453 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -116.78 98.59 6.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.835 -1.166 . . . . 0.0 109.192 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 21' ' ' THR . 0.8 OUTLIER -119.76 -159.72 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.618 ' H ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -121.08 132.86 55.13 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.023 -1.048 . . . . 0.0 109.521 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.46 ' HD2' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.39 0 O-C-N 121.304 -0.873 . . . . 0.0 109.682 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.505 ' HB2' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -159.0 134.96 8.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.018 -1.051 . . . . 0.0 110.059 -179.425 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.541 ' CD1' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -115.11 -170.11 1.69 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.274 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.4 ' O ' ' CG2' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -162.97 -164.48 0.98 Allowed 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.868 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.515 ' CE2' ' CD2' ' A' ' 84' ' ' PHE . 48.7 m-85 -132.37 106.37 13.32 Favored Pre-proline 0 C--N 1.291 -1.949 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.495 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 2.8 Cg_exo -54.94 -149.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.986 1.79 . . . . 0.0 110.659 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 151.67 154.53 6.62 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -130.15 28.27 3.89 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 4.3 mptp? 74.35 160.18 0.23 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.615 -0.933 . . . . 0.0 109.238 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.899 HG21 ' HG2' ' A' ' 5' ' ' GLN . 2.4 tt -155.34 58.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.322 -0.861 . . . . 0.0 109.222 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 42' ' ' MET . 3.9 mm-40 -84.32 -127.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.298 -0.877 . . . . 0.0 109.314 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.425 ' C ' ' O ' ' A' ' 41' ' ' GLU . 4.6 mtp -44.66 163.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.858 -1.151 . . . . 0.0 109.629 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.6 -131.08 3.43 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.531 ' CB ' ' OE1' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -132.3 -64.44 0.77 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.144 -1.209 . . . . 0.0 109.553 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.828 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -146.19 -178.09 0.74 Allowed Pre-proline 0 C--N 1.305 -1.369 0 O-C-N 121.369 -0.832 . . . . 0.0 108.821 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.828 ' CD ' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -68.09 -10.76 29.89 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.945 1.763 . . . . 0.0 110.338 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -100.76 -56.15 2.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.335 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.564 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.9 tt0 -58.5 -40.18 82.11 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.608 1.194 . . . . 0.0 108.741 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.59 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -43.38 -60.02 1.88 Allowed 'General case' 0 C--N 1.273 -2.719 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.446 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.574 HG13 ' CH2' ' A' ' 85' ' ' TRP . 9.8 p -81.45 -11.52 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.473 -0.767 . . . . 0.0 110.88 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.608 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -66.04 -50.44 69.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.608 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -59.55 -35.73 74.8 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.279 177.171 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.45 ' HA ' ' HB2' ' A' ' 56' ' ' GLU . 25.7 mt-10 -73.02 -21.23 60.86 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.767 HD23 ' HE1' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -60.84 -55.89 27.65 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.523 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 10.6 mt-30 -80.79 -22.57 39.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 109.742 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 53' ' ' GLU . 2.5 mt-10 -80.67 17.31 1.16 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.096 -1.003 . . . . 0.0 110.455 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.627 ' HB3' ' CD1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -137.75 -61.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.873 -1.142 . . . . 0.0 109.892 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.737 HG22 ' CD1' ' A' ' 95' ' ' TRP . 4.3 m -128.59 -34.03 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 109.704 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 90.94 36.2 6.83 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.746 ' CD1' HD13 ' A' ' 11' ' ' ILE . 17.1 pt -92.53 -166.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.053 -1.263 . . . . 0.0 109.521 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.759 ' N ' ' CD ' ' A' ' 62' ' ' PRO . 0.6 OUTLIER 93.05 13.77 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.292 -179.274 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.759 ' CD ' ' N ' ' A' ' 61' ' ' THR . 3.5 Cg_endo -63.75 -22.84 69.52 Favored 'Trans proline' 0 C--N 1.326 -0.615 0 CA-C-N 119.909 1.003 . . . . 0.0 110.401 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.617 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 7.1 mm100 -86.78 -68.7 0.73 Allowed 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.617 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 3.8 t-160 167.52 158.27 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.21 0.529 . . . . 0.0 110.545 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.689 ' HB2' HG12 ' A' ' 87' ' ' VAL . 29.4 p90 -141.99 171.22 14.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.318 -0.864 . . . . 0.0 109.118 177.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' O ' ' A' ' 86' ' ' LEU . 73.2 m -163.77 128.76 2.91 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.036 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.946 HD13 ' CZ3' ' A' ' 83' ' ' TRP . 0.6 OUTLIER -80.21 124.95 29.25 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.604 -1.31 . . . . 0.0 108.898 179.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.653 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 27.9 p90 -73.2 -52.18 15.05 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.55 -0.719 . . . . 0.0 109.701 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.653 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 2.4 tt0 176.74 138.74 0.06 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.656 -0.652 . . . . 0.0 109.808 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.41 165.6 11.15 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.07 -1.019 . . . . 0.0 109.029 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.031 HD21 ' OD1' ' A' ' 119' ' ' ASN . 0.4 OUTLIER -129.44 -170.1 2.23 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.352 -0.842 . . . . 0.0 109.456 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.738 ' HG3' HG23 ' A' ' 81' ' ' THR . 19.1 tt0 -145.6 146.6 31.42 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.423 -0.798 . . . . 0.0 109.194 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.499 ' N ' ' HG2' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -144.84 79.92 1.61 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.422 -0.799 . . . . 0.0 109.36 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.4 OUTLIER -81.69 114.58 20.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 109.34 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.547 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -79.45 176.69 3.49 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 1.7 Cg_endo -63.3 -8.77 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 121.67 1.58 . . . . 0.0 109.734 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -102.69 -66.87 0.9 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.402 -0.811 . . . . 0.0 110.881 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.04 -171.62 2.53 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.192 -0.942 . . . . 0.0 110.686 -177.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.557 ' N ' ' CD2' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -105.49 88.18 2.78 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.3 mm -81.71 118.2 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 109.474 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.738 HG23 ' HG3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -119.05 146.56 44.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.606 HD22 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -131.14 123.94 29.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 108.893 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.946 ' CZ3' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -119.0 124.29 46.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.363 -0.835 . . . . 0.0 110.082 -177.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.694 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -129.07 103.17 6.84 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 120.489 -1.382 . . . . 0.0 109.975 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.78 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -82.42 98.9 9.12 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.706 0.765 . . . . 0.0 109.156 179.331 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.097 HD22 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -63.14 118.52 8.03 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.735 -1.228 . . . . 0.0 109.712 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.067 ' CG2' HG23 ' A' ' 11' ' ' ILE . 19.3 m -81.24 -167.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 120.95 -1.094 . . . . 0.0 109.686 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 8.9 mt-10 -125.14 -45.76 1.84 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.165 -0.959 . . . . 0.0 110.49 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.541 ' HB3' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -160.94 171.2 19.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.183 -0.948 . . . . 0.0 109.963 -179.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 1.136 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 38.8 p90 -170.14 -175.02 1.88 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.2 1.0 . . . . 0.0 111.052 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.617 ' N ' ' HG2' ' A' ' 62' ' ' PRO . 2.6 tt0 -120.69 -34.5 3.57 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.381 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.678 ' CA ' HG22 ' A' ' 60' ' ' ILE . . . -80.18 -155.93 11.78 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 121.092 -1.005 . . . . 0.0 110.911 -178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.696 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -105.31 127.97 27.54 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.437 -1.037 . . . . 0.0 109.456 -179.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.967 ' HB3' HD12 ' A' ' 11' ' ' ILE . 2.8 Cg_endo -58.74 133.83 56.58 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.432 2.088 . . . . 0.0 111.705 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.767 ' HE1' HD23 ' A' ' 54' ' ' LEU . 4.8 p-90 -110.56 -171.74 1.89 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.923 -1.111 . . . . 0.0 108.49 178.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . 146.18 -42.91 0.92 Allowed Glycine 0 C--N 1.296 -1.679 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 100' ' ' GLN . 1.1 ptmm? -66.08 126.48 28.76 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.651 -0.911 . . . . 0.0 109.781 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -93.57 -49.56 5.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.198 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.91 5.58 5.42 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.528 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 1.3 mt-30 -109.09 160.57 27.0 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.27 -1.135 . . . . 0.0 109.43 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 102' ' ' GLY . 1.9 Cg_endo -66.21 -30.43 46.05 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.156 1.904 . . . . 0.0 111.427 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . 56.66 162.55 0.03 OUTLIER Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -161.58 -168.7 2.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.66 -1.494 . . . . 0.0 110.503 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.505 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 31.9 m95 -107.47 132.34 53.32 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.556 -0.715 . . . . 0.0 109.219 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.493 ' HE1' HD22 ' A' ' 33' ' ' LEU . 30.2 ttp -108.29 147.63 31.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.268 -0.895 . . . . 0.0 109.217 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.528 ' OG ' HG23 ' A' ' 108' ' ' VAL . 45.6 t -83.66 138.71 33.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.891 -1.131 . . . . 0.0 109.126 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.446 HD12 HD11 ' A' ' 18' ' ' ILE . 3.1 tt -108.29 59.73 0.61 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.211 -0.931 . . . . 0.0 109.411 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.528 HG23 ' OG ' ' A' ' 106' ' ' SER . 2.1 t -93.44 19.31 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 145.03 49.85 0.03 OUTLIER Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.848 HD23 ' OD2' ' A' ' 114' ' ' ASP . 1.1 mt -41.59 142.59 0.6 Allowed 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.694 -0.886 . . . . 0.0 109.317 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 2.4 t-20 -133.71 155.9 48.92 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 109.51 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.563 ' HB2' ' HE2' ' A' ' 127' ' ' LYS . . . -63.64 -19.02 64.53 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.271 -0.893 . . . . 0.0 108.747 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 113' ' ' ASP . 26.3 t0 -93.0 22.5 4.9 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.429 -0.795 . . . . 0.0 109.487 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.848 ' OD2' HD23 ' A' ' 110' ' ' LEU . 0.5 OUTLIER -78.16 -1.61 33.5 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.551 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -160.5 160.32 25.89 Favored Pre-proline 0 C--N 1.3 -1.553 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.291 177.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 32' ' ' LYS . 74.7 Cg_exo -36.69 124.6 0.39 Allowed 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.828 2.352 . . . . 0.0 110.403 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.716 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 4.6 Cg_exo -58.55 144.2 97.42 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 122.561 2.174 . . . . 0.0 111.382 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 156.67 -19.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 1.031 ' OD1' HD21 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -119.88 42.15 2.99 Favored 'General case' 0 C--O 1.205 -1.286 0 O-C-N 121.316 -0.865 . . . . 0.0 109.368 -179.364 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.639 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 6.0 mt-10 -60.16 -39.12 66.05 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 120.949 -1.094 . . . . 0.0 113.243 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 5.2 Cg_exo -62.29 -46.8 11.38 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.229 1.953 . . . . 0.0 113.011 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.859 ' HB ' HD23 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -90.22 -30.09 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.417 -1.427 . . . . 0.0 108.95 -178.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.644 HD12 ' CE1' ' A' ' 115' ' ' PHE . 1.6 mm -64.06 -34.38 68.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.502 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -60.95 -20.38 62.19 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.419 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.73 -61.75 1.88 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.399 -0.813 . . . . 0.0 110.985 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 1.009 ' HB2' HD13 ' A' ' 129' ' ' LEU . 0.6 OUTLIER -78.82 22.69 0.36 Allowed 'General case' 0 C--N 1.31 -1.137 0 O-C-N 120.803 -1.186 . . . . 0.0 111.403 -178.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.563 ' HE2' ' HB2' ' A' ' 112' ' ' ALA . 5.3 mtmt -65.91 -35.57 81.0 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.652 -1.28 . . . . 0.0 107.932 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.534 ' O ' ' C ' ' A' ' 129' ' ' LEU . 9.0 mtm180 -78.77 -0.03 28.76 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.897 -0.502 . . . . 0.0 110.03 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 1.009 HD13 ' HB2' ' A' ' 126' ' ' LEU . 4.3 tp . . . . . 0 N--CA 1.5 2.032 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.882 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 79' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.678 ' O ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -133.09 147.41 52.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.735 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 7' ' ' ALA . 4.4 mt -121.98 168.61 14.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.325 -0.86 . . . . 0.0 108.895 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.559 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . -135.74 98.31 3.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.123 -0.986 . . . . 0.0 109.618 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.599 HG22 ' N ' ' A' ' 9' ' ' GLY . 7.3 p -106.92 161.89 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.811 . . . . 0.0 109.366 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.599 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -141.33 121.21 1.83 Allowed Glycine 0 C--N 1.297 -1.621 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.582 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -94.33 156.6 3.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.034 HG22 ' CZ3' ' A' ' 90' ' ' TRP . 2.2 mt -143.15 124.1 10.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 118.486 -1.286 . . . . 0.0 111.308 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.548 ' HD3' ' CG1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -122.21 136.31 54.89 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.268 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.401 ' N ' ' HG3' ' A' ' 12' ' ' ARG . 25.0 p30 -109.12 -169.37 1.47 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 0.0 110.179 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -81.12 0.21 37.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.682 -0.636 . . . . 0.0 109.327 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.446 ' OD1' ' OE2' ' A' ' 17' ' ' GLU . 6.5 t-20 -89.34 12.82 15.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.282 -0.886 . . . . 0.0 109.063 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.582 ' ND2' HG23 ' A' ' 108' ' ' VAL . 18.4 t30 57.41 44.07 22.1 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.768 0.795 . . . . 0.0 109.224 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 3.4 mt-10 -143.25 149.21 37.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.091 -1.006 . . . . 0.0 109.038 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.548 ' CG1' ' HD3' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -128.19 151.24 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.094 -1.004 . . . . 0.0 109.864 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.582 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 21.8 t80 -85.97 66.83 9.78 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.839 HG23 ' N ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -83.91 -155.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.102 -0.999 . . . . 0.0 110.303 -178.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.839 ' N ' HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -132.11 142.16 49.4 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.557 ' HG2' ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 O-C-N 121.039 -1.038 . . . . 0.0 110.675 -178.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.79 140.78 34.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.843 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.557 ' CD2' ' HG2' ' A' ' 22' ' ' ARG . 5.3 mt -103.7 -172.72 2.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.452 -0.78 . . . . 0.0 109.026 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -160.68 -154.68 0.38 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.626 ' CE2' ' CZ ' ' A' ' 84' ' ' PHE . 3.6 m-85 -150.65 137.49 11.43 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.415 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 2.6 Cg_endo -61.19 -160.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.87 1.713 . . . . 0.0 109.582 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 152.87 158.42 8.51 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.096 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.78 20.85 2.88 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.18 158.51 0.16 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.509 -0.995 . . . . 0.0 109.516 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.678 HG22 ' O ' ' A' ' 5' ' ' GLN . 11.2 tt -138.43 101.61 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.349 -0.844 . . . . 0.0 109.222 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -111.77 -7.45 14.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.81 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.56 -76.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.167 -0.958 . . . . 0.0 109.307 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.78 4.82 18.86 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.09 -79.4 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.046 -1.267 . . . . 0.0 109.585 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.508 ' OG1' ' HD2' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -160.8 169.07 10.61 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.846 -1.159 . . . . 0.0 109.762 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 8.5 Cg_endo -74.59 19.21 0.47 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 123.255 2.637 . . . . 0.0 112.004 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.496 ' HB2' ' CG2' ' A' ' 45' ' ' THR . 2.0 mt-10 -111.5 -46.07 3.31 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.857 -1.152 . . . . 0.0 108.789 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.537 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -73.28 -55.06 6.92 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.245 1.021 . . . . 0.0 109.1 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . -38.3 -59.94 0.83 Allowed 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.089 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 51' ' ' VAL . 7.1 p -66.26 -33.11 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.214 -0.929 . . . . 0.0 108.936 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.629 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -45.5 -58.2 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.428 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.629 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -66.37 -28.93 69.03 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.308 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.532 ' HA ' ' CG ' ' A' ' 56' ' ' GLU . 4.2 mm-40 -72.64 -6.79 46.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.016 -1.053 . . . . 0.0 109.058 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.781 HD11 HE22 ' A' ' 63' ' ' GLN . 0.1 OUTLIER -80.5 -60.64 2.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.555 -0.716 . . . . 0.0 109.659 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.498 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 5.7 mt-30 -80.57 -23.44 39.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.294 -0.879 . . . . 0.0 110.708 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.532 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 1.4 pp20? -80.86 20.15 0.79 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.024 -1.048 . . . . 0.0 110.615 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 95' ' ' TRP . 3.0 mt-10 -142.18 -63.18 0.44 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.742 -1.224 . . . . 0.0 110.061 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.021 HG13 ' HB3' ' A' ' 95' ' ' TRP . 2.0 m -123.52 -31.78 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.985 -1.072 . . . . 0.0 109.154 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 67.88 66.2 2.42 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.6 ' CG2' ' HB2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -83.19 155.67 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.55 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.701 HG23 ' HD3' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -107.46 -60.99 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.263 0 O-C-N 120.527 -1.358 . . . . 0.0 111.834 -177.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.701 ' HD3' HG23 ' A' ' 61' ' ' THR . 7.0 Cg_endo -73.7 52.7 2.57 Favored 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 122.031 1.821 . . . . 0.0 110.875 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.781 HE22 HD11 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -105.82 69.28 0.81 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.867 -1.146 . . . . 0.0 110.054 -178.535 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -63.68 115.08 4.41 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.671 ' HB3' HG12 ' A' ' 87' ' ' VAL . 39.3 p90 -131.14 176.0 8.63 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 122.941 1.353 . . . . 0.0 112.209 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 68' ' ' PHE . 19.1 m -163.04 130.16 3.53 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 85' ' ' TRP . 26.6 tp -50.31 96.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.486 -1.384 . . . . 0.0 109.162 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.683 ' HE2' HG13 ' A' ' 122' ' ' VAL . 0.1 OUTLIER -43.06 -74.33 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.618 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 3.3 tt0 -162.61 161.83 26.86 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.352 0.596 . . . . 0.0 109.704 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HG2' ' N ' ' A' ' 71' ' ' LEU . 22.3 ttmt -116.16 154.3 30.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 0.0 109.174 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.021 HD21 ' CE1' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -126.67 -174.89 3.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.078 -1.014 . . . . 0.0 109.642 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -157.29 151.22 24.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.389 -0.819 . . . . 0.0 109.2 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.496 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . 6.8 t80 -154.39 165.13 37.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.058 -1.026 . . . . 0.0 110.082 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -148.14 122.24 9.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.414 -0.803 . . . . 0.0 109.365 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -82.32 172.27 9.96 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.55 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 6.0 Cg_exo -58.38 -15.77 25.87 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.934 1.756 . . . . 0.0 110.01 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -156.81 7.28 0.18 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.513 -0.742 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.539 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 1.8 mmm180 -129.18 -169.59 2.12 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 120.659 -1.276 . . . . 0.0 109.613 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.49 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 35.5 m80 -144.48 129.74 18.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.333 -0.854 . . . . 0.0 108.969 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.728 HG22 HD13 ' A' ' 82' ' ' LEU . 2.7 mm -116.26 83.98 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.93 . . . . 0.0 110.03 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.26 86.62 6.2 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.728 HD13 HG22 ' A' ' 80' ' ' ILE . 1.4 mp -102.31 167.52 9.92 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.181 -0.949 . . . . 0.0 110.364 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.541 ' CD1' ' O ' ' A' ' 6' ' ' ILE . 1.7 m95 -122.65 164.26 18.56 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 1.021 ' CE1' HD21 ' A' ' 71' ' ' LEU . 1.8 m-85 -136.51 88.94 2.42 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.07 -1.019 . . . . 0.0 109.557 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.645 ' CZ2' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.04 151.53 21.61 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.388 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.582 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 14.7 tp -142.55 127.67 18.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.787 -1.195 . . . . 0.0 109.615 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.979 ' CG2' HG23 ' A' ' 11' ' ' ILE . 9.1 m -99.07 -161.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.314 -0.866 . . . . 0.0 109.997 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -141.99 -23.42 0.7 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.287 -0.883 . . . . 0.0 111.484 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.669 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -159.96 -167.43 1.96 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.343 -1.473 . . . . 0.0 110.672 -179.186 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 1.034 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 28.6 p90 158.68 171.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.517 1.151 . . . . 0.0 110.294 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.607 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 8.9 tt0 -111.93 -63.19 1.45 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.743 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.587 ' N ' HG22 ' A' ' 60' ' ' ILE . . . -56.74 -156.39 0.01 OUTLIER Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.747 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.2 pm0 -105.8 128.09 27.14 Favored Pre-proline 0 C--N 1.307 -1.244 0 O-C-N 121.38 -1.07 . . . . 0.0 109.348 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.97 ' HB3' HD12 ' A' ' 11' ' ' ILE . 13.5 Cg_exo -46.77 144.91 7.32 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.465 2.11 . . . . 0.0 112.05 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 1.021 ' HB3' HG13 ' A' ' 58' ' ' VAL . 11.1 p-90 -107.51 -167.72 1.3 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.61 -96.18 0.14 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.525 ' HB2' ' N ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -118.0 138.74 51.99 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.506 -0.996 . . . . 0.0 109.25 179.515 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.444 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 12.0 tm-20 -92.66 68.88 4.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 109.202 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.45 ' O ' ' HD3' ' A' ' 101' ' ' PRO . . . 175.13 -31.89 0.09 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.424 ' HB3' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -92.74 111.19 49.94 Favored Pre-proline 0 C--N 1.297 -1.689 0 O-C-N 121.65 -0.912 . . . . 0.0 108.745 179.363 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 99' ' ' GLY . 1.1 Cg_endo -63.25 82.14 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.059 1.839 . . . . 0.0 110.935 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -86.12 170.61 43.41 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -161.33 172.88 15.81 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.586 -1.538 . . . . 0.0 111.504 -179.282 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.493 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 4.6 m0 -84.91 106.86 16.74 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.44 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 3.7 ttp -107.8 136.56 47.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.335 -0.853 . . . . 0.0 109.067 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.86 85.81 4.9 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.227 -0.921 . . . . 0.0 109.359 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.891 HD13 ' HA ' ' A' ' 110' ' ' LEU . 1.4 mt -76.96 -52.58 9.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.916 . . . . 0.0 109.59 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.783 HG12 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER 72.52 27.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 122.155 0.979 . . . . 0.0 108.579 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 163.63 50.6 0.02 OUTLIER Glycine 0 N--CA 1.485 1.944 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.891 ' HA ' HD13 ' A' ' 107' ' ' LEU . 0.7 OUTLIER -38.12 144.28 0.1 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.769 -0.842 . . . . 0.0 109.98 -178.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -156.43 151.87 26.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.122 -0.986 . . . . 0.0 109.801 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.887 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -68.36 -7.5 31.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.264 -0.898 . . . . 0.0 109.403 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -61.02 -42.73 99.01 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.256 -0.902 . . . . 0.0 109.93 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.506 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -79.12 -9.2 59.49 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.096 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.534 ' CE2' ' CE2' ' A' ' 35' ' ' PHE . 9.6 m-85 -98.43 137.43 20.71 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.005 -1.059 . . . . 0.0 109.456 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 115' ' ' PHE . 1.9 Cg_endo -68.8 164.19 34.35 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.256 1.97 . . . . 0.0 110.281 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.721 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.5 Cg_endo -63.29 119.07 5.99 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.404 2.07 . . . . 0.0 110.434 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 161.74 -51.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 109.831 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.562 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 28.2 m-20 -106.19 38.38 2.05 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.234 -0.916 . . . . 0.0 109.347 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.68 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 20.2 mt-10 -65.89 -36.71 14.59 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.346 -0.846 . . . . 0.0 112.704 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.8 Cg_exo -63.34 -36.2 57.42 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.099 1.866 . . . . 0.0 112.425 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.948 ' HB ' HD23 ' A' ' 71' ' ' LEU . 1.2 t -98.51 -39.3 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 120.449 -1.407 . . . . 0.0 108.003 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.961 ' HA ' HD21 ' A' ' 126' ' ' LEU . 25.2 mm -58.66 -30.57 42.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.553 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -70.3 -26.37 63.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.468 -0.77 . . . . 0.0 110.688 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.417 ' HG2' ' OE1' ' A' ' 69' ' ' GLU . 16.9 tptt -76.19 -57.21 4.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.882 -1.136 . . . . 0.0 110.522 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.961 HD21 ' HA ' ' A' ' 123' ' ' ILE . 2.4 pt? -74.84 11.78 0.99 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.054 -1.029 . . . . 0.0 111.219 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.553 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 37.4 mttt -49.51 -43.05 45.22 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.353 -1.467 . . . . 0.0 107.695 178.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.477 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -109.84 46.15 1.04 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.797 -0.565 . . . . 0.0 110.842 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.565 ' CD2' ' HB2' ' A' ' 126' ' ' LEU . 1.3 mp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.336 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.646 HD12 ' O ' ' A' ' 79' ' ' HIS . 23.5 mt . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.251 0.548 . . . . 0.0 109.801 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.478 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . 1.1 mp0 -87.46 116.47 25.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.228 -0.92 . . . . 0.0 108.869 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 38' ' ' GLY . 1.4 mp -112.47 141.18 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.094 -1.004 . . . . 0.0 109.791 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.408 ' O ' ' CA ' ' A' ' 37' ' ' GLY . . . -103.8 110.72 22.94 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.765 HG23 ' C ' ' A' ' 36' ' ' PRO . 3.0 p -127.78 100.09 5.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.131 -0.981 . . . . 0.0 110.352 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.566 ' HA2' ' CD1' ' A' ' 85' ' ' TRP . . . -84.58 118.5 4.74 Favored Glycine 0 C--N 1.296 -1.683 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.568 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 1.8 mt -81.49 173.49 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 120.867 -1.373 . . . . 0.0 107.541 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.926 HD12 ' CB ' ' A' ' 94' ' ' PRO . 0.4 OUTLIER -144.56 153.54 14.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 118.039 -1.464 . . . . 0.0 110.435 -178.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 17' ' ' GLU . 37.7 ttp180 -159.3 131.52 6.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.517 -0.739 . . . . 0.0 109.24 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.31 -162.69 0.97 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.14 -0.975 . . . . 0.0 110.577 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.36 -7.32 58.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.626 -0.671 . . . . 0.0 109.713 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.536 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 5.2 t30 -84.53 12.61 6.68 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.124 -0.985 . . . . 0.0 108.667 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 107' ' ' LEU . 11.6 t-20 60.03 43.38 14.57 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.64 -0.662 . . . . 0.0 110.522 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.536 ' CG ' ' HB3' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -127.37 154.27 45.19 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.568 HD11 HD11 ' A' ' 107' ' ' LEU . 1.6 mt -119.78 156.34 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.859 -1.15 . . . . 0.0 110.203 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 26.0 t80 -103.15 86.11 2.63 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.049 HD12 ' O ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -78.73 176.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.187 0.994 . . . . 0.0 110.101 -178.319 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.627 ' N ' ' CG2' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -153.46 144.24 22.7 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.604 ' CG ' ' HA ' ' A' ' 33' ' ' LEU . 6.4 tpm_? . . . . . 0 C--N 1.3 -1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 110.062 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.8 m120 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.491 ' O ' ' HG2' ' A' ' 22' ' ' ARG . 5.9 mmtp -114.55 129.08 56.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.195 -0.941 . . . . 0.0 109.991 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.659 HD21 ' CB ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -146.21 -175.71 4.87 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.797 0.808 . . . . 0.0 109.544 179.6 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.049 ' O ' HD12 ' A' ' 20' ' ' ILE . 2.3 tt0 -163.06 -154.21 0.28 Allowed 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.757 ' HB3' HG21 ' A' ' 8' ' ' VAL . 85.4 m-85 -114.02 158.97 37.92 Favored Pre-proline 0 C--N 1.285 -2.206 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.765 ' C ' HG23 ' A' ' 8' ' ' VAL . 3.3 Cg_exo -58.21 -154.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 121.854 1.703 . . . . 0.0 110.167 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.408 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 82.48 -170.65 50.7 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.453 ' O ' HG13 ' A' ' 6' ' ' ILE . . . 177.66 -37.61 0.09 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -168.79 143.61 3.25 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.562 -0.964 . . . . 0.0 109.076 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.666 ' O ' HG23 ' A' ' 40' ' ' ILE . 15.5 tt -100.35 115.32 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.103 -0.998 . . . . 0.0 109.705 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 42' ' ' MET . 4.7 mt-10 -101.85 -175.93 2.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.337 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.47 ' O ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 49.16 -178.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.913 . . . . 0.0 109.331 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.98 148.21 10.91 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.444 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 39.6 mp0 -91.47 121.75 33.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.177 -1.19 . . . . 0.0 109.75 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.782 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -159.96 178.61 1.61 Allowed Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.428 -0.795 . . . . 0.0 109.642 179.738 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.782 ' CD ' HG22 ' A' ' 45' ' ' THR . 6.1 Cg_endo -73.62 -20.1 20.73 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.596 2.198 . . . . 0.0 110.903 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.503 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -124.12 -59.04 1.52 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.075 -1.016 . . . . 0.0 110.085 -179.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.628 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -44.14 -32.99 1.36 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.285 1.04 . . . . 0.0 110.596 -179.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.445 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -81.76 -57.17 3.55 Favored 'General case' 0 C--N 1.272 -2.8 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.988 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.421 HG22 ' CH2' ' A' ' 95' ' ' TRP . 1.3 p -81.9 4.98 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.395 -0.816 . . . . 0.0 110.513 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 48' ' ' GLN . 13.2 p -82.75 -37.65 14.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.523 ' N ' HG13 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -74.65 -31.1 61.85 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.879 -1.509 . . . . 0.0 108.659 178.575 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -72.0 -7.12 46.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.122 -0.986 . . . . 0.0 109.075 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.781 HD22 ' CZ2' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -76.55 -68.11 0.63 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.651 -0.656 . . . . 0.0 109.428 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -82.33 -17.52 45.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.493 -0.754 . . . . 0.0 111.335 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.513 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 2.3 mm-40 -80.28 18.22 0.92 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.791 -1.193 . . . . 0.0 110.461 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 95' ' ' TRP . 7.1 mm-40 -146.76 -65.38 0.28 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.734 -1.229 . . . . 0.0 110.565 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.856 HG21 ' O ' ' A' ' 93' ' ' GLU . 3.7 m -124.8 -32.56 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.156 -0.965 . . . . 0.0 108.979 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.407 ' N ' HG23 ' A' ' 58' ' ' VAL . . . 72.16 67.64 1.79 Allowed Glycine 0 N--CA 1.483 1.815 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.616 HG21 ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -95.52 171.11 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.351 -1.087 . . . . 0.0 108.17 178.439 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.552 ' HB ' ' CB ' ' A' ' 91' ' ' GLU . 2.7 m -112.99 89.36 13.57 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 1.4 Cg_endo -59.3 131.12 39.17 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.093 1.862 . . . . 0.0 110.177 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.507 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -92.71 -55.48 3.36 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.553 -0.717 . . . . 0.0 110.164 -178.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 12.0 t-160 -142.27 112.47 7.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.91 -1.119 . . . . 0.0 110.2 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.832 ' CB ' HG12 ' A' ' 87' ' ' VAL . 5.5 p90 -135.25 175.26 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.141 -0.974 . . . . 0.0 110.368 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.3 m -162.39 -179.71 7.19 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.976 HD21 ' HD3' ' A' ' 70' ' ' LYS . 34.8 tp -105.95 107.63 18.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.953 -1.092 . . . . 0.0 109.014 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.764 ' CE2' HG13 ' A' ' 122' ' ' VAL . 3.3 t80 -47.33 -83.53 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.625 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -147.12 175.56 10.63 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.492 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.976 ' HD3' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.33 129.02 38.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 0.0 109.61 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.507 ' HG ' HG21 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -120.94 -176.89 3.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 109.505 179.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.18 158.87 33.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.363 -0.836 . . . . 0.0 109.388 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.0 147.15 31.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 0.0 109.737 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.73 116.74 10.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.077 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 1.1 m-85 -83.99 172.99 7.98 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.348 -0.845 . . . . 0.0 109.379 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 4.0 Cg_exo -59.17 -12.95 17.54 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.152 1.901 . . . . 0.0 110.791 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -165.16 16.18 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 110.585 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.526 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -131.17 -172.89 2.95 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 120.632 -1.293 . . . . 0.0 109.445 -179.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.646 ' O ' HD12 ' A' ' 4' ' ' LEU . 21.9 m80 -146.32 136.64 23.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.352 -0.843 . . . . 0.0 109.018 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 80' ' ' ILE . 22.4 mm -140.04 80.31 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.093 -1.004 . . . . 0.0 110.169 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.61 130.57 34.99 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.586 HD11 HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -136.86 113.58 10.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.955 -1.091 . . . . 0.0 110.366 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -79.86 156.04 27.54 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.98 ' CD2' HG11 ' A' ' 122' ' ' VAL . 2.0 m-85 -135.87 71.12 1.42 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.94 -1.1 . . . . 0.0 109.838 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.836 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -84.05 145.17 28.62 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.707 ' CD2' HD22 ' A' ' 129' ' ' LEU . 20.9 tp -134.8 127.25 30.49 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.951 -1.093 . . . . 0.0 110.139 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.832 HG12 ' CB ' ' A' ' 65' ' ' PHE . 34.5 m -98.1 -174.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.73 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' ARG . 2.9 mt-10 -126.43 -29.88 2.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.845 . . . . 0.0 109.428 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.507 ' HG3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.72 169.3 20.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.195 -0.941 . . . . 0.0 109.326 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.767 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 46.1 p90 -164.95 -169.83 1.79 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.102 -0.999 . . . . 0.0 110.015 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.552 ' CB ' ' HB ' ' A' ' 61' ' ' THR . 30.6 tt0 -131.34 99.13 4.74 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.972 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.557 ' CA ' HG22 ' A' ' 60' ' ' ILE . . . 128.88 -152.13 19.27 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.627 -1.273 . . . . 0.0 109.946 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.856 ' O ' HG21 ' A' ' 58' ' ' VAL . 14.5 tp10 -99.96 127.06 34.61 Favored Pre-proline 0 N--CA 1.486 1.339 0 O-C-N 121.324 -1.103 . . . . 0.0 109.187 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.926 ' CB ' HD12 ' A' ' 11' ' ' ILE . 4.0 Cg_exo -52.36 144.96 37.93 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.665 2.244 . . . . 0.0 111.706 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.813 ' HB3' HG13 ' A' ' 58' ' ' VAL . 23.4 p-90 -113.15 -175.55 2.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.523 -0.736 . . . . 0.0 109.09 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.56 ' HA3' ' HB3' ' A' ' 36' ' ' PRO . . . 158.06 -62.36 0.32 Allowed Glycine 0 N--CA 1.484 1.843 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.296 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -105.31 171.47 7.31 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.355 -1.085 . . . . 0.0 109.631 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.467 ' HA ' ' OE2' ' A' ' 57' ' ' GLU . 2.9 tp10 -39.23 -37.41 0.41 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.65 -0.656 . . . . 0.0 109.438 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.511 ' C ' ' HD3' ' A' ' 101' ' ' PRO . . . -126.18 -160.42 10.6 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.643 ' N ' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -117.85 40.15 0.32 Allowed Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.137 -1.213 . . . . 0.0 111.541 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.643 ' HD3' ' N ' ' A' ' 100' ' ' GLN . 6.9 Cg_endo -68.13 -6.81 18.16 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 C-N-CA 121.327 1.351 . . . . 0.0 110.106 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -41.83 163.53 0.02 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.458 ' CD ' HG22 ' A' ' 20' ' ' ILE . 6.1 pm0 -119.17 131.08 55.81 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.405 -1.056 . . . . 0.0 109.175 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.46 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 10.8 m0 -78.21 95.77 5.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.199 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.31 -163.35 0.6 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.403 -0.811 . . . . 0.0 109.653 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 t -141.33 158.08 44.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.628 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.691 HD21 HD12 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -113.4 63.0 0.64 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.347 -0.846 . . . . 0.0 108.974 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.2 p -104.33 -26.55 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.367 -0.833 . . . . 0.0 109.208 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -168.25 43.92 0.23 Allowed Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 109' ' ' GLY . 1.1 mt -45.46 145.79 1.16 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.217 -1.166 . . . . 0.0 108.676 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -125.24 9.98 8.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 110.182 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.435 ' CB ' HG22 ' A' ' 123' ' ' ILE . . . 52.59 19.64 1.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.902 -1.124 . . . . 0.0 108.39 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -100.82 -34.41 9.83 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.358 -0.839 . . . . 0.0 109.747 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.659 ' CB ' HD21 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -76.69 -3.66 39.17 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.31 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.647 ' CD2' HD12 ' A' ' 123' ' ' ILE . 22.3 m-85 -96.44 109.99 50.53 Favored Pre-proline 0 N--CA 1.485 1.281 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.539 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 7.1 Cg_exo -50.14 154.96 4.98 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.166 1.911 . . . . 0.0 110.512 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.714 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 5.4 Cg_exo -58.38 121.2 9.59 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.553 2.169 . . . . 0.0 110.995 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 158.54 -37.21 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.566 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 18.2 m120 -115.36 41.25 2.5 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.507 -0.746 . . . . 0.0 109.472 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.66 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 20.0 mt-10 -66.53 -41.48 40.43 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.95 -1.094 . . . . 0.0 112.427 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 1.1 Cg_endo -67.7 -30.89 33.79 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.581 2.187 . . . . 0.0 112.231 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.98 HG11 ' CD2' ' A' ' 84' ' ' PHE . 2.1 t -95.32 -43.77 12.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 120.593 -1.317 . . . . 0.0 107.493 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.647 HD12 ' CD2' ' A' ' 115' ' ' PHE . 12.2 mm -56.67 -29.0 28.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.22 -35.12 63.88 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.703 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -80.4 -61.73 1.89 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.916 -1.115 . . . . 0.0 110.945 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.655 ' HB2' HD21 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -80.87 27.38 0.38 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.918 -1.114 . . . . 0.0 110.522 -179.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.592 ' HG3' ' N ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -71.33 -31.48 67.44 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.592 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 2.2 ptt180 -119.63 44.74 2.31 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.632 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.707 HD22 ' CD2' ' A' ' 86' ' ' LEU . 1.1 mp . . . . . 0 C--N 1.308 -1.228 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.971 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -118.27 162.31 18.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.717 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.63 119.08 31.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -0.874 . . . . 0.0 109.52 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.412 ' HA ' HD12 ' A' ' 4' ' ' LEU . 49.5 tp -116.43 128.57 55.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.581 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.935 ' O ' HG22 ' A' ' 40' ' ' ILE . 12.4 mt-30 -137.86 119.51 15.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.035 . . . . 0.0 109.809 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.706 HG22 ' H ' ' A' ' 7' ' ' ALA . 12.9 mm -102.46 179.66 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.431 -0.793 . . . . 0.0 109.665 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.706 ' H ' HG22 ' A' ' 6' ' ' ILE . . . -142.38 108.21 5.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.197 -0.939 . . . . 0.0 108.849 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.652 HG23 ' C ' ' A' ' 36' ' ' PRO . 7.8 p -113.07 164.15 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.024 . . . . 0.0 110.221 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -149.73 120.63 1.17 Allowed Glycine 0 N--CA 1.482 1.719 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.115 HD12 ' CD2' ' A' ' 86' ' ' LEU . 1.2 mt -98.99 152.91 4.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 121.181 -1.188 . . . . 0.0 108.793 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.903 ' O ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -120.62 153.44 23.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 118.902 -1.119 . . . . 0.0 109.138 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.506 ' O ' ' O ' ' A' ' 88' ' ' GLU . 38.2 ttp180 -155.76 114.13 3.43 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.565 -0.709 . . . . 0.0 109.823 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.602 ' HB3' ' CZ3' ' A' ' 90' ' ' TRP . 43.4 p-10 -158.76 -159.59 0.8 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.975 . . . . 0.0 109.883 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER 77.89 -72.52 0.09 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.991 0.9 . . . . 0.0 108.759 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.41 -47.3 0.17 Allowed 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 122.286 1.041 . . . . 0.0 108.236 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 108' ' ' VAL . 6.1 t-20 179.15 35.44 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.527 ' C ' HD13 ' A' ' 18' ' ' ILE . 3.0 mt-10 -107.29 148.93 28.37 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.637 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.903 HG22 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -116.8 156.1 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 109.857 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.575 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 11.5 t80 -92.5 69.48 4.94 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 176.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.716 HG23 ' N ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -82.05 -161.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 122.126 0.965 . . . . 0.0 112.093 -176.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.716 ' N ' HG23 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -141.01 132.21 26.46 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.454 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 9.9 ttp180 -136.96 -175.52 4.06 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.373 -0.829 . . . . 0.0 109.929 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.461 ' HD3' ' CB ' ' A' ' 27' ' ' ALA . 1.7 ptt180 -72.32 99.18 2.35 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.35 -0.844 . . . . 0.0 109.832 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -44.86 -85.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 108.958 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.91 52.57 2.04 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.554 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 31.8 t0 -145.67 -128.8 0.07 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.195 -0.94 . . . . 0.0 109.451 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 26' ' ' ASP . . . 67.8 154.03 0.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.758 -1.214 . . . . 0.0 109.238 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -103.27 -70.39 0.76 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 0.0 109.605 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.31 151.85 40.71 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.297 -0.877 . . . . 0.0 109.524 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.82 174.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.63 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -104.77 145.35 30.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.396 -0.815 . . . . 0.0 109.376 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.47 141.51 43.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.09 -1.006 . . . . 0.0 109.781 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.827 HD21 ' HB3' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -136.79 -178.02 5.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -0.8 . . . . 0.0 109.679 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.625 ' O ' HD11 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -161.66 -155.86 0.41 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.716 0.769 . . . . 0.0 109.771 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.683 ' CZ ' ' CZ ' ' A' ' 115' ' ' PHE . 95.0 m-85 -117.3 150.3 46.11 Favored Pre-proline 0 C--N 1.296 -1.721 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.652 ' C ' HG23 ' A' ' 8' ' ' VAL . 6.2 Cg_exo -58.01 -152.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 121.884 1.723 . . . . 0.0 109.671 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 134.96 170.02 12.06 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.119 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -164.8 -61.3 0.02 OUTLIER Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 1.3 tttt 178.15 153.46 0.32 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.507 -0.996 . . . . 0.0 109.369 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.935 HG22 ' O ' ' A' ' 5' ' ' GLN . 7.6 tt -129.78 50.97 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.869 . . . . 0.0 109.623 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.424 ' HG3' ' HG2' ' A' ' 39' ' ' LYS . 2.2 mt-10 -118.63 7.2 11.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 109.654 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.2 tpp -108.57 -3.01 18.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.174 -0.954 . . . . 0.0 109.729 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.18 172.68 14.6 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.81 -13.5 13.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.166 -1.197 . . . . 0.0 109.808 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.816 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -144.38 179.53 1.15 Allowed Pre-proline 0 C--N 1.305 -1.335 0 O-C-N 121.044 -1.035 . . . . 0.0 109.496 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.816 ' CD ' HG22 ' A' ' 45' ' ' THR . 4.9 Cg_endo -72.94 1.61 6.32 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.347 2.031 . . . . 0.0 110.843 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.528 ' O ' HG12 ' A' ' 51' ' ' VAL . 1.9 mt-10 -124.02 -51.88 1.78 Allowed 'General case' 0 C--O 1.198 -1.654 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.524 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -49.62 -34.81 19.09 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 122.388 1.09 . . . . 0.0 108.378 178.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.486 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -67.63 -60.74 2.31 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.323 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.694 HG22 ' HH2' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -75.95 -48.01 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.123 -0.986 . . . . 0.0 109.162 -179.059 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.581 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 3.1 p -39.48 -48.92 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 121.533 0.682 . . . . 0.0 109.163 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.581 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -75.73 -33.15 60.26 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 3.1 mm-40 -67.07 -10.64 52.07 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.739 HD21 ' OE1' ' A' ' 63' ' ' GLN . 0.3 OUTLIER -60.4 -64.6 0.89 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.44 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -81.79 -25.77 34.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.556 -0.715 . . . . 0.0 109.37 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.514 ' HG3' ' HG3' ' A' ' 52' ' ' ARG . 29.3 mm-40 -81.57 32.14 0.35 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.168 -0.958 . . . . 0.0 110.479 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.586 ' HB3' ' CB ' ' A' ' 95' ' ' TRP . 5.3 mm-40 -147.03 -67.78 0.26 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.965 -1.085 . . . . 0.0 109.27 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.679 ' HB ' ' HB3' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -114.27 -46.59 4.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.469 ' N ' ' CG1' ' A' ' 58' ' ' VAL . . . 100.48 53.49 1.06 Allowed Glycine 0 N--CA 1.482 1.713 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.458 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.648 HG21 ' CD1' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -90.33 167.73 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.665 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.2 m -119.02 -65.13 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.587 -1.32 . . . . 0.0 111.299 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.665 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 18.8 Cg_endo -77.5 33.66 0.45 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.628 1.552 . . . . 0.0 110.905 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.739 ' OE1' HD21 ' A' ' 54' ' ' LEU . 55.8 tt0 -82.27 65.74 7.54 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.584 0.707 . . . . 0.0 109.636 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -51.28 144.85 8.98 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.623 ' HB3' HG12 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -153.93 170.94 19.85 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.596 -1.315 . . . . 0.0 111.21 -179.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.0 -177.51 6.16 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.0 tp -105.71 127.04 52.84 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.732 -1.23 . . . . 0.0 109.728 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.785 ' CE2' HD21 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -86.18 -70.48 0.6 Allowed 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.666 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -173.96 117.19 0.24 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.112 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -87.4 138.36 31.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.33 -0.856 . . . . 0.0 109.137 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.938 HD23 HG22 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -96.9 -170.93 2.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.244 -0.91 . . . . 0.0 110.63 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -154.4 137.24 15.35 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.413 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -131.11 175.39 9.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.934 -1.103 . . . . 0.0 110.407 -179.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -158.55 126.29 5.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.473 -0.767 . . . . 0.0 109.175 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.641 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -88.5 177.9 2.36 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.846 . . . . 0.0 109.258 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.641 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 2.6 Cg_exo -56.24 -16.82 18.52 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.864 1.709 . . . . 0.0 110.408 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -165.99 15.09 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.345 -0.847 . . . . 0.0 110.623 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.533 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 6.4 mmm180 -124.49 178.94 5.15 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 120.818 -1.176 . . . . 0.0 109.097 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -129.41 110.76 12.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.0 109.26 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.413 ' HB ' ' HB3' ' A' ' 73' ' ' TYR . 24.3 mm -106.16 109.27 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 109.695 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.9 m -116.69 142.35 47.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.336 -0.852 . . . . 0.0 109.139 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.483 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -149.87 167.0 27.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.68 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.64 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 1.1 m95 -124.48 155.63 38.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.375 -0.828 . . . . 0.0 109.402 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.499 ' CZ ' ' CD2' ' A' ' 35' ' ' PHE . 3.0 m-85 -133.43 88.38 2.48 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.438 -0.789 . . . . 0.0 109.046 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.583 ' O ' ' CG ' ' A' ' 85' ' ' TRP . 1.2 p-90 -111.39 104.43 12.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.474 -1.391 . . . . 0.0 109.55 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.115 ' CD2' HD12 ' A' ' 10' ' ' ILE . 1.9 mm? -80.97 141.43 34.46 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.282 0.563 . . . . 0.0 111.178 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.801 HG22 ' HA ' ' A' ' 11' ' ' ILE . 5.0 m -99.53 -174.33 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 O-C-N 121.217 -0.927 . . . . 0.0 108.906 178.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.506 ' O ' ' O ' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -120.8 -46.87 2.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.986 -1.071 . . . . 0.0 111.444 -179.039 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.63 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.35 150.5 14.49 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.366 -1.459 . . . . 0.0 110.75 -179.222 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.787 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 11.6 p90 -151.41 178.4 9.33 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 122.066 0.936 . . . . 0.0 109.896 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.577 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 22.6 tt0 -128.66 86.74 2.48 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.484 ' O ' ' CD1' ' A' ' 90' ' ' TRP . . . 148.99 175.07 21.12 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.609 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.2 mt-10 -80.26 118.55 72.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.141 -1.211 . . . . 0.0 108.21 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.717 ' HB3' HD12 ' A' ' 11' ' ' ILE . 3.4 Cg_endo -70.3 167.44 25.14 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.516 2.144 . . . . 0.0 112.064 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.694 ' HH2' HG22 ' A' ' 50' ' ' VAL . 29.2 p-90 -113.64 -167.86 1.26 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 36' ' ' PRO . . . 162.01 -78.86 0.16 Allowed Glycine 0 N--CA 1.481 1.669 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.563 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -101.88 -174.86 2.68 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.726 -0.867 . . . . 0.0 108.701 179.149 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -125.24 -53.8 1.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.937 -1.102 . . . . 0.0 109.575 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.48 -0.09 89.61 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.643 ' OE1' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -113.07 128.92 25.05 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.178 -1.19 . . . . 0.0 109.452 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.69 -71.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.116 1.877 . . . . 0.0 110.503 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . 95.74 166.18 34.64 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -159.27 159.49 34.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.566 -1.549 . . . . 0.0 111.08 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.553 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -84.37 94.74 8.55 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 1.1 ttm -86.77 132.11 33.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.225 -0.922 . . . . 0.0 109.662 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.442 ' HB3' ' CD ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -111.26 99.3 8.15 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.419 -0.8 . . . . 0.0 109.43 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.931 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.0 mt -122.75 -85.97 0.65 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 109.575 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 107' ' ' LEU . 1.5 t -177.82 -55.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -159.68 88.2 0.11 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.748 HD13 ' CE2' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -40.39 143.74 0.29 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.518 -0.989 . . . . 0.0 110.015 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.454 ' ND2' ' HA ' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -128.64 -171.02 2.36 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.451 -0.781 . . . . 0.0 109.184 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . . . -75.98 -9.34 58.53 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.197 -0.939 . . . . 0.0 109.431 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -62.81 -56.66 15.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.871 . . . . 0.0 109.687 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.827 ' HB3' HD21 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -81.3 -13.63 58.22 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.785 ' CG ' HD12 ' A' ' 123' ' ' ILE . 3.1 m-85 -90.58 110.6 42.39 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.514 ' CG ' ' O ' ' A' ' 33' ' ' LEU . 6.6 Cg_exo -50.96 141.19 37.51 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.953 1.769 . . . . 0.0 110.094 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.723 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 4.4 Cg_exo -59.35 126.52 21.03 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.195 1.93 . . . . 0.0 110.804 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.723 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 152.97 -18.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.559 ' HB3' HG12 ' A' ' 123' ' ' ILE . 0.9 OUTLIER -123.33 48.52 1.82 Allowed 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.655 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.2 mm-40 -65.99 -35.88 12.07 Favored Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.655 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 6.2 Cg_exo -60.59 -35.11 91.32 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 121.678 1.585 . . . . 0.0 112.094 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.938 HG22 HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -102.67 -46.66 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 120.588 -1.32 . . . . 0.0 108.672 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.785 HD12 ' CG ' ' A' ' 115' ' ' PHE . 24.8 mm -50.15 -38.35 14.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 127' ' ' LYS . . . -52.06 -44.35 64.25 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -71.08 -42.63 69.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.41 -0.806 . . . . 0.0 109.782 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.785 HD21 ' CE2' ' A' ' 68' ' ' PHE . 1.4 mt -63.01 -9.73 11.21 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.276 -0.89 . . . . 0.0 109.732 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.454 ' HA ' ' ND2' ' A' ' 111' ' ' ASN . 55.6 mttt -56.81 -48.7 77.35 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.14 -0.975 . . . . 0.0 108.69 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 129' ' ' LEU . 1.8 ptt180 -89.33 0.95 56.42 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.407 -0.808 . . . . 0.0 109.27 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 126' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.851 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.427 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 2' ' ' LYS . 6.8 ptmm? -179.34 46.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.151 -0.968 . . . . 0.0 109.653 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -110.57 89.82 3.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.977 . . . . 0.0 109.229 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.772 ' H ' HD12 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -115.61 176.94 4.85 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.112 0.958 . . . . 0.0 110.546 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.447 ' O ' ' O ' ' A' ' 4' ' ' LEU . 8.8 mt-30 58.36 126.53 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.568 0.699 . . . . 0.0 110.485 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.603 HG23 ' N ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -129.89 176.05 9.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.603 ' N ' HG23 ' A' ' 6' ' ' ILE . . . -117.79 80.26 1.48 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.841 -1.162 . . . . 0.0 110.283 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.742 HG23 ' CB ' ' A' ' 36' ' ' PRO . 3.2 p -100.18 145.27 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 118.896 -1.122 . . . . 0.0 108.485 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -129.37 110.36 1.06 Allowed Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.14 HD12 ' CD1' ' A' ' 86' ' ' LEU . 1.3 mt -92.49 166.19 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.024 HG23 HG21 ' A' ' 87' ' ' VAL . 0.7 OUTLIER -154.48 146.42 13.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.271 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.545 ' CZ ' HD23 ' A' ' 129' ' ' LEU . 38.2 ttp180 -161.5 77.27 0.54 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.532 -0.73 . . . . 0.0 110.039 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.512 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 20.2 m-80 -160.1 -162.04 0.95 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -0.893 . . . . 0.0 109.543 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.37 -85.98 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.619 0.723 . . . . 0.0 109.528 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 13' ' ' ASN . 28.9 t-20 -94.75 28.68 2.59 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.529 -0.732 . . . . 0.0 109.335 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 15' ' ' ASN . 30.1 t30 42.31 43.73 3.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.475 -0.766 . . . . 0.0 109.318 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 105' ' ' MET . 2.5 mt-10 -129.41 149.33 51.24 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.689 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 3.0 mt -101.12 156.99 4.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 118.326 -1.35 . . . . 0.0 110.672 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.519 ' HB3' HG13 ' A' ' 11' ' ' ILE . 60.3 t80 -97.03 78.25 2.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.97 HG21 HD13 ' A' ' 33' ' ' LEU . 11.3 mm -78.09 167.14 2.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.404 -0.81 . . . . 0.0 110.084 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.665 HG21 ' HB2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -128.01 139.88 52.3 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.848 178.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' A' ' 32' ' ' LYS . 1.2 ttp180 -145.71 144.73 30.55 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.055 -1.028 . . . . 0.0 109.433 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.703 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -64.41 109.25 1.87 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.27 -0.894 . . . . 0.0 110.658 -179.499 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 23' ' ' ARG . . . 79.22 -6.03 1.91 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.727 -0.608 . . . . 0.0 110.034 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 58.71 21.27 8.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.973 . . . . 0.0 109.686 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.98 154.05 48.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.171 -0.956 . . . . 0.0 109.419 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.62 143.61 33.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 109.847 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -103.28 -31.0 10.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.573 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -133.45 137.86 45.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 109.524 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.425 ' C ' ' OD1' ' A' ' 31' ' ' ASN . . . 48.98 -172.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.306 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.425 ' OD1' ' C ' ' A' ' 30' ' ' ALA . 1.5 m120 -134.39 114.19 12.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 109.612 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.469 ' O ' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -108.13 135.0 50.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.317 -0.864 . . . . 0.0 109.375 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.97 HD13 HG21 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -104.63 -176.94 3.22 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.351 -0.843 . . . . 0.0 109.073 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -162.17 -155.91 0.39 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 110.073 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.461 ' HB3' HG21 ' A' ' 8' ' ' VAL . 21.8 m-85 -142.31 141.41 21.06 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.742 ' CB ' HG23 ' A' ' 8' ' ' VAL . 5.9 Cg_exo -57.54 -150.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.87 1.714 . . . . 0.0 110.074 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.567 ' HA2' ' CA ' ' A' ' 8' ' ' VAL . . . 148.78 -149.08 21.04 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.086 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . 144.93 -79.93 0.23 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.464 ' HG2' ' HG3' ' A' ' 41' ' ' GLU . 0.2 OUTLIER 178.07 133.87 0.07 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.395 -1.061 . . . . 0.0 109.652 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.677 ' O ' HG23 ' A' ' 40' ' ' ILE . 9.0 tt -121.84 74.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.253 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.464 ' HG3' ' HG2' ' A' ' 39' ' ' LYS . 1.9 mm-40 -113.04 -179.71 3.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.611 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.2 ttm 44.09 83.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.31 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 168.85 124.31 0.72 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.21 -11.17 39.09 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.19 -1.183 . . . . 0.0 110.192 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.848 HG22 ' H ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -125.18 149.03 62.53 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 120.927 -1.108 . . . . 0.0 108.715 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.721 ' HD2' HG23 ' A' ' 45' ' ' THR . 9.3 Cg_endo -71.12 14.98 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.753 2.302 . . . . 0.0 112.343 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.848 ' H ' HG22 ' A' ' 45' ' ' THR . 0.8 OUTLIER -124.01 -60.92 1.4 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.508 -1.37 . . . . 0.0 109.766 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.575 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -48.12 -28.5 2.95 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.823 1.296 . . . . 0.0 109.379 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . -67.54 -67.17 0.48 Allowed 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.374 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.745 HG13 ' CZ3' ' A' ' 85' ' ' TRP . 10.0 p -83.29 3.55 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.259 -0.901 . . . . 0.0 111.463 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.582 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 4.9 p -81.92 -43.67 19.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.582 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -69.34 -29.08 66.82 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 113.745 -1.571 . . . . 0.0 108.101 177.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 49' ' ' ALA . 69.9 mt-10 -70.36 -22.78 62.74 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.128 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.034 HD13 ' HG3' ' A' ' 62' ' ' PRO . 3.4 mt -63.43 -48.09 79.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -0.908 . . . . 0.0 109.467 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.513 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 2.1 pt20 -81.37 -30.64 33.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.937 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 9.1 mm-40 -81.88 32.56 0.37 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.219 -0.926 . . . . 0.0 111.014 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.655 ' CB ' ' CD1' ' A' ' 95' ' ' TRP . 25.6 mm-40 -155.3 -57.63 0.1 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.629 -1.294 . . . . 0.0 109.985 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.053 HG22 ' CD1' ' A' ' 95' ' ' TRP . 10.6 m -113.92 -49.8 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.587 ' N ' HG23 ' A' ' 58' ' ' VAL . . . 92.4 37.69 5.82 Favored Glycine 0 C--N 1.299 -1.482 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -79.83 174.67 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -1.092 . . . . 0.0 108.255 178.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.565 ' HB ' ' CB ' ' A' ' 91' ' ' GLU . 8.1 m -115.3 90.13 23.59 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 1.034 ' HG3' HD13 ' A' ' 54' ' ' LEU . 4.3 Cg_endo -61.0 122.75 11.66 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 121.809 1.672 . . . . 0.0 110.11 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.528 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 1.8 mt-30 -86.89 -34.18 19.5 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.834 -0.541 . . . . 0.0 109.773 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.46 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 45.5 t60 -176.42 97.48 0.06 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.179 -0.951 . . . . 0.0 110.315 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.477 ' HB2' HG12 ' A' ' 87' ' ' VAL . 13.7 p90 -111.7 175.5 5.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.908 -1.12 . . . . 0.0 109.307 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.1 m -161.97 173.18 14.81 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.624 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.941 HD22 ' CZ3' ' A' ' 83' ' ' TRP . 4.6 tp -116.09 114.16 24.15 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.215 -0.928 . . . . 0.0 109.153 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.641 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 2.6 p90 -73.78 -53.76 9.57 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.294 -0.879 . . . . 0.0 109.876 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.641 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 0.5 OUTLIER 176.45 149.59 0.13 Allowed 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.039 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -111.66 163.46 14.09 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.312 -0.868 . . . . 0.0 109.895 -179.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.941 HD23 ' CG2' ' A' ' 122' ' ' VAL . 0.3 OUTLIER -113.93 -164.6 0.94 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 109.145 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -136.03 156.28 48.96 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.133 -0.979 . . . . 0.0 109.557 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.57 82.85 1.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.616 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 1.0 OUTLIER -103.12 114.2 28.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 110.327 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.522 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -81.69 177.04 3.25 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 1.9 Cg_endo -63.95 2.67 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.926 1.751 . . . . 0.0 111.42 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -125.52 -55.05 1.55 Allowed 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.623 -1.298 . . . . 0.0 111.162 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.524 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -118.49 -179.42 3.78 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.253 -0.904 . . . . 0.0 110.387 -178.114 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.616 ' CD2' ' HG3' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -128.51 96.44 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 12.6 mt -97.74 128.68 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.506 -0.746 . . . . 0.0 110.815 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.445 ' CB ' ' H ' ' A' ' 5' ' ' GLN . 3.7 m -115.85 118.43 32.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 108.769 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.581 ' CB ' HD11 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -81.93 132.15 35.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.154 -0.966 . . . . 0.0 109.81 -179.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.941 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -122.9 113.64 19.39 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.31 -0.869 . . . . 0.0 109.575 -178.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.657 ' CE1' HG11 ' A' ' 122' ' ' VAL . 0.1 OUTLIER -122.37 113.54 19.52 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 120.358 -1.464 . . . . 0.0 109.955 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.837 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -83.34 87.05 6.97 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.363 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.14 ' CD1' HD12 ' A' ' 10' ' ' ILE . 0.6 OUTLIER -44.39 107.87 0.1 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.038 -1.039 . . . . 0.0 109.21 -179.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.024 HG21 HG23 ' A' ' 11' ' ' ILE . 19.8 m -81.0 174.66 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.531 -0.73 . . . . 0.0 110.308 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.495 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 1.0 OUTLIER -129.22 -18.48 3.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 110.422 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.495 ' HD3' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -162.16 174.08 13.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.89 -1.131 . . . . 0.0 110.252 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.881 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 35.1 p90 174.65 -179.71 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.093 0.949 . . . . 0.0 109.883 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.633 ' O ' HG22 ' A' ' 60' ' ' ILE . 1.4 tt0 -134.7 109.17 8.43 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.727 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.52 ' CA ' HG22 ' A' ' 60' ' ' ILE . . . 114.37 -156.97 15.28 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.333 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.476 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 1.9 mt-10 -107.29 102.22 42.65 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.344 -1.092 . . . . 0.0 109.067 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 1.038 ' C ' HG11 ' A' ' 58' ' ' VAL . 3.4 Cg_endo -66.46 -169.82 0.19 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.118 1.879 . . . . 0.0 111.972 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 1.053 ' CD1' HG22 ' A' ' 58' ' ' VAL . 4.8 p-90 -136.01 -168.27 2.19 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.69 0.757 . . . . 0.0 108.986 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 36' ' ' PRO . . . -159.98 -77.86 0.03 OUTLIER Glycine 0 C--N 1.295 -1.742 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.665 ' HB2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -87.06 -179.27 6.44 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.524 -0.986 . . . . 0.0 109.494 179.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -92.59 -36.04 13.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.346 -0.846 . . . . 0.0 109.819 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -139.76 9.61 3.12 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.543 ' HB3' ' CB ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -99.04 109.59 54.64 Favored Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 121.189 -1.183 . . . . 0.0 109.694 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.97 122.2 11.03 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.949 1.766 . . . . 0.0 109.679 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -98.22 168.58 23.29 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -125.81 154.61 42.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.857 -1.378 . . . . 0.0 110.086 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.443 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -94.65 104.01 15.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.543 -0.723 . . . . 0.0 109.351 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 1.2 ttm -92.51 168.73 11.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.178 -0.951 . . . . 0.0 109.257 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.4 t -116.21 65.63 0.71 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.176 -0.953 . . . . 0.0 109.567 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.505 ' CD1' ' HD2' ' A' ' 12' ' ' ARG . 3.1 tp 48.03 59.52 4.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.274 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.34 -72.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 109.555 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.501 ' HA3' ' HB2' ' A' ' 114' ' ' ASP . . . -100.75 30.92 9.27 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.964 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -67.24 -20.6 65.69 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.311 -1.111 . . . . 0.0 109.33 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -78.93 -177.89 5.77 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.427 -0.795 . . . . 0.0 109.731 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.656 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . -68.76 -6.81 28.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.378 -0.826 . . . . 0.0 109.656 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -62.91 -54.77 33.53 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.257 -0.902 . . . . 0.0 109.944 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.501 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 19.8 t0 -90.56 -6.7 54.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.872 . . . . 0.0 109.811 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.629 ' CD2' HD11 ' A' ' 123' ' ' ILE . 1.8 m-85 -89.32 142.13 29.57 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.026 -1.046 . . . . 0.0 109.388 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.538 ' CG ' ' O ' ' A' ' 33' ' ' LEU . 2.1 Cg_endo -71.65 158.13 54.19 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.303 2.002 . . . . 0.0 110.584 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.641 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 2.8 Cg_endo -60.62 -177.04 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.484 2.123 . . . . 0.0 110.563 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.641 ' HB3' ' O ' ' A' ' 117' ' ' PRO . . . 74.43 -1.85 2.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.458 -0.776 . . . . 0.0 109.902 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.589 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 0.9 OUTLIER -127.15 41.7 3.47 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.032 -1.042 . . . . 0.0 109.511 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.675 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 26.6 mt-10 -74.94 -39.12 3.24 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.299 -0.875 . . . . 0.0 112.065 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.6 Cg_exo -62.37 -32.36 81.26 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.954 1.769 . . . . 0.0 112.089 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.941 ' CG2' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -101.4 -50.4 10.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 120.508 -1.37 . . . . 0.0 109.288 -179.592 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.656 HG21 ' HA ' ' A' ' 112' ' ' ALA . 14.1 mm -50.95 -36.88 16.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -58.73 -43.85 90.3 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -63.01 -41.46 99.57 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.293 -0.88 . . . . 0.0 109.465 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.549 HD12 HD13 ' A' ' 129' ' ' LEU . 5.3 mp -58.06 -17.21 16.29 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.233 -0.917 . . . . 0.0 109.678 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.446 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 13.8 mmtt -57.07 -53.46 57.87 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -91.25 9.77 29.96 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.009 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.991 HD11 ' CD2' ' A' ' 86' ' ' LEU . 3.4 tp . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.748 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.44 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 2.7 ttt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.3 10.51 2.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 0.0 109.16 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.5 ' O ' ' O ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -103.27 131.34 50.4 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -162.43 48.55 0.17 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.387 -0.821 . . . . 0.0 109.83 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.471 ' C ' HG12 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -164.26 119.66 1.52 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.695 -1.253 . . . . 0.0 110.713 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.992 HG22 HD13 ' A' ' 82' ' ' LEU . 6.0 mm -152.02 157.49 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.507 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -146.42 119.31 8.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.762 -1.211 . . . . 0.0 110.465 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.976 HG12 HD11 ' A' ' 82' ' ' LEU . 7.5 p -122.2 147.17 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.576 ' HA3' ' CZ3' ' A' ' 95' ' ' TRP . . . -129.1 119.55 2.99 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.09 HD12 HD13 ' A' ' 86' ' ' LEU . 1.2 mt -92.2 166.15 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.967 HD11 ' CB ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -149.19 153.38 10.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 118.584 -1.246 . . . . 0.0 110.492 -178.3 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 88' ' ' GLU . 11.0 ttp180 -129.39 122.23 29.01 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.39 -169.46 1.8 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.098 -1.001 . . . . 0.0 110.632 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -78.36 -6.93 56.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.558 -0.714 . . . . 0.0 110.302 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.489 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 24.3 t30 -88.43 21.35 2.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.443 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 20.2 t30 48.46 42.92 19.35 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.413 -0.804 . . . . 0.0 109.339 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 15' ' ' ASN . 2.9 mt-10 -140.45 147.65 39.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 108.835 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.881 HG22 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.09 153.92 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.111 -0.993 . . . . 0.0 109.415 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 56.6 t80 -88.84 73.15 8.46 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.696 HG13 HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -80.06 -161.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.344 -0.848 . . . . 0.0 109.354 -178.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.851 HG23 ' HA2' ' A' ' 102' ' ' GLY . 0.2 OUTLIER -159.96 152.66 21.31 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.823 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.52 ' HG3' ' HA ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -136.33 161.21 36.42 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.518 ' NH2' ' HB2' ' A' ' 23' ' ' ARG . 0.2 OUTLIER -85.36 61.35 6.81 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.92 -1.113 . . . . 0.0 109.991 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.619 ' O ' ' HB3' ' A' ' 25' ' ' ALA . . . 51.21 174.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.905 . . . . 0.0 109.887 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . 71.36 86.34 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.877 . . . . 0.0 109.64 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.94 122.26 20.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.181 -0.95 . . . . 0.0 109.185 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.19 155.18 39.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 109.561 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -125.32 11.32 8.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.893 . . . . 0.0 109.45 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 19.0 mtt -155.57 -48.79 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 109.358 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.14 -153.26 0.26 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.144 -0.973 . . . . 0.0 109.534 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.39 127.2 3.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.286 -0.884 . . . . 0.0 109.536 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.517 ' O ' ' CD ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -151.55 125.88 9.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.424 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.696 HD23 HG13 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -121.17 -165.38 1.22 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.349 -0.844 . . . . 0.0 109.36 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.2 -160.89 0.82 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.337 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.69 ' CE2' ' CZ ' ' A' ' 84' ' ' PHE . 5.8 m-85 -156.12 70.47 5.09 Favored Pre-proline 0 C--N 1.294 -1.833 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.706 ' O ' HG23 ' A' ' 8' ' ' VAL . 4.3 Cg_exo -55.19 164.69 3.5 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.046 1.831 . . . . 0.0 109.588 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . -161.57 -147.71 5.07 Favored Glycine 0 N--CA 1.486 1.969 0 C-N-CA 119.325 -1.417 . . . . 0.0 109.814 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -134.51 -76.03 0.09 OUTLIER Glycine 0 N--CA 1.484 1.887 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 13.1 tttt 176.38 155.7 0.23 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.628 -0.924 . . . . 0.0 109.822 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.831 HD11 ' O ' ' A' ' 6' ' ' ILE . 15.2 mm -78.92 107.5 11.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.465 ' OE1' ' HD3' ' A' ' 52' ' ' ARG . 5.6 mt-10 -116.63 177.78 4.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.963 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.437 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 54.3 mmm 71.38 -164.99 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.863 . . . . 0.0 109.732 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.8 -26.53 3.29 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.551 ' HB2' ' NE2' ' A' ' 48' ' ' GLN . 0.9 OUTLIER -79.61 -154.91 0.09 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.399 -1.059 . . . . 0.0 109.19 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.73 HG23 ' HD3' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -160.82 -58.09 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.032 -1.043 . . . . 0.0 111.374 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.73 ' HD3' HG23 ' A' ' 45' ' ' THR . 1.3 Cg_endo -67.62 3.88 1.62 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 121.492 1.461 . . . . 0.0 112.765 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.534 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -148.91 -69.28 0.21 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.331 -1.48 . . . . 0.0 109.157 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.61 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 13.3 mt-30 -51.37 -27.57 10.2 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 122.54 1.162 . . . . 0.0 110.116 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 45' ' ' THR . . . -65.65 -66.18 0.58 Allowed 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.671 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.499 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 9.9 p -81.9 -6.59 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 111.25 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.61 ' CG1' ' HA ' ' A' ' 48' ' ' GLN . 3.1 p -72.38 -48.3 48.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.58 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -75.09 -22.5 58.23 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -52.98 -21.45 4.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.89 -1.131 . . . . 0.0 108.808 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.621 HD21 ' HG3' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -66.08 -59.44 3.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.419 -0.801 . . . . 0.0 110.401 -179.435 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.544 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 7.2 pt20 -79.97 -30.22 39.73 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.177 -0.952 . . . . 0.0 111.891 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.544 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 1.1 pp20? -79.64 -29.17 40.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.869 -1.144 . . . . 0.0 111.377 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 1.052 ' HG3' HG12 ' A' ' 58' ' ' VAL . 4.4 pt-20 -91.59 -46.63 7.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.684 -1.26 . . . . 0.0 110.428 -178.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.052 HG12 ' HG3' ' A' ' 57' ' ' GLU . 0.5 OUTLIER -147.96 -67.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.353 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.736 ' H ' HG13 ' A' ' 58' ' ' VAL . . . 119.99 71.36 0.33 Allowed Glycine 0 N--CA 1.48 1.589 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.841 HG22 ' N ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -107.52 -156.49 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 91' ' ' GLU . 2.3 m -146.51 91.87 5.27 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.621 ' HG3' HD21 ' A' ' 54' ' ' LEU . 1.8 Cg_endo -66.05 150.55 85.23 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.34 2.027 . . . . 0.0 110.729 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -121.28 -40.07 2.62 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.592 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -128.69 -179.56 5.13 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.665 ' CD2' HG12 ' A' ' 87' ' ' VAL . 22.9 m-85 -148.7 170.65 17.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.144 -0.972 . . . . 0.0 110.053 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.523 ' HB3' ' O ' ' A' ' 86' ' ' LEU . 3.8 t -159.24 0.84 0.09 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.296 -0.877 . . . . 0.0 111.96 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.058 HD22 ' CZ3' ' A' ' 85' ' ' TRP . 9.6 tp -29.0 148.52 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 CA-C-O 121.911 0.863 . . . . 0.0 110.991 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.651 ' HE2' HG22 ' A' ' 122' ' ' VAL . 14.3 p90 -116.46 -51.19 2.61 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.811 0.815 . . . . 0.0 109.431 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.528 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.3 pt-20 -179.18 161.84 1.15 Allowed 'General case' 0 C--N 1.291 -1.946 0 O-C-N 121.743 -0.598 . . . . 0.0 110.135 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.619 ' HD3' ' CE3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -105.59 -175.8 2.9 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.311 -0.868 . . . . 0.0 110.221 -179.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.81 HD12 ' N ' ' A' ' 72' ' ' GLU . 3.8 pp -147.51 -161.52 1.35 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.262 -0.899 . . . . 0.0 109.564 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.81 ' N ' HD12 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -143.45 162.16 36.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.461 -0.775 . . . . 0.0 109.425 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -141.09 164.07 31.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.709 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -158.5 108.69 2.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.427 -0.796 . . . . 0.0 109.097 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.58 ' HB2' ' HG3' ' A' ' 78' ' ' ARG . 2.1 m-85 -79.31 170.6 15.36 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.2 Cg_exo -57.84 -10.52 7.69 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.905 1.737 . . . . 0.0 111.204 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 1' ' ' MET . 2.1 t0 -153.54 -5.69 0.18 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.87 -1.144 . . . . 0.0 112.204 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.58 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 3.7 ptt180 -133.34 -176.91 4.3 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.406 -1.434 . . . . 0.0 109.548 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.5 ' O ' ' O ' ' A' ' 3' ' ' LYS . 5.9 m80 -134.99 156.11 49.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.157 -0.965 . . . . 0.0 109.381 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.435 HD13 ' O ' ' A' ' 79' ' ' HIS . 33.1 mm -148.87 92.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.084 -1.01 . . . . 0.0 109.897 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.0 m -79.33 90.52 4.99 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.992 HD13 HG22 ' A' ' 6' ' ' ILE . 11.0 tp -108.24 141.57 39.82 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.315 -0.866 . . . . 0.0 109.614 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.833 ' H ' HD12 ' A' ' 82' ' ' LEU . 8.7 m95 -89.56 -174.54 4.38 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.521 -0.737 . . . . 0.0 109.388 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.69 ' CZ ' ' CE2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -144.05 76.13 1.49 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 1.058 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 55.7 m95 -81.46 157.89 24.74 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 122.218 1.008 . . . . 0.0 110.628 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.09 HD13 HD12 ' A' ' 10' ' ' ILE . 6.2 tp -150.24 98.12 2.64 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.812 ' CG2' HG23 ' A' ' 11' ' ' ILE . 15.8 m -93.64 178.46 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.8 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -110.59 -28.15 8.62 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.23 -0.919 . . . . 0.0 112.32 -178.094 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -161.68 153.77 19.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.547 -1.346 . . . . 0.0 110.788 -178.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.7 ' NE1' ' O ' ' A' ' 92' ' ' GLY . 0.9 OUTLIER -161.96 -167.43 1.66 Allowed 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.582 -0.699 . . . . 0.0 109.564 178.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.535 ' O ' ' O ' ' A' ' 92' ' ' GLY . 22.7 tt0 -90.89 -105.82 0.1 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.274 -0.891 . . . . 0.0 110.062 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.841 ' N ' HG22 ' A' ' 60' ' ' ILE . . . -45.18 173.25 0.01 OUTLIER Glycine 0 N--CA 1.495 2.598 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.852 ' N ' ' HD3' ' A' ' 94' ' ' PRO . 1.5 pt-20 -115.26 28.53 0.11 Allowed Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 119.354 1.577 . . . . 0.0 113.29 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.998 ' CG ' HG21 ' A' ' 58' ' ' VAL . 60.6 Cg_endo -90.41 -123.54 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 122.508 2.139 . . . . 0.0 108.447 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.967 ' CB ' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER 85.76 75.53 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.042 -1.036 . . . . 0.0 111.707 177.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 161.26 -121.77 1.05 Allowed Glycine 0 C--N 1.297 -1.634 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.514 ' CD ' ' HB2' ' A' ' 100' ' ' GLN . 7.3 tttt -94.5 145.86 24.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.109 -1.23 . . . . 0.0 109.995 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.454 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 11.6 pt-20 -89.72 -33.81 16.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.168 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.454 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . -88.11 -10.83 68.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.632 ' HG2' HG22 ' A' ' 21' ' ' THR . 7.1 tt0 -102.65 113.2 66.02 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 121.374 -1.074 . . . . 0.0 109.381 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.29 102.62 0.33 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.041 1.827 . . . . 0.0 110.726 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.851 ' HA2' HG23 ' A' ' 21' ' ' THR . . . -65.38 172.31 22.83 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.536 ' O ' HG22 ' A' ' 20' ' ' ILE . 4.2 pt-20 -147.0 134.22 20.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.543 -1.563 . . . . 0.0 110.14 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.599 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -81.81 94.72 7.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.448 -0.783 . . . . 0.0 109.08 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.443 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -85.04 169.51 13.88 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.082 -1.011 . . . . 0.0 109.471 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.406 ' HB3' HG23 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -96.43 145.51 25.59 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.199 -0.938 . . . . 0.0 109.596 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.492 ' HG ' HD12 ' A' ' 110' ' ' LEU . 1.8 tt -101.39 61.41 0.92 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.406 HG23 ' HB3' ' A' ' 106' ' ' SER . 21.2 t -98.59 -25.95 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.565 -0.709 . . . . 0.0 109.505 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -162.58 38.04 0.35 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.492 HD12 ' HG ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -43.13 145.82 0.48 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.397 -1.061 . . . . 0.0 109.632 -179.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.457 ' ND2' ' HE2' ' A' ' 127' ' ' LYS . 2.6 t30 -156.87 163.12 39.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.082 -1.011 . . . . 0.0 110.028 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.647 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . -61.29 -15.64 37.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 109.184 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -68.44 -33.15 73.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.425 -0.797 . . . . 0.0 109.4 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -79.13 2.09 22.07 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.605 ' CE1' ' CE2' ' A' ' 35' ' ' PHE . 10.2 m-85 -130.97 104.72 15.28 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.443 -0.786 . . . . 0.0 109.179 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.464 ' HG3' ' HB2' ' A' ' 32' ' ' LYS . 21.6 Cg_exo -43.18 160.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.513 2.142 . . . . 0.0 110.831 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.703 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 5.0 Cg_exo -58.03 130.25 37.2 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.518 2.145 . . . . 0.0 111.365 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 160.31 -56.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.549 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 16.1 m-20 -107.84 42.41 1.35 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.641 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -61.51 -38.68 54.33 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.433 -0.792 . . . . 0.0 113.004 -179.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 1.9 Cg_endo -65.06 -37.46 32.8 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 122.0 1.8 . . . . 0.0 111.977 -177.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.651 HG22 ' HE2' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -90.23 -39.34 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.523 -1.361 . . . . 0.0 108.186 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.647 HG21 ' HA ' ' A' ' 112' ' ' ALA . 6.6 mm -56.35 -34.31 40.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.43 -36.78 74.15 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.871 -0.731 . . . . 0.0 109.271 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -55.1 8.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.91 . . . . 0.0 109.967 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -50.65 -17.66 0.56 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.199 -0.938 . . . . 0.0 110.126 -179.475 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.457 ' HE2' ' ND2' ' A' ' 111' ' ' ASN . 15.2 mttt -47.59 -46.37 28.2 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 120.825 -1.172 . . . . 0.0 108.923 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -95.98 47.71 1.1 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.459 -0.775 . . . . 0.0 109.319 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.821 HD21 ' CD2' ' A' ' 86' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.305 -1.345 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.658 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.357 0.599 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.65 -174.52 3.67 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.193 -0.942 . . . . 0.0 109.457 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -106.17 85.06 2.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.358 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.4 tp -83.89 127.05 33.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -0.852 . . . . 0.0 109.508 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.771 ' C ' HG22 ' A' ' 40' ' ' ILE . 2.0 mt-30 -118.12 159.25 23.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 0.0 109.177 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.695 HG23 ' N ' ' A' ' 7' ' ' ALA . 2.1 tt -134.4 -173.94 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.132 -0.98 . . . . 0.0 109.365 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.695 ' N ' HG23 ' A' ' 6' ' ' ILE . . . -138.31 104.92 5.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.198 -0.939 . . . . 0.0 109.311 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 7.6 p -113.08 139.96 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.428 -0.795 . . . . 0.0 109.567 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.609 ' CA ' ' NE1' ' A' ' 85' ' ' TRP . . . -121.77 126.32 6.44 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.639 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.931 HD11 ' CD2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -107.17 144.27 16.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.085 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.843 HG23 HG21 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -123.69 156.04 30.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.866 -1.146 . . . . 0.0 109.253 179.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -157.44 125.25 5.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.474 -0.766 . . . . 0.0 109.451 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.577 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 26.9 p-10 -156.63 -168.48 2.7 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.879 -1.138 . . . . 0.0 111.169 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 13' ' ' ASN . 3.8 mt-10 66.16 -83.44 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.863 0.84 . . . . 0.0 110.048 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -132.68 -59.21 0.91 Allowed 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 122.004 0.907 . . . . 0.0 109.593 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -164.72 32.55 0.07 Allowed 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 3.7 mt-10 -89.39 148.95 23.21 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.903 HD11 ' HB2' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -131.21 154.91 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.06 -1.025 . . . . 0.0 109.582 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.586 ' CZ ' ' OE1' ' A' ' 100' ' ' GLN . 9.6 t80 -116.63 84.87 2.21 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.632 HD11 ' HB ' ' A' ' 18' ' ' ILE . 0.6 OUTLIER -107.3 -152.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 108.619 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.966 HG21 ' HD3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -131.23 151.32 51.59 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.015 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -131.22 -159.59 0.98 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.43 -0.794 . . . . 0.0 109.818 -179.399 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.965 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 5.3 ptt180 -73.08 81.82 1.26 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.421 -0.799 . . . . 0.0 109.874 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.77 7.68 25.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.286 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.08 -42.01 0.15 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.36 -0.838 . . . . 0.0 109.577 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -169.76 133.84 1.29 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.98 . . . . 0.0 109.738 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.965 ' HB2' ' HB3' ' A' ' 23' ' ' ARG . . . -121.69 122.61 39.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.343 -0.848 . . . . 0.0 109.243 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -48.44 -28.07 3.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.843 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 17.9 mtt -126.97 -152.92 0.54 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.049 -1.032 . . . . 0.0 109.797 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.56 -88.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.34 -0.85 . . . . 0.0 109.505 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -100.78 129.65 46.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.938 . . . . 0.0 109.327 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.533 ' HB2' ' HG3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -148.81 132.31 16.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.206 -0.934 . . . . 0.0 109.339 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.587 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -93.6 -176.86 4.21 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 120.93 -1.106 . . . . 0.0 108.389 179.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.491 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 4.8 tt0 -163.44 -158.9 0.49 Allowed 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 118.804 -1.159 . . . . 0.0 111.067 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 1.051 ' CE2' HD11 ' A' ' 123' ' ' ILE . 57.8 m-85 -161.64 64.75 1.85 Allowed Pre-proline 0 C--N 1.299 -1.601 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 34' ' ' GLU . 2.3 Cg_endo -60.62 -84.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.235 1.957 . . . . 0.0 110.706 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 105.6 -120.64 6.51 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -156.46 -77.85 0.02 OUTLIER Glycine 0 N--CA 1.488 2.1 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 6.0 tttp 177.41 132.31 0.06 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.483 -1.01 . . . . 0.0 109.318 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.771 HG22 ' C ' ' A' ' 5' ' ' GLN . 14.2 tt -118.93 120.04 62.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.378 -0.826 . . . . 0.0 108.978 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -85.55 144.73 27.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.033 -1.042 . . . . 0.0 109.826 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.17 165.15 23.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.372 -0.83 . . . . 0.0 109.406 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.67 -17.23 57.08 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.24 -153.95 0.44 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.588 -0.948 . . . . 0.0 108.816 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.852 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -122.1 176.96 1.74 Allowed Pre-proline 0 C--N 1.307 -1.277 0 O-C-N 120.791 -1.193 . . . . 0.0 108.526 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.852 ' CD ' HG22 ' A' ' 45' ' ' THR . 10.2 Cg_endo -76.96 -7.57 17.42 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.052 1.835 . . . . 0.0 110.986 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.593 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -113.59 -62.34 1.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.934 -1.104 . . . . 0.0 110.609 -178.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.54 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 2.5 tt0 -39.29 -36.22 0.32 Allowed 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.658 1.218 . . . . 0.0 109.502 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 47' ' ' GLU . . . -60.42 -67.08 0.43 Allowed 'General case' 0 C--N 1.271 -2.824 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.313 -178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.545 HG22 ' HH2' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -81.55 -44.0 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.271 -0.893 . . . . 0.0 110.447 -178.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 47' ' ' GLU . 7.4 p -39.95 -45.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.571 ' N ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -73.94 -37.36 64.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.114 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 50' ' ' VAL . 5.1 mm-40 -67.4 -7.06 22.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.197 -0.939 . . . . 0.0 109.446 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.891 HD23 ' HE1' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -76.45 -54.76 6.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.957 -1.089 . . . . 0.0 109.62 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -80.02 -29.77 39.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.009 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.493 ' HG3' ' HG3' ' A' ' 52' ' ' ARG . 11.9 mm-40 -81.55 35.37 0.4 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.136 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.516 ' HB2' ' CD1' ' A' ' 95' ' ' TRP . 12.3 mt-10 -150.53 -66.52 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.901 -1.124 . . . . 0.0 109.613 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.071 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.4 p -122.56 -27.21 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 O-C-N 121.043 -1.035 . . . . 0.0 109.788 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.02 70.23 1.21 Allowed Glycine 0 N--CA 1.489 2.177 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.26 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.649 HD12 ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -90.12 172.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.716 ' CB ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -123.36 -70.02 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 120.201 -1.562 . . . . 0.0 111.221 -178.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.716 ' HD3' ' CB ' ' A' ' 61' ' ' THR . 12.3 Cg_endo -75.35 49.04 2.24 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 122.057 1.838 . . . . 0.0 111.251 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.815 HE22 HD21 ' A' ' 54' ' ' LEU . 11.7 tt0 -101.52 72.3 1.39 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.672 -1.267 . . . . 0.0 109.276 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -65.59 105.13 1.14 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.792 ' CB ' HG12 ' A' ' 87' ' ' VAL . 30.5 p90 -125.41 179.58 5.05 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.758 1.266 . . . . 0.0 111.97 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 68' ' ' PHE . 4.9 m -162.19 131.82 4.54 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.777 HD21 ' HE3' ' A' ' 70' ' ' LYS . 43.5 tp -49.04 94.76 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.726 -1.234 . . . . 0.0 109.578 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.713 ' HE2' HG13 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -42.93 -77.15 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.586 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 3.3 mm-40 -156.67 -173.5 4.51 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.777 ' HE3' HD21 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -140.43 147.81 40.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.065 -1.022 . . . . 0.0 109.845 -179.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.719 HD23 ' HB ' ' A' ' 122' ' ' VAL . 0.5 OUTLIER -124.32 -178.45 4.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.15 -0.969 . . . . 0.0 109.671 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -160.88 146.77 14.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.478 -0.764 . . . . 0.0 109.398 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -129.3 -163.53 1.3 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.957 . . . . 0.0 109.29 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -157.44 117.6 3.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 0.0 109.187 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.74 ' CE2' HD13 ' A' ' 80' ' ' ILE . 1.4 m-85 -79.62 170.37 16.24 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.0 Cg_exo -56.89 -6.34 1.7 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.063 1.842 . . . . 0.0 111.983 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.63 -17.04 0.32 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.566 -1.334 . . . . 0.0 112.113 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.526 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -131.44 -177.76 4.55 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.446 -1.409 . . . . 0.0 110.507 -178.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -121.67 121.69 37.91 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.74 HD13 ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -101.92 161.38 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.083 -1.011 . . . . 0.0 109.734 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.4 m -152.42 105.28 3.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.417 -0.802 . . . . 0.0 109.354 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.65 ' HG ' HG22 ' A' ' 6' ' ' ILE . 1.2 mp -85.94 149.93 24.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 109.821 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.603 ' CE2' ' HB3' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -110.35 115.97 30.62 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.931 ' CD2' HD11 ' A' ' 10' ' ' ILE . 2.2 m-85 -97.55 100.72 12.14 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.327 -0.858 . . . . 0.0 111.695 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.612 ' O ' ' CG ' ' A' ' 85' ' ' TRP . 29.1 p-90 -105.72 82.8 1.84 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.8 -1.188 . . . . 0.0 108.263 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.715 HD13 ' HB ' ' A' ' 10' ' ' ILE . 24.7 tp -78.06 146.01 35.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.434 -0.791 . . . . 0.0 110.673 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.843 HG21 HG23 ' A' ' 11' ' ' ILE . 17.7 m -113.13 -163.01 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.548 -0.72 . . . . 0.0 109.642 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 7.3 mt-10 -141.35 -29.72 0.63 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -0.981 . . . . 0.0 111.041 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.707 ' O ' ' HB3' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -143.78 -172.85 3.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.745 -1.222 . . . . 0.0 109.432 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.715 ' CE3' HG22 ' A' ' 11' ' ' ILE . 17.2 p90 154.47 162.59 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 122.72 1.248 . . . . 0.0 110.968 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.595 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 46.8 tt0 -126.11 90.11 3.13 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.186 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 157.66 -158.1 28.74 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 1.071 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -121.37 78.68 35.98 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 1.003 ' HA ' HG11 ' A' ' 58' ' ' VAL . 16.7 Cg_exo -40.02 156.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.064 2.509 . . . . 0.0 112.906 -177.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.891 ' HE1' HD23 ' A' ' 54' ' ' LEU . 45.4 p-90 -98.91 -163.4 1.03 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.461 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . 161.1 -21.99 0.22 Allowed Glycine 0 C--N 1.295 -1.708 0 C-N-CA 119.233 -1.46 . . . . 0.0 109.738 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.966 ' HD3' HG21 ' A' ' 21' ' ' THR . 29.6 tttt -146.44 160.03 42.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.418 -1.048 . . . . 0.0 109.312 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -44.24 104.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 108.587 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.98 -133.09 11.61 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.604 ' N ' ' HD3' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -150.09 53.58 1.31 Allowed Pre-proline 0 C--N 1.306 -1.322 0 O-C-N 120.926 -1.338 . . . . 0.0 110.24 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.604 ' HD3' ' N ' ' A' ' 100' ' ' GLN . 9.4 Cg_endo -71.16 -15.95 31.87 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.0 1.8 . . . . 0.0 110.236 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -64.04 -173.64 3.06 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.43 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 2.0 pm0 -156.96 169.62 24.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -1.148 . . . . 0.0 109.753 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -99.48 105.27 17.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -0.838 . . . . 0.0 109.228 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.491 ' HE3' ' HB2' ' A' ' 105' ' ' MET . 0.1 OUTLIER -83.44 163.26 20.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 109.506 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.89 91.48 3.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.315 -0.866 . . . . 0.0 109.302 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 mt 49.55 51.59 16.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 109.735 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.658 ' O ' HG12 ' A' ' 108' ' ' VAL . 44.6 t -104.33 26.74 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 108.955 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 114' ' ' ASP . . . 104.22 60.03 0.68 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.911 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -64.25 -13.99 52.82 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.201 -1.176 . . . . 0.0 108.663 179.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.27 -177.35 5.12 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.363 -0.836 . . . . 0.0 109.462 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.796 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . -62.32 -12.15 19.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 109.712 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -60.04 -52.63 64.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.845 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 13.6 t0 -79.17 -2.87 42.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.351 -0.843 . . . . 0.0 108.908 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.656 ' CZ ' ' CZ ' ' A' ' 35' ' ' PHE . 18.1 m-85 -109.27 108.19 60.08 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.288 -0.882 . . . . 0.0 108.816 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.533 ' HG3' ' HB2' ' A' ' 32' ' ' LYS . 10.0 Cg_exo -49.83 160.35 1.26 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.516 2.144 . . . . 0.0 111.152 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.71 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 4.8 Cg_exo -59.17 118.08 4.91 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.397 2.065 . . . . 0.0 110.232 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 161.28 -36.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.559 ' OD1' ' CZ ' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -118.49 39.53 3.44 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.348 -0.845 . . . . 0.0 109.193 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.688 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.9 mt-10 -69.92 -34.65 4.51 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.411 -0.806 . . . . 0.0 112.575 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.3 Cg_exo -59.56 -37.2 90.1 Favored 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 121.644 1.563 . . . . 0.0 112.012 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.719 ' HB ' HD23 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -102.18 -42.75 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.441 -1.412 . . . . 0.0 108.128 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 1.051 HD11 ' CE2' ' A' ' 35' ' ' PHE . 14.7 mm -54.05 -28.66 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.571 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -73.1 -36.35 66.76 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.518 -0.739 . . . . 0.0 109.571 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -70.49 -48.3 56.37 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.209 -0.932 . . . . 0.0 110.51 -179.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 1.045 ' HB2' HD13 ' A' ' 129' ' ' LEU . 0.9 OUTLIER -80.59 20.59 0.71 Allowed 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.842 -1.161 . . . . 0.0 110.741 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.571 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 17.2 mttt -63.63 -40.6 97.31 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.9 -1.125 . . . . 0.0 108.394 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.493 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -79.11 7.43 7.49 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.903 -0.498 . . . . 0.0 110.125 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 1.045 HD13 ' HB2' ' A' ' 126' ' ' LEU . 4.7 tp . . . . . 0 N--CA 1.499 2.011 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.447 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttm . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? 48.03 -144.37 0.38 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 109.337 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? -142.98 168.83 18.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.997 . . . . 0.0 109.635 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.837 HD13 ' OG1' ' A' ' 81' ' ' THR . 2.5 pp -87.46 121.39 29.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.892 . . . . 0.0 109.984 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.491 ' CG ' ' C ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER 169.84 99.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 109.81 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.842 HD13 HG23 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -122.02 167.1 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.716 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -134.15 81.8 1.94 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.341 -0.849 . . . . 0.0 109.133 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 83' ' ' TRP . 12.1 p -88.84 139.28 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.359 -0.838 . . . . 0.0 108.751 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.27 117.22 2.23 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.061 HD12 ' CD1' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -100.28 170.06 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.246 -1.15 . . . . 0.0 108.692 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.869 ' HA ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -147.58 154.71 11.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.981 -1.075 . . . . 0.0 110.479 -179.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.472 ' HD2' ' HG ' ' A' ' 107' ' ' LEU . 1.4 ttp180 -161.32 117.76 2.2 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.524 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 1.9 t-20 -105.54 -153.32 0.49 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.873 -1.142 . . . . 0.0 110.831 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -80.45 -5.4 56.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.748 -0.595 . . . . 0.0 109.536 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -79.71 5.57 13.05 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.233 -0.917 . . . . 0.0 108.952 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 21.9 t-20 52.86 42.91 32.06 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.467 -0.77 . . . . 0.0 109.338 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 2.6 mt-10 -134.82 150.1 50.45 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.865 HD13 HD11 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -110.48 155.09 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.025 -1.047 . . . . 0.0 109.459 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.582 ' HB3' ' CG1' ' A' ' 11' ' ' ILE . 45.0 t80 -103.36 71.68 1.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 0.0 109.29 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.879 HG21 HD12 ' A' ' 33' ' ' LEU . 2.5 mm -81.16 -177.73 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.542 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.797 HG23 ' CA ' ' A' ' 102' ' ' GLY . 0.1 OUTLIER -155.89 144.14 19.99 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.144 -0.972 . . . . 0.0 109.15 179.127 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.65 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -156.64 124.97 5.7 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.994 -178.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 16.5 ptt180 -84.76 46.96 1.31 Allowed 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.178 -0.952 . . . . 0.0 109.372 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.65 ' HB2' ' CZ ' ' A' ' 22' ' ' ARG . . . -82.31 122.1 27.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.163 -0.96 . . . . 0.0 109.687 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.58 -32.97 21.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.366 -0.834 . . . . 0.0 109.192 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 58.7 p30 -102.22 -141.6 0.35 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.401 -0.812 . . . . 0.0 108.977 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 26' ' ' ASP . . . 63.97 82.41 0.18 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.009 -1.057 . . . . 0.0 109.111 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -84.61 144.77 28.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.282 -0.886 . . . . 0.0 109.697 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.471 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 1.3 ttt 63.7 97.65 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.353 -0.842 . . . . 0.0 109.808 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 29' ' ' MET . . . 63.7 131.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.896 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.439 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 1.8 m-20 -119.34 -171.83 2.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 0.0 109.422 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.683 ' C ' HD22 ' A' ' 33' ' ' LEU . 12.1 mttp -92.09 170.19 10.03 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.363 -0.836 . . . . 0.0 108.754 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.879 HD12 HG21 ' A' ' 20' ' ' ILE . 3.0 mm? -105.5 176.66 5.09 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 109.58 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 22' ' ' ARG . 2.8 tt0 -160.97 -160.9 0.78 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 122.246 1.022 . . . . 0.0 110.577 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.636 ' CD1' ' HG3' ' A' ' 117' ' ' PRO . 29.3 m-85 -144.59 84.72 8.95 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.573 ' HG3' ' CB ' ' A' ' 21' ' ' THR . 3.1 Cg_exo -60.13 -150.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.405 2.07 . . . . 0.0 110.208 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 151.08 -168.71 30.75 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -147.46 18.05 1.49 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER 69.34 149.11 0.07 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.35 -1.088 . . . . 0.0 109.919 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.09 131.71 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 42' ' ' MET . 4.8 mt-10 -134.81 -147.82 0.29 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.09 -1.006 . . . . 0.0 110.052 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 41' ' ' GLU . 1.9 ptm -39.7 162.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.559 -0.713 . . . . 0.0 110.137 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.51 -157.08 27.1 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -125.34 -34.86 2.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -1.165 . . . . 0.0 109.426 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.544 ' OG1' ' HD2' ' A' ' 46' ' ' PRO . 0.5 OUTLIER -160.32 171.55 7.02 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 5.0 Cg_exo -59.02 -1.96 1.0 Allowed 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.536 2.157 . . . . 0.0 112.971 -178.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.576 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -102.5 -54.24 2.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.479 -1.388 . . . . 0.0 109.056 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.489 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 2.3 tt0 -63.79 -46.7 84.01 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 122.55 1.167 . . . . 0.0 108.738 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -45.36 -49.63 12.82 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.042 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.729 HG22 ' HH2' ' A' ' 95' ' ' TRP . 3.5 p -79.94 -20.32 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.343 -0.848 . . . . 0.0 110.003 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.615 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -61.04 -50.98 78.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.615 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -57.62 -35.86 71.03 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 113.114 -1.857 . . . . 0.0 109.847 178.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.464 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 2.4 mt-10 -64.87 -24.75 67.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.816 -1.178 . . . . 0.0 109.153 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.916 HD13 ' NE1' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -73.53 -70.98 0.34 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.525 -0.735 . . . . 0.0 109.909 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.595 ' HA ' ' CA ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -59.19 -21.15 58.99 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.974 -0.454 . . . . 0.0 111.504 -178.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.464 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 8.8 pt-20 -80.74 1.52 29.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.578 -1.326 . . . . 0.0 110.549 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -135.72 -59.38 0.76 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.927 -1.108 . . . . 0.0 110.982 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.657 ' CG1' ' HB3' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -114.18 -42.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.228 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.595 ' CA ' ' HA ' ' A' ' 55' ' ' GLN . . . 59.42 72.25 0.64 Allowed Glycine 0 C--N 1.293 -1.835 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.85 ' H ' HD11 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -79.78 163.4 3.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.652 ' CB ' ' HD3' ' A' ' 62' ' ' PRO . 1.3 m -100.91 -68.93 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 120.219 -1.55 . . . . 0.0 110.471 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.652 ' HD3' ' CB ' ' A' ' 61' ' ' THR . 5.6 Cg_endo -70.36 49.31 0.83 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.152 1.901 . . . . 0.0 111.766 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.612 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 1.3 pt20 -83.81 55.73 3.37 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.953 -1.092 . . . . 0.0 109.231 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -62.22 118.02 6.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.185 -0.947 . . . . 0.0 109.278 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.42 ' CB ' ' HA ' ' A' ' 87' ' ' VAL . 48.0 p90 -133.18 -173.52 3.23 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.171 0.986 . . . . 0.0 110.764 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 67' ' ' LEU . 8.0 t -157.51 -4.02 0.1 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.12 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.852 HD22 ' CH2' ' A' ' 83' ' ' TRP . 21.9 tp 55.18 110.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.889 -1.132 . . . . 0.0 110.164 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.837 ' CD2' HD21 ' A' ' 126' ' ' LEU . 0.9 OUTLIER -55.92 -75.07 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.58 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.3 mt-10 -155.25 -169.15 3.07 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.309 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.406 ' HE2' ' CE3' ' A' ' 83' ' ' TRP . 8.0 ttmt -145.86 126.66 14.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.261 -0.9 . . . . 0.0 109.55 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.808 HD23 ' HB ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -112.48 -169.29 1.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.131 -0.981 . . . . 0.0 109.49 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -146.64 140.82 26.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.917 . . . . 0.0 109.216 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.401 ' OH ' ' O ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -129.74 169.93 14.49 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.246 -0.909 . . . . 0.0 109.923 -179.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 2.2 tt0 -161.05 113.6 1.92 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.609 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -79.23 175.2 4.99 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.086 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.609 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 1.4 Cg_endo -63.87 2.69 0.94 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.149 1.899 . . . . 0.0 111.88 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.82 -24.96 0.46 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.507 -1.371 . . . . 0.0 111.899 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 1.3 ptt180 -131.65 179.72 5.88 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.611 -1.305 . . . . 0.0 110.974 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.533 ' HB2' ' N ' ' A' ' 4' ' ' LEU . 1.1 m170 -119.11 135.41 54.66 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.842 HG23 HD13 ' A' ' 6' ' ' ILE . 22.8 mm -146.27 107.99 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.032 -1.043 . . . . 0.0 110.716 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.837 ' OG1' HD13 ' A' ' 4' ' ' LEU . 3.1 m -101.67 105.26 16.15 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.55 HD22 ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -79.89 131.66 35.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.962 -1.086 . . . . 0.0 110.41 -178.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.852 ' CH2' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -121.76 124.03 43.24 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.68 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -124.1 119.99 31.07 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.444 -1.41 . . . . 0.0 110.036 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.813 ' CZ3' HG12 ' A' ' 87' ' ' VAL . 18.5 p-90 -100.41 87.97 3.54 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.061 ' CD1' HD12 ' A' ' 10' ' ' ILE . 2.8 mm? -56.35 130.29 44.03 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.571 0.701 . . . . 0.0 110.474 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.869 HG22 ' HA ' ' A' ' 11' ' ' ILE . 3.7 m -103.53 -170.85 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.475 -0.766 . . . . 0.0 109.322 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 1.0 OUTLIER -138.93 -36.09 0.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.914 -1.116 . . . . 0.0 110.643 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -142.72 178.88 7.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.051 -1.031 . . . . 0.0 109.906 -179.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.823 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 41.3 p90 168.68 168.47 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.628 1.204 . . . . 0.0 110.74 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.565 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 9.9 tt0 -125.9 99.17 5.82 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.905 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.489 ' O ' ' HD3' ' A' ' 94' ' ' PRO . . . 135.12 -169.25 23.4 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.568 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -99.23 104.98 29.7 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.652 ' HB3' HD12 ' A' ' 11' ' ' ILE . 4.5 Cg_exo -55.73 178.5 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.257 1.971 . . . . 0.0 112.256 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.916 ' NE1' HD13 ' A' ' 54' ' ' LEU . 3.7 p-90 -125.58 -167.32 1.67 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.797 0.808 . . . . 0.0 109.468 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.35 -32.12 0.08 OUTLIER Glycine 0 N--CA 1.482 1.759 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.552 ' HG3' ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -126.0 -145.27 0.32 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -115.09 38.56 3.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.133 -0.979 . . . . 0.0 108.834 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.31 55.53 0.76 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.506 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -119.85 151.99 53.17 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.275 -1.132 . . . . 0.0 109.8 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -67.08 98.61 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.355 2.037 . . . . 0.0 110.339 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.797 ' CA ' HG23 ' A' ' 21' ' ' THR . . . -82.35 -171.35 46.44 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -147.46 123.44 10.71 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.957 -1.319 . . . . 0.0 109.471 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.49 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 26.8 m95 -77.99 84.2 4.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.039 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.818 ' HE2' HD11 ' A' ' 33' ' ' LEU . 12.6 ttp -80.46 148.55 30.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 0.0 109.224 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.52 160.7 6.68 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.119 -0.988 . . . . 0.0 109.976 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.928 ' O ' HD13 ' A' ' 107' ' ' LEU . 1.6 tm? -130.63 70.91 1.45 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.2 t -103.14 -43.7 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 109.78 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -139.95 50.91 0.75 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.865 HD11 HD13 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -42.79 141.61 1.05 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.424 -1.045 . . . . 0.0 109.732 -179.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.491 ' HB3' ' OD2' ' A' ' 113' ' ' ASP . 4.4 t30 -157.41 -173.88 4.62 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.466 -0.771 . . . . 0.0 108.995 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.458 ' HB2' ' HE3' ' A' ' 127' ' ' LYS . . . -80.77 -10.34 59.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.731 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.491 ' OD2' ' HB3' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -66.57 -37.58 85.25 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.067 -1.021 . . . . 0.0 110.637 -179.167 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.682 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -96.85 27.7 3.84 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.968 -1.083 . . . . 0.0 109.483 -179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.64 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -146.26 89.81 5.85 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.939 . . . . 0.0 109.207 179.593 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.597 ' N ' ' HD3' ' A' ' 117' ' ' PRO . 36.9 Cg_endo -98.93 36.18 0.09 OUTLIER 'Trans proline' 0 CA--C 1.556 1.6 0 C-N-CA 123.58 2.854 . . . . 0.0 115.941 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.727 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 10.5 Cg_endo -73.55 -1.05 10.14 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 121.686 1.591 . . . . 0.0 110.06 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 117' ' ' PRO . . . 80.35 24.98 0.34 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.589 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 10.4 m120 -107.22 42.0 1.39 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.593 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.2 mt-10 -47.09 -44.12 47.22 Favored Pre-proline 0 C--N 1.296 -1.735 0 O-C-N 121.164 -0.96 . . . . 0.0 112.083 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 5.3 Cg_exo -61.88 -39.18 53.39 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.881 1.721 . . . . 0.0 112.562 -178.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.808 ' HB ' HD23 ' A' ' 71' ' ' LEU . 1.6 t -90.23 -54.95 6.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 O-C-N 120.291 -1.506 . . . . 0.0 107.842 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.89 ' HA ' HD12 ' A' ' 126' ' ' LEU . 11.4 mm -43.84 -33.96 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.47 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -52.33 -52.94 50.38 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -42.86 98.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.51 -0.744 . . . . 0.0 109.787 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.89 HD12 ' HA ' ' A' ' 123' ' ' ILE . 1.9 mt -66.42 -5.32 10.51 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.104 -0.997 . . . . 0.0 110.328 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.47 ' HE3' ' HA ' ' A' ' 124' ' ' ALA . 22.3 mttt -56.41 -49.65 73.88 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.051 -1.031 . . . . 0.0 108.351 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 129' ' ' LEU . 11.6 mtp180 -90.3 34.89 0.86 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.451 -0.781 . . . . 0.0 108.984 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 126' ' ' LEU . 1.2 mt . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.893 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HA ' ' HE2' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 1' ' ' MET . 34.5 mmtt 60.09 -114.74 0.67 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 0.0 109.334 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -166.72 146.87 5.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.706 -1.246 . . . . 0.0 109.84 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.592 HD11 HG12 ' A' ' 80' ' ' ILE . 2.6 pp -153.77 120.78 5.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 109.406 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.535 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . 26.1 mt-30 -133.01 150.61 52.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.201 -0.937 . . . . 0.0 109.853 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.591 HG22 ' N ' ' A' ' 7' ' ' ALA . 9.9 mt -121.76 167.15 15.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.357 -0.839 . . . . 0.0 109.495 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.591 ' N ' HG22 ' A' ' 6' ' ' ILE . . . -132.82 106.02 7.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -0.952 . . . . 0.0 109.543 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.788 HG13 ' O ' ' A' ' 8' ' ' VAL . 8.5 p -122.08 83.88 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.216 -0.927 . . . . 0.0 109.778 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.97 ' H ' HD11 ' A' ' 54' ' ' LEU . . . -68.97 117.22 7.86 Favored Glycine 0 C--N 1.294 -1.786 0 N-CA-C 107.496 -2.242 . . . . 0.0 107.496 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.595 HG22 ' H ' ' A' ' 11' ' ' ILE . 0.7 OUTLIER -76.42 -172.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.071 -1.253 . . . . 0.0 107.688 -179.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.963 ' HA ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -144.97 149.53 16.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 117.864 -1.534 . . . . 0.0 111.371 -176.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.51 ' HD2' HD13 ' A' ' 107' ' ' LEU . 10.4 ttp180 -148.53 128.27 13.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.634 ' ND2' ' CH2' ' A' ' 90' ' ' TRP . 1.2 m-20 -98.07 -160.68 0.82 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.817 -1.177 . . . . 0.0 110.74 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 81.3 tt0 -91.56 -6.05 53.04 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.393 0.616 . . . . 0.0 109.367 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.504 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 3.2 t-20 -85.21 14.5 5.13 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.48 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 13.6 t30 58.41 48.24 12.56 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.571 -0.706 . . . . 0.0 109.908 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 105' ' ' MET . 1.4 pt-20 -136.73 171.84 13.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.251 -0.906 . . . . 0.0 109.235 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.487 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 1.3 mt -125.35 157.67 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.932 . . . . 0.0 109.427 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.65 ' CD2' ' CD1' ' A' ' 11' ' ' ILE . 46.0 t80 -106.87 83.13 1.79 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.686 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -79.81 -173.68 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 120.988 -1.07 . . . . 0.0 110.163 -178.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.603 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -130.75 142.85 50.43 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.199 -0.601 . . . . 0.0 109.815 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.572 ' HG3' ' CD2' ' A' ' 33' ' ' LEU . 6.1 ttm180 -142.46 161.73 37.29 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.247 -0.908 . . . . 0.0 109.91 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.498 ' NH1' ' CG ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -85.43 56.54 4.0 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.421 -0.799 . . . . 0.0 109.527 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.583 ' O ' ' HB3' ' A' ' 25' ' ' ALA . . . 59.13 176.4 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.063 -1.023 . . . . 0.0 109.296 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . 69.03 -177.1 0.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 109.531 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -125.08 99.07 5.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.232 -0.918 . . . . 0.0 109.4 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.778 ' HB1' ' CB ' ' A' ' 31' ' ' ASN . . . -66.61 129.85 41.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.871 . . . . 0.0 109.546 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -73.39 -149.3 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.257 -0.902 . . . . 0.0 109.402 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.6 mtp -65.01 -17.77 64.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 109.565 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.486 ' O ' ' CB ' ' A' ' 31' ' ' ASN . . . -104.53 -141.39 0.36 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -0.856 . . . . 0.0 109.456 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.778 ' CB ' ' HB1' ' A' ' 27' ' ' ALA . 0.4 OUTLIER 74.12 -163.97 0.09 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.072 -1.018 . . . . 0.0 109.569 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.56 139.28 34.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 109.881 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.595 ' HB2' ' CD1' ' A' ' 115' ' ' PHE . 25.3 mt -105.77 -174.3 2.5 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.379 -0.825 . . . . 0.0 108.943 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.686 ' O ' HD11 ' A' ' 20' ' ' ILE . 3.1 tt0 -161.39 -157.5 0.51 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.564 -1.335 . . . . 0.0 110.732 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.78 ' HB3' HG21 ' A' ' 8' ' ' VAL . 81.1 m-85 -152.65 152.51 28.85 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.758 ' C ' HG23 ' A' ' 8' ' ' VAL . 2.0 Cg_endo -63.08 -151.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.17 1.913 . . . . 0.0 109.861 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 91.79 179.21 41.95 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.45 -40.59 0.05 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -167.19 169.85 12.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.18 -1.188 . . . . 0.0 109.765 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.785 HD12 ' NE1' ' A' ' 83' ' ' TRP . 14.1 tt -133.69 123.94 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.379 -0.825 . . . . 0.0 109.1 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -80.26 130.92 35.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 110.027 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 42' ' ' MET . 31.1 ttp -117.32 72.22 0.83 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 109.105 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.67 1.53 5.18 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -151.59 -71.1 0.16 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.114 -1.227 . . . . 0.0 110.026 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.787 HG23 ' H ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -154.62 168.19 12.44 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 120.904 -1.122 . . . . 0.0 109.776 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.516 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 2.1 Cg_endo -67.88 -27.93 36.62 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.786 2.324 . . . . 0.0 112.103 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 1.06 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -78.56 -69.75 0.54 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.832 -1.167 . . . . 0.0 109.197 -179.208 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.708 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 12.7 tt0 -37.63 -34.66 0.11 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 122.938 1.352 . . . . 0.0 109.078 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.517 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -52.64 -67.72 0.23 Allowed 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.254 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.737 ' CG2' HD12 ' A' ' 54' ' ' LEU . 9.0 p -80.99 -43.87 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.096 -1.003 . . . . 0.0 111.274 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.06 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.3 p -43.6 -48.88 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.449 -0.782 . . . . 0.0 109.168 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.492 ' N ' HG13 ' A' ' 51' ' ' VAL . 1.2 ttt180 -81.39 -26.12 35.71 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.308 -0.87 . . . . 0.0 110.506 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 3.4 mm-40 -72.88 -67.23 0.58 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.748 -1.22 . . . . 0.0 110.674 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.97 HD11 ' H ' ' A' ' 9' ' ' GLY . 14.1 mt -54.06 -38.18 64.99 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.303 -0.873 . . . . 0.0 110.726 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.494 ' O ' ' HA2' ' A' ' 59' ' ' GLY . 3.7 pt20 -67.89 -32.12 72.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.971 -1.08 . . . . 0.0 110.075 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.493 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 1.3 pt-20 -78.59 -4.7 50.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.878 -1.139 . . . . 0.0 109.596 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.34 -49.19 5.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.174 -0.954 . . . . 0.0 109.538 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.838 HG22 HD13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -114.04 -30.07 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.182 -0.949 . . . . 0.0 108.49 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 55' ' ' GLN . . . 74.25 90.2 0.17 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.445 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.02 HD12 ' O ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -114.54 170.53 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.367 -1.078 . . . . 0.0 108.48 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.729 ' CB ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -118.17 -70.4 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.807 -1.183 . . . . 0.0 109.596 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.729 ' HD3' ' CB ' ' A' ' 61' ' ' THR . 10.0 Cg_endo -74.73 40.69 0.65 Allowed 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 122.006 1.804 . . . . 0.0 111.325 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.628 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 0.9 OUTLIER -81.68 59.07 4.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 109.783 -179.219 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -65.62 126.54 28.7 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.734 ' CB ' HG12 ' A' ' 87' ' ' VAL . 4.0 p90 -146.63 -177.42 5.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.738 -1.226 . . . . 0.0 111.755 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.4 m -161.77 143.53 11.33 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 84' ' ' PHE . 36.8 tp -71.49 97.13 1.6 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.604 -1.31 . . . . 0.0 109.792 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.666 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -44.79 -77.96 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.728 ' O ' HG21 ' A' ' 122' ' ' VAL . 0.6 OUTLIER -158.94 125.19 4.53 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -90.57 151.96 21.1 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.141 -0.974 . . . . 0.0 110.112 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.94 HD21 ' OD1' ' A' ' 119' ' ' ASN . 0.7 OUTLIER -116.43 -167.25 1.25 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -160.04 161.9 34.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.896 -1.128 . . . . 0.0 110.275 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -154.46 127.22 8.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.493 -0.754 . . . . 0.0 109.205 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -99.88 122.26 42.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 109.735 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.579 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -84.01 177.97 2.68 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.579 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 3.9 Cg_exo -56.71 -10.4 5.28 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.828 1.686 . . . . 0.0 111.736 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -161.7 -3.3 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.728 -1.232 . . . . 0.0 112.484 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.543 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -128.1 -172.38 2.67 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.212 -1.555 . . . . 0.0 110.041 -179.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -132.03 91.94 3.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.395 -0.816 . . . . 0.0 109.613 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.592 HG12 HD11 ' A' ' 4' ' ' LEU . 11.4 mt -81.84 102.5 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 109.462 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.23 126.05 52.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.738 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.31 150.04 41.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.29 -0.881 . . . . 0.0 109.073 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.785 ' NE1' HD12 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -120.06 149.04 42.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.054 -1.029 . . . . 0.0 109.574 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.563 ' CG ' HG11 ' A' ' 122' ' ' VAL . 6.5 m-85 -113.35 94.41 4.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.222 -0.924 . . . . 0.0 109.221 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.502 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 77.7 m95 -88.51 90.37 8.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.043 -1.036 . . . . 0.0 108.948 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.014 HD21 HD21 ' A' ' 129' ' ' LEU . 10.7 tp -79.28 117.45 20.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.478 -0.763 . . . . 0.0 109.442 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.963 HG22 ' HA ' ' A' ' 11' ' ' ILE . 3.1 m -88.46 -161.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 O-C-N 121.213 -0.93 . . . . 0.0 110.33 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 20.7 mt-10 -147.67 -33.97 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.987 . . . . 0.0 111.231 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.628 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -147.21 164.39 33.32 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.658 -1.276 . . . . 0.0 110.479 -179.134 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.634 ' CH2' ' ND2' ' A' ' 13' ' ' ASN . 13.6 p90 179.19 171.44 0.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 122.029 0.918 . . . . 0.0 109.644 178.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.55 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 77.2 tt0 -116.34 -92.86 0.51 Allowed 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.509 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . -23.76 -91.47 0.01 OUTLIER Glycine 0 N--CA 1.499 2.866 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 1.02 ' O ' HD12 ' A' ' 60' ' ' ILE . 1.6 mt-10 -131.19 166.09 30.34 Favored Pre-proline 0 C--O 1.188 -2.138 0 O-C-N 121.647 -0.913 . . . . 0.0 108.862 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.638 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 6.1 Cg_exo -36.7 -93.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.281 -3.023 0 C-N-CA 123.106 2.537 . . . . 0.0 112.091 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.815 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.0 t90 171.03 -21.6 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.132 -0.98 . . . . 0.0 111.265 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' A' ' 36' ' ' PRO . . . -107.21 -101.21 2.7 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.469 -1.348 . . . . 0.0 109.821 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.487 ' N ' ' HB3' ' A' ' 36' ' ' PRO . 3.0 tttt 41.07 94.12 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.493 -1.004 . . . . 0.0 110.215 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -116.52 52.56 0.92 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.88 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.57 2.35 53.2 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -124.61 123.34 25.73 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.205 -1.173 . . . . 0.0 109.701 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -60.85 111.4 1.05 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.939 1.759 . . . . 0.0 109.899 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.603 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -93.41 -179.81 39.34 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -138.07 161.18 37.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.073 -1.251 . . . . 0.0 111.137 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.464 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 34.7 m0 -94.73 93.37 7.48 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.526 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -82.45 -173.89 4.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.016 -1.052 . . . . 0.0 109.674 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.05 160.77 15.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.891 . . . . 0.0 109.153 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.877 HD11 HD23 ' A' ' 129' ' ' LEU . 1.8 tp -108.9 45.84 1.01 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.145 -0.972 . . . . 0.0 109.795 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.547 ' O ' HG12 ' A' ' 108' ' ' VAL . 18.2 t -103.39 19.06 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.082 -1.011 . . . . 0.0 108.83 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 132.82 74.05 0.1 OUTLIER Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 110' ' ' LEU . 2.7 mt -43.49 138.77 2.33 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.372 -1.075 . . . . 0.0 109.626 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.44 98.79 11.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.439 -0.788 . . . . 0.0 109.777 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.583 ' CB ' HG22 ' A' ' 123' ' ' ILE . . . -64.59 -21.76 66.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 108.971 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -68.6 -27.79 66.36 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.488 -0.758 . . . . 0.0 109.506 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.506 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 2.8 t0 -78.43 -9.99 59.52 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.687 ' CZ ' ' CZ ' ' A' ' 35' ' ' PHE . 11.0 m-85 -94.03 154.98 40.59 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 108.83 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.545 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 1.2 Cg_endo -71.42 144.7 46.06 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.994 1.796 . . . . 0.0 110.211 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.721 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.2 Cg_endo -64.71 112.71 2.06 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.341 2.028 . . . . 0.0 110.41 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 162.35 -22.56 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 109.84 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.94 ' OD1' HD21 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -119.76 45.25 2.2 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.092 -1.005 . . . . 0.0 109.314 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.68 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 7.1 mt-10 -68.87 -32.77 3.7 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.5 Cg_exo -58.83 -38.78 86.8 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.409 1.406 . . . . 0.0 111.992 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.899 ' HB ' HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -104.37 -38.06 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 120.434 -1.416 . . . . 0.0 108.784 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.583 HG22 ' CB ' ' A' ' 112' ' ' ALA . 7.4 mm -55.25 -38.81 48.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.483 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -55.32 -46.27 76.32 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.522 -0.736 . . . . 0.0 109.292 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -66.85 -33.92 76.67 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.424 -0.798 . . . . 0.0 109.563 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.516 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 4.2 mp -54.32 -25.78 25.84 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.192 -0.942 . . . . 0.0 109.551 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.547 ' HE2' ' HB3' ' A' ' 112' ' ' ALA . 33.7 mttt -58.2 -49.45 77.0 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.454 ' O ' ' C ' ' A' ' 129' ' ' LEU . 6.5 mtp180 -84.62 -1.47 56.05 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.699 -0.625 . . . . 0.0 109.532 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 1.014 HD21 HD21 ' A' ' 86' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.824 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.519 ' CE ' ' O ' ' A' ' 77' ' ' ASP . 10.2 mtm . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -70.22 -82.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.968 -1.083 . . . . 0.0 109.231 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.639 ' N ' ' CE1' ' A' ' 79' ' ' HIS . 0.0 OUTLIER 176.87 117.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.467 -0.77 . . . . 0.0 110.031 179.46 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 4' ' ' LEU . 14.8 tp -97.23 155.87 16.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.325 -0.86 . . . . 0.0 108.885 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.529 ' HG2' ' CZ2' ' A' ' 83' ' ' TRP . 0.9 OUTLIER -145.35 128.38 16.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.041 -1.037 . . . . 0.0 110.834 -179.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.701 HG22 ' H ' ' A' ' 7' ' ' ALA . 5.3 mm -102.93 -163.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.319 -0.863 . . . . 0.0 108.807 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.701 ' H ' HG22 ' A' ' 6' ' ' ILE . . . -144.86 117.29 8.52 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.739 -1.225 . . . . 0.0 110.605 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.915 ' CG1' HD12 ' A' ' 82' ' ' LEU . 3.2 p -133.45 129.74 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.108 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.6 ' HA2' ' NE1' ' A' ' 85' ' ' TRP . . . -117.04 119.32 4.43 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.061 HD12 ' CD1' ' A' ' 86' ' ' LEU . 1.2 mt -96.98 159.16 3.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.265 -1.138 . . . . 0.0 108.781 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.907 HD12 ' HG2' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -154.24 146.62 13.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 108.822 -178.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.518 ' C ' ' ND2' ' A' ' 13' ' ' ASN . 20.9 ttp180 -157.96 84.26 0.87 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.406 -0.809 . . . . 0.0 110.626 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.574 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 10.9 m-80 -160.59 179.46 8.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.924 -1.11 . . . . 0.0 109.662 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 2.9 mm-40 81.44 -68.94 0.09 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.888 0.851 . . . . 0.0 109.219 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.502 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 38.4 t-20 -111.15 22.94 14.67 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.431 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 23.4 t-20 49.71 47.52 22.78 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 15' ' ' ASN . 3.7 mt-10 -140.69 147.61 39.52 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 11' ' ' ILE . 1.5 mt -96.97 151.94 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.904 -1.123 . . . . 0.0 110.56 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -100.07 76.96 1.96 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.545 HD11 ' CE1' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -79.7 -178.02 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.952 0.882 . . . . 0.0 110.611 -177.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.559 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -114.3 137.17 52.13 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.505 ' HG3' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -125.88 133.55 51.88 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.963 -1.086 . . . . 0.0 109.683 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.882 ' CZ ' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -49.1 102.09 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.398 -0.814 . . . . 0.0 110.221 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 44.71 -154.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.448 -0.782 . . . . 0.0 109.951 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.7 -79.09 0.21 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.912 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -83.35 169.4 15.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.027 -1.046 . . . . 0.0 109.647 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.882 ' HB2' ' CZ ' ' A' ' 23' ' ' ARG . . . -115.18 163.92 14.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.738 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -93.04 68.96 4.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.214 -0.929 . . . . 0.0 109.344 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.598 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 5.1 mtt 57.28 60.88 2.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 109.572 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 169.77 115.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.343 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.424 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 36.1 m120 -77.0 120.92 22.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 109.355 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -146.6 126.85 13.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.172 -0.955 . . . . 0.0 109.488 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.517 ' O ' ' HG3' ' A' ' 116' ' ' PRO . 7.2 mt -93.45 -165.17 1.28 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -149.53 -163.86 1.89 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.68 -1.263 . . . . 0.0 110.194 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.781 ' CE2' HD11 ' A' ' 123' ' ' ILE . 6.5 m-85 -162.25 -66.62 0.01 OUTLIER Pre-proline 0 C--N 1.292 -1.909 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.769 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.797 ' HA ' HD11 ' A' ' 82' ' ' LEU . 15.3 Cg_exo -40.26 153.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.775 1.65 . . . . 0.0 110.467 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 97' ' ' LYS . . . -110.98 -86.59 1.69 Allowed Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -117.18 -61.07 0.31 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 170.93 175.84 0.06 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.179 -1.189 . . . . 0.0 110.069 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -144.25 102.4 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.53 -3.43 5.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.971 -1.081 . . . . 0.0 109.725 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.441 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 1.2 mpt? -53.06 -27.36 19.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.0 108.976 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.48 15.97 26.92 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 42' ' ' MET . 45.3 mm-40 -86.32 -80.68 0.23 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.539 -0.977 . . . . 0.0 109.782 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.798 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -148.51 177.5 1.77 Allowed Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 120.949 -1.094 . . . . 0.0 109.968 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.798 ' CD ' HG22 ' A' ' 45' ' ' THR . 6.3 Cg_endo -73.77 -40.24 1.51 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.694 2.263 . . . . 0.0 111.063 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.01 -52.85 5.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.324 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.57 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 2.1 tt0 -45.01 -29.1 0.78 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 122.441 1.115 . . . . 0.0 110.026 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.48 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . -72.86 -59.84 2.52 Favored 'General case' 0 C--N 1.271 -2.834 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.576 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.909 HG21 ' NE1' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -81.82 -3.08 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.016 -1.052 . . . . 0.0 111.029 -178.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 4.5 p -81.8 -45.3 20.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.571 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -70.64 -28.57 64.91 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.168 177.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.56 ' O ' ' NE1' ' A' ' 95' ' ' TRP . 3.0 mt-10 -76.6 -17.81 58.99 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.594 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.024 HD13 ' HG3' ' A' ' 62' ' ' PRO . 5.7 mt -71.1 -54.96 9.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.482 -0.761 . . . . 0.0 110.432 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.476 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 0.1 OUTLIER -82.64 -37.11 25.37 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.705 -1.247 . . . . 0.0 111.355 -178.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -80.66 35.03 0.34 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.722 -1.236 . . . . 0.0 111.52 -178.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 1.1 mm-40 -149.8 -58.23 0.19 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.581 -1.324 . . . . 0.0 110.098 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.813 HG12 ' CD1' ' A' ' 95' ' ' TRP . 5.2 p -123.07 -10.75 7.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.287 -0.883 . . . . 0.0 108.677 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 60.84 73.09 0.53 Allowed Glycine 0 N--CA 1.486 1.98 0 O-C-N 121.775 -0.578 . . . . 0.0 112.901 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -112.26 179.97 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.289 -1.124 . . . . 0.0 108.428 177.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 47.2 m -131.34 86.88 48.95 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 1.024 ' HG3' HD13 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -59.72 129.04 29.07 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.107 1.871 . . . . 0.0 110.572 -177.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.452 ' HG3' ' HB3' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -83.69 -37.58 22.57 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.499 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 65' ' ' PHE . 0.8 OUTLIER -168.47 51.6 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.779 -1.2 . . . . 0.0 111.49 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.597 ' CB ' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -46.75 173.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.601 -1.312 . . . . 0.0 109.475 179.19 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -161.26 157.14 25.1 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.565 -0.709 . . . . 0.0 109.651 179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.777 HD12 ' HA ' ' A' ' 85' ' ' TRP . 50.0 tp -112.01 92.85 4.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.186 -0.946 . . . . 0.0 109.19 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.7 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -53.76 -59.52 4.51 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.605 0.717 . . . . 0.0 109.635 -179.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.7 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.8 tp10 -168.28 141.41 3.1 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.643 -0.66 . . . . 0.0 110.032 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.451 ' HG3' ' HA ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -121.14 138.94 53.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.426 -0.796 . . . . 0.0 109.008 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -109.88 -171.49 1.85 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.078 -1.014 . . . . 0.0 109.941 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -143.83 175.04 10.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.472 -0.767 . . . . 0.0 108.971 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 80' ' ' ILE . 1.6 t80 -150.13 163.44 38.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.934 -1.103 . . . . 0.0 110.155 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.0 tt0 -142.45 109.14 5.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.409 -0.807 . . . . 0.0 109.19 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.632 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -78.83 173.52 7.57 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.066 -1.021 . . . . 0.0 108.901 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.632 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 5.7 Cg_exo -51.4 -26.07 20.24 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.723 1.615 . . . . 0.0 109.543 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.519 ' O ' ' CE ' ' A' ' 1' ' ' MET . 30.1 t0 -148.16 2.22 0.66 Allowed 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.888 -0.508 . . . . 0.0 110.071 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.503 ' HG3' ' HB3' ' A' ' 75' ' ' PHE . 4.8 mtp180 -122.68 -161.58 0.96 Allowed 'General case' 0 C--N 1.31 -1.142 0 O-C-N 120.9 -1.125 . . . . 0.0 109.547 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.639 ' CE1' ' N ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -162.01 109.46 1.37 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.005 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 73' ' ' TYR . 25.2 mm -99.3 124.85 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.031 -1.043 . . . . 0.0 110.038 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.511 ' HB ' ' HG3' ' A' ' 5' ' ' GLN . 67.6 m -130.08 116.51 18.61 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.915 HD12 ' CG1' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -107.98 153.52 22.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.068 -1.02 . . . . 0.0 110.229 -179.135 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.625 ' O ' HG13 ' A' ' 8' ' ' VAL . 3.2 m95 -110.54 118.17 35.51 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.654 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.1 m-85 -99.97 70.71 1.61 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.123 -0.986 . . . . 0.0 109.362 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.909 ' NE1' HG21 ' A' ' 50' ' ' VAL . 46.5 p-90 -80.28 84.18 5.99 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.138 -1.425 . . . . 0.0 108.889 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.061 ' CD1' HD12 ' A' ' 10' ' ' ILE . 1.6 tp -64.1 121.51 14.35 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.152 0.501 . . . . 0.0 109.918 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.85 HG13 HG23 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -102.96 161.59 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 119.095 -1.042 . . . . 0.0 108.986 179.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.46 ' N ' ' CG2' ' A' ' 87' ' ' VAL . 9.0 pm0 -118.35 -24.0 7.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.919 . . . . 0.0 110.768 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.452 ' HB3' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -146.81 152.88 39.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.807 -1.183 . . . . 0.0 110.56 -179.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.574 ' CZ3' ' HB2' ' A' ' 13' ' ' ASN . 28.2 p90 -168.64 -173.41 1.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.842 0.829 . . . . 0.0 109.367 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.655 ' O ' HG22 ' A' ' 60' ' ' ILE . 9.4 tt0 -137.18 113.63 10.13 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.357 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.452 ' O ' ' HD3' ' A' ' 94' ' ' PRO . . . 106.65 169.45 22.64 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.6 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -79.13 115.0 49.41 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.296 -1.12 . . . . 0.0 108.935 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.907 ' HG2' HD12 ' A' ' 11' ' ' ILE . 5.5 Cg_endo -73.77 177.03 8.59 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.672 2.248 . . . . 0.0 112.571 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.813 ' CD1' HG12 ' A' ' 58' ' ' VAL . 3.1 p-90 -115.1 -163.01 0.85 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.415 ' N ' ' HE3' ' A' ' 95' ' ' TRP . . . 179.61 -32.7 0.06 OUTLIER Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.418 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -129.2 -163.96 1.35 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 9.9 pt-20 -55.15 -46.13 75.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.956 -1.09 . . . . 0.0 108.554 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.444 ' C ' ' HD3' ' A' ' 101' ' ' PRO . . . -124.84 -129.73 3.42 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.668 ' N ' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -125.24 42.78 0.79 Allowed Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.01 -1.288 . . . . 0.0 110.971 179.191 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.668 ' HD3' ' N ' ' A' ' 100' ' ' GLN . 6.2 Cg_endo -67.56 -12.9 37.25 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 C-N-CA 121.471 1.448 . . . . 0.0 110.011 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -61.09 179.84 3.05 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -141.99 160.93 39.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.076 -1.249 . . . . 0.0 110.3 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -89.03 103.49 16.1 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.394 -0.817 . . . . 0.0 109.576 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 13.9 ttm -87.44 129.51 35.02 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.306 -0.871 . . . . 0.0 109.515 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.792 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -92.96 72.67 4.76 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.314 -0.867 . . . . 0.0 109.452 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 107' ' ' LEU . 6.0 tp 49.85 50.92 17.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.134 -0.979 . . . . 0.0 109.565 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 106' ' ' SER . 29.3 t -139.2 101.3 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.261 -0.9 . . . . 0.0 109.473 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 114' ' ' ASP . . . 92.99 17.24 44.5 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.92 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -62.64 -18.03 61.49 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.296 -1.12 . . . . 0.0 108.987 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.494 ' ND2' ' HD3' ' A' ' 127' ' ' LYS . 10.2 m-20 -78.3 178.33 7.74 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.738 -0.601 . . . . 0.0 109.461 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.962 ' CA ' HG21 ' A' ' 123' ' ' ILE . . . -67.51 -6.85 21.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.47 -53.03 60.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.249 -0.907 . . . . 0.0 110.11 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.517 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -79.33 -12.78 59.93 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.1 -1.0 . . . . 0.0 108.817 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.615 ' CZ ' ' CZ ' ' A' ' 35' ' ' PHE . 12.8 m-85 -94.59 140.41 22.63 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.517 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 5.7 Cg_exo -63.31 148.4 92.93 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.99 1.794 . . . . 0.0 110.037 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.704 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 3.9 Cg_exo -58.87 118.61 5.52 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.13 1.886 . . . . 0.0 110.33 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 162.37 -24.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.491 -0.756 . . . . 0.0 109.132 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.533 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 0.9 OUTLIER -123.14 43.97 2.8 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.307 -0.871 . . . . 0.0 109.732 -179.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.678 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 7.0 mt-10 -66.34 -39.14 24.74 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 112.161 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 2.9 Cg_endo -64.51 -34.55 52.63 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 122.117 1.878 . . . . 0.0 112.371 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.654 HG11 ' CD2' ' A' ' 84' ' ' PHE . 1.1 t -93.76 -50.04 12.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.962 HG21 ' CA ' ' A' ' 112' ' ' ALA . 8.8 mm -49.53 -33.73 7.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -53.24 -47.11 69.32 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -66.73 -28.76 68.67 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.322 -0.861 . . . . 0.0 109.524 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.808 HD12 HD13 ' A' ' 123' ' ' ILE . 11.4 mt -70.74 -10.69 60.01 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.143 -0.973 . . . . 0.0 109.646 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 124' ' ' ALA . 1.3 mmtp -56.76 -52.92 63.14 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.251 -0.906 . . . . 0.0 109.195 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -98.42 26.76 5.21 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.406 -0.809 . . . . 0.0 109.049 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.642 HD21 HD21 ' A' ' 86' ' ' LEU . 2.4 tp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.558 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.93 176.65 5.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.299 -0.875 . . . . 0.0 109.348 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.72 ' C ' HD23 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -106.77 136.15 47.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.525 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.72 HD23 ' C ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -105.56 95.34 5.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.243 -0.911 . . . . 0.0 109.306 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.578 ' HB2' HG21 ' A' ' 40' ' ' ILE . 7.0 mt-30 -96.42 114.03 25.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.229 -0.92 . . . . 0.0 109.509 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.621 HG22 ' H ' ' A' ' 7' ' ' ALA . 3.1 mm -99.42 -175.99 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.248 -0.908 . . . . 0.0 109.231 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.621 ' H ' HG22 ' A' ' 6' ' ' ILE . . . -149.39 101.83 3.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.719 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.826 HG11 ' HB3' ' A' ' 35' ' ' PHE . 10.2 p -108.51 135.06 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.154 -0.966 . . . . 0.0 108.538 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.28 106.56 1.43 Allowed Glycine 0 N--CA 1.484 1.87 0 C-N-CA 119.372 -1.394 . . . . 0.0 109.696 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.826 ' HB ' HD12 ' A' ' 86' ' ' LEU . 1.7 mt -82.89 143.99 10.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.876 HG22 ' CZ3' ' A' ' 90' ' ' TRP . 1.8 mt -131.51 128.97 61.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.819 -177.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 88' ' ' GLU . 5.9 ttp180 -139.75 125.99 20.04 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.464 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 6.0 p30 -118.72 -167.16 1.33 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.983 . . . . 0.0 109.985 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -71.64 -2.39 17.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 109.944 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.486 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 1.5 t30 -79.78 5.66 12.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.176 -0.952 . . . . 0.0 109.136 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.478 ' OD1' ' HB ' ' A' ' 108' ' ' VAL . 22.6 t30 54.95 46.57 24.07 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.264 -0.898 . . . . 0.0 109.619 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 15' ' ' ASN . 4.5 mt-10 -146.5 133.63 20.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 108.892 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.855 HD11 ' HB2' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -102.16 160.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.221 -0.924 . . . . 0.0 108.801 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 25.8 t80 -118.55 82.03 1.78 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.922 -1.111 . . . . 0.0 108.565 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.627 HD11 ' HB ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -121.04 -160.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.592 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -117.31 138.48 51.73 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.39 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HG3' ' OD1' ' A' ' 31' ' ' ASN . 4.9 ttp180 -133.95 121.49 21.73 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.288 -0.882 . . . . 0.0 109.465 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.584 ' O ' ' CG ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -50.79 106.4 0.13 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.248 -0.907 . . . . 0.0 109.164 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.32 109.98 0.99 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.984 -1.073 . . . . 0.0 109.45 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 27' ' ' ALA . . . -170.0 60.83 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.167 -0.958 . . . . 0.0 109.528 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 28' ' ' HIS . 67.5 m-20 53.39 -90.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.179 -0.951 . . . . 0.0 109.477 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.591 ' CB ' ' ND2' ' A' ' 31' ' ' ASN . . . 43.14 -92.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.408 -0.808 . . . . 0.0 109.727 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.54 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER 78.69 135.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.368 -0.832 . . . . 0.0 109.412 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' A' ' 28' ' ' HIS . 7.4 mtt 65.56 -92.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.327 -0.858 . . . . 0.0 109.406 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.47 95.55 9.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.234 -0.916 . . . . 0.0 109.283 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.591 ' ND2' ' CB ' ' A' ' 27' ' ' ALA . 3.0 t-20 -130.74 175.29 9.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.588 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.44 ' HB3' ' HG3' ' A' ' 116' ' ' PRO . 6.8 mmmt -95.29 125.03 39.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.641 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.571 ' CD1' ' CE2' ' A' ' 115' ' ' PHE . 56.5 mt -107.8 -174.59 2.56 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -160.69 -162.11 0.91 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.027 -1.045 . . . . 0.0 110.878 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.826 ' HB3' HG11 ' A' ' 8' ' ' VAL . 65.5 m-85 -155.18 69.27 5.51 Favored Pre-proline 0 C--N 1.295 -1.788 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.522 ' CD ' ' OG1' ' A' ' 21' ' ' THR . 2.4 Cg_endo -61.74 -81.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.173 1.915 . . . . 0.0 110.409 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 100.49 -150.02 18.74 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -139.8 24.15 2.75 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.614 ' HD2' HG23 ' A' ' 6' ' ' ILE . 2.5 mptt 70.25 148.2 0.07 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -1.143 . . . . 0.0 110.034 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.166 HD11 ' CZ2' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -101.57 119.27 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.459 ' O ' ' C ' ' A' ' 42' ' ' MET . 0.6 OUTLIER -79.06 -159.58 0.19 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.008 -1.058 . . . . 0.0 108.845 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.459 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -42.04 -52.78 4.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.372 -0.83 . . . . 0.0 108.997 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 42' ' ' MET . . . 58.38 122.77 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.236 -1.145 . . . . 0.0 110.236 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -106.53 -9.72 16.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -1.106 . . . . 0.0 108.785 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.678 HG23 ' H ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -160.55 171.54 6.98 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.546 ' HA ' ' CH2' ' A' ' 83' ' ' TRP . 3.7 Cg_exo -61.36 -37.2 74.16 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.294 1.996 . . . . 0.0 111.706 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.678 ' H ' HG23 ' A' ' 45' ' ' THR . 1.0 OUTLIER -86.45 -56.98 3.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.809 -1.182 . . . . 0.0 109.583 -179.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.664 ' H ' HG22 ' A' ' 45' ' ' THR . 1.7 tt0 -38.13 -32.28 0.06 Allowed 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.252 1.025 . . . . 0.0 110.049 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 47' ' ' GLU . . . -64.82 -65.29 0.69 Allowed 'General case' 0 C--N 1.272 -2.797 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.66 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.523 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 1.2 p -81.21 -45.45 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.898 -1.126 . . . . 0.0 110.301 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.601 HG13 ' N ' ' A' ' 52' ' ' ARG . 6.1 p -40.62 -47.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.653 -0.654 . . . . 0.0 109.332 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.601 ' N ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -74.61 -34.57 62.85 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.52 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 2.4 mt-10 -60.07 -19.95 55.65 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.903 -1.123 . . . . 0.0 108.363 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.631 ' CD2' ' CH2' ' A' ' 95' ' ' TRP . 13.8 mt -75.31 -68.61 0.54 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.197 0.522 . . . . 0.0 110.381 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.403 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 2.4 pt20 -61.3 -28.62 69.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.775 -1.203 . . . . 0.0 111.637 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 1.2 pp20? -72.88 1.02 9.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.701 -1.249 . . . . 0.0 109.56 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.457 ' HB3' ' HD1' ' A' ' 95' ' ' TRP . 3.5 mm-40 -143.78 -68.74 0.33 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.415 -0.803 . . . . 0.0 109.96 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.701 HG21 ' O ' ' A' ' 93' ' ' GLU . 2.4 p -111.55 -54.59 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.691 -1.255 . . . . 0.0 107.62 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.585 ' N ' ' CG1' ' A' ' 58' ' ' VAL . . . 81.84 47.2 6.36 Favored Glycine 0 N--CA 1.479 1.567 0 O-C-N 121.438 -0.789 . . . . 0.0 113.86 175.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.731 HG21 ' CD1' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -79.68 124.53 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 120.12 1.96 . . . . 0.0 106.403 176.362 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.718 ' H ' ' HD3' ' A' ' 62' ' ' PRO . 8.4 t -149.26 23.77 0.04 OUTLIER Pre-proline 0 C--N 1.279 -2.5 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.718 ' HD3' ' H ' ' A' ' 61' ' ' THR . 2.2 Cg_endo -62.35 -47.15 10.37 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 CA-C-N 120.072 1.061 . . . . 0.0 109.725 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 89' ' ' ARG . 1.2 pt20 -162.88 -31.24 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.962 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.612 ' O ' ' CG ' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -42.76 113.73 0.5 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 122.214 1.007 . . . . 0.0 112.962 -177.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.409 ' CB ' ' O ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER 171.74 130.58 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.159 -0.963 . . . . 0.0 110.044 177.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -163.67 -35.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 110.574 179.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.601 ' HB2' ' CE3' ' A' ' 85' ' ' TRP . 37.7 tp 39.35 96.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.765 0.793 . . . . 0.0 109.273 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.663 ' CZ ' HD21 ' A' ' 126' ' ' LEU . 30.2 p90 -66.62 -54.03 27.74 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.446 -0.784 . . . . 0.0 110.705 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.61 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER 178.35 134.11 0.08 Allowed 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.247 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.551 ' CB ' ' HB3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -94.69 168.55 10.76 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.498 -0.751 . . . . 0.0 109.79 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.966 HD23 ' HB ' ' A' ' 122' ' ' VAL . 1.2 pp -126.41 -166.53 1.59 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.096 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -160.0 142.62 13.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 109.625 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.416 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -130.03 96.12 4.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.343 -0.848 . . . . 0.0 109.41 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.465 ' HG2' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -84.15 109.39 17.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.4 -0.813 . . . . 0.0 109.297 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.599 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -79.63 179.63 1.76 Allowed Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.599 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 6.0 Cg_endo -75.81 40.76 0.75 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.329 2.019 . . . . 0.0 111.198 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 76' ' ' PRO . 0.1 OUTLIER 172.3 -25.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.712 -1.243 . . . . 0.0 110.214 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -124.44 170.45 10.84 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 109.977 -178.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.465 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 6.1 m80 -126.01 92.11 3.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.438 -0.789 . . . . 0.0 108.969 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.441 ' CD1' HD12 ' A' ' 4' ' ' LEU . 27.1 mm -79.4 137.19 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.29 -0.881 . . . . 0.0 109.503 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.54 84.52 1.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.299 -0.876 . . . . 0.0 109.454 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.625 ' CD1' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -108.09 158.58 17.28 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.348 -0.845 . . . . 0.0 109.407 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 1.166 ' CZ2' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -131.03 151.91 50.9 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.964 -1.085 . . . . 0.0 110.75 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.784 ' CB ' HD11 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.71 120.98 38.18 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.601 ' CE3' ' HB2' ' A' ' 67' ' ' LEU . 10.9 m95 -96.4 98.09 9.98 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.002 -1.061 . . . . 0.0 110.202 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.826 HD12 ' HB ' ' A' ' 10' ' ' ILE . 1.0 OUTLIER -68.61 89.5 0.37 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.827 HG21 HG23 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -60.52 174.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.633 0.73 . . . . 0.0 110.533 -178.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' A' ' 12' ' ' ARG . 11.0 mm-40 -97.05 -72.29 0.65 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.049 -0.661 . . . . 0.0 109.371 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.533 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -159.2 148.85 18.77 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.876 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 3.7 p90 -136.95 -171.41 2.93 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.833 -1.167 . . . . 0.0 111.243 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.512 ' H ' ' CG ' ' A' ' 62' ' ' PRO . 15.6 tt0 -128.88 -33.69 2.0 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.68 -134.82 0.11 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.701 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.0 OUTLIER -121.66 132.51 24.21 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.197 -1.178 . . . . 0.0 110.156 -179.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.867 ' CB ' HD12 ' A' ' 11' ' ' ILE . 2.4 Cg_endo -71.82 119.53 6.27 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.581 2.187 . . . . 0.0 109.814 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.667 ' CG ' ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -126.31 38.64 4.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.02 -1.05 . . . . 0.0 112.923 -177.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -49.71 -20.42 2.79 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HG2' HG23 ' A' ' 21' ' ' THR . 0.0 OUTLIER -108.73 -171.9 1.94 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.422 -1.046 . . . . 0.0 109.912 -179.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -141.5 -41.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.441 -0.787 . . . . 0.0 109.045 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.28 23.87 1.1 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.434 ' CG ' ' HD2' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -102.61 172.05 4.67 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.417 -1.049 . . . . 0.0 109.639 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' A' ' 102' ' ' GLY . 4.9 Cg_endo -70.88 5.54 2.08 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.538 2.159 . . . . 0.0 111.443 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.592 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -39.77 146.91 0.23 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 9.8 pt-20 -161.33 -171.51 3.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.614 -0.933 . . . . 0.0 110.434 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.563 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 20.6 m0 -94.53 100.56 12.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.569 -0.707 . . . . 0.0 109.772 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -84.42 -163.17 0.76 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.142 -0.974 . . . . 0.0 108.908 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.58 103.21 4.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.315 -0.865 . . . . 0.0 109.369 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.855 ' HB2' HD11 ' A' ' 18' ' ' ILE . 18.4 mt -139.57 -78.28 0.32 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.527 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER 67.53 25.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.002 0.906 . . . . 0.0 108.814 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 178.39 44.74 0.07 OUTLIER Glycine 0 N--CA 1.485 1.902 0 N-CA-C 107.187 -2.365 . . . . 0.0 107.187 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.705 HD11 ' CE2' ' A' ' 115' ' ' PHE . 1.1 mt -36.42 153.69 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 O-C-N 122.103 -0.645 . . . . 0.0 109.886 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.667 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 0.7 OUTLIER -134.81 9.01 3.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.139 -0.976 . . . . 0.0 109.667 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 73.91 -9.94 1.17 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.062 -1.024 . . . . 0.0 110.47 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -74.71 -42.1 58.97 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.833 -1.167 . . . . 0.0 109.101 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' CD2' ' A' ' 110' ' ' LEU . 3.4 p30 -78.62 0.61 25.73 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.705 ' CE2' HD11 ' A' ' 110' ' ' LEU . 10.1 m-85 -120.0 106.29 41.44 Favored Pre-proline 0 N--CA 1.485 1.323 0 O-C-N 121.441 -0.787 . . . . 0.0 109.073 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 115' ' ' PHE . 35.4 Cg_exo -40.17 152.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.281 1.988 . . . . 0.0 110.71 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.717 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 5.9 Cg_exo -56.19 -160.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.622 2.215 . . . . 0.0 111.357 -178.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 117' ' ' PRO . . . 82.97 -42.67 0.11 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.73 -0.606 . . . . 0.0 109.674 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.544 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 2.9 m120 -98.0 33.66 2.09 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.087 -1.008 . . . . 0.0 109.357 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.645 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 4.2 mt-10 -62.49 -38.85 49.84 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.374 -0.829 . . . . 0.0 112.688 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.3 Cg_exo -58.89 -41.97 57.12 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.776 1.651 . . . . 0.0 112.314 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.966 ' HB ' HD23 ' A' ' 71' ' ' LEU . 1.1 t -97.43 -47.98 12.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 120.44 -1.412 . . . . 0.0 108.295 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.64 HG22 ' HB2' ' A' ' 112' ' ' ALA . 7.5 mm -47.61 -34.35 3.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.364 -0.835 . . . . 0.0 108.802 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.34 -45.15 72.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.494 -0.754 . . . . 0.0 109.598 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.65 -52.36 65.48 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.228 -0.92 . . . . 0.0 109.849 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.663 HD21 ' CZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -53.98 -15.83 1.6 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.182 -0.949 . . . . 0.0 110.347 -179.234 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.528 ' HE2' ' O ' ' A' ' 111' ' ' ASN . 12.6 mttt -51.41 -51.42 54.91 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.815 -1.178 . . . . 0.0 108.715 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -94.89 46.45 1.13 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.65 HD21 ' CD2' ' A' ' 86' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.777 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.474 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 64.48 72.13 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -0.835 . . . . 0.0 109.551 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 2' ' ' LYS . 0.2 OUTLIER 167.86 92.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.871 . . . . 0.0 109.693 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -157.85 97.58 1.57 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.36 -0.838 . . . . 0.0 108.887 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.631 ' HB3' HG21 ' A' ' 40' ' ' ILE . 72.1 mt-30 -133.59 142.51 48.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.188 -0.945 . . . . 0.0 110.0 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.636 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.5 mt -149.26 157.7 6.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.462 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -111.84 126.63 55.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.123 -0.986 . . . . 0.0 108.973 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 1.062 HG11 HD21 ' A' ' 82' ' ' LEU . 1.4 p -125.46 83.89 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.918 . . . . 0.0 110.202 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.504 ' HA2' ' CD1' ' A' ' 85' ' ' TRP . . . -74.21 117.42 5.59 Favored Glycine 0 C--N 1.291 -1.952 0 N-CA-C 107.732 -2.147 . . . . 0.0 107.732 178.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.759 HD12 ' CD1' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -97.21 172.19 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 120.973 -1.31 . . . . 0.0 109.755 -178.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.837 HD12 ' HB3' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -140.49 154.82 22.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.438 -0.788 . . . . 0.0 109.211 -179.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.501 ' CD ' HD23 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -160.34 68.19 0.36 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.343 -0.848 . . . . 0.0 110.281 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.6 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 52.1 m-80 -163.83 -171.58 2.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.185 -0.947 . . . . 0.0 109.628 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 6.1 tt0 83.95 -46.15 0.11 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.86 0.838 . . . . 0.0 109.542 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.427 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 47.7 t30 -142.13 25.2 1.93 Allowed 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.472 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 12.4 t30 55.64 45.85 23.9 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 105' ' ' MET . 4.0 mt-10 -140.41 149.85 43.14 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.099 -1.0 . . . . 0.0 109.386 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.555 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 0.4 OUTLIER -97.95 151.67 4.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.305 -0.872 . . . . 0.0 109.22 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.547 ' HB3' HG12 ' A' ' 11' ' ' ILE . 50.3 t80 -88.54 82.5 6.91 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.605 HG22 ' N ' ' A' ' 21' ' ' THR . 42.2 mm -78.28 167.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.295 -0.878 . . . . 0.0 110.122 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.849 HG21 ' HB2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -121.73 128.36 51.7 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.525 ' N ' ' OE1' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -160.55 106.99 1.51 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.512 -0.743 . . . . 0.0 109.193 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.671 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -49.65 105.89 0.1 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.103 -0.998 . . . . 0.0 109.691 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' A' ' 23' ' ' ARG . . . 73.45 -169.73 0.12 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.156 -0.965 . . . . 0.0 109.465 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 26' ' ' ASP . . . -133.83 -144.34 0.22 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.232 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.592 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 3.1 m-20 64.45 -118.4 0.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.191 -0.943 . . . . 0.0 109.348 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 26' ' ' ASP . . . 68.41 100.89 0.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.735 -1.228 . . . . 0.0 109.408 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -110.78 -44.41 3.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.425 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -45.92 -60.93 1.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.138 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.78 112.92 6.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.11 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -80.25 128.39 33.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.931 . . . . 0.0 109.728 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -134.63 137.74 43.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 109.264 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.561 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 3.1 mt -99.13 -169.68 1.8 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.259 -0.901 . . . . 0.0 108.722 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.49 -156.52 0.48 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.12 -0.987 . . . . 0.0 109.837 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -144.57 158.27 54.08 Favored Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.721 ' C ' HG23 ' A' ' 8' ' ' VAL . 3.1 Cg_exo -55.71 -153.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.186 1.924 . . . . 0.0 109.816 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 163.24 -166.98 37.33 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.564 -1.303 . . . . 0.0 110.009 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . 173.95 -80.12 0.08 OUTLIER Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 9.0 tttt 166.72 136.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.494 -1.004 . . . . 0.0 109.198 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.814 HD11 ' NE1' ' A' ' 83' ' ' TRP . 3.8 mt -115.2 105.77 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 109.158 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.543 ' O ' ' CB ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -108.23 17.2 22.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.086 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.543 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 78.85 -137.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.47 -112.27 1.66 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.495 ' HB3' ' OE1' ' A' ' 48' ' ' GLN . 9.7 tt0 -127.99 -38.99 1.79 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.315 -1.109 . . . . 0.0 109.467 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.656 HG23 ' H ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -156.97 167.76 13.88 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.072 -1.017 . . . . 0.0 108.957 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 3.3 Cg_exo -60.25 -18.1 50.27 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.879 2.386 . . . . 0.0 112.851 -177.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.994 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -79.74 -63.12 1.49 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.795 -1.191 . . . . 0.0 109.251 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.629 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 3.2 tt0 -38.02 -32.71 0.07 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.578 1.18 . . . . 0.0 109.626 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 47' ' ' GLU . . . -61.79 -65.51 0.68 Allowed 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.537 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.57 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 4.3 p -80.86 -43.97 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.927 -1.108 . . . . 0.0 110.79 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.994 HG12 ' O ' ' A' ' 47' ' ' GLU . 7.5 p -42.6 -33.52 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HB3' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -75.82 -43.74 44.57 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.57 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 2.7 pt-20 -70.84 -7.3 44.46 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 118.74 -1.184 . . . . 0.0 108.5 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.718 HD23 ' HE1' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -64.99 -62.56 1.48 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.495 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 25.5 mt-30 -81.56 -24.19 36.7 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.569 -0.707 . . . . 0.0 109.458 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 52' ' ' ARG . 4.1 mm-40 -81.66 31.04 0.35 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.28 -0.887 . . . . 0.0 110.813 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.568 ' HB3' ' CB ' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -148.67 -64.01 0.24 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.696 -1.253 . . . . 0.0 109.863 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.918 HG11 ' C ' ' A' ' 94' ' ' PRO . 1.0 OUTLIER -118.78 -36.79 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.061 -1.025 . . . . 0.0 108.263 178.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 89.93 55.08 2.06 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.704 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -82.08 -179.28 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.183 -1.186 . . . . 0.0 109.834 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.795 ' O ' HG23 ' A' ' 61' ' ' THR . 8.6 t -135.41 58.31 25.03 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.704 ' HD3' ' HB ' ' A' ' 60' ' ' ILE . 4.6 Cg_exo -53.8 129.17 32.72 Favored 'Trans proline' 0 C--N 1.29 -2.541 0 C-N-CA 122.35 2.033 . . . . 0.0 111.08 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.554 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 0.7 OUTLIER -81.21 -42.91 20.04 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.463 -179.198 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -160.85 114.96 2.08 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.676 -1.21 . . . . 0.0 111.018 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.488 ' CB ' ' HA ' ' A' ' 87' ' ' VAL . 1.8 p90 -121.98 177.89 5.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -0.846 . . . . 0.0 109.088 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 m -161.31 158.68 27.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.863 HD12 ' HA ' ' A' ' 85' ' ' TRP . 47.5 tp -84.76 96.25 9.2 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.876 -1.14 . . . . 0.0 109.536 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.666 ' HB3' HD23 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -41.76 -76.09 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.837 0.827 . . . . 0.0 108.904 179.267 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.64 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 4.0 tp10 -171.09 126.95 0.69 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 83' ' ' TRP . 8.9 ptpt -89.41 153.49 20.8 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.339 -0.85 . . . . 0.0 110.051 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.907 HD22 ' CG2' ' A' ' 122' ' ' VAL . 0.5 OUTLIER -127.41 -157.36 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.333 -0.854 . . . . 0.0 109.114 178.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.531 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -161.02 165.09 30.39 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.359 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.482 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . 1.1 t80 -152.82 175.39 12.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.543 -0.723 . . . . 0.0 109.174 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -160.43 109.33 1.69 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.665 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.604 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -79.71 177.16 3.09 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.604 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 6.3 Cg_endo -74.34 31.31 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.496 2.13 . . . . 0.0 111.335 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.29 -39.1 0.05 Allowed 'General case' 0 N--CA 1.482 1.157 0 O-C-N 120.509 -1.369 . . . . 0.0 110.112 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -135.99 -177.22 4.59 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.363 -0.835 . . . . 0.0 110.299 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.499 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 3.5 m170 -113.55 126.72 55.6 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.496 HD13 ' N ' ' A' ' 80' ' ' ILE . 1.6 mm -94.6 149.22 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.168 -0.958 . . . . 0.0 109.652 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.1 m -157.21 107.51 2.26 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 1.062 HD21 HG11 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -136.34 129.02 30.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.149 -0.969 . . . . 0.0 110.1 -178.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.814 ' NE1' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -119.05 149.21 42.05 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.237 -0.914 . . . . 0.0 110.108 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.602 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -127.67 123.03 34.53 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.863 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -91.13 80.9 5.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.616 -1.303 . . . . 0.0 109.209 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.759 ' CD1' HD12 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -42.43 121.15 1.85 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.249 -0.907 . . . . 0.0 110.306 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.763 HG22 ' HA ' ' A' ' 11' ' ' ILE . 18.9 m -87.61 170.19 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.517 ' HB3' ' HD2' ' A' ' 89' ' ' ARG . 5.2 mt-10 -122.54 -19.79 6.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.854 -1.153 . . . . 0.0 111.078 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.554 ' HG3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.93 156.64 20.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.597 -1.314 . . . . 0.0 110.238 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.788 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 6.2 p90 177.27 -169.38 0.07 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.096 0.951 . . . . 0.0 110.445 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.643 ' N ' ' CD1' ' A' ' 90' ' ' TRP . 7.2 tt0 -147.53 128.28 14.31 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.839 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 119.85 -165.92 13.48 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.848 -1.167 . . . . 0.0 110.279 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.58 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -111.01 105.07 56.98 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.166 -1.196 . . . . 0.0 109.05 179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.918 ' C ' HG11 ' A' ' 58' ' ' VAL . 4.8 Cg_exo -58.96 176.38 0.47 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.782 2.321 . . . . 0.0 113.066 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.911 ' CD1' HG13 ' A' ' 58' ' ' VAL . 3.8 p-90 -122.57 -161.28 0.93 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.764 0.793 . . . . 0.0 109.834 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.569 ' HA3' ' HB3' ' A' ' 36' ' ' PRO . . . 165.79 -107.31 0.29 Allowed Glycine 0 N--CA 1.481 1.696 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.849 ' HB2' HG21 ' A' ' 21' ' ' THR . 11.1 tttp -60.99 -178.94 0.11 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.981 -1.305 . . . . 0.0 108.568 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.58 -73.35 0.66 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.952 -1.092 . . . . 0.0 109.713 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.96 10.81 56.81 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -110.33 121.99 39.9 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 121.033 -1.275 . . . . 0.0 109.447 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.43 -53.51 0.78 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.144 1.896 . . . . 0.0 111.155 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . 90.29 172.0 44.38 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 7.4 pt-20 -140.5 144.92 36.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.715 -1.462 . . . . 0.0 110.246 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.599 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -89.94 107.25 19.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.332 -0.855 . . . . 0.0 109.208 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 7.4 ttm -96.25 152.08 18.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.128 -0.982 . . . . 0.0 109.671 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.463 ' O ' ' HG ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -108.12 105.47 15.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 109.372 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.757 ' O ' HG12 ' A' ' 108' ' ' VAL . 49.1 mt -147.98 -65.66 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.15 -0.969 . . . . 0.0 109.651 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.757 HG12 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER 77.15 -1.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.484 -0.76 . . . . 0.0 109.821 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -138.99 25.77 2.77 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 107.072 -2.411 . . . . 0.0 107.072 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.712 HD13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -40.11 145.18 0.17 Allowed 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.935 -0.744 . . . . 0.0 110.149 -179.134 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.9 -171.71 1.95 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.371 -0.831 . . . . 0.0 108.991 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.547 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -91.12 10.26 27.64 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.238 -0.914 . . . . 0.0 109.3 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -85.99 -43.83 12.84 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.26 -0.9 . . . . 0.0 109.894 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.498 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -79.31 -14.89 58.71 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.256 -0.903 . . . . 0.0 108.744 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.712 ' CE2' HD13 ' A' ' 110' ' ' LEU . 1.4 m-85 -96.53 140.0 21.95 Favored Pre-proline 0 N--CA 1.489 1.516 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.854 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.505 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 1.8 Cg_endo -67.01 145.07 72.49 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.028 1.819 . . . . 0.0 110.446 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.715 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.8 Cg_endo -63.13 127.48 20.34 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.376 2.051 . . . . 0.0 110.574 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 156.9 -32.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.841 ' OD1' HD21 ' A' ' 71' ' ' LEU . 41.0 m-80 -112.81 46.85 1.16 Allowed 'General case' 0 C--O 1.201 -1.49 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.633 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 15.5 mt-10 -61.14 -41.39 80.56 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.237 -0.914 . . . . 0.0 112.901 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 1.3 Cg_endo -67.3 -29.05 39.15 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.544 2.162 . . . . 0.0 111.736 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.907 ' CG2' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -95.08 -41.25 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.021 -1.049 . . . . 0.0 108.444 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.547 HG22 ' HB2' ' A' ' 112' ' ' ALA . 8.8 mm -58.36 -35.42 53.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.02 -39.25 63.02 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . 20.2 mmtt -80.63 -31.56 36.51 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.41 -0.806 . . . . 0.0 109.803 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 4.3 mp -56.9 -25.13 56.53 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.3 -0.875 . . . . 0.0 109.212 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -56.43 -46.5 80.23 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 129' ' ' LEU . 7.3 mtt180 -84.72 -7.02 59.37 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.721 -0.612 . . . . 0.0 109.476 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 126' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.812 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mmt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.437 ' HD2' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -130.66 169.26 15.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.406 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.8 107.12 9.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.359 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.754 ' HG ' HG22 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -115.48 -177.46 3.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.321 -0.862 . . . . 0.0 109.476 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.751 ' HG3' HG23 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -152.9 159.44 42.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.881 . . . . 0.0 109.387 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.658 HD13 ' HA ' ' A' ' 39' ' ' LYS . 11.6 mm -116.89 168.44 8.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.226 -0.921 . . . . 0.0 109.353 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.61 ' N ' HG22 ' A' ' 6' ' ' ILE . . . -125.74 115.25 19.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.096 -1.002 . . . . 0.0 110.167 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 35' ' ' PHE . 5.8 p -129.54 146.13 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.53 112.33 1.08 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.024 HD12 ' CD1' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -94.25 162.12 2.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.043 HG22 ' CZ3' ' A' ' 90' ' ' TRP . 2.2 mt -146.03 135.95 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 118.319 -1.352 . . . . 0.0 112.037 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 35.1 ttp180 -126.98 129.57 48.36 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.536 ' OD1' ' CZ2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -98.48 -156.95 0.57 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.895 -1.128 . . . . 0.0 111.012 -178.062 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -85.67 -5.51 59.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.753 -0.592 . . . . 0.0 109.758 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.553 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 6.6 t-20 -91.34 23.12 3.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.919 . . . . 0.0 108.839 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 48.32 46.38 20.19 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.615 -0.678 . . . . 0.0 110.897 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.553 ' CG ' ' HB3' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -134.2 165.94 23.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.197 -0.94 . . . . 0.0 108.649 178.562 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.826 HG13 HD22 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -116.66 167.65 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.113 -0.992 . . . . 0.0 109.439 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 94' ' ' PRO . 57.3 t80 -120.13 88.21 2.89 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 121.028 -1.045 . . . . 0.0 108.963 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.898 HG21 HD13 ' A' ' 33' ' ' LEU . 9.4 mm -77.81 174.57 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.644 HG21 ' N ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -118.16 128.51 54.78 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.863 -1.148 . . . . 0.0 108.67 178.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 1.4 tpt180 -160.67 122.9 3.17 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.155 -0.966 . . . . 0.0 109.865 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.649 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.3 OUTLIER -86.73 43.51 1.09 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.169 -0.957 . . . . 0.0 109.134 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 167.24 -159.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -0.892 . . . . 0.0 109.659 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -173.21 -170.0 0.59 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 109.631 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.61 154.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.875 . . . . 0.0 109.611 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.567 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . . . -178.46 -62.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.139 -0.976 . . . . 0.0 109.698 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 46.79 40.71 9.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.955 . . . . 0.0 109.543 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.94 -41.41 0.06 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 0.0 109.581 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 31' ' ' ASN . . . -140.62 -38.27 0.44 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.144 -0.972 . . . . 0.0 109.653 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.567 ' OD1' ' HB3' ' A' ' 27' ' ' ALA . 68.3 m-20 57.57 104.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 109.074 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -137.67 128.89 27.74 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.699 -179.538 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.898 HD13 HG21 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -96.51 -174.57 3.07 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 21' ' ' THR . 5.6 mm-40 -119.37 172.88 7.31 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.936 -1.103 . . . . 0.0 110.271 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.657 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -161.12 -66.02 0.02 OUTLIER Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 35' ' ' PHE . 11.5 Cg_exo -42.81 150.08 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.115 1.21 . . . . 0.0 109.489 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -116.17 -85.89 1.23 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.72 53.52 0.48 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.658 ' HA ' HD13 ' A' ' 6' ' ' ILE . 4.6 mptt 64.75 175.52 0.2 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.44 -1.035 . . . . 0.0 109.716 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.751 HG23 ' HG3' ' A' ' 5' ' ' GLN . 1.3 tt -148.44 79.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.385 -0.822 . . . . 0.0 109.78 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 42' ' ' MET . 0.6 OUTLIER -150.22 148.95 29.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.92 -1.113 . . . . 0.0 110.05 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.476 ' HB3' ' O ' ' A' ' 41' ' ' GLU . 0.5 OUTLIER 164.31 -33.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.19 37.04 0.2 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 48' ' ' GLN . 39.9 mt-10 -131.84 -148.12 0.34 Allowed 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.487 -1.007 . . . . 0.0 109.915 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.821 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -142.66 -176.77 0.59 Allowed Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.215 -0.928 . . . . 0.0 108.695 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.821 ' CD ' HG22 ' A' ' 45' ' ' THR . 1.1 Cg_endo -69.12 -3.17 11.05 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.808 1.672 . . . . 0.0 110.68 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.461 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -108.14 -45.5 3.93 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.001 -1.062 . . . . 0.0 109.165 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.539 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -75.67 -54.83 6.35 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.341 1.067 . . . . 0.0 109.396 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 48' ' ' GLN . . . -38.02 -54.29 1.33 Allowed 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.176 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.499 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 5.3 p -76.12 -31.55 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.141 -0.975 . . . . 0.0 109.119 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.627 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -44.53 -58.05 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.627 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -67.92 -28.87 67.87 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.541 ' OE2' ' HB1' ' A' ' 7' ' ' ALA . 3.9 mt-10 -56.47 -18.79 12.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.831 -1.168 . . . . 0.0 108.301 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.722 HD13 ' HG3' ' A' ' 62' ' ' PRO . 14.6 mt -68.9 -42.73 76.51 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.372 -0.83 . . . . 0.0 109.056 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -81.25 -41.82 21.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 110.485 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.534 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 14.6 pt-20 -80.94 37.82 0.44 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.023 -1.048 . . . . 0.0 110.98 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.601 ' HB3' ' CG ' ' A' ' 95' ' ' TRP . 58.0 mm-40 -146.69 -55.76 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.881 -1.137 . . . . 0.0 109.204 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.854 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.6 m -143.83 -33.08 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.523 -0.736 . . . . 0.0 109.279 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.46 59.77 1.98 Allowed Glycine 0 N--CA 1.479 1.558 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.617 HG12 ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -95.6 164.91 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.489 -1.006 . . . . 0.0 109.012 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 97.4 m -112.53 83.98 5.95 Favored Pre-proline 0 C--N 1.3 -1.577 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.722 ' HG3' HD13 ' A' ' 54' ' ' LEU . 2.4 Cg_endo -59.48 117.63 4.39 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.439 2.093 . . . . 0.0 110.246 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.561 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 1.2 mt-30 -79.55 -28.02 41.25 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.559 -0.713 . . . . 0.0 109.183 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.437 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 12.5 t-160 -171.1 117.17 0.45 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.936 -1.102 . . . . 0.0 111.037 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.613 ' HB2' HG12 ' A' ' 87' ' ' VAL . 11.3 p90 -129.66 171.19 12.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.245 -0.909 . . . . 0.0 109.586 178.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.18 161.4 24.97 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.382 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.793 HD12 ' HA ' ' A' ' 85' ' ' TRP . 27.0 tp -109.31 108.78 19.49 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.87 ' CZ ' HD21 ' A' ' 126' ' ' LEU . 27.1 p90 -69.62 -56.62 6.78 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.308 -0.87 . . . . 0.0 111.117 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.645 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 3.3 tp10 -172.23 144.68 1.63 Allowed 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.348 -0.845 . . . . 0.0 109.857 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.591 ' HD3' ' CE3' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -111.59 158.11 19.61 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.336 -0.853 . . . . 0.0 110.549 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.806 HD23 ' HB ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -113.02 -165.08 0.96 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 1.7 pt-20 -149.07 133.96 17.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.822 -1.174 . . . . 0.0 110.353 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.617 ' HB2' HD11 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -96.29 117.74 31.42 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.277 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -110.94 99.76 8.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.156 -0.965 . . . . 0.0 109.547 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.55 ' HB2' ' HG3' ' A' ' 78' ' ' ARG . 5.1 m-85 -79.49 170.17 17.15 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 2.2 Cg_endo -62.87 -2.39 3.54 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.01 1.807 . . . . 0.0 111.516 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -143.18 -20.62 0.63 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.692 -1.255 . . . . 0.0 111.764 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.55 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -126.63 163.18 24.02 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.663 -1.273 . . . . 0.0 110.642 -178.495 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -127.35 74.24 1.5 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.754 HG22 ' HG ' ' A' ' 4' ' ' LEU . 0.9 OUTLIER -78.91 -174.85 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.352 -0.843 . . . . 0.0 110.576 -178.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 72' ' ' GLU . 3.0 m -151.01 153.62 35.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.421 -0.799 . . . . 0.0 109.209 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.528 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -129.34 143.1 50.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.083 -1.011 . . . . 0.0 109.324 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.638 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -133.11 128.91 37.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 109.837 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.734 ' CE1' HG11 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -121.83 101.16 7.4 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.702 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.793 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -79.89 83.44 5.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.188 -0.945 . . . . 0.0 110.594 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.024 ' CD1' HD12 ' A' ' 10' ' ' ILE . 3.4 tp -52.38 114.02 1.23 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 109.574 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.033 HG21 HG23 ' A' ' 11' ' ' ILE . 8.5 m -85.11 -163.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.218 -0.926 . . . . 0.0 109.581 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 12' ' ' ARG . 76.3 mt-10 -137.57 -31.82 0.78 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.113 -0.992 . . . . 0.0 110.355 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.561 ' HG3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -161.95 175.5 11.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.82 -1.175 . . . . 0.0 110.019 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 1.043 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 42.3 p90 -179.6 -168.24 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.081 0.943 . . . . 0.0 110.362 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.512 ' HB3' ' HB ' ' A' ' 61' ' ' THR . 17.4 tt0 -141.27 96.46 2.99 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.913 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.56 ' CA ' HG22 ' A' ' 60' ' ' ILE . . . 144.34 -152.12 24.05 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.273 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.854 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -106.51 112.36 63.76 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.22 -1.165 . . . . 0.0 109.601 -179.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.997 ' CB ' HD12 ' A' ' 11' ' ' ILE . 3.6 Cg_endo -56.81 130.71 41.35 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.155 2.57 . . . . 0.0 113.661 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.638 ' HE1' HD23 ' A' ' 54' ' ' LEU . 33.7 p-90 -107.01 -168.96 1.47 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 165.11 -15.72 0.09 OUTLIER Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.988 -1.577 . . . . 0.0 111.242 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.644 ' N ' HG21 ' A' ' 21' ' ' THR . 11.3 tttp -117.49 -99.15 0.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.829 -1.395 . . . . 0.0 109.765 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 97' ' ' LYS . 1.3 tt0 -134.81 28.11 3.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.22 -0.925 . . . . 0.0 109.407 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.79 22.9 19.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.483 ' HG2' ' HD2' ' A' ' 101' ' ' PRO . 2.0 mt-30 -103.15 166.88 11.06 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.136 -1.214 . . . . 0.0 109.619 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.483 ' HD2' ' HG2' ' A' ' 100' ' ' GLN . 1.1 Cg_endo -64.94 128.19 20.23 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.346 2.031 . . . . 0.0 110.513 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.553 ' HA3' ' CZ ' ' A' ' 19' ' ' PHE . . . -104.05 174.14 22.1 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.453 ' HA ' ' OE1' ' A' ' 103' ' ' GLU . 45.6 mm-40 -112.87 151.56 30.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.891 -1.358 . . . . 0.0 110.672 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.602 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -103.25 101.09 11.01 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.042 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.517 ' SD ' ' N ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -100.55 -166.81 1.36 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.974 -1.079 . . . . 0.0 110.002 -179.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -111.9 151.86 28.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 109.825 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.904 HD21 ' O ' ' A' ' 129' ' ' LEU . 7.0 tt -61.94 -27.58 68.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.44 -0.787 . . . . 0.0 110.183 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 109' ' ' GLY . 62.6 t -65.24 112.7 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.189 -0.945 . . . . 0.0 109.433 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 108' ' ' VAL . . . 45.1 40.71 7.42 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.826 HD22 HG13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -51.82 -42.69 62.72 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.476 -1.014 . . . . 0.0 110.127 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.781 ' HB2' HD12 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -130.28 -165.68 1.57 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.378 -0.826 . . . . 0.0 110.071 -179.436 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.844 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . 87.48 -25.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -120.43 -37.72 3.0 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.334 -0.854 . . . . 0.0 108.937 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.465 ' O ' HD23 ' A' ' 33' ' ' LEU . 9.8 t0 -96.3 0.86 51.42 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.414 -0.804 . . . . 0.0 109.002 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.608 ' CE1' ' HB3' ' A' ' 111' ' ' ASN . 1.7 m-85 -91.46 164.57 24.01 Favored Pre-proline 0 N--CA 1.489 1.501 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.498 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.529 ' HD2' ' CD2' ' A' ' 115' ' ' PHE . 1.3 Cg_endo -67.7 142.21 57.39 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.949 1.766 . . . . 0.0 109.794 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.699 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.6 Cg_endo -64.53 96.78 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.26 1.973 . . . . 0.0 110.31 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 161.3 -21.42 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.387 -0.821 . . . . 0.0 109.765 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.552 ' HB3' HG13 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -97.51 29.88 3.11 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.135 -0.978 . . . . 0.0 109.411 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.672 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 22.5 mt-10 -68.79 -34.2 5.08 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.47 -0.769 . . . . 0.0 112.891 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.0 Cg_exo -58.6 -37.38 94.69 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.545 1.497 . . . . 0.0 111.674 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.806 ' HB ' HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -101.79 -47.83 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.633 -1.292 . . . . 0.0 107.863 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.844 HG21 ' HA ' ' A' ' 112' ' ' ALA . 12.4 mm -47.81 -31.1 2.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.507 -0.745 . . . . 0.0 109.013 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 127' ' ' LYS . . . -52.92 -49.86 65.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.388 -0.82 . . . . 0.0 108.857 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -41.31 92.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.453 -0.78 . . . . 0.0 109.263 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.87 HD21 ' CZ ' ' A' ' 68' ' ' PHE . 10.9 mt -57.13 -13.78 3.31 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.232 -0.917 . . . . 0.0 109.768 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.612 ' HE2' ' HB1' ' A' ' 112' ' ' ALA . 25.1 mttt -61.7 -46.04 91.37 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.701 -1.249 . . . . 0.0 108.816 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 129' ' ' LEU . 14.9 mtm180 -88.45 11.87 15.84 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.425 -0.797 . . . . 0.0 109.563 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.904 ' O ' HD21 ' A' ' 107' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.402 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.46 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.6 mmtm -67.44 -99.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.356 -0.84 . . . . 0.0 110.204 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.64 ' C ' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -123.89 -159.38 0.86 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 110.19 -179.084 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.64 HD23 ' C ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -157.13 -97.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.443 -0.786 . . . . 0.0 109.895 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.709 ' OE1' HG21 ' A' ' 81' ' ' THR . 1.8 mt-30 -63.66 154.25 33.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.151 -0.968 . . . . 0.0 110.847 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.549 ' CG2' ' N ' ' A' ' 7' ' ' ALA . 5.1 mm -141.79 171.26 11.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.549 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . -132.23 89.96 2.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.797 -1.189 . . . . 0.0 109.848 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.644 HG23 ' C ' ' A' ' 36' ' ' PRO . 7.2 p -100.98 164.41 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.229 -0.919 . . . . 0.0 109.67 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.617 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -147.87 114.43 0.69 Allowed Glycine 0 N--CA 1.48 1.603 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.693 HD12 HD13 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -97.21 123.43 49.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.063 HD12 ' HB3' ' A' ' 94' ' ' PRO . 3.4 mt -117.8 153.21 19.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.201 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.516 ' CZ ' ' OE2' ' A' ' 88' ' ' GLU . 9.1 tpp180 -78.08 -147.41 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.912 0 O-C-N 120.965 -1.085 . . . . 0.0 108.763 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.564 ' CB ' ' HB2' ' A' ' 17' ' ' GLU . 0.9 OUTLIER -146.55 -11.46 0.46 Allowed 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.34 -0.85 . . . . 0.0 111.656 -179.174 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 13' ' ' ASN . 0.6 OUTLIER 82.97 -36.23 0.08 Allowed 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.603 -0.686 . . . . 0.0 109.274 -178.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 16' ' ' ASN . 14.9 t-20 -94.45 26.14 3.56 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.542 ' HB3' ' O ' ' A' ' 15' ' ' ASN . 18.8 t-20 71.16 37.17 1.25 Allowed 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.815 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.564 ' HB2' ' CB ' ' A' ' 13' ' ' ASN . 3.6 mt-10 -127.86 -163.5 1.27 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.639 -1.288 . . . . 0.0 109.353 178.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.588 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 1.1 mt -151.65 154.33 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.816 -1.178 . . . . 0.0 109.737 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 82.7 t80 -95.19 66.28 2.91 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.782 HG23 ' N ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -81.73 -156.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.849 0.833 . . . . 0.0 110.736 -177.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.98 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -145.51 147.1 31.77 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.385 0.612 . . . . 0.0 109.721 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 24' ' ' ALA . 0.7 OUTLIER -109.89 -158.14 0.64 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.293 -0.879 . . . . 0.0 110.144 -179.453 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.491 ' NH1' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -49.62 88.87 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.567 -0.708 . . . . 0.0 110.047 -179.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . -114.18 -2.33 13.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.517 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.36 -57.41 1.48 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.159 -0.963 . . . . 0.0 109.405 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.12 -71.98 0.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.878 . . . . 0.0 109.679 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.48 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . . . 57.75 77.03 0.3 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.12 -0.987 . . . . 0.0 109.054 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -86.81 131.76 34.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 110.205 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.479 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 1.2 mtp 66.32 119.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.811 . . . . 0.0 110.21 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 29' ' ' MET . . . 63.55 169.43 0.15 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.37 -0.831 . . . . 0.0 109.634 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.452 ' O ' ' HE3' ' A' ' 32' ' ' LYS . 1.5 m-20 -83.62 149.65 26.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.39 -0.819 . . . . 0.0 109.418 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HG3' ' HG3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -137.38 146.14 44.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 109.292 179.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.98 HD23 ' O ' ' A' ' 21' ' ' THR . 0.7 OUTLIER -105.1 -174.15 2.47 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.209 -0.932 . . . . 0.0 109.341 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -162.02 -155.34 0.37 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.988 0.899 . . . . 0.0 109.985 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.594 ' HB3' HG21 ' A' ' 8' ' ' VAL . 17.9 m-85 -132.26 131.32 22.33 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.644 ' C ' HG23 ' A' ' 8' ' ' VAL . 5.3 Cg_exo -57.41 -157.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.071 1.847 . . . . 0.0 111.004 -178.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.556 ' CA ' ' HA ' ' A' ' 8' ' ' VAL . . . 85.2 154.55 22.63 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.99 -31.82 0.15 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.412 ' HA ' HD13 ' A' ' 6' ' ' ILE . 6.5 ttpt -171.15 161.94 6.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.815 -1.403 . . . . 0.0 110.529 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.742 HG13 ' HB1' ' A' ' 49' ' ' ALA . 2.9 tt -136.25 98.29 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.474 -0.766 . . . . 0.0 109.151 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 42' ' ' MET . 7.0 mt-10 -81.56 -173.51 4.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.207 -0.933 . . . . 0.0 110.122 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 12.8 mtt 63.62 -94.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.47 -0.769 . . . . 0.0 109.594 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.01 31.73 4.64 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -71.54 0.44 Allowed 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.601 -0.94 . . . . 0.0 109.463 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.853 HG23 ' HD2' ' A' ' 46' ' ' PRO . 24.2 m -133.84 144.01 49.97 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.054 -1.029 . . . . 0.0 109.08 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.853 ' HD2' HG23 ' A' ' 45' ' ' THR . 2.0 Cg_endo -55.66 -8.63 2.14 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.69 2.26 . . . . 0.0 112.33 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.713 ' H ' HG22 ' A' ' 45' ' ' THR . 0.5 OUTLIER -103.06 -36.26 8.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.762 -1.211 . . . . 0.0 108.686 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.499 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -62.0 -50.72 70.93 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.598 1.19 . . . . 0.0 108.811 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.742 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -38.23 -60.61 0.76 Allowed 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.339 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.715 HG21 ' CD1' ' A' ' 85' ' ' TRP . 2.3 p -71.95 -29.84 34.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.018 -1.051 . . . . 0.0 109.923 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.626 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -42.55 -56.33 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 122.039 0.923 . . . . 0.0 108.781 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.626 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -65.87 -33.34 75.63 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.39 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 5.8 mt-10 -73.08 -5.02 36.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.113 -0.992 . . . . 0.0 109.416 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.782 HD11 ' CH2' ' A' ' 85' ' ' TRP . 3.7 mt -79.92 -62.88 1.55 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 0.0 109.43 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.511 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 3.0 mm100 -81.94 -23.64 36.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.205 -0.935 . . . . 0.0 110.999 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -80.58 17.79 1.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.688 -1.257 . . . . 0.0 110.816 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.597 ' HB3' ' CD1' ' A' ' 95' ' ' TRP . 1.6 mt-10 -130.59 -65.3 0.8 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.673 -1.267 . . . . 0.0 110.003 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.852 HG21 ' O ' ' A' ' 93' ' ' GLU . 2.8 m -121.92 -26.47 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 108.907 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 95.99 59.7 1.05 Allowed Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.746 HG12 ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -95.84 174.01 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -1.172 . . . . 0.0 110.7 -179.527 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.722 ' N ' ' CD ' ' A' ' 62' ' ' PRO . 10.3 t -144.99 41.22 0.3 Allowed Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.722 ' CD ' ' N ' ' A' ' 61' ' ' THR . 4.8 Cg_exo -43.29 122.39 2.94 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.711 2.274 . . . . 0.0 110.852 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -98.89 -5.85 30.07 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.352 -178.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.71 39.31 2.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.165 -1.584 . . . . 0.0 111.952 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.593 ' CA ' HG23 ' A' ' 87' ' ' VAL . 45.0 p90 -79.9 168.07 19.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.63 -1.294 . . . . 0.0 110.52 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.5 m -164.38 145.23 8.15 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.571 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 84' ' ' PHE . 44.7 tp -73.91 98.1 2.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.562 -1.336 . . . . 0.0 108.897 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.712 ' CE2' HG12 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -44.77 -80.14 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.748 0.785 . . . . 0.0 108.981 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.582 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 16.0 mt-10 -152.9 164.45 37.88 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.297 0.57 . . . . 0.0 109.809 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 13.4 ttpp -134.33 108.87 8.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.996 -1.065 . . . . 0.0 110.214 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.77 HD23 HG22 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -98.55 -167.82 1.55 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.177 -0.952 . . . . 0.0 109.32 179.284 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -149.62 146.32 27.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.92 . . . . 0.0 109.689 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 74' ' ' GLU . 47.7 t80 -136.01 152.69 51.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 108.988 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 52.6 tt0 -143.2 115.05 8.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.552 ' HB2' ' HG3' ' A' ' 78' ' ' ARG . 3.9 m-85 -78.94 172.31 10.23 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.3 Cg_exo -59.61 -7.37 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.814 1.676 . . . . 0.0 111.453 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.46 ' O ' ' CG ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -154.27 -8.51 0.14 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.819 -1.175 . . . . 0.0 112.186 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.552 ' HG3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -130.93 178.52 6.61 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.282 -1.511 . . . . 0.0 109.92 -179.158 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.55 ' O ' ' HA ' ' A' ' 4' ' ' LEU . 27.6 m80 -125.4 161.99 25.81 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.355 -0.84 . . . . 0.0 108.977 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 80' ' ' ILE . 34.7 mm -149.99 74.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 110.005 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.709 HG21 ' OE1' ' A' ' 5' ' ' GLN . 18.7 m -79.64 136.91 36.94 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.714 HD23 ' CE1' ' A' ' 84' ' ' PHE . 12.5 tp -132.98 150.26 52.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.965 -1.085 . . . . 0.0 110.676 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.637 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -123.45 109.67 14.14 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.139 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.714 ' CE1' HD23 ' A' ' 82' ' ' LEU . 3.0 m-85 -79.73 88.41 5.2 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.14 -0.975 . . . . 0.0 109.865 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.782 ' CH2' HD11 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -86.59 74.91 9.79 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 123.514 1.626 . . . . 0.0 107.135 178.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.693 HD13 HD12 ' A' ' 10' ' ' ILE . 8.0 tp -67.17 133.85 50.59 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.431 -177.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.629 HG22 ' N ' ' A' ' 88' ' ' GLU . 7.3 p -144.28 168.61 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.476 -0.765 . . . . 0.0 109.197 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.629 ' N ' HG22 ' A' ' 87' ' ' VAL . 7.0 mt-10 -144.36 -18.95 0.55 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.916 -1.115 . . . . 0.0 111.923 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -110.85 141.88 43.63 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.313 -1.492 . . . . 0.0 109.303 -179.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.616 ' CD1' ' CG2' ' A' ' 60' ' ' ILE . 14.3 p90 178.62 -172.57 0.14 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.502 1.144 . . . . 0.0 111.002 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.475 ' N ' ' CD1' ' A' ' 90' ' ' TRP . 15.3 tt0 -147.14 85.98 1.62 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.798 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 168.46 -156.04 27.17 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.852 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -117.04 102.42 52.84 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.281 -1.129 . . . . 0.0 109.889 -179.296 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 1.063 ' HB3' HD12 ' A' ' 11' ' ' ILE . 31.9 Cg_exo -39.26 128.27 1.51 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 123.388 2.725 . . . . 0.0 113.289 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.794 ' HB3' HG13 ' A' ' 58' ' ' VAL . 2.0 p-90 -105.09 -164.83 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 154.61 92.95 0.09 OUTLIER Glycine 0 C--N 1.298 -1.537 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.541 ' HB2' ' N ' ' A' ' 37' ' ' GLY . 17.8 tttm 58.89 105.99 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.365 -1.08 . . . . 0.0 109.907 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -68.76 105.51 2.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.255 -0.903 . . . . 0.0 109.345 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.403 ' O ' ' HD3' ' A' ' 101' ' ' PRO . . . 132.1 -11.75 5.32 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.577 ' NE2' ' HA ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -101.46 108.58 56.01 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 121.347 -1.09 . . . . 0.0 109.157 179.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 99' ' ' GLY . 2.0 Cg_endo -61.89 89.99 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.068 1.845 . . . . 0.0 110.62 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -86.99 177.56 47.92 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.414 ' OE2' ' CZ ' ' A' ' 22' ' ' ARG . 14.1 pt-20 -159.11 177.6 10.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.65 -1.5 . . . . 0.0 111.108 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.485 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 35.0 m0 -87.88 110.95 20.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.698 -0.627 . . . . 0.0 109.799 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 30.5 ttp -101.75 144.46 30.41 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.273 -0.892 . . . . 0.0 108.804 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.36 131.1 41.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.937 . . . . 0.0 109.869 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.649 ' CD1' HD23 ' A' ' 129' ' ' LEU . 0.4 OUTLIER -107.08 57.5 0.63 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.297 -0.877 . . . . 0.0 109.247 179.653 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.98 -19.35 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 178.29 49.01 0.07 OUTLIER Glycine 0 N--CA 1.487 2.04 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 109' ' ' GLY . 0.7 OUTLIER -37.31 143.31 0.1 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.954 -0.733 . . . . 0.0 110.441 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -148.67 -174.5 4.63 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.461 -0.775 . . . . 0.0 109.092 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.623 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . -80.41 5.56 14.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 109.325 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -74.08 -48.54 29.07 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.305 -0.872 . . . . 0.0 110.079 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.755 ' O ' HD12 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -79.66 -15.24 57.95 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.228 -0.92 . . . . 0.0 108.941 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -102.86 130.77 23.13 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.624 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.534 ' CG ' ' O ' ' A' ' 33' ' ' LEU . 1.8 Cg_endo -62.93 158.97 40.33 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.035 1.824 . . . . 0.0 110.082 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.7 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 3.1 Cg_exo -59.49 -172.8 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.43 2.087 . . . . 0.0 110.937 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' A' ' 117' ' ' PRO . . . 77.73 -0.71 2.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.502 -0.749 . . . . 0.0 109.775 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.606 ' HB3' HG12 ' A' ' 123' ' ' ILE . 2.0 m-80 -133.66 49.03 2.31 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.103 -0.998 . . . . 0.0 109.776 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.647 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 4.6 mm-40 -75.46 -39.98 3.24 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 112.52 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 2.1 Cg_endo -64.54 -25.85 62.38 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.948 1.765 . . . . 0.0 111.837 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.77 HG22 HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -104.01 -50.85 8.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 120.79 -1.194 . . . . 0.0 109.115 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.71 ' HA ' HD12 ' A' ' 126' ' ' LEU . 19.7 mm -55.15 -37.98 45.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -49.57 -40.61 39.07 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.529 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -80.1 -35.23 37.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.53 -0.731 . . . . 0.0 109.776 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' A' ' 123' ' ' ILE . 9.5 mt -73.25 -4.12 31.08 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.191 -0.943 . . . . 0.0 109.825 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 110' ' ' LEU . 11.1 mttt -64.23 -49.05 73.48 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.277 -0.889 . . . . 0.0 109.185 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.27 -0.75 42.22 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.373 -0.83 . . . . 0.0 109.339 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.649 HD23 ' CD1' ' A' ' 107' ' ' LEU . 2.3 tp . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.716 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.153 0.501 . . . . 0.0 109.664 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.69 33.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.829 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.4 74.21 0.68 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.95 . . . . 0.0 109.895 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 4' ' ' LEU . 28.2 tp -131.84 103.58 6.4 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.576 -0.703 . . . . 0.0 109.29 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.544 ' HB2' HG21 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -125.31 148.49 48.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.081 -1.012 . . . . 0.0 109.558 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.645 HG22 ' H ' ' A' ' 7' ' ' ALA . 5.5 mm -107.04 178.37 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.248 -0.908 . . . . 0.0 109.409 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.645 ' H ' HG22 ' A' ' 6' ' ' ILE . . . -139.29 96.63 3.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 109.616 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.812 HG21 ' HB3' ' A' ' 35' ' ' PHE . 11.8 p -121.22 135.36 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 110.257 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.32 115.94 2.79 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.587 ' HB ' HD13 ' A' ' 86' ' ' LEU . 1.5 mt -84.28 157.83 3.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.792 ' O ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -127.29 148.72 32.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.897 -1.127 . . . . 0.0 110.137 -178.068 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.484 ' HD3' HD12 ' A' ' 18' ' ' ILE . 32.9 ttp180 -153.26 115.87 4.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.699 -0.625 . . . . 0.0 109.319 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.74 -153.65 0.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.087 -1.008 . . . . 0.0 109.751 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.587 ' CG ' ' NH1' ' A' ' 89' ' ' ARG . 51.8 mt-10 -89.07 -5.13 58.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.749 . . . . 0.0 109.882 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.538 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 55.6 t30 -94.72 33.64 1.43 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 15' ' ' ASN . 1.8 m120 33.74 41.46 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.59 0.71 . . . . 0.0 110.814 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 15' ' ' ASN . 5.0 mt-10 -119.94 128.81 53.94 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.792 HG22 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -105.7 150.21 8.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.643 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 13.6 t80 -98.24 81.7 2.82 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.721 HG23 ' N ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -93.09 -157.9 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 110.177 -178.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.721 ' N ' HG23 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -125.01 169.2 12.35 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.201 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -160.57 -154.33 0.37 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 120.821 -1.174 . . . . 0.0 110.453 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -44.22 103.47 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.648 -0.657 . . . . 0.0 109.971 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -138.63 22.87 2.69 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.454 -0.779 . . . . 0.0 109.244 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 24' ' ' ALA . . . 179.21 92.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.267 -0.896 . . . . 0.0 109.433 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER 44.97 76.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 109.307 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 23' ' ' ARG . . . -170.8 86.73 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.192 -0.942 . . . . 0.0 109.584 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -116.39 -14.32 10.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.08 -1.012 . . . . 0.0 109.622 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.729 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 3.5 ttm -107.17 134.62 50.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.138 -0.976 . . . . 0.0 109.575 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 29' ' ' MET . . . 83.99 -22.27 0.23 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.7 -0.625 . . . . 0.0 110.084 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 30' ' ' ALA . 3.4 m-20 59.52 116.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.017 -1.052 . . . . 0.0 109.477 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -131.08 136.15 48.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.361 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.566 ' CB ' ' O ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -135.59 -179.53 5.7 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.151 -0.968 . . . . 0.0 109.41 179.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -164.53 -154.96 0.26 Allowed 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.545 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.812 ' HB3' HG21 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -122.95 93.39 48.4 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.511 ' CD ' ' OG1' ' A' ' 21' ' ' THR . 5.9 Cg_exo -57.11 -153.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.501 2.134 . . . . 0.0 110.749 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 140.1 -153.84 23.58 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -148.94 23.62 1.28 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 73.58 160.58 0.23 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.134 . . . . 0.0 109.215 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.544 HG21 ' HB2' ' A' ' 5' ' ' GLN . 2.9 tt -102.07 129.24 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.197 -0.939 . . . . 0.0 109.347 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -126.54 -70.54 0.72 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.945 . . . . 0.0 109.554 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.48 108.61 20.13 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.405 0.622 . . . . 0.0 109.376 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.12 141.28 3.43 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.1 -10.59 15.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -1.142 . . . . 0.0 109.984 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.791 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -146.24 177.23 1.84 Allowed Pre-proline 0 N--CA 1.486 1.353 0 O-C-N 120.963 -1.086 . . . . 0.0 109.87 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.791 ' CD ' HG22 ' A' ' 45' ' ' THR . 6.3 Cg_endo -74.55 -4.93 16.18 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.466 2.111 . . . . 0.0 110.548 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.477 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 2.9 mt-10 -105.36 -37.28 6.9 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.202 -0.936 . . . . 0.0 108.884 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.453 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -73.04 -57.52 3.98 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.362 1.077 . . . . 0.0 108.868 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 53' ' ' GLU . . . -46.11 -43.12 14.57 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.52 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.609 ' CG2' ' CE3' ' A' ' 85' ' ' TRP . 14.5 p -79.79 -27.64 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.378 -0.827 . . . . 0.0 109.175 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.631 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -54.44 -57.93 5.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.631 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -81.22 -25.01 37.02 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.418 -178.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.597 ' CG ' ' HA ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -81.08 -31.58 34.31 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.003 -1.686 . . . . 0.0 111.457 -177.564 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.895 HD11 ' C ' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -79.86 -42.34 24.44 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.008 -1.058 . . . . 0.0 109.995 -179.321 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.483 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 1.7 mt-30 -67.96 -34.45 76.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.013 -1.054 . . . . 0.0 109.901 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.52 -9.68 58.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.033 -1.042 . . . . 0.0 110.132 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.495 ' OE1' ' CA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -101.2 -64.06 1.08 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.089 -1.007 . . . . 0.0 109.675 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.583 HG21 ' HA ' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -101.85 -29.16 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.457 -0.777 . . . . 0.0 109.158 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 59.5 53.48 45.74 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.691 HG22 ' H ' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -92.43 -165.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.547 ' HB ' ' CB ' ' A' ' 91' ' ' GLU . 98.8 m -137.51 91.04 14.38 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.595 -1.316 . . . . 0.0 109.418 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.611 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 1.8 Cg_endo -63.93 157.22 53.88 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.33 2.02 . . . . 0.0 110.809 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -120.73 -45.39 2.4 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 110.037 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.87 104.24 3.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.997 -1.064 . . . . 0.0 109.759 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.8 OUTLIER -134.84 172.29 13.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.197 -0.94 . . . . 0.0 110.317 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.59 151.99 17.5 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.897 HD12 ' O ' ' A' ' 84' ' ' PHE . 27.1 tp -70.27 100.64 1.74 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.906 -1.121 . . . . 0.0 109.594 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.651 ' HE2' HG13 ' A' ' 122' ' ' VAL . 0.7 OUTLIER -43.43 -77.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.662 ' O ' HG21 ' A' ' 122' ' ' VAL . 2.3 tt0 -169.15 114.87 0.58 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.775 -0.578 . . . . 0.0 109.572 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -86.35 163.65 17.53 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.371 -0.831 . . . . 0.0 110.119 -179.623 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.984 HD23 ' HB ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -126.13 -165.69 1.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.702 ' HG3' HG23 ' A' ' 81' ' ' THR . 3.5 tt0 -153.42 145.92 24.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.011 -1.056 . . . . 0.0 110.278 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.59 174.44 10.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 109.06 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 13.9 tt0 -155.63 113.68 3.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.147 -0.97 . . . . 0.0 109.623 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.595 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -79.59 -178.35 1.09 Allowed Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.724 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.595 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 4.8 Cg_endo -73.2 30.51 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.109 1.873 . . . . 0.0 111.486 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.464 ' OD2' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -162.52 -44.69 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.376 -1.452 . . . . 0.0 110.51 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.464 ' HG2' ' OD2' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -133.16 -178.18 4.86 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.163 -0.961 . . . . 0.0 110.069 -178.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -108.3 121.52 45.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.355 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.9 mt -90.28 88.26 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.052 -1.03 . . . . 0.0 109.639 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.702 HG23 ' HG3' ' A' ' 72' ' ' GLU . 1.3 m -85.28 120.63 26.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.288 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.48 ' HG ' ' HB ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -120.77 138.21 54.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.552 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.525 ' CD1' ' O ' ' A' ' 6' ' ' ILE . 1.4 m95 -96.43 165.27 12.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.371 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.897 ' O ' HD12 ' A' ' 67' ' ' LEU . 2.5 m-85 -130.59 74.62 1.61 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.915 . . . . 0.0 109.261 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.696 ' HD1' HD13 ' A' ' 67' ' ' LEU . 2.9 m0 -79.68 86.43 5.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.193 -0.942 . . . . 0.0 109.741 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.587 HD13 ' HB ' ' A' ' 10' ' ' ILE . 28.4 tp -88.37 106.32 18.17 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 10' ' ' ILE . 16.3 m -87.75 177.21 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.028 -1.045 . . . . 0.0 110.235 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -132.58 -23.44 2.08 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.395 -0.816 . . . . 0.0 110.118 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.587 ' NH1' ' CG ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -147.87 148.84 31.28 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 120.841 -1.162 . . . . 0.0 110.944 -179.503 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.634 ' NE1' ' O ' ' A' ' 92' ' ' GLY . 4.1 p90 -166.4 -172.26 2.16 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.663 0.744 . . . . 0.0 109.579 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' CB ' ' HB ' ' A' ' 61' ' ' THR . 5.3 tt0 -92.76 -84.1 0.29 Allowed 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.837 -178.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.691 ' H ' HG22 ' A' ' 60' ' ' ILE . . . -46.59 178.83 0.01 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.802 ' N ' ' CD ' ' A' ' 94' ' ' PRO . 1.6 tt0 -87.32 -25.5 0.33 Allowed Pre-proline 0 N--CA 1.502 2.168 0 O-C-N 121.222 -1.164 . . . . 0.0 114.078 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.802 ' CD ' ' N ' ' A' ' 93' ' ' GLU . 49.3 Cg_endo -94.51 -159.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.951 0 C-N-CA 124.333 3.355 . . . . 0.0 110.566 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.895 ' C ' HD11 ' A' ' 54' ' ' LEU . 3.1 t90 150.59 35.88 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 123.551 0.741 . . . . 0.0 110.815 176.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -135.13 -105.85 0.84 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -93.92 146.1 24.15 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.358 -1.084 . . . . 0.0 108.884 179.34 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -101.54 133.44 46.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 109.369 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.25 -11.09 72.15 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.463 ' CG ' ' HD2' ' A' ' 101' ' ' PRO . 8.4 tp60 -88.64 138.94 29.6 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.433 -1.039 . . . . 0.0 108.888 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 102' ' ' GLY . 6.3 Cg_exo -57.48 -78.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.98 1.787 . . . . 0.0 110.916 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.671 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . 51.87 174.49 0.03 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.6 OUTLIER -160.27 176.57 11.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.606 -1.526 . . . . 0.0 111.437 -178.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.562 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 3.9 m0 -95.8 144.85 25.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.783 -0.573 . . . . 0.0 109.869 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.523 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.6 ttm -110.37 -176.0 2.87 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.512 ' O ' HG23 ' A' ' 108' ' ' VAL . 29.1 t -131.57 32.79 4.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.846 -1.159 . . . . 0.0 110.342 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.503 ' C ' ' O ' ' A' ' 106' ' ' SER . 1.0 OUTLIER 33.04 59.4 0.44 Allowed 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.141 0.496 . . . . 0.0 109.988 179.419 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 106' ' ' SER . 70.9 t -108.87 -40.42 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.163 -0.961 . . . . 0.0 109.779 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -149.79 35.71 1.0 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 109' ' ' GLY . 1.0 OUTLIER -45.48 138.45 4.34 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.208 -1.172 . . . . 0.0 109.207 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -160.91 154.13 21.59 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.256 -0.902 . . . . 0.0 109.852 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.429 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -60.47 -14.64 20.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -0.892 . . . . 0.0 109.039 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.94 -41.85 97.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.898 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.539 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 1.5 t0 -77.82 -10.57 59.62 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.445 ' CG ' HD12 ' A' ' 123' ' ' ILE . 8.6 m-85 -103.79 106.53 53.02 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.506 ' HG2' ' O ' ' A' ' 33' ' ' LEU . 11.7 Cg_exo -48.37 158.47 1.01 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.804 1.67 . . . . 0.0 110.047 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.725 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 6.1 Cg_exo -56.71 -173.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.185 1.923 . . . . 0.0 110.86 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 117' ' ' PRO . . . 84.39 -21.08 0.27 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.81 -0.556 . . . . 0.0 110.118 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.884 ' OD1' HD21 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -124.27 39.89 3.86 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.932 -1.105 . . . . 0.0 109.869 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.694 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.9 mm-40 -71.76 -33.99 2.83 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 112.712 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 4.9 Cg_exo -61.79 -36.31 74.33 Favored 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 121.842 1.695 . . . . 0.0 112.088 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.984 ' HB ' HD23 ' A' ' 71' ' ' LEU . 1.2 t -100.92 -43.53 10.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 O-C-N 120.498 -1.376 . . . . 0.0 108.399 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.694 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 22.5 mm -54.6 -32.92 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 O-C-N 121.494 -0.754 . . . . 0.0 109.41 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.92 -39.55 26.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.544 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.45 -33.17 36.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.361 -0.837 . . . . 0.0 110.909 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.943 HD12 HD11 ' A' ' 129' ' ' LEU . 4.4 mm? -47.86 -31.4 5.02 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.907 -1.121 . . . . 0.0 109.801 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -60.78 -52.28 65.77 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.53 ' O ' ' C ' ' A' ' 129' ' ' LEU . 4.7 mtt180 -82.19 10.1 7.46 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.472 -0.767 . . . . 0.0 109.275 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.943 HD11 HD12 ' A' ' 126' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 117.937 -1.03 . . . . 0.0 111.023 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.53 ' CB ' ' NE2' ' A' ' 79' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 1' ' ' MET . 2.7 mptt 71.45 105.75 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.58 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.51 117.07 2.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.484 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 4' ' ' LEU . 12.3 tp -119.6 139.23 52.51 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.274 -0.892 . . . . 0.0 109.131 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.899 ' HG2' HG21 ' A' ' 40' ' ' ILE . 3.4 tt0 -143.68 158.95 43.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.208 -0.933 . . . . 0.0 109.433 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.606 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -123.04 167.43 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.097 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.734 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -129.93 93.23 3.46 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.07 -1.019 . . . . 0.0 109.609 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.694 HG13 ' HB3' ' A' ' 84' ' ' PHE . 7.5 p -102.32 155.65 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.209 -0.932 . . . . 0.0 109.861 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.464 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -140.4 125.49 2.91 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.097 HD12 HD22 ' A' ' 86' ' ' LEU . 1.0 OUTLIER -104.37 155.85 5.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.006 -1.291 . . . . 0.0 107.565 -179.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.136 HG22 ' CZ3' ' A' ' 90' ' ' TRP . 2.0 mt -147.03 138.39 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.518 -1.364 . . . . 0.0 111.504 -176.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 23.4 ttp180 -140.46 127.53 20.86 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.57 ' OD1' ' CZ2' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -108.09 -169.46 1.52 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.258 -0.901 . . . . 0.0 110.66 -178.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.68 -5.3 19.48 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.56 -0.712 . . . . 0.0 110.075 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -79.1 7.32 7.66 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.457 ' O ' ' CG ' ' A' ' 16' ' ' ASN . 5.4 t-20 53.75 44.56 29.44 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.776 0.798 . . . . 0.0 109.759 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 4.9 mt-10 -140.85 153.41 45.74 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.9 mt -119.56 163.71 16.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.99 -1.069 . . . . 0.0 109.453 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -116.78 98.59 6.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.835 -1.166 . . . . 0.0 109.192 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 21' ' ' THR . 0.8 OUTLIER -119.76 -159.72 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.618 ' H ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -121.08 132.86 55.13 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.023 -1.048 . . . . 0.0 109.521 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.46 ' HD2' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -145.21 132.16 20.24 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.304 -0.873 . . . . 0.0 109.682 -179.49 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -69.55 87.02 0.47 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.264 -0.898 . . . . 0.0 109.555 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.87 87.69 0.25 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.839 . . . . 0.0 109.512 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 26' ' ' ASP . . . -154.77 54.94 0.67 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.952 . . . . 0.0 109.447 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.558 ' OD2' ' CD2' ' A' ' 28' ' ' HIS . 10.3 t70 74.01 74.52 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.671 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.85 53.68 0.68 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.938 . . . . 0.0 109.365 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.558 ' CD2' ' OD2' ' A' ' 26' ' ' ASP . 31.7 p80 -93.81 -33.01 13.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.327 -0.858 . . . . 0.0 109.493 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.9 ppp? -69.56 -23.1 63.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.906 . . . . 0.0 109.584 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -165.85 121.24 1.26 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 109.7 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -83.3 144.43 29.71 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.271 -0.893 . . . . 0.0 108.941 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.505 ' HB2' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -159.0 134.96 8.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.018 -1.051 . . . . 0.0 110.059 -179.425 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.541 ' CD1' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -115.11 -170.11 1.69 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.274 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.4 ' O ' ' CG2' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -162.97 -164.48 0.98 Allowed 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.868 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.515 ' CE2' ' CD2' ' A' ' 84' ' ' PHE . 48.7 m-85 -132.37 106.37 13.32 Favored Pre-proline 0 C--N 1.291 -1.949 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.495 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 2.8 Cg_exo -54.94 -149.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.986 1.79 . . . . 0.0 110.659 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 151.67 154.53 6.62 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -130.15 28.27 3.89 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 4.3 mptp? 74.35 160.18 0.23 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.615 -0.933 . . . . 0.0 109.238 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.899 HG21 ' HG2' ' A' ' 5' ' ' GLN . 2.4 tt -155.34 58.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.322 -0.861 . . . . 0.0 109.222 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 42' ' ' MET . 3.9 mm-40 -84.32 -127.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.298 -0.877 . . . . 0.0 109.314 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.425 ' C ' ' O ' ' A' ' 41' ' ' GLU . 4.6 mtp -44.66 163.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.858 -1.151 . . . . 0.0 109.629 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.6 -131.08 3.43 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.531 ' CB ' ' OE1' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -132.3 -64.44 0.77 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.144 -1.209 . . . . 0.0 109.553 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.828 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -146.19 -178.09 0.74 Allowed Pre-proline 0 C--N 1.305 -1.369 0 O-C-N 121.369 -0.832 . . . . 0.0 108.821 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.828 ' CD ' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -68.09 -10.76 29.89 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.945 1.763 . . . . 0.0 110.338 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -100.76 -56.15 2.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.335 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.564 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.9 tt0 -58.5 -40.18 82.11 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.608 1.194 . . . . 0.0 108.741 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.59 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -43.38 -60.02 1.88 Allowed 'General case' 0 C--N 1.273 -2.719 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.446 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.574 HG13 ' CH2' ' A' ' 85' ' ' TRP . 9.8 p -81.45 -11.52 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.473 -0.767 . . . . 0.0 110.88 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.608 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -66.04 -50.44 69.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.608 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -59.55 -35.73 74.8 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.279 177.171 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.45 ' HA ' ' HB2' ' A' ' 56' ' ' GLU . 25.7 mt-10 -73.02 -21.23 60.86 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.767 HD23 ' HE1' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -60.84 -55.89 27.65 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.612 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.523 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 10.6 mt-30 -80.79 -22.57 39.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 109.742 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 53' ' ' GLU . 2.5 mt-10 -80.67 17.31 1.16 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.096 -1.003 . . . . 0.0 110.455 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.627 ' HB3' ' CD1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -137.75 -61.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.873 -1.142 . . . . 0.0 109.892 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.737 HG22 ' CD1' ' A' ' 95' ' ' TRP . 4.3 m -128.59 -34.03 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 109.704 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 90.94 36.2 6.83 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.746 ' CD1' HD13 ' A' ' 11' ' ' ILE . 17.1 pt -92.53 -166.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.053 -1.263 . . . . 0.0 109.521 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.759 ' N ' ' CD ' ' A' ' 62' ' ' PRO . 0.6 OUTLIER 93.05 13.77 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.292 -179.274 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.759 ' CD ' ' N ' ' A' ' 61' ' ' THR . 3.5 Cg_endo -63.75 -22.84 69.52 Favored 'Trans proline' 0 C--N 1.326 -0.615 0 CA-C-N 119.909 1.003 . . . . 0.0 110.401 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.617 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 7.1 mm100 -86.78 -68.7 0.73 Allowed 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.617 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 3.8 t-160 167.52 158.27 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.21 0.529 . . . . 0.0 110.545 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.689 ' HB2' HG12 ' A' ' 87' ' ' VAL . 29.4 p90 -141.99 171.22 14.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.318 -0.864 . . . . 0.0 109.118 177.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' O ' ' A' ' 86' ' ' LEU . 73.2 m -163.77 128.76 2.91 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.036 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.946 HD13 ' CZ3' ' A' ' 83' ' ' TRP . 0.6 OUTLIER -80.21 124.95 29.25 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.604 -1.31 . . . . 0.0 108.898 179.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.653 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 27.9 p90 -73.2 -52.18 15.05 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.55 -0.719 . . . . 0.0 109.701 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.653 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 2.4 tt0 176.74 138.74 0.06 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.656 -0.652 . . . . 0.0 109.808 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.41 165.6 11.15 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.07 -1.019 . . . . 0.0 109.029 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.031 HD21 ' OD1' ' A' ' 119' ' ' ASN . 0.4 OUTLIER -129.44 -170.1 2.23 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.352 -0.842 . . . . 0.0 109.456 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.738 ' HG3' HG23 ' A' ' 81' ' ' THR . 19.1 tt0 -145.6 146.6 31.42 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.423 -0.798 . . . . 0.0 109.194 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.499 ' N ' ' HG2' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -144.84 79.92 1.61 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.422 -0.799 . . . . 0.0 109.36 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.4 OUTLIER -81.69 114.58 20.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 109.34 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.547 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -79.45 176.69 3.49 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 1.7 Cg_endo -63.3 -8.77 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 121.67 1.58 . . . . 0.0 109.734 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -102.69 -66.87 0.9 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.402 -0.811 . . . . 0.0 110.881 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.418 ' HA ' ' HB3' ' A' ' 1' ' ' MET . 0.1 OUTLIER -129.04 -171.62 2.53 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.192 -0.942 . . . . 0.0 110.686 -177.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.557 ' N ' ' CD2' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -105.49 88.18 2.78 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.3 mm -81.71 118.2 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 109.474 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.738 HG23 ' HG3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -119.05 146.56 44.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.606 HD22 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -131.14 123.94 29.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 108.893 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.946 ' CZ3' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -119.0 124.29 46.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.363 -0.835 . . . . 0.0 110.082 -177.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.694 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -129.07 103.17 6.84 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 120.489 -1.382 . . . . 0.0 109.975 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.78 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -82.42 98.9 9.12 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.706 0.765 . . . . 0.0 109.156 179.331 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.097 HD22 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -63.14 118.52 8.03 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.735 -1.228 . . . . 0.0 109.712 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.067 ' CG2' HG23 ' A' ' 11' ' ' ILE . 19.3 m -81.24 -167.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 120.95 -1.094 . . . . 0.0 109.686 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 8.9 mt-10 -125.14 -45.76 1.84 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.165 -0.959 . . . . 0.0 110.49 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.541 ' HB3' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -160.94 171.2 19.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.183 -0.948 . . . . 0.0 109.963 -179.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 1.136 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 38.8 p90 -170.14 -175.02 1.88 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 122.2 1.0 . . . . 0.0 111.052 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.617 ' N ' ' HG2' ' A' ' 62' ' ' PRO . 2.6 tt0 -120.69 -34.5 3.57 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.381 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.678 ' CA ' HG22 ' A' ' 60' ' ' ILE . . . -80.18 -155.93 11.78 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 121.092 -1.005 . . . . 0.0 110.911 -178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.696 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -105.31 127.97 27.54 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.437 -1.037 . . . . 0.0 109.456 -179.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.967 ' HB3' HD12 ' A' ' 11' ' ' ILE . 2.8 Cg_endo -58.74 133.83 56.58 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.432 2.088 . . . . 0.0 111.705 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.767 ' HE1' HD23 ' A' ' 54' ' ' LEU . 4.8 p-90 -110.56 -171.74 1.89 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.923 -1.111 . . . . 0.0 108.49 178.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . 146.18 -42.91 0.92 Allowed Glycine 0 C--N 1.296 -1.679 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 100' ' ' GLN . 1.1 ptmm? -66.08 126.48 28.76 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.651 -0.911 . . . . 0.0 109.781 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -93.57 -49.56 5.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.198 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.91 5.58 5.42 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.528 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 1.3 mt-30 -109.09 160.57 27.0 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.27 -1.135 . . . . 0.0 109.43 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 102' ' ' GLY . 1.9 Cg_endo -66.21 -30.43 46.05 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.156 1.904 . . . . 0.0 111.427 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . 56.66 162.55 0.03 OUTLIER Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -161.58 -168.7 2.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.66 -1.494 . . . . 0.0 110.503 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.505 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 31.9 m95 -107.47 132.34 53.32 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.556 -0.715 . . . . 0.0 109.219 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.493 ' HE1' HD22 ' A' ' 33' ' ' LEU . 30.2 ttp -108.29 147.63 31.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.268 -0.895 . . . . 0.0 109.217 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.528 ' OG ' HG23 ' A' ' 108' ' ' VAL . 45.6 t -83.66 138.71 33.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.891 -1.131 . . . . 0.0 109.126 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.446 HD12 HD11 ' A' ' 18' ' ' ILE . 3.1 tt -108.29 59.73 0.61 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.211 -0.931 . . . . 0.0 109.411 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.528 HG23 ' OG ' ' A' ' 106' ' ' SER . 2.1 t -93.44 19.31 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 145.03 49.85 0.03 OUTLIER Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.848 HD23 ' OD2' ' A' ' 114' ' ' ASP . 1.1 mt -41.59 142.59 0.6 Allowed 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.694 -0.886 . . . . 0.0 109.317 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 2.4 t-20 -133.71 155.9 48.92 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 109.51 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.563 ' HB2' ' HE2' ' A' ' 127' ' ' LYS . . . -63.64 -19.02 64.53 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.271 -0.893 . . . . 0.0 108.747 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 113' ' ' ASP . 26.3 t0 -93.0 22.5 4.9 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.429 -0.795 . . . . 0.0 109.487 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.848 ' OD2' HD23 ' A' ' 110' ' ' LEU . 0.5 OUTLIER -78.16 -1.61 33.5 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.551 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -160.5 160.32 25.89 Favored Pre-proline 0 C--N 1.3 -1.553 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.291 177.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 32' ' ' LYS . 74.7 Cg_exo -36.69 124.6 0.39 Allowed 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.828 2.352 . . . . 0.0 110.403 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.716 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 4.6 Cg_exo -58.55 144.2 97.42 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 122.561 2.174 . . . . 0.0 111.382 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 156.67 -19.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 1.031 ' OD1' HD21 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -119.88 42.15 2.99 Favored 'General case' 0 C--O 1.205 -1.286 0 O-C-N 121.316 -0.865 . . . . 0.0 109.368 -179.364 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.639 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 6.0 mt-10 -60.16 -39.12 66.05 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 120.949 -1.094 . . . . 0.0 113.243 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 5.2 Cg_exo -62.29 -46.8 11.38 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.229 1.953 . . . . 0.0 113.011 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.859 ' HB ' HD23 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -90.22 -30.09 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.417 -1.427 . . . . 0.0 108.95 -178.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.644 HD12 ' CE1' ' A' ' 115' ' ' PHE . 1.6 mm -64.06 -34.38 68.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.502 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -60.95 -20.38 62.19 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.419 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.73 -61.75 1.88 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.399 -0.813 . . . . 0.0 110.985 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 1.009 ' HB2' HD13 ' A' ' 129' ' ' LEU . 0.6 OUTLIER -78.82 22.69 0.36 Allowed 'General case' 0 C--N 1.31 -1.137 0 O-C-N 120.803 -1.186 . . . . 0.0 111.403 -178.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.563 ' HE2' ' HB2' ' A' ' 112' ' ' ALA . 5.3 mtmt -65.91 -35.57 81.0 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.652 -1.28 . . . . 0.0 107.932 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.534 ' O ' ' C ' ' A' ' 129' ' ' LEU . 9.0 mtm180 -78.77 -0.03 28.76 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.897 -0.502 . . . . 0.0 110.03 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 1.009 HD13 ' HB2' ' A' ' 126' ' ' LEU . 4.3 tp . . . . . 0 N--CA 1.5 2.032 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.882 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.483 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -116.51 -141.99 0.37 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 109.432 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -158.51 119.49 3.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.052 -1.03 . . . . 0.0 109.699 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 79' ' ' HIS . 0.7 OUTLIER -119.67 138.29 53.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 109.169 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.678 ' O ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -133.09 147.41 52.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.735 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 7' ' ' ALA . 4.4 mt -121.98 168.61 14.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.325 -0.86 . . . . 0.0 108.895 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.559 ' N ' ' CG2' ' A' ' 6' ' ' ILE . . . -135.74 98.31 3.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.123 -0.986 . . . . 0.0 109.618 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.599 HG22 ' N ' ' A' ' 9' ' ' GLY . 7.3 p -106.92 161.89 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.811 . . . . 0.0 109.366 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.599 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -141.33 121.21 1.83 Allowed Glycine 0 C--N 1.297 -1.621 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.582 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -94.33 156.6 3.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.034 HG22 ' CZ3' ' A' ' 90' ' ' TRP . 2.2 mt -143.15 124.1 10.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 118.486 -1.286 . . . . 0.0 111.308 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.548 ' HD3' ' CG1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -122.21 136.31 54.89 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.268 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.401 ' N ' ' HG3' ' A' ' 12' ' ' ARG . 25.0 p30 -109.12 -169.37 1.47 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 0.0 110.179 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -81.12 0.21 37.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.682 -0.636 . . . . 0.0 109.327 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.446 ' OD1' ' OE2' ' A' ' 17' ' ' GLU . 6.5 t-20 -89.34 12.82 15.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.282 -0.886 . . . . 0.0 109.063 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.582 ' ND2' HG23 ' A' ' 108' ' ' VAL . 18.4 t30 57.41 44.07 22.1 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.768 0.795 . . . . 0.0 109.224 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 16' ' ' ASN . 3.4 mt-10 -143.25 149.21 37.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.091 -1.006 . . . . 0.0 109.038 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.548 ' CG1' ' HD3' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -128.19 151.24 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.094 -1.004 . . . . 0.0 109.864 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.582 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 21.8 t80 -85.97 66.83 9.78 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.839 HG23 ' N ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -83.91 -155.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.102 -0.999 . . . . 0.0 110.303 -178.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.839 ' N ' HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -132.11 142.16 49.4 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.557 ' HG2' ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.04 -161.33 0.89 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.039 -1.038 . . . . 0.0 110.675 -178.011 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.97 94.27 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.541 -0.724 . . . . 0.0 110.18 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.713 ' O ' ' HB3' ' A' ' 25' ' ' ALA . . . -110.74 94.4 4.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.277 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . 79.3 153.64 0.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.417 -0.802 . . . . 0.0 109.549 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 27' ' ' ALA . 24.1 m-20 49.87 -106.29 0.21 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.335 -0.853 . . . . 0.0 109.351 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 26' ' ' ASP . . . 42.41 86.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.984 -1.073 . . . . 0.0 109.591 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -84.53 -84.88 0.14 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 109.793 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -107.48 178.25 4.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 109.566 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 31' ' ' ASN . . . 48.48 92.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.917 . . . . 0.0 109.603 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 30' ' ' ALA . 82.3 m-20 -43.71 113.74 0.55 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.309 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.79 140.78 34.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.843 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.557 ' CD2' ' HG2' ' A' ' 22' ' ' ARG . 5.3 mt -103.7 -172.72 2.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.452 -0.78 . . . . 0.0 109.026 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -160.68 -154.68 0.38 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.626 ' CE2' ' CZ ' ' A' ' 84' ' ' PHE . 3.6 m-85 -150.65 137.49 11.43 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 2.6 Cg_endo -61.19 -160.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.87 1.713 . . . . 0.0 109.582 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . 152.87 158.42 8.51 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.096 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.78 20.85 2.88 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.18 158.51 0.16 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.509 -0.995 . . . . 0.0 109.516 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.678 HG22 ' O ' ' A' ' 5' ' ' GLN . 11.2 tt -138.43 101.61 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.349 -0.844 . . . . 0.0 109.222 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -111.77 -7.45 14.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.81 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.56 -76.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.167 -0.958 . . . . 0.0 109.307 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.78 4.82 18.86 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.09 -79.4 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.046 -1.267 . . . . 0.0 109.585 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.508 ' OG1' ' HD2' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -160.8 169.07 10.61 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.846 -1.159 . . . . 0.0 109.762 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HD2' ' OG1' ' A' ' 45' ' ' THR . 8.5 Cg_endo -74.59 19.21 0.47 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 123.255 2.637 . . . . 0.0 112.004 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.496 ' HB2' ' CG2' ' A' ' 45' ' ' THR . 2.0 mt-10 -111.5 -46.07 3.31 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.857 -1.152 . . . . 0.0 108.789 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.537 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -73.28 -55.06 6.92 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.245 1.021 . . . . 0.0 109.1 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . -38.3 -59.94 0.83 Allowed 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.089 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 51' ' ' VAL . 7.1 p -66.26 -33.11 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.214 -0.929 . . . . 0.0 108.936 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.629 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -45.5 -58.2 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.428 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.629 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -66.37 -28.93 69.03 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.308 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.532 ' HA ' ' CG ' ' A' ' 56' ' ' GLU . 4.2 mm-40 -72.64 -6.79 46.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.016 -1.053 . . . . 0.0 109.058 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.781 HD11 HE22 ' A' ' 63' ' ' GLN . 0.1 OUTLIER -80.5 -60.64 2.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.555 -0.716 . . . . 0.0 109.659 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.498 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 5.7 mt-30 -80.57 -23.44 39.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.294 -0.879 . . . . 0.0 110.708 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.532 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 1.4 pp20? -80.86 20.15 0.79 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.024 -1.048 . . . . 0.0 110.615 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 95' ' ' TRP . 3.0 mt-10 -142.18 -63.18 0.44 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.742 -1.224 . . . . 0.0 110.061 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.021 HG13 ' HB3' ' A' ' 95' ' ' TRP . 2.0 m -123.52 -31.78 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.985 -1.072 . . . . 0.0 109.154 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 55' ' ' GLN . . . 67.88 66.2 2.42 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.6 ' CG2' ' HB2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -83.19 155.67 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.55 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.701 HG23 ' HD3' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -107.46 -60.99 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.263 0 O-C-N 120.527 -1.358 . . . . 0.0 111.834 -177.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.701 ' HD3' HG23 ' A' ' 61' ' ' THR . 7.0 Cg_endo -73.7 52.7 2.57 Favored 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 122.031 1.821 . . . . 0.0 110.875 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.781 HE22 HD11 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -105.82 69.28 0.81 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.867 -1.146 . . . . 0.0 110.054 -178.535 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -63.68 115.08 4.41 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.671 ' HB3' HG12 ' A' ' 87' ' ' VAL . 39.3 p90 -131.14 176.0 8.63 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 122.941 1.353 . . . . 0.0 112.209 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 68' ' ' PHE . 19.1 m -163.04 130.16 3.53 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 85' ' ' TRP . 26.6 tp -50.31 96.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.486 -1.384 . . . . 0.0 109.162 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.683 ' HE2' HG13 ' A' ' 122' ' ' VAL . 0.1 OUTLIER -43.06 -74.33 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.618 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 3.3 tt0 -162.61 161.83 26.86 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.352 0.596 . . . . 0.0 109.704 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HG2' ' N ' ' A' ' 71' ' ' LEU . 22.3 ttmt -116.16 154.3 30.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 0.0 109.174 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.021 HD21 ' CE1' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -126.67 -174.89 3.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.078 -1.014 . . . . 0.0 109.642 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -157.29 151.22 24.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.389 -0.819 . . . . 0.0 109.2 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.496 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . 6.8 t80 -154.39 165.13 37.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.058 -1.026 . . . . 0.0 110.082 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -148.14 122.24 9.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.414 -0.803 . . . . 0.0 109.365 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -82.32 172.27 9.96 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.55 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 6.0 Cg_exo -58.38 -15.77 25.87 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.934 1.756 . . . . 0.0 110.01 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -156.81 7.28 0.18 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.513 -0.742 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.539 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 1.8 mmm180 -129.18 -169.59 2.12 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 120.659 -1.276 . . . . 0.0 109.613 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.49 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 35.5 m80 -144.48 129.74 18.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.333 -0.854 . . . . 0.0 108.969 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.728 HG22 HD13 ' A' ' 82' ' ' LEU . 2.7 mm -116.26 83.98 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.93 . . . . 0.0 110.03 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.26 86.62 6.2 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.728 HD13 HG22 ' A' ' 80' ' ' ILE . 1.4 mp -102.31 167.52 9.92 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.181 -0.949 . . . . 0.0 110.364 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.541 ' CD1' ' O ' ' A' ' 6' ' ' ILE . 1.7 m95 -122.65 164.26 18.56 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 1.021 ' CE1' HD21 ' A' ' 71' ' ' LEU . 1.8 m-85 -136.51 88.94 2.42 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.07 -1.019 . . . . 0.0 109.557 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.645 ' CZ2' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.04 151.53 21.61 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.388 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.582 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 14.7 tp -142.55 127.67 18.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.787 -1.195 . . . . 0.0 109.615 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.979 ' CG2' HG23 ' A' ' 11' ' ' ILE . 9.1 m -99.07 -161.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.314 -0.866 . . . . 0.0 109.997 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -141.99 -23.42 0.7 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.287 -0.883 . . . . 0.0 111.484 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.669 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -159.96 -167.43 1.96 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.343 -1.473 . . . . 0.0 110.672 -179.186 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 1.034 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 28.6 p90 158.68 171.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.517 1.151 . . . . 0.0 110.294 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.607 ' HB2' ' CG ' ' A' ' 62' ' ' PRO . 8.9 tt0 -111.93 -63.19 1.45 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.743 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.587 ' N ' HG22 ' A' ' 60' ' ' ILE . . . -56.74 -156.39 0.01 OUTLIER Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.747 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.2 pm0 -105.8 128.09 27.14 Favored Pre-proline 0 C--N 1.307 -1.244 0 O-C-N 121.38 -1.07 . . . . 0.0 109.348 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.97 ' HB3' HD12 ' A' ' 11' ' ' ILE . 13.5 Cg_exo -46.77 144.91 7.32 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.465 2.11 . . . . 0.0 112.05 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 1.021 ' HB3' HG13 ' A' ' 58' ' ' VAL . 11.1 p-90 -107.51 -167.72 1.3 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.61 -96.18 0.14 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.525 ' HB2' ' N ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -118.0 138.74 51.99 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.506 -0.996 . . . . 0.0 109.25 179.515 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.444 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 12.0 tm-20 -92.66 68.88 4.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 109.202 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.45 ' O ' ' HD3' ' A' ' 101' ' ' PRO . . . 175.13 -31.89 0.09 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.424 ' HB3' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -92.74 111.19 49.94 Favored Pre-proline 0 C--N 1.297 -1.689 0 O-C-N 121.65 -0.912 . . . . 0.0 108.745 179.363 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 99' ' ' GLY . 1.1 Cg_endo -63.25 82.14 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.059 1.839 . . . . 0.0 110.935 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -86.12 170.61 43.41 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -161.33 172.88 15.81 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.586 -1.538 . . . . 0.0 111.504 -179.282 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.493 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 4.6 m0 -84.91 106.86 16.74 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.44 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 3.7 ttp -107.8 136.56 47.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.335 -0.853 . . . . 0.0 109.067 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.86 85.81 4.9 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.227 -0.921 . . . . 0.0 109.359 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.891 HD13 ' HA ' ' A' ' 110' ' ' LEU . 1.4 mt -76.96 -52.58 9.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.916 . . . . 0.0 109.59 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.783 HG12 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER 72.52 27.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 122.155 0.979 . . . . 0.0 108.579 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . 163.63 50.6 0.02 OUTLIER Glycine 0 N--CA 1.485 1.944 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.891 ' HA ' HD13 ' A' ' 107' ' ' LEU . 0.7 OUTLIER -38.12 144.28 0.1 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.769 -0.842 . . . . 0.0 109.98 -178.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -156.43 151.87 26.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.122 -0.986 . . . . 0.0 109.801 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.887 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -68.36 -7.5 31.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.264 -0.898 . . . . 0.0 109.403 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -61.02 -42.73 99.01 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.256 -0.902 . . . . 0.0 109.93 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.506 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -79.12 -9.2 59.49 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.096 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.534 ' CE2' ' CE2' ' A' ' 35' ' ' PHE . 9.6 m-85 -98.43 137.43 20.71 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.005 -1.059 . . . . 0.0 109.456 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 115' ' ' PHE . 1.9 Cg_endo -68.8 164.19 34.35 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.256 1.97 . . . . 0.0 110.281 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.721 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.5 Cg_endo -63.29 119.07 5.99 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.404 2.07 . . . . 0.0 110.434 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 161.74 -51.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 109.831 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.562 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 28.2 m-20 -106.19 38.38 2.05 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.234 -0.916 . . . . 0.0 109.347 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.68 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 20.2 mt-10 -65.89 -36.71 14.59 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.346 -0.846 . . . . 0.0 112.704 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.8 Cg_exo -63.34 -36.2 57.42 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.099 1.866 . . . . 0.0 112.425 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.948 ' HB ' HD23 ' A' ' 71' ' ' LEU . 1.2 t -98.51 -39.3 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 120.449 -1.407 . . . . 0.0 108.003 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.961 ' HA ' HD21 ' A' ' 126' ' ' LEU . 25.2 mm -58.66 -30.57 42.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.553 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -70.3 -26.37 63.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.468 -0.77 . . . . 0.0 110.688 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.417 ' HG2' ' OE1' ' A' ' 69' ' ' GLU . 16.9 tptt -76.19 -57.21 4.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.882 -1.136 . . . . 0.0 110.522 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.961 HD21 ' HA ' ' A' ' 123' ' ' ILE . 2.4 pt? -74.84 11.78 0.99 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.054 -1.029 . . . . 0.0 111.219 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.553 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 37.4 mttt -49.51 -43.05 45.22 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.353 -1.467 . . . . 0.0 107.695 178.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.477 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -109.84 46.15 1.04 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.797 -0.565 . . . . 0.0 110.842 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.565 ' CD2' ' HB2' ' A' ' 126' ' ' LEU . 1.3 mp . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.336 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.57 144.2 48.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.62 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.613 ' O ' HD23 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -57.1 148.46 21.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.351 -0.843 . . . . 0.0 109.321 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.646 HD12 ' O ' ' A' ' 79' ' ' HIS . 23.5 mt -134.32 73.67 1.5 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 109.801 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.478 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . 1.1 mp0 -87.46 116.47 25.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.228 -0.92 . . . . 0.0 108.869 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 38' ' ' GLY . 1.4 mp -112.47 141.18 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.094 -1.004 . . . . 0.0 109.791 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.408 ' O ' ' CA ' ' A' ' 37' ' ' GLY . . . -103.8 110.72 22.94 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.765 HG23 ' C ' ' A' ' 36' ' ' PRO . 3.0 p -127.78 100.09 5.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.131 -0.981 . . . . 0.0 110.352 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.566 ' HA2' ' CD1' ' A' ' 85' ' ' TRP . . . -84.58 118.5 4.74 Favored Glycine 0 C--N 1.296 -1.683 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.568 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 1.8 mt -81.49 173.49 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 120.867 -1.373 . . . . 0.0 107.541 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.926 HD12 ' CB ' ' A' ' 94' ' ' PRO . 0.4 OUTLIER -144.56 153.54 14.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 118.039 -1.464 . . . . 0.0 110.435 -178.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 17' ' ' GLU . 37.7 ttp180 -159.3 131.52 6.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.517 -0.739 . . . . 0.0 109.24 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.31 -162.69 0.97 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.14 -0.975 . . . . 0.0 110.577 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.36 -7.32 58.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.626 -0.671 . . . . 0.0 109.713 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.536 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 5.2 t30 -84.53 12.61 6.68 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.124 -0.985 . . . . 0.0 108.667 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 107' ' ' LEU . 11.6 t-20 60.03 43.38 14.57 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.64 -0.662 . . . . 0.0 110.522 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.536 ' CG ' ' HB3' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -127.37 154.27 45.19 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.568 HD11 HD11 ' A' ' 107' ' ' LEU . 1.6 mt -119.78 156.34 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.859 -1.15 . . . . 0.0 110.203 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 26.0 t80 -103.15 86.11 2.63 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.049 HD12 ' O ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -78.73 176.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.187 0.994 . . . . 0.0 110.101 -178.319 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.627 ' N ' ' CG2' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -153.46 144.24 22.7 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.604 ' CG ' ' HA ' ' A' ' 33' ' ' LEU . 6.4 tpm_? -154.6 106.23 2.7 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 110.062 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.467 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -60.64 100.81 0.11 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.196 -0.94 . . . . 0.0 109.231 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -37.52 109.13 0.09 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.639 -0.663 . . . . 0.0 109.89 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.45 ' O ' ' CB ' ' A' ' 26' ' ' ASP . . . -125.9 36.41 4.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.21 -0.931 . . . . 0.0 109.65 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 1.2 m-20 71.2 4.95 5.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 109.791 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 45.13 -159.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.942 . . . . 0.0 109.623 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.493 ' O ' ' CB ' ' A' ' 29' ' ' MET . 1.4 t60 -176.16 49.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.525 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.493 ' CB ' ' O ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER 163.57 -87.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.4 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.64 -88.75 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 109.228 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -104.8 114.0 27.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.258 -0.901 . . . . 0.0 108.918 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.491 ' O ' ' HG2' ' A' ' 22' ' ' ARG . 5.9 mmtp -114.55 129.08 56.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.195 -0.941 . . . . 0.0 109.991 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.659 HD21 ' CB ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -146.21 -175.71 4.87 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.797 0.808 . . . . 0.0 109.544 179.6 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.049 ' O ' HD12 ' A' ' 20' ' ' ILE . 2.3 tt0 -163.06 -154.21 0.28 Allowed 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.757 ' HB3' HG21 ' A' ' 8' ' ' VAL . 85.4 m-85 -114.02 158.97 37.92 Favored Pre-proline 0 C--N 1.285 -2.206 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.765 ' C ' HG23 ' A' ' 8' ' ' VAL . 3.3 Cg_exo -58.21 -154.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 121.854 1.703 . . . . 0.0 110.167 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.408 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 82.48 -170.65 50.7 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.453 ' O ' HG13 ' A' ' 6' ' ' ILE . . . 177.66 -37.61 0.09 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -168.79 143.61 3.25 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.562 -0.964 . . . . 0.0 109.076 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.666 ' O ' HG23 ' A' ' 40' ' ' ILE . 15.5 tt -100.35 115.32 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.103 -0.998 . . . . 0.0 109.705 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 42' ' ' MET . 4.7 mt-10 -101.85 -175.93 2.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.337 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.47 ' O ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 49.16 -178.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.913 . . . . 0.0 109.331 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.98 148.21 10.91 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.444 ' N ' ' OE1' ' A' ' 44' ' ' GLU . 39.6 mp0 -91.47 121.75 33.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.177 -1.19 . . . . 0.0 109.75 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.782 HG22 ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -159.96 178.61 1.61 Allowed Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.428 -0.795 . . . . 0.0 109.642 179.738 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.782 ' CD ' HG22 ' A' ' 45' ' ' THR . 6.1 Cg_endo -73.62 -20.1 20.73 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.596 2.198 . . . . 0.0 110.903 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.503 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -124.12 -59.04 1.52 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.075 -1.016 . . . . 0.0 110.085 -179.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.628 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -44.14 -32.99 1.36 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.285 1.04 . . . . 0.0 110.596 -179.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.445 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -81.76 -57.17 3.55 Favored 'General case' 0 C--N 1.272 -2.8 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.988 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.421 HG22 ' CH2' ' A' ' 95' ' ' TRP . 1.3 p -81.9 4.98 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.395 -0.816 . . . . 0.0 110.513 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 48' ' ' GLN . 13.2 p -82.75 -37.65 14.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.523 ' N ' HG13 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -74.65 -31.1 61.85 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.879 -1.509 . . . . 0.0 108.659 178.575 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -72.0 -7.12 46.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.122 -0.986 . . . . 0.0 109.075 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.781 HD22 ' CZ2' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -76.55 -68.11 0.63 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.651 -0.656 . . . . 0.0 109.428 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -82.33 -17.52 45.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.493 -0.754 . . . . 0.0 111.335 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.513 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 2.3 mm-40 -80.28 18.22 0.92 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.791 -1.193 . . . . 0.0 110.461 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 95' ' ' TRP . 7.1 mm-40 -146.76 -65.38 0.28 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.734 -1.229 . . . . 0.0 110.565 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.856 HG21 ' O ' ' A' ' 93' ' ' GLU . 3.7 m -124.8 -32.56 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.156 -0.965 . . . . 0.0 108.979 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.407 ' N ' HG23 ' A' ' 58' ' ' VAL . . . 72.16 67.64 1.79 Allowed Glycine 0 N--CA 1.483 1.815 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.616 HG21 ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -95.52 171.11 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.351 -1.087 . . . . 0.0 108.17 178.439 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.552 ' HB ' ' CB ' ' A' ' 91' ' ' GLU . 2.7 m -112.99 89.36 13.57 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 1.4 Cg_endo -59.3 131.12 39.17 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.093 1.862 . . . . 0.0 110.177 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.507 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -92.71 -55.48 3.36 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.553 -0.717 . . . . 0.0 110.164 -178.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 12.0 t-160 -142.27 112.47 7.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.91 -1.119 . . . . 0.0 110.2 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.832 ' CB ' HG12 ' A' ' 87' ' ' VAL . 5.5 p90 -135.25 175.26 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.141 -0.974 . . . . 0.0 110.368 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.3 m -162.39 -179.71 7.19 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.976 HD21 ' HD3' ' A' ' 70' ' ' LYS . 34.8 tp -105.95 107.63 18.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.953 -1.092 . . . . 0.0 109.014 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.764 ' CE2' HG13 ' A' ' 122' ' ' VAL . 3.3 t80 -47.33 -83.53 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.625 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -147.12 175.56 10.63 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.492 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.976 ' HD3' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.33 129.02 38.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 0.0 109.61 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.507 ' HG ' HG21 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -120.94 -176.89 3.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 109.505 179.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.18 158.87 33.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.363 -0.836 . . . . 0.0 109.388 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.0 147.15 31.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 0.0 109.737 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.73 116.74 10.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.077 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 1.1 m-85 -83.99 172.99 7.98 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.348 -0.845 . . . . 0.0 109.379 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 4.0 Cg_exo -59.17 -12.95 17.54 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.152 1.901 . . . . 0.0 110.791 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -165.16 16.18 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 110.585 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.526 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -131.17 -172.89 2.95 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 120.632 -1.293 . . . . 0.0 109.445 -179.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.646 ' O ' HD12 ' A' ' 4' ' ' LEU . 21.9 m80 -146.32 136.64 23.81 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.352 -0.843 . . . . 0.0 109.018 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 80' ' ' ILE . 22.4 mm -140.04 80.31 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.093 -1.004 . . . . 0.0 110.169 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.61 130.57 34.99 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.586 HD11 HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -136.86 113.58 10.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.955 -1.091 . . . . 0.0 110.366 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -79.86 156.04 27.54 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.98 ' CD2' HG11 ' A' ' 122' ' ' VAL . 2.0 m-85 -135.87 71.12 1.42 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.94 -1.1 . . . . 0.0 109.838 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.836 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -84.05 145.17 28.62 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.707 ' CD2' HD22 ' A' ' 129' ' ' LEU . 20.9 tp -134.8 127.25 30.49 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.951 -1.093 . . . . 0.0 110.139 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.832 HG12 ' CB ' ' A' ' 65' ' ' PHE . 34.5 m -98.1 -174.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.73 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' ARG . 2.9 mt-10 -126.43 -29.88 2.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.845 . . . . 0.0 109.428 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.507 ' HG3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.72 169.3 20.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.195 -0.941 . . . . 0.0 109.326 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.767 ' CZ3' HG22 ' A' ' 11' ' ' ILE . 46.1 p90 -164.95 -169.83 1.79 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.102 -0.999 . . . . 0.0 110.015 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.552 ' CB ' ' HB ' ' A' ' 61' ' ' THR . 30.6 tt0 -131.34 99.13 4.74 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.972 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.557 ' CA ' HG22 ' A' ' 60' ' ' ILE . . . 128.88 -152.13 19.27 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.627 -1.273 . . . . 0.0 109.946 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.856 ' O ' HG21 ' A' ' 58' ' ' VAL . 14.5 tp10 -99.96 127.06 34.61 Favored Pre-proline 0 N--CA 1.486 1.339 0 O-C-N 121.324 -1.103 . . . . 0.0 109.187 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.926 ' CB ' HD12 ' A' ' 11' ' ' ILE . 4.0 Cg_exo -52.36 144.96 37.93 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.665 2.244 . . . . 0.0 111.706 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.813 ' HB3' HG13 ' A' ' 58' ' ' VAL . 23.4 p-90 -113.15 -175.55 2.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.523 -0.736 . . . . 0.0 109.09 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.56 ' HA3' ' HB3' ' A' ' 36' ' ' PRO . . . 158.06 -62.36 0.32 Allowed Glycine 0 N--CA 1.484 1.843 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.296 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -105.31 171.47 7.31 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.355 -1.085 . . . . 0.0 109.631 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.467 ' HA ' ' OE2' ' A' ' 57' ' ' GLU . 2.9 tp10 -39.23 -37.41 0.41 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.65 -0.656 . . . . 0.0 109.438 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.511 ' C ' ' HD3' ' A' ' 101' ' ' PRO . . . -126.18 -160.42 10.6 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.643 ' N ' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -117.85 40.15 0.32 Allowed Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.137 -1.213 . . . . 0.0 111.541 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.643 ' HD3' ' N ' ' A' ' 100' ' ' GLN . 6.9 Cg_endo -68.13 -6.81 18.16 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 C-N-CA 121.327 1.351 . . . . 0.0 110.106 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -41.83 163.53 0.02 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.458 ' CD ' HG22 ' A' ' 20' ' ' ILE . 6.1 pm0 -119.17 131.08 55.81 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.405 -1.056 . . . . 0.0 109.175 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.46 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 10.8 m0 -78.21 95.77 5.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.199 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.31 -163.35 0.6 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.403 -0.811 . . . . 0.0 109.653 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 t -141.33 158.08 44.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.628 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.691 HD21 HD12 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -113.4 63.0 0.64 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.347 -0.846 . . . . 0.0 108.974 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.2 p -104.33 -26.55 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.367 -0.833 . . . . 0.0 109.208 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 110' ' ' LEU . . . -168.25 43.92 0.23 Allowed Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 109' ' ' GLY . 1.1 mt -45.46 145.79 1.16 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.217 -1.166 . . . . 0.0 108.676 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -125.24 9.98 8.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 110.182 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.435 ' CB ' HG22 ' A' ' 123' ' ' ILE . . . 52.59 19.64 1.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.902 -1.124 . . . . 0.0 108.39 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -100.82 -34.41 9.83 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.358 -0.839 . . . . 0.0 109.747 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.659 ' CB ' HD21 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -76.69 -3.66 39.17 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.31 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.647 ' CD2' HD12 ' A' ' 123' ' ' ILE . 22.3 m-85 -96.44 109.99 50.53 Favored Pre-proline 0 N--CA 1.485 1.281 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.539 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 7.1 Cg_exo -50.14 154.96 4.98 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.166 1.911 . . . . 0.0 110.512 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.714 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 5.4 Cg_exo -58.38 121.2 9.59 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.553 2.169 . . . . 0.0 110.995 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 117' ' ' PRO . . . 158.54 -37.21 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.566 ' O ' ' CG1' ' A' ' 123' ' ' ILE . 18.2 m120 -115.36 41.25 2.5 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.507 -0.746 . . . . 0.0 109.472 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.66 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 20.0 mt-10 -66.53 -41.48 40.43 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.95 -1.094 . . . . 0.0 112.427 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 1.1 Cg_endo -67.7 -30.89 33.79 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.581 2.187 . . . . 0.0 112.231 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.98 HG11 ' CD2' ' A' ' 84' ' ' PHE . 2.1 t -95.32 -43.77 12.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 120.593 -1.317 . . . . 0.0 107.493 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.647 HD12 ' CD2' ' A' ' 115' ' ' PHE . 12.2 mm -56.67 -29.0 28.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.22 -35.12 63.88 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.703 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -80.4 -61.73 1.89 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.916 -1.115 . . . . 0.0 110.945 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.655 ' HB2' HD21 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -80.87 27.38 0.38 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.918 -1.114 . . . . 0.0 110.522 -179.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.592 ' HG3' ' N ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -71.33 -31.48 67.44 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.592 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 2.2 ptt180 -119.63 44.74 2.31 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.632 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.707 HD22 ' CD2' ' A' ' 86' ' ' LEU . 1.1 mp . . . . . 0 C--N 1.308 -1.228 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.971 -179.998 . . . . . . . . 1 1 . 1 stop_ save_